Citrus Sinensis ID: 003092
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 848 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.942 | 0.94 | 0.450 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.935 | 0.936 | 0.443 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.935 | 0.940 | 0.440 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.922 | 0.938 | 0.449 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.941 | 0.931 | 0.435 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.955 | 0.954 | 0.423 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.926 | 0.930 | 0.428 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.935 | 0.929 | 0.429 | 1e-175 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.895 | 0.969 | 0.421 | 1e-173 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.918 | 0.925 | 0.407 | 1e-172 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 690 bits (1780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/839 (45%), Positives = 533/839 (63%), Gaps = 40/839 (4%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
+S++A+TL+ + I T+VSP FELGFF PG Y+GIWY+ I T VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNP-VAQLLDNGNLVIRDN 151
NR++P+ G L +S+ NLV+L+QS+ +WS+N++ +V++P VA+LLDNGN V+RD+
Sbjct: 85 NRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDS 143
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S + + LWQSFD+PTDT+L MKLGWD +TG R+ SWKS DDPS G+F+ +L+
Sbjct: 144 KNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P++ ++N ++ +GPWNG+ F P F + +K+EV Y + S +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVY 262
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L ++ G +QR W E + W F+ AP C Y +CG C + + C C++GF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++ Q + CVR C GD F +L +KLPD S++ + +KECE +C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + GSGC+ W G+L D++ + G +Y+R+ A++ +K+
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIR--NYAKGGQDLYVRLAATDLEDKRNRSA 440
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLD---TNQDLLAFDVNMGITTRT 493
+I + + +++L I W RK+K + ET +D ++DLL +V I++R
Sbjct: 441 KIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVV--ISSRR 498
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
+ E + D D LPL F V AT NFS +KLG+GGFG VYKG+LL+GQE+A
Sbjct: 499 HISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EFKNE+ LIA+LQH NLVRLL CC++ GEK+LIYEY+ N SLD LF
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
D ++ L WQ+R II+GIA+GLLYLHQ SR RIIHRDLKASNILLD++M PKISDFGM
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733
AR+FG DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+SSK+N G YN
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 734 TD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVSL---PMLVRYINVALLCVQENAEDRPT 789
+D NLLG W K + E++DP++ + S ++R I + LLCVQE AEDRPT
Sbjct: 733 SDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPT 792
Query: 790 MSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
MS V+ M+ +E +P PK P + + SS+S E +VN +TVS++ R
Sbjct: 793 MSLVILMLGSESTTIPQPKAPGY-CLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 677 bits (1747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/844 (44%), Positives = 528/844 (62%), Gaps = 51/844 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS+ A + T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA +LLD GN V+RD
Sbjct: 83 NRDNPLSSSNGTLKISD-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSADDPSPGNFTHRLDI 210
S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+ DDPS G+F+ +L
Sbjct: 141 SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI------VVQNKDEVYYMYES 264
P+ +YN + +GPW G F S P +P+ +N +V Y Y
Sbjct: 201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPG-----MKPVDYIDNSFTENNQQVVYSYRV 255
Query: 265 YSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHC 323
+ I IL ++ G +QRL W E + W+ + +P C +Y +CG C + + C
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPIC 315
Query: 324 ECLEGFKFKSQQNQT------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKE 377
C++GF+ ++Q CVR C D F +L ++LPD + S+++ + LKE
Sbjct: 316 NCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKE 375
Query: 378 CEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNK 437
CE CLK C+C A+AN+ + +GGSGC++W G L D++ + G +Y+RV A + +K
Sbjct: 376 CEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR--NYAKGGQDLYVRVAAGDLEDK 433
Query: 438 KLLWIIVI---LVLPLVILPCVYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGI 489
++ +I + + +++L I W RK+K + T +L +QD L ++
Sbjct: 434 RIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKAS 493
Query: 490 TTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNG 549
+ T++ ++K+ LPL + ++ AT NFS +KLG+GGFG VYKG LL+G
Sbjct: 494 RSYTSK--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDG 545
Query: 550 QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609
+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD
Sbjct: 546 KEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 605
Query: 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKIS
Sbjct: 606 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 665
Query: 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729
DFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+S K+N
Sbjct: 666 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 725
Query: 730 GVYNTD-SFNLLGHAWSLCKNDRAHELMDPV----LQNEVSLPMLVRYINVALLCVQENA 784
G YN++ NLLG W K + E++DP+ L +E ++R I + LLCVQE A
Sbjct: 726 GFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERA 785
Query: 785 EDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSL 844
EDRP MS V+ M+ +E +P PK P F + SS+ST E C+VN VT+S+
Sbjct: 786 EDRPVMSSVMVMLGSETTAIPQPKRPGFCV-GRSSLEVDSSSSTQRDDE-CTVNQVTLSV 843
Query: 845 IYPR 848
I R
Sbjct: 844 IDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/840 (44%), Positives = 531/840 (63%), Gaps = 47/840 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA +LLDNGN ++RD
Sbjct: 83 NRDNPLSSSNGTLKISG-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S LWQSFD+PTDT+L MKLGWD +TG R SWK+ DDPS G F+ +L+
Sbjct: 141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P+ + + + +GPWNG+ F S P + +K+EV Y Y + +
Sbjct: 197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLY 256
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L +N G +QRL W E + W+ + +P C +Y CG C + +C C++GF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++Q + C+R C D F +L +KLPD ++ + LK C+ C
Sbjct: 317 KPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERC 376
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + +GGSGC++W +++D++ + G +Y+R+ A+E +K++
Sbjct: 377 LEDCNCTAFANADIRNGGSGCVIWTREILDMR--NYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLDT--NQDLLAFDVNMGITTRTN 494
+I + + +++L I W RK+K + +T N+D +QD L DV + T+
Sbjct: 435 KIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTS 494
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAV 554
+ + KS+ LPL ++ AT NFS +KLG+GGFG VYKGRLL+G+E+AV
Sbjct: 495 K--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 555 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614
KRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD LFD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKISDFGMA
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734
R+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+S K+N G YN+
Sbjct: 667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726
Query: 735 D-SFNLLGHAWSLCKNDRAHELMDPV----LQNEVSLPMLVRYINVALLCVQENAEDRPT 789
+ NLLG W K E++DP+ L ++ ++R I + LLCVQE AEDRP
Sbjct: 727 NRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPV 786
Query: 790 MSDVVSMINNELFNLPSPKEPPFTTFTKGKN-MKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
MS V+ M+ +E +P PK P F G++ ++ S+S++ + C+VN +T+S+I R
Sbjct: 787 MSSVMVMLGSETTAIPQPKRPGFCI---GRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/845 (44%), Positives = 505/845 (59%), Gaps = 63/845 (7%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNS 97
++ DT+ +RDGE ++S +RF GFFS G S+ RYVGIWY QI T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 98 PIVDKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSG 153
PI D +G++ SNRGNL + N T IWS+NVS + P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 154 SNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVL 213
S W+SFD+PTDT L M+LG+ + GL+R TSWKS DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 214 PQVCVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMI 272
PQ+ +Y G + G W G + P +IF V N+DEV + Y + +I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 273 LRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSV--DQTSHCECLEGF 329
VN G + R W W F++ P C +Y CGPN C +T C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 330 K-------FKSQQNQTCVRS-HSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
+ F + C + +S C D F KL +K+PD D S++ ++ LKEC+
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 382 CLKNCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE------ 433
CLKNCSC AYA++ + G GCL W G ++D + N +G YIRV E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 434 ---QGNKKLLWIIVILV----LPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVN 486
G +++L I++ L+ L VIL CV R RK N ++ N + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRER-----RKSNRHRSSSANFAPVPFD-- 483
Query: 487 MGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRL 546
F E+ +DK+++ LPLF ++ AAT NFS Q+KLG GGFGPVYKG L
Sbjct: 484 ---------FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVL 534
Query: 547 LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NK
Sbjct: 535 QNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNK 594
Query: 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666
SLD F+F ++ L W R+ I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLD M P
Sbjct: 595 SLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIP 654
Query: 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
KISDFGMAR+FGG++++G T R+VGT+GYM+PEYA+EG FS+KSDV+SFGVLMLEI++ K
Sbjct: 655 KISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGK 714
Query: 727 KNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV-SLPMLVRYINVALLCVQENAE 785
KN+ ++ +S NL+GH W L +N A E++D ++ E +++ I + LLCVQENA
Sbjct: 715 KNS-AFHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENAS 773
Query: 786 DRPTMSDVVSMINNELFNLPSPKEPPFTTFTK--GKNMKYSSNSTSGTSEFCSVNDVTVS 843
DR MS VV M+ + NLP+PK P FT+ + G+N T SVNDVT S
Sbjct: 774 DRVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTG-----ISVNDVTFS 828
Query: 844 LIYPR 848
I R
Sbjct: 829 DIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/843 (43%), Positives = 525/843 (62%), Gaps = 45/843 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNR-YVGIWYQQIPD-TVVWV 92
S+ +TL+ T I +TLVSP FE+GFF ++ +R Y+G+WY+++ D T VWV
Sbjct: 29 LSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWYKKVSDRTYVWV 85
Query: 93 ANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR--EVKNPVAQLLDNGNLVIRD 150
ANR++P+ + G L +S NLVLL+ SN +W +N++R E VA+LL NGN V+RD
Sbjct: 86 ANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRD 144
Query: 151 NSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDI 210
+S ++++E YLWQSFDYPTDT+L MKLG++L+TGL R+ TSW+S+DDPS GNF+++L+
Sbjct: 145 SSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLET 203
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPI 269
LP+ + + +GPWNG+ F P + + ++N +EV Y + ++
Sbjct: 204 QSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSF 263
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAP-DPFCH-YGDCGPNSICSVDQTSHCECLE 327
L + G QRL W+ W F+++P DP C Y CGP + C V+ + C C++
Sbjct: 264 YSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQ 323
Query: 328 GFKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEA 380
GF ++ Q C+R C SGD F ++ +KLP+ +++ S+ +KEC+
Sbjct: 324 GFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKK 382
Query: 381 ECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKK-TDNHTNGVSIYIRVPASEQGNK-- 437
C+ +C+C A+AN+ + +GGSGC++W L D++ + +G +Y+R+ A++ K
Sbjct: 383 RCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRN 442
Query: 438 ---KLLWIIV-ILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRT 493
K++ + V + VL L+I+ C++ +Q K N NQ+L +N + +
Sbjct: 443 ASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNL---PMNEMVLSSK 499
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
EF G+ K ++ LPL +V ATENFS +KLG+GGFG VYKGRLL+G+E+A
Sbjct: 500 REF-----SGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIA 554
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EF NE+ LIA+LQH NLV++LGCCIE EK+LIYEY+ N SLD +LF
Sbjct: 555 VKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLF 614
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
T++ L W R I +G+A+GLLYLHQ SR RIIHRDLK SNILLD++M PKISDFGM
Sbjct: 615 GKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGM 674
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733
AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFGV++LEI+S KKN G YN
Sbjct: 675 ARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYN 734
Query: 734 TDSFN-LLGHAWSLCKNDRAHELMDPVLQNEVSL-------PMLVRYINVALLCVQENAE 785
D N LL + WS K RA E++DPV+ + +S +++ I + LLCVQE AE
Sbjct: 735 LDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAE 794
Query: 786 DRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLI 845
RP MS VV M +E +P PK P + + SS+ +E +VN T S+I
Sbjct: 795 HRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVI 854
Query: 846 YPR 848
R
Sbjct: 855 DAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 645 bits (1665), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/852 (42%), Positives = 532/852 (62%), Gaps = 42/852 (4%)
Query: 26 FSSLIFYWVIKFSLAADTLTPTTLIRDG---ETLVSPSQRFELGFFSPGKSQNRYVGIWY 82
S +++++ + S+AA+T+ +RDG + LVSP + FELGFFSPG S +R++GIWY
Sbjct: 11 LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70
Query: 83 QQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREV---KNPVA 138
I D VVWVANR +PI D++GVL +SN GNLVLL+ N T+WSSN+ N V
Sbjct: 71 GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADD 198
+ D GN V+ + T+ +W+SF++PTDT L M++ + +TG SW+S D
Sbjct: 131 SIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETD 186
Query: 199 PSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGPWNGVAFGSAPSN---TTFIFQPIVVQN 254
PSPGN++ +D P++ ++ G+ + +G WN F P+ T +++ +
Sbjct: 187 PSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSP 246
Query: 255 KDE---VYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCG 310
DE VY+ Y +++ +V G + L W+E W F + PD C Y CG
Sbjct: 247 PDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCG 306
Query: 311 PNSICSVDQTSH-CECLEGFKFKSQQN--QTCVRSHSSDCKSG-----DRFKKLDDIKLP 362
IC + ++ C C+ G++ S N + C R C+ D F L +KLP
Sbjct: 307 KFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLP 366
Query: 363 DLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG 422
D ++ + ++ ++C CL+NCSC AY+ GG GC++W DL+DL++ + G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFE--AGG 419
Query: 423 VSIYIRVPASEQG-NKKLLWIIVILVLPLVILPCVYIARQWSRKRKENET-----KNLDT 476
S++IR+ SE G N+K +++ VL VIL ++ W KRK++ + KN DT
Sbjct: 420 SSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDT 479
Query: 477 NQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEG 536
+ + + T+ + + +GK S LP+FS ++ AT +F +++LG G
Sbjct: 480 SVVVADLTKSKETTSAFSGSVDIMIEGK-AVNTSELPVFSLNAIAIATNDFCKENELGRG 538
Query: 537 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596
GFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK
Sbjct: 539 GFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEK 598
Query: 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656
+L+YEYM NKSLD FLFD TK+ L+ W+LR II+GIA+GLLYLH+ SRLRIIHRDLK S
Sbjct: 599 MLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVS 658
Query: 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716
N+LLD MNPKISDFGMAR+FGG++ + NT R+VGTYGYMSPEYA+EG+FSVKSDV+SFG
Sbjct: 659 NVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFG 718
Query: 717 VLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVA 776
VL+LEI+S K+NT + +++ +L+G+AW L + R+ EL+DP ++ S +R I+VA
Sbjct: 719 VLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVA 778
Query: 777 LLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCS 836
+LCVQ++A +RP M+ V+ M+ ++ L +P++P FT+ T+ ++ + S S
Sbjct: 779 MLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTS-TRRNSIDVNFALDSSQQYIVS 837
Query: 837 VNDVTVSLIYPR 848
N++T +++ R
Sbjct: 838 SNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 637 bits (1643), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/844 (42%), Positives = 514/844 (60%), Gaps = 58/844 (6%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIV 100
+T+ + ++DG+ + S +RF GFFS G S+ RYVGIWY Q+ + T+VWVANR+ PI
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 101 DKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSGSNS 156
D +G++ S RGNL + NGT IWS++V ++ P VA+L D GNLV+ D S
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 157 TESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQV 216
W+SF++PT+T+L MK G+ ++G++R TSW+S DP GN T+R++ PQ+
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 217 CVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMILRV 275
+Y G + TG W G + P T FIF V N DEV Y + + + +
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 276 NPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTS--HCECLEGFKFK 332
N G +QR W+ W F++AP+ C Y CG N C T C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 333 SQQN-------QTCVRSHS-SDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK 384
+ ++ C R + S C + F KL +K+P+ V+++ ++ LKECE CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 385 NCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE----QGN-- 436
NCSC AYA++ + DG GCL W G+++D + ++G Y+RV SE GN
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTY--LSSGQDFYLRVDKSELARWNGNGA 436
Query: 437 --KKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA---FDVNMGITT 491
KK L +I+I ++ +V+L + ++R+ ++ L A FD+
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 492 RTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
E DKS+ LPLF +++ AT NF+ Q+KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NKSLD F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 612 LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
+F ++ L W R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731
G+AR+FGG++++G+T R+VGTYGYMSPEYA++G FS+KSDV+SFGVL+LEI++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
Query: 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV-SLPMLVRYINVALLCVQENAEDRPTM 790
Y +S NL+ H W +N A E++D ++ E +++ +++ LLCVQEN+ DRP M
Sbjct: 728 YE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDM 786
Query: 791 SDVVSMINNELFNLPSPKEPPFT------TFTKGKNMKYSSNSTSGTSEFCSVNDVTVSL 844
S VV M+ + +LPSPK P FT T T G + + S TS T +NDVT++
Sbjct: 787 SSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSST-----INDVTLTD 841
Query: 845 IYPR 848
+ R
Sbjct: 842 VQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 363/845 (42%), Positives = 513/845 (60%), Gaps = 52/845 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
S++ +TL+ T I +T+VSP FELGFF + Y+GIWY++I T VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNP-VAQLLDNGNLVIRDNS 152
NR++P+ + G+L +SN NLV+L+ S+ +WS+N++ V++ VA+LLDNGN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 153 GSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHV 212
N ++ +LWQSFD+PTDT+L MKLG D + GL R+ TSWKS+ DPS G+F +L+
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 213 LPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTF---IFQPIVVQNKDEVYYMYESYSSPI 269
LP+ + + +GPW+G+ F + I+ +N++EV Y +
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNS 262
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEG 328
L +N +G+++ +W W +F+ P C YG CGP + C + + C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322
Query: 329 FKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
F+ S Q+ C R C DRF +L ++K+P +++ + LKECE +
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 382 CLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLW 441
C +C+C AYANS + +GGSGC++W G+ D++ + +G +++R+ A+E G ++ +
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIR--NYAADGQDLFVRLAAAEFGERRTIR 439
Query: 442 II---------VILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTR 492
++LVL +I C + +Q + D Q+L+
Sbjct: 440 GKIIGLIIGISLMLVLSFIIY-CFWKKKQKRARATAAPIGYRDRIQELII---------- 488
Query: 493 TNEFCEADG-DGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
TN + G + +D LPL F +V ATENFS + LG GGFG VYKGRLL+GQE
Sbjct: 489 TNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQE 548
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCI EKILIYEY+ N SLD
Sbjct: 549 IAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSH 608
Query: 612 LFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670
LF+ T+ + L WQ R II+GIA+GLLYLHQ SR +IIHRDLKASN+LLD++M PKISD
Sbjct: 609 LFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISD 668
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730
FGMAR+F DE + NT+++VGTYGYMSPEYA+EG+FSVKSDVFSFGVL+LEI+S K+N G
Sbjct: 669 FGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRG 728
Query: 731 VYNT-DSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPML------VRYINVALLCVQEN 783
+N+ NLLG+ W K + E++D ++ + S L +R I + LLCVQE
Sbjct: 729 FHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQER 788
Query: 784 AEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVS 843
AEDRP MS VV M+ +E +P PK P + + SS+ST SE +VN +TVS
Sbjct: 789 AEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVS 848
Query: 844 LIYPR 848
+I R
Sbjct: 849 VINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 608 bits (1569), Expect = e-173, Method: Compositional matrix adjust.
Identities = 356/845 (42%), Positives = 495/845 (58%), Gaps = 86/845 (10%)
Query: 24 NIFSSLI--FYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
N+ LI + I + A D L ++DG+T+VS FE+GFFSPG S+NRY+GIW
Sbjct: 5 NVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV-----SREVKN 135
Y++I TVVWVANR+SP+ D +G L VS G+L L N N IWSS+ ++N
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P+ Q+LD GNLV+R NSG + + Y+WQS DYP D L GMK G + TGL R+ TSW++
Sbjct: 125 PIVQILDTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQN 254
DDPS GN+T+++D + +PQ + S TGPWNG+ F P+ I++ V
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNS 313
++EVYY Y+ + ++ +++NP G +QR W + W + +A C Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 314 ICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSG-DRFKKLDDIKLPDLL 365
C+++++ C CL+GF K+ Q ++ CVR DC G D F K+ +KLPD
Sbjct: 302 SCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 366 DVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+++M+L EC+ CL+NC+C S
Sbjct: 362 TSWYDKNMDLNECKKVCLRNCTC-----------------------------------SA 386
Query: 426 YIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDV 485
Y + G +LW ++ + R+ NE QDL
Sbjct: 387 YSPFDIRDGGKGCILWFGDLIDI-----------------REYNEN-----GQDLYVRLA 424
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+ I T E K + +D LP +V+ AT FS +KLG+GGFGPVYKG
Sbjct: 425 SSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGT 483
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG C+++ E++LIYEY N
Sbjct: 484 LACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPN 543
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD ++ L W RV II GIA+G+LYLH+ SRLRIIHRDLKASN+LLD MN
Sbjct: 544 KSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMN 603
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS 725
KISDFG+AR GGDE + NT R+VGTYGYMSPEY ++G FS+KSDVFSFGVL+LEI+S
Sbjct: 604 AKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSG 663
Query: 726 KKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVS-LPMLVRYINVALLCVQEN 783
++N G N + NLLGHAW D+A+E++D + + + ++R I++ LLCVQ++
Sbjct: 664 RRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQD 723
Query: 784 AEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVS 843
+DRP MS VV ++ + L P++P F F + +N+ + S++ S E S N T+S
Sbjct: 724 PKDRPNMS-VVVLMLSSEMLLLDPRQPGF--FNE-RNLLF-SDTVSINLEIPSNNFQTMS 778
Query: 844 LIYPR 848
+I PR
Sbjct: 779 VIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 606 bits (1562), Expect = e-172, Method: Compositional matrix adjust.
Identities = 344/845 (40%), Positives = 495/845 (58%), Gaps = 66/845 (7%)
Query: 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQI-PDTVVWVANRNSP 98
+++ T IR+G++L+S + FELGFF+P S RYVGIWY+ I P TVVWVANR P
Sbjct: 28 TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKP 87
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
++D G L +++ GNLV++N N TIWS+NV E N VA L G+LV+ +S
Sbjct: 88 LLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDS---DRR 144
Query: 159 SYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCV 218
+ W+SF+ PTDT L GM++ + G R WKS DPSPG ++ +D ++ +
Sbjct: 145 KWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVI 204
Query: 219 YNGSAKYTCTGPWNGVAFGSAP-----SNTTFIFQPIVVQNKD-EVYYMYESYSSPIIMI 272
+ G + +GPWN F P +N + F+ ++D VY+ Y + S +
Sbjct: 205 WEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLR 264
Query: 273 LRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQ---TSHCECLEG 328
+ P G ++ W++ W + P C Y CG S+C + + C C++G
Sbjct: 265 FWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDG 324
Query: 329 FKFKSQQNQTCVRSHSSDCK--------------SGDRFKKLDDIKLPDLLDVSLNESMN 374
F+ Q+Q R S C+ D F L IK+PD V L+ N
Sbjct: 325 FE-PVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--N 381
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
+ C+ C ++CSC+AYA G GC++W DLID++ + N SI IR+ S+
Sbjct: 382 SETCKDVCARDCSCKAYALVV----GIGCMIWTRDLIDMEHFERGGN--SINIRLAGSKL 435
Query: 435 GNKK---LLWIIVILVLPLVILP-CVYIARQWSR-------KRKENETKNLDTNQDLLAF 483
G K LWIIV V+ +L C++I ++ + K+K+ ++ N+D +
Sbjct: 436 GGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSS 495
Query: 484 DVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
+ + + D+ LP+FSF SV +AT +F+ ++KLG+GGFG VYK
Sbjct: 496 PIKVLVG--------------DQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYK 541
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCCIE EK+L+YEYM
Sbjct: 542 GNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYM 601
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSLD FLFD +K+ L W+ R +I GIA+GLLYLH+ SRL+IIHRDLKASNILLD
Sbjct: 602 PNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTE 661
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
MNPKISDFGMAR+F + NT R+VGTYGYM+PEYA+EG+FS KSDV+SFGVL+LEI+
Sbjct: 662 MNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIV 721
Query: 724 SSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQEN 783
S +KN TD +L+G+AW L + E++DP++++ + +R I+V +LC Q++
Sbjct: 722 SGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDS 781
Query: 784 AEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVS 843
RP M V+ M+ ++ LP P++P F +F +++ + + + SVNDVT +
Sbjct: 782 VIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDG----HDVASVNDVTFT 837
Query: 844 LIYPR 848
I R
Sbjct: 838 TIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 848 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.929 | 0.982 | 0.502 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.932 | 0.951 | 0.492 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.906 | 0.711 | 0.493 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.936 | 0.965 | 0.497 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.936 | 0.327 | 0.468 | 0.0 | |
| 255555127 | 834 | S-locus-specific glycoprotein S6 precurs | 0.950 | 0.966 | 0.476 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.876 | 0.463 | 0.505 | 0.0 | |
| 356514907 | 778 | PREDICTED: G-type lectin S-receptor-like | 0.893 | 0.974 | 0.475 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.922 | 0.963 | 0.481 | 0.0 | |
| 359496546 | 866 | PREDICTED: receptor-like serine/threonin | 0.969 | 0.949 | 0.464 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/846 (50%), Positives = 562/846 (66%), Gaps = 58/846 (6%)
Query: 17 MEILPCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNR 76
ME LP F FS+L + S +AD +TP ++DG+TL+S SQ FELGFFSPG S+ R
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 77 YVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNP 136
YVGIWY++ P+TVVWVANRN+P+ D GVLT+ NRGNLVLL+Q IWSSN S + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 137 VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSA 196
VAQLLD+GNLV+RDN S +TESY WQSFD P+DT+L GMKLGW+L+TG ERY +W+S
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKD 256
DPSPG+FT+RLDIH LPQ+ + GS K +GPWNG+ FG P +F+PI+V+N+D
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
E+YY Y ++ + L +N G V+RL+ + ++GW ++ P C +YG CG N IC
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300
Query: 316 SVDQTSHCECLEGFKFKSQQ---------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLD 366
+ CECL+GFK ++ ++ C + DC+SG+ F KL +KLPDLL+
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360
Query: 367 VSLNESMNLKECEAECLKNCSCRAYANSKVTDG--GSGCLMWFGDLIDLKKTDNHTNGVS 424
LNESMNLKECEAEC KNCSC A+A + ++ G GSGCLMWFG+LID+++ T G
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQD 420
Query: 425 IYIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFD 484
I+IRVPASE + +AR S+++K +T + + LL
Sbjct: 421 IHIRVPASE----------------------LEMARS-SKRKKMLKTALVASMSALLGIF 457
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDS-SLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
V+ G D+ K+ PLF ++ AT NF+ S +G GGFG VYK
Sbjct: 458 VS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSVYK 501
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG CI + E++LIYEYM
Sbjct: 502 GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYM 561
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSLD F+FD + LLGW+ R II GIA+GLLYLHQ S+L+I+HRDLK SN+LLD +
Sbjct: 562 PNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSN 621
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ PKISDFG+AR+ G D + T+R++GTYGYM+PEYA++G FSVKSDVFS GVL+LEI+
Sbjct: 622 LIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLEII 681
Query: 724 SSKKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQE 782
S KKN G + D +LLGHAW + RA EL+D L++ L+R I V LLCVQ+
Sbjct: 682 SGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELIDTGLEDTSGKSQLLRCIQVGLLCVQK 741
Query: 783 NAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTV 842
EDRP MS VV M+ NE LP PK+P F F + ++ S +TS + S N+ +
Sbjct: 742 LPEDRPVMSTVVFMLANEGAVLPQPKQPGF--FIERGSV---SEATSRNEDSYSTNEANI 796
Query: 843 SLIYPR 848
+++ R
Sbjct: 797 TILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/844 (49%), Positives = 557/844 (65%), Gaps = 53/844 (6%)
Query: 28 SLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD 87
S++F+ I S A +++ T + DG+TLVS FELGFFSPG S+NRY+GIWY++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 88 -TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
TVVWVANRN+P+ D +G+L + GNL +N +NGTIWSSN+SR NPVAQLLD GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
V+R + N E++LWQSFDYP D+ L GMK G TGL RY TSWKS DPS G +T+
Sbjct: 137 VVRAEN-DNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSA---PSNTTFIFQPIVVQNKDEVYYMYE 263
+LD + LPQ + GS +GPWNG+ F N + F+ V N++E+YY Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFE--FVFNQEEIYYKYQ 253
Query: 264 SYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH 322
+S ++ + ++P G +QR W + + W ++ TA C + CG + +C+++ +
Sbjct: 254 IANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPA 313
Query: 323 CECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNL 375
C+CL+ F+ KS + +Q CVR DC +G+ F K IK+PD N+++NL
Sbjct: 314 CDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINL 373
Query: 376 KECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPAS--- 432
+ECE CLKNCSC AYAN V DGGSGC++WFGDLID+++ + NG IYIR+ AS
Sbjct: 374 EECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNE--NGQDIYIRIAASVID 431
Query: 433 ----EQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETK---NLDTNQDLLAFDV 485
+G K++ I++ + L L + + ++ RK K+ + N+ TN
Sbjct: 432 KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNP------- 484
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
E D + +++D LPLF A++T AT FSI +KLG+GGFGPVYKG
Sbjct: 485 ------------EQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGI 532
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCCIE E++LIYEYM N
Sbjct: 533 LQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPN 592
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD + LL W R II+GIA+GLLYLHQ SRLRIIHRDLKASNILLD MN
Sbjct: 593 KSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMN 652
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS 725
PKISDFGMAR FGGDE NT RIVGTYGYMSPEYA++G+FSVKSDVFSFGVL+LEI+S
Sbjct: 653 PKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 712
Query: 726 KKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENA 784
+KN G + + NLLGHAW L K R +L+D + + + ++R I VALLCVQ++
Sbjct: 713 RKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSP 772
Query: 785 EDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSL 844
EDRP MS VV M+++++ LP PKEP F FT+ +++ S+ST E SVN++T +L
Sbjct: 773 EDRPKMSIVVLMLSSDIV-LPQPKEPGF--FTE-RDLSNDSSSTI-KHEISSVNELTSTL 827
Query: 845 IYPR 848
+ R
Sbjct: 828 LEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/825 (49%), Positives = 531/825 (64%), Gaps = 56/825 (6%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
AD++ I D ETLVS Q FELGFFSPG S+NRY+GIWY+ P T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST-ES 159
D GVLT+ N G LVLLNQS IWS N+SR +NPVAQLL+ GNLV+RD GSN T +S
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
Y+WQSFD P+DTML GMK+GW+L+TGL+R TSWKS+DDPS G+F++ DI+VLP + +
Sbjct: 414 YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473
Query: 220 NGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLG 279
GS+K +GPWNG+ F +++ + V N DEVY +YES ++ II L +N G
Sbjct: 474 VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533
Query: 280 QVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ--- 335
+QRL+ + S+ W ++ P C +YG CG N IC + + CECL GF KSQ+
Sbjct: 534 FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWD 593
Query: 336 ----NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAY 391
+ C R DC+ + F K+ +KLPDL+D + ++L+EC+ CL NCSC AY
Sbjct: 594 MFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAY 653
Query: 392 ANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG---NKKLLWIIVILVL 448
A + +G GCLMW GDLID+++ + + IYIR+ SE G N+K +++ILV+
Sbjct: 654 AYTN-PNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 449 P----LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGK 504
++ L + R W ++ MG D +
Sbjct: 713 STFSGILTLGLSFWFRFWKKR--------------------TMGT------------DQE 740
Query: 505 DKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 564
K ++ LPLF ++ AT NFS +K+G GGFG VYKG L G VAVKRLS S QG
Sbjct: 741 SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQG 800
Query: 565 LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ 624
++EFKNE +LIAKLQH+NLVRLLGCCI+ E+IL+YEYM NKSLD F+FD ++ LL W
Sbjct: 801 VQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWD 860
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
R I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+FG +E++
Sbjct: 861 KRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMET 920
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHA 743
TKRIVGTYGYMSPEY ++G FS+K DVFSFGVL+LEI+S +KN G + D NLLGHA
Sbjct: 921 RTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLGHA 980
Query: 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803
W L + +RA ELMD L++ ++R I V LLCVQ DRP MS V+ M+ NE
Sbjct: 981 WLLWEQNRALELMDACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNEGAT 1040
Query: 804 LPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
LP PK P F T + +++ SG E S N VT+S++ R
Sbjct: 1041 LPQPKHPGFFT----ERSSVDTDTMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/826 (49%), Positives = 536/826 (64%), Gaps = 32/826 (3%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPIV 100
+TL P ++DGETL+S FELGFFS G S++RY+GIWY++IP TVVWV NR P
Sbjct: 10 ETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNREVPSF 69
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
D GVL V+ +G ++L N + G IWSSN SR KNPV QLLD+GNL+++D +G+N ++
Sbjct: 70 DNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNGNN-PDNI 128
Query: 161 LWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN 220
+WQSFD+P +T+L MKLGW+L GL RY TSWKS DDP+ GNF+ +D+ PQ+ +
Sbjct: 129 VWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMKK 188
Query: 221 GSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLG 279
G A +GPWNG+ F +P N +F V NK E+YY YE ++ ++ L V+ G
Sbjct: 189 GDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEKG 248
Query: 280 QVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKSQQNQT 338
++R W + + W +FF+ P C Y CG + C+++ C CLEGF KS + +
Sbjct: 249 ALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFVPKSPTDWS 308
Query: 339 -------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAY 391
CVR C +GD F+KL +KLPD ++ SM+LKECE CL+NCSC AY
Sbjct: 309 ASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLAY 368
Query: 392 ANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWIIVILVLPLV 451
ANS + GSGCL+WF LID++K G +YIR+ ASE K V +++ +
Sbjct: 369 ANSDIR--GSGCLLWFDHLIDMRKFTE--GGQDLYIRIAASELAKGKSHGKRVAIIVSCL 424
Query: 452 ILPCVYIARQ---WSRKRKENETKN-----LDTNQDLLAFDVNMGITTRTNEFCEADGDG 503
I+ A ++RKRK N L + + F + G+ T + E GD
Sbjct: 425 IIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKET--YIENYGDN 482
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ 563
K +D+ L F ++ AT NFS +KLGEGGFGPVYKG LL+GQE+AVKRLS SGQ
Sbjct: 483 GAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSGQ 541
Query: 564 GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGW 623
G KEFKNE++LIA+LQHRNLV+LLGCCI EK+LIYEYM NKSLD F+FD + LL W
Sbjct: 542 GGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLDW 601
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
+ RII GIA+GLLYLHQ SRLRIIHRDLKASNILLD MNPKISDFG+AR FG D+
Sbjct: 602 HMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQNA 661
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGH 742
NTKR+VGTYGYMSPEYA++G+FSVKSDVFSFGVL+LEI+S K+N G + D S NLLGH
Sbjct: 662 ANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLGH 721
Query: 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802
AW L +RA EL D Q+E S+ ++R I V LLCVQ DRP MS VV M+ +E
Sbjct: 722 AWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLGSE-S 780
Query: 803 NLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
+LP PK+P F T + + ++S++ S N+++ +LI PR
Sbjct: 781 SLPQPKQPGFYT----ERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/870 (46%), Positives = 550/870 (63%), Gaps = 76/870 (8%)
Query: 26 FSSLIF-YWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
F++L+ + +++ S+A DTLT +I DGET+ S FELGFFSP S+NRYVGIWY++
Sbjct: 4 FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63
Query: 85 IPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDN 143
+ TVVWVANR P+ +G+L V++RG LV+LN +N TIWSSN SR +NP AQLLD+
Sbjct: 64 VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123
Query: 144 GNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGN 203
GNLV+++ + S+S E++LWQSFDYP +T+L GMK G + TGL+RY +SWK+ DDPS GN
Sbjct: 124 GNLVMKNGNDSDS-ENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIGN 182
Query: 204 FTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMY 262
FT+RLD PQ+ V NGS +GPWNG+ F P ++ + N E YY +
Sbjct: 183 FTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKETYYTF 242
Query: 263 ESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTS 321
E +S +I L ++P G QR W + ++ W ++ +A C Y CG IC ++++
Sbjct: 243 ELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEINRSP 302
Query: 322 HCECLEGFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMN 374
CEC++GF+ K Q N CVRS C+ + F K +KLPD + NESMN
Sbjct: 303 KCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNESMN 362
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
LKEC + CL NCSC AY NS + GGSGCL+WFGDLID+++ NG YIR+ SE
Sbjct: 363 LKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTE--NGQDFYIRMAKSEL 420
Query: 435 G------------------------------------NKKLLWIIV--ILVLPLVILPCV 456
G K W+IV + ++ +++L V
Sbjct: 421 GMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIILLSLV 480
Query: 457 YIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFS 516
+KR + NL + + ++N ++ +D LPLF
Sbjct: 481 LTLYVLRKKRLRRKGNNLYSKHNCKGAEIN------------------EREEDLELPLFD 522
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
++ AT+NFS +KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE+ I+
Sbjct: 523 LDTILNATDNFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHIS 582
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
KLQHRNLV+LLGCCI EK+LIYEYM NKSLD F+FD + +L W R II+GIA+G
Sbjct: 583 KLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARG 642
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
LLYLHQ SRLRIIHRDLKA N+LLD MNP+ISDFGMAR F G+E + TKR+VGTYGYM
Sbjct: 643 LLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYM 702
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRAHEL 755
SPEYA++GV+S+KSDVFSFGVL+LEI++ K+N G + D + NLLGHAW+L + EL
Sbjct: 703 SPEYAIDGVYSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHAWTLYMEGKPLEL 762
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTF 815
+D + + + ++R +NV LLCVQ + +DRP+MS VV M+++E L PKEP F F
Sbjct: 763 IDASMGDSCNQSEVLRALNVGLLCVQRSPDDRPSMSSVVLMLSSE-SALHQPKEPGF--F 819
Query: 816 TKGKNMKYSSNSTSGTSEFCSVNDVTVSLI 845
T+ +NM S+S S + F S N+ T++LI
Sbjct: 820 TE-RNMLEGSSSASKHAIF-SGNEHTITLI 847
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/845 (47%), Positives = 552/845 (65%), Gaps = 39/845 (4%)
Query: 21 PCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
P F F+ L FY +FS ++DTLT T + +G+TL+S Q+FELGFF+PG S+N YVGI
Sbjct: 12 PIFLFFTFLSFY-APRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWYVGI 70
Query: 81 WYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQ 139
WY+ I D T VWVANR++P+ + +G+ + N+ ++VL +Q N IWSSN + NPV Q
Sbjct: 71 WYKNISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSNQIK-ATNPVMQ 128
Query: 140 LLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDP 199
LLD G+LV+R+ +N YLWQSFDYPTDT+L MKLGWDL L RY +SWKS DDP
Sbjct: 129 LLDTGDLVLRE---ANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKSKDDP 185
Query: 200 SPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEV 258
G+++ +LD H P++ ++N K +GPWNG+ F P + V N+ EV
Sbjct: 186 GAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVTNQSEV 245
Query: 259 YYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSV 317
+Y + S+ L V G++QR W W F+ AP C Y +CGP IC
Sbjct: 246 FYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPYGICDS 305
Query: 318 DQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLN 370
+ + C+C+ GF+ K+ Q + CVR C + D+F L +IKLP+ ++
Sbjct: 306 NASPVCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPESSTSFVD 364
Query: 371 ESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVP 430
++LK CE CL+NCSC AYANS +++GG+GC++WFG+L+D+++ G +Y+R+
Sbjct: 365 RIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQY-TEGGGQDLYVRLA 423
Query: 431 ASEQGNKK-----LLWIIVILVLPLVILPCVYIARQWSRKRKENETKNL-DTNQDLLAFD 484
AS+ G+ K ++ I V + L+ L +I W R+ E K + + +Q+LL +
Sbjct: 424 ASDIGDGKNVAALIIGISVGIGTLLLGLAACFI---WKRRSVRKEQKGVQERSQNLLLNE 480
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKG 544
V I+++ + E D D + LPLF F ++ AT+NFS ++KLG+GGFG VYKG
Sbjct: 481 VV--ISSKRDYSGEKDKD------ELELPLFDFGTIATATDNFSDENKLGQGGFGCVYKG 532
Query: 545 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604
RL+ GQ VAVKRLS S QG++EFKNE+ LIA+LQHRNLVRLLGCCIE EK+LIYEYM
Sbjct: 533 RLVEGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYME 592
Query: 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664
++SLD +F+ K+ LL WQ R I+ GIA+GLLY+HQ SR RIIHRDLKASNILLD
Sbjct: 593 HRSLDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEW 652
Query: 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
NPKISDFGMAR+FGGD+ + +TKR+VGTYGYMSPEYA++G FSVKSDVFSFGVL+LEI+S
Sbjct: 653 NPKISDFGMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVLEIVS 712
Query: 725 SKKNTGVYNTDS-FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQEN 783
KN G Y+++S NLLGHAW L K ++ E++D + + S ++R I V LLCVQE
Sbjct: 713 GNKNRGFYHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVLRCIQVGLLCVQER 772
Query: 784 AEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVS 843
AEDRPTMS VV M+++E +P PK P F G+N + +S+ E +VN VTV+
Sbjct: 773 AEDRPTMSSVVLMLSSENATMPHPKTPGFCL---GRNPFETDSSSGKQDESYTVNQVTVT 829
Query: 844 LIYPR 848
++ R
Sbjct: 830 MLDAR 834
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/795 (50%), Positives = 522/795 (65%), Gaps = 52/795 (6%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPI 99
DT+ L+RDGE L S FELGFF P S RY+G+WY+++ TVVWVANR +P+
Sbjct: 813 VDTIALNQLLRDGEILTSAGGSFELGFFRPDNSSRRYLGMWYKKVSIRTVVWVANRETPL 872
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
D +GVL V+++G L +LN +N +WSSN SR +NP AQ+L++GNLV++D + N E+
Sbjct: 873 ADSSGVLKVTDQGTLAVLNGTNTILWSSNSSRSARNPTAQILESGNLVMKDGNDDNP-EN 931
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+LWQSFDYP +T+L GMKLG + TGL+RY ++WKSADDPS G+FT+RLD PQ+ +
Sbjct: 932 FLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILR 991
Query: 220 NGSAKYTCTGPWNGVAFGSAPS---NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVN 276
GSA +GPWNGV F P N+ + ++ V N+ E+Y+ YE +S ++ L +N
Sbjct: 992 KGSAVTFRSGPWNGVRFSGFPELGPNSIYTYE--FVFNEKEMYFRYELVNSSVVSRLVLN 1049
Query: 277 PLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ 335
P G QR+ W + + GW ++ +AP C Y CG IC+++++ CEC+EGF K Q
Sbjct: 1050 PDGSKQRVNWIDRTNGWILYSSAPKDDCDSYALCGVYGICNINRSPKCECMEGFVPKFQN 1109
Query: 336 N-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSC 388
+ CVRS DC++G+ F K +KLPD + N SM L EC A CL NCSC
Sbjct: 1110 DWDMADWSNGCVRSTPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSC 1169
Query: 389 RAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN----------KK 438
AY N + DGGSGCL+WFGDLID+++ + NG IY+R+ ASE G KK
Sbjct: 1170 TAYTNLDIRDGGSGCLLWFGDLIDIREFNE--NGQEIYVRMAASELGGSKESGSNLKGKK 1227
Query: 439 LLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCE 498
WIIV V +VI+ + K K K + +++ +G
Sbjct: 1228 RKWIIVGSVSSVVIILVSLFLTLYLLKTKRQRKKGT------MGYNLEVG---------- 1271
Query: 499 ADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS 558
+DS L LF FA+V+ AT +FS +KLGEGGFG VYKG L GQE+AVKRLS
Sbjct: 1272 -------HKEDSKLQLFDFATVSKATNHFSFDNKLGEGGFGLVYKGILQEGQEIAVKRLS 1324
Query: 559 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
SGQGL E KNE++ IAKLQHRNLVRLLGCCI EK+LIYEYM NKSLD F+FD T+
Sbjct: 1325 KDSGQGLDELKNEVIYIAKLQHRNLVRLLGCCIHGEEKMLIYEYMSNKSLDSFIFDKTQS 1384
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L W R II+GIA+GLLYLHQ SRLRIIHRDLKA NILLD+ M PKISDFGMAR FG
Sbjct: 1385 MELDWNKRFLIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDEEMAPKISDFGMARSFG 1444
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SF 737
G+E + NTKR+VGTYGYMSPEYA++G++S KSDVFSFGVL+LEI+S K+N G + D S
Sbjct: 1445 GNETEANTKRVVGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSL 1504
Query: 738 NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
NLLGHAW+L R ELMD ++ + ++R I+V LLCVQ A+DRP+MS VV M+
Sbjct: 1505 NLLGHAWTLYTEGRYLELMDAMVGDTFQPSEVLRSIHVGLLCVQHCADDRPSMSSVVLML 1564
Query: 798 NNELFNLPSPKEPPF 812
++E+ LP P+EP F
Sbjct: 1565 SSEV-ALPQPREPGF 1578
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514907|ref|XP_003526143.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1916), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/852 (47%), Positives = 538/852 (63%), Gaps = 94/852 (11%)
Query: 17 MEILPCFNIFSS-LIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQN 75
M + +FS+ L+F+ + S A DT+T + + DG TLVS FELGFF+PG S N
Sbjct: 1 MALFLAMLVFSNPLVFF--SQISYATDTITQSQPLLDGSTLVSKEGTFELGFFTPGNSPN 58
Query: 76 RYVGIWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVK 134
YVGIW++ IP TVVWVANR++P DK+ +L++S GNL+LL ++ IWS+N + V
Sbjct: 59 HYVGIWFKNIPMRTVVWVANRDNPAKDKSNMLSLSKDGNLILLGKNRSLIWSTNATIAVS 118
Query: 135 NPVAQLLDNGNLVIRDNSGSN--STESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTS 192
NPV QLLDNGNLVIR+ N + E+++WQSFDYP DT LQGMKLGW+L+TGL RY T+
Sbjct: 119 NPVVQLLDNGNLVIREEKDDNMDNEENFVWQSFDYPCDTQLQGMKLGWNLKTGLNRYLTA 178
Query: 193 WKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGV----AFGSAPSNTTFIFQ 248
WK+ +DPS G+FT L + P++ + GS +Y +GPWNG+ FG +P+ +F+
Sbjct: 179 WKNWEDPSSGDFTSGLKLGTNPELVISKGSNEYYRSGPWNGIFSSGVFGFSPNP---LFE 235
Query: 249 PIVVQNKDEVYYMYESYSSPIIMILRVN-PLGQVQRLIWHEMSTGWQVFFTAPDPFCH-Y 306
VQN+DEVY Y +S +I I+ +N L QR+ W + W V+ + P C Y
Sbjct: 236 YKYVQNEDEVYVRYTLKNSSVISIIVLNQTLFLRQRITWIPHTRTWSVYQSLPQDSCDVY 295
Query: 307 GDCGPNSICSVDQTSHCECLEGFKFKSQQN-------QTCVRSHSSDC--KSGDRFKKLD 357
CG C ++ + C+CLEGFK KS Q+ + CVRS C K+ D F+ +
Sbjct: 296 NVCGAYGNCMINASPVCQCLEGFKPKSPQDWNQMDWTKGCVRSEPWSCGVKNKDGFRLIA 355
Query: 358 DIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTD 417
+K+PD +N SM L++C+A+CLKNCSC A+AN GGSGC +WFGDL+DL+ ++
Sbjct: 356 GMKMPDTTHSWINRSMTLEDCKAKCLKNCSCTAFANMDTGGGGSGCSIWFGDLVDLRISE 415
Query: 418 NHTNGVSIYIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTN 477
+G +Y+R+ SE G W+ ++ + +NL+
Sbjct: 416 ---SGQDLYVRMAISENGT-------------------------WTEEKDDGGQENLE-- 445
Query: 478 QDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGG 537
LP F A++ AT NFSI +KLGEGG
Sbjct: 446 ----------------------------------LPFFDLATIINATNNFSIDNKLGEGG 471
Query: 538 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597
FGPVYKG +L+G E+AVKRLS SGQGLKEFKNE++L AKLQHRNLV++LGCC+E EK+
Sbjct: 472 FGPVYKGTMLDGHEIAVKRLSKSSGQGLKEFKNEVILCAKLQHRNLVKVLGCCVEGEEKM 531
Query: 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657
L+YEYM N+SLD F+FDP + LL W R I+ IA+GLLYLHQ SRLRIIHRDLKASN
Sbjct: 532 LLYEYMPNRSLDSFIFDPAQSKLLDWPTRFNILCAIARGLLYLHQDSRLRIIHRDLKASN 591
Query: 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGV 717
ILLD +MNPKISDFG+A+M GGD+++GNT RIVGTYGYM+PEYA++G+FS+KSDVFSFGV
Sbjct: 592 ILLDNNMNPKISDFGLAKMCGGDQVEGNTNRIVGTYGYMAPEYAIDGLFSIKSDVFSFGV 651
Query: 718 LMLEILSSKKN-TGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVA 776
L+LEI+S KKN T Y S NL+GHAW L K +L+D L + ++ LVR I V
Sbjct: 652 LLLEIISGKKNRTVTYEEHSDNLIGHAWRLWKEGIPEQLIDASLVDSCNISELVRCIQVG 711
Query: 777 LLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCS 836
LLC+Q + EDRP M+ VV M+++E +L PK P F KN+ G E CS
Sbjct: 712 LLCLQHHPEDRPNMTTVVVMLSSE-NSLSQPKVPGFLI----KNISIEGEQPCGRQESCS 766
Query: 837 VNDVTVSLIYPR 848
N+VTVSL+ R
Sbjct: 767 TNEVTVSLLNAR 778
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/848 (48%), Positives = 523/848 (61%), Gaps = 66/848 (7%)
Query: 25 IFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
IF +F+ ++K S A D + T +RDGETLVS FELGFF+P S +RY+G+WY++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 85 IPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNG 144
P TVVWVANR PI +K G L V+++G LVLLN +N +WSSN S V+NPVAQLLD+G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 145 NLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNF 204
NLV+RD + N +++LWQSFDYP DT+L GMKLG +L TGL + +SWK ++P+PG F
Sbjct: 127 NLVVRDGN-DNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 205 THRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS---NTTFIFQPIVVQNKDEVYYM 261
T +D+ PQ+ + + G WNG F P + + F+ V N++EVY+
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFE--FVFNRNEVYFK 243
Query: 262 YESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQT 320
+E +S + L V P G VQ W + W VF TA C +Y CG N+ C + +
Sbjct: 244 FELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSS 303
Query: 321 SHCECLEGFKFKS-----QQNQT--CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESM 373
C+CL+GF KS QN T C+R DC D F+ +KLPD ++S
Sbjct: 304 PVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSF 363
Query: 374 NLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE 433
+L ECE C++NCSC AYAN GSGCL WFGDLID ++ G IYIR+ AS+
Sbjct: 364 SLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAE--GGQDIYIRLAASQ 421
Query: 434 QG-----------NKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA 482
G + ++ VIL ++IL V+ R +RK + N +
Sbjct: 422 SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIR----RRKHRKNGNFEDR----- 472
Query: 483 FDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY 542
K ++ LP+ ++ AT+NFS KLGEGGFG VY
Sbjct: 473 -----------------------KEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVY 509
Query: 543 KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
KG L+ GQE+AVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCCI + EK+LIYEY
Sbjct: 510 KGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEY 569
Query: 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662
M N+SLD F+FDPT++ L W R IIDGIA+GLLYLHQ SRLRIIHRD+KASNILLD
Sbjct: 570 MPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDN 629
Query: 663 HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+NPKISDFG+ARMFGGD+ + NTKR+VGTYGYMSPEYAL+G FSVKSDVFSFGVL+LEI
Sbjct: 630 ELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEI 689
Query: 723 LSSKKNTGVYNTD--SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCV 780
+S KKN G + D NLLGHAW L N EL+D + + +R I+VALLCV
Sbjct: 690 VSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEALRCIHVALLCV 749
Query: 781 QENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDV 840
Q+ EDRP MS VV M+ +E LP PK+P F + SSN S N+V
Sbjct: 750 QQRPEDRPNMSSVVLMLGSE-NPLPQPKQPGFFMGSNPPEKDTSSNKHQSH----SANEV 804
Query: 841 TVSLIYPR 848
TV+L+ R
Sbjct: 805 TVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/876 (46%), Positives = 553/876 (63%), Gaps = 54/876 (6%)
Query: 9 IFLFSVISMEILPC---FNIFSSLIFYWVIKFSL---AADTLTPTTLIRDGETLVSPSQR 62
+FLFS E + C F ++ L F ++ F + + DT+T I +G+TLVS
Sbjct: 9 VFLFSHFLSETVCCITGFLCYNVLCFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGD 68
Query: 63 FELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPIV--DKNGVLTVSNRGNLVLLNQ 119
FELGFFSPG S+ YVGIWY+ IP + VVWVANR++PI+ V+ + +RGN+V++++
Sbjct: 69 FELGFFSPGDSK-WYVGIWYKNIPKERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDE 127
Query: 120 SNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLG 179
WS+N S V NPVAQLLD GNLV+R++ ++ E+YLWQSFDY TDT+L GMKLG
Sbjct: 128 DLHVFWSTNESTAV-NPVAQLLDTGNLVVREDKDADP-ENYLWQSFDYLTDTLLPGMKLG 185
Query: 180 WDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSA 239
WD +TG RY TSWKS +DPS G+++ +LD P++ ++N K +GPWNGV F
Sbjct: 186 WDQKTGSNRYLTSWKSKEDPSSGDYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGV 245
Query: 240 P---SNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVF 296
P S++ F F N+D YY YE + I L V+ G +QR W E W ++
Sbjct: 246 PEMKSSSVFTFD--FEWNQDGAYYSYELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLY 303
Query: 297 FTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCK 348
+ AP C Y +CGP IC + + C+C GF+ K+ Q + C R DC
Sbjct: 304 WFAPKDQCDDYRECGPYGICDTNSSPVCKCPRGFEPKNPQAWNLRDGSDGCSRKTEFDCN 363
Query: 349 SGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFG 408
+GD F L +KLP+ +++SM+LK+CE C KNCSC YAN ++T GC++W
Sbjct: 364 NGDGFLALKRMKLPETGSSFVDKSMSLKDCEMTCRKNCSCTGYANPEITSD-KGCIIWTT 422
Query: 409 DLIDLKKTDNHTNGVSIYIRVPASEQGNK-------KLLWIIVILVLPLVILPCVYIARQ 461
DL+D+++ G +YIRV ASE G++ K++ + I V V+L + I
Sbjct: 423 DLLDMREYAEGEGGQDLYIRVAASELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYL 482
Query: 462 WSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEF--------CEADGDGKDKSKDSSLP 513
W RK+ + ++ + G++ R++++ + D + K+ + LP
Sbjct: 483 WKRKKMKIIVAHIVSKP---------GLSERSHDYILNEAVIPSKRDYTDEVKTDELELP 533
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMM 573
LF F ++ AT NFS +KLG+GGFG VYKG LL G+E+AVKRL+ SGQG++EF NE+
Sbjct: 534 LFDFGTIVLATNNFSDTNKLGQGGFGCVYKGMLLEGEEIAVKRLAKNSGQGIEEFMNEVR 593
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
LIA+LQHRNLV+LLGCC+E EK+LIYEYM N+SLD LFD K LL W R II G+
Sbjct: 594 LIARLQHRNLVQLLGCCVEMEEKMLIYEYMQNRSLDSILFDEKKSSLLDWGRRFNIICGV 653
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+GLLYLHQ SR RIIHRDLKASN+LLD MNPKISDFGMAR+FG D+ + NTKR+VGTY
Sbjct: 654 ARGLLYLHQDSRFRIIHRDLKASNVLLDGEMNPKISDFGMARIFGRDQTEANTKRVVGTY 713
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHAWSLCKNDRA 752
GYMSPEYA++G+FSVKSDVFSFGVL+LEI+S KKN G Y+ D NLLGHAW L + +
Sbjct: 714 GYMSPEYAMDGLFSVKSDVFSFGVLVLEIISGKKNRGFYHLNDEHNLLGHAWRLWREGKG 773
Query: 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPF 812
ELMD + + ++R I V LLCVQE+AEDRP MS VV M+++E LP PK P F
Sbjct: 774 LELMDSSVSESCAPYDVLRCIQVGLLCVQEHAEDRPVMSSVVLMLSSETATLPLPKNPGF 833
Query: 813 TTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
G+ + + +S+S E +VN VTV+++ R
Sbjct: 834 CL---GRKLVETDSSSSKQEETFTVNQVTVTVMDAR 866
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 848 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.964 | 0.962 | 0.436 | 1e-180 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.391 | 0.424 | 0.554 | 8.1e-179 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.955 | 0.956 | 0.435 | 3.5e-178 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.948 | 0.953 | 0.430 | 1.9e-177 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.387 | 0.403 | 0.566 | 2.2e-165 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.918 | 0.917 | 0.420 | 1.5e-161 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.931 | 0.938 | 0.401 | 2.5e-152 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.385 | 0.406 | 0.533 | 9.5e-150 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.354 | 0.354 | 0.645 | 2e-149 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.392 | 0.392 | 0.576 | 2.5e-147 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1754 (622.5 bits), Expect = 1.0e-180, P = 1.0e-180
Identities = 377/864 (43%), Positives = 527/864 (60%)
Query: 17 MEILPCF-NIFSSLIFYWVIKF---SLAADTLTPTT--LIRDGETLVSPSQRFELGFFSP 70
M LP F + ++ F+ +I F S++A+TL+ + I T+VSP FELGFF P
Sbjct: 1 MRGLPNFYHSYTFFFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKP 60
Query: 71 GKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV 129
G Y+GIWY+ I T VWVANR++P+ G L +S+ NLV+L+QS+ +WS+N+
Sbjct: 61 GLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNL 119
Query: 130 SR-EVKNP-VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLE 187
+ +V++P VA+LLDNGN V+RD+ S + + LWQSFD+PTDT+L MKLGWD +TG
Sbjct: 120 TGGDVRSPLVAELLDNGNFVLRDSKNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFN 178
Query: 188 RYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF 247
R+ SWKS DDPS G+F+ +L+ P++ ++N ++ +GPWNG+ F P F +
Sbjct: 179 RFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEY 238
Query: 248 QPI-VVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-H 305
+K+EV Y + S + L ++ G +QR W E + W F+ AP C
Sbjct: 239 MVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDE 298
Query: 306 YGDCGPNSICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXX 358
Y +CG C + + C C++GFK ++ Q + CVR C GD F
Sbjct: 299 YKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKK 358
Query: 359 XXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDN 418
S++ + +KECE +CL++C+C A+AN+ + GSGC+ W G+L D++ N
Sbjct: 359 MKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIR---N 415
Query: 419 HTNG-VSIYIRVPASE---QGNKKXXXXXXXXXXXXXXXXXXYIARQWSRKRKEN---ET 471
+ G +Y+R+ A++ + N+ I W RK+K + ET
Sbjct: 416 YAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIET 475
Query: 472 KNLD---TNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFS 528
+D ++DLL +V I++R + E LPL F V AT NFS
Sbjct: 476 PIVDHQLRSRDLLMNEVV--ISSRRHISRE------NNTDDLELPLMEFEEVAMATNNFS 527
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+KLG+GGFG VYKG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL
Sbjct: 528 NANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLA 587
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
CC++ GEK+LIYEY+ N SLD LFD ++ L WQ+R II+GIA+GLLYLHQ SR RI
Sbjct: 588 CCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRI 647
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
IHRDLKASNILLD++M PKISDFGMAR+FG DE + NT+++VGTYGYMSPEYA++G+FS+
Sbjct: 648 IHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSM 707
Query: 709 KSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVSL- 766
KSDVFSFGVL+LEI+SSK+N G YN+D NLLG W K + E++DP++ + S
Sbjct: 708 KSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTF 767
Query: 767 --PMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYS 824
++R I + LLCVQE AEDRPTMS V+ M+ +E +P PK P + + S
Sbjct: 768 RQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYC-LERSLLDTDS 826
Query: 825 SNSTSGTSEFCSVNDVTVSLIYPR 848
S+S E +VN +TVS++ R
Sbjct: 827 SSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 8.1e-179, Sum P(2) = 8.1e-179
Identities = 188/339 (55%), Positives = 248/339 (73%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
LP +V+ AT FS +KLG+GGFGPVYKG L GQEVAVKRLS S QG++EFKNE
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNE 509
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ LIAKLQHRNLV++LG C+++ E++LIYEY NKSLD F+FD ++ L W RV II
Sbjct: 510 IKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIK 569
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+G+LYLH+ SRLRIIHRDLKASN+LLD MN KISDFG+AR GGDE + NT R+VG
Sbjct: 570 GIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVG 629
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKND 750
TYGYMSPEY ++G FS+KSDVFSFGVL+LEI+S ++N G N + NLLGHAW D
Sbjct: 630 TYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLED 689
Query: 751 RAHELMDPVLQNEVS-LPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
+A+E++D + + + ++R I++ LLCVQ++ +DRP MS VV M+++E+ L P++
Sbjct: 690 KAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLL-DPRQ 748
Query: 810 PPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
P F F + +N+ +S ++ S E S N T+S+I PR
Sbjct: 749 PGF--FNE-RNLLFS-DTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1730 (614.0 bits), Expect = 3.5e-178, P = 3.5e-178
Identities = 371/852 (43%), Positives = 512/852 (60%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F +F ++F + FS+ A + T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 12 FILFIIILF---LAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSA 196
+LLD GN V+RD S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+
Sbjct: 128 AELLDYGNFVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTT 186
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF-QPIVVQNK 255
DDPS G+F+ +L P+ +YN + +GPW G F S P + +N
Sbjct: 187 DDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENN 246
Query: 256 DEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSI 314
+V Y Y + I IL ++ G +QRL W E + W+ + +P C +Y +CG
Sbjct: 247 QQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGY 306
Query: 315 CSVDQTSHCECLEGFKFKSQQ------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
C + + C C++GF+ ++Q + CVR C D F S
Sbjct: 307 CDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETS 366
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
+++ + LKECE CLK C+C A+AN+ + +GGSGC++W G L D++ N+ G +Y+
Sbjct: 367 VDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR---NYAKGGQDLYV 423
Query: 428 RVPASEQGNK--KXXXXXXXXXXXXXXXXXXYIARQ-WSRKRKENETKNLDTNQDLLAFD 484
RV A + +K K +I W RK+K + T + T D
Sbjct: 424 RVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSIT--IQTP----IVD 477
Query: 485 VNMGITTRTNEFCEAXXXXXXXXXXXX---LPLFSFASVTAATENFSIQSKLGEGGFGPV 541
+ + NE +A LPL + ++ AT NFS +KLG+GGFG V
Sbjct: 478 LVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537
Query: 542 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
YKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYE
Sbjct: 538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
Y+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD
Sbjct: 598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
++M PKISDFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LE
Sbjct: 658 KNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 717
Query: 722 ILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPV----LQNEVSLPMLVRYINVA 776
I+S K+N G YN++ NLLG W K + E++DP+ L +E ++R I +
Sbjct: 718 IISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIG 777
Query: 777 LLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCS 836
LLCVQE AEDRP MS V+ M+ +E +P PK P F + SS+ST E C+
Sbjct: 778 LLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVD-SSSSTQRDDE-CT 835
Query: 837 VNDVTVSLIYPR 848
VN VT+S+I R
Sbjct: 836 VNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1723 (611.6 bits), Expect = 1.9e-177, P = 1.9e-177
Identities = 368/855 (43%), Positives = 519/855 (60%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F IF LI + + FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 11 FFIFLILILF--LAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSAD 197
+LLDNGN ++RD S LWQSFD+PTDT+L MKLGWD +TG R SWK+ D
Sbjct: 128 AELLDNGNFLLRD-----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTD 182
Query: 198 DPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKD 256
DPS G F+ +L+ P+ + + + +GPWNG+ F S P + +K+
Sbjct: 183 DPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE 242
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
EV Y Y + + L +N G +QRL W E + W+ + +P C +Y CG C
Sbjct: 243 EVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYC 302
Query: 316 SVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
+ +C C++GFK ++Q + C+R C D F
Sbjct: 303 DSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATI 362
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
++ + LK C+ CL++C+C A+AN+ + +GGSGC++W +++D++ N+ G +Y+
Sbjct: 363 VDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMR---NYAKGGQDLYV 419
Query: 428 RVPASEQGNKKXXXXXXXXXXXXXXXX---XXYIARQWSRKRKEN---ETKNLDT--NQD 479
R+ A+E +K+ I W RK+K + +T N+D +QD
Sbjct: 420 RLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQD 479
Query: 480 LLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFG 539
L DV + +R LPL ++ AT NFS +KLG+GGFG
Sbjct: 480 SLINDV---VVSR-----RGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFG 531
Query: 540 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599
VYKGRLL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LI
Sbjct: 532 IVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 591
Query: 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
YEY+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct: 592 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 651
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
LD++M PKISDFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+
Sbjct: 652 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 711
Query: 720 LEILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRAHELMDPVLQNEVS--LPM--LVRYIN 774
LEI+S K+N G YN++ NLLG W K E++DP+ + +S P ++R I
Sbjct: 712 LEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQ 771
Query: 775 VALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTFTKGKN-MKYSSNSTSGTSE 833
+ LLCVQE AEDRP MS V+ M+ +E +P PK P F G++ ++ S+S++ +
Sbjct: 772 IGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCI---GRSPLEADSSSSTQRDD 828
Query: 834 FCSVNDVTVSLIYPR 848
C+VN +T+S+I R
Sbjct: 829 ECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 2.2e-165, Sum P(2) = 2.2e-165
Identities = 192/339 (56%), Positives = 251/339 (74%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
LP+F +++ AT++FS + LG GGFGPVYKG+L +GQE+AVKRLS SGQG++EFKNE
Sbjct: 485 LPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNE 544
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ LIAKLQHRNLVRLLGCCI+ E +LIYEYM NKSLD F+FD + L W+ R+ II+
Sbjct: 545 VKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIIN 604
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
G+A+G+LYLHQ SRLRIIHRDLKA N+LLD MNPKISDFG+A+ FGGD+ + +T R+VG
Sbjct: 605 GVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVG 664
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKND 750
TYGYM PEYA++G FSVKSDVFSFGVL+LEI++ K N G + D NLLGH W + D
Sbjct: 665 TYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVED 724
Query: 751 RAHELMDPVLQNEVS-LPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
R E+ + E S +P ++R I+VALLCVQ+ EDRPTM+ VV M ++ +LP P +
Sbjct: 725 REIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-SLPHPTQ 783
Query: 810 PPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
P F FT +N+ S+S S S+ N+V+++++ R
Sbjct: 784 PGF--FTN-RNVPDISSSLSLRSQ----NEVSITMLQGR 815
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1573 (558.8 bits), Expect = 1.5e-161, P = 1.5e-161
Identities = 345/820 (42%), Positives = 499/820 (60%)
Query: 56 LVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNL 114
LVSP + FELGFFSPG S +R++GIWY I D VVWVANR +PI D++GVL +SN GNL
Sbjct: 44 LVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNL 103
Query: 115 VLLNQSNGTIWSSNVSREV---KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDT 171
VLL+ N T+WSSN+ N V + D GN V+ + T+ +W+SF++PTDT
Sbjct: 104 VLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD----TDRPIWESFNHPTDT 159
Query: 172 MLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGP 230
L M++ + +TG SW+S DPSPGN++ +D P++ ++ G+ + +G
Sbjct: 160 FLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ 219
Query: 231 WNGVAFGSAPSN---TTFIFQPIVVQNKDEVYYMYESY--SSPIIMI-LRVNPLGQVQRL 284
WN F P+ T +++ + DE +Y +Y S P +++ +V G + L
Sbjct: 220 WNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEEL 279
Query: 285 IWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH-CECLEGFKFKSQQNQT--CV 340
W+E W F + PD C Y CG IC + ++ C C+ G++ S N + C
Sbjct: 280 RWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCR 339
Query: 341 RSHSSDCKS----GDRFXXXXXXXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKV 396
R C+ G+ + + ++ ++C CL+NCSC AY S V
Sbjct: 340 RRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAY--SLV 397
Query: 397 TDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG-NKKXXXXXXXXXXXXXXXXX 455
GG GC++W DL+DL++ + G S++IR+ SE G N+K
Sbjct: 398 --GGIGCMIWNQDLVDLQQFE--AGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIG 453
Query: 456 XYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXX-- 508
+ W KRK++ + KN DT+ ++ D+ T T+ F +
Sbjct: 454 IFALLLWRFKRKKDVSGAYCGKNTDTS--VVVADLTKSKET-TSAFSGSVDIMIEGKAVN 510
Query: 509 XXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF 568
LP+FS ++ AT +F +++LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EF
Sbjct: 511 TSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEF 570
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR 628
KNE++LIAKLQHRNLVRLLGCC E EK+L+YEYM NKSLD FLFD TK+ L+ W+LR
Sbjct: 571 KNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFS 630
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
II+GIA+GLLYLH+ SRLRIIHRDLK SN+LLD MNPKISDFGMAR+FGG++ + NT R
Sbjct: 631 IIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVR 690
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748
+VGTYGYMSPEYA+EG+FSVKSDV+SFGVL+LEI+S K+NT + +++ +L+G+AW L
Sbjct: 691 VVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYT 750
Query: 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808
+ R+ EL+DP ++ S +R I+VA+LCVQ++A +RP M+ V+ M+ ++ L +P+
Sbjct: 751 HGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPR 810
Query: 809 EPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
+P FT+ T+ ++ + S S N++T +++ R
Sbjct: 811 QPTFTS-TRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1486 (528.2 bits), Expect = 2.5e-152, P = 2.5e-152
Identities = 334/832 (40%), Positives = 472/832 (56%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQI-PDTVVWVANRNSPI 99
+++ T IR+G++L+S + FELGFF+P S RYVGIWY+ I P TVVWVANR P+
Sbjct: 29 SNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPL 88
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
+D G L +++ GNLV++N N TIWS+NV E N VA L G+LV+ +S
Sbjct: 89 LDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDS---DRRK 145
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+ W+SF+ PTDT L GM++ + G R WKS DPSPG ++ +D ++ ++
Sbjct: 146 WYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIW 205
Query: 220 NGSAKYTCTGPWNGVAFGSAPSN---TTFI--FQPIVVQNKD-EVYYMYESYSSPIIMIL 273
G + +GPWN F P T +I F+ ++D VY+ Y + S +
Sbjct: 206 EGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRF 265
Query: 274 RVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQ---TSHCECLEGF 329
+ P G ++ W++ W + P C Y CG S+C + + C C++GF
Sbjct: 266 WIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGF 325
Query: 330 K--FKSQQNQT-----CVRSHSSDCKSG------DRFXXXXXXXXXXXXXVSLNESMNLK 376
+ + Q N C R +C D F V L+ N +
Sbjct: 326 EPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NSE 383
Query: 377 ECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN 436
C+ C ++CSC+AYA V G GC++W DLID++ + G SI IR+ S+ G
Sbjct: 384 TCKDVCARDCSCKAYA--LVV--GIGCMIWTRDLIDMEHFER--GGNSINIRLAGSKLGG 437
Query: 437 KKXXXXXXXXXXXXXXXXXXYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEF 496
K + K K++ L +D+ D+ I R
Sbjct: 438 GKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDI---IENRDYSS 494
Query: 497 CEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR 556
LP+FSF SV +AT +F+ ++KLG+GGFG VYKG G+E+AVKR
Sbjct: 495 SPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKR 554
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPT 616
LS +S QGL+EFKNE++LIAKLQHRNLVRLLGCCIE EK+L+YEYM NKSLD FLFD +
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
K+ L W+ R +I GIA+GLLYLH+ SRL+IIHRDLKASNILLD MNPKISDFGMAR+
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736
F + NT R+VGTYGYM+PEYA+EG+FS KSDV+SFGVL+LEI+S +KN TD
Sbjct: 675 FNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDH 734
Query: 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+L+G+AW L + E++DP++++ + +R I+V +LC Q++ RP M V+ M
Sbjct: 735 GSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLM 794
Query: 797 INNELFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
+ ++ LP P++P F +F +++ + + + SVNDVT + I R
Sbjct: 795 LESQTSQLPPPRQPTFHSFLNSGDIELNFDG----HDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 877 (313.8 bits), Expect = 9.5e-150, Sum P(2) = 9.5e-150
Identities = 181/339 (53%), Positives = 237/339 (69%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L F ++ AT NFS+ +KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LI+KLQHRNLVR+LGCCIE+ EK+LIYE+MVNKSLD FLFD K+ + W R II
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLH SRLR+IHRDLK SNILLD+ MNPKISDFG+ARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV-YNTDSFNLLGHAWSLCKND 750
T GYMSPEYA G+FS KSD++SFGVLMLEI+S +K + Y + L+ +AW
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715
Query: 751 RAHELMDPVLQNEVSLPMLV-RYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
R +L+D L + P+ V R I + LLCVQ DRP ++++M+ +LPSPK+
Sbjct: 716 RGIDLLDQDLADSCH-PLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQ 773
Query: 810 PPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
P F T+ + S +++ +VN +T S+I R
Sbjct: 774 PTFAFHTR--------DDESLSNDLITVNGMTQSVILGR 804
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1009 (360.2 bits), Expect = 2.0e-149, Sum P(2) = 2.0e-149
Identities = 197/305 (64%), Positives = 240/305 (78%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L +FSF SV AT+ FS +KLGEGGFGPVYKGRL++G+EVA+KRLS SGQGL EFKNE
Sbjct: 512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
MLIAKLQH NLV+LLGCC+E+ EK+LIYEYM NKSLD FLFDP +K +L W+LR RI++
Sbjct: 572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GI QGLLYLH+YSRL++IHRD+KA NILLD+ MNPKISDFGMAR+FG E + NTKR+ G
Sbjct: 632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS--FNLLGHAWSLCKN 749
T+GYMSPEY EG+FS KSDVFSFGVLMLEI+ +KN ++ NL+ H W+L K
Sbjct: 692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKE 751
Query: 750 DRAHELMDPVL-QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN-LPSP 807
+R E++DP L + V P ++R + VALLCVQ+NA+DRP+M DVVSMI + N L P
Sbjct: 752 NRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLP 811
Query: 808 KEPPF 812
KEP F
Sbjct: 812 KEPAF 816
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 2.5e-147, Sum P(2) = 2.5e-147
Identities = 195/338 (57%), Positives = 257/338 (76%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L ++S + AT NFS +KLGEGGFGPVY G L G+EVAVKRL SGQGL+EFKNE
Sbjct: 515 LKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKNE 574
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LIAKLQHRNLVRLLGCCI + EKIL+YEYM NKSLD FLF+P K+ LL W+ R II+
Sbjct: 575 VILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDIIE 634
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLH+ SRLR++HRDLKASNILLD M PKISDFGMARMFGGD+ Q NT R+VG
Sbjct: 635 GIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVG 694
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY-NTDSFNLLGHAWSLCKND 750
T+GYMSPEYA+EG+FSVKSDV+ FGVL+LEI++ K+ + + DS N+ G+AW D
Sbjct: 695 TFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNED 754
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
A EL+DPV++ S+ ++R I++ALLCVQ++A++RP + V+ M++N+ +LP+P+ P
Sbjct: 755 NAAELIDPVIRASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPR-P 813
Query: 811 PFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
P T +G+ ++ S +S S S+ VT++ ++ R
Sbjct: 814 P-TLMLRGREIESSKSSEKDRSH--SIGTVTMTQLHGR 848
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4505 | 0.9422 | 0.94 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_XI001046 | hypothetical protein (802 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 848 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-45 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-40 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-40 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-38 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-28 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-26 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-25 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-19 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 6e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 5e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 8e-57
Identities = 92/280 (32%), Positives = 139/280 (49%), Gaps = 34/280 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ ++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPE 699
IHRDL A N L+ +++ KISDFG++R D+ + K + +M+PE
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
EG F+ KSDV+SFGVL+ EI + + G+ N + L + + L + +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL- 232
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
++ L C E+ EDRPT S++V ++
Sbjct: 233 ---------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 92/279 (32%), Positives = 138/279 (49%), Gaps = 31/279 (11%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ +++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVGTYGYMSPEY 700
IHRDL A N L+ +++ KISDFG++R ++ D + ++ +M+PE
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
EG F+ KSDV+SFGVL+ EI + + G+ N + L + L K +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL-- 233
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ L C E+ EDRPT S++V ++
Sbjct: 234 --------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 95/280 (33%), Positives = 140/280 (50%), Gaps = 34/280 (12%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 586
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LG C E+ L+ EYM L +L F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVGTYGYMSPE 699
+ +HRDL A N L+ + + KISDFG++R ++ D + T + +M+PE
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
+G+F+ KSDV+SFGVL+ EI + + G+ N + L + L K + + +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL- 236
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
Y + L C Q + EDRPT S++V +
Sbjct: 237 --------------Y-ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 92/284 (32%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 580
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N+VRLLG C + ++ EYM L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRIVGTYGYMS 697
+HRDL A N L+ +++ KISDFG++R D+ +G K + +M+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA-WSLCKNDRAHELM 756
PE +G F+ KSDV+SFGVL+ EI + LG + N+ EL+
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELL 217
Query: 757 D---PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ + + E L Y + L C + EDRPT S++V +
Sbjct: 218 EDGYRLPRPENCPDEL--Y-ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ L+ EY SL L + K L +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 651 RDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSV 708
RDLK NILLD + K++DFG++++ D+ T IVGT YM+PE L +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 709 KSDVFSFGVLMLEI 722
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+ I KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
RL ++ + L+ EY L L + Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH I+HRDLK NILLD+ + K++DFG+AR E VGT YM+PE
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
L + D++S GV++ E+L+ K
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
VRL+ ++ L+ EY L +L ++ L +I I +GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
IIHRDLK NILLD++ KI+DFG+A+ + VGT YM+PE L
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLG 172
Query: 704 G-VFSVKSDVFSFGVLMLEILSSK 726
G + K DV+S GV++ E+L+ K
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 57/115 (49%), Positives = 72/115 (62%), Gaps = 6/115 (5%)
Query: 86 PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGN 145
TVVWVANR +P+ D + L + + GNLVL + + +WSSN S + VA L D+GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 146 LVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200
LV+ DNSG LWQSFD+PTDT+L G K G ++ G R TSWKS DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 54/120 (45%), Positives = 71/120 (59%), Gaps = 6/120 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS FELGFF Y I Y+ TVVWVANR++P + LT+
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168
+ GNLV+ + S +WSSN +R N V LLD+GNLV+ D+ G ++LWQSFDYP
Sbjct: 62 QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 79/202 (39%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 585 RLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+L C + E I I EYM SL FL K L QL V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMAYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEY 700
IHRDL A NIL+ +++ KI+DFG+AR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEI 722
A G F++KSDV+SFG+L+ EI
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 56/119 (47%), Positives = 73/119 (61%), Gaps = 7/119 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS + FELGFF+ QN Y I Y+ TVVWVANR++P V + LT+
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GNLVL + +WSSN + N V LLD+GNLVI D+ G ++LWQSFDY
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 71/273 (26%), Positives = 118/273 (43%), Gaps = 44/273 (16%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 589 CCIEQGEK-ILIY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
++ + + I+ EY+ SL L +R I +GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-------VIRKYTRQ-ILEGLAYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+HRD+K +NIL+D K++DFG A+ G E T + GT +M+PE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
+ +D++S G ++E+ + K WS N + +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK---------------PPWSELGN--PMAALYKIGS 218
Query: 762 NEVSLPMLVRYI-----NVALLCVQENAEDRPT 789
+ P + ++ + C++ + + RPT
Sbjct: 219 SG-EPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 20/207 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-----HLL--GWQLRVRIIDGIAQGL 637
L C +I E M SL FL P + L+ Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YL + IHRDL A NIL+ + + K++DFG+AR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE A G FS KSDV+SFG+L+ E+ +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 36/284 (12%)
Query: 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 585 RLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ G C + G + LI EY+ + SL +L + + + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEY 700
R IHRDL A NIL++ KISDFG+A++ D + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760
FS SDV+SFGV + E+ + + + ++G A + + +L
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA----QGQMIVTRLLELL 239
Query: 761 QNEVSLP----------MLVRYINVALLCVQENAEDRPTMSDVV 794
+ LP L++ LC + +DRP+ +D++
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK------LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 81/271 (29%), Positives = 128/271 (47%), Gaps = 34/271 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLH 641
+V+ +G +I EY N SL + KK L + + QGL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE-Y 700
+ +IHRD+KA+NIL + K++DFG+A + +VGT +M+PE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVI 171
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA--WSLCKNDRAHELMDP 758
+ G S SD++S G ++E+L TG N ++L A + + ++D P
Sbjct: 172 EMSGA-STASDIWSLGCTVIELL-----TG--NPPYYDLNPMAALFRIVQDDH------P 217
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
L +S + + + C Q++ RPT
Sbjct: 218 PLPEGISPELK----DFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
F I K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 586 LLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
G +++ E ++ E+ SL D+ + L + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK---STNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
IIHRD+KA+NILL K+ DFG++ +VGT +M+PE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGK 172
Query: 705 VFSVKSDVFSFGVLMLE 721
+ K+D++S G+ +E
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 77/213 (36%), Positives = 113/213 (53%), Gaps = 25/213 (11%)
Query: 533 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIIDG 632
LLG C ++ +++EY+ + L FL D T K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVG 691
IA G+ YL S +HRDL A N L+ + + KISDFG++R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M PE L G F+ +SD++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYL 640
+V+ G ++GE ++ EYM SL L K + V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H + IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY------NTDSFNLLGHAWSLCKNDRAHE 754
+S +D++S G+ +LE G + F L+ +C
Sbjct: 172 IQGESYSYAADIWSLGLTLLECA-----LGKFPFLPPGQPSFFELMQA---ICDGP---- 219
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
P L E P +I+ C+Q++ + RP+
Sbjct: 220 --PPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-31
Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 20/316 (6%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 581
++ I KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+L ++G L+ EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGD----ELQGNTKRIVGTYGYM 696
IIHRD+K NILLD+ K+ DFG+A++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 697 SPEYALEGVF---SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753
+PE L S SD++S G+ + E+L+ + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELP-T 232
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFT 813
+ L + ++ + ++ ++R + S +S L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 814 TFTKGKNMKYSSNSTS 829
++ S +
Sbjct: 293 KPDDSAPLRLSLPPSL 308
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 63/203 (31%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 533 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLH 641
LG C+ ++ LI + M L ++ + ++LL W ++ IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDL A N+L+ + KI+DFG+A++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
L +++ KSDV+S+GV + E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 87/280 (31%), Positives = 138/280 (49%), Gaps = 30/280 (10%)
Query: 528 SIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
+I+ +G G FG V +GRL L G++ VA+K L S + +F E ++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++RL G + ++I EYM N SLD FL + K V ++ GIA G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK--RIVGTYGYMSPEY 700
S + +HRDL A NIL++ ++ K+SDFG++R E TK +I + +PE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEA 179
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV- 759
F+ SDV+SFG++M E++S Y + W + D + D
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS-------YGERPY------WDMSNQDVIKAVEDGYR 226
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
L + P + + L C Q++ +RPT S +VS ++
Sbjct: 227 LPPPMDCPSALYQL--MLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 42/285 (14%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ I ++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL--RVRIIDGIAQ---GL 637
+++ E+G+ ++ EY L + KK + +I+D Q L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+S
Sbjct: 117 KYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLS 171
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
PE + ++ KSD++S G ++ E+ + K F +L EL
Sbjct: 172 PE-LCQNKPYNYKSDIWSLGCVLYELCTLKH--------PFE----GENL------LELA 212
Query: 757 DPVLQNEVSLPMLVRY----INVALLCVQENAEDRPTMSDVVSMI 797
+L+ + P+ +Y N+ +Q++ E+RP+++ ++
Sbjct: 213 LKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 80/269 (29%), Positives = 117/269 (43%), Gaps = 29/269 (10%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652
Q ++ EYM N L +L +K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 653 LKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALEGVFSVKS 710
L A N L+ + K+SDFG+AR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 711 DVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768
DV+SFGVLM E+ S K N++ + + L R V
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVYT------- 232
Query: 769 LVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ C E EDRP ++S +
Sbjct: 233 ------IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLRVRIIDGI 633
G C E I+++EYM + L+ FL D L QL ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL-LQIAVQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT- 692
A G++YL + +HRDL N L+ + KI DFGM+R D + R+ G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHT 184
Query: 693 ---YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M PE + F+ +SDV+SFGV++ EI + K
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 528 SIQ--SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
SIQ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++
Sbjct: 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQ 65
Query: 586 LLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
L C E I I E M SL +L + L QL + + +A G+ YL +
Sbjct: 66 LYAVCT-LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMAYLEAQN 123
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPEYA 701
IHRDL A N+L+ ++ K++DFG+AR+ D + G + +PE A
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAA 176
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
L FS+KSDV+SFG+L+ EI++
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 15/196 (7%)
Query: 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
+ +G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG
Sbjct: 12 ATIGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ ++ EYM SL +L + + Q +D + +G+ YL + +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLEEK---NFVH 125
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPEYALEGVFSV 708
RDL A N+L+ + + K+SDFG+A+ + QG G + +PE E FS
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFST 178
Query: 709 KSDVFSFGVLMLEILS 724
KSDV+SFG+L+ EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 90/285 (31%), Positives = 140/285 (49%), Gaps = 41/285 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIID---GIAQGLLYL 640
RL + Q +I EYM N SL FL P G +L + ++ID IA+G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFI 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMS 697
R IHRDL+A+NIL+ + + KI+DFG+AR+ +E +G I T +
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----A 171
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSL-CKNDRAHE 754
PE G F++KSDV+SFG+L+ EI++ + G+ N + L + + ++ E
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
L + + LC +E E+RPT + S++ +
Sbjct: 232 LYE-----------------LMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 575
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIID 631
+K H+N+VRL+G E+ + ++ E M L FL + P + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMAR-MFGGDELQGNT 686
+A+G YL + IHRD+ A N LL P KI+DFGMAR ++ +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746
+ ++ +M PE L+G+F+ K+DV+SFGVL+ EI S LG+
Sbjct: 180 RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYP 223
Query: 747 CKNDRAHELMDPV-----LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
+ ++ E+M+ V L P + C Q EDRP + ++ I
Sbjct: 224 GRTNQ--EVMEFVTGGGRLDPPKGCP--GPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 35/245 (14%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
E+ L++E+M + L +L ++ + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPEYALEGVFSV 708
DL A N L+ ++ K+SDFGM R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 709 KSDVFSFGVLMLEILSSKK---------------NTG-------VYNTDSFNLLGHAWSL 746
KSDV+SFGVLM E+ S K N G + + + L+ H W
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE 240
Query: 747 CKNDR 751
DR
Sbjct: 241 RPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
E + K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
N+V + E ++ EYM SL + + + + QG
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQG 128
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
L YLH +IHRD+K+ NILL + + K++DFG A + + +VGT +M
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWM 183
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEIL 723
+PE + K D++S G++ +E+
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 83/282 (29%), Positives = 122/282 (43%), Gaps = 45/282 (15%)
Query: 533 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 588 GCCIEQGEKILIYEYMVNK-SLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G C +GE +++ + L +L L +V A G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM--FGGDELQGNT--KRIVGTYGYMSPE 699
+HRDL A N+LL KISDFGM+R G D + T + + Y +PE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APE 168
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
G FS KSDV+S+GV + E S +K + + +L L + + + +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY 228
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
++ C + EDRPT S++ S
Sbjct: 229 SIML----------------SCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 580
+ +++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 581 RNLVRLLGCCIE--QGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
N+VRL +G +++EYM + S +V + K + QL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-QL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL YLH I+HRD+K SNIL++ K++DFG+AR + T R++ T
Sbjct: 110 -LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y PE L + + D++S G ++ E+ K
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 34/282 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
RL ++ +I EYM SL FL K G L ++ID IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPE 699
R IHRDL+A+N+L+ + + KI+DFG+AR+ +E T R + + +PE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 174
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
G F++KSDV+SFG+L+ EI++ K G+ N+D + L + +
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------- 223
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
P ++N P ++ C +E AE+RPT + S++++
Sbjct: 224 PRMEN---CP--DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 43/273 (15%)
Query: 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRL 586
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G G+ + EYM SLD L + +LG +I + +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH-- 117
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ +IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQG 173
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD------ 757
+SVKSD++S G+ ++E+ + + N + EL+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-------------ELLQYIVNEP 220
Query: 758 -PVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
P L + P ++N LC+ ++ +RP+
Sbjct: 221 PPRLPSGKFSPDFQDFVN---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 86/278 (30%), Positives = 130/278 (46%), Gaps = 31/278 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ KL H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
+L G C +Q ++ EYM N L +L + K QL + + + +G+ YL Q
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESKQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPE 699
+ IHRDL A N L+D K+SDFG++R DE + VG+ + PE
Sbjct: 121 F-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPE 171
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
L FS KSDV++FGVLM E+ S K + ++ ++ K + L P
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKM-------PYERFNNSETVEKVSQGLRLYRPH 224
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
L +E + + C E AE+RPT ++S I
Sbjct: 225 LASE-------KVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F I +K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLLY 639
++R +++G+ ++ EY N L L + L W+ ++I+ GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH +I+HRD+K+ N+ LD + N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
+ ++ KSDV++ GV++ E + K
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 80/287 (27%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 585
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
LLG C E +I EY L FL + K L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L S R +HRDL A N L+ K+S +++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHA---WSLCKN--DRA 752
E FS KSDV+SFGVLM E+ + + G+ + + N L + + R
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
++LM C N +DRP+ S++VS +
Sbjct: 249 YKLM--------------------TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 533 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 585
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKH-LLGWQLRVRIIDG---------- 632
LLG C L++EYM L+ FL P + L R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGN 685
+A G+ YL S + +HRDL N L+ ++M KI+DFG++R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 69/200 (34%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+++ ++ E + SL FL T K LL L A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA------AAGMEYLESKN-- 113
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGD--ELQGNTKRIVGTYGYMSPEYALEG 704
IHRDL A N L+ ++ KISDFGM+R G + K+I + +PE G
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYG 170
Query: 705 VFSVKSDVFSFGVLMLEILS 724
++ +SDV+S+G+L+ E S
Sbjct: 171 RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
V+ G + + ++ EY S D + T K L ++ I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ IHRD+KA NILL++ K++DFG++ + NT ++GT +M+PE
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
E ++ K+D++S G+ +E+ K
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 533 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 584
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH----LLGWQLRVRIIDGIAQGLLYL 640
+LLG C+ + +I E M L +L D + LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMAR-MFGGDELQGNTKRIVGTYG 694
Q + IHRDL A N L+ + KI DFG+AR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE L+G F+ +SDV+SFGVLM EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 79/294 (26%), Positives = 138/294 (46%), Gaps = 40/294 (13%)
Query: 527 FSIQSKLGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
+ LGEG FG V +G+L + +VAVK +L + ++EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIID 631
N+++L+G C E ++I +M + L FL L Q ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDEL-QGNTKRI 689
IA G+ YL S IHRDL A N +L + M ++DFG+++ ++ GD QG ++
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLC 747
+++ E + V++ KSDV++FGV M EI + + GV N + ++ L H L
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235
Query: 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
+ + + +D + S C + + +DRPT + + ++ N L
Sbjct: 236 QPE---DCLDELYDLMYS-------------CWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 85/271 (31%), Positives = 136/271 (50%), Gaps = 33/271 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL K+L QL V + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEYA 701
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E QG I T +PE A
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSL-CKNDRAHELMDP 758
L G F++KSDV+SFG+L+ E+ + + G+ N + + + + + C + L D
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
+ Q C ++ E+RPT
Sbjct: 236 MCQ-----------------CWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 57/300 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FD-PTKKHLLGWQ 624
++VRLLG +++ E M L +L PT + +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQ 683
IA G+ YL + +HRDL A N ++ + + KI DFGM R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLLG 741
K ++ +M+PE +GVF+ KSDV+SFGV++ E+ L+ + G+ N + +
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
Query: 742 HAWSL----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
L D+ ELM +C Q N + RPT ++VS +
Sbjct: 236 DGGHLDLPENCPDKLLELM--------------------RMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-26
Identities = 34/67 (50%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMW 406
C GD F +L ++KLPD ++ S+ LKECE CL NCSC AYA + + GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 407 FGDLIDL 413
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 83/272 (30%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 532 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHL----------LGWQLRVRIIDGI 633
G C E ++++EYM + L+ FL P K L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A G++YL + L +HRDL N L+ Q + KI DFGM+R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT--GVYNTDSFNLLGHAWSL----- 746
+M PE L F+ +SD++SFGV++ EI + K + NT++ + L
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248
Query: 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALL 778
C + + +M Q E M+++ I+ L
Sbjct: 249 CPPE-VYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 89/285 (31%), Positives = 143/285 (50%), Gaps = 41/285 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L E+ I + E+M SL FL + K+L QL V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEY 700
R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSL-CKN---DRAHE 754
AL G F++KSDV+SFG+L+ E+++ + G+ N + + + + C + HE
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
LM LC +++ ++RPT + S + +
Sbjct: 235 LMK--------------------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 82/271 (30%), Positives = 137/271 (50%), Gaps = 35/271 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D+ + KK L ++ I G QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ R IHRD+KA NILL + K++DFG A + N+ VGT +M+PE L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
EG + K DV+S G+ +E+ +++ ++N ++ + L H + +ND P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPT 233
Query: 760 LQ-NEVSLPMLVRYINVALLCVQENAEDRPT 789
L N+ S + N C+Q+ +DRP+
Sbjct: 234 LSSNDWSD----YFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 39/282 (13%)
Query: 528 SIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
+++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C + +I E+M +L +L + ++ + L + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-LYMATQISSAMEYLEKKN-- 124
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALEG 704
IHRDL A N L+ ++ K++DFG++R+ GD K + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180
Query: 705 VFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHELMD 757
FS+KSDV++FGVL+ EI + + G+ + + LL + + C +ELM
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK-VYELM- 238
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
C Q N DRP+ +++
Sbjct: 239 -------------------RACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 39/286 (13%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L E+ I + EYM SL FL D + L L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIE- 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPE 699
R+ IHRDL+++NIL+ + KI+DFG+AR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSL-CKND---RAH 753
AL G F++KSDV+SFG+L+ E+++ + G+ N + + + + C D H
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
ELM L C +++ E+RPT + S + +
Sbjct: 234 ELM--------------------LQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 87/307 (28%), Positives = 130/307 (42%), Gaps = 73/307 (23%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 573
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKH---LLGWQL 625
++++L N+ RLLG C +I EYM N L+ FL L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--EL 682
+ + IA G+ YL L +HRDL N L+ ++ KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742
QG R +M+ E L G F+ KSDV++FGV + EIL
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL------------------- 226
Query: 743 AWSLCKNDRAHELMDP-VLQN----------EVSLPMLVR-----YINVALLCVQENAED 786
+LC+ L D V++N ++ LP Y + L C + + ED
Sbjct: 227 --TLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY-ELMLECWRRDEED 283
Query: 787 RPTMSDV 793
RPT ++
Sbjct: 284 RPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 75/216 (34%), Positives = 115/216 (53%), Gaps = 29/216 (13%)
Query: 532 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIID 631
LLG ++ +I+ Y + L FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNTKR 688
IA G+ +L S ++H+DL N+L+ +N KISD G+ R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +MSPE + G FS+ SD++S+GV++ E+ S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 82/279 (29%), Positives = 120/279 (43%), Gaps = 47/279 (16%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
+Q ++ E+M N L +L ++ L + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMSPEYALEGV 705
DL A N L+ K+SDFGM R DE + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177
Query: 706 FSVKSDVFSFGVLMLEILS-------SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
+S KSDV+SFGVLM E+ + K N V S R L P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS--------------RGFRLYRP 223
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
L M V V C E E RPT ++++ I
Sbjct: 224 KLA-----SMTV--YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 81/295 (27%), Positives = 126/295 (42%), Gaps = 62/295 (21%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRNLV 584
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDP--------TKKHLLGWQL 625
LLG C ++G ++ EY + +L FL D T+K L+ +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+V A+G+ +L + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 140 QV------ARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH--- 742
T +M+PE + V++ +SDV+SFGVL+ EI F L G
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI--------------FTLGGSPYP 236
Query: 743 ---AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
L K + M+ L L+R C E RPT +V
Sbjct: 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRD------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNL 583
+ K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQG 636
++LL +G+ L++E+M + L + D + K L +Q + QG
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQG 110
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
L + H + I+HRDLK N+L++ K++DFG+AR FG V T Y
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYR 165
Query: 697 SPEYAL-EGVFSVKSDVFSFGVLMLEILS 724
+PE L + +S D++S G + E+LS
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 76/204 (37%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 530 QSKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 584 VRLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V+ GCC EQG K LI EY+ SL +L KH L + I +G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEY 700
IHRDL A N+LLD KI DFG+A+ G E + + + E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
E FS SDV+SFGV + E+L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 74/206 (35%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+ ++ +GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NL
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL 61
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRLLG + G I++ E M +L FL + LL + L V A+G+
Sbjct: 62 VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV------AEGME 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL +++HRDL A NIL+ + K+SDFG+AR+ G N+K V + +P
Sbjct: 115 YLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAP 166
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E FS KSDV+S+GVL+ E+ S
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 83/275 (30%), Positives = 141/275 (51%), Gaps = 34/275 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ GC + + L+ EY + + D L + KK L ++ + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++ +IHRD+KA NILL + K+ DFG A + VGT +M+PE L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
EG + K DV+S G+ +E+ +++ ++N ++ + L H + +N+ P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQNE------SPA 233
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
LQ+ +++ C+Q+ +DRPT S+V+
Sbjct: 234 LQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 74/280 (26%), Positives = 135/280 (48%), Gaps = 43/280 (15%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 585
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LG E L E+M S+ L + K+ ++ + + + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 644 SRLRIIHRDLKASNILLD---QHMNPKISDFGMA-----RMFGGDELQGNTKRIVGTYGY 695
+IIHRD+K +N+L+D Q + +I+DFG A + G E QG +++GT +
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAF 174
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHAWSLCKNDRAHE 754
M+PE + DV+S G +++E+ ++K ++ L+ S E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
+ P L+ +V L C++ EDRP +++
Sbjct: 235 HLSPGLR------------DVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 82/276 (29%), Positives = 114/276 (41%), Gaps = 32/276 (11%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLHQY 643
G + ++ E SL D +K LG L + D IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYA 701
R IHRDL A NILL KI DFG+ R D V + + +PE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
FS SDV+ FGV + E+ + Y + + L + L K D+ E ++ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLE---R 222
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
E NV L C N DRPT + + +
Sbjct: 223 PEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 531 SKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 586 LLGCCIEQGEK--ILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
G C G + L+ EY+ SL +L D K L Q I +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGM 121
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG---TYG 694
YL R +HRDL NIL++ KI DFG+ ++ D+ + R G +
Sbjct: 122 EYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFW 177
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKN 728
Y +PE E FSV SDV+SFGV++ E+ + S K+
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 588
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------IAQGLLY 639
+ EK+ L+ EY L HL R + I L Y
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--------FSHL---SKEGRFSEERARFYAAEIVLALEY 108
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH L II+RDLK NILLD + K++DFG+A+ + + NT GT Y++PE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
L + D +S GVL+ E+L+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 79/278 (28%), Positives = 140/278 (50%), Gaps = 33/278 (11%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D L + KK L ++ I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
EG + K DV+S G+ +E+ +++ ++N ++ + L H + +N+ P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQNE------SPT 243
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
LQ+ +++ C+Q+ +DRPT +++ +
Sbjct: 244 LQSNEWSDYFRNFVDS---CLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 80/283 (28%), Positives = 138/283 (48%), Gaps = 37/283 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
+L + + +I E+M SL FL K Q ++ID IA+G+ ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPE 699
Q + IHRDL+A+NIL+ + KI+DFG+AR+ +E T R + + +PE
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCKNDRA-HELM 756
G F++KSDV+SFG+L++EI++ + G+ N + L + + + + EL
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + + C + E+RPT + S++++
Sbjct: 234 N-----------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 53/293 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQH 580
I+ +G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGL 637
N++ L G + +++ EYM N SLD FL +KH QL V ++ GIA G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQL-VGMLRGIASGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
YL S + +HRDL A NIL++ ++ K+SDFG++R+ D T R G
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKI 171
Query: 695 ---YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND- 750
+ +PE F+ SDV+S+G++M E++S Y + W + D
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDV 218
Query: 751 -----RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
+ L P + +L L+ L C Q++ +RP +VS+++
Sbjct: 219 IKAIEEGYRLPAP-MDCPAALHQLM------LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 52/292 (17%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 575
NF I+ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEY--------MVN--KSLDVFLFDPTKKHLLGWQL 625
+L H N+++ L IE E ++ E M+ K + + T W+
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-----WKY 111
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
V++ + H +S+ RI+HRD+K +N+ + K+ D G+ R F +
Sbjct: 112 FVQLCSALE------HMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLLGHA 743
+ VGT YMSPE E ++ KSD++S G L+ E+ L S + D NL
Sbjct: 165 SL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNL---- 213
Query: 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795
+SLCK + P L + L ++ C+ + E RP +S V+
Sbjct: 214 YSLCKKIEKCDY--PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/285 (28%), Positives = 143/285 (50%), Gaps = 45/285 (15%)
Query: 530 QSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
Q +G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL G + ++I EYM N +LD +L D +QL V ++ GIA G+ YL S
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQL-VGMLRGIAAGMKYL---S 124
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMSP 698
+ +HRDL A NIL++ ++ K+SDFG++R+ L+ + + T G + +P
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAP 179
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
E F+ SDV+SFG++M E++S + + W + HE+M
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS-------FGERPY------WDMSN----HEVMKA 222
Query: 759 V-----LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
+ L + P V + L C Q++ RP D+V++++
Sbjct: 223 INDGFRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 85/310 (27%), Positives = 142/310 (45%), Gaps = 69/310 (22%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----------------------FDPT 616
H ++++L G C + G +LI EY SL FL +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 617 KKHL-------LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
++ L WQ I++G+ YL + ++++HRDL A N+L+ + KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 670 DFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
DFG++R ++ ++ + RI +M+ E + +++ +SDV+SFGVL+ EI++
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 728 N--TGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAE 785
N G+ FNLL + + + + E M N+ L C ++ +
Sbjct: 228 NPYPGIAPERLFNLLKTGYRMERPENCSEEM----------------YNLMLTCWKQEPD 271
Query: 786 DRPTMSDVVS 795
RPT +D+
Sbjct: 272 KRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 532 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF--------------DPTKKHLLGWQLRVRIID 631
LLG ++ +++EY+ L FL D T K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIV 690
IA G+ YL + +H+DL A NIL+ + ++ KISD G++R ++ D + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M PE + G FS SD++SFGV++ EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 54/276 (19%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
LG E + + I+ E + SL L + + ++ +L R I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVI--RLYTR---QILLGLEYLH-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL- 702
R +HRD+K +NIL+D + K++DFGMA+ K G+ +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK---------NDRAH 753
+G + + +D++S G +LE+ + K WS + +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKP---------------PWSQLEGVAAVFKIGRSKEL 220
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
+ L +E + L C+Q + RPT
Sbjct: 221 PPIPDHLSDEAK--------DFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 53/237 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL 578
++F +GEG F V + +E A+K L + Q +KE K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVN----------KSLDVFLFDPTKKHLLGWQLRV 627
H +++L ++ + EY N SLD +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE----KCTRFYAA----- 109
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL----- 682
I+ + YLH IIHRDLK NILLD+ M+ KI+DFG A++ +
Sbjct: 110 EILLALE----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 683 -------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+ VGT Y+SPE E SD+++ G ++ ++L+ K
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E S+LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 583 LVRLLGCCIE--QGEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIA 634
+V+ G ++ + EY SLD K+ +LG +I + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEI 722
YM+PE +S+ SDV+S G+ +LE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 35/273 (12%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQYS 644
GC + E + I+ EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQILEGVEYLH--- 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV-GTYGYMSPEYALE 703
I+HRD+K +NIL D N K+ DFG ++ G + V GT +MSPE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS--FNLLGHAWSLCKNDRAHELMDPVLQ 761
+ K+DV+S G ++E+L+ K + + F + A + +P L
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------------ATQPTNPQLP 229
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
+ VS P ++ ENA+ RP+ +++
Sbjct: 230 SHVS-PDARNFLR---RTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 9e-23
Identities = 73/216 (33%), Positives = 111/216 (51%), Gaps = 36/216 (16%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQ 579
+ KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELK 56
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL------FDPTK-KHLLGWQLRVRIID 631
H N+V+LL I K+ L++EY + L +L P K ++ +QL
Sbjct: 57 HPNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM-YQL------ 107
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+GL Y H + RI+HRDLK NIL+++ K++DFG+AR F G L+ T +V
Sbjct: 108 --LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV- 160
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L +S D++S G + E+++ K
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-23
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 533 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 592 EQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
E G + E + SL L + P K + + I +GL YLH +I
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QILEGLKYLHD---NQI 129
Query: 649 IHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-- 705
+HRD+K N+L++ + KISDFG ++ G + T+ GT YM+PE +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 706 FSVKSDVFSFGVLMLEILSSK 726
+ +D++S G ++E+ + K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 37/277 (13%)
Query: 535 EGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLG 588
EG FG ++ G L++ +EV VK + + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 589 CCIEQGEK-ILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
CIE GE ++Y YM +L +FL L Q V + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE--LQGNTKRIVGTYGYMSPE 699
+ +IH+D+ A N ++D+ + KI+D ++R +F D L N R V +M+ E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
+ +S SDV+SFGVL+ E+++ + V D F + A L D
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTPYV-EIDPFEM------------AAYLKDGY 236
Query: 760 -LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795
L ++ P V C + E+RP+ S +V
Sbjct: 237 RLAQPINCPD--ELFAVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLR 626
H ++V+ G C+E I+++EYM + L+ FL P + L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ I IA G++YL + +HRDL N L+ +++ KI DFGM+R D +
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDY 175
Query: 687 KRIVG----TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
R+ G +M PE + F+ +SDV+S GV++ EI + K
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 43/232 (18%)
Query: 530 QSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNE 571
+ KLGEG FG V+ ++N Q+ VAVK L + + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTK 617
+ ++++L+ N++RLLG C+++ +I EYM N L+ FL P
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 618 KHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L + + + IA G+ YL S L +HRDL N L+ +++ KI+DFGM+R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 676 -MFGGD--ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++ GD +QG R V +M+ E L G F+ SDV++FGV + EIL
Sbjct: 187 NLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 87/311 (27%), Positives = 138/311 (44%), Gaps = 71/311 (22%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EF 568
+ + KLGEG FG V+ ++ VAVK L + + + +F
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHL 620
E+ ++++L+ N++RLL CI +I EYM N L+ FL +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
+ + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+R ++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 680 D--ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF 737
D +QG R V +MS E L G F+ SDV++FGV + EIL
Sbjct: 184 DYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL-------------- 226
Query: 738 NLLGHAWSLCKNDRAHELMDP-VLQN----------EVSLPMLVR----YINVALLCVQE 782
+LCK +L D V++N +V LP + L C +
Sbjct: 227 -------TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279
Query: 783 NAEDRPTMSDV 793
NA++RP+ ++
Sbjct: 280 NAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 82/286 (28%), Positives = 136/286 (47%), Gaps = 43/286 (15%)
Query: 529 IQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNL 583
I+ +G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
+ L G + ++I E+M N +LD FL F QL V ++ GIA G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-------QL-VGMLRGIAAGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG---TYG 694
YL S + +HRDL A NIL++ ++ K+SDFG++R D +G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRA 752
+ +PE F+ SDV+S+G++M E++S + + N D N + + L
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL------ 230
Query: 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
P + +L L+ L C Q++ RP +VS ++
Sbjct: 231 ----PPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 529 IQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ +LGEG FG V+ N VAVK L + + K+F+ E L+ LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLF------------DPTK-KHLLGWQLRVRI 629
+V+ G C + I+++EYM + L+ FL P + K LG + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
IA G++YL + +HRDL N L+ ++ KI DFGM+R D + R+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 690 VG----TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
G +M PE + F+ +SDV+SFGV++ EI + K
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E+ S LG G G V K + G +A K + + + K+ E+ ++ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G + + + E+M SLD P +LG +I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
Y+ RI+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD--- 757
G ++VKSDV+S G+ ++E+ K N D L D +++
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL---DLLQQIVQEPP 230
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
P L + L +++ C+ ++ +RPT + +M
Sbjct: 231 PRLPSSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 68/198 (34%), Positives = 112/198 (56%), Gaps = 12/198 (6%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C+ + L+ + M + L ++ + K +G QL + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
R++HRDL A N+L+ + KI+DFG+AR+ GDE + N +M+ E F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 707 SVKSDVFSFGVLMLEILS 724
+ +SDV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-22
Identities = 77/270 (28%), Positives = 136/270 (50%), Gaps = 33/270 (12%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GC +++ L+ EY + + D L + KK L ++ I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN--- 141
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL---EG 704
+IHRD+KA NILL + K++DFG A VGT +M+PE L EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
+ K DV+S G+ +E+ +++ ++N ++ + L H + +ND P LQ+
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPTLQSNE 244
Query: 765 SLPMLVRYINVALLCVQENAEDRPTMSDVV 794
+++ C+Q+ ++RP ++++
Sbjct: 245 WTDSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 97/320 (30%), Positives = 141/320 (44%), Gaps = 55/320 (17%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTKKH--LL 621
+ +H+N++ LLG C ++G +I EY +L FL FD TK L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++ V +A+G+ YL SR R IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNL 739
T +M+PE + V++ +SDV+SFG+LM EI L G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 740 L--GHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM- 796
L GH ++ HEL ML+R C RPT +V
Sbjct: 249 LREGHRMD-KPSNCTHELY-----------MLMRE------CWHAVPTQRPTFKQLVEAL 290
Query: 797 ------INNELFNLPSPKEP 810
++ E +L P E
Sbjct: 291 DKVLAAVSEEYLDLSMPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGLLYLH 641
+ + L++E+ LD+ L KK++ L L + + QG+ Y H
Sbjct: 66 VVHSENKLYLVFEF-----LDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDLK N+L+D+ K++DFG+AR F G ++ T +V T Y +PE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 702 LEG-VFSVKSDVFSFGVLMLEILSSK 726
L +S D++S G + E+++ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + + ++ E+ +LD + ++ L Q+R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEY 700
+ ++IHRDLKA NILL + K++DFG++ LQ KR +GT +M+PE
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPEV 174
Query: 701 ALEGVFS-----VKSDVFSFGVLMLEI 722
F K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 87/277 (31%), Positives = 139/277 (50%), Gaps = 35/277 (12%)
Query: 533 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 588 GCCIEQ-GEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
G C+ G +++ YM + L F+ PT K L+G+ L+V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG--NTKRIVGTYGYMSPEY 700
+ +HRDL A N +LD+ K++DFG+AR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760
F+ KSDV+SFGVL+ E++ ++ + DSF++ + L + R +L
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM-TRGAPPYPDVDSFDITVY---LLQGRR-------LL 222
Query: 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
Q E L V L C E RPT S++VS I
Sbjct: 223 QPEYCPDPLY---EVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 589 CCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+++ LI+E++ + K LD P +++ ++ + I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQ-ILQGILFCH---S 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
R++HRDLK N+L+D K++DFG+AR F G ++ T +V T Y +PE L
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 706 -FSVKSDVFSFGVLMLEILSSK 726
+S D++S G + E+ + K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 31/193 (16%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 575
++ I KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL---RVR---- 628
KL+H N+V L+ +E+ +K K V++ P H L L V+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSK------RKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ + +G+ YLH+ I+HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 685 NTKRIVGTYGYMS 697
GT Y +
Sbjct: 173 KGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ + E L+ Y+ SL + + L + ++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEY 700
+ IHRD+KA NILL + + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
+ + K+D++SFG+ +E+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 585 RLLGCCIEQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ G ++ EYM SL +L + L G L +D + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLEAN 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ +HRDL A N+L+ + K+SDFG+ + Q K V + +PE E
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVK---WTAPEALRE 173
Query: 704 GVFSVKSDVFSFGVLMLEILS 724
FS KSDV+SFG+L+ EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 70/226 (30%), Positives = 123/226 (54%), Gaps = 23/226 (10%)
Query: 533 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 588 GCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLL 638
G C++ E ++I +M + L FL L Q+ V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDEL-QGNTKRIVGTYGYM 696
YL S IHRDL A N +L+++MN ++DFG++ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL 740
+ E + V++ KSDV+SFGV M EI + + GV N++ ++ L
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEM 572
++ KLGEG FG V+ E VAVK L ++ + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL---------GW 623
++++L++ N++RLLG C+ +I EYM N L+ FL +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD-- 680
+ + IA G+ YL + L +HRDL N L+ H KI+DFGM+R ++ GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+QG R V +M+ E L G F+ SDV++FGV + E+ +
Sbjct: 186 RIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 527 FSIQSKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 580
+ + +G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKH 58
Query: 581 RNLVRLLGCCI-EQGEKILIY-EY--------MVNKSLDVFLFDPTKKHLLGWQLRVRII 630
N+VR I + + I EY ++ K + + I
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF----------IW 108
Query: 631 DGIAQGLLYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ Q LL L+ ++HRDLK +NI LD + N K+ DFG+A++ G D
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSF 166
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K VGT YMSPE + KSD++S G L+ E+ +
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 82/299 (27%), Positives = 136/299 (45%), Gaps = 53/299 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 577
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEY-----MVN---KSLDVFLFDPTKKHLLGWQLRVR 628
L H N+V LLG C G ++I EY ++N + + FL T + LL + +V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQV- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGN 685
A+G+ +L + IHRDL A N+LL KI DFG+AR D ++GN
Sbjct: 151 -----AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGV-YNTDSFNLLGH 742
+ V +M+PE V++ +SDV+S+G+L+ EI S N G+ ++ + L+
Sbjct: 203 ARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
+ + + + A + +++ C + RPT +V +I +L
Sbjct: 260 GYRMAQPEHAPAEIYDIMKT----------------CWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQHRNLV 584
KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 585 RLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
LL + L++E+M V K + L K + LR GL
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR---------GLE 116
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH I+HRDLK +N+L+ K++DFG+AR FG + + V T Y +P
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAP 171
Query: 699 EYALEGV--FSVKSDVFSFGVLMLEIL 723
E L G + V D++S G + E+L
Sbjct: 172 EL-LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 526 NFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 583 LVR-----LLGC--CIEQGEKILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIA 634
++ L G CI + EY L + K + L+ Q RI +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+GL LH+ +I+HRDLK++NILL + KI D G++++ + K +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPH 166
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
YM+PE +S KSD++S G L+ E+ +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-21
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 343 HSSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDG 399
+C D F KL D+KLPD ++ +++L+EC CL NCSC AYA +G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAY---NNG 55
Query: 400 GSGCLMWFGDLIDLKKTDNHTNGVSIYIRVP 430
GCL+W G L +L+ + G ++Y+R+
Sbjct: 56 SGGCLLWNGLLNNLRSLSS--GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 582
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ LG ++ + EY+ S+ L L + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG--NTKR--IVGTYGYMSP 698
+R IIHRD+K +NIL+D KISDFG+++ + L N R + G+ +M+P
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E + ++ K+D++S G L++E+L+ K
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 82/308 (26%), Positives = 145/308 (47%), Gaps = 41/308 (13%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 574
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------DPTKKHLLGWQLRV 627
+ ++VRLLG + +++ E M + L +L + + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNT 686
++ IA G+ YL+ + +HRDL A N ++ KI DFGM R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLLGHAW 744
K ++ M+PE +GVF+ SD++SFGV++ EI L+ + G+ N +
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804
L + D E + +++ +C Q N + RPT ++V+++ ++L
Sbjct: 239 YLDQPDNCPERVTDLMR----------------MCWQFNPKMRPTFLEIVNLLKDDLH-- 280
Query: 805 PSPKEPPF 812
PS E F
Sbjct: 281 PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL-----GWQLRVRIIDGIAQG 636
N+++ IE E ++ E L + K+ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
SPE E ++ KSD++S G L+ E+ + + + D NL +SLCK + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLCK--KIEQCD 224
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
P L ++ L + +N +C+ + E RP ++ V +
Sbjct: 225 YPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 41/217 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKL 578
+ I ++GEG G V+K + G+ VA+K+++ + +G L+E K +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
QH +V+LL +L+ EYM V + + L + K + L+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK------ 110
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
G+ Y+H I+HRDLK +N+L+ KI+DFG+AR+F +E + + + V T
Sbjct: 111 ---GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VAT 163
Query: 693 YGYMSPEYAL------EGVFSVKSDVFSFGVLMLEIL 723
Y +PE GV D+++ G + E+L
Sbjct: 164 RWYRAPELLYGARKYDPGV-----DLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G ++ + +I EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR---IVGTYGYMSPEYA 701
IHRD+KA+NILL + + K++DFG++ +L + VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 702 LEGVFSVKSDVFSFGVLMLEIL 723
+ + K+D++S G+ +E+
Sbjct: 171 KQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 66/194 (34%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ ++ E + D F KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 652 DLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
DL A N L+ ++ KISDFGM+R G K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 711 DVFSFGVLMLEILS 724
DV+S+G+L+ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + + L++E++ ++ L F+ D + + L + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ R++HRDLK N+L++ K++DFG+AR F G ++ T +V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 703 EGVF-SVKSDVFSFGVLMLEILSSK 726
+ S D++S G + E+++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA-------QG 636
V G + + + ++ EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT--KR--IVGT 692
L YLH+ IHRD+K +NILL + + K++DFG++ T KR +GT
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGT 164
Query: 693 YGYMSPEYALE---GVFSVKSDVFSFGVLMLE 721
+M+PE A G + K D+++ G+ +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 56/284 (19%)
Query: 532 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 588
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 589 CCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
+ + EK+ I+ EY +L+ L +H V + +GL YLH +
Sbjct: 67 VEVHR-EKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFG------GDELQGNTKRIVGTYGYMSPE 699
I+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPE 173
Query: 700 YALEGVFSVK---SDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
G +D++S G ++LE+ + K WS N+ ++M
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGK---------------RPWSELDNE--FQIM 216
Query: 757 -------DPVL-QNEVSLPMLVRYINVALLCVQENAEDRPTMSD 792
P + + P +++ C++ + + RPT S+
Sbjct: 217 FHVGAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 581
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------- 632
LV L Q E+ Y+V +D+ LLG LR +
Sbjct: 61 FLVNL--WYSFQDEE---NMYLV---VDL---------LLGGDLRYHLSQKVKFSEEQVK 103
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I L YLH IIHRD+K NILLD+ + I+DF +A D T
Sbjct: 104 FWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
GT GYM+PE +SV D +S GV E L K+
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 86/303 (28%), Positives = 139/303 (45%), Gaps = 56/303 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 580
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLR 626
N++ LLG C +G L EY + +L FL DP T L QL
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
D +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R G E+
Sbjct: 128 HFAAD-VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--V 178
Query: 687 KRIVGTYG--YMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGH 742
K+ +G +M+ E V++ SDV+S+GVL+ EI+S G+ + + L
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238
Query: 743 AWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
+ L K +D ++LM C +E +RP+ + ++ +N
Sbjct: 239 GYRLEKPLNCDDEVYDLMRQ--------------------CWREKPYERPSFAQILVSLN 278
Query: 799 NEL 801
L
Sbjct: 279 RML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL-RVRIIDG-IAQGLLYLHQYSRL 646
+ + L+ M L +++ + G+ R I GL +LHQ
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
RI++RDLK N+LLD H N +ISD G+A G K GT GYM+PE V+
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 707 SVKSDVFSFGVLMLEILSSK 726
D F+ G + E+++ +
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 533 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 587 LGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
G C E G LI E++ + SL +L P K+ + + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT-YGYMSPEYA 701
Y +HRDL A N+L++ KI DFG+ + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
++ F + SDV+SFGV + E+L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 71/232 (30%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 583
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 584 VRLLGCCIEQGEKILIYEYM---VNKSLDVF----LFDPTKKHLLGWQLRVRIIDGIAQG 636
VRL + + +L++EYM + K +D DP +QL +G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--------LKG 112
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGY 695
+ + H+ R++HRDLK N+L+++ K++DFG+AR FG + NT V T Y
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWY 166
Query: 696 MSPEYALEG-VFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDS----FNLLG 741
+P+ L +S D++S G +M E+++ + G N D F ++G
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 30/277 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLG----WQLRVRIIDGIAQG 636
N+++ L IE E ++ E L + + +K L+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
SPE E ++ KSD++S G L+ E+ + + + D NL SLC+ + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF----SLCQ--KIEQCD 224
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
P L E L ++ +C+ + + RP + V
Sbjct: 225 YPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 39/295 (13%)
Query: 523 ATENFSIQSKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 575
A E ++ +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 576 AKLQHRNLVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL--FDPTKKHLLGWQL-----RV 627
+ ++VRLLG + QG+ L I E M L +L P ++ +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNT 686
++ IA G+ YL+ + +HRDL A N ++ + KI DFGM R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLLGHAW 744
K ++ +MSPE +GVF+ SDV+SFGV++ EI L+ + G+ N +
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
L K D +++ +++ +C Q N + RP+ +++S I
Sbjct: 239 LLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 533 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
GC ++ EK L EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-IVGTYGYMSPEYAL 702
I+HRD+K +NIL D N K+ DFG ++ + G R + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
+ K+DV+S G ++E+L+ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 28/220 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 579
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDPT--KKH----LLGWQLR 626
H N++ LLG C +G + EY +L FL DP K+H L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFG++R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 687 KRIVGTYG--YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K+ +G +M+ E V++ KSDV+SFGVL+ EI+S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 71/271 (26%), Positives = 132/271 (48%), Gaps = 32/271 (11%)
Query: 533 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
++ ++ EY +L + K L ++ + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV- 705
I+HRD+K NI L + K+ DFG++++ G + T +VGT YMSPE +GV
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC-QGVK 177
Query: 706 FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765
++ KSD+++ G ++ E+L+ K+ D+ N L + + + + V +E
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR-----TFDATNPLNLVVKIVQG--NYTPVVSVYSSE-- 228
Query: 766 LPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
L LV +Q++ E RPT +V+
Sbjct: 229 LISLVHS------LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 71/236 (30%), Positives = 121/236 (51%), Gaps = 30/236 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 580
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLF------DPTKKHLLGWQLRVR 628
N+++L+G + K ++I +M + L FL +P L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDEL-QGNT 686
+ IA G+ YL S IHRDL A N +L+++M ++DFG+++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL 740
++ +++ E + V++ SDV++FGV M EI++ + GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QH 580
T F + +GEG +G VYK R GQ VA+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 581 RNLVRLLGCCIEQGEKI------LIYEY--------MVNKSLDVFLFDPTKKHLLGWQLR 626
N+ G I++ L+ E +V K+ + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAY--- 117
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
I+ +GL YLH+ ++IHRD+K NILL ++ K+ DFG++ + NT
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 687 KRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLE 721
+GT +M+PE + + +SDV+S G+ +E
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 6e-19
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 228 TGPWNGVAFGSAP-----SNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQ 282
+GPWNG+ F P S + F +N +EVYY Y ++ I L ++ G ++
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 283 RLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKS 333
R W S W +F++AP C YG CGP C V+ + C C++GF K+
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 580
+ I+ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 581 RNLVRLLGCCIEQGEKI--LIYEYMVNKSLDVFLF----------DPTKKHLLGWQLRVR 628
N+V L+ +E +K L+++Y + + F K LL WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMF------- 677
I G+ YLH ++HRDLK +NIL+ + KI D G+AR+F
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 678 -GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
D +V T Y +PE L K+ D+++ G + E+L+ +
Sbjct: 170 ADLD-------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 589
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+E +++ EY +L ++ L I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD----EDTILHFFVQILLALHHVHTKLIL 123
Query: 650 HRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
HRDLK NILLD+H M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 709 KSDVFSFGVLMLEILSSKK 727
KSD+++ G ++ E+ S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ R G ++ + +I EY+ S LD+ P ++ + LR I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 KQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 74/287 (25%), Positives = 133/287 (46%), Gaps = 51/287 (17%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 581
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 582 NLVRLLGCCIEQGEKIL-IY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
N+V+ LG E E+ L I+ EY+ S+ L F+ QL + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--------QLVRFFTEQVL 118
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN--TKRIVGT 692
+GL YLH I+HRDLKA N+L+D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 693 YGYMSPE--YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750
+M+PE ++ +S K D++S G ++LE+ + ++ + + L
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKR 228
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALL--CVQENAEDRPTMSDVVS 795
A P + +VS M + + + L C N ++RPT +++
Sbjct: 229 SA-----PPIPPDVS--MNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 589 CCIEQGEKILIYEYM---VNKSLDV---FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ + K +D F +P +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDLK N+L+D+ N K++DFG+AR F G ++ T +V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175
Query: 702 LEG-VFSVKSDVFSFGVLMLEILSSK 726
L +S D++S G + E+++ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 72/245 (29%), Positives = 118/245 (48%), Gaps = 30/245 (12%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLL 621
+ +H+N++ LLG C + G +I EY +L +L +D + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNL 739
T +M+PE + V++ +SDV+SFGVLM EI L G+ + F L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 740 L--GH 742
L GH
Sbjct: 252 LKEGH 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTK----KHLLGWQLRVRIIDGIAQGLLYLHQ 642
LG C+ + LI + M L ++ + ++LL W ++ IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
R++HRDL A N+L+ + KI+DFG+A++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+++ +SDV+S+GV + E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
H N+V L +G L++EY+ L++ P WQL
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------L 110
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR----IV 690
Q + Y H IIHRD+K NIL+ + K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 691 GTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILS 724
T Y +PE + K DV++ G +M E+L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 532 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 584
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPEYAL 702
+HRDL A N+LL KISDFG+++ G D+ R G + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
FS +SDV+S+G+ M E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGL 637
LG C G + L+ + SL D ++H LL W ++ IA+G+
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YL ++ R++HR+L A NILL +I+DFG+A + D+ + +M+
Sbjct: 123 YYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
E L G ++ +SDV+S+GV + E++S
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 76/281 (27%), Positives = 130/281 (46%), Gaps = 42/281 (14%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 590 CIEQGEKILIYEYMVNKSLDVF---LFDPTKKHL----LGWQLRVRIIDGIAQGLLYLHQ 642
+G+ + E M + SLD F +++ K + LG +I + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI--VGTYGYMSPE- 699
L+IIHRD+K SNILLD++ N K+ DFG++ +L + + G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 178
Query: 700 ---YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-LLGHAWSLCKNDRAHEL 755
A +G + V+SDV+S G+ + E+ TG + +N + + K D +
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWNSVFDQLTQVVKGDPP--I 230
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+ + E S V +IN LC+ ++ RP +++
Sbjct: 231 LSNSEEREFSPSF-VNFIN---LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 589
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
C Q + I I +V D F T+ L + +++++ A G+ YL I
Sbjct: 62 CT-QKQPIYIVMELVQGG-DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 650 HRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
HRDL A N L+ + KISDFGM+R G G K+I + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 708 VKSDVFSFGVLMLEILS 724
+SDV+SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 46/224 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 577
+ + +++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 578 LQHRNLVRL----LGCCIEQGEKILIY---EYMVN--KSL-----DVFLFDPTKKHLLGW 623
LQH N+V + +G +++ IY EY+ + KSL FL K +L
Sbjct: 61 LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML-- 113
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
QL + G+A +LH I+HRDLK SN+LL+ KI DFG+AR + G L+
Sbjct: 114 QL----LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLK 161
Query: 684 GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T+ +V T Y +PE L +S D++S G + E+L+ K
Sbjct: 162 PYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 30/237 (12%)
Query: 533 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G +I EY +L +L ++PT+ + L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLL--GH 742
+M+PE + +++ +SDV+SFGVL+ EI L GV + F LL GH
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 59/206 (28%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG G+ ++ E+ ++D + + + L Q++V I + + L YLH
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS- 128
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEYA 701
++IIHRDLKA N+LL + K++DFG++ ++ +R +GT +M+PE
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 702 L-----EGVFSVKSDVFSFGVLMLEI 722
+ + + K+D++S G+ ++E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 525 ENFSIQSKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQ 635
+H +V+ GC + EK L EYM S+ D K + L + R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGTYG 694
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+MSPE + K+DV+S ++E+L+ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 19/201 (9%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 586
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 587 LGCC-IEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
L C + ++ L++E+ V++ L +L K L ++ ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ RI+HRDLK NIL+ KI+DFG+AR++ + +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
L+ ++ D++S G + E+
Sbjct: 179 LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 582
+ I K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEY--------MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V E G ++ EY +N+ V ++ +L W ++ I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQ------IS 111
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTY 693
GL ++H +I+HRD+K+ NI L ++ M K+ DFG+AR T VGT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTP 166
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y+SPE ++ K+D++S G ++ E+ + K
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 532 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 584
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KH+ + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNI-TELVHQVSMGMKYLEETN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTYGYMSPEY 700
+HRDL A N+LL KISDFG+++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
FS KSDV+SFGVLM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
LG C++ + E++ S+ L F P + + + +I+DG+A YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV----GTYGYMSPEY 700
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
E + KSD++S G + E+ + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 56/201 (27%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + L+ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 QQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 36/216 (16%)
Query: 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNL 583
+++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 584 VRLLGCCI-----EQGEKILIYEYMVNKSLDVFLF---DP-----TKKHLLGWQLRVRII 630
VRL C + + L++E+ V++ L +L +P T K ++ +QL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM-FQL----- 119
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+GL +LH + R++HRDLK NIL+ K++DFG+AR++ Q +V
Sbjct: 120 ---LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 170
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L+ ++ D++S G + E+ K
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 30/213 (14%)
Query: 533 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 587
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLRVRIIDGI 633
G C +G L EY + +L FL DP T L QL + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL-LHFAADV 121
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G E+ K+ +G
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRL 173
Query: 694 G--YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+ E V++ SDV+S+GVL+ EI+S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 579
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 580 HRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQG 636
H +V+ GC + E+ L E+M S+ D K + L + + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGTYGY 695
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
MSPE + K+D++S G ++E+L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + LR I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL +H K++DFG+A +++ N VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 KQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 577
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 578 LQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR-IIDGIAQ 635
L H N+V+L E E ++EYM +L + D K + +R II I Q
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS--ESVIRSIIYQILQ 110
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN---TKRIVGT 692
GL ++H + HRDLK N+L+ KI+DFG+AR E++ T V T
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVST 161
Query: 693 YGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
Y +PE L +S D+++ G +M E+ + +
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 79/279 (28%), Positives = 134/279 (48%), Gaps = 46/279 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGLL 638
LG C+ + L+ + M L D +++ LL W ++ IA+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQ------IAKGMS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL + +R++HRDL A N+L+ + KI+DFG+AR+ DE + + +M+
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
E L F+ +SDV+S+GV + E+++ +K G+ + +LL K +R +
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE------KGERLPQ-- 232
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795
P+ +V + M+ C ++E RP ++V
Sbjct: 233 PPICTIDVYMIMVK--------CWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 21/199 (10%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 587
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
G ++ +I EY S+ + P + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI--VGTYGYMSPEYALEG 704
+IHRD+KA+NIL+ N K+ DFG+A + Q ++KR VGT +M+PE EG
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 705 V-FSVKSDVFSFGVLMLEI 722
+ K+D++S G+ + E+
Sbjct: 177 KYYDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
F I ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 584 VRLLGCCI----------EQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRII 630
V L ++G L++EYM + L+ L ++ H+ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSFM 122
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ +GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y PE L E + DV+S G ++ E+ + K
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-17
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L + I I +GL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LHQ+ ++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 181
Query: 700 YAL-----EGVFSVKSDVFSFGVLMLEI 722
+ + KSD++S G+ +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-17
Identities = 71/271 (26%), Positives = 128/271 (47%), Gaps = 28/271 (10%)
Query: 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++ + G G YKG+ + NG + VK +++ + E + + KLQH N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIG 750
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
C + LI+EY+ K+L L + L W+ R +I GIA+ L +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
+ +L I++D P + + + D I + Y++PE +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITE 857
Query: 709 KSDVFSFGVLMLEILSSKKNT----GVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
KSD++ FG++++E+L+ K GV + + +S C D +DP ++ +V
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDM---WIDPSIRGDV 913
Query: 765 SLPM--LVRYINVALLCVQENAEDRPTMSDV 793
S+ +V +N+AL C + RP +DV
Sbjct: 914 SVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-17
Identities = 93/334 (27%), Positives = 145/334 (43%), Gaps = 54/334 (16%)
Query: 533 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G ++ EY +L +L FD K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLL--GHAWS 745
+M+PE + V++ +SDV+SFGVL+ EI L G+ + F LL GH
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR-- 254
Query: 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805
MD L M++R C RPT +V + + + +
Sbjct: 255 ----------MDKPANCTHELYMIMRE------CWHAVPSQRPTFKQLVEDL-DRVLTVT 297
Query: 806 SPKE-----PPFTTFTKGKNMKYSSNSTSGTSEF 834
S E PF ++ G SS S+ S F
Sbjct: 298 STDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
++ Q LG G G VYK LL + +AVK + + + + K+ +E+ ++ K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ G + + E+M SLDV+ P +H+LG RI + +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIP--EHVLG-----RIAVAVVKGLTYLWS 113
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L+I+HRD+K SN+L++ K+ DFG++ + K VGT YM+PE
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERIS 166
Query: 703 EGVFSVKSDVFSFGVLMLEI 722
+ + SDV+S G+ +E+
Sbjct: 167 GEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 527 FSIQSKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 576
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
KL H +V+ +E+ +I EY + LD L T K L Q + +
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ----VCEWFI 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEI 722
YMSPE + KSD++S G ++ E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 53/231 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 573
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVR 628
++ +++H N++ L+ +E L+ + M + K +D + L + K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
I GL LH++ +HRDL +NI ++ KI+DFG+AR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 689 I------------VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE + + D++S G + E+L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
LG G +G V K R + G +AVKR+ + + Q K ++ + + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV------RIIDGIAQGLLYLHQY 643
+G+ + E M + SLD F K + L + +I I + L YLH
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI-VGTYGYMSPE--- 699
S+L +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 700 --YALEGVFSVKSDVFSFGVLMLEI 722
+G + VKSDV+S G+ M+E+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRN 582
F +++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLGWQL----------RVR-II 630
+V L E +V K LD +FL + L L +V+ ++
Sbjct: 68 IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ +GL YLH+ IIHRDLK SN+LL KI+DFG+AR + G + T ++V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170
Query: 691 GTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
T Y +PE L + D+++ G ++ E+L+ K
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 14/218 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E+ ++ +GEG FG VY+G ++ VAVK N + ++E F E ++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I + E L +L K+ L + ++ L Y
Sbjct: 66 HPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L R +HRD+ A N+L+ K+ DFG++R + +K + +M+PE
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPE 178
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTD 735
F+ SDV+ FGV M EIL K GV N D
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNL 583
+++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 584 VRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRL+ C ++ K+ L++E+ V++ L +L L ++ ++ +GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLD 122
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
+LH I+HRDLK NIL+ K++DFG+AR++ Q +V T Y +P
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAP 176
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E L+ ++ D++S G + E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 35/214 (16%)
Query: 528 SIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
I+ LG G FG + +G +L + +E VA+ L + S + + F E + + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGLLY 639
+VRL G +++ EYM N +LD FL +KH L+ QL + ++ G+A G+ Y
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQL-MGMLPGLASGMKY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS-- 697
L S + +H+ L A +L++ + KIS F + + Y MS
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGK 169
Query: 698 -------PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE FS SDV+SFG++M E++S
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 530 QSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRN 582
+K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHEN 72
Query: 583 LVRLLGCCIEQGEK--------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V L+ C + L++E+ L L + K L +++ +++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLS-EIK-KVMKMLL 129
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG---GDELQGNTKRIVG 691
GL Y+H R +I+HRD+KA+NIL+ + K++DFG+AR F + T R+V
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLE 721
T Y PE L E + D++ G +M E
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 54/214 (25%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L + S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ +L++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ N+LL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + E+ SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 702 L---EGVFSVKSDVFSFGVLMLEI 722
+G ++ D+++ G+ +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LL + ++ E+ ++D + + ++ L Q+RV + + L YLH+
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN 122
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI------VGTYGYMS 697
+IIHRDLKA NIL + K++DFG++ NT+ I +GT +M+
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMA 171
Query: 698 PEYAL-----EGVFSVKSDVFSFGVLMLEI 722
PE + + + K+DV+S G+ ++E+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + EY SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++ HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 702 L---EGVFSVKSDVFSFGVLMLEI 722
G ++ D+++ G+ +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 573
F +V T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L+ L+H N++ L I E I Y V + L L L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-----MFGGDELQGNTKR 688
+GL Y+H ++HRDLK SNIL++++ + KI DFG+AR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 689 IVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + V+ D++S G + E+L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 63/213 (29%), Positives = 111/213 (52%), Gaps = 14/213 (6%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 571
L + SV + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRII 630
++++ + +H N+V L + E ++ EY+ SL DV T+ + Q+ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAA-VC 121
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT +M+PE + K D++S G++ +E++
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 586
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 587 LGCCIEQ--GEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVR-IIDGIAQGLLYLH 641
+ ++ G L++E M D+ L++ K K L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
R I HRD+K NIL+ K++DFG R G T+ I T Y +PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170
Query: 702 L-EGVFSVKSDVFSFGVLMLEILS 724
L +G + K D+++ G + EILS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 3e-15
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 49/212 (23%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 590 CIEQGEKILIYEYMVNKSLD-------VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
GE ++ E+M SL+ FL D ++ I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
R I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERIN 241
Query: 700 ----------YALEGVFSVKSDVFSFGVLMLE 721
YA D++S GV +LE
Sbjct: 242 TDLNHGAYDGYA--------GDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 533 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRLR 647
+ + L+ M L +++ +++ + R I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
II+RDLK N+LLD N +ISD G+A + Q TK GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 708 VKSDVFSFGVLMLEILSSK 726
D F+ GV + E+++++
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKL- 58
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----------IIDGIAQGL 637
Y +K L + L LR R I +
Sbjct: 59 ------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH II+RDLK N+LLD + K+ DFG A+ + T GT Y++
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA 160
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEIL 723
PE L + D +S G+L+ E+L
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 60/191 (31%), Positives = 92/191 (48%), Gaps = 32/191 (16%)
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
T + L+ + +V A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR
Sbjct: 171 TLEDLISYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
Query: 676 MF--GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGV 731
D ++ R+ +M+PE + V++ +SDV+SFGVL+ EI S + GV
Sbjct: 222 DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
Query: 732 YNTDSF-NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTM 790
+ F L + + A E+ ML C N EDRPT
Sbjct: 280 QIDEEFCRRLKEGTRMRAPEYATP--------EIYSIMLD--------CWHNNPEDRPTF 323
Query: 791 SDVVSMINNEL 801
S++V ++ + L
Sbjct: 324 SELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 21/156 (13%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY ++ L + DP +QL +GL + H
Sbjct: 67 VLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQL--------LKGLAFCHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ ++HRDLK N+L++++ K++DFG+AR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + L + + + + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 711 DVFSFGVLMLEIL 723
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNL 583
+ S +G G +G V G++VA+K+LS QS K E+ L+ + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 584 VRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ LL + Y+V + L + K L ++ I +GL Y+H
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK SNI +++ KI DFG+AR DE+ G V T Y +PE L
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYRAPEIML 188
Query: 703 EGVFSVKS-DVFSFGVLMLEILSSK 726
+ ++ D++S G +M E+L+ K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
SK+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGW--QLRVRIIDGIAQGLLYLHQYSR 645
+ + L++EY D + + +K+ G L +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG- 704
IHRD+K NIL+ + K+ DFG AR+ G + V T Y +PE L G
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPEL-LVGD 175
Query: 705 -VFSVKSDVFSFGVLMLEILSS 725
+ DV++ G + E+L+
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + + +E K E+ ++ K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L I I +GL +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH + ++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 191
Query: 700 YAL-----EGVFSVKSDVFSFGVLMLEI 722
+ + +SD++S G+ +E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 533 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 583
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQ 642
V+L +G+ LI +++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L II+RDLK NILLD+ + K++DFG+++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+ +D +SFGVLM E+L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 76/302 (25%), Positives = 138/302 (45%), Gaps = 40/302 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
NLV L+ + L++E++ + LD P + L + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEY 700
++ IIHRD+K NIL+ Q K+ DFG AR E+ + V T Y +PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171
Query: 701 ALEGVFSVKS-DVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKN--DRAHELM 756
+ ++ D+++ G L+ E+L+ + ++ DS + L H N R E+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEP---LFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
Query: 757 D--PVLQNEVSLP-------MLVRY-------INVALLCVQENAEDRPTMSDVVSMINNE 800
P+ + LP + R+ +++A C++ + +DRP+ S ++++E
Sbjct: 229 QKNPLFAG-MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ---LLHHE 284
Query: 801 LF 802
F
Sbjct: 285 FF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 33/286 (11%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQE--VAVKRLSNQS---GQGLKE-------FKNEMM 573
+++ LG G FG VYK R N + +A+K ++ + G+ +E +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 574 LIAK-LQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+I + L+H N+VR +E ++ + + L + F KK + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L YLH+ R I+HRDL +NI+L + I+DFG+A+ + +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751
T Y PE + K+DV++FG ++ ++ Y+T N+L A +
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYST---NMLSLATKI----- 225
Query: 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ +P+ E V V C+ +AE RP + V +MI
Sbjct: 226 VEAVYEPL--PEGMYSEDVTD--VITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
IA GL +LH II+RDLK N++LD + KI+DFGM + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE + D ++FGVL+ E+L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 536 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCI 591
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 592 EQGEK--ILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
QG+K L+ EY+ L L D + I I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHSNG 113
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFG------MARMFGGDELQGNTKRIVGTYGYMSP 698
IIHRDLK NIL+D + + K++DFG + R ++ + KRIVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH+ II+RDLK N+LLD + KI+DFGM + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++ GVL+ E+L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 41/213 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 574
+ I KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 575 IAKL-QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ +L H N+V+LL + +K L++EYM + L + ++L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI-- 689
+ + L Y+H S +IHRDLK SNILL+ K++DFG+AR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 690 ---VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
V T Y +PE L S ++ GV M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 531 SKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ E G ++ +Y + D++ ++ +L + +I+D Q L L
Sbjct: 63 QYQESFEENGNLYIVMDYC--EGGDLYKKINAQRGVLFPE--DQILDWFVQICLALKHVH 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSPEYALE 703
+I+HRD+K+ NI L + K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICEN 175
Query: 704 GVFSVKSDVFSFGVLMLEILSSK 726
++ KSD+++ G ++ E+ + K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 88/340 (25%), Positives = 136/340 (40%), Gaps = 90/340 (26%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRN 582
LG G FG V + + VAVK L + G E K M +LI H N
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72
Query: 583 LVRLLGCCIE-QGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQ 635
+V LLG C + G ++I E+ +L FL F P ++ + R R + ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 636 G-------------------------------------------LLYLHQYSR------- 645
+ Y Q +R
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYALE 703
+ IHRDL A NILL ++ KI DFG+AR D ++ + R+ +M+PE +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFD 250
Query: 704 GVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
V++ +SDV+SFGVL+ EI S + GV + F C+ + M
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------CQRLKDGTRMR---A 298
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
E + P + R + L C Q + ++RPT S +V ++ + L
Sbjct: 299 PENATPEIYR---IMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 43/217 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F LG G FG V R + A+K LS LK+ NE ++ ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRV--RIIDGIA 634
LV L G Q + L Y+V ++ LF LR R + +A
Sbjct: 61 PFLVNLYGS--FQDDSNL---YLV---MEYVPGGELFS---------HLRKSGRFPEPVA 103
Query: 635 Q--------GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ L YLH L I++RDLK N+LLD KI+DFG A+ ++G T
Sbjct: 104 RFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRT 155
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ GT Y++PE L + D ++ G+L+ E+L
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ---GLLYLHQY 643
+ L+ M L +++ ++ G ++ R+I AQ G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEME-RVIHYSAQITCGILHLHS- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ I++RD+K N+LLD N ++SD G+A + G + T+R GT GYM+PE
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR-AGTNGYMAPEILK 167
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
E +S D F+ G + E+++ +
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 582
++F S+LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE- 172
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
L+G +SV+SD++S G+ ++E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 28/175 (16%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRI 689
+AQG+ +L + IHRD+ A N+LL KI DFG+AR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN---TGVYNTDSFNLLGHAWSL 746
V +M+PE + V++V+SDV+S+G+L+ EI S K+ + N+ + ++ + +
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334
Query: 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
+ D A + +++ +C +RPT S + +I +L
Sbjct: 335 SRPDFAPPEIYSIMK----------------MCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 51/227 (22%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIA 576
+ + +G G +G V G++VA+K++SN F + E+ L+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 577 KLQHRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQL 625
L+H N++ LL + + ++ E M V KS + L
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS---------PQPLT--DD 103
Query: 626 RVRIIDGIAQ---GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
++ + Q GL YLH +IHRDLK SNIL++ + + KI DFG+AR DE
Sbjct: 104 HIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 683 QGN--TKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
+ T+ +V T Y +PE L ++ D++S G + E+L+ K
Sbjct: 159 EKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 522 AATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 578
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH-----LLGWQLRVRIIDG 632
+H N+V LL I E + ++EYM + P H L +QL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------- 112
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL Y+H I+HRDLK N+L+ K++DFG+AR Q + +V T
Sbjct: 113 -LRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-T 166
Query: 693 YGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
Y P+ L +S D++ G + +E+L
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL--LGWQLRVRIIDG--IAQGLLYLHQ 642
+ L+ M L ++ H+ G++ + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-----HMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYA 701
RI++RDLK NILLD H + +ISD G+A + G ++G VGT GYM+PE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 173
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
++ D ++ G L+ E+++ +
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 12/194 (6%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 591 IEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+ E ++ E++ +L D+ T + Q+ + + + L +LH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHAQ---GVI 137
Query: 650 HRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVK 709
HRD+K+ +ILL K+SDFG + + K +VGT +M+PE + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTE 195
Query: 710 SDVFSFGVLMLEIL 723
D++S G++++E++
Sbjct: 196 VDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 47/226 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 578
+ S +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 579 QHRNLVRLLGC----CIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----- 628
+H N++ +L E + ++ E M T + L ++ +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-----------ETDLYKL---IKTQHLSND 106
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ I +GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR+ D
Sbjct: 107 HIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 685 NTKRI---VGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
+T + V T Y +PE L K+ D++S G ++ E+LS++
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 533 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 588 -----GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
IE ++ Y+V + L + K L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK SN+ +++ +I DFG+AR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 703 EGV-FSVKSDVFSFGVLMLEILSSK 726
+ ++ D++S G +M E+L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 44/154 (28%)
Query: 594 GEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GE + E+M SLD L KK ++LG +I + +GL YL + + +
Sbjct: 72 GEISICMEHMDGGSLDQVL----KKAGRIPENILG-----KISIAVLRGLTYLRE--KHK 120
Query: 648 IIHRDLKASNILLDQHMNPKISDFG--------MARMFGGDELQGNTKRIVGTYGYMSPE 699
I+HRD+K SNIL++ K+ DFG MA F VGT YMSPE
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPE 168
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY 732
L+G ++V+SD++S G+ ++E+ G Y
Sbjct: 169 -RLQGTHYTVQSDIWSLGLSLVEMA-----IGRY 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ L ++ L +QL +GL Y HQ
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQL--------LRGLAYCHQ 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R++HRDLK N+L+ + K++DFG+AR
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYL 640
N+V L + L++EY+ +K L +L D ++ +L + + +GL Y
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL---FLFQLLRGLNYC 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPE 699
H R +++HRDLK N+L+++ K++DFG+AR + T V T Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPD 174
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSK 726
L +S + D++ G + E+ + +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-12
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 549 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCIEQGEKILIYEYM 603
G EVA+K L + + + F+ E L A+L H N+V LL G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 604 VNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
++L +V D +L ++++D +A +++ I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALA------CAHNQ-GIVHRDLKPQNIMVSQ 114
Query: 661 -DQHMNPKISDFGMARMFGG----DELQGN-TKRIVGTYGYMSPEYALEGVFSVKSDVFS 714
+ K+ DFG+ + G D T ++GT Y +PE + SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 715 FGVLMLEILSSK 726
+G++ LE L+ +
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 65/257 (25%), Positives = 102/257 (39%), Gaps = 39/257 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 582
F I +++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+LL + L EY+ L L R + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L IHRDLK N L+D + K++DFG+++ G +VG+ YM+PE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 703 EGVFSVKSDVFSFGVLMLEIL--------SSKKNT-------------GVYNTDSFNLLG 741
+ D +S G ++ E L S+ T VY+ FNL
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 742 HAWSL---CKNDRAHEL 755
AW L ND +
Sbjct: 232 EAWDLITKLINDPSRRF 248
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 27/267 (10%)
Query: 533 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 590 CIEQGEKILIYEYM-VNKSLDVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
+GE L+Y M + D++ K LL V IA L YLH+
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
I+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180
Query: 708 VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLP 767
KSDV++ G + E+ + K +N N L + R E P + + S P
Sbjct: 181 YKSDVWALGCCVYEMATLKH---AFNAKDMNSLVY--------RIIEGKLPPMPKDYS-P 228
Query: 768 MLVRYINVALLCVQENAEDRPTMSDVV 794
L I +L + E RP++ ++
Sbjct: 229 ELGELIA-TMLSKR--PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+ L+ M L + FD + + I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
LH R RI++RDLK NILLD + + +ISD G+A + G+ ++G VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E ++ D + G L+ E++ K
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 45/217 (20%)
Query: 531 SKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
S +G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 588 GCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLR--VR-----------II 630
+ +SL DV+L HL+G L V+ +I
Sbjct: 83 DV------------FTPARSLEEFNDVYLV----THLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR DE+ G V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 178
Query: 691 GTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
T Y +PE L + ++ D++S G +M E+L+ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 27/235 (11%)
Query: 497 CEADGDGKDKSKDSSL-PLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK 555
+ D D L P A A+ +++ L G G V+ GQ V
Sbjct: 37 DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95
Query: 556 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
Q G L E ML+ + H +++R+ + ++ + S D++ +
Sbjct: 96 LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLT 148
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ L + I I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 676 ------MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
F G + GT +PE ++ K+D++S G+++ E+L+
Sbjct: 206 FPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
++F S+LG G G V+K +G +A K + + ++ + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE- 172
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
L+G +SV+SD++S G+ ++E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 78/308 (25%), Positives = 123/308 (39%), Gaps = 51/308 (16%)
Query: 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
CC + +++ VN +F +++ + R R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHDKG-- 116
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYGYMSPEYALEG 704
II+RDLK N+LLD + K++DFGM + +F G T GT Y++PE E
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQEM 171
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
++ D ++ GVL+ E+L GHA +N+ +L + +L +EV
Sbjct: 172 LYGPSVDWWAMGVLLYEMLC----------------GHAPFEAENE--DDLFEAILNDEV 213
Query: 765 SLPMLVRYINVALL-------------CVQENAEDRPTMSDVVSMINNELFNLPSPKEPP 811
P + V +L + E+ ++ E N EPP
Sbjct: 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN-RRQIEPP 272
Query: 812 FTTFTKGK 819
F K +
Sbjct: 273 FRPRIKSR 280
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 49/237 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQH 580
+ + I +G+GG G VY + + VA+K++ + S L K F E + A L H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG--WQLRV----------- 627
+V + C G+ +Y M ++ T K LL WQ
Sbjct: 62 PGIVPVYSIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 628 ----RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE-- 681
I I + Y+H S+ ++HRDLK NILL I D+G A +E
Sbjct: 113 GAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 682 ---LQGNTK-----------RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ + + +IVGT YM+PE L S +D+++ GV++ ++L+
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRI 689
+A+G+ +L + IHRDL A NILL KI DFG+AR D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
V +M+PE V++ +SDV+S+G+L+ EI S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L L++EY+ +K L ++ D +++ + I +GL Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH 121
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
R +++HRDLK N+L+++ K++DFG+AR + T V T Y P+
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDV 175
Query: 701 AL-EGVFSVKSDVFSFGVLMLEILSSK 726
L +S + D++ G + E+ S +
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 15/130 (11%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H ++R +++RDLK +NILLD+H + +ISD G+A F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 701 ALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
+GV + +D FS G ++ ++L + T + + DR M
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---------DRMTLTMAVE 217
Query: 760 LQNEVSLPML 769
L + S +
Sbjct: 218 LPDSFSPELR 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 34/93 (36%), Positives = 54/93 (58%)
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
Y++PE +S K+D+FS GVL+ E+L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHR 581
+ + K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 582 N-LVRLLGCCIEQGE----KILIY---EYMVNKSLDVFL----------FDPTKKHLLGW 623
+VRLL +E E K +Y EY+ + L F+ +
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDEL 682
QL +G+ + H++ ++HRDLK N+L+D+ KI+D G+ R F +
Sbjct: 118 QL--------LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPV 165
Query: 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
+ T IV T Y +PE L +S D++S G + E+
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 72/282 (25%), Positives = 111/282 (39%), Gaps = 40/282 (14%)
Query: 532 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G CIE +L+ E+ L +L K L R+ +A GLL+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLLW 115
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
LHQ IH DL N L ++ KI D+G+A + D V +++P
Sbjct: 116 LHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAP 171
Query: 699 EYA-------LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751
E L + KS+++S GV M E L + + + +L ++
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWE-LFTAADQPYPDLSDEQVLKQV----VREQ 226
Query: 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
+L P L L R+ V C + E RPT +V
Sbjct: 227 DIKLPKPQLD----LKYSDRWYEVMQFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 36/275 (13%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-----LHQY 643
+ ++ L+++Y + + F K + V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSP 698
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 699 EYALEGVFSVKS-DVFSFGVLMLEILSSK----------KNTGVYNTDS----FNLLGHA 743
E L K+ D+++ G + E+L+S+ K + Y+ D FN++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 744 ----WSLCKNDRAHE-LMDPVLQNEVSLPMLVRYI 773
W K H LM +N + L++Y+
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 37/89 (41%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
G+ LHQ IIHRD+K N+L+DQ + K++DFG++R G E K+ VGT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDY 159
Query: 696 MSPEYALEGVFSVK-SDVFSFGVLMLEIL 723
++PE + GV K SD +S G ++ E L
Sbjct: 160 LAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G++ R + A+ L L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFE-EERALFYAAEILCGLEDLHRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
++RDLK NILLD + + +ISD G+A ++ G+ ++G VGT GYM+PE
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQR 177
Query: 706 FSVKSDVFSFGVLMLEILSSK 726
+++ D + G L+ E++ +
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 51/283 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR 581
+ ++G G G VYK R G +AVK++ + +E K +M + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 582 --NLVRLLGCCIEQGEKILIYEYMVN--KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G I + + E M L + P + +LG ++ V I+ + L
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-KMTVAIV----KAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYM 696
YL + + +IHRD+K SNILLD N K+ DFG++ R+ + + T R G YM
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYM 181
Query: 697 SPEY----ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752
+PE + +++DV+S G+ ++E+ TG + + CK +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELA-----TGQF----------PYKNCKTE-- 224
Query: 753 HELMDPVLQNEVSLPML-------VRYINVALLCVQENAEDRP 788
E++ +LQ E P L + + LC+ ++ RP
Sbjct: 225 FEVLTKILQEE--PPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
VR+ IA+ +L L +L II+RD+K NILLD + ++DFG+++ F +E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 686 TKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILS 724
GT YM+PE G D +S GVL E+L+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNL 583
F + +GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L +G+ L++EY+ L++ P ++ I Q + +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWC 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ I+HRD+K N+L+ + K+ DFG AR + N V T Y SPE L
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLG 175
Query: 704 GVFSVKSDVFSFGVLMLEI 722
+ D++S G ++ E+
Sbjct: 176 APYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
I E + L++EY V+ L ++ P L +QL +GL Y+H
Sbjct: 70 DIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL--------LRGLSYIH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
Q I+HRDLK N+L+ K++DFG+AR + +T V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 701 ALEGV-FSVKSDVFSFGVLMLEIL 723
L +S D++ G + +E++
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 711 DVFSFGVLMLEILSSK 726
D++S G++++E++ +
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 532 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
G C E +L+ E+ L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-- 703
IH DL N LL + KI D+G++ ++ ++ +++PE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 704 GVFSV-----KSDVFSFGVLMLEIL 723
G V +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 532 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 711 DVFSFGVLMLEILSSK 726
D++S G++++E++ +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 7/94 (7%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIV 690
+A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE + V++++SDV+SFGVL+ EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 526 NFSIQSKLGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ +GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLL 638
V G ++ EY L + + +L W ++ + G+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQ 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
++H+ R++HRD+K+ NI L Q+ K+ DFG AR+ T VGT Y+ P
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPP 169
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E ++ KSD++S G ++ E+ + K
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH+ II+RDLK N+LLD+ + KI+DFGM + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L+ G+ LI EY+ L +F+ D +L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL----------SEISLAL 113
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN--TKRIVGTYGY 695
+LHQ II+RDLK NILLD + K++DFG+ + + + T GT Y
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
M+PE + D +S G LM ++L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
+G + EYM SLD + + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG---- 704
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 705 --VFSVKSDVFSFGVLMLEI 722
++V+SDV+S G+ +LE+
Sbjct: 181 NPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 533 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 588 GCCIEQGEKILIYE--YMVNKSL--DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
I Q I +E Y+V + + D+ + + L ++V + I +GL YLH
Sbjct: 66 D--ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ-ILRGLKYLHS- 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
I+HRD+K N+L++ + KI DFG+AR+ DE + T+ +V Y Y +PE L
Sbjct: 122 --AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI-LM 177
Query: 704 GV--FSVKSDVFSFGVLMLEILSSK 726
G ++ D++S G + E+L +
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G+ + R I A+ L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQ-RAIFYAAELCCGLEDLQRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
RI++RDLK NILLD + +ISD G+A ++ G+ ++G VGT GYM+PE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 706 FSVKSDVFSFGVLMLEIL 723
++ D + G L+ E++
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 527 FSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIA 576
F + LG G FG V YK G+ A+K L + + L K
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRII 630
+H LV L C + + EY L DVF + R
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----------EPRAVFY 106
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
+ GL YLH+ +I++RDLK N+LLD KI+DFG+ + M GD T
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TS 159
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT +++PE E ++ D + GVL+ E+L
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 32/84 (38%), Positives = 53/84 (63%), Gaps = 6/84 (7%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H ++R +++RDLK +NILLD+H + +ISD G+A F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 701 ALEGV-FSVKSDVFSFGVLMLEIL 723
+G + +D FS G ++ ++L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G++VA+K+LS QS K E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 590 CIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ Y+V + L K L +Q+ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
IIHRDLK N+ +++ KI DFG+AR E+ G V T Y +PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRAPEVI 186
Query: 702 LEGVFSVKS-DVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+L+ K
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 17/209 (8%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDG----IAQGLLYLHQY 643
+ ++ L+++Y + + F +K + QL ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSP 698
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 699 EYALEGVFSVKS-DVFSFGVLMLEILSSK 726
E L K+ D+++ G + E+L+S+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ L F + + V+I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L +LH +L II+RD+K NILLD + + ++DFG+++ F DE++ GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 696 MSPEYAL--EGVFSVKSDVFSFGVLMLEILS 724
M+P+ +G D +S GVLM E+L+
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L + L++EY+ + L +L D + +++ + + +GL Y H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +I+HRDLK N+L+++ K++DFG+AR
Sbjct: 121 ---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
+ S+ T+ + I +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 573 MLIAKL-QHRNLVRLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPTKKHLL--GWQ 624
++ L H N+V+ G + G+ L+ E S+ + K LL G +
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 625 LRVRIIDGIAQG-LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L +I I G LL L RIIHRD+K +NILL K+ DFG++ L+
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 684 GNTKRIVGTYGYMSPEY-----ALEGVFSVKSDVFSFGVLMLEI 722
NT VGT +M+PE + + + DV+S G+ +E+
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQ 635
++RL +Q ++ EY+ L +L F + + I
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVC 112
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L YLH I++RDLK NILLD+ + K++DFG A+ +L+ T + GT Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
++PE + D ++ G+L+ E+L
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV F++ + +G G G V + GQ VA+K+LS Q+ K
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKILIYEYMVNKSLDVFLFDPTKKHL- 620
E++L+ + H+N++ LL Q + L+ E M V D + +
Sbjct: 62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS 121
Query: 621 -LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
L +Q+ G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 122 YLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ T +V Y Y +PE L + D++S G +M E++
Sbjct: 171 SFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAK 577
+ +G G +G V +G++VA+K++ + + L+E K ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDG---- 632
+H N++ + I DV++ D L+ L II
Sbjct: 61 FKHDNIIAIRD----------ILRPPGADFKDVYVVMD-----LMESDLH-HIIHSDQPL 104
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGG 679
+ +GL Y+H + +IHRDLK SN+L+++ +I DFGMAR
Sbjct: 105 TEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 680 DELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEIL 723
E + V T Y +PE L ++ D++S G + E+L
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH I++RDLK NILLD + KI+DFGM + M G T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE L ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-10
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 48/289 (16%)
Query: 469 NETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE--- 525
E +N DL A + ++ D D +PL A + E
Sbjct: 90 GELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQ-AKLKHDDEFLA 148
Query: 526 NFSIQSKLGEGGFGPVY--KGRLLNGQEVAVKRLSNQSGQGLKEFK-------------- 569
+F + L G FG ++ R + A +R N + QG + +
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEA-RRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 570 ----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE---YMVNKSLDV----FLFDPT-- 616
NE++ + +L H N++++ E+IL E YM+ + D F++D
Sbjct: 208 IQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFD 259
Query: 617 -KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
K L Q R I+ + + Y+H ++IHRD+K NI L+ + DFG A
Sbjct: 260 WKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
F E + VGT SPE + +D++S G+++L++LS
Sbjct: 316 PF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 528 SIQSKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLL 638
N++ + I E ++ M S + L K H L I+ + L
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQ----GNTKRIVGTY 693
Y+H IHR +KAS+ILL +S + M + Q K V
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 694 GYMSPEY---ALEGVFSVKSDVFSFGV 717
++SPE L+G ++ KSD++S G+
Sbjct: 173 PWLSPEVLQQNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYG 694
L++LH++ +I+RDLK NILLD + K++DFGM + + G T GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPD 161
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y++PE E + D ++ GVLM E+++ +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 533 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL-- 80
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDP--------TKKHLLGWQLRVR-IIDGIAQGLLYL 640
+ + +++ D +L P KH + R++ ++ + +GL Y+
Sbjct: 81 ------DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H IIHRDLK N+ +++ KI DFG+AR E+ G V T Y +PE
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYRAPEV 186
Query: 701 ALEGV-FSVKSDVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+L+ K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 348 KSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMW 406
KS D F +L + KLP + ++ +L+EC ++CL NCSCR++ + G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 407 -FGDLIDLKKTDNHTNGVSIYIRV 429
L D + + GV +Y ++
Sbjct: 57 SESSLGDARLFPSG--GVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IA GL +LH II+RDLK N++LD + KI+DFGM + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y++PE + D ++FGVL+ E+L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 549 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCIEQG 594
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 595 EKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ EYM + L+ L +QL +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--------LRGLKYIHSAN---VLHR 138
Query: 652 DLKASNILLDQH-MNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSPEYALEGVFSVK 709
DLK +N+ ++ + KI DFG+AR+ +G + T Y SP L K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198
Query: 710 S-DVFSFGVLMLEILSSK 726
+ D+++ G + E+L+ K
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 63/243 (25%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
++F + +G G FG V+ R + +V A+K L NQ + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 577 KLQHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+V+L Q E+ L + EYM L + +R +
Sbjct: 57 DADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEET 102
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA--------RMFGGD 680
IA+ +L L +L IHRD+K NIL+D + K++DFG+ R + +
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 681 ELQGNTKR-------------------IVGTYGYMSPEYALEGV-FSVKSDVFSFGVLML 720
+ R VGT Y++PE L G + ++ D +S GV++
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221
Query: 721 EIL 723
E+L
Sbjct: 222 EML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ GL +LH R II+RDLK N++LD + KI+DFGM + M G T+
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
GT Y++PE + D +++GVL+ E+L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV A F++ + +G G G V + G VAVK+LS Q+ K
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKH 619
E++L+ + H+N++ LL Q + Y+V + +D L D +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 620 LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
L +Q + G+ +LH IIHRDLK SNI++ KI DFG+AR
Sbjct: 127 YLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175
Query: 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ + T +V Y Y +PE L + D++S G +M E++
Sbjct: 176 NFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ EK+ VN ++F ++ L + R R +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG-ELFFHLQRERCFL--EPRARFYAAEVASAIGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
II+RDLK NILLD + ++DFG+ + G E + T GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 707 SVKSDVFSFGVLMLEIL 723
D + G ++ E+L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGL 565
F SV F++ + +G G G V Y L + VA+K+LS Q+
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 566 KEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
K E++L+ + H+N++ LL +E+ + + Y+V + +D L + L
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV----YLVMELMDANLCQVIQMEL 116
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
++ + + G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 117 DHERMSYLLYQMLC-GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+ T +V Y Y +PE L + D++S G +M E++ K
Sbjct: 173 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 579
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI-----A 634
H V L G ++ L+ E+++ FL + R + + A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAA 138
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q +L L I++RDLK N+LLD+ K++DFG A++ + T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
Y++PE L +D ++ G+ + EIL
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 533 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 582
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L G C+ E I++ EY+ LDVFL L W+L V +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-------KISDFGMARMFGG-DELQGNTKRIVGTYG 694
+++H ++ NIL+ ++ K+SD G+ +E +RI
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169
Query: 695 YMSPEYALEGVFSVKS--DVFSFGVLMLEILS 724
+++PE G S+ D +SFG +LEI S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ +K+ VN ++F ++ + R R IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGG-ELFFHLQRERSFP--EPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
II+RDLK NILLD + ++DFG+ + G E T GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 707 SVKSDVFSFGVLMLEILS 724
D + G ++ E+L
Sbjct: 174 DRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI 575
F S ++ + I +G+G +G V+K NG + AVK L +E + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 576 AKLQ-HRNLVRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ G ++ G+++ L+ E S+ + K+ G ++ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPI 125
Query: 630 IDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
I I GL +LH + IHRD+K +NILL K+ DFG++ L+ N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 686 TKRIVGTYGYMSPEY-----ALEGVFSVKSDVFSFGVLMLEI 722
T VGT +M+PE L+ + + DV+S G+ +E+
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ + L+ + + + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFS--EDEVRFYSGEIIL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L +LH +L I++RD+K NILLD + ++DFG+++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 696 MSPEYAL-EGVFSVKSDVFSFGVLMLEILS 724
M+PE +G D +S G+L+ E+L+
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVG 691
+A+ +L + +L +HRD+K N+LLD++ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 692 TYGYMSPEY--ALE---GVFSVKSDVFSFGVLMLEIL 723
T Y+SPE A+E G + + D +S GV M E+L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 527 FSIQSK------LGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMM 573
F + +K +G G +G V + ++VA+K+++N + + L+E K
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK---- 56
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
L+ L H N++ + E + ++YE M + +S L D ++ L
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLY 115
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
LR GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR E
Sbjct: 116 QLLR---------GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEK 161
Query: 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L ++ DV+S G + E+L K
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH II+RDLK N++LD+ + KI+DFGM + +FG
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQ 579
+ + +LG+G +G V + VA+K+++N + + K E+ L+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 580 -HRNLVRLLGCCI---EQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRI 629
H+N+ L I ++ +YE ++ L L D + + +Q
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQ----- 113
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTK 687
I GL Y+H + ++HRDLK N+L++ KI DFG+AR F E G
Sbjct: 114 ---ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 688 RIVGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
V T Y +PE L K+ DV+S G ++ E+L K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 533 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQY 643
G C+ E I++ EY+ SLD +L + W+L V A+ L + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV------AKQLAWALHFL 116
Query: 644 SRLRIIHRDLKASNILL-----DQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYGY 695
+ H ++ A N+LL + NP K+SD G++ E+ +RI +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PW 170
Query: 696 MSPEYALEG-VFSVKSDVFSFGVLMLEILS 724
+ PE S+ +D +SFG + EI S
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A+G+ +L + +HRDL A N+LL Q KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE + +++ SDV+S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 24/187 (12%)
Query: 550 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEY 602
+ VA+K+LS Q+ K E++L+ + H+N++ LL +E+ + + I
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 603 MVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
+++ +L + D + L +Q+ G+ +LH IIHRDLK SNI+
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIV 158
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ KI DFG+AR G + T +V Y Y +PE L + D++S G +M
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 720 LEILSSK 726
E++
Sbjct: 216 GEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 27/275 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLLYLHQYSRL 646
G C+E +L++EY L +L L + R+ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALE-- 703
+H DL N L + K+ D+G+ + D ++ + V +++PE E
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVGEFH 177
Query: 704 -GVFSVK----SDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
G+ + + S+V++ GV + E+ + + +L H D+ +L P
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQP-YSHLSDREVLNHVI----KDQQVKLFKP 232
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
L+ LP R+ V C + E R T +V
Sbjct: 233 QLE----LPYSERWYEVLQFC-WLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 18/137 (13%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750
GT Y++PE + D ++ GVLM E+++ + F+++G + + +N
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDNPDQNT 209
Query: 751 RAHELMDPVLQNEVSLP 767
+ L +L+ ++ +P
Sbjct: 210 EDY-LFQVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVG 691
IA+ +L +H +L +HRD+K N+LLD + + +++DFG +M +Q + VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 692 TYGYMSPEY--ALE---GVFSVKSDVFSFGVLMLEIL 723
T Y+SPE A+E G + + D +S GV M E+L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 45/217 (20%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 578
+F + LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSL------------DVFLFDPTKKHLLGWQLR 626
H +V ++ ++ + E++V L DV F +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE--------- 126
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ YLH II+RDLK N+LLD + K++DFG A+ ++ T
Sbjct: 127 ------LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRT 172
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ GT Y++PE D ++ GVL+ E +
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+ L L + +I+RDLK NILLD + + DFG+ ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
Y++PE L ++ D ++ GVL+ E+L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQYSRL 646
+ EK+ VN LF ++ + R R IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
I++RDLK NILLD + ++DFG+ + G T GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 707 SVKSDVFSFGVLMLEIL 723
D + G ++ E+L
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 27/245 (11%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ + +Y+ L F ++ + R R IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
I++RDLK NILLD + ++DFG+ + E G T GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 707 SVKSDVFSFGVLMLEIL------SSKKNTGVYNTDSFNLLGHAWSLCKN--DRAHELMDP 758
D + G ++ E+L S+ +Y+ N+L L N + A L++
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKPNITNSARHLLEG 229
Query: 759 VLQNE 763
+LQ +
Sbjct: 230 LLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMMLIAKLQ 579
+ IQ +G+G +G V G++VA+K++++ + + L+E K L+ L+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK----LLRLLR 57
Query: 580 HRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKH--LLGWQLR 626
H ++V + + E + +++E M V K+ D D T +H +QL
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQL- 112
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGN 685
+ L Y+H + + HRDLK NIL + KI DFG+AR F
Sbjct: 113 -------LRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKS----DVFSFGVLMLEILSSK 726
V T Y +PE L G F K D++S G + E+L+ K
Sbjct: 163 WTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 3e-07
Identities = 72/302 (23%), Positives = 131/302 (43%), Gaps = 67/302 (22%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHR 581
+ + K+G G FG V+ + QE + S +GLKE + ++I +L+H+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDV-----------FLFDPTKKHLLGWQLRVRII 630
N+VR + + + + L Y++ + D +F ++H + V I
Sbjct: 73 NIVRYIDRFLNKANQKL---YILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDIT 124
Query: 631 DGIAQGLLYLHQY----SRLRIIHRDLKASNILLD---QHMN--------------PKIS 669
+ L Y H + R++HRDLK NI L +H+ KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV--KSDVFSFGVLMLEILSSKK 727
DFG+++ G ++ VGT Y SPE L S KSD+++ G ++ E+ S K
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK- 240
Query: 728 NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR 787
T + ++F+ L + + R +L P+ L +L++ + + +A++R
Sbjct: 241 -TPFHKANNFSQL-----ISELKRGPDL--PIKGKSKELNILIKNL------LNLSAKER 286
Query: 788 PT 789
P+
Sbjct: 287 PS 288
|
Length = 1021 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 15/99 (15%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L +LH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSK 726
GT Y++PE L G FSV D ++ GVLM E+++ +
Sbjct: 158 GTPNYIAPE-ILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 2/156 (1%)
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR 628
++E+ +A H +V+ + +LI EY L+ + K+HL + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE +S K+D++S GV++ E+L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I L +LH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
GT Y++PE + D ++ GVLM E+++ +
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 23/214 (10%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-------SGQGLKEFKNEM 572
+ ++I S L G G V+ V K Q + G K E+
Sbjct: 87 ASVVRMQYNILSSLTPGSEGEVF---------VCTKHGDEQRKKVIVKAVTGGKTPGREI 137
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
++ + HR ++ L+ K + M D+F + + L + + I
Sbjct: 138 DILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRR 193
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ + L YLH IIHRD+K NI LD+ N + DFG A GT
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
SPE + K+D++S G+++ E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 584 VRL--------LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGW---QLRVRIID 631
+ L L ++ + L+ EY++ + L H+ G+ ++ V+ I
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+A L YLH++ IIHRDLK N+L+ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH S +++RDLK N++LD+ + KI+DFG+ + G + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735
Y++PE + + D + GV+M E++ + YN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 579
E+F I +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
++ + L ++ L+ +Y V L + L + L R +A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY----LAEMVIA 114
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
+ +L +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 699 EY--ALE---GVFSVKSDVFSFGVLMLEIL 723
E A+E G + + D +S GV M E+L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 22/172 (12%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A G+ +L + +HRDL A N+L+ + KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS---SKKNTGVYNTDSFNLLGHAWSLCKN 749
+M+PE +++ SDV+SFG+L+ EI + + N +N + + + K
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
A + + ++Q C +E E RP S +V ++ + L
Sbjct: 365 AHASDEIYEIMQK----------------CWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 46/222 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 573
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 574 ---LIAKLQHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFL--FDPTKKHLLGWQLR 626
++A +V+L Q +K L + EYM L + +D +K W
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WA-- 144
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGN 685
A+ +L L + IHRD+K N+LLD+ + K++DFG +M ++ +
Sbjct: 145 ---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 686 TKRIVGTYGYMSPEYAL----EGVFSVKSDVFSFGVLMLEIL 723
T VGT Y+SPE +G + + D +S GV + E+L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IA+ +L L + I++RDLK NILLD + + DFG+++ D NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEI 722
Y++PE L E ++ D +S GVL+ E+
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSN-----QSGQGLKEFKNEMMLIAKL 578
E++ + +G G FG V R + Q+V A+K LS +S F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
+V+L C Q +K L + EYM L + +D +K W A
Sbjct: 101 NSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TA 149
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTY 693
+ +L L + +IHRD+K N+LLD+H + K++DFG +M ++ +T VGT
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTP 207
Query: 694 GYMSPEY----ALEGVFSVKSDVFSFGVLMLEIL 723
Y+SPE +G + + D +S GV + E+L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +++RDLK N++LD+ + KI+DFG+ + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
Y++PE + + D + GV+M E++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 51/228 (22%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQ 579
+ +++ + + +G G FG VY+ ++ E VA+K++ ++KN E++++ L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 580 HRNLVRLLGC----CIEQGEKIL------------IYEYMV-----NKSLDVFLFDPTKK 618
H N++ L C ++ EK + +++YM N +L +FL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK---- 173
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMAR-M 676
L +QL + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ +
Sbjct: 174 -LYSYQL--------CRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
G Q + I + Y +PE L ++ D++S G ++ E++
Sbjct: 222 LAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 13/150 (8%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RL 586
S L G VY ++ +K ++ +E + ++ + + V ++
Sbjct: 1 SSIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKV 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
L G L+ E++ ++LD + + I + +A+ L LHQ L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLL 108
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARM 676
+ H DL NIL+D I D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 7/108 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +I++RDLK N++LD+ + KI+DFG+ + G K GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740
Y++PE + + D + GV+M E++ + YN D L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +++RD+K N++LD+ + KI+DFG+ + D K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735
Y++PE + + D + GV+M E++ + YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM---------FGG----DELQ 683
L YLH Y I+HRDLK N+L+ + K++DFG++++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
K++ GT Y++PE L + D ++ G+++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 74/322 (22%), Positives = 125/322 (38%), Gaps = 71/322 (22%)
Query: 529 IQSKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 584 VRLLGCCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+ +I +M N L + + + L+G I+ G +GL Y
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNY 116
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-----QGNTKRIVGTYG 694
LHQ IHR++KAS+IL IS G+ + G L G ++V +
Sbjct: 117 LHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165
Query: 695 --------YMSPEYALEGV--FSVKSDVFSFGVLMLEI---------------LSSKKNT 729
++SPE + + ++VKSD++S G+ E+ L K
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225
Query: 730 GVYNTDSFNLLGHAWSLCKNDRA----------------HELMDPVLQNEVSLPMLVRYI 773
Y+ S KN ++ + L+ S +
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285
Query: 774 NVALLCVQENAEDRPTMSDVVS 795
N+ LC+Q++ E RP+ S ++S
Sbjct: 286 NLVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A+ +L +H ++ +HRD+K N+L+D+ + K++DFG A +++ N+K VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGT 166
Query: 693 YGYMSPEY------ALEGVFSVKSDVFSFGVLMLEIL 723
Y++PE +G + V+ D +S GV+ E++
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 35/127 (27%), Positives = 54/127 (42%), Gaps = 36/127 (28%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM------------ARMFGGD 680
IA+ +L + +L IHRD+K N+LLD + K+SDFG+ R+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 681 ----------------ELQGNTKR--------IVGTYGYMSPEYALEGVFSVKSDVFSFG 716
KR VGT Y++PE L+ ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 717 VLMLEIL 723
V+M E+L
Sbjct: 227 VIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 53/268 (19%), Positives = 112/268 (41%), Gaps = 44/268 (16%)
Query: 541 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK- 596
+YKG N +EV ++ + +NE+ + ++ N++++ G I+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 597 ---ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653
LI EY L L K+ L ++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS---VKS 710
+ + L+ ++ KI G+ ++ L + V Y S + L +FS +K
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKD 203
Query: 711 DVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLV 770
D++S GV++ EI + K F +N E+ D ++ SL + +
Sbjct: 204 DIYSLGVVLWEIFTGKI--------PF----------ENLTTKEIYDLIINKNNSLKLPL 245
Query: 771 ---RYI-NVALLCVQENAEDRPTMSDVV 794
I + C ++ RP + +++
Sbjct: 246 DCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLL 638
+ N ++L +LI +Y+ K D LFD KK L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYI--KDGD--LFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
LH++ IIH D+K N+L D+ + + D+G+ ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + V D ++ GVL E+L+ K
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L++++ H +L + G C+ E I++ E++ + LDV L + + W++ V +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQL 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNIL-----LDQHMNP--KISDFGMARMFGGDELQGNT 686
A L YL + ++H ++ A NIL L + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 687 KRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEI 722
+RI +++PE G S +D +SFG +LEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-------------RMFGG 679
+A+ +L + +L IHRD+K NIL+D+ + K+SDFG++ ++ G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 680 DELQ-GNTKR-------------------------------IVGTYGYMSPEYALEGVFS 707
+ R VGT Y++PE L+ +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 708 VKSDVFSFGVLMLEIL 723
+ D +S G +M E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+ +L L + IHRD+K N+LLD+ + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTP 207
Query: 694 GYMSPEY----ALEGVFSVKSDVFSFGVLMLEIL 723
Y+SPE +G + + D +S GV + E+L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 61/269 (22%), Positives = 101/269 (37%), Gaps = 48/269 (17%)
Query: 469 NETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSK-DSSLPLFSFASVTAATENF 527
++++ D L D +M I + F +D+S D+SL L + A F
Sbjct: 41 EMNPGIESDDDCLYEDKHMDIDI-FDIF-----ADEDESDADASLALCAEARAGIEKAGF 94
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
SI G G + E V + + G E ++ + H ++++L
Sbjct: 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTA-----TEAHILRAINHPSIIQLK 149
Query: 588 G--------CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA----- 634
G C I K +Y Y+ K + I D +A
Sbjct: 150 GTFTYNKFTCLILPRYKTDLYCYLAAKR------------------NIAICDILAIERSV 191
Query: 635 -QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + YLH+ RIIHRD+KA NI ++ + + DFG A F D GT
Sbjct: 192 LRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGTI 247
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+PE + D++S G+++ E+
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ +T+ F I S LGEG FG V + +E AVK + N + ++ K E+ + K+
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKV 182
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLR--------- 626
+ + ++ + I Y N++ + + P K+ LL W ++
Sbjct: 183 RQADPA-------DRFPLMKIQRYFQNETGHMCIVMP--KYGPCLLDWIMKHGPFSHRHL 233
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----------QHMNP-----KISD 670
+II L Y H + L ++H DLK NIL++ + + P +I D
Sbjct: 234 AQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
G DE T IV T Y SPE L + +D++S G ++ E+ + K
Sbjct: 292 LGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 33/124 (26%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----------- 681
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 682 ------LQG-NTKR---------------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
Q N+KR VGT Y++PE ++ ++ D +S GV+M
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 720 LEIL 723
E+L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 41/132 (31%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-----------GG-- 679
IA+ + ++ IHRD+K NIL+D+ + K++DFG+ F G
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 680 --------DELQGNTKR--------------------IVGTYGYMSPEYALEGVFSVKSD 711
+E + +VGT Y++PE L ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 712 VFSFGVLMLEIL 723
+S GV++ E+L
Sbjct: 227 WWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 33/124 (26%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG-------------------- 672
IA+ +L + +L IHRD+K N+LLD + K+SDFG
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 673 ---------MARMFGGDELQGNTKRI----VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
M + + N +++ VGT Y++PE ++ ++ D +S GV+M
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 720 LEIL 723
E+L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 5e-04
Identities = 18/45 (40%), Positives = 23/45 (51%), Gaps = 2/45 (4%)
Query: 804 LPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVSLIYPR 848
+P PK+P F SS+ST E +VN VTVS+I R
Sbjct: 6 IPQPKQPGFCVGRSPYET-DSSSSTQR-DESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMML----- 574
++F + KLGEG FG VYK L+N + +K+ + + G ++ + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 575 -IAKLQHRNLVRLLGCCIEQGEKILIYEY---------MVNK----SLDVFLFDPTKKHL 620
A + L + ++ E L++ Y M +K +++ +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 621 LGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMA 674
G + +II I + +L+ L I+HRD+K NI+ + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/136 (25%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-------------- 678
IA+ L + ++ IHRD+K NIL+D + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 679 -------------------GDELQGNTKR------------IVGTYGYMSPEYALEGVFS 707
GD L+ +R +VGT Y++PE L ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 708 VKSDVFSFGVLMLEIL 723
D +S GV++ E+L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 29/162 (17%)
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
++ ++ H+++V L G C+ E I++ E++ LD+F+ + W+ +V +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV--AKQL 114
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILL-----DQHMNP--KISDFG-----MARMFGGDE 681
A L YL ++H ++ NILL D P K+SD G ++R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEI 722
Q +RI +++PE + S+ +D +SFG + EI
Sbjct: 166 -QECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 848 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.6 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.43 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.22 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.02 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.95 | |
| PLN02236 | 344 | choline kinase | 96.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.74 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.19 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.86 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=452.99 Aligned_cols=287 Identities=43% Similarity=0.739 Sum_probs=253.3
Q ss_pred CCCeeeHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeee
Q 003092 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590 (848)
Q Consensus 511 ~l~~~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~ 590 (848)
....|++.++..+|++|.-.+.||+|+||.||+|.+.+++.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765443256699999999999999999999999
Q ss_pred eeCC-eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 591 IEQG-EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 591 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
.+.+ +.+||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876554 88999999999999999999999988899999999999999999999999
Q ss_pred ccccccccCCCccccceeee-eccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-CCcccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRI-VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHAWSLC 747 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~ 747 (848)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|.||++|+++.+... .....+..|++...
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997654311 111112 79999999999999999999999999999999999998876543 34445788888888
Q ss_pred ccCccccccccccc-cCCCH-HHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 748 KNDRAHELMDPVLQ-NEVSL-PMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 748 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
......+++|+.+. +.... .++.++..++..|++.+|++||+|.||+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88899999999987 45554 6888899999999999999999999999999655
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=398.22 Aligned_cols=261 Identities=31% Similarity=0.506 Sum_probs=212.3
Q ss_pred CcceeeeecccCCccEEEEEecCCceEEEEEecccCcc--cHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-eEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-~~~lV~Ey 602 (848)
.+.+.+.||+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34455679999999999999955445999999765322 2568999999999999999999999999888 79999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 681 (848)
|++|+|..+++.. .+..+++..+++++.|||+||.|||++++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999764 56789999999999999999999999874 99999999999999997 99999999998765432
Q ss_pred cccceeeeeccccccChhhhh--cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYAL--EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~--~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||...... .. +... ....
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~---~~~v---------~~~~ 262 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QV---ASAV---------VVGG 262 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HH---HHHH---------HhcC
Confidence 2222368999999999999 669999999999999999999999998754431 11 1111 1111
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.+...+......+..++..||+.||++||++.+++.+|+.......
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1122222345578889999999999999999999999987754443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=370.99 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=207.4
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-eEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-~~~lV~Ey 602 (848)
+.+..+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||+++|+|+... ++.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556689999999999999986 4788999999544 3445688999999999999999999999999999 59999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
|++|+|+.++.. .+.+++...-+|+.+|++||.|||+.. +||||||||+||||+..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999998843 356899999999999999999999742 4999999999999999999999999999987654
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.|+........ ...++++.+..+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIVDE 297 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHhcC
Confidence 34567999999999999999999999999999999999999999765321111 122333333322
Q ss_pred C---CCH-HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 E---VSL-PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~---~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+ .+. ....++.+++..||++||.+||++.|+++
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 122 25668999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.07 Aligned_cols=198 Identities=30% Similarity=0.538 Sum_probs=179.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.+|.+.++||+|+||+||+|+++ ++.+||||.+... ..+..+.+..|+.+|++++|||||++++++..++.++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888999999999999999976 4789999999765 45567778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC------CCceeecccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH------MNPKISDFGMAR 675 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~------~~~kl~DFGla~ 675 (848)
||.+|+|..+++ +.+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 4447999999999999999999999998 9999999999999765 458999999999
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
.+.... ...+.||++.|||||+++..+|+.|+|+||+|+++||+++|+.||..
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 887543 23457999999999999999999999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=386.37 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=211.7
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.+|...+.||+|||++||+++. ..|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 67999999999764 3445677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|+|.+++|..++. +.+.+++.++..+++||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998883 6678999999999999999999999987 999999999999999999999999999988755
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .+..+.||||.|.|||++....++..+||||+||+||-|+.|++||+... +.+.++.+.
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik 231 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIK 231 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHH
Confidence 3 23456899999999999999999999999999999999999999986432 112222222
Q ss_pred ccC--CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNE--VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... .+.....+..+++..+|+.+|.+|||+++|+.
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 221 22234556789999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=383.06 Aligned_cols=255 Identities=32% Similarity=0.482 Sum_probs=212.6
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
+.+.+.+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 445667899999999999999987779999999764 3445788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
.|+|.++|.. .....+.....+.++.|||+|++||++++ +|||||.++||||+++..+||+|||||+.+.++.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 34567888899999999999999999987 9999999999999999999999999999666555433
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.. .-.-...|.|||.+..+.|+.|||||||||+||||+| |+.|++..... .+.+.++.-.+-.
T Consensus 361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~GyRlp 424 (468)
T KOG0197|consen 361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGYRLP 424 (468)
T ss_pred cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccCcCC
Confidence 22 2345679999999999999999999999999999999 77776543321 1112222222223
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.+..++.++.+++..||+.+|++|||+..+...|+..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 3444667899999999999999999999999888765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=366.78 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=200.8
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcc-------cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
.+.|.+.+.||+|+||.|-+|.. .+|+.||||+++++... ......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 46788899999999999999975 46999999999765321 12335799999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC---CCceeeccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFG 672 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFG 672 (848)
.|+||||+++|.|.+.+- ..+.+.+..-..+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999977773 4456777777889999999999999998 9999999999999765 779999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCC---CcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF---SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
+|+..+.. ...++.||||.|.|||++..+.+ ..++|+||+||+||-+++|-+||...-.+.
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------- 388 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------- 388 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------------
Confidence 99987643 34566899999999999987653 358899999999999999999986432211
Q ss_pred CccccccccccccC------CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 DRAHELMDPVLQNE------VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.++++.+. .-....++.++++.+||..||++|||+.|+++
T Consensus 389 ----sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 ----SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1112222221 11235668899999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=396.79 Aligned_cols=259 Identities=30% Similarity=0.472 Sum_probs=217.1
Q ss_pred HhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
...+.+..++||+|+||+||+|+... .+.||||.++..... ..++|++|+++|..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 34566778899999999999997532 356999999877555 78899999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC-----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 596 KILIYEYMVNKSLDVFLFDPT-----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
+++|+|||..|+|.+||.... ....|+..+.+.|+.|||.|+.||-+++ +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999985321 1334888999999999999999999887 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCC-CCccccccc
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN-TDSFNLLGH 742 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~-~~~~~~~~~ 742 (848)
.|||+||||++.+...+++.....-.-..+|||||.++.++|+.+||||||||+|||+++ |+.|+.... ++..+..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-- 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-- 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH--
Confidence 999999999999887777665544556789999999999999999999999999999999 888875433 2221111
Q ss_pred cccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 743 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+.+++ -..+..++.++..|++.||+.+|++||+++||-..|+..
T Consensus 719 -----~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 719 -----RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -----HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11111 123445667899999999999999999999999999775
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.35 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=209.8
Q ss_pred cCcceeeeecccCCccEEEEE-ecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeee-eeeeCCe-EEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCIEQGE-KILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~-~~~~~~~-~~lV 599 (848)
.+|+++++||+|.||+||++. +.+|..||.|.++-. +.+..+.+..|+.+|+.|+|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 568999999999999999997 567999999988733 3455677899999999999999999998 5566666 8999
Q ss_pred EEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCC-CceEecccCCCcEEeccCCCceeecccccccc
Q 003092 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSR-LRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~-~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
|||+..|+|..++... ..++.+++..+++++.|++.||..+|+.=+ .-|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999988654 445679999999999999999999998321 13899999999999999999999999999998
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...... ....+|||.||+||.+.+.+|+.||||||+||++|||..-.+||...+ ..++-.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------------------~~~L~~ 238 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------------------LLSLCK 238 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------------------HHHHHH
Confidence 765433 345799999999999999999999999999999999999999985331 112222
Q ss_pred cccccCC---C-HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 758 PVLQNEV---S-LPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 758 ~~l~~~~---~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
++-+++. + .-++.++..++..|+..||+.||+...++..+..
T Consensus 239 KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2222222 2 4467789999999999999999996555555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=358.28 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=201.7
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|+++++||+|+||+||.++..+ ++.||+|++++.. ....+..++|..+|.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4789999999999999999998654 8899999998753 33567788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+||+.||.|..+| +++..+++..+.-++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999998888 45667899999999999999999999998 99999999999999999999999999996533
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. ...+.+++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. +.++.+
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------~~~~~I 237 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------KMYDKI 237 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------------------HHHHHH
Confidence 2 23455689999999999999999999999999999999999999998643321 112222
Q ss_pred cccC--CCHH-HHHHHHHHHHhccccCcCCCC
Q 003092 760 LQNE--VSLP-MLVRYINVALLCVQENAEDRP 788 (848)
Q Consensus 760 l~~~--~~~~-~~~~l~~l~~~cl~~dP~~RP 788 (848)
+.+. ..+. ...+..+++...++.||++|.
T Consensus 238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2221 1111 344678899999999999996
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.17 Aligned_cols=267 Identities=27% Similarity=0.435 Sum_probs=216.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.+.....+.++||+|-||.|.++....+..||||.++..... ...+|.+|+++|.+++|||||+++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 345667788999999999999999977899999999877544 4588999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|||++|+|..++....... +.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999996553333 445556789999999999999886 999999999999999999999999999988877
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh--CCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
++.....+.+-..+|||||.+.-++++.++|||+||+++||+++ .+.|++....+. .....-.+...+.....+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcceec--
Confidence 77776667788899999999999999999999999999999987 567765433221 111111111111111110
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..+.-+...+.++++.||..+-++||+++++...|.+.
T Consensus 767 ----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11223455788999999999999999999999988664
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.73 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=208.5
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..+.|++.++||.|..++||+|+. +.+..||||++.-.. ....+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 347899999999999999999985 458899999997543 334688999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
.||.+|++.+++..... ..+++..+..|++++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999888865433 34889999999999999999999998 999999999999999999999999987655332
Q ss_pred c-ccc-ceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 681 E-LQG-NTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 681 ~-~~~-~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
. ... +..+.+||+.|||||+++. ..|+.|+||||||++..||.+|..||..+++-...+... +.....+.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL------qn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL------QNDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh------cCCCCCcc
Confidence 2 111 1155789999999999654 458999999999999999999999998776533211110 11111111
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
-..+..+........+.+++..||++||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111222336788999999999999999999975
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=367.46 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=214.7
Q ss_pred CcceeeeecccCCccEEEEEecC-C---ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
...|.++||.|.||.|++|+++- | ..||||.++... ++...+|..|+.+|.+++||||++|.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678999999999999999753 3 469999998764 456788999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|||+||+|+.||.... ..+.+.+..-++++||.|++||-+.+ +|||||.++||||+.+..+|++||||++.+.++
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 9999999999996543 55888888999999999999999887 999999999999999999999999999988655
Q ss_pred cc-ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 681 EL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 681 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. ...+..-.-..+|.|||.+...+++.++||||||++|||.++ |++|+-. +. ++.+...++.
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd--------------mS-NQdVIkaIe~ 849 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------------MS-NQDVIKAIEQ 849 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc--------------cc-hHHHHHHHHh
Confidence 41 111111233579999999999999999999999999999998 8888521 11 1122223333
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
-++-+.+..++..+.+|++.|||+|-.+||.+.+|+.+|++.+.+
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 344455666788999999999999999999999999999988544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.56 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=200.1
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc-c-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~-~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+.|+.+.++|+|+||+||+++.++ |+.||||++..... . ..+-.++|+++|+.++|||+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999765 99999999975433 2 33456899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC-C
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG-D 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~-~ 680 (848)
|++..-|+++- .....++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99987776543 23445788999999999999999999987 99999999999999999999999999998863 2
Q ss_pred ccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCC-Cccccccc--------cccc-ccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNT-DSFNLLGH--------AWSL-CKN 749 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~-~~~~~~~~--------~~~~-~~~ 749 (848)
+.. +..+.|..|+|||.+.+ .+|...+||||+||++.||++|.+-|....+ +....... ...+ ..+
T Consensus 156 d~Y---TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 156 DNY---TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred chh---hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 222 23578999999999987 6899999999999999999999988764432 11111000 0000 011
Q ss_pred CccccccccccccC-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 DRAHELMDPVLQNE-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....-+.-|..... .-+....-+++++..|++.||.+|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111000 01112335789999999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=355.48 Aligned_cols=270 Identities=28% Similarity=0.453 Sum_probs=214.4
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~ 594 (848)
..++.+..+.+.+.+.||+|.||+||+|++. ..||||+++... .+..+.|++|+.++++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3556666677888999999999999999984 369999998653 446789999999999999999999999999887
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
. .+|..+|++.+|..+++..+ ..++....+.|++||++|+.|||.++ |||||||..||+|.++++|||+||||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 99999999999999997543 56788889999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
..-....-........|...|||||+++. .+|++.+||||||+++|||++|..|+...+.+.. +......+..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-ifmVGrG~l~--- 611 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-IFMVGRGYLM--- 611 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-EEEecccccC---
Confidence 75543221122223457889999999974 4689999999999999999999999874333321 1111111000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
. |.. ........++.+|+..||.+++++||.+.+|+.+|++.+..+|
T Consensus 612 -p---d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 612 -P---DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred -c---cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 0 110 1122344578889999999999999999999999988865443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.32 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=202.0
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC--eEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~--~~~lV~E 601 (848)
.++...+.||+|+||+||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999998754 8999999987654333677899999999999999999999855444 6899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCC-
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGG- 679 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~- 679 (848)
|+++|+|.+++..... .+++..+.++++||++||+|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999998854332 6899999999999999999999987 999999999999999 79999999999987764
Q ss_pred CccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCC-CCCccccccccccccccCccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY-NTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...........||+.|||||++..+. ...++|||||||++.||+||++||... .... ......... ..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~-----~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE-----ALLLIGRED-----SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH-----HHHHHhccC-----CC
Confidence 12223344578999999999999643 345999999999999999999998653 1110 000000010 11
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
| .++.....+..+++..|++.+|++|||+.++++.
T Consensus 242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1 2333345578899999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=354.79 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=207.6
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
..|...++||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999974 468899999998766666677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|.+.+ ....+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999998877 4445899999999999999999999998 99999999999999999999999999998865543
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
....++|||.|||||++....|++|.||||||++++||+-|++|+-..+. +...+....++. +.+ .
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~------P~l--k 490 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGT------PKL--K 490 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCC------CCc--C
Confidence 44568999999999999999999999999999999999999999742111 111111111111 111 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++.+||+.|+++||++.|+++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12234457889999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.85 Aligned_cols=263 Identities=28% Similarity=0.399 Sum_probs=204.0
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.++||+|+||.||+|... .++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999742 24679999987543 23356789999999999 8999999999887644
Q ss_pred -eEEEEEEeccCCcccccccCCCc--------------------------------------------------------
Q 003092 595 -EKILIYEYMVNKSLDVFLFDPTK-------------------------------------------------------- 617 (848)
Q Consensus 595 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 617 (848)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 68899999999999887753211
Q ss_pred ---ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeecccc
Q 003092 618 ---KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (848)
Q Consensus 618 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (848)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 234778888999999999999999987 99999999999999999999999999987643322222223456789
Q ss_pred ccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHH
Q 003092 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYI 773 (848)
Q Consensus 695 y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 773 (848)
|+|||++.+..++.++||||||+++|||++ |..||........ +. ........ . ..+......+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~----~~~~~~~~-----~----~~~~~~~~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC----QRLKDGTR-----M----RAPENATPEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH----HHHhcCCC-----C----CCCCCCCHHHH
Confidence 999999999999999999999999999997 8888754322110 00 00000000 0 01112234688
Q ss_pred HHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 774 NVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 774 ~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
+++..||+.||++||++.|++++|++.+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=353.38 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=207.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
...+|...+.||+|+|++|++|+.. .+++||||++.+. .+...+.+..|-.+|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3468999999999999999999854 5899999998764 233345577899999999 8999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|+||+++|+|..+|. +.+.+++.....++.+|+.||+|||+.+ ||||||||+|||||+|+++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999998884 4467899999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccc---------cce--eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 678 GGDELQ---------GNT--KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 678 ~~~~~~---------~~~--~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
...... ... ..++||..|.+||++..+..+..+|+|+|||+||+|+.|++||...++- .++.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFq----- 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQ----- 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHH-----
Confidence 643222 112 4589999999999999999999999999999999999999998543321 1110
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.+++- .-.++....+...+|+...|-.||.+|+|..+|.+.
T Consensus 298 -------kI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 -------KIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------HHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11110 112222233577889999999999999999998763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=379.06 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=214.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC--Cc----eEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
..+.++.+.||+|+||.||+|...+ +. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456778899999999999998654 43 4999999765 456678899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
++++|||++|+|..+|.+.. ....+...+.+.++.+||+|+.|||+++ +|||||..+|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999996542 2456888999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
||+.+...++......-.-...|||||.+..+.|+.|+|||||||+|||++| |..|++...... +...+ ...+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~~---~~gg- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLDV---LEGG- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHHH---HhCC-
Confidence 9997776666655544445679999999999999999999999999999999 778875433211 11000 0000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+-+.+..+.+.+.+++..||+.+|++||++..|++.+..+.
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 11223345668889999999999999999999999876654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=315.75 Aligned_cols=275 Identities=26% Similarity=0.381 Sum_probs=207.1
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcc--cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|...++||+|.||.||+|+. ..|+.||||+++..... ......+||+.|+.++|+||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999985 46999999999754322 23457899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
||+. +|+..+.+ +...+....+..++.++++||+|||.+. |+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 67777744 4557889999999999999999999987 9999999999999999999999999999987654
Q ss_pred cccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCC-CccccccccccccccCc--------
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNT-DSFNLLGHAWSLCKNDR-------- 751 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~-------- 751 (848)
... .+.+-|..|.|||.+.+. .|+..+|+||.||++.||+-|.+-+....+ ++....-.+......+.
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 322 223779999999999875 589999999999999999998876543321 11110000000011110
Q ss_pred ----cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCC
Q 003092 752 ----AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810 (848)
Q Consensus 752 ----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~ 810 (848)
....-.+.+.. .-.....+.++++..++.+||.+|++++|++++ ..+...|.|..|
T Consensus 234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~ 293 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPP 293 (318)
T ss_pred cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCCh
Confidence 01011111111 223345567999999999999999999999874 233444544433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.95 Aligned_cols=281 Identities=26% Similarity=0.407 Sum_probs=212.6
Q ss_pred CCCCCCeeeHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeee
Q 003092 508 KDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587 (848)
Q Consensus 508 ~~~~l~~~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~ 587 (848)
..+++|.+-...+. ++.++.+.||+|.||.||+|.+ .|+.||||++...++.++.+ +.||.....|+|+||+.++
T Consensus 197 SGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfr-EtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFR-ETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCCCchhHhHHhhh---heeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhh-HHHHHHHHHhccchhhhhh
Confidence 34567766555443 6788999999999999999999 68999999998765554433 4455556677999999999
Q ss_pred eeeeeCC----eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-----cCCCceEecccCCCcE
Q 003092 588 GCCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-----YSRLRIIHRDLKASNI 658 (848)
Q Consensus 588 ~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~iiHrDlkp~NI 658 (848)
+.-..+. +++||.+|+++|||.++| ....++....++++..+|.||++||. ++++.|.|||||++||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 9876553 789999999999999999 34678899999999999999999994 6888999999999999
Q ss_pred EeccCCCceeeccccccccCCC--ccccceeeeeccccccChhhhhcCC----CC--cccceeehHHHHHHHHhCCCCCC
Q 003092 659 LLDQHMNPKISDFGMARMFGGD--ELQGNTKRIVGTYGYMSPEYALEGV----FS--VKSDVFSFGVLMLEILSSKKNTG 730 (848)
Q Consensus 659 Ll~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~APE~~~~~~----~~--~ksDVwSlGvvl~elltg~~p~~ 730 (848)
|+.+++.+.|+|+|||-..... ......+..+||.+|||||++.+.. +. ..+||||||+++||+.-+..--+
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 9999999999999999877544 3333455678999999999987543 21 36999999999999975432211
Q ss_pred CCCCCccccccccccccccCcc---------cccccccccc-CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 731 VYNTDSFNLLGHAWSLCKNDRA---------HELMDPVLQN-EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...+-...+ ..+...+.. .+.+.|.+.+ ..+.+.+..+.++++.||..+|.-|.|+-.|.+.|.+.
T Consensus 428 i~eey~~Py----yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 428 IVEEYQLPY----YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred EehhhcCCc----ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 111100111 111112211 1223333332 34567788899999999999999999999999988776
Q ss_pred c
Q 003092 801 L 801 (848)
Q Consensus 801 ~ 801 (848)
.
T Consensus 504 ~ 504 (513)
T KOG2052|consen 504 S 504 (513)
T ss_pred h
Confidence 3
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=341.25 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=200.0
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~l 598 (848)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.... ........+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688889999999999999985 569999999987654 44456678999999999999999999999877 68999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|+|||++ +|.-++. ...-.+++.++..+++|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 4444442 23345889999999999999999999998 9999999999999999999999999999886
Q ss_pred CCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccc--------cccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLL--------GHAWSLCK 748 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~--------~~~~~~~~ 748 (848)
......-+ ..+-|..|.|||++.+. .|+.++|+||.||||.||+.|++.+....+-. .+.. ...|...+
T Consensus 270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 65544333 34669999999999875 69999999999999999999999876443211 1100 01121000
Q ss_pred cCcccccccc------ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDP------VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
-.....+.+ .+.+. -.......++|+..+|..||.+|.|+.++++
T Consensus 349 -LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 -LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred -CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000011111 11111 1112335678888999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.83 Aligned_cols=265 Identities=28% Similarity=0.459 Sum_probs=202.4
Q ss_pred hcCcceeeeecccCCccEEEEEecC-----------------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 585 (848)
.++|++.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678999999999999999997532 3369999987643 334567999999999999999999
Q ss_pred eeeeeeeCCeEEEEEEeccCCcccccccCCC----------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceE
Q 003092 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT----------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649 (848)
Q Consensus 586 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ii 649 (848)
+++++.+.+..++||||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999988774321 1234788889999999999999999987 99
Q ss_pred ecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhC--CC
Q 003092 650 HRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS--KK 727 (848)
Q Consensus 650 HrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg--~~ 727 (848)
||||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443322223334567899999999999999999999999999999974 45
Q ss_pred CCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 728 NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 728 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
|+...... ............... ......+......+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55432211 111111000000000 00001112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.46 Aligned_cols=234 Identities=28% Similarity=0.366 Sum_probs=200.4
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||.|+||+|.+++.+. |..+|+|++++..- ...+...+|..+|+.+.||.++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 678999999999999999999764 78899999987532 23455678999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||.++|.|..+|. +...+++..+..++.||+.||+|||+.+ |++|||||+|||||++|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999883 4557899999999999999999999988 9999999999999999999999999999764
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
..+-+.||||.|+|||+++.+.|+.++|.|||||++|||+.|.+||...++ .+..++++
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------~~iY~KI~ 254 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------IQIYEKIL 254 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------HHHHHHHH
Confidence 346678999999999999999999999999999999999999999864332 12233333
Q ss_pred ccCC--CHHHHHHHHHHHHhccccCcCCC
Q 003092 761 QNEV--SLPMLVRYINVALLCVQENAEDR 787 (848)
Q Consensus 761 ~~~~--~~~~~~~l~~l~~~cl~~dP~~R 787 (848)
.+.. +.-...++.+++...++.|-.+|
T Consensus 255 ~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3332 22234567888999999998888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=346.40 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=206.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. .+..+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999854 57899999997653 3456778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+.+ +|..+|. ....++++.+..|+.+++.||.|||++. |+|||+||+|||++.++++|++|||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 8888883 4456899999999999999999999987 9999999999999999999999999999775432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....+.|||.|||||+..+.+|+..+|+||+||++||+.+|++||-.. .+.+++..++.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------------------si~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------------------SITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------------------HHHHHHHHHhc
Confidence 3344578999999999999999999999999999999999999997321 11222222332
Q ss_pred cC--CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NE--VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+ .+......+.+++...+++||.+|.+-.+++.
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22 22245567889999999999999999998875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.05 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=203.1
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHH--HHHHHHHHHcC-CCceeeeeeeeeeCC-eEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEF--KNEMMLIAKLQ-HRNLVRLLGCCIEQG-EKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~--~~Ei~~l~~l~-Hpniv~l~~~~~~~~-~~~ 597 (848)
..++|.+.++||.|.||.||+|+- ..+..||||++++.-. .+++. .+|+..|++|+ |||||++++++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347899999999999999999984 4688999999976432 24443 57999999998 999999999999888 999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|||||+. +|.+++.+. .+.+++..+..|+.||++||+|+|.+| +.||||||+|||+.....+||+||||||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999977 566666543 778999999999999999999999988 999999999999999999999999999988
Q ss_pred CCCccccceeeeeccccccChhhhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-c---cc-cccccccc-
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-L---LG-HAWSLCKN- 749 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~---~~-~~~~~~~~- 749 (848)
....- -+..+.|..|+|||++. .+.|+.+.|+||+||+++|+.+-++-|...++-.. . + ++ ..+..+..
T Consensus 161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 65432 23467899999999976 56789999999999999999998887755432111 0 0 00 00000000
Q ss_pred Cccccccc---ccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 750 DRAHELMD---PVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 750 ~~~~~~~d---~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
......+. +...+ .+-+....++++++..|++.||++|||+.|++++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00001111 00000 1112256688999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.31 Aligned_cols=267 Identities=27% Similarity=0.399 Sum_probs=204.3
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHH--HcCCCceeeeeeeeeeCC----eEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA--KLQHRNLVRLLGCCIEQG----EKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~--~l~Hpniv~l~~~~~~~~----~~~l 598 (848)
...++.++||+|+||.||||.+ +++.||||++... ..+.|.+|-++.+ .|+|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4556678999999999999998 4599999999764 3455666666654 468999999999987666 8999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc------CCCceEecccCCCcEEeccCCCceeeccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY------SRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
|+||.++|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||..|++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 556799999999999999999999963 45789999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCC-C-----cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-S-----VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~-----~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
||..+............+||.+|||||++.+..- . .+.||||+|.+||||+++.........+.+++. ....
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp--fe~e 439 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP--FEAE 439 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc--hhHH
Confidence 9999987766666777899999999999976432 2 368999999999999997654422111111110 0000
Q ss_pred cccCc---------ccccccccccc-CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 747 CKNDR---------AHELMDPVLQN-EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 747 ~~~~~---------~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+.. +.+..+|.+.. ....+-+.-+.+.+..||..||+.|.|+.=|-+.+.+..
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 01111 11112222221 112234556788999999999999999999998887764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.81 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=203.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc----Cc-ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~----~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~ 595 (848)
...+|.+.+.||+|+||+|+.|... ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999764 5899999977653 12 23456778999999998 9999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeeccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMA 674 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla 674 (848)
+++||||+.+|+|.+++.. ...+.+.++.++++|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999888843 566888999999999999999999987 9999999999999999 99999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCC-CC-cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FS-VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~-~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+..
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----------------- 229 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----------------- 229 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-----------------
Confidence 9874 1122345579999999999999987 85 7899999999999999999999752211
Q ss_pred ccccccccccCCCHH--H-HHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 753 HELMDPVLQNEVSLP--M-LVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~--~-~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
.+...+..+.+..+ . ..++..++..|++.||.+|+++.+|+
T Consensus 230 -~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 230 -NLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -HHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11111111111111 1 55788999999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=352.44 Aligned_cols=264 Identities=29% Similarity=0.405 Sum_probs=208.4
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCC----ce-EEEEEecc---cCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNG----QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~----~~-vAvK~~~~---~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~ 593 (848)
...++..+.++||+|+||.||+|++..+ .. ||||..+. .......+|.+|+++|+.++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 3445666679999999999999987542 23 89999875 2356688999999999999999999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..+++|||+|.||+|+++|.... ..++..++.+++.++|.||+|||+++ +|||||.++|+|++.++.+||+||||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999995432 26889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
++.-. .+........-..+|+|||.+..+.|+.++|||||||++||+++ |..|+....... ...
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--v~~----------- 373 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--VKA----------- 373 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--HHH-----------
Confidence 87543 11111112245679999999999999999999999999999999 777764332110 000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCC
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPS 806 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 806 (848)
.+.....+-..+...+..+..++..||+.+|++||+|.++.+.|+........
T Consensus 374 -kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 -KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 00011111122223445677788899999999999999999999887655443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=344.37 Aligned_cols=241 Identities=28% Similarity=0.436 Sum_probs=199.1
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCccc
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
++=||.|+.|.||+|++ .++.||||+++... +.+|+-|++|+||||+.+.|+|....-++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 46899999999999999 56899999886432 35788899999999999999999999999999999999999
Q ss_pred ccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeee
Q 003092 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (848)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (848)
..|. ....+.......+..+||.|+.|||.+. |||||||.-||||..+..+||+|||-++..... ...-.+
T Consensus 201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 9984 3455677788899999999999999986 999999999999999999999999999876543 223357
Q ss_pred eccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHH
Q 003092 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPML 769 (848)
Q Consensus 690 ~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 769 (848)
+||..|||||++...+.++|+||||||||||||+||+.|+...+... ..|..-. ..+.-..+..++
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGVGs---------NsL~LpvPstcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGVGS---------NSLHLPVPSTCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEeccC---------CcccccCcccCc
Confidence 89999999999999999999999999999999999999975332211 1111111 112223344455
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 770 VRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 770 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.-+.-|+.+||+..|..||++++|+..|+-.-
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 67788999999999999999999999886543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=338.44 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=206.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..|+..+.||+|.||.||+|... .++.||+|++... ....++++.+|+.+|..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777789999999999999864 5889999999765 344578889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
|.+|++.+.| .....+.+....-|+++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999998877 33344577777889999999999999987 99999999999999999999999999988765543
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. ...++||+.|||||++....|+.|+||||||++.+||++|.+|+...++... .... .+-.-|.+.+
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lflI------pk~~PP~L~~ 233 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LFLI------PKSAPPRLDG 233 (467)
T ss_pred c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EEec------cCCCCCcccc
Confidence 3 3568999999999999988999999999999999999999999865544211 1111 1112233334
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.++ ..+.+++..||++||+.||++.++++
T Consensus 234 ~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 DFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 333 35788999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.82 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=208.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.-|.+.+.||+|+.|.|-.|++. +|+.+|||++.+.. ......+++|+.+|+.+.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999864 69999999997652 223456789999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|.|.+++ ..++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.....+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999998887 46678999999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. .-.+-||.|.|.|||++++.+| ..++||||.|||||.|++|+.||+..+ +..++.+.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------------------ir~LLlKV 224 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------------------IRVLLLKV 224 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------------------HHHHHHHH
Confidence 3 2334699999999999999999 689999999999999999999997322 22333333
Q ss_pred cccCC--CHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 760 LQNEV--SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 760 l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..+.+ +.....+..+|+..|+..||++|.|+.||++.
T Consensus 225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 33322 22344578899999999999999999999873
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=346.54 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=207.2
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCe
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~ 595 (848)
....++|.+.++||+|.||+|+++.++. ++.+|||.+++.. ....+..+.|.+++... +||.++.++.++...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3455789999999999999999999764 7889999998763 45567788899988887 59999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
+++||||+.+|++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954443 4467899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
.-.. ....+.++||||.|||||++.+..|+.++|.|||||+||||+.|..||...+++ ++
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------e~ 576 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------EV 576 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------HH
Confidence 6432 233567799999999999999999999999999999999999999999755433 44
Q ss_pred cccccccCCC--HHHHHHHHHHHHhccccCcCCCCCH
Q 003092 756 MDPVLQNEVS--LPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 756 ~d~~l~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
.|.++..+.. .-...+.+.++..++..+|++|.-+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4444443322 2345678899999999999999887
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.11 Aligned_cols=260 Identities=28% Similarity=0.382 Sum_probs=202.6
Q ss_pred hcCcceeeeecccCCccEEEEEe------cCCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~ 595 (848)
.++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 235689999987543 33456788999999999 89999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003092 596 KILIYEYMVNKSLDVFLFDPT----------------------------------------------------------- 616 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 616 (848)
.++||||+++|+|..++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999987774321
Q ss_pred -------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 617 -------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 617 -------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1124788899999999999999999987 999999999999999999999999999876543222
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.......++..|+|||++.+..++.++||||||+++|||++ |..|+........ .. .....+. ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~----~~~~~~~---------~~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FY----KMIKEGY---------RM 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HH----HHHHhCc---------cC
Confidence 22222345678999999999999999999999999999998 7888754322110 00 0001100 00
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..+.....++.+++..||+.||++||++.||+++|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.81 Aligned_cols=245 Identities=18% Similarity=0.318 Sum_probs=197.3
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCccc---HHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEEEEEEec
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYM 603 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~lV~Ey~ 603 (848)
..||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5899999999999998 68999999997653332 5778899999999999999999999877 34789999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|..++.. ...+++....+++.+++.||+|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999998843 346889999999999999999999852 37899999999999999999999999998654322
Q ss_pred cceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... +... ..... ..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~---i~~~~---------~~ 240 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDL---IINKN---------NS 240 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHH---HHhcC---------CC
Confidence 22468899999999976 678999999999999999999999986432211 0000 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111222345788999999999999999999999999765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.55 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=199.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--------------ccHHHHHHHHHHHHHcCCCceeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------QGLKEFKNEMMLIAKLQHRNLVRLL 587 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------------~~~~~~~~Ei~~l~~l~Hpniv~l~ 587 (848)
..++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999864 589999999865321 1246788999999999999999999
Q ss_pred eeeee--CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 588 GCCIE--QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 588 ~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
.+..+ .+.+|||+|||..|.+...- .....++++++.++++++..||+|||.++ ||||||||+|+||+++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 99865 45899999999988765433 22223899999999999999999999998 999999999999999999
Q ss_pred ceeeccccccccCCCc---cccceeeeeccccccChhhhhcCC---C-CcccceeehHHHHHHHHhCCCCCCCCCCCccc
Q 003092 666 PKISDFGMARMFGGDE---LQGNTKRIVGTYGYMSPEYALEGV---F-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN 738 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~---~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~ 738 (848)
+||+|||.+..+.... ........+|||.|+|||.+.++. + +.+.||||+||+||-|+.|+.||...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~------ 322 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD------ 322 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc------
Confidence 9999999998763221 111223368999999999998743 3 57899999999999999999998421
Q ss_pred cccccccccccCccccccccccccCC----CHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEV----SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
...++.+++....+ .++.-+++.++++++|++||++|.+..+|...
T Consensus 323 ------------~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 323 ------------FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ------------hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 12233333333322 22345678899999999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=351.65 Aligned_cols=261 Identities=29% Similarity=0.425 Sum_probs=202.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3467999999999999999998742 23579999997543 23356688999999999 8999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 616 (848)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999988764311
Q ss_pred ---------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccccee
Q 003092 617 ---------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687 (848)
Q Consensus 617 ---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (848)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1124788889999999999999999987 9999999999999999999999999998664332211112
Q ss_pred eeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCH
Q 003092 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSL 766 (848)
Q Consensus 688 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 766 (848)
...++..|||||++.+..++.++|||||||++|||++ |+.||........ .. ..... ......+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~----~~~~~---------~~~~~~~~ 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FY----KMVKR---------GYQMSRPD 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HH----HHHHc---------ccCccCCC
Confidence 2335678999999999999999999999999999997 9999754322110 00 00000 00000111
Q ss_pred HHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 767 PMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 767 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
....++.+++..||+.||++||++.+|+++|++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=338.46 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=202.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
..++|+++++||+|+||.||+++-+ .|..+|+|++++.. ....+.++.|-.+|...++|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999865 58999999998753 3445667889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||++||++..+| .+...|++..+..++.+++-||..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999998888 56678999999999999999999999988 9999999999999999999999999986432
Q ss_pred CC----------------------cccc-----c------------------eeeeeccccccChhhhhcCCCCccccee
Q 003092 679 GD----------------------ELQG-----N------------------TKRIVGTYGYMSPEYALEGVFSVKSDVF 713 (848)
Q Consensus 679 ~~----------------------~~~~-----~------------------~~~~~gt~~y~APE~~~~~~~~~ksDVw 713 (848)
.. +... . ....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 0 1125799999999999999999999999
Q ss_pred ehHHHHHHHHhCCCCCCCCCCCcc--ccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCC--
Q 003092 714 SFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-- 789 (848)
Q Consensus 714 SlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-- 789 (848)
|||||+||||.|-+||....+... .+..|. ..+..+...+...+..++|.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999865443221 111111 111111122223577889999888 9999976
Q ss_pred -HHHHHH
Q 003092 790 -MSDVVS 795 (848)
Q Consensus 790 -~~evl~ 795 (848)
+.||.+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 555543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=338.33 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=203.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.+.||+|+||.||+++.. .+..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 368999999999999999999875 47889999987542 2345679999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999988843 345789999999999999999999854 49999999999999999999999999998654321
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-cccc-c-------cc-cc-ccC
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-LLGH-A-------WS-LC-KND 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-~~~~-~-------~~-~~-~~~ 750 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+......... .... . +. .. ...
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 23356999999999999999999999999999999999999998543211100 0000 0 00 00 000
Q ss_pred -----------------cccccccccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 751 -----------------RAHELMDPVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 751 -----------------~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
...+..+..... ........++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 0011234578899999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.30 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=202.4
Q ss_pred hcCcceeeeecccCCccEEEEEec----CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999753 35689999987653 2334678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|..++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999888532 346889999999999999999999987 9999999999999999999999999876543
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+....... .... . ...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~---~-~~~------- 224 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKA---V-EDG------- 224 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH---H-HCC-------
Confidence 22111 1112345678999999999999999999999999999875 999875332211 0000 0 000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.....+......+.+++..||+.+|++||++.+|++.|++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00011122344688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.77 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=198.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999888743 345788889999999999999999987 999999999999999999999999999876432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ..... .+
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~----~i~~~--------~~ 232 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYE----KILAG--------RL 232 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHH----HHhcC--------Cc
Confidence 22357999999999999999999999999999999999999998532211 0000 00000 00
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..+.....++.+++..||+.||++||+ +.+++.
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011112346789999999999999997 577664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.73 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=205.1
Q ss_pred cCcceeeeecccCCccEEEEEecC-C-----ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.+.||+|+||.||+|.... + +.||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999998643 2 579999986543 234567899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 598 LIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999888753211 145788899999999999999999987 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 743 (848)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+....... +..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~-- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIE-- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence 999999999987644333222333457889999999998999999999999999999998 888875332211 000
Q ss_pred ccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
..... .....+.....++.+++..||+.+|++||++.||++.|++
T Consensus 238 --~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 00000 0011122345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=346.53 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=204.8
Q ss_pred HhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~ 594 (848)
..++|++.++||+|+||.||+|+... +..||||++..... ...+.+.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45789999999999999999997532 34699999975432 33567899999999996 999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 616 (848)
..++||||+++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999987764321
Q ss_pred -----------------------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 617 -----------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 617 -----------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
....+++..+.+++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124778888999999999999999987 99999999999999
Q ss_pred cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccc
Q 003092 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLL 740 (848)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 740 (848)
+++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.....+...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 999999999999987644332222233457788999999999999999999999999999997 88887533211100
Q ss_pred cccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 741 GHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 741 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....... . ...........+.+++.+||+.+|++||++.+|+++|+..+
T Consensus 350 ---~~~~~~~-----~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 ---YNKIKSG-----Y----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHhcC-----C----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0000000 0 00111223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=339.17 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=202.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999976 48899999997542 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999998884 3346788999999999999999999987 99999999999999999999999999986543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... ...+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~------~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYW------KETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhc------cccccCCC
Confidence 22345799999999999999999999999999999999999999864332111 0000000 00000000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..........++.+++..||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.78 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=198.8
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 68999999986432 2234567899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|...+... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998776432 2335789999999999999999999987 9999999999999999999999999998754322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..... .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~--------~~~~~--~ 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDR--------RVKED--Q 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHH--------Hhhcc--c
Confidence 1 12346899999999999999999999999999999999999998643321100 00000 00000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..........+.+++..||+.||++||+ +.++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1112223446889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.22 Aligned_cols=251 Identities=34% Similarity=0.539 Sum_probs=193.5
Q ss_pred ceeeeecccCCccEEEEEec-----CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.+.+.||.|.||.||+|.+. .+..|+||.++... .+..++|.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999876 25689999996543 3347889999999999999999999999998888999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.++|... ....+++..+..++.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999988543 2356899999999999999999999987 9999999999999999999999999998774332
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.............|+|||.+....++.++||||||+++|||++ |+.|+...... .+... . ... .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~---~-~~~---------~ 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEK---L-KQG---------Q 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHH---H-HTT---------E
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc---c-ccc---------c
Confidence 2222233457789999999999999999999999999999999 67776433211 11000 0 000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
....+......+.+++..||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111122344688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=329.81 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=205.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999998643 478999998765443 467899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCC-----------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 597 ILIYEYMVNKSLDVFLFDP-----------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
++||||+++++|..++... .....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999998888532 12345788999999999999999999987 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAW 744 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 744 (848)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... .....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~- 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECI- 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH-
Confidence 99999999986543332222223456789999999999999999999999999999998 999875332211 00000
Q ss_pred cccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
..... ..........+.+++..||+.+|++||++.||++.|+
T Consensus 238 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 ---TQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00000 0111123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=349.24 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=210.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCC-ceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeee-eee------
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC-CIE------ 592 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~-~~~------ 592 (848)
...-++++.+.|.+|||+.||.|....+ .+||+|++-..++...+.+++||++|++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3446788999999999999999998765 999999988778888899999999999997 9999999993 221
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
.-+.+|.||||.+|.|-+++...... .|++.++++|+.++++|+++||... ++|||||||-+||||..+++.||+|||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 23789999999999988887543333 3999999999999999999999975 689999999999999999999999999
Q ss_pred cccccCCCccccc-------eeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccc
Q 003092 673 MARMFGGDELQGN-------TKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742 (848)
Q Consensus 673 la~~~~~~~~~~~-------~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 742 (848)
.|........... .-....|+-|+|||++. +.+.++|+|||+|||+||-|+....||+..+.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 9875432221100 00124799999999874 67889999999999999999999999974422
Q ss_pred cccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 743 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..+++..+.-+..+++..++.+||..||+.||++||++.+|+..+-++
T Consensus 264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 122233333334467888999999999999999999999999877655
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=324.22 Aligned_cols=255 Identities=30% Similarity=0.450 Sum_probs=205.2
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36799999999999999999998788899999986532 34578899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999998887543 2345788889999999999999999987 999999999999999999999999999876543221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....++..|+|||++....++.++||||||+++|||++ |+.|+....... ..... ... .. .
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~----~~~-----~~----~ 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSAL----QRG-----YR----M 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHH----HcC-----CC----C
Confidence 1 122346778999999998899999999999999999998 888875432111 00000 000 00 0
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.........+.+++.+|++.+|++||++.+++++|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.17 Aligned_cols=244 Identities=23% Similarity=0.263 Sum_probs=198.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999988874 3345788999999999999999999987 999999999999999999999999999866432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ... .+.....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~------------~i~~~~~ 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYE------------KILAGKL 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCCc
Confidence 223579999999999999999999999999999999999999985432111 000 0000000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..+......+.+++..||+.||++||+ +.++++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111122346789999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=330.81 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=208.8
Q ss_pred cCcceeeeecccCCccEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.+|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999743 245699999876665556789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 599 IYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999998875321 2235889999999999999999999987 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAW 744 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 744 (848)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~---- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI---- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----
Confidence 99999999986644332222233456789999999999999999999999999999999 898875433211 00
Q ss_pred cccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
.........+ .....+..+.+++.+||+.+|++||++.+|+++|++....
T Consensus 236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0001111000 1111234688999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=329.09 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=200.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999976 47899999987542 2345678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765442 2345888999999999999999999887 9999999999999999999999999998764332
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccc--------cccccccCc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGH--------AWSLCKNDR 751 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~--------~~~~~~~~~ 751 (848)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+... .........
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122235789999999999998999999999999999999999999864332110 00000 000000000
Q ss_pred cccccccccccC------CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQNE------VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+..... ........+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 01113346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.78 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=205.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346799999999999999999998778899999986543 3457789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999998885432 345789999999999999999999987 99999999999999999999999999987753221
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. .......+..|+|||++.+..++.++||||||+++|||++ |+.|+....... ... ..... ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~---------~~ 222 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ----QVDQG---------YR 222 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcC---------CC
Confidence 1 1111223468999999999899999999999999999999 888875332110 000 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.99 Aligned_cols=245 Identities=23% Similarity=0.403 Sum_probs=206.6
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
-+|++.+.||+|.||.|-+++. ..|+.||||.+++.. .+..-.+.+||++|..|+||||+.++.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4799999999999999999974 679999999997653 445566789999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||..+|.|.+++ .....|++.++..+++||..|+.|+|.+. ++|||||.+|||+|+++++||+||||+-.+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 45567999999999999999999999886 999999999999999999999999999887654
Q ss_pred ccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ..++||++.|.+||++.+.+| .+.+|-|||||+||-|+.|..||+..+-. .++.++
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------------------~lvrQI 265 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------------------RLVRQI 265 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------------------HHHHHh
Confidence 32 345899999999999999999 68899999999999999999998654321 111111
Q ss_pred cccCC-CHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 760 LQNEV-SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 760 l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
-.+.+ .++......-++++||..+|++|.|+.+|...
T Consensus 266 s~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 SRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111 11223355678999999999999999999764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=328.23 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=202.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
..++|++.+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999753 24679999986432 2345678899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 596 KILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
.++||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999888754221 234678888999999999999999986 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+....... ... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~----~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLR----FV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HH
Confidence 99999986644332222222345788999999999999999999999999999999 677775332211 000 00
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
...... ..+......+.+++.+||+.+|++||++.|++++|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000000 0111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=378.22 Aligned_cols=260 Identities=25% Similarity=0.436 Sum_probs=208.3
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
..|...++||+|+||.||+|+. .+++.||||++...... ...|++++++++|||||+++++|.++...++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577778999999999999986 46889999998654322 235688999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|.+++. .++|..+.+++.||++||+|||..+..+|+||||||+||+++.++..++. ||.+......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999883 37899999999999999999997766679999999999999999888875 6665433211
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc-
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN- 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~- 762 (848)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+..++............+++.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1236889999999999999999999999999999999999998543322233333333333333344455665543
Q ss_pred -CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 763 -EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 763 -~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....++..++.+++.+||+.+|++||+|.||+++|++..
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 234556778899999999999999999999999998774
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.34 Aligned_cols=267 Identities=29% Similarity=0.366 Sum_probs=202.8
Q ss_pred cceeeeecccCCccEEEEEe-----cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~l 598 (848)
|++.+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 246789999987543 23457788999999999999999999988654 36889
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999888742 34899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccc-ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 432211 1112245667999999998889999999999999999999999875433222111111111111111111122
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.......+.....++.+++..||+.+|++||++++++++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111122223445788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=335.99 Aligned_cols=241 Identities=21% Similarity=0.271 Sum_probs=194.0
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999987532 233456788999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccce
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (848)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9987774 3346889999999999999999999987 9999999999999999999999999997542211 123
Q ss_pred eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCH
Q 003092 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSL 766 (848)
Q Consensus 687 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 766 (848)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .... .... +. ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~----~~~~------~~----~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL----ILME------EI----RFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHHH----HHcC------CC----CCCC
Confidence 34679999999999999999999999999999999999999985322111 0000 0000 00 1112
Q ss_pred HHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 767 PMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 767 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
....++.+++..||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2344678999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=325.38 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=209.7
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+..+|++.++||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678999999999999999999888899999999876655677899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.... ...+++..+.+++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999886532 346789999999999999999999987 99999999999999999999999999987644322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....... .... +.....
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~-------------~~~~~~ 222 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQ-------------ITAGYR 222 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH-------------HHhCCc
Confidence 11 12346778999999998899999999999999999998 788875432111 0000 000001
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
...+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.87 Aligned_cols=251 Identities=29% Similarity=0.432 Sum_probs=200.6
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468889999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99998887532 235789999999999999999999987 999999999999999999999999999865433221
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||++....++.++||||||+++|||++ |+.|+...... ...... ..... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i---~~~~~---~~~------ 222 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMI---SRGFR---LYR------ 222 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH---HCCCC---CCC------
Confidence 1112235678999999998889999999999999999999 88887533211 111100 00000 000
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111234678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=333.91 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=200.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCc----eEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.+|++.+.||+|+||.||+|++. +++ .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56999999999999999999864 333 48999987543 34457789999999999999999999998765 5779
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|+||+++|+|.+++... ...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999998887532 345788899999999999999999987 9999999999999999999999999998775
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............++..|+|||++.+..++.++||||||+++|||++ |+.|+....... +. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~----~~~~~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHhCC-------
Confidence 4332222222334678999999999999999999999999999998 888875332111 00 000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...........++.+++..||+.+|++||++.+++..|....
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000111122346788999999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=338.54 Aligned_cols=262 Identities=29% Similarity=0.432 Sum_probs=202.8
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC-
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ- 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~- 593 (848)
+.++|++.++||+|+||.||+|... .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3468999999999999999999642 24689999987542 23346678899999999 899999999988654
Q ss_pred CeEEEEEEeccCCcccccccCCCc--------------------------------------------------------
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTK-------------------------------------------------------- 617 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 617 (848)
...+++|||+++++|..++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578899999999999877743211
Q ss_pred --ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccc
Q 003092 618 --KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695 (848)
Q Consensus 618 --~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 695 (848)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125789999999999999999999987 999999999999999999999999999876443322223334567889
Q ss_pred cChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHH
Q 003092 696 MSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYIN 774 (848)
Q Consensus 696 ~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 774 (848)
+|||++.+..++.++|||||||++|||++ |..|+........ + ........ ....+.....++.+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~~---------~~~~~~~~~~~~~~ 307 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEGT---------RMRAPEYATPEIYS 307 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhccC---------CCCCCccCCHHHHH
Confidence 99999999999999999999999999998 8888753221110 0 00000000 00011122346889
Q ss_pred HHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 775 VALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 775 l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
++.+||+.+|++||++.|++++|+..+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.66 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=211.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe-EEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE-KILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~-~~lV~ 600 (848)
++|...+++|+|+||.++..+++ +++.|++|.+.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999865 4778999988644 33344567899999999999999999999999998 99999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
+|++||+|.+.+.+.. ...++++.+.+++.||+.|+.|||++. |+|||||+.||+++++..|||+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999885533 567899999999999999999999776 999999999999999999999999999998765
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .....+.||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.. .++.++.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------------------~Li~ki~ 219 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------------------ELILKIN 219 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------------------HHHHHHh
Confidence 4 2344579999999999999999999999999999999999999988643321 2222222
Q ss_pred ---ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 761 ---QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 761 ---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
....+..+..++..++..|++.+|+.||++.+++.+
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 234455567789999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=302.24 Aligned_cols=266 Identities=23% Similarity=0.258 Sum_probs=211.3
Q ss_pred HHhcCcceeeeecccCCccEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----e
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----E 595 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-----~ 595 (848)
...++|++.+.||+|||+.||.++ ..++..||+|++.-...++.+..++|++.-++++||||++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456899999999999999999998 4568899999997766778889999999999999999999999876543 5
Q ss_pred EEEEEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
.|++++|...|+|.+.+.... ++..+++.+.++|+.+|.+||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999988775543 4447999999999999999999999986 47999999999999999999999999998
Q ss_pred cccCCCcccc-------ceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccc
Q 003092 675 RMFGGDELQG-------NTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAW 744 (848)
Q Consensus 675 ~~~~~~~~~~-------~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 744 (848)
....-.-... .-....-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-.....+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl----- 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL----- 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----
Confidence 7653211100 000123688999999886 4456899999999999999999999986322111000
Q ss_pred cccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
........+.-+...+..+.+.+++.+|+|.||.+||+..+++..++..
T Consensus 252 -------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0111222222233334677899999999999999999999999988764
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.07 Aligned_cols=242 Identities=20% Similarity=0.258 Sum_probs=192.3
Q ss_pred ecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998653 233456788899999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 888743 345889999999999999999999987 9999999999999999999999999998643222 12334
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . .+... ...+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~---~---------~~~~~--~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MYR---K---------ILQEP--LRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HHH---H---------HHcCC--CCCCCcC
Confidence 679999999999999999999999999999999999999985322110 000 0 00000 0111223
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 769 LVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
...+.+++..||+.||++||++..+.+.|.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346788999999999999987544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=350.99 Aligned_cols=249 Identities=19% Similarity=0.242 Sum_probs=202.4
Q ss_pred CcceeeeecccCCccEEEEEec-C-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4899999999999999999754 3 5788999876555555567888999999999999999999999999999999999
Q ss_pred cCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 604 VNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 604 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
++|+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999998877542 23446788999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .+...+.+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------------------~~~~~~~~ 286 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------------------IMQQVLYG 286 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHHhC
Confidence 223345679999999999999999999999999999999999999975322110 00000000
Q ss_pred ---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 ---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++..||+.+|++||++.+++.
T Consensus 287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111123346889999999999999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.89 Aligned_cols=257 Identities=30% Similarity=0.462 Sum_probs=201.9
Q ss_pred cCcceeeeecccCCccEEEEEe-----cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.++||+|+||.||+|.. ..++.||+|.+.... .+...++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688899999999999999974 235789999987533 3345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC--------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 599 IYEYMVNKSLDVFLFDPT--------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
||||+++++|..++.... ....+++.....++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999988874221 1235788899999999999999999987 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 743 (848)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999987644332222333456778999999998889999999999999999998 88886432211 000000
Q ss_pred ccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
..... + ........++.+++..||+.+|++||++.+|++.|..
T Consensus 240 ----~~~~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 ----RKRQL-------L--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HcCCc-------C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00000 0 1111223467889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.63 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=199.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC--CceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~--~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.++||+|+||.||+|.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998643 368999998643 22345678899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999888843 346889999999999999999999987 9999999999999999999999999998654
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . +.+.
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~---~---------i~~~ 243 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQ---K---------ILEG 243 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHH---H---------HhcC
Confidence 32 234679999999999999889999999999999999999999986432110 000 0 0000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVSM 796 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 796 (848)
.. ..+......+.+++..|++.+|++|+ +++++++.
T Consensus 244 ~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 II--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 01111234578899999999999995 88888753
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.30 Aligned_cols=260 Identities=28% Similarity=0.450 Sum_probs=206.4
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999742 24568999987766566778999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCce
Q 003092 598 LIYEYMVNKSLDVFLFDPT----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 667 (848)
+||||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999988874321 2235899999999999999999999987 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 746 (848)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....... ... .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~----~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----C 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----H
Confidence 999999986644332222223346788999999999899999999999999999998 888874332111 000 0
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....... .........+.+++.+||+.+|++||++.++++.|++..
T Consensus 235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 0000000 001112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.26 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=206.3
Q ss_pred HHhcCcceeeeecccCCccEEEEEecC------CceEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~ 593 (848)
...++|++.+.||+|+||.||++.... ...+|+|.+... ..+...++.+|+.++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345679999999999999999998642 357999998754 233456788999999999 899999999999999
Q ss_pred CeEEEEEEeccCCcccccccCC-------------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 594 GEKILIYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
+..+++|||+++++|..++... .....+++..+.+++.|++.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999998887432 22356889999999999999999999887 9999999999999
Q ss_pred ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccc
Q 003092 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNL 739 (848)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~ 739 (848)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 9999999999999987654332222222345678999999999999999999999999999998 8888653321110
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
. ...... .....+......+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 244 ~----~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 F----KLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H----HHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0 000000 00011222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.21 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=203.6
Q ss_pred cCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.+.||+|+||.||+|.+.. ...||||.+.... .....+|.+|+.++++++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999998743 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|..++... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999888542 236889999999999999999999977 99999999999999999999999999998752
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~----~~~~~-------- 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIK----AVEDG-------- 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHH----HHHcC--------
Confidence 221111222345678999999999999999999999999999998 888874322110 000 00000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.....+......+.+++.+||+.+|++||++.||++.|++.
T Consensus 225 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 -YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.05 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.+|++.++||+|+||.||+|... .++.||+|++... ....+++.+|++++++++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 46888999999999999999865 4789999998653 334677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999998887442 2345789999999999999999999987 999999999999999999999999999876543221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . +.... .....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~---------~~~~~ 224 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLE---------KGYRM 224 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHH---------CCCCC
Confidence 1111234678999999999999999999999999999998 888875322111 0 00000 00111
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..+......+.+++.+||+.+|++||++.+++++|++.
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122335788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.34 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=203.1
Q ss_pred CcceeeeecccCCccEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
+|++.+.||+|+||.||+|.... ...+|+|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999997532 25689998875432 345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCC---------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 599 IYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999988764311 1235788999999999999999999887 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCc
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDS 736 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~ 736 (848)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986643322222223456778999999998889999999999999999998 888875332111
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+ +..... ............++.+++..||+.+|++||++.|+++.|++.+
T Consensus 238 --~----~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 --L----FNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --H----HHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 0 001000 0011111223347889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.09 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=201.4
Q ss_pred cCcceeeeecccCCccEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.+|++.++||+|+||.||+|.... ++.||+|++...... ..+.+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998632 478999999755432 3466889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCC-------------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 598 LIYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
+++||+++++|..++... .....+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999998877321 12235788889999999999999999987 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 743 (848)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+....... ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~-- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VIE-- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH--
Confidence 999999999987644332222233456789999999998999999999999999999998 777764322110 000
Q ss_pred ccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
...... ...........+.+++..||+.+|++||++.+|++.|+.
T Consensus 238 --~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 --MIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000000 011122234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.70 Aligned_cols=199 Identities=28% Similarity=0.381 Sum_probs=173.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 47889999887542 2345678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999988843 345788999999999999999999853 49999999999999999999999999997653321
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.67 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=196.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999865 57899999986543 23345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 77666632 2335788899999999999999999987 99999999999999999999999999976543221
Q ss_pred ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cccc--------ccccc-cccCc
Q 003092 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLG--------HAWSL-CKNDR 751 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~--------~~~~~-~~~~~ 751 (848)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .... ..|.. .....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223468999999999875 5689999999999999999999999854332110 0000 00000 00000
Q ss_pred cccccccccccC----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQNE----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+..... .......+..+++..|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111110000 01112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.55 Aligned_cols=252 Identities=30% Similarity=0.446 Sum_probs=201.2
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.+.||+|+||+||+|...++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999988777789999986432 345778999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|.+++... ...+++..+.+++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99998887432 236789999999999999999999987 999999999999999999999999999866433211
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .... . .... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~---~-~~~~---------~~~ 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEK---V-SQGL---------RLY 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHH---H-hcCC---------CCC
Confidence 1111235678999999998889999999999999999998 888875433211 0000 0 0000 000
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
........+.+++..||+.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11112357889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=350.43 Aligned_cols=257 Identities=21% Similarity=0.297 Sum_probs=203.6
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~---- 594 (848)
...++|++.++||+|+||+||+++.. +++.||||++... .......+.+|+.++..++|+|+++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999854 6899999998654 2344567889999999999999999988775432
Q ss_pred ----eEEEEEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 595 ----EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 595 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
.+++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999988885432 3356889999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .. ..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~---~~-~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMH---KT-LA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH---HH-hc
Confidence 9999987654332333345679999999999999999999999999999999999999985322110 000 00 00
Q ss_pred CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 750 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
. ..+ ..+.....++.+++..||+.+|++||++.++++.
T Consensus 260 ~----~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 G----RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C----CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 000 1122234578899999999999999999999763
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.00 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=200.5
Q ss_pred cceeeeecccCCccEEEEEecC----CceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe-----
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~----- 595 (848)
|++.+.||+|+||.||+|.... +..||+|+++... ....+++.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998643 3679999987542 3345678999999999999999999999876554
Q ss_pred -EEEEEEeccCCcccccccCCC---cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 596 -KILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 596 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
.++|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999988874432 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccC
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKND 750 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 750 (848)
|+++...............++..|+|||.+....++.++||||||+++|||++ |..|+....... ..... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcC
Confidence 99987654433222222345678999999988899999999999999999999 778774322111 10000 000
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
. ....+.....++.+++.+||+.||++||++.|+++.|++.
T Consensus 232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0011122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.65 Aligned_cols=241 Identities=22% Similarity=0.279 Sum_probs=193.8
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 5889999999754 2334567889999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccce
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (848)
+|...+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9977773 3346889999999999999999999987 9999999999999999999999999987543221 122
Q ss_pred eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCH
Q 003092 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSL 766 (848)
Q Consensus 687 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 766 (848)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .. .. +. ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~~~---~~-~~------~~----~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFEL---IL-ME------DI----KFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HHHH---hc-cC------Cc----cCCC
Confidence 34579999999999999999999999999999999999999985332111 0000 00 00 00 1111
Q ss_pred HHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 767 PMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 767 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
....++.+++..||+.||++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 2334678899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.30 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=206.4
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeee-CCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~ 595 (848)
..++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998765 6789999987542 3345678899999999999999999998876 467
Q ss_pred EEEEEEeccCCcccccccCCCcc-----cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeec
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKK-----HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
.++++||+++++|..++...... ..+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999998887543222 56889999999999999999999886 99999999999999999999999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccccccc
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+...... .+... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAY----LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHc
Confidence 999987644332222222346778999999998889999999999999999999 99987543221 11110 000
Q ss_pred CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 750 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
. ...........++.+++.+||+.+|++||++.+++++|+...
T Consensus 235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000011112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.26 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=201.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 58899999987532 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999998888432 56889999999999999999999977 999999999999999999999999999876443
Q ss_pred c---------------------------cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 003092 681 E---------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (848)
Q Consensus 681 ~---------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~ 733 (848)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223569999999999999999999999999999999999999986433
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCC-HHHHHHH
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-MSDVVSM 796 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 796 (848)
.... .. .... . ...+...........+.+++..|++ +|++||+ +.++++.
T Consensus 235 ~~~~--~~---~i~~------~-~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET--YN---KIIN------W-KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH--HH---HHhc------c-CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2110 00 0000 0 0000000111124467889999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.68 Aligned_cols=248 Identities=27% Similarity=0.346 Sum_probs=205.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 368999999999999999999865 46789999987542 23457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+||.+.|.+...|.+. ....+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999998888532 3456788889999999999999999886 9999999999999999999999999997643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.....+.|||..|+|||...+..++..+|+|++|++.||++.|.+||.....+.. + +.-...++.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-Y--------krI~k~~~~--- 240 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-Y--------KRIRKVDLK--- 240 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-H--------HHHHHcccc---
Confidence 2344568999999999999999999999999999999999999999864331110 0 000001111
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+........+++..|+..+|.+|.+..|++.
T Consensus 241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12233446889999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=304.37 Aligned_cols=279 Identities=24% Similarity=0.326 Sum_probs=202.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc-c-HHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-G-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-~-~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV 599 (848)
+.|+.++.|++|.||.||+|+.+ +++.||+|+++-.... + --.-.+||.+|.+++|||||.+-.+.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57899999999999999999875 4788999999754322 1 12347899999999999999998887643 579999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||||+. +|..++.. ....+...++..++.|+++|++|||.+- |+||||||+|+|+.+.|.+||+|||||+.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 56665633 2346778888999999999999999986 99999999999999999999999999998876
Q ss_pred CccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cc----ccccc-cccccc---
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FN----LLGHA-WSLCKN--- 749 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~----~~~~~-~~~~~~--- 749 (848)
.. ...+..+-|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|....+-. .+ +++.- ...|..
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 52 223346789999999999875 58999999999999999999998775433211 10 01000 000000
Q ss_pred ------CccccccccccccCCCHH-HHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 003092 750 ------DRAHELMDPVLQNEVSLP-MLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFT 813 (848)
Q Consensus 750 ------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~ 813 (848)
-...+.....+++.+... ..+.-.+++..++.+||++|.|+.|.++ ++...+.|.|..|.+.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMF 376 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhc
Confidence 000000000111111111 3356678889999999999999999876 3444555666555544
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=326.77 Aligned_cols=264 Identities=24% Similarity=0.284 Sum_probs=194.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999875 588999999875432 233567889999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 9965 55554432 2345788889999999999999999987 9999999999999999999999999997643222
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc--ccccC------cc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS--LCKND------RA 752 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~------~~ 752 (848)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+...... ..... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1 1123468999999999875 457899999999999999999999986533211110000000 00000 00
Q ss_pred ccc----c----ccccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HEL----M----DPVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~----~----d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... . ...+... ........+.+++..|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 0 0000000 00011245778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=322.60 Aligned_cols=271 Identities=25% Similarity=0.394 Sum_probs=202.0
Q ss_pred cCcceeeeecccCCccEEEEEec-----CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~ 597 (848)
.+|++.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999743 477899999987666667889999999999999999999998754 34689
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999888432 345889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccc-ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc-ccccCccccc
Q 003092 678 GGDELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS-LCKNDRAHEL 755 (848)
Q Consensus 678 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 755 (848)
....... ......++..|+|||++.+..++.++||||||++++||++|..++................ ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332111 1111224456999999999899999999999999999999876643221110000000000 0000000001
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+..............++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111000011122345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.04 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=195.0
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
++||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999876543 33456789999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 888743 2345789999999999999999999987 99999999999999999999999999976543221111111
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLP 767 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 767 (848)
..++..|+|||.+.++.++.++||||||+++|||++ |..|+....... .. ..+...........
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~-------------~~~~~~~~~~~~~~ 220 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TR-------------EAIEQGVRLPCPEL 220 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HH-------------HHHHcCCCCCCccc
Confidence 123467999999999999999999999999999998 777764322110 00 00000001111222
Q ss_pred HHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 768 MLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 768 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
....+.+++.+|++.+|++||++.++.++|.
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3447889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.09 Aligned_cols=256 Identities=26% Similarity=0.453 Sum_probs=197.5
Q ss_pred cceeeeecccCCccEEEEEecCC-c--eEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------Ce
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLNG-Q--EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GE 595 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~~-~--~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~~ 595 (848)
|.+.++||+|+||.||+|..... + .||+|.++.. .....+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999987543 2 5899988653 234467789999999999999999999987532 25
Q ss_pred EEEEEEeccCCcccccccCC---CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 596 KILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
.+++|||+++++|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998776322 22345889999999999999999999986 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~----~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIY----DYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHHHcCC
Confidence 9987654332222222346778999999999999999999999999999999 77887532211 110 0011110
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.. .........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 01112334688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.36 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=204.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC-----------------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-----------------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 585 (848)
.++|++.++||+|+||.||++.... +..||+|.+.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999987643 2458999987553 335678899999999999999999
Q ss_pred eeeeeeeCCeEEEEEEeccCCcccccccCCC--------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 586 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
+++++..++..++||||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999988875432 1236889999999999999999999987 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh--CCCCCCCCCCC
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTD 735 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt--g~~p~~~~~~~ 735 (848)
|++++++.++|+|||+++...............+++.|+|||.+....++.++||||||+++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999987644433222334456789999999998899999999999999999998 55665432211
Q ss_pred ccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 736 SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
.................. .........++.+++..||+.+|++||++.||++.|+
T Consensus 241 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 --QVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111000000000 0011122357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=334.96 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=193.8
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 57899999997532 2345678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999888743 345788889999999999999999987 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccceeeeeccccccChhhhhcCCCCcccceeehH
Q 003092 682 L---------------------------------------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716 (848)
Q Consensus 682 ~---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlG 716 (848)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHh--ccccCcCCCCCHHHHH
Q 003092 717 VLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALL--CVQENAEDRPTMSDVV 794 (848)
Q Consensus 717 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~evl 794 (848)
|++|||++|+.||........... .... ...+..........++.+++.+ |+..+|..||++.+++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~-----i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLK-----VINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHH-----HHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999864332111000 0000 0000000011122356667766 5566677799999998
Q ss_pred H
Q 003092 795 S 795 (848)
Q Consensus 795 ~ 795 (848)
.
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.99 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=199.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCc----eEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.+.||+|+||.||+|.+. +++ .+|+|.+..... ....++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888899999999999999864 344 478888764432 34567888999999999999999999875 456788
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999988853 2346889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............++..|+|||++.++.++.++||||||+++|||++ |+.|+....... .. ........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~----~~~~~~~~--~~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VP----DLLEKGER--LAQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHHCCCc--CCC
Confidence 4332222233457789999999999999999999999999999998 888875332111 00 00011000 000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.......+.+++..||+.+|++||++.|+++.|....
T Consensus 233 -------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 -------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0112235678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=336.06 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=196.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 58899999997532 234466788999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999888743 345889999999999999999999987 999999999999999999999999998765321
Q ss_pred cccc------------------------------------ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh
Q 003092 681 ELQG------------------------------------NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (848)
Q Consensus 681 ~~~~------------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt 724 (848)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCC---HHHHHH
Q 003092 725 SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT---MSDVVS 795 (848)
Q Consensus 725 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 795 (848)
|..||........ .. ..... ...+...........+.+++..|+. +|++|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~~--~~---~i~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQET--YR---KIINW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHH--HH---HHHcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999864332110 00 00000 0000000011123466788888886 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=333.76 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=192.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|+..++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999865 589999999865432 3356789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.... ...+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999985432 3456777889999999999999987 9999999999999999999999999998764322
Q ss_pred ccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||............ ......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~--~~~~~~-------- 291 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM--CAICMS-------- 291 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH--HHHhcc--------
Confidence 11233579999999998743 23456899999999999999999998632221110000 000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...........++.+++..||+.||++||++.|+++
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111223447889999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.88 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=192.1
Q ss_pred cCcceeeeecccCCccEEEEEec--CCceEEEEEecccC--cccHHHHHHHHHHHHHc---CCCceeeeeeeeee-----
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIE----- 592 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~~----- 592 (848)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36899999999999999999863 36789999986532 22234566788777766 69999999998852
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
....++||||++ ++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456899999997 4777766432 2335789999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccccccccccC
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWSLCKND 750 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~ 750 (848)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99876433 122345789999999999999999999999999999999999999864332110 0000000000000
Q ss_pred cc------ccccccccc---cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RA------HELMDPVLQ---NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~------~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ...+.+... ..........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 0001112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=324.65 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=200.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC---------------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLL 587 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~---------------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~ 587 (848)
.++|++.++||+|+||.||+++... ...||+|.++... ......|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3689999999999999999987532 1248999987542 33456789999999999999999999
Q ss_pred eeeeeCCeEEEEEEeccCCcccccccCCC---------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcE
Q 003092 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPT---------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (848)
Q Consensus 588 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NI 658 (848)
+++......++||||+++++|..++.... ....+++..+.+++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999988874321 1124688899999999999999999987 99999999999
Q ss_pred EeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh--CCCCCCCCCCCc
Q 003092 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDS 736 (848)
Q Consensus 659 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt--g~~p~~~~~~~~ 736 (848)
++++++.+||+|||++................++..|+|||++.++.++.++||||||++++||++ +..|+.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986543322222222345778999999999999999999999999999998 445554322111
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
............ ...............+.+++.+||+.+|++||++.+|++.|.+
T Consensus 241 --~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 100000000000 0000001111223478999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.41 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=201.6
Q ss_pred HhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
..++|++.+.||+|++|.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34679999999999999999998753 4679999886543 3334678999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC---Ccee
Q 003092 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKI 668 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl 668 (848)
.++||||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999998875432 1235889999999999999999999987 99999999999998765 5899
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||....... +... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~---~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEF---VT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH---HH
Confidence 99999987643332222222234568999999999999999999999999999997 888875332211 0000 00
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
... ....+......+.+++..|++.+|++||++.+|++.|+
T Consensus 236 ~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 00111222346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=330.90 Aligned_cols=241 Identities=20% Similarity=0.273 Sum_probs=192.8
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999987542 234556788999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccce
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (848)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9977773 3346889999999999999999999987 9999999999999999999999999987542221 112
Q ss_pred eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCH
Q 003092 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSL 766 (848)
Q Consensus 687 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 766 (848)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+........ .. ....... ..+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~------------~~~~~~~--~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE------------LILMEEI--RFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HH------------HHhcCCC--CCCC
Confidence 235799999999999999999999999999999999999999853321110 00 0000000 0111
Q ss_pred HHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 767 PMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 767 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.....+.+++..||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234678899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=336.08 Aligned_cols=258 Identities=17% Similarity=0.201 Sum_probs=193.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..+|++.++||+|+||.||++... .++.||+|.... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999864 578999997532 3467899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+. ++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 96 56666553 2345789999999999999999999987 9999999999999999999999999997543211
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc------cccccccccc-------c--
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS------FNLLGHAWSL-------C-- 747 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~------~~~~~~~~~~-------~-- 747 (848)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ..+....... .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 112234579999999999999999999999999999999999998753221100 0000000000 0
Q ss_pred ccCcccccc----cccccc---CC----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAHELM----DPVLQN---EV----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~----d~~l~~---~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+.. ...... .. ......++.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000000 00 0123446889999999999999999999986
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.44 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=202.7
Q ss_pred cCcceeeeecccCCccEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 57888999999999999999642 255799999877666667789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCc------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 599 IYEYMVNKSLDVFLFDPTK------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
||||+++++|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999888754221 135789999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..|+........ .. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~---~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IE---C 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HH---H
Confidence 9999999986543332222222345788999999999999999999999999999998 8888643221110 00 0
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
. .... ....+......+.+++.+||+.||++||++.||++.|+
T Consensus 237 ~-~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 I-TQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0000 00111122346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.31 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=206.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999865 6889999987642 2333457889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+++++|..++.... ....+++..+..++.||++||+|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999987774322 2345788999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.........+.... ... .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~---------~~~---~ 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI---------EQC---D 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH---------hcC---C
Confidence 321 11234688899999999988899999999999999999999999743221111111000 000 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
............+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00111123345788999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.52 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=204.2
Q ss_pred hcCcceeeeecccCCccEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4689999999999999999998643 3689999986543 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCc-------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 597 ILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
++||||+++++|..++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999888854321 234788899999999999999999887 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+....... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~----~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF----VI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH----Hh
Confidence 9999987654433222333456789999999998899999999999999999998 888875322111 0000 00
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
..... ..+.....++.+++..||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00000 111122457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.38 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=199.9
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++.|++.++||+|.|+.||+... +.|+.+|+|++... +..+.+++++|+.+-+.|+||||+++.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 347889999999999999999865 46899999987532 445788999999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~ 676 (848)
+|+|.+++|-.-+ ......++..+-..++||+++|.|+|.++ |||||+||+|+|+.. ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999984433 23356788889999999999999999997 999999999999943 44589999999998
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
+..+... ...+|||+|||||++...+|+..+|||+-||+||-|+.|..||-..+.. .+.
T Consensus 163 l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------------------rly 221 (355)
T KOG0033|consen 163 VNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------------RLY 221 (355)
T ss_pred eCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------------------HHH
Confidence 8743322 2357999999999999999999999999999999999999998432211 111
Q ss_pred ccccccCC--C----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEV--S----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~--~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+..+.. + ....++..+++++||..||.+|.|+.|.++
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111111 1 112346788999999999999999999864
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=316.87 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=200.0
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
.+|++.+.||+|+||.||++....+..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999998777789999986432 234678899999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99998887532 236889999999999999999999987 9999999999999999999999999998664322111
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .... . .... ...
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~---~------~~~~----~~~ 221 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVES---V------SAGY----RLY 221 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHH---H------HcCC----cCC
Confidence 111224458999999999999999999999999999999 788875432211 0000 0 0000 001
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
.+.....++.+++.+||+.+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.77 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=202.3
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.++||+|+||.||+|+..++..||+|++.... ...+++.+|++++++++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999988777789999987532 34567899999999999999999999874 45679999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999998888542 2345788999999999999999999987 999999999999999999999999999876543321
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......++..|+|||+..+..++.++||||||+++|||++ |..|+....... ... .... ....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~---------~~~~ 222 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD----QVER---------GYRM 222 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HHH----HHhc---------CCCC
Confidence 1122346778999999999999999999999999999999 777764322111 000 0000 0000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.........+.+++..|++.+|++||++.+++++|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=335.94 Aligned_cols=201 Identities=24% Similarity=0.361 Sum_probs=171.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 57899999987532 2345678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999888743 345788889999999999999999987 9999999999999999999999999986432100
Q ss_pred ---------------------------------------------cccceeeeeccccccChhhhhcCCCCcccceeehH
Q 003092 682 ---------------------------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716 (848)
Q Consensus 682 ---------------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlG 716 (848)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 003092 717 VLMLEILSSKKNTGVY 732 (848)
Q Consensus 717 vvl~elltg~~p~~~~ 732 (848)
|++|||++|+.||...
T Consensus 236 vil~elltG~~Pf~~~ 251 (382)
T cd05625 236 VILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=328.52 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=192.1
Q ss_pred eeecccCCccEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 47889999987531 23345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++. ....+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999988773 3345778888899999999999999987 9999999999999999999999999987543222
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...+... .. ..+.....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~~------------~~~~~~~~-- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--TI------------DKILKGKL-- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--HH------------HHHHcCCC--
Confidence 12233579999999999999889999999999999999999999986432110 00 00000000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..+......+.+++..||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=326.29 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=204.0
Q ss_pred hcCcceeeeecccCCccEEEEEecC--------CceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~ 593 (848)
.++|.+.+.||+|+||.||+++... ...+|+|.+.... .....++.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999997532 2469999997542 34456788999999999 799999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
+..++||||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999998885432 1235889999999999999999999886 9999999999999
Q ss_pred ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccc
Q 003092 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNL 739 (848)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~ 739 (848)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+...+... +
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence 9999999999999986643322222222234578999999999899999999999999999998 778875332111 0
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.. ...... ....+.....++.+++..||+.+|++||++.+|++.|++++
T Consensus 252 ~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 252 FK----LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HH----HHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 00 000000 00111122347788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.34 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=195.3
Q ss_pred CcceeeeecccCCccEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
+|++.++||+|+||.||+++.. .++.||+|++.+.. ....+.+..|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998753 47899999986431 23345678899999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999887743 345889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... ........ .
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~-------~ 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL-------K 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh-------c
Confidence 543221 1223457999999999998654 789999999999999999999998643221100 00000000 0
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.++. .+......+.+++..||+.||++|| ++.++++
T Consensus 226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0111 1112234678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.46 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=203.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~ 594 (848)
..++|.+.++||+|+||.||+|++. .++.||||+++.... ...+.+++|+.+|.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999853 246899999975432 23457889999999997 999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 616 (848)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999988875321
Q ss_pred -------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 617 -------------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 617 -------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124677788899999999999999876 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543222112222357789999999999889999999999999999998 8888754322110
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
. ......+ .....+......+.+++..||+.+|++||++++|++.|++.+
T Consensus 351 ~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 F----YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H----HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 0000000 000111122357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.00 Aligned_cols=240 Identities=26% Similarity=0.340 Sum_probs=188.4
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47889999987532 23345556677777654 899999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999877743 345888999999999999999999987 9999999999999999999999999998653322 22
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. ... .. .+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~---~i~-~~------~~----~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFD---SIL-ND------RP----HFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHH---HHH-cC------CC----CCC
Confidence 334679999999999999999999999999999999999999986433211 000 000 00 00 111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHH-HHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMS-DVV 794 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 794 (848)
.....++.+++..||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234677899999999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=330.97 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=193.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----CeEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEKI 597 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~~~ 597 (848)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999865 5889999998743 223446788999999999999999999988643 2579
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 56766663 3345889999999999999999999987 999999999999999999999999999865
Q ss_pred CCCccc-cceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-ccccccc--------cc
Q 003092 678 GGDELQ-GNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHA--------WS 745 (848)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~--------~~ 745 (848)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 332211 11223579999999999876 678999999999999999999999985432110 0000000 00
Q ss_pred ccccCcccccccccccc-CCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQN-EVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+...... ... ......+.+++..||+.+|++||++.|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000000 000 012235788999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.24 Aligned_cols=244 Identities=27% Similarity=0.449 Sum_probs=205.0
Q ss_pred eecccCCccEEEEEecCC-ceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccc
Q 003092 532 KLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 610 (848)
+||+|.||+||.|++.+. ..+|||.+.....+..+.+..||.+-+.|+|.|||+++|.+.+++..-+.||-.+||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999997664 5799999988877778889999999999999999999999999999999999999999999
Q ss_pred cccCCCccccc--CHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCceeeccccccccCCCcccccee
Q 003092 611 FLFDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTK 687 (848)
Q Consensus 611 ~l~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (848)
+|... =+++ .+...-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.+..- ...+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 88432 2334 67788889999999999999987 99999999999996 4688999999999987543 34566
Q ss_pred eeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 688 RIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 688 ~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
++.||..|||||++..++ |..++|||||||++.||.||++||...+.....++... .. .....++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG--my-----------KvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG--MY-----------KVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc--ce-----------ecCCCCc
Confidence 788999999999998765 78999999999999999999999976554332221111 00 0123456
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+...+...++++|...+|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677888999999999999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=333.13 Aligned_cols=201 Identities=24% Similarity=0.335 Sum_probs=173.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||+||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 48899999997532 233466888999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999888843 356889999999999999999999987 999999999999999999999999999765321
Q ss_pred ccc---------------------------------cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC
Q 003092 681 ELQ---------------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 681 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~ 727 (848)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 003092 728 NTGV 731 (848)
Q Consensus 728 p~~~ 731 (848)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.31 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=198.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999865 58899999997542 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999888432 246889999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhh------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ . ........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~---~~i~~~~~--- 226 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--Y---NNIMNFQR--- 226 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--H---HHHHcCCC---
Confidence 222 223347999999999987 45678999999999999999999999854322110 0 00000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.-.........+.+++..|++ +|++||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 ----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000111233467788889997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=324.87 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=205.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
..++|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999742 23479999986542 34567789999999999 89999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
....++||||+++++|..++.... ....+++..+..++.||++||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999998885421 1235788889999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
+++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 99999999999999987754333222333456778999999999899999999999999999998 677764322111
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+. ....... ...........+.+++..||+.+|++||++.|+++.|++++
T Consensus 248 ~~----~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 LF----KLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HH----HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 00 0000000 00111223457888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.02 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=200.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-----------------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-----------------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~ 585 (848)
.++|++.++||+|+||.||++... ++..||+|++.... ....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 367999999999999999998532 13468999987543 334568999999999999999999
Q ss_pred eeeeeeeCCeEEEEEEeccCCcccccccCCC--------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 586 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
+++++..++..++||||+++++|..++.... ....+++..+..++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999988875422 1234778889999999999999999987 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh--CCCCCCCCCCC
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTD 735 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt--g~~p~~~~~~~ 735 (848)
||+++++.++|+|||+++.+.............+++.|+|||....+.++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986643322222222345678999999988899999999999999999998 56666432211
Q ss_pred ccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 736 SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
. .............. ... ...+......+.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~--~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q--VIENTGEFFRDQGR-QVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H--HHHHHHHHHhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 11000000000000 000 0111123357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.62 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=201.6
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357899999999999999999988888899999875432 3567899999999999999999999875 45688999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999998888542 2345789999999999999999999987 999999999999999999999999999876443211
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..... +......
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~-------------~~~~~~~ 222 (260)
T cd05070 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ-------------VERGYRM 222 (260)
T ss_pred c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH-------------HHcCCCC
Confidence 1 112235678999999998899999999999999999999 88887532211 01000 0000001
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
..+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122234568899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.14 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=204.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC--------CceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~ 593 (848)
..+|++.+.||+|+||.||+++... ...||+|.+.... ....+++.+|+.+++++ +||||+++++++.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3578999999999999999997421 2368999887532 34467899999999999 899999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
+..+++|||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999988875421 2335788899999999999999999987 9999999999999
Q ss_pred ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccc
Q 003092 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNL 739 (848)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~ 739 (848)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...+....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 9999999999999987654322222222334578999999999999999999999999999998 7777643321110
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
. ...... ............+.+++..||+.+|++||++.|+++.|++...
T Consensus 246 ~----~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 F----KLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0 000000 0001112234468899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.86 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=212.1
Q ss_pred HHhcCcceeeeecccCCccEEEEEecC---Cc--eEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~---~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
...+...+.+.||+|-||.||+|.+.+ |+ .||||..+.. .....+.|..|+.+|+.++|||||+++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334556667899999999999998643 22 5899998764 455678899999999999999999999999754 7
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++|||.++-|.|..+|. .++..++......++.||..+|+|||+.. +|||||..+|||+....-+||+||||++
T Consensus 465 ~WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 899999999999999995 35567888888999999999999999986 9999999999999999999999999999
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCC-CCccccccccccccccCccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN-TDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 753 (848)
.+..+.+...+ ...-...|||||.+.-..++.++|||.|||.+|||+. |..||.... .+..
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------------- 602 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------------- 602 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------
Confidence 99887766554 4566789999999999999999999999999999998 889975322 2111
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
-.++.--+-+.++.++..+..++.+||.++|.+||++.|+...|+..+
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 111111122445556778899999999999999999999998876554
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=327.00 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=191.5
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|+.. .++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 47899999987532 23445677899998876 799999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99987773 3345788999999999999999999987 9999999999999999999999999987543222 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ... ..... +. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~---~i~~~----~~-------~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE---SILHD----DV-------LYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH---HHHcC----CC-------CCC
Confidence 234579999999999999999999999999999999999999986433211 000 00000 00 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCC-------CHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRP-------TMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~ 795 (848)
.....++.+++..||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11234678899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=322.57 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=202.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
..++|++.++||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997532 4579999886443 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCC-------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 596 KILIYEYMVNKSLDVFLFDPT-------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
.++||||+++|+|..++.... ....+.+..+.+++.|++.||+|||+++ |+||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999885321 1234567788899999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..|+....... ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~----- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKF----- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH-----
Confidence 99999986644332222222345778999999999999999999999999999998 677764322111 0000
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..+... ..........+.+++..||+.+|++||++.++++.|.+.
T Consensus 234 -------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 -------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 000000 001111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.11 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=191.6
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHH---HHcCCCceeeeeeeeeeCCeEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l---~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
|++.++||+|+||.||+|... +++.||||+++... ....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 58899999997532 23345667776665 456799999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|...+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999977663 246899999999999999999999987 99999999999999999999999999875432
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .... . ..
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~~---~i~~-~------~~- 218 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VFD---SIVN-D------EV- 218 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HHH---HHHh-C------CC-
Confidence 11 12234679999999999999999999999999999999999999985432111 000 0000 0 00
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..+......+.+++.+||+.||++|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01112234678899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.32 Aligned_cols=255 Identities=31% Similarity=0.465 Sum_probs=203.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 346899999999999999999998888999999987543 3456889999999999999999999886 45678999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999998877443 2346789999999999999999999887 99999999999999999999999999987653222
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.. .....++..|+|||++....++.++||||||+++|||++ |+.|+....... .... +.....
T Consensus 158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~-------------~~~~~~ 221 (260)
T cd05067 158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQN-------------LERGYR 221 (260)
T ss_pred cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHH-------------HHcCCC
Confidence 11 112345678999999998899999999999999999999 999875332111 0000 000000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.........++.+++.+|++.+|++||++++++++|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111223478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=335.37 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=193.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.+|++.++||+|+||.||+++.. .++.||||++.... ....+.+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 48899999986532 233566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999988843 345788888999999999999999987 999999999999999999999999998533100
Q ss_pred c-----------------------------------------cccceeeeeccccccChhhhhcCCCCcccceeehHHHH
Q 003092 681 E-----------------------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719 (848)
Q Consensus 681 ~-----------------------------------------~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl 719 (848)
. ........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCC---CHHHHHH
Q 003092 720 LEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP---TMSDVVS 795 (848)
Q Consensus 720 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~evl~ 795 (848)
|||++|+.||..............+ ...+...........+.+++..|+ .+|++|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINW------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhcc------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998644321110000000 000000001112234556666665 4999999 7888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.25 Aligned_cols=271 Identities=25% Similarity=0.376 Sum_probs=201.1
Q ss_pred cCcceeeeecccCCccEEEEEec-----CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~ 596 (848)
..|++.++||+|+||.||++++. .++.||+|.++... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788999999999999999742 46789999987543 33456799999999999999999999998775 568
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|..++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999887432 235789999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|....-......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6533211 112234567789999999988899999999999999999998765321100000000000000000000000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+..............++.+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000111122345789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=333.24 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=198.3
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
..++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3468999999999999999999875 5889999998643 22334557889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999888742 34778888899999999999999987 9999999999999999999999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcC----CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEG----VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .. ........
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~---~~i~~~~~--- 264 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TY---SKIMDHKN--- 264 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--HH---HHHHcCCC---
Confidence 33211 12235799999999998753 47899999999999999999999986432210 00 00000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 795 (848)
.+.-.........+.+++..||+.+|++ ||++.|+++
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0000011123457788999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.13 Aligned_cols=259 Identities=28% Similarity=0.411 Sum_probs=203.5
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~ 595 (848)
.++|++.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 367999999999999999999742 24579999987543 33456789999999999 79999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|..++.... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999988885322 234789999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........ .. +
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~-------------~ 255 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY-------------K 255 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH-------------H
Confidence 6644322111222346788999999999999999999999999999998 8888754322110 00 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.++.............++.+++..|++.+|++||++.|+++.|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000001111234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.59 Aligned_cols=246 Identities=29% Similarity=0.403 Sum_probs=193.7
Q ss_pred eecccCCccEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 532 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+||+|+||.||+|.+. +++.+|+|++.... ....+++.+|+.++++++||||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999653 46789999986543 234577899999999999999999999875 45678999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc-c
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-N 685 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 685 (848)
+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9988874 2345889999999999999999999987 9999999999999999999999999998765432211 1
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+....... ... .++.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~-------------~i~~~~~~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQ-------------MIESGERMEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------HHHCCCCCCC
Confidence 112234679999999988889999999999999999998 888875432211 000 0000001111
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
+.....++.+++..||+.||++||++.+|++.|++
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22234578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.89 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=189.1
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||.||+++.. +++.||+|++... .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4789999999754 223445678899988877 899999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99977763 3346889999999999999999999987 9999999999999999999999999997542211 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc---ccccccccccccCcccccccccccc
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF---NLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+...... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~--~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--------cCC--C
Confidence 2345799999999999999999999999999999999999999853221110 00000000000 000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
..+......+.+++..||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1222234467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=328.49 Aligned_cols=241 Identities=20% Similarity=0.267 Sum_probs=192.1
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.||+|+||.||++... +++.||+|++.... ......+.+|++++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999997542 234566788999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9987773 33468899999999999999999997 55 9999999999999999999999999987543221 11
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..... .. ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~----~i~~~------~~----~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME------EI----RFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HH----HHhcC------CC----CCC
Confidence 2335799999999999999999999999999999999999999854322110 00 00000 00 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.....++.+++..||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 11234678899999999999996 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.68 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=200.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecc--cCcccHHHHHHHHHHHHHcCCCceeeeeeeeee-----CCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-----QGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-----~~~ 595 (848)
...|...+.||+|+||.|..+... +|+.||||++.+ ......++..+|+.+|+.++|+||+.+++++.- -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 356666789999999999999865 589999999973 344567788999999999999999999998865 357
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.|+|+|+| ..+|...+. .+..++......++.||++||+|+|+.+ |+||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 457777772 3344888999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCC-CccccccccccccccCc--
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNT-DSFNLLGHAWSLCKNDR-- 751 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~-- 751 (848)
...........+..+-|..|.|||++.. ..|+.+.||||.||++.||++|++-|...+. ++..+..........+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8865422333345678999999999864 5799999999999999999999998865442 22222211111111111
Q ss_pred ------ccccccccccc-CCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 ------AHELMDPVLQN-EVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ------~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+...-.. ..+ +......++++.+||..||.+|+|+.|+++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111110000 000 112235788999999999999999999986
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=333.47 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=194.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||++... +++.||||++.... ....+.+++|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999864 58899999986532 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999888743 345788889999999999999999987 999999999999999999999999999643211
Q ss_pred cc------------cc---------------------------------ceeeeeccccccChhhhhcCCCCcccceeeh
Q 003092 681 EL------------QG---------------------------------NTKRIVGTYGYMSPEYALEGVFSVKSDVFSF 715 (848)
Q Consensus 681 ~~------------~~---------------------------------~~~~~~gt~~y~APE~~~~~~~~~ksDVwSl 715 (848)
.. .. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCC---CCHHH
Q 003092 716 GVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR---PTMSD 792 (848)
Q Consensus 716 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~e 792 (848)
||++|||++|+.||....... .... ...... .+ .+.. ......++.+++..|++ +|++| +++.|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--~~~~---i~~~~~--~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--TYRK---IINWRE--TL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--HHHH---HHccCC--cc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999985432211 0000 000000 00 0000 01123457788888997 67665 58888
Q ss_pred HHHH
Q 003092 793 VVSM 796 (848)
Q Consensus 793 vl~~ 796 (848)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=311.63 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=207.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 6899999988642 2234577899999999999999999999999999999999
Q ss_pred EeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+++++|..++... .....+++..+..++.++++||+|||+.+ |+||||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999998887543 23445889999999999999999999987 99999999999999999999999999986643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+............. +...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~ 223 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-------------IEKC 223 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh-------------hhcC
Confidence 3211 223468899999999999899999999999999999999999974322111100000 0000
Q ss_pred cccCCC-HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 760 LQNEVS-LPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 760 l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.....+ ......+.+++..||+.+|++||++.+|+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 001111 13345688999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.66 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=199.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCc----eEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|++.++||+|+||+||+|+.. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 367899999999999999999853 444 48999987543 3345678899999999999999999999875 4577
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+++||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999998887532 346889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... +.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~------ 227 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPD----LLEKG------ 227 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HHHCC------
Confidence 53322111112235678999999999999999999999999999998 888875322111 000 00000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...........++.+++..||+.||++||++.++++.|+..
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 228 ---ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ---CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 00011112334678899999999999999999999988766
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.14 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=191.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCC-ceeeeeeeeeeCCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hp-niv~l~~~~~~~~~~~lV~ 600 (848)
+|++.+.||+|+||.||+|+.. .++.||||++... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999875 4678999998753 233456788899999999765 5888999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999987773 2345788999999999999999999987 999999999999999999999999998753221
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... . ....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~---i---------~~~~- 217 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQS---I---------MEHN- 217 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHH---H---------HcCC-
Confidence 1 12334679999999999999999999999999999999999999985432211 0000 0 0000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
...+.....++.+++..||+.+|++|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01111223467889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.07 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=203.8
Q ss_pred HhcCcceeeeecccCCccEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
..++|.+.++||+|+||.||+++.. ....||+|.+.... .....++.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467899999999999999999742 24579999987542 34456788999999999 69999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
....++||||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999988885421 1245889999999999999999999887 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987654322222222234568999999999999999999999999999999 788774332111
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+.. ....... .........++.+++.+||+.+|++||++.++++.|++..
T Consensus 245 ~~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 LFK----LLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHH----HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 000 0000000 0111222346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.16 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=196.3
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
...++|++.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999875 4789999998642 2223456788999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999888732 34788889999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCC----CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .........
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-----~~~i~~~~~-- 264 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-----YSKIMDHKN-- 264 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCc--
Confidence 43221 1223457999999999997643 78899999999999999999999864321100 000000000
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVSM 796 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 796 (848)
.+.-.........+.+++..|++.+|++ ||++.|+++.
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000011112345677888888755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.48 Aligned_cols=238 Identities=26% Similarity=0.309 Sum_probs=190.5
Q ss_pred eeecccCCccEEEEEe----cCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 531 SKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
+.||+|+||.||+++. ..++.||+|++.... ......+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 247899999997542 2234567889999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988773 3346889999999999999999999987 9999999999999999999999999998654321 1
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ... ....... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~------------~i~~~~~--~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMT------------MILKAKL--GM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHH------------HHHcCCC--CC
Confidence 2334679999999999999889999999999999999999999985332110 000 0000000 11
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHH
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSD 792 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~e 792 (848)
+......+.+++..||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122346788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=321.11 Aligned_cols=240 Identities=24% Similarity=0.306 Sum_probs=189.5
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 47899999987532 23445667788888765 899999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999877743 345788999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... .. ..+.+ +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~----~~------~~~~~----~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESI----RV------DTPHY----P 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH----Hh------CCCCC----C
Confidence 334679999999999999999999999999999999999999985432211 00000 00 00111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHH-HHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMS-DVV 794 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 794 (848)
.....++.+++..||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234678899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.59 Aligned_cols=236 Identities=25% Similarity=0.332 Sum_probs=188.8
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998753 233456677888888877 699999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99987774 2345889999999999999999999987 9999999999999999999999999987543221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. ...... . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~----~i~~~~------~----~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFE----AILNDE------V----VYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHH----HHhcCC------C----CCC
Confidence 234579999999999999999999999999999999999999986433211 000 000000 0 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
.....++.+++..||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.25 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=200.0
Q ss_pred cCcceeeeecccCCccEEEEEecC-Cc--eEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.++||+|+||.||+|...+ +. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998754 33 4788888743 334456789999999999 799999999999999999999
Q ss_pred EEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999988875321 1235888999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~---- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYE---- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----
Confidence 99999998643211 11111223567999999999899999999999999999998 888875332111 000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
. +........+......+.+++..||+.+|.+||++.++++.|++.+.
T Consensus 230 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 K---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred H---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 00000001111233467899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.44 Aligned_cols=271 Identities=27% Similarity=0.396 Sum_probs=204.9
Q ss_pred cCcceeeeecccCCccEEEEEec-----CCceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~ 596 (848)
+.|++.+.||+|+||.||++.+. .++.||||.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999854 2678999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999888532 235889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7532211 111123455679999999988999999999999999999999988643222111110000000000001111
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+..............++.+++.+||+.+|++||++.||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111222335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.53 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=200.5
Q ss_pred cCcceeeeecccCCccEEEEEecC-C---ceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..|++.+.||+|+||.||+|.... + ..||||.+... .....++|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999998653 3 36999998754 334467899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999998887432 345789999999999999999999987 99999999999999999999999999886643
Q ss_pred Cccccceeeee---ccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccc
Q 003092 680 DELQGNTKRIV---GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 680 ~~~~~~~~~~~---gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
........... .+..|+|||.+....++.++||||||+++|||++ |..|+...... ...... . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i----~-----~~ 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI----E-----QD 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----H-----cC
Confidence 32111111111 2457999999999999999999999999999886 88887533211 110000 0 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..-......+..+.+++..||+.+|++||++.+|+++|++.
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011112234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.26 Aligned_cols=237 Identities=22% Similarity=0.286 Sum_probs=185.4
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57899999986532 222344555554 57889999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99977663 3345788888899999999999999987 9999999999999999999999999987532221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .... .....+ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~------------i~~~~~--~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MYDN------------ILHKPL--QLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HHHH------------HhcCCC--CCC
Confidence 334579999999999999999999999999999999999999985432111 0000 000000 111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMS 791 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~ 791 (848)
......+.+++..|++.+|++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22344678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.47 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=202.1
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.+.||+|+||.||++... ++..||+|++.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 35789999987543 33456789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC-------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 597 ILIYEYMVNKSLDVFLFDPT-------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
++||||+++++|..++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999988875321 1234788889999999999999999987 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCc
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDS 736 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~ 736 (848)
||+++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986543332222222345678999999999999999999999999999998 777764222110
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
... ........ ..+.....++.+++.+||+.+|++||++.|+++.|++
T Consensus 241 --~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VIY----YVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 000 00000000 0111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.62 Aligned_cols=266 Identities=25% Similarity=0.317 Sum_probs=195.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-c-cHHHHHHHHHHHHHcCCCc-eeeeeeeeeeCC------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQG------ 594 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~-~~~~~~~Ei~~l~~l~Hpn-iv~l~~~~~~~~------ 594 (848)
..|...++||+|+||+||+|+.. +|+.||+|+++-... + ......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45677789999999999999854 689999999976543 2 3345689999999999999 999999998877
Q ss_pred eEEEEEEeccCCcccccccCCCcc-cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++|+||++. +|..++...... ..++...+..+++||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78999999965 666666443322 45666889999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-----ccccc-cccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-----NLLGH-AWSL 746 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-----~~~~~-~~~~ 746 (848)
|+.+.-... .-...++|.-|.|||++.+. .|+...||||+||++.||++++.-|....+... .+++. ....
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 997653221 12345789999999999987 689999999999999999998877654432110 00000 0000
Q ss_pred cccCccccccccccccC-----CCH---HHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 747 CKNDRAHELMDPVLQNE-----VSL---PMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~-----~~~---~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
|.........+...... ... ....+..+++.+|++.+|.+|.|+..++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000000011111100 000 011367889999999999999999999874
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.10 Aligned_cols=241 Identities=25% Similarity=0.309 Sum_probs=191.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999875 47799999987542 22345567788888877 5899999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999987773 2345788999999999999999999987 999999999999999999999999999754322
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... +....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~------------i~~~~- 217 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQS------------IMEHN- 217 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHH------------HHhCC-
Confidence 1 12234579999999999999999999999999999999999999986433211 1000 00000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
...+.....++.+++..|++.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01112234467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.54 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=206.2
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||++.. .+++.||||.+.... ....+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 468899999876432 234467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+++++|..++... .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999998877532 23456889999999999999999999987 99999999999999999999999999887643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..|+.....+....... ......+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~- 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---------IEQCDYP- 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh---------hhcCCCC-
Confidence 3211 223468899999999999899999999999999999999999975322211111000 0000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..........+.+++.+||+.+|++||||.+|++++.+.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011112345788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.65 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=200.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||+|+.. +++.||+|++..........+++|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999864 5889999999765555566788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999887742 345789999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
......|++.|+|||.+. ...++.++||||||+++|||++|+.|+........... .... ....+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-----~~~~----~~~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-----MSKS----NFQPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-----eecC----CCCCCC
Confidence 122346889999999885 34578899999999999999999998743221110000 0000 000011
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
... .......+.+++..||+.+|++||++.++++.
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 100 11223478899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.75 Aligned_cols=257 Identities=29% Similarity=0.424 Sum_probs=200.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCc--eEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.+.||+|+||.||+|.+. ++. .+|+|.+... ......++.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57899999999999999999864 344 4688877643 233456788999999999 899999999999999999999
Q ss_pred EEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
|||+++++|..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999988875332 1235789999999999999999999887 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++..... .......++..|+|||++....++.++||||||+++|||++ |..|+....... .....
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL-- 236 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHH--
Confidence 99999998643211 11111234678999999988889999999999999999998 888875332211 00000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
.. .............+.+++.+||+.+|++||++.+++++|+.++.
T Consensus 237 --~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 237 --PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred --hc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 00000111123467899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.06 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=199.5
Q ss_pred hcCcceeeeecccCCccEEEEEe------cCCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC-C
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ-G 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~-~ 594 (848)
.++|++.++||+|+||.||+|.. ..++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999973 246789999997543 23456788999999999 689999999988654 4
Q ss_pred eEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 616 (848)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999987764311
Q ss_pred ------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeee
Q 003092 617 ------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690 (848)
Q Consensus 617 ------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 690 (848)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999987 9999999999999999999999999998754332222222234
Q ss_pred ccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHH
Q 003092 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPML 769 (848)
Q Consensus 691 gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 769 (848)
++..|+|||++.+..++.++||||||+++|||++ |..|+........ .. ....+.. .. ..+....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~----~~~~~~~-----~~----~~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGT-----RM----RAPDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HH----HHHhccC-----CC----CCCCCCC
Confidence 5678999999999999999999999999999997 8888643221110 00 0000000 00 0011122
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 770 VRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 770 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.++.+++..||+.+|++||++.||++.|+..+
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 36788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.95 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=192.7
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+++.. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 57899999997532 23456688899999998 799999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99977763 3346899999999999999999999987 9999999999999999999999999987532111 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc---cccccccccccccCcccccccccccc
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS---FNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......... ......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--
Confidence 234679999999999999999999999999999999999999986432111 0000000000 000000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCC------HHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPT------MSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~ 795 (848)
..+.....++.+++..||+.||++||+ +.++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111223446789999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.39 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=193.9
Q ss_pred ecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||+||++... +++.||+|.+.... ....+.+..|+.++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 58899999986532 22346678899999999999999999999999999999999999999
Q ss_pred cccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccccee
Q 003092 609 DVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687 (848)
Q Consensus 609 ~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (848)
...+... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8776433 23456899999999999999999999987 99999999999999999999999999987644322 123
Q ss_pred eeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc--CCC
Q 003092 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN--EVS 765 (848)
Q Consensus 688 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~ 765 (848)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......... .+.....+.. ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--------------~~~~~~~~~~~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--------------KELKQRILNDSVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--------------HHHHHhhcccCCCCc
Confidence 357899999999999999999999999999999999999998643221100 0000000000 112
Q ss_pred HHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
......+.+++..||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 22345788999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.03 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=202.4
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|++|.||++... +++.|++|.+... .....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999875 5889999998643 334567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999888543 2356889999999999999999999886 99999999999999999999999999987654322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....|++.|+|||++.+..++.++||||||++++||++|+.|+....... ... . ..... ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~---~---------~~~~~-~~ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL---K---------IIRGV-FP 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH---H---------HHcCC-CC
Confidence 1 223468899999999999999999999999999999999999986433111 000 0 00000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111133457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.39 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=196.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||+|... +++.||+|.+... .....+++.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999864 5889999998654 233456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999886542 3578888899999999999999987 9999999999999999999999999998654322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc-ccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG-HAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+............ ......... ..+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL- 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC-
Confidence 22357899999999999999999999999999999999999998543221110000 000000000 00000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......++.+++.+|++.+|++||++.|+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 01112346789999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.88 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=198.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986532 2223557889999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998777432 2345889999999999999999999987 9999999999999999999999999998754322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ... ....+... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~---------~~~~~~~~-~ 221 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REE---------VERRVKED-Q 221 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHH---------HHHHhhhc-c
Confidence 1 1234689999999999999999999999999999999999999864322110 000 00000000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..........+.+++..||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 111222445678999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=313.37 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=191.7
Q ss_pred eeecccCCccEEEEEecC---CceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 45799998875432 33457889999999999999999999999999999999999999
Q ss_pred cccccccCCC--cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 607 SLDVFLFDPT--KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 607 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|.+++.... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9998885432 2234667788899999999999999987 9999999999999999999999999997654333222
Q ss_pred ceeeeeccccccChhhhhcC-------CCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 685 NTKRIVGTYGYMSPEYALEG-------VFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~-------~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
......++..|+|||++... .++.++||||||+++|||++ |+.|+........ .... .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT----VREQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH----hhcccCCCC
Confidence 22334578899999998642 35789999999999999996 9989854332211 0000 000001111
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
++.+. ......+.+++..|+ .+|++|||+.||++.|+
T Consensus 232 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 112335777888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.61 Aligned_cols=251 Identities=28% Similarity=0.374 Sum_probs=207.1
Q ss_pred cCcceeeeecccCCccEEEEEecC--Cc--eEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~--~~--~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
++..+.|+||+|.||.|++|.+.. |+ .||||.++..... ....|.+|+.+|.+|+|||+++|+|+..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 445567899999999999998753 44 5899999876544 67899999999999999999999999887 788999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+|.++.|+|.+.|++ ..+..+.......++.|||.||.||.+++ +|||||..+|+||.....+||+||||.+.+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999988876 55667778888999999999999999987 99999999999999999999999999998865
Q ss_pred Cc-cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 680 DE-LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~-~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.+ .+.......-...|.|||.+....|+.++|||+|||+||||+| |+.||-.... ..+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhcc
Confidence 43 2222222345678999999999999999999999999999999 6777643221 12233344
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..-.-..+..+.+++++++..||..+|++|||+..|.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 32222345567889999999999999999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.37 Aligned_cols=240 Identities=21% Similarity=0.272 Sum_probs=187.5
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+++.. +++.||+|++.... .....++..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999864 58899999986532 223345556655 46778999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99977763 3446889999999999999999999987 9999999999999999999999999987542211 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. ..+...+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~------------~~~~~~~--~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYD------------NILHKPL--VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HHH------------HHHcCCc--cCC
Confidence 234579999999999999999999999999999999999999985432111 000 0000000 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
+.....+.+++..|++.+|++||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12334677899999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.34 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=202.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC-C---ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+++.+|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578889999999999999998753 3 369999986542 3345678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999998888432 346789999999999999999999987 9999999999999999999999999998664
Q ss_pred CCccccce-eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDELQGNT-KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
........ .....+..|+|||++....++.++||||||+++|||++ |+.|+....... ... .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~---~i-~-------- 224 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMK---AI-N-------- 224 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH---HH-h--------
Confidence 33211111 11223467999999998889999999999999999998 999975322110 000 00 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..............+.+++.+||+.+|++||++.+|++.|++.
T Consensus 225 -~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 -DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001111112345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=337.17 Aligned_cols=261 Identities=19% Similarity=0.292 Sum_probs=189.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-------- 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-------- 593 (848)
..++|++.++||+|+||.||+|... .++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999875 57899999885432 2345799999999999999998876432
Q ss_pred CeEEEEEEeccCCcccccccC-CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-Cceeecc
Q 003092 594 GEKILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDF 671 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DF 671 (848)
..+++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999986 44444422 234456889999999999999999999987 99999999999998665 6999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc--cc
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL--CK 748 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~ 748 (848)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+....... ..
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 9998764332 12235689999999998764 68999999999999999999999986432211 000000000 00
Q ss_pred c-------Ccccc-----ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 N-------DRAHE-----LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~-------~~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ....+ .....+...++.....++.+++..||+.||++|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 00000 00000111111122357889999999999999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=309.82 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=189.9
Q ss_pred CcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----eEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-----~~~lV 599 (848)
.|...+++|.|+||.||+|.... +++||||+.-...+. --.|+++|++++|||||++.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999998654 689999987544321 146899999999999999998886533 33589
Q ss_pred EEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeecccccccc
Q 003092 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMF 677 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~ 677 (848)
||||+. +|...+.+. ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 555555332 23455677777889999999999999976 9999999999999976 99999999999988
Q ss_pred CCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCC-ccccccccccccccCcc---
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRA--- 752 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~--- 752 (848)
..++.. ....-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...... +......+......+.+
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 655422 334568899999999875 6899999999999999999999887653321 11111111111111000
Q ss_pred ----ccccccccc-----cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 753 ----HELMDPVLQ-----NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 753 ----~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.+...+.+. .-.......+.++++.++++++|.+|.++.|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 011111111 11222344578899999999999999999999863
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.06 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=200.5
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.++||+|++|.||++....+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35689999999999999999998777789999886533 34567899999999999999999998875 45688999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999998888543 2335789999999999999999999887 999999999999999999999999999876433221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..... ... ...
T Consensus 159 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~----~~~---------~~~ 222 (260)
T cd05069 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQV----ERG---------YRM 222 (260)
T ss_pred c-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcC---------CCC
Confidence 1 112346778999999998899999999999999999999 888875322111 00000 000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.........+.+++.+||+.+|++||++.+|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=310.02 Aligned_cols=250 Identities=35% Similarity=0.513 Sum_probs=202.4
Q ss_pred eeecccCCccEEEEEecC----CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||++.... +..||+|.+...... ..+.+.+|++++..++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999765433 367899999999999999999999999999999999999999
Q ss_pred CcccccccCCCc------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 606 KSLDVFLFDPTK------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 606 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
++|..++..... ...+++..+..++.|+++||+|||+++ ++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999998865421 367899999999999999999999987 99999999999999999999999999988765
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
...........++..|+|||.+....++.++||||||+++|||++ |..|+....... +.. ..... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~~~~~-----~-- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLE----YLRKG-----Y-- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcC-----C--
Confidence 432223334567889999999998889999999999999999999 588875432111 100 00000 0
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
....+.....++.+++..||+.+|++||++.|+++.|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111222457889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.69 Aligned_cols=256 Identities=31% Similarity=0.475 Sum_probs=204.9
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.++||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 347899999999999999999998778899999987533 3457899999999999999999999999988999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999998888543 2245789999999999999999999987 99999999999999999999999999987653221
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ..... .....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~-------------~~~~~ 222 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQV-------------ERGYR 222 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-------------HcCCC
Confidence 1 1112234678999999998889999999999999999998 888874322110 00000 00000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
...+.....++.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=312.69 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=201.5
Q ss_pred cCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.+|++.+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999998642 3369999986543 33456889999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999888532 245788999999999999999999987 99999999999999999999999999987654
Q ss_pred Ccccc-ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 680 DELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... ......++..|+|||++.+..++.++||||||+++||+++ |..|+....... ..... .+. .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~----~~~-----~- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAI----EEG-----Y- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHH----hCC-----C-
Confidence 32111 1111223568999999999899999999999999999887 998875432211 00000 000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
........+..+.+++.+|++.+|++||+|.++++.|++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011112234678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.08 Aligned_cols=248 Identities=27% Similarity=0.391 Sum_probs=193.5
Q ss_pred eecccCCccEEEEEec---CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCc
Q 003092 532 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
.||+|+||.||+|.+. .+..||+|++..... ...+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 345799999876533 33567899999999999999999999875 457899999999999
Q ss_pred ccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc-e
Q 003092 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-T 686 (848)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~ 686 (848)
|.+++.. ....+++..+.+++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988743 2346889999999999999999999987 99999999999999999999999999986543322111 1
Q ss_pred eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 687 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
....++..|+|||++....++.++||||||+++||+++ |..|+........ . ..+........+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~-------------~~~~~~~~~~~~ 220 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV--M-------------SFIEQGKRLDCP 220 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH--H-------------HHHHCCCCCCCC
Confidence 11234578999999998889999999999999999996 8888754322110 0 000000011122
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.....++.+++..||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23345788899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.63 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=196.3
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCccc
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
++||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876533 23456889999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeee
Q 003092 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (848)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (848)
.++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 877432 345789999999999999999999887 999999999999999999999999999765432211 11122
Q ss_pred eccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 690 ~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
.++..|+|||++....++.++||||||+++|||++ |..|+....... ... ..... .........
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~----~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--ARE----QVEKG---------YRMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHHcC---------CCCCCCCCC
Confidence 34678999999998899999999999999999998 888875332111 000 00000 000111223
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 769 LVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
...+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.34 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357889999999999999999874 78999999976543 5678999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999988874322 236899999999999999999999987 99999999999999999999999999987632221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
...++..|+|||.+..+.++.++||||||++++||++ |..|+....... +.... ... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~----~~~---------~~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHV----EKG---------YRM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----hcC---------CCC
Confidence 2235668999999998899999999999999999997 888875432111 10000 000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
......+..+.+++.+||+.+|++||++.|++++|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1111224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=319.87 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=186.2
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHH-HHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~-~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||+||+|+.. +++.||+|++.... .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986532 222344555554 56789999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988774 3346788999999999999999999987 9999999999999999999999999987542221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. ..+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~------------~i~~~~~--~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYD------------NILNKPL--RLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HHH------------HHHcCCC--CCC
Confidence 334579999999999999999999999999999999999999985432111 000 0000000 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMS 791 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~ 791 (848)
......+.+++..|++.||++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12244678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.66 Aligned_cols=241 Identities=25% Similarity=0.305 Sum_probs=192.4
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||+||+++.. +++.||||++.... ......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47899999997542 23456678899999888 799999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99987773 2346889999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... .. ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~----~i~~~------~~----~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQ----SILED------EV----RYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHH----HHHcC------CC----CCC
Confidence 234579999999999999999999999999999999999999985432111 000 00000 00 011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCH-----HHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTM-----SDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 795 (848)
......+.+++..||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223467899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=345.58 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=201.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|... .++.||||++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 48899999987532 223567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCC--------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 601 EYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
||+++++|..++.... ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999988774311 1234567778899999999999999987 9999999999999999999999999
Q ss_pred cccccCCCcc----------------ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc
Q 003092 673 MARMFGGDEL----------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (848)
Q Consensus 673 la~~~~~~~~----------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~ 736 (848)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123469999999999999999999999999999999999999985422111
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHhcccC
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-TMSDVVSMINNELF 802 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 802 (848)
.... . ...++... .........+.+++.+|++.||++|| ++.++++.|+..+.
T Consensus 239 i~~~---------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR---------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh---------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 0 00000000 00012234577899999999999995 57777777766543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.19 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=199.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|.+.+.||+|++|.||++... ++++||+|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 58899999886432 1234578899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999887742 345788899999999999999999987 9999999999999999999999999998654
Q ss_pred CCccccc-eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGN-TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
....... .....|+..|+|||++.+..++.++||||||+++|||++|+.|+........ . ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~-------- 222 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-I----FKIATQ-------- 222 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-H----HHHhcc--------
Confidence 3221111 1234678899999999998899999999999999999999999753211100 0 000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
......+......+.+++..||+.+|++||++.++++.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00011122234467889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=327.66 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=196.9
Q ss_pred hcCcceeeeecccCCccEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..+|++.++||+|+||.||++... .++.||+|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3578999988643 33568999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|++. ++|..++ .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 4665655 23456899999999999999999999987 999999999999999999999999999876554
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc--ccccccccc-------ccccCc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS--FNLLGHAWS-------LCKNDR 751 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~--~~~~~~~~~-------~~~~~~ 751 (848)
..........||+.|+|||++....++.++|||||||++|||++|+.|+....... ..+...... ......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 43333445679999999999999999999999999999999999999985433211 000000000 000000
Q ss_pred --ccc---ccccccccCCC-------HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 --AHE---LMDPVLQNEVS-------LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 --~~~---~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ........... .....++.+++..||+.||++||++.|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00000000000 012346778999999999999999999986
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.50 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=197.2
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCccc
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5578899999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeee
Q 003092 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (848)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (848)
.++... ...+++..+..++.+++++|+|||+++ ++||||||+|||++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 887432 235788889999999999999999887 999999999999999999999999999866432222222223
Q ss_pred eccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 690 ~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
.++..|+|||.+.++.++.++||||||+++|||++ |..|+........ .. .+........+...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~-------------~~~~~~~~~~~~~~ 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RE-------------RIESGYRMPAPQLC 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HH-------------HHhcCCCCCCCccC
Confidence 34677999999998899999999999999999999 7777643321110 00 00000000111123
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 769 LVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
...+.+++.+|++.+|++||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=320.25 Aligned_cols=240 Identities=25% Similarity=0.335 Sum_probs=189.8
Q ss_pred eeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999987542 23345567788888764 899999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999887742 345788899999999999999999987 9999999999999999999999999987542221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... .. ..+.. +
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i----~~------~~~~~----~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSI----RM------DNPCY----P 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHH----Hh------CCCCC----C
Confidence 334679999999999999999999999999999999999999985432111 10000 00 00111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHH-HHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMS-DVV 794 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 794 (848)
.....++.+++..||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11234678899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.72 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=201.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57999999999999999999864 58899999997665555678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999988873 234788899999999999999999987 99999999999999999999999999886543221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........... ..... .+.+ .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-----~~~~~------~~~~--~ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-----IATNG------TPEL--Q 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-----HhcCC------CCCC--C
Confidence 11234688999999999988899999999999999999999999854322110000 00000 0000 0
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11123346788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=326.65 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=173.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 5889999998643 2334567888999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999988874 3346889999999999999999999987 999999999999999999999999998755321
Q ss_pred ccc---------------------------------cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC
Q 003092 681 ELQ---------------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 681 ~~~---------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~ 727 (848)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113479999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003092 728 NTGVY 732 (848)
Q Consensus 728 p~~~~ 732 (848)
||...
T Consensus 235 Pf~~~ 239 (360)
T cd05627 235 PFCSE 239 (360)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.88 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=206.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+-|.+.++||+|+||.||++.++ .|+.+|||++... ...+++..|+.+|++.+.|+||+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 44778899999999999999876 4899999998754 45788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
..|+..+++. .+.+.+.++++..+++..++||+|||... -||||||+.|||++-+|++||+|||.|..+....
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 9999998884 45668999999999999999999999876 7999999999999999999999999998775432
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
....++.|||.|||||++.+-.|+.++||||||++..||..|++|+...++-..- .-.. .... |.+ .
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----FMIP-T~PP-----PTF--~ 250 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----FMIP-TKPP-----PTF--K 250 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----Eecc-CCCC-----CCC--C
Confidence 3344578999999999999999999999999999999999999997543321100 0000 0000 111 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.....++-++++.||-.+|++|.|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 12334567889999999999999999998875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.46 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=191.2
Q ss_pred ecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||.||+++.. +++.||+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999986432 12234556799999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8777432 2334788999999999999999999987 9999999999999999999999999998764322 1223
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
..|++.|+|||++.+..++.++|||||||++|||++|+.|+.......... .... ......... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-~~~~---------~~~~~~~~~-~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-ELKR---------RTLEDEVKF-EHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-HHHH---------Hhhcccccc-ccccC
Confidence 468999999999999999999999999999999999999986432211000 0000 000000000 00112
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 769 LVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..++.+++..||+.||++||++.|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 3467899999999999999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=322.98 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=186.8
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHH-HHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei-~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||+||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 46789999986532 12233444444 456788999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999887743 345778888889999999999999987 9999999999999999999999999997543221 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... +..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~------------i~~~~~--~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDN------------ILNKPL--QLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHH------------HHhCCc--CCC
Confidence 334679999999999999999999999999999999999999985332111 0000 000000 111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+.+++..|++.+|++||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 122346788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.80 Aligned_cols=248 Identities=27% Similarity=0.432 Sum_probs=197.3
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeee-eCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI-EQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~-~~~~~~lV~Ey~ 603 (848)
++|++.+.||+|+||.||++.. .+..||+|.+... ...+.+.+|+.++++++|+|++++++++. ++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 4788999998653 23567899999999999999999999765 456789999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999998887532 2235789999999999999999999987 9999999999999999999999999988653321
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ... ..+ ...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~---~~~-~~~---------~~~ 218 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV---PRV-EKG---------YKM 218 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HH---HHH-hcC---------CCC
Confidence 12345678999999998899999999999999999998 888875322111 00 000 000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.........+.+++.+||+.+|++|||+.++++.|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.37 Aligned_cols=245 Identities=32% Similarity=0.496 Sum_probs=198.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..|+-++.||.|+||.||-++.. +.+.||||+++-. +.+.+..+..|+..|.+++|||+|.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667789999999999999864 5788999999744 3445788999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|||-| +-.+++. ..++++.+.++..|+.+.++||+|||+++ .||||||+.|||+.+.|.|||+|||.|.....
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99965 4444442 23456888889999999999999999987 99999999999999999999999999976533
Q ss_pred ccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...++|||.|||||++. .+.|+-|+||||||++..||.-.++|....+. ....+++..++.
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----MSALYHIAQNes------ 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES------ 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----HHHHHHHHhcCC------
Confidence 34579999999999985 68899999999999999999999998543221 111122222211
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
|.+. +......+.+++..||+.-|++|||..++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 3345667889999999999999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=322.43 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=211.7
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++....+.....+||-|.||.||.|.++. .-.||||.++.+ ....++|..|+.+|+.++|||+|+|+|+|..+...||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 34444567778999999999999999865 568999999754 4567899999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|.|||.+|+|.++|.+..+. .++.-..+.++.||+.|++||..++ +|||||..+|.|+.++..+||+||||++.+.
T Consensus 341 iTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999765443 4556667889999999999999887 9999999999999999999999999999987
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.+.+..-. ...-.+.|.|||-+.-..++.|+|||+|||+||||.| |-.|+...+-. .+.++++
T Consensus 417 gDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS---------------qVY~LLE 480 (1157)
T KOG4278|consen 417 GDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYGLLE 480 (1157)
T ss_pred CCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH---------------HHHHHHh
Confidence 76543321 1234678999999999999999999999999999999 66665432211 1122222
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.-++-.-+.-+...+.++++.||+..|.+||++.|+.+.++..+
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22222223334557899999999999999999999999887654
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.20 Aligned_cols=249 Identities=29% Similarity=0.386 Sum_probs=197.5
Q ss_pred eeecccCCccEEEEEecC--C--ceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999998643 2 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc-c
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-G 684 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 684 (848)
++|..++..... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999888855332 56899999999999999999999987 999999999999999999999999999877542211 1
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .... ..... .. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~---~~~~~-------~~--~~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK---IDKEG-------ER--LE 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---HHhcC-------Cc--CC
Confidence 1123457789999999999999999999999999999999 999875322111 0000 00000 00 00
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
.+......+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=310.32 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=187.8
Q ss_pred eeecccCCccEEEEEecC-------------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 531 SKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
+.||+|+||.||+|+... ...||+|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 479999999999997532 2258999887655555667889999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-------ceeec
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-------PKISD 670 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kl~D 670 (848)
+||||+++++|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999887743 2345889999999999999999999987 999999999999987664 89999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhh-cCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
||++...... ....++..|+|||++. +..++.++||||||+++|||++ |..|+.........
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---------- 219 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE---------- 219 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----------
Confidence 9998755322 2245788999999887 4668999999999999999985 77765432111000
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
....... ....+....+.+++..||+.||++||++.+|++.|+
T Consensus 220 -----~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 -----RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000000 011122356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.43 Aligned_cols=250 Identities=30% Similarity=0.460 Sum_probs=198.4
Q ss_pred cceeeeecccCCccEEEEEecC-CceEEEEEecccCcccH--HHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~--~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
|++.+.||+|+||+||+++... ++.||+|++........ .....|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999765 66899999987643332 23456999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999988885 4567899999999999999999999987 99999999999999999999999999986411 12
Q ss_pred cceeeeeccccccChhhhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.|+........ .. .........+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~---------~~~~~~~~~~~~ 221 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LE---------IIEKILKRPLPS 221 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HH---------HHHHHHHTHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hh---------hhhhcccccccc
Confidence 2333457899999999998 88899999999999999999999999764310000 00 000000000000
Q ss_pred CC--CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EV--SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ..+....+.+++..||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011267899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.93 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=188.1
Q ss_pred eeecccCCccEEEEEecC---CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
++||+|+||.||+|.... ...+|+|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3568888876443 233567889999999999999999999999999999999999999
Q ss_pred cccccccCCCc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 607 SLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 607 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99998854322 234567788899999999999999987 9999999999999999999999999987643332222
Q ss_pred ceeeeeccccccChhhhhc-------CCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 685 NTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
......+++.|+|||++.. ..++.++||||||+++|||++ |..|+....... ... ..... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---~~~~~-~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK---QVVRE-QDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH---HHhhc-cCccCC
Confidence 2223346778999999753 356789999999999999999 677764332111 000 00000 001111
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
.+.+ .......+.+++..|| .||++||++.+|+++|.
T Consensus 232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 1122345667788888 49999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.50 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=189.6
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 47899999997542 23456688999999888 699999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99987763 3346899999999999999999999987 9999999999999999999999999997532211 12
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccccccccccccCccccccccccccCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............ ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~--~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EKP--IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hCC--CCC
Confidence 334679999999999999999999999999999999999999986432211 110000000000 000 011
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
+......+.+++..||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11223467889999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.74 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=199.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 47889999886542 23346688999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++.. ...+++..+..++.|+++||+|||+.. +++||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 999999988843 355788999999999999999999842 49999999999999999999999999987653321
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-ccccccc-ccccC----------
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-LLGHAWS-LCKND---------- 750 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~~---------- 750 (848)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+......... ....... .....
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 22357899999999998888999999999999999999999997532211100 0000000 00000
Q ss_pred ------cccccccccccc---CC-CHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 751 ------RAHELMDPVLQN---EV-SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 751 ------~~~~~~d~~l~~---~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
...+..+..... .. ......++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00 01133468899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.17 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=202.6
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.++||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34789999999999999999999777788999988653 2345678999999999999999999999887 778999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999998888543 2345788889999999999999999886 99999999999999999999999999987643322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......++..|+|||++....++.++||||||+++||+++ |+.|+....... ... ...... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~----~~~~~~---------~ 221 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERGY---------R 221 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhCCC---------C
Confidence 1 1112345678999999998889999999999999999999 888875332111 000 000000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
..........+.+++.+|++.+|++||++.++.++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.35 Aligned_cols=248 Identities=32% Similarity=0.438 Sum_probs=194.6
Q ss_pred eeecccCCccEEEEEecC-C---ceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|.+.. + ..||+|.+..... ...+++.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 2 6899999876543 34567899999999999999999999875 5578999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc-
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG- 684 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~- 684 (848)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999888532 36789999999999999999999887 9999999999999999999999999998764332211
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||.+....++.++||||||+++|||++ |..|+...+... +.... .... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~----~~~~---------~~~ 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAML----ESGE---------RLP 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH----HcCC---------cCC
Confidence 1111224568999999999999999999999999999998 899875433211 11100 0000 001
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
........+.+++.+||+.+|++||++.++++.|++.
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.24 Aligned_cols=250 Identities=30% Similarity=0.439 Sum_probs=193.7
Q ss_pred eeecccCCccEEEEEecC-Cc--eEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||.||+|...+ +. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 57889887532 34456788999999999 899999999999999999999999999
Q ss_pred CcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 606 KSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 606 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99988875321 1235789999999999999999999976 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||....... .... . ...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~---~-~~~- 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK---L-PQG- 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHH---H-hCC-
Confidence 98632211 11111234568999999998889999999999999999997 888874322110 0000 0 000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
............+.+++.+||+.+|.+||++.++++.|++++
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111122346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=324.99 Aligned_cols=257 Identities=20% Similarity=0.228 Sum_probs=196.8
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
+....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445589999999999999999999875 4789999998642 12234567889999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999888732 34788888999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCC----CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
....... .......||+.|+|||++.... ++.++|||||||++|||++|+.||...+... . .........
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~---~~~i~~~~~ 264 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T---YSKIMNHKN 264 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--H---HHHHHcCCC
Confidence 7643221 1223457999999999987543 7899999999999999999999986432110 0 000000000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVSM 796 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 796 (848)
. +.-.........+.+++..|++.++.+ ||++.|+++.
T Consensus 265 ~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 S-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 000011123446778889999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.36 Aligned_cols=194 Identities=24% Similarity=0.305 Sum_probs=165.9
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..+|.+.++||+|+||.||++.+.. ++.||||.... ..+.+|+++|++++|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998764 78899996432 3457899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+. ++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 566666532 2346899999999999999999999987 99999999999999999999999999987644322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCC
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
........||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999987654
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.36 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=200.3
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+|++.++||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 5889999998643 3345677889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++... ....+++.....++.||+.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998776432 3345788999999999999999999987 99999999999999999999999999986643221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......|++.|+|||++.+..++.++||||||+++|+|++|+.|+...+... .. .... ... .. .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~---~~~~-~~~----~~-----~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LI---LKVC-QGS----YK-----P 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HH---HHHh-cCC----CC-----C
Confidence 1223568899999999998889999999999999999999999985432111 00 0000 000 00 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.+......+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111233467889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.50 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=196.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999875 58899999986432 23346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
++ ++|..++........+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 98 577666644344456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--cc-------ccccccccc-Cc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN--LL-------GHAWSLCKN-DR 751 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~--~~-------~~~~~~~~~-~~ 751 (848)
......+++.|+|||++.+. .++.++||||||+++|||++|+.|+......... .. ...|..... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223578899999988764 4689999999999999999999988643211000 00 000000000 00
Q ss_pred ccccccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........... ........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 001112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.90 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=201.4
Q ss_pred cCcceeeeecccCCccEEEEEecC-Cc----eEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.+|++.+.||+|+||.||+|.... ++ .||+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578899999999999999998643 33 589998875533 345778999999999999999999999887 78899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999888532 334889999999999999999999976 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............++..|+|||.+....++.++||||||+++||+++ |+.|+....... +... . ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~-~~~~------ 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDL---L-EKGE------ 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHH---H-hCCC------
Confidence 3322111112234678999999988899999999999999999998 999875432211 0000 0 0000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||..+|++||++.++++.|++..
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111112346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=319.32 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=191.2
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 600 (848)
+|+..+.||+|+||+||++... +++.||+|++.... ....+.+..|+.++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 58899999987532 234456788999998886 577888999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988773 3345889999999999999999999987 999999999999999999999999999754322
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ... .++....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~------------~i~~~~~ 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQ------------SIMEHNV 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCCC
Confidence 21 2233569999999999999999999999999999999999999986432211 000 0000000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
..+.....++.+++.+|++.+|++|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223467889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.69 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=205.1
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++++.||+|.-|+||++++.+ +..+|+|++.+.. .+...+...|-+||+.++||-++.|++.+..+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 568888999999999999999865 5889999997653 344566778999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|||+||+|..+++ .+..+.++++.+..++.+++-||+|||..| ||.|||||+||||.++|++.|+||.|+......
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999988774 355677999999999999999999999988 999999999999999999999999997533110
Q ss_pred ----------------------------------c--------------------cccceeeeeccccccChhhhhcCCC
Q 003092 681 ----------------------------------E--------------------LQGNTKRIVGTYGYMSPEYALEGVF 706 (848)
Q Consensus 681 ----------------------------------~--------------------~~~~~~~~~gt~~y~APE~~~~~~~ 706 (848)
. ....+..++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0011234679999999999999999
Q ss_pred CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCC
Q 003092 707 SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAED 786 (848)
Q Consensus 707 ~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~ 786 (848)
+.++|.|+|||++|||+.|..||-..+.+.. ...++-+.+.-...+..+..+.+||+..|.+||++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999865543321 11111111111111234457889999999999999
Q ss_pred CCC----HHHHHH
Q 003092 787 RPT----MSDVVS 795 (848)
Q Consensus 787 RPt----~~evl~ 795 (848)
|.. +.||.+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 888865
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.78 Aligned_cols=194 Identities=23% Similarity=0.327 Sum_probs=163.9
Q ss_pred HHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.....+|++.+.||+|+||.||+|+.. .++.||+|..... ....|+.++++++||||+++++++.++...++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 344568999999999999999999875 4678999975432 235689999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+||+. ++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 99996 466665532 3346889999999999999999999987 99999999999999999999999999975432
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCC
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 222356999999999999999999999999999999999865543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.68 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=199.9
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
.+|++.+.||+|+||.||++...+++.+|+|.+.... ....++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688899999999999999988778899999886432 335678999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|.+++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99998887432 235788999999999999999999987 9999999999999999999999999998664332211
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....++.+|+|||.+.++.++.++||||||+++|||++ |..|+....... ... ..... .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~~~~---~~~~~~----- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE---TINAG---FRLYKP----- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH---HHhCC---CCCCCC-----
Confidence 112235678999999998899999999999999999998 888875322111 000 00000 000111
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
......+.+++.+||+.+|++||++.|+++.|
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.56 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=207.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcc---cHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~ 597 (848)
....|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34679999999999999999999765 999999999765432 3468899999999998 999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC----CCceeecccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISDFGM 673 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGl 673 (848)
+|||++.+|.|.+.+... .+++.++..++.||+.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999998877544 2899999999999999999999987 9999999999999543 4799999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||........... . ....
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-----i-~~~~-- 254 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-----I-LRGD-- 254 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-----H-HcCC--
Confidence 998765 3345668999999999999999999999999999999999999999864432221110 0 0000
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......-........+++..++..||.+|+|+.++++
T Consensus 255 ----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 ----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 01111122233557889999999999999999999987
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=327.46 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=194.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----eEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-----~~~ 597 (848)
+|++.++||+|+||.||++... +++.||||++... .....+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999864 6899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|+||+.+ +|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999975 5555542 3346889999999999999999999987 999999999999999999999999999865
Q ss_pred CCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc---
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH--- 753 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 753 (848)
...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+.... ..............
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 433211 11224578999999998874 479999999999999999999999864332110 00000000000000
Q ss_pred -------ccc-c-----ccccc--CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 -------ELM-D-----PVLQN--EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 -------~~~-d-----~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+ . +.... ........++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 0 00000 011122456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.43 Aligned_cols=252 Identities=23% Similarity=0.426 Sum_probs=199.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888999999999999999864 58899999987665555667889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999988773 2346889999999999999999999987 9999999999999999999999999997664321
Q ss_pred cceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.......|++.|+|||++. ...++.++|||||||++|||++|+.|+........ ... ..... ...+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~----~~~~~----~~~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL----MTKSN----FQPPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHh----hhccC----CCCCcc
Confidence 1223457899999999975 45688999999999999999999998743322110 000 00000 000001
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ......+.+++..|++.+|++||++.++++
T Consensus 232 ~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 112346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.91 Aligned_cols=196 Identities=27% Similarity=0.396 Sum_probs=167.4
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-C-----CceeeeeeeeeeCCeEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pniv~l~~~~~~~~~~~l 598 (848)
+|.+.+.||+|.||.|.++... +++.||||++++.. .-..+-..|+.+|..|+ | -|+|++++++...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999854 58999999997653 33455678999999996 4 489999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC--CCceeeccccccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARM 676 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~ 676 (848)
|+|.+.. +|.++|... +...++...+..|+.||+.||..||+.+ |||+||||+||||.+. ..+||+|||.|..
T Consensus 266 VfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9998855 778887543 3345889999999999999999999887 9999999999999654 3699999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
.....+ ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|...
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 644322 356788999999999999999999999999999999997766433
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=317.51 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=195.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999865 57889999987543 22345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 986 56555532 2345788889999999999999999987 99999999999999999999999999976543221
Q ss_pred ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccc--------cccccccC-c
Q 003092 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGH--------AWSLCKND-R 751 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~--------~~~~~~~~-~ 751 (848)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ..... .|...... .
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1122467899999999875 4579999999999999999999999864332110 00000 00000000 0
Q ss_pred ccccccccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....-.+.... ........++.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.88 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=197.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC------
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~------ 593 (848)
.+++.|++.+.||+|+||.||+|... .++.||+|++.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999865 47889999986543 3456788999999999 799999999998753
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999998887542 2346889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
+....... .......|++.|+|||++. +..++.++|||||||++|||++|+.|+.......... ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence 98654322 1223457899999999986 3457889999999999999999999985332111000 0000
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. . . ...........+.+++.+||+.+|++||++.++++
T Consensus 231 ~-~----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N-P----A----PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C-C----C----CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 0 0 00011122346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.72 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=190.8
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHc---CCCceeeeeeeeee-----CC
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCIE-----QG 594 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~~-----~~ 594 (848)
+|++.+.||+|+||+||+|+.. +++.||+|.+..... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999875 588999999875322 2234556777777766 69999999998864 34
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||+++ +|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 666666432 2235789999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccc-----cccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHA-----WSLC 747 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~-----~~~~ 747 (848)
+...... ......||..|+|||++.+..++.++|||||||++|||++|++||........ .+.... ....
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8764322 12234689999999999999999999999999999999999998754322110 000000 0000
Q ss_pred ccCc-cccccccccc---cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDR-AHELMDPVLQ---NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~-~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... ......+... ..........+.+++..|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000000 0011123446789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.32 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=197.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.|++.++||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999865 58899999986532 2223557889999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999998877432 2235889999999999999999999887 9999999999999999999999999997654322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ... ....+. ..
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~---------~~~~~~-~~ 221 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV---------ERLVKE-VQ 221 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHH---------Hhhhhh-hh
Confidence 1 12246899999999999999999999999999999999999998643211000 000 000000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..........+.+++..||+.||++||+ +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0111122345788999999999999999 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.62 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=202.2
Q ss_pred cCcceeeeecccCCccEEEEEecC------CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.+.||+|+||.||+|+... .+.||+|.+...... ..+++.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 678899999999999999998642 457999988765443 4578999999999999999999999999989999
Q ss_pred EEEEeccCCcccccccCCCcc------cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999888543322 25899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccC
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKND 750 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 750 (848)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLN----RLQAG 234 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHH----HHHcC
Confidence 998755332211 1222356788999999998889999999999999999999 677764322111 000 00000
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
.. ...........+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 00111223347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.84 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=198.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666679999999999999865 47789999987766666778999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~ 679 (848)
||+++++|..++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999988854322212277888899999999999999887 999999999999976 67899999999976543
Q ss_pred CccccceeeeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
... ......|++.|+|||++.... ++.++||||||+++|||++|+.|+........... . .. ..
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~----~---~~-----~~ 227 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF----K---VG-----MF 227 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh----h---hh-----hh
Confidence 221 122245889999999987654 78999999999999999999999754322111000 0 00 00
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+.....++.+++.+||+.+|++||++.|+++
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0001112223456888999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.29 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=171.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 4889999998642 2234566889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999888843 2345788999999999999999999987 999999999999999999999999999765433
Q ss_pred ccccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCC
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 211 1223469999999999873 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.21 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=198.5
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc---------cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ---------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 5789999988654221 23568899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999888842 345788899999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccc----ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 676 MFGGDELQG----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 676 ~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~----~------~ 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AI----F------K 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HH----H------H
Confidence 775322111 1123458899999999999889999999999999999999999986432110 00 0 0
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+ ..+......+.+++..||+.+|++||++.|+++
T Consensus 224 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0001111 112223457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=324.05 Aligned_cols=261 Identities=23% Similarity=0.257 Sum_probs=193.0
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----- 594 (848)
..++|++.+.||+|+||.||++... .++.||||++... ......++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 5889999998643 2334567889999999999999999999886443
Q ss_pred -eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++||||++++. ...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l-~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDANL-CQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcCH-HHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 5799999998753 33331 23678888899999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccc----------
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLG---------- 741 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~---------- 741 (848)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . ...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 97653322 12234689999999999999999999999999999999999999864331100 0 000
Q ss_pred -----ccccccccC------cccccccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 742 -----HAWSLCKND------RAHELMDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 742 -----~~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......... ...+........ .........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000000000000 001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.73 Aligned_cols=251 Identities=32% Similarity=0.489 Sum_probs=197.0
Q ss_pred eeecccCCccEEEEEecC-------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 24467889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-----Cceeecccc
Q 003092 603 MVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-----NPKISDFGM 673 (848)
Q Consensus 603 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGl 673 (848)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999998885432 2234788999999999999999999876 99999999999999887 899999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
++...............++..|+|||++.++.++.++||||||+++|||++ |+.|+...... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~----~~~-- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHV----TAG-- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHH----hcC--
Confidence 987654333222223346789999999999999999999999999999998 88887532211 111000 000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
............+.+++.+||+.+|++||++.++++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0001112234567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.56 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=202.4
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||.||+|.... ++.||+|.+..... .+++.+|++++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999765 78999999875432 678999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999888743 2356889999999999999999999987 99999999999999999999999999987654321
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........... ... ...+.+ .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~-----~~~~~~--~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPN-----KPPPTL--S 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hcc-----CCCCCC--C
Confidence 22334588999999999999999999999999999999999999764322110000 000 000000 0
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+......+.+++..||+.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11123346889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.65 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=193.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4788999998652 2223455788999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999888532 346788899999999999999999987 999999999999999999999999999876443
Q ss_pred ccccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
... ......||+.|+|||++.+ +.++.++||||||+++|||++|+.||...+... ... ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~---~i~~~~~~~~- 228 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG---KIMNHEERFQ- 228 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--HHH---HHHcCCCccc-
Confidence 221 1223579999999999875 567899999999999999999999985432111 000 0000000000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 795 (848)
+.+. ......++.+++.+|+..++++ |+++.++++
T Consensus 229 ~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0000 0112346778888888765543 467877765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.53 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=198.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCc----eEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.+.||+|+||.||+|... +++ .||+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56888899999999999999864 343 479998865432 3345788999999999999999999998754 5679
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999998887432 335788899999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. ........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~~----- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IP----DLLEKGER----- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHCCCC-----
Confidence 4332222223346778999999998999999999999999999998 888875332111 00 00000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..........+.+++..||..+|++||++.++++.|+..
T Consensus 230 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111234678899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.57 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=198.4
Q ss_pred CcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
-|++.++||+|+||.||+|.... +..+|+|.+........+.+.+|+++++.++||||+++++++..+...++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36788999999999999998754 77899999876665667788999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++.. ....+++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999877643 2346889999999999999999999987 9999999999999999999999999997654321 1
Q ss_pred ceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 685 NTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
......+++.|+|||++. +..++.++|||||||++|||++|+.|+........ .. ....... +.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~----~~~~~~~------~~ 227 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LL----KIAKSEP------PT 227 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HH----HHhhcCC------CC
Confidence 223356899999999984 44578899999999999999999999754321110 00 0000000 00
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+ ..+.....++.+++..||+.+|++||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011112346889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.41 Aligned_cols=251 Identities=28% Similarity=0.424 Sum_probs=190.9
Q ss_pred eeecccCCccEEEEEecC----CceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeee-eCCeEEEEEEecc
Q 003092 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI-EQGEKILIYEYMV 604 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~-~~~~~~lV~Ey~~ 604 (848)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 478999999999998542 357999998643 2344678889999999999999999999876 4556889999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc-
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ- 683 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~- 683 (848)
+++|..++... ...+++..+..++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999888532 234567788899999999999999886 999999999999999999999999999865432211
Q ss_pred -cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC-CCCCCCCCccccccccccccccCccccccccccc
Q 003092 684 -GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 684 -~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.......++..|+|||.+.+..++.++||||||+++|||++|+. |+..... ..+.... .... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~---~~~~------~~--- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYL---LQGR------RL--- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---hcCC------CC---
Confidence 11122346778999999998899999999999999999999654 4432111 1111000 0000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+...+..+.+++..||+.+|++||++.++++.|++..
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.31 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=204.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 57889999986542 33567899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999888854333356889999999999999999999887 99999999999999999999999999987654332
Q ss_pred cc--ceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 683 QG--NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 683 ~~--~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ......|+..|+|||++... .++.++||||||+++|||++|+.|+........ .. ..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQN------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcC------CCCC
Confidence 21 22335689999999999877 789999999999999999999999864332110 00 00000 0011
Q ss_pred cccCC-CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEV-SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.... .......+.+++..||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11110 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.69 Aligned_cols=250 Identities=23% Similarity=0.377 Sum_probs=202.1
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999986 46899999999765555567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999988873 235788899999999999999999987 99999999999999999999999999986543321
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....... ..... .+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~~~-- 235 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TPEL-- 235 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CCCC--
Confidence 1 2234688999999999998899999999999999999999999854322111000 00000 0000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.92 Aligned_cols=248 Identities=24% Similarity=0.415 Sum_probs=201.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999865 58899999987543 34456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999888743 26889999999999999999999987 9999999999999999999999999998775432
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
.......+++.|+|||++.+..++.++||||||+++|||++|+.|+...+.... . . .... ...+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~---~-~~~~-----~~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--L---F-LIPK-----NNPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--H---H-Hhhh-----cCCCCCcc
Confidence 122335688899999999998899999999999999999999999854331110 0 0 0000 00111111
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .....+.+++..||+.+|++||++.++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 13346788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=326.28 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=208.5
Q ss_pred ceeeeecccCCccEEEEEe-cCC----ceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 528 SIQSKLGEGGFGPVYKGRL-LNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~-~~~----~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
...++||+|+||+||+|.+ +.| -+||||++... ..+..+++.+|+.+|.+++|||++||+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999975 344 37999998755 4556789999999999999999999999998776 889999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
||+.|.|.++++. .+..+..+..+.+..|||+||.|||++. ++||||..+||||....++||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999998854 4456788899999999999999999876 9999999999999999999999999999987766
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+. +.++++.-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhccc
Confidence 5554444556788999999999999999999999999999999 888865443221 122222222
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+-.-++-+..++..++..||..|++.||+++++...+.+..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 22234446678899999999999999999999988776654
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.88 Aligned_cols=197 Identities=26% Similarity=0.424 Sum_probs=158.7
Q ss_pred eeeecccCCccEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEEEEEecc
Q 003092 530 QSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMV 604 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~ 604 (848)
.++||+|+||+||+|+.. .++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 35789999986532 23457889999999999999999998854 456889999987
Q ss_pred CCcccccccCC------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe----ccCCCceeeccccc
Q 003092 605 NKSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMA 674 (848)
Q Consensus 605 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla 674 (848)
+ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 554444211 12235889999999999999999999987 9999999999999 45678999999999
Q ss_pred cccCCCccc-cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 675 RMFGGDELQ-GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 675 ~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
+.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543211 122345789999999999874 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.51 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=201.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|.+.++||+|+||.||+|...+ ...||||...... .+..+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568899999999999999998643 2468999887654 3456789999999999999999999998865 56789
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999988432 335789999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
........ ...++..|+|||.+....++.++||||||+++||+++ |..||....... .... ......
T Consensus 159 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~---~~~~~~------ 226 (270)
T cd05056 159 DESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGR---IENGER------ 226 (270)
T ss_pred cccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH---HHcCCc------
Confidence 44222111 2234568999999988889999999999999999996 999875433211 0000 000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
. .........+.+++.+|+..+|++||++.++++.|++..
T Consensus 227 ~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 227 L----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 011122346888999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.88 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=201.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 5889999987643 344567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.... ...+++..+..++.|++++|+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999998885432 346789999999999999999999887 99999999999999999999999999987644332
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... . ..... ... . .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~---~~~~~-~~~--------~-~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN--L---VVKIV-QGN--------Y-T 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH--H---HHHHH-cCC--------C-C
Confidence 2233568999999999998889999999999999999999999875322111 0 00000 000 0 0
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
........++.+++..||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0112234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.73 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=201.4
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecc--cCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~l 598 (848)
+....|+++++||+||.+.||++...+.+.||+|++.. .+.+...-|.+|+.+|.+|+ |.+||+|++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 44567999999999999999999988888899987653 35566788999999999995 9999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||- .-+|..+|... ...++.-.+..+..||++++.++|+++ |||.||||.|+|+-+ |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99975 44777777432 223332267789999999999999998 999999999999954 689999999999998
Q ss_pred CCccccceeeeeccccccChhhhhcCC-----------CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGV-----------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~-----------~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
.+.........+||+.||+||.+.... .+.++||||+||+||+|+.|+.||+.+....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~----------- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI----------- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----------
Confidence 887777777889999999999986322 5678999999999999999999987543211
Q ss_pred ccCccccccccccccCC-CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAHELMDPVLQNEV-SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+...+.+|--.-.+ ..+.-.++++++..||+.||++||+..|+++
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 012233333111000 1111223899999999999999999999986
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.69 Aligned_cols=263 Identities=19% Similarity=0.268 Sum_probs=192.4
Q ss_pred eeeeeccc--CCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 529 IQSKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 529 i~~~LG~G--~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.++||+| +|++||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46799999 68899999864 58899999987542 233456788999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc-
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL- 682 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~- 682 (848)
++++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999988874322 234789999999999999999999987 99999999999999999999999987654321110
Q ss_pred ----ccceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccc---ccccccccc----
Q 003092 683 ----QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL---GHAWSLCKN---- 749 (848)
Q Consensus 683 ----~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~---- 749 (848)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 011122356788999999976 4589999999999999999999999864321110000 000000000
Q ss_pred --------------Ccccc--c---cccc----cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 --------------DRAHE--L---MDPV----LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 --------------~~~~~--~---~d~~----l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+ . ..+. ............+.+++..||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 0 0000 000111223446889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.14 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=200.0
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.|++.++||+|+||.||+|.... ++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 679999999999999999998754 8899999998766666788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999997766332 345889999999999999999999886 9999999999999999999999999987643221
Q ss_pred cceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.......+++.|+|||++. ...++.++|||||||++|||++|+.|+........ .. ..... ..+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~------~~~ 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LL----KIAKS------EPP 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HH----HHhcC------CCc
Confidence 1223356889999999885 34568899999999999999999999754332110 00 00000 000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ........++.+++.+||+.+|++||++.++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 011123346788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=309.22 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=188.9
Q ss_pred eeecccCCccEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+.||+|+||.||+|.... ..+||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 235888988665555567889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC--------ceeeccccc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--------PKISDFGMA 674 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kl~DFGla 674 (848)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999888543 235788999999999999999999987 999999999999988765 599999988
Q ss_pred cccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCC-CCCCCCCCCccccccccccccccCcc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSK-KNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
...... ....+++.|+|||++.+. .++.++||||||+++|||++|. .|+........ .
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~------------ 215 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--L------------ 215 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--H------------
Confidence 754322 234678899999999874 5799999999999999999985 44432211100 0
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
..... ....+.+...++.+++..||+.+|++|||+.++++.|+
T Consensus 216 -~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 -QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00112222346889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.25 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=199.3
Q ss_pred CcceeeeecccCCccEEEEEecCCceEEEEEecccC------cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988788999999886432 12345688999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999988843 235788899999999999999999887 99999999999999999999999999986532
Q ss_pred Cc----cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 680 DE----LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 680 ~~----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
.. .........|+..|+|||++.+..++.++||||||+++|||++|+.|+........ ... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~----~~~----~~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFY----IGA----HRG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHH----hhh----ccC
Confidence 11 11122235689999999999988899999999999999999999999854321110 000 000 000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+ .........+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 LMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001 112223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.20 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=204.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 368999999999999999999875 4788999999876556678899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999998877432 245889999999999999999999987 9999999999999999999999999998664321
Q ss_pred ccceeeeeccccccChhhhhcC---CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG---VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~---~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+........... .... ....+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~----~~~~~~ 225 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKS----NFPPPK 225 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhc----cCCCcc
Confidence 112234688899999999876 789999999999999999999999754321110000 0000 000001
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+ ........++.+++.+||+.+|++||++.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 112234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.14 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=199.2
Q ss_pred CcceeeeecccCCccEEEEEecC--CceEEEEEeccc----------CcccHHHHHHHHHHHHH-cCCCceeeeeeeeee
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIE 592 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~--~~~vAvK~~~~~----------~~~~~~~~~~Ei~~l~~-l~Hpniv~l~~~~~~ 592 (848)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999987532 12234567788888875 799999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
++..++||||+++++|.+++... .....+++..+.+++.|++.||.|||+.. +++|+||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998776432 23446888999999999999999999632 4999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... . ..... .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~---~~~~~-~-- 227 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--L---ATKIV-E-- 227 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--H---HHHHh-h--
Confidence 9998765432 2234568999999999999889999999999999999999999975322110 0 00000 0
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
....+.. .......+.+++.+||+.||++||++.|+..+++
T Consensus 228 --~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 --AVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --ccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0001111 1112346888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.15 Aligned_cols=238 Identities=26% Similarity=0.454 Sum_probs=187.8
Q ss_pred eeecccCCccEEEEEecCCc-----------eEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 531 SKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999876432 4788877654333 6788999999999999999999999988 788999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-------Cceeeccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-------NPKISDFG 672 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kl~DFG 672 (848)
|||+++++|..++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999998885432 26889999999999999999999887 99999999999999888 79999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhC-CCCCCCCCCCcccccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSS-KKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......... . ...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~----~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--R----FYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--H----HHh-
Confidence 9986543 1224567789999999876 789999999999999999994 6665432211000 0 000
Q ss_pred CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 750 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
. ....+.+....+.+++..||+.+|++||++.++++.|+
T Consensus 221 -------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------D---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------c---CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011111257889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.58 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=197.6
Q ss_pred cceeeeecccCCccEEEEEec----CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
|.+.++||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3678999998654 2334677899999999999999999999886532
Q ss_pred eEEEEEEeccCCcccccccCC---CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 595 EKILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
..++++||+++++|..++... .....+++....+++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247889999999998776422 12235788999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccC
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKND 750 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 750 (848)
|+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+...... ....... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~---~~~ 232 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI---KGN 232 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH---cCC
Confidence 99987654332222223346678999999999999999999999999999999 77876533211 1110000 000
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
. + .........+.+++.+||+.+|++||++.++++.|+++
T Consensus 233 ~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 R--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred c--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 01112335788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.21 Aligned_cols=248 Identities=24% Similarity=0.402 Sum_probs=199.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34677789999999999999864 47889999987443 34456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988773 245788999999999999999999887 99999999999999999999999999987653321
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+......... ... .....+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~~~------~~~~~~---- 219 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-----FLI------PKNSPP---- 219 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-----hhh------hcCCCC----
Confidence 122246888999999999989999999999999999999999997533211100 000 000011
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.........+.+++..||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112234568899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.57 Aligned_cols=238 Identities=22% Similarity=0.336 Sum_probs=185.4
Q ss_pred eecccCCccEEEEEecC-------------------------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeee
Q 003092 532 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l 586 (848)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876544455678899999999999999999
Q ss_pred eeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC--
Q 003092 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-- 664 (848)
Q Consensus 587 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-- 664 (848)
++++.++...++||||+++++|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999888743 2346788999999999999999999886 99999999999997654
Q ss_pred -----CceeeccccccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHH-hCCCCCCCCCCCcc
Q 003092 665 -----NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEIL-SSKKNTGVYNTDSF 737 (848)
Q Consensus 665 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~ell-tg~~p~~~~~~~~~ 737 (848)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998654221 12357788999998875 56899999999999999995 68888753221110
Q ss_pred ccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 738 NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
.. ..... ...+.+....+.+++..||+.+|++||++.+|++.|
T Consensus 231 --~~-------------~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 --ER-------------FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred --HH-------------HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 00 00000 001111223678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=291.89 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=198.3
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cc---cHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQ---GLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~---~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
...+|.-.+.||.|..++|.++.++ .|+++|+|++.... ++ -.++-..|+.+|+++ .||+|+.+.+++..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778899999999999998765 58899999985432 11 124456799999998 69999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
+...++|+|.|+.|.|.++| ...-.+++....+|++|+.+|+.|||..+ ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 99999999999999999998 44557899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhh------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
+|..+..+.. ....||||+|+|||.+. ...|+..+|+|+.||+||.|+.|.+||- +.....
T Consensus 169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRkQml-------- 235 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRKQML-------- 235 (411)
T ss_pred eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHHHHH--------
Confidence 9998876542 33479999999999885 2347889999999999999999999972 110000
Q ss_pred cccCccccccccccccCC--C----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 CKNDRAHELMDPVLQNEV--S----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~--~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.-++.+.+ . ........+++.+||+.||.+|.|++|++.
T Consensus 236 --------MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 --------MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --------HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0011111111 1 123446789999999999999999999975
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=310.83 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=202.0
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.+|++.++||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5699999999999999999985 468999999997665555678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999988773 235789999999999999999999987 999999999999999999999999998866443221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...... .+.+.
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~~------~~~~~-- 236 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG------TPELQ-- 236 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcC------CcccC--
Confidence 223468899999999998889999999999999999999999985432211000 000000 00000
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11122346778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.24 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=201.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888999999999999999865 58899999886543 33457889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++.. ...+++..+..++.+++.+|.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999887732 345789999999999999999999742 49999999999999999999999999987543221
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc-
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ- 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~- 761 (848)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+........... ......+.+.....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 228 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-------DPMGILDLLQQIVQE 228 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-------hhhHHHHHHHHHhhc
Confidence 2235789999999999888999999999999999999999999864332110000 00000001111100
Q ss_pred --cCC-CHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 762 --NEV-SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 762 --~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
... .......+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001 11134468889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.97 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=201.4
Q ss_pred eeHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeee-
Q 003092 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI- 591 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~- 591 (848)
+.+..+..+.++|++.+.||+|+||.||++... .++.+|+|++.... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344455567789999999999999999999865 47899999886432 2346688899999999 6999999999884
Q ss_pred ----eCCeEEEEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 592 ----EQGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 592 ----~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
.+...++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999998876432 23346788999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ +.
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~- 239 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LF- 239 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hh-
Confidence 9999999987643321 1223468999999998753 4578899999999999999999999754322110 00
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..... ......+ +......+.+++.+||+.+|++||++.|+++.
T Consensus 240 ---~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ---KIPRN-PPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hcccc-CCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000 0000000 11123468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=319.64 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=193.9
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------ 593 (848)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4478999999999999999999864 58899999987532 23456778899999999999999999988643
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||++++ +...+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 3579999999764 433331 24778888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccc---------
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGH--------- 742 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~--------- 742 (848)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .....
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 12235789999999999999999999999999999999999999864321100 00000
Q ss_pred ------ccccccc-Cccc-----ccc-ccccc--cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 743 ------AWSLCKN-DRAH-----ELM-DPVLQ--NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 743 ------~~~~~~~-~~~~-----~~~-d~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
....... .... ... +.... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000 000 00000 00111123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.06 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=196.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|++++++++|+||+++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999864 58899999986532 2234557889999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998777542 2345899999999999999999999987 9999999999999999999999999997654322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......... ..... ..... ..
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-~~~~~------~~~~~-~~--- 222 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-EEVDR------RVLET-EE--- 222 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH------hhhcc-cc---
Confidence 112346899999999999999999999999999999999999998643221100 00000 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
.........+.+++..|++.+|++||+ +.+++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111122346778999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.44 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=201.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..|+..++||+|+||.||+|... .++.||+|.+.... ....+.+.+|+.+++++.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999865 58899999987543 34567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999988773 235788889999999999999999886 99999999999999999999999999987654322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ..+......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------~~~~~~~~~ 219 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------FLIPKNNPP 219 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------hhhhcCCCC
Confidence 122346888999999999888999999999999999999999997543221100 000000011
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++..||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 222334567889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.82 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=199.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.+.||+|+||.||++... .++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 5899999988654 233456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++........+++..+..++.||++||.|||+.. +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999888754333446899999999999999999999742 49999999999999999999999999997653321
Q ss_pred ccceeeeeccccccChhhhhcCC------CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~------~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||....... ..... ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~---------~~~~ 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQL---------SAIV 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHH---------HHHh
Confidence 22345888999999985543 5789999999999999999999985322111 00000 0000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.. ..........++.+++..||+.+|++||++.+++.
T Consensus 224 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 000 01122234557889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.84 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=201.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||++... +++.||+|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999875 5789999999766656667899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999998887432 345889999999999999999999987 9999999999999999999999999987654322
Q ss_pred ccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.......+++.|+|||++. ...++.++||||||+++|||++|+.|+........ .. .. .... .
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~---~~-~~~~-----~ 225 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL---KI-LKSE-----P 225 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH---HH-hcCC-----C
Confidence 1223356899999999985 34567899999999999999999999854322110 00 00 0000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+. .+......+.+++..||+.+|++||++.++++
T Consensus 226 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0000 01112346788999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=314.41 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=192.8
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+++... ++.||+|++.+. .......+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998764 678999998642 1223455888999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999988853 2345788899999999999999999987 999999999999999999999999999765332
Q ss_pred ccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ... ....... ..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--~~~---~i~~~~~--~~ 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG---KIMNHKE--RF 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--HHH---HHhCCCc--cc
Confidence 21 1222357999999999986 3467899999999999999999999985332111 000 0000000 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcC--CCCCHHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAE--DRPTMSDVVSM 796 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~evl~~ 796 (848)
... .........+.+++..|+..+|+ .|+++.|+++.
T Consensus 228 ---~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00011234567788887765444 46889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.05 Aligned_cols=251 Identities=34% Similarity=0.520 Sum_probs=199.0
Q ss_pred cceeeeecccCCccEEEEEecC-----CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
|++.+.||+|+||.||++.... +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999888753221 12899999999999999999999987 999999999999999999999999999877554
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
...... ...+++.|+|||.+....++.++||||||++++||++ |..|+....... +... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~~----~~~~~~------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLEY----LKKGYR------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HhcCCC-------
Confidence 322221 2337789999999988889999999999999999998 677765322111 0000 000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
.........++.+++.+|++.+|++|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011111344688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=342.67 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=196.7
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-CceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~ 597 (848)
..++|++.++||+|+||+||++.... ++.||+|.+... .......|..|+.+++.|+|||||++++++... ..++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44789999999999999999998754 678999988643 233456789999999999999999999988653 5689
Q ss_pred EEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCC----CceEecccCCCcEEecc----------
Q 003092 598 LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSR----LRIIHRDLKASNILLDQ---------- 662 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~iiHrDlkp~NILl~~---------- 662 (848)
+||||+++++|..+|... .....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999998888542 223468999999999999999999998542 35999999999999964
Q ss_pred -------CCCceeeccccccccCCCccccceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 003092 663 -------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (848)
Q Consensus 663 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~ 733 (848)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999998764332 1233579999999999864 458899999999999999999999985432
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... .+.. ..... +.+. ......++.+++..||+.+|++||++.|++.
T Consensus 248 ~~~-qli~----~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS-QLIS----ELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH-HHHH----HHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 0000 00000 0000 0112346889999999999999999999984
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.11 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=207.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.-|.+.+.||+|.|.+|-++++- .|..||||++.+.. ......+.+|++.|+.++|||||+|+.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 34777899999999999999854 69999999997653 3345668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe-ccCCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~ 680 (848)
.-.+|+|.+++... ...+.+..+.+++.||+.||.|+|+.+ +|||||||+||.+ .+-|-+||.|||++-.+...
T Consensus 98 LGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999998543 345889999999999999999999987 9999999999866 56788999999999877654
Q ss_pred ccccceeeeeccccccChhhhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. .....||+..|.|||++.+..|+ +++|||||||+||.|+.|+.||+.-+... .+..++|-.
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TLTmImDCK 235 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TLTMIMDCK 235 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hhhhhhccc
Confidence 3 23457999999999999999995 67999999999999999999997544322 122233332
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .++.....++.+++..||+.||++|.+..||+.
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 344556778999999999999999999999975
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.52 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=192.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~ 596 (848)
.+|+..+.||+|+||.||+|... .++.||+|++.... .+..+.+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999865 48899999886432 1234568899999999999999999998875 3577
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++++||+++++|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999888743 334788889999999999999999886 99999999999999999999999999986
Q ss_pred cCCCcc-ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... ........++..|+|||++.+..++.++||||||+++|||++|+.|+........ . ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~----~~~~~-----~~ 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-I----FKIAT-----QP 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-H----HHHhc-----CC
Confidence 543211 1112234688999999999988899999999999999999999999853321110 0 00000 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+ ..+......+.+++ .||..+|++||++.||++
T Consensus 226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011 11122233445555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=301.47 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=198.5
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee-CCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~~~lV~E 601 (848)
+|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999865 47889999986532 3345678999999999999999999988764 446789999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999998887542 2345889999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+...+.... ..... ... +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~-~~~----~----- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VYRII-EGK----L----- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHH-hcC----C-----
Confidence 1 22335689999999999999999999999999999999999998753221110 00000 000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112234457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=311.06 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=195.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 57899999986443 23345678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 86 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LDK-DLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 984 776666432 345788899999999999999999987 99999999999999999999999999976533221
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cc--------cccccccc-ccCc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NL--------LGHAWSLC-KNDR 751 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~--------~~~~~~~~-~~~~ 751 (848)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||...+.... .. ....|... ....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11223578999999998764 478899999999999999999999864332110 00 00000000 0000
Q ss_pred ccccccccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....-.+.... .........+.+++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000 001112335788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.22 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=187.9
Q ss_pred eeecccCCccEEEEEecCC---ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 531 SKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
++||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677765433 334578999999999999999999999999999999999999999
Q ss_pred cccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 607 SLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 607 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
+|..++.... .....++.....++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9988885432 2234667778899999999999999887 99999999999999999999999999865332222222
Q ss_pred eeeeeccccccChhhhhc-------CCCCcccceeehHHHHHHHHhC-CCCCCCCCCCccccccccccccccCccccccc
Q 003092 686 TKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILSS-KKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... ..... .. ......+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~---~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNH---VI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH---HH-hhcccccCC
Confidence 234568899999998753 2457899999999999999974 5565432211 11100 00 111112222
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
+.+.. ....++.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 23346777888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.04 Aligned_cols=196 Identities=27% Similarity=0.431 Sum_probs=158.2
Q ss_pred eeecccCCccEEEEEecC---CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~~ 605 (848)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 4689999986542 23467889999999999999999998854 5578999999986
Q ss_pred CcccccccC------CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe----ccCCCceeecccccc
Q 003092 606 KSLDVFLFD------PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (848)
Q Consensus 606 gsL~~~l~~------~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 675 (848)
+|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 44443321 112335888999999999999999999987 9999999999999 566789999999998
Q ss_pred ccCCCccc-cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 122345789999999998764 5799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=330.42 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=190.3
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCC------ceeeeeeee
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCC 590 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp------niv~l~~~~ 590 (848)
..+....++|++.++||+|+||+||+|... .++.||||+++... ....++..|+.++.+++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 334455689999999999999999999865 47889999996432 2344567788888887654 588888888
Q ss_pred eeC-CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCC----
Q 003092 591 IEQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHM---- 664 (848)
Q Consensus 591 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~---- 664 (848)
... ...++|||++ +++|..++. +...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 754 4788999988 556666553 234688999999999999999999974 5 99999999999998765
Q ss_pred ------------CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 665 ------------NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 665 ------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 223467999999999999999999999999999999999999998654
Q ss_pred CCCc-ccccccc----cccc----ccCccccccc------ccc---------ccC-C-CHHHHHHHHHHHHhccccCcCC
Q 003092 733 NTDS-FNLLGHA----WSLC----KNDRAHELMD------PVL---------QNE-V-SLPMLVRYINVALLCVQENAED 786 (848)
Q Consensus 733 ~~~~-~~~~~~~----~~~~----~~~~~~~~~d------~~l---------~~~-~-~~~~~~~l~~l~~~cl~~dP~~ 786 (848)
+... ....... ...+ ......++++ +.. ... . .......+.+++..||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 3211 0000000 0000 0000000000 000 000 0 0011235779999999999999
Q ss_pred CCCHHHHHH
Q 003092 787 RPTMSDVVS 795 (848)
Q Consensus 787 RPt~~evl~ 795 (848)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=306.53 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=198.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 58899999986432 2234568899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++. ....+++..+..++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998877653 2335889999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--cccccccc-------ccc-C
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN--LLGHAWSL-------CKN-D 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~-------~~~-~ 750 (848)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ........ ... .
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1122457889999999876 55789999999999999999999998643321100 00000000 000 0
Q ss_pred ccccccccccccCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAHELMDPVLQNEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+......+ ......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000000 112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.43 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=197.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||.||+|... .++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999976 488999998865422 234678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..+... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999988776532 234789999999999999999999987 9999999999999999999999999998764432
Q ss_pred cccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccccccccc-------Cc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWSLCKN-------DR 751 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-------~~ 751 (848)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ .+.......... ..
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 12234678999999998754 468899999999999999999988753321000 000000000000 00
Q ss_pred c-cccccccccc-----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 A-HELMDPVLQN-----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~-~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .....+.... .........+.+++..||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000 001123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=302.02 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=199.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+|+..+.||+|++|.||+|... +++.||+|.+.... .+..+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999876 68899999886533 23457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+||+++++|..++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999888743 235788999999999999999999987 99999999999999999999999999987644
Q ss_pred CccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.|+........ .........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~------- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKIGRSKE------- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHHHhccc-------
Confidence 32 223356889999999998776 89999999999999999999999864331100 000000000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+......+.+++.+||+.+|++||++.++++
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00111223356788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=319.98 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=193.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------ 593 (848)
..++|++.++||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999864 4789999998753 233456788999999999999999999987543
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||++++ |...+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCCC-HHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 3579999999764 444442 23678888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccc--------
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHA-------- 743 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~-------- 743 (848)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ......
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654322 12234689999999999999999999999999999999999999864331100 000000
Q ss_pred -------ccccccCc------cccccccccc---cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 -------WSLCKNDR------AHELMDPVLQ---NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 -------~~~~~~~~------~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....+.. .......... ..........+.+++.+|++.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 0000000000 0001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.95 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=194.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~ 596 (848)
.+|++.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999865 48899999875321 12346788999999999999999999988764 467
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++.. ...+++....+++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999888742 234788888999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... .......|+..|+|||++.+..++.++||||||+++|||++|+.|+........ .. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~-------------~~ 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-IF-------------KI 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-HH-------------HH
Confidence 5432111 122335688999999999988899999999999999999999999753321100 00 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+......+.+++..|+. +|++||++.||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000111223344567788888885 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.19 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=183.6
Q ss_pred ecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc---CCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
||+|+||+||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 58899999986432 12233455677777665 699999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99987774 3446889999999999999999999987 9999999999999999999999999997543222 12
Q ss_pred eeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 686 TKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.. .. .... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~---~i-~~~~------~~~~~-- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYR---NI-AFGK------VRFPK-- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHH---HH-HcCC------CCCCC--
Confidence 2346799999999998765 47999999999999999999999985332111 000 00 0000 00000
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCC----HHHHHH
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPT----MSDVVS 795 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 795 (848)
......+.+++..||+.||++||+ +.++++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112346778999999999999985 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.91 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=196.0
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5689999999999999999975 67889999986532 346789999999999999999999998654 4799999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999988885432 335788999999999999999999886 9999999999999999999999999997643221
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ..... ....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~---------~~~~ 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKE----CVEKG---------YRME 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHH----HHhCC---------CCCC
Confidence 11234568999999998899999999999999999998 888875332111 000 00000 0001
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
........+.+++.+||+.+|++||++.++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111234567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.07 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=196.8
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc----------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG----------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~----------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~ 594 (848)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999854 588999998753211 11346788999999999999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||+++++|..++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999998887432 46888999999999999999999986 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+...............|+..|+|||.+.... ++.++||||||+++||+++|..|+....... . ........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~~~-~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-A----MFKLGNKR-S 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-H----HHHhhccc-c
Confidence 8654322222223356889999999988755 7899999999999999999999975322110 0 00000000 0
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+. ..........+.+++..||+.+|++||++.+|++
T Consensus 230 ~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00011 1111123457888999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=310.44 Aligned_cols=204 Identities=26% Similarity=0.413 Sum_probs=168.2
Q ss_pred CcceeeeecccCCccEEEEEecC---CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~ 597 (848)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47889999999999999998654 7899999997632 33446778899999999999999999999988 7899
Q ss_pred EEEEeccCCcccccccC-CCc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc----CCCceeecc
Q 003092 598 LIYEYMVNKSLDVFLFD-PTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDF 671 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~-~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DF 671 (848)
+||||+++. +..++.. ... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999999864 4443322 222 236888999999999999999999987 999999999999999 999999999
Q ss_pred ccccccCCCcc-ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCC
Q 003092 672 GMARMFGGDEL-QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (848)
Q Consensus 672 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~ 733 (848)
|+++....... ........+++.|+|||++.+. .++.++||||||++++||++|+.|+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987644322 1122345688999999988764 57899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.13 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=199.5
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5889999998643 233456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|..++... ....+++..+.+++.|++.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998877432 2235788899999999999999999987 99999999999999999999999999987644321
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....|++.|+|||++.+..++.++||||||++++||++|+.|+....... . .... +... ..
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~---~~~~---------~~~~-~~ 219 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--L---VLKI---------IRGS-YP 219 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--H---HHHH---------hcCC-CC
Confidence 1 223458899999999999999999999999999999999999875322110 0 0000 0000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.....++.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.35 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=200.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999876 4789999988653 23345778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|++++.+..+.. +...+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887765542 2345789999999999999999999987 9999999999999999999999999998775443
Q ss_pred cccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccccc-------ccc-cC
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWS-------LCK-ND 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~-------~~~-~~ 750 (848)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+........ ........ ... ..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122235678999999999888 789999999999999999999998764321100 00000000 000 00
Q ss_pred c-----cccccccc-cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 R-----AHELMDPV-LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~-----~~~~~d~~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+..++. ...........++.+++..||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 00000000 000111122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=305.13 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=199.7
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeee-
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE- 592 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~- 592 (848)
++.++..+.+.|++.+.||+|+||.||+|... .++.||+|++.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556788999999999999999999874 57899999886543 3346788999999999 69999999999863
Q ss_pred -----CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCce
Q 003092 593 -----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (848)
Q Consensus 593 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 667 (848)
....+++|||+++++|..++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999998877532 2345778888999999999999999987 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 742 (848)
|+|||++....... .......|++.|+|||++. ...++.++||||||+++|||++|+.|+..........
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 99999987653221 1223356899999999876 3467889999999999999999999985332111000
Q ss_pred cccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 743 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..................+.+++..||+.||++||++.|+++
T Consensus 237 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -----------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000000011123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=308.32 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=197.8
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
.|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++||||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444568999999999999864 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 9999887732 34788999999999999999999987 9999999999999999999999999997654322 1
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... . ....+.+....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~---~------~~~~~~~~~~~-- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR---R------IRDNLPPRVKD-- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---H------HHhcCCCcccc--
Confidence 2233568999999999998899999999999999999999999975322110 000 0 00011111111
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+.+++..|++.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122346778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=302.79 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=200.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.+.||+|++|.||++... +++.||+|++.... ....+++.+|++++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999876 58899999987653 34456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
+++++|.+++.... ..+++....+++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999988885322 567889999999999999999998 65 9999999999999999999999999987653321
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+................. .... .
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~-~ 221 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------VNEP-P 221 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---------hcCC-C
Confidence 1 115688999999999999999999999999999999999999864322111111100000 0000 0
Q ss_pred cCCCHH-HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLP-MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ....+.+++..||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011111 3456889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=316.98 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=191.3
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------ 593 (848)
..++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3478999999999999999999864 57899999986532 22345678899999999999999999887543
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999987 667766652 345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccc-------
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHA------- 743 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~------- 743 (848)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... .+....
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223578999999999877 5689999999999999999999999854321100 000000
Q ss_pred ccccccCccccccccccccCCC-------HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 WSLCKNDRAHELMDPVLQNEVS-------LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............+.. +..... ......+.+++.+|++.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 240 LKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 000000 001124678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.30 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=199.7
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|++|.||++.... ++.||+|.+..... ...+.+.+|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999998754 88999999876432 24567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+.+++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999998887432 3356889999999999999999999987 999999999999999999999999998755322
Q ss_pred ccc---------------------------cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 003092 681 ELQ---------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (848)
Q Consensus 681 ~~~---------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~ 733 (848)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999999889999999999999999999999985433
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCC----HHHHHH
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT----MSDVVS 795 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 795 (848)
.... + ....+....-.........+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~~~~-~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET-F-------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH-H-------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 0 0000100000011113457889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.96 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=199.3
Q ss_pred CcceeeeecccCCccEEEEEe-cCCceEEEEEecccCc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ...+.+++|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 4588999999864321 235678999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-Cceeecccccccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 677 (848)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999988743 346788999999999999999999987 99999999999998776 5999999999876
Q ss_pred CCCccc--cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 678 GGDELQ--GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 678 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... .......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+........ ... ..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~---------~~~~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LAL---------IFKI 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHH---------HHHH
Confidence 543211 112235688999999999888899999999999999999999999753321110 000 0000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.....++.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0000111222334457889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=304.99 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=192.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.++||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986432 22335678899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 55555432 2345899999999999999999999987 99999999999999999999999999986543221
Q ss_pred ccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc---cC---ccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK---ND---RAHEL 755 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~~ 755 (848)
......+++.|+|||++.+.. ++.++||||||+++|||++|+.|+.........+.. ...... .. ...+.
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH-HHHHhCCCChHHhHHhhhc
Confidence 112235788999999987754 689999999999999999999885322211110000 000000 00 00000
Q ss_pred cc----ccccc-----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MD----PVLQN-----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d----~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+ +.... ........++.+++..||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 00000 011123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.23 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=200.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36889999999999999999875 47899999987543 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999988843 345789999999999999999999987 999999999999999999999999998742111
Q ss_pred cc-------------ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 681 EL-------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 681 ~~-------------~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~~----~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQ----V 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----H
Confidence 00 00111245788999999999888999999999999999999999997532211 00000 0
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
... ....+.. .......+.+++.+||+.+|++||++.++.++|+..+
T Consensus 229 ~~~---~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 229 ISD---DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred Hhc---ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 000 0000000 0123346789999999999999999888887776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.55 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=196.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+|++.++||+|++|.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 5889999999754322 245577899999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+ +++|..++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889988884322 36899999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc---------cc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC---------KN 749 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~ 749 (848)
... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..++....... ......... ..
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence 321 1122356788999998865 457899999999999999999977664322110 000000000 00
Q ss_pred CccccccccccccC-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 DRAHELMDPVLQNE-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.............. ........+.+++..||+.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000 11122457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.29 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=203.7
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.+.|.|...||.|+||.||++..++ +-..|-|.+...+.+..+.|.-||++|..++||+||+|++.|+.++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3568888999999999999998765 445677888877788889999999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
|.||..+.++.. -...|.+..+.-+++|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-- 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-- 183 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--
Confidence 999999887743 3457889999999999999999999987 999999999999999999999999998754322
Q ss_pred ccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
......+.|||.|||||+++ ..+|+.++||||||++|.||..+.+|-...+.-.. .....+. ....++.
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----llKiaKS-ePPTLlq 257 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKS-EPPTLLQ 257 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----HHHHhhc-CCCcccC
Confidence 12234578999999999975 56899999999999999999999998653322110 1111111 1111221
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+......+.+++..||..||+.||++.++++
T Consensus 258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1223456889999999999999999999875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.14 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=193.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|++|.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999875 578999999865432 2234567899999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 787766432 236788999999999999999999987 99999999999999999999999999875432211
Q ss_pred ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc---ccCcc------
Q 003092 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC---KNDRA------ 752 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~------ 752 (848)
. .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+.........+. ..+... .....
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH-KIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHhcCCCChhhhhhhhhc
Confidence 1 112346889999999876 4578999999999999999999999854321100000 000000 00000
Q ss_pred ---cc----cc-ccccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 ---HE----LM-DPVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ---~~----~~-d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. .. ...+... ........+.+++..|++.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 0000000 00111246788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.66 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=200.6
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~ 593 (848)
...++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33445556789999999999999999999874 58899999986532 2346678899999999 899999999998754
Q ss_pred -----CeEEEEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCce
Q 003092 594 -----GEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (848)
Q Consensus 594 -----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 667 (848)
...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999998877432 23346889999999999999999999886 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhhcCC-----CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-----FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-----~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 742 (848)
|+|||++......... .....|+..|+|||++.... ++.++|||||||++|||++|+.|+....... .+.
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~-- 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLF-- 243 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHH--
Confidence 9999999876433211 12346889999999986443 6889999999999999999999975432211 000
Q ss_pred cccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 743 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... ....... ........+.+++.+||+.+|++||++.|+++
T Consensus 244 --~~~~-~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 --KIPR-NPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHhc-CCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 0000000 01122346889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=297.34 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=198.6
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 5789999998654 233467889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 681 (848)
+++++|.+++... ....+++..+.+++.+++++|+|||+++ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999888542 2345789999999999999999999987 99999999999998654 57999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+...+.... .. .. .... .
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~---~~---------~~~~-~ 218 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VL---KI---------MSGT-F 218 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HH---HH---------HhcC-C
Confidence 12234688999999999988899999999999999999999998754322110 00 00 0000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+.+++..||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111123446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.70 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=204.4
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.+.||+|++|.||+++... ++.||||++..... ...+.+.+|+..+.+++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 89999999876543 4467899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
+++++|..++... ..+++..+..++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999888432 568899999999999999999999 76 9999999999999999999999999998765433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-CccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT-DSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ ......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------~~~~~~ 220 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA------------ICDGPP 220 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH------------HhcCCC
Confidence 22 1235688999999999999999999999999999999999999864432 11111100 000000
Q ss_pred ccCCCHH-HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLP-MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ....+.+++..|++.+|++||++.++++
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 -PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011111 3457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.93 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=200.0
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~lV~ 600 (848)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5789999998643 23345678899999999999999999998764 45679999
Q ss_pred EeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
||+++++|..++... .....+++..+..++.||+.||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999998887542 22456889999999999999999999332 334999999999999999999999999999877
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+....... +.. ....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~-------- 224 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LAS----KIKE-------- 224 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHH----HHhc--------
Confidence 543321 223468999999999999889999999999999999999999986433111 000 0000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+.....++.+++..|++.+|++||++.+|++
T Consensus 225 -~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 -GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0011122233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=305.05 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=196.5
Q ss_pred eeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCc
Q 003092 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3458999999999999864 588999999876555556778899999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccccee
Q 003092 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687 (848)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 687 (848)
|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 987663 245789999999999999999999987 99999999999999999999999999976543321 123
Q ss_pred eeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHH
Q 003092 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLP 767 (848)
Q Consensus 688 ~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 767 (848)
...|+..|+|||++.+..++.++||||||+++|||++|+.|+....... ... ... ... .+... ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~---~~~-~~~-----~~~~~--~~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK---RLR-DSP-----PPKLK--NAHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHh-ccC-----CCCcc--ccCC
Confidence 3578999999999999899999999999999999999999975332111 000 000 000 00000 0111
Q ss_pred HHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 768 MLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 768 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
....+.+++..||+.+|++||++.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 23457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=302.05 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68999999999999999999854 57899999987555555677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999888732 34778899999999999999999987 99999999999999999999999999876644322
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......|++.|+|||.+.+..++.++||||||+++||+++|+.||.......... ....... +.. .
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~------~~~--~ 236 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT------PEL--Q 236 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC------CCC--C
Confidence 1223468899999999998889999999999999999999999986432211100 0000000 000 0
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
........+.+++..||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223467889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.77 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=191.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHH-HHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~-l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.+.||+|+||.||++... +++.||+|++.... .....++..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999875 58999999987542 2234455666665 566789999999999999999999999
Q ss_pred eccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|++ ++|..++... .....+++..+..++.||+.||+|||++. +++||||||+|||++.++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5666665432 23456899999999999999999999862 3999999999999999999999999999866432
Q ss_pred ccccceeeeeccccccChhhhhc----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
. ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.........+.. .. ...
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~------~~~ 224 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VV------EEP 224 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HH------hcC
Confidence 1 1122468899999998864 45688999999999999999999997532221111000 00 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+ .......++.+++..||+.+|++||++.++++
T Consensus 225 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 01112356889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.79 Aligned_cols=258 Identities=27% Similarity=0.389 Sum_probs=199.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV~ 600 (848)
++|+..+.||.|++|.||++... .++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 578999999875432 3457789999999999999999999988653 4789999
Q ss_pred EeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998776432 23445788999999999999999999987 99999999999999999999999999876533
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............. ....... .+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~-----~~~ 227 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMP-----NPE 227 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCC-----chh
Confidence 22 1234578899999999999999999999999999999999999864422110000000 0000000 011
Q ss_pred cccCC--CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEV--SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111 1223457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.01 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=200.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 588999999876544 3567899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999988743 345788899999999999999999987 99999999999999999999999999987754332
Q ss_pred ccc--eeeeeccccccChhhhhcCC---CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 683 QGN--TKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 683 ~~~--~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
... .....+++.|+|||++.+.. ++.++||||||++++||++|+.||.......... ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~~~------~~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHVGA------GHK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHHhc------CCC
Confidence 211 12346789999999998766 8899999999999999999999985432111000 00000 000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+.. .......+.+++..||+.+|++||++.+++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01110 0111345778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.14 Aligned_cols=244 Identities=25% Similarity=0.324 Sum_probs=198.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46899999999999999999865 58899999986532 234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ...+++..+..++.||++||+|||+.+ |+|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999888743 356889999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.|+....... .. ....... .
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~~------~-- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--IY----EKILEGK------V-- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHhcCC------c--
Confidence 233568999999999988888999999999999999999999975432110 00 0000000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..+......+.+++..||+.+|++|| ++.|+++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11112234778999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.60 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=198.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
-|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 57899999886432 334567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|..++. ...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999988773 235789999999999999999999987 99999999999999999999999999987644321
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......++..|+|||.+.+..++.++||||||+++|||++|..|+........ . ... .... .+ .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~---~~~-~~~~-----~~----~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--L---FLI-PKNN-----PP----T 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--H---HHH-hcCC-----CC----C
Confidence 12234688899999999988899999999999999999999999754322110 0 000 0000 00 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11123346788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.43 Aligned_cols=247 Identities=23% Similarity=0.420 Sum_probs=197.5
Q ss_pred CcceeeeecccCCccEEEEEe-cCCceEEEEEeccc-CcccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.|++.++||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 45889999998754 3345677889999999997 999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999887732 36889999999999999999999987 999999999999999999999999999877543
Q ss_pred ccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+......... . .... ...+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~----~~~~-----~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--M----LIPK-----SKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--h----cccc-----CCCCC
Confidence 31 12234689999999998754 4689999999999999999999998543211100 0 0000 00011
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+... ....++.+++..||+.+|++||++.++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111 12346788999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.06 Aligned_cols=264 Identities=25% Similarity=0.304 Sum_probs=193.5
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++++|++.++||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 588999999875432 23346788999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+. +++...+.. ....+.+..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 455444432 2234677888899999999999999987 999999999999999999999999999765332
Q ss_pred ccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc-----------
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK----------- 748 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 748 (848)
... .....+++.|+|||++.+. .++.++||||||+++|||++|+.|+.........+ ...+....
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH-HHHHHHcCCCChhhhhhhh
Confidence 211 1223578999999998764 47889999999999999999999986433211100 00000000
Q ss_pred -c-CccccccccccccC-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 -N-DRAHELMDPVLQNE-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 -~-~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ....+......... ........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 00000000000000 00011346778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.10 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=198.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~------ 594 (848)
++++|++.+.||+|++|.||+|... +++.+|+|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5688999999999999999999875 478899999875433 456789999999999 7999999999997644
Q ss_pred eEEEEEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999988775422 2456889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
+....... .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+....... .+.. . .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----~-~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFK----I-P 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHH----h-h
Confidence 87654322 12223568999999998753 346789999999999999999999985322111 0000 0 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... .+.+ ........++.+++.+||+.||++|||+.++++
T Consensus 232 ~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0000 011123457889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=291.40 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=202.3
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
+|++.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|||++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 588999999977655566889999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|.+++.... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999988874322 46899999999999999999999976 99999999999999999999999999987654332
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
.....++..|+|||.+....++.++||||||+++++|++|+.|+.......... . . ....... +..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~---~-~~~~~~~-----~~~-- 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--K---I-ATNGPPG-----LRN-- 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--H---H-HhcCCCC-----cCc--
Confidence 234578999999999998889999999999999999999999975432111000 0 0 0000000 000
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+.+++..||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111356889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=298.71 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=196.9
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+|++.++||+|++|.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 588999999875433 23566788999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++ +|..++........+++..+.+++.||+.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 67666654444456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-cccccccccccCccc-----cc
Q 003092 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLGHAWSLCKNDRAH-----EL 755 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~-----~~ 755 (848)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ . .... .......... ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI-MGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCChhhHHHHhcCch
Confidence 11224578899999998764 468999999999999999999999764322110 0 0000 0000000000 00
Q ss_pred ccccc-------ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVL-------QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... ...........+.+++..|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00011122446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.09 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=198.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999865 58899999987643 33456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+ +++|..++.... ..+++..+..++.||+++|+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999988775332 56889999999999999999999987 99999999999999999999999999987654321
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccc----------ccccccc-C
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH----------AWSLCKN-D 750 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~-~ 750 (848)
.......|+..|+|||.+.+. .++.++||||||++++||++|.+++....... .+... .|..... .
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcc
Confidence 112234689999999998654 46899999999999999999977764322110 00000 0000000 0
Q ss_pred ccccccccccc----cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAHELMDPVLQ----NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+... ..........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0001122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.61 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=199.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999875 48899999987542 2346789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+.+++|..++.. ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999888743 246889999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......|+..|+|||.+....++.++|+||||+++|+|++|+.|+............ ..... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------~~~~~-~~ 218 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR------------AKQET-AD 218 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH------------HHhcc-cc
Confidence 122356888999999999888999999999999999999999997643321100000 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCH--HHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTM--SDVV 794 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 794 (848)
...+......+.+++.+||+.+|++||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122233578899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.66 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=203.9
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV~ 600 (848)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 588999999876542 4567899999999999999999999999988 8999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++... ..+++..+..++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999998887432 27899999999999999999999976 999999999999999999999999999877654
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
..........++..|+|||.+.+..++.++||||||+++++|++|..|+........ ..+..... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~---------~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYKIGSS---------GE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHhcccc---------CC
Confidence 322122345688999999999988899999999999999999999999865441111 11111100 00
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+......+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01112222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=298.98 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++.|++.+.||+|++|.||+|... +++.||+|++..... ..+.+.+|+++++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4467888899999999999999876 588999999976544 56778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999885432 37899999999999999999999976 9999999999999999999999999987654322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.|+...+...... ..... ... + ..
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-----~~~~~-~~~----~-~~ 237 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-----LITTK-GIP----P-LK 237 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhc-CCC----C-Cc
Confidence 1 1223457889999999998889999999999999999999999975432211000 00000 000 0 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++.+|++.+|.+||++.++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=311.23 Aligned_cols=262 Identities=25% Similarity=0.358 Sum_probs=202.1
Q ss_pred CcceeeeecccCCccEEEEEe-cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------eEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------EKI 597 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------~~~ 597 (848)
.+...+.||+|+||.||+|+. ..|+.||||.+++.. ....+...+|+++|++++|||||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355668999999999999995 469999999998653 334567789999999999999999999876543 568
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--cCCC--ceeecccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMN--PKISDFGM 673 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~--~kl~DFGl 673 (848)
+|||||.+|+|...|.+..+...|++.+.+.++..+..||.|||+++ |+||||||.||++- .+|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999999999999999999999999999999887 99999999999983 3343 69999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc--C
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN--D 750 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~ 750 (848)
|+.+..+. ....+.||..|++||+... +.|+..+|.|||||++||++||..||-....+..+. ...|....+ .
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITKKPS 246 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhccCCC
Confidence 99887654 4566899999999999985 889999999999999999999999986554332111 011111111 0
Q ss_pred cccccccccc------------ccCCCHHHHHHHHHHHHhccccCcCCCC--CHHHHH
Q 003092 751 RAHELMDPVL------------QNEVSLPMLVRYINVALLCVQENAEDRP--TMSDVV 794 (848)
Q Consensus 751 ~~~~~~d~~l------------~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~evl 794 (848)
.+.....+.. ....+.....++-.....++..+|++|- ...+..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F 304 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF 304 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence 0111111111 1123344555677777788888999998 444433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=300.37 Aligned_cols=260 Identities=17% Similarity=0.221 Sum_probs=180.5
Q ss_pred hcCcceeeeecccCCccEEEEEecC----CceEEEEEecccCcccH-----------HHHHHHHHHHHHcCCCceeeeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLLG 588 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~Ei~~l~~l~Hpniv~l~~ 588 (848)
.++|++.++||+|+||+||+|...+ +..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 34566665432221111 11122334455668999999999
Q ss_pred eeeeCC----eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 589 CCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 589 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
++.... ..++++|++.. ++...+. .....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 776543 34667776643 3333331 1223467788899999999999999987 99999999999999999
Q ss_pred CceeeccccccccCCCcc-----ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc
Q 003092 665 NPKISDFGMARMFGGDEL-----QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL 739 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~ 739 (848)
.++|+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 111223469999999999999999999999999999999999999986543221100
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
..... +....+....+. .......+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKC-----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHH-----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00000 000011111000 1112346889999999999999999999998763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=302.45 Aligned_cols=246 Identities=31% Similarity=0.463 Sum_probs=192.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
+.|++.++||+|+||.||+|... +++.||+|++.... .+..+++.+|+++++.++||||+++++++..++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888999999999999999865 58899999986432 233467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++ ++.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99975 45444422 2335889999999999999999999987 999999999999999999999999998765322
Q ss_pred ccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+...+.... ........ .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~~-~----- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQND-S----- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcCC-C-----
Confidence 2246788999999874 45688999999999999999999998743221110 00000000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
+. .........+.+++..||+.+|++||++.+++..
T Consensus 232 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0111234568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.39 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=204.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.+.|+.-++||+||||.||-++.. .|+-||.|++.+. ..++..-..+|-.+|.+++.+.||.+-..+...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999754 5899999988654 234555678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
+..|.+|+|..+|+.... ..++++.+..++.+|+.||++||... ||.|||||+|||||+.|+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999976544 67899999999999999999999987 99999999999999999999999999998876
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
..... ..+||.+|||||++.++.|+...|.|||||+||||+.|+.||..+.+.. ..+.+|..
T Consensus 340 g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdrr 401 (591)
T KOG0986|consen 340 GKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDRR 401 (591)
T ss_pred CCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHHH
Confidence 54322 2389999999999999999999999999999999999999986443211 11122222
Q ss_pred c---ccCCCHHHHHHHHHHHHhccccCcCCCCCHH
Q 003092 760 L---QNEVSLPMLVRYINVALLCVQENAEDRPTMS 791 (848)
Q Consensus 760 l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 791 (848)
. ...++....++..++....|+.||++|..-+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1134455667888999999999999996533
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=298.41 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=197.4
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
|...++||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 5789999998765555566789999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999888743 45788999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .... .. .. ...+.... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~---~~-~~-----~~~~~~~~--~ 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMK---RI-RD-----NLPPKLKN--L 238 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHH---HH-Hh-----cCCCCCcc--c
Confidence 22346899999999999888999999999999999999999997532211 0000 00 00 00011111 1
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 113347889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.63 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=193.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999865 47899999987543 234567889999999996 9999999999999999999999
Q ss_pred eccCCcccccccC--CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 602 YMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 602 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|+.. ++..+... ......+++..+..++.|+++||+|||+.. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9875 43332211 112356889999999999999999999752 399999999999999999999999999986543
Q ss_pred CccccceeeeeccccccChhhhhcC---CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEG---VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~---~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.. ......|++.|+|||++.+. .++.++||||||+++|||++|+.|+......... ....... .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~------~ 227 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ----LTQVVKG------D 227 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH----HhhhcCC------C
Confidence 22 11234688999999999876 6899999999999999999999998643311000 0000000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+..........++.+++..||+.+|++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111122234557889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.11 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=193.9
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888999999999999999875 58899999886442 22346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5676666432 2346789999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc--------C---
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN--------D--- 750 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~--- 750 (848)
......+++.|+|||++.+.. ++.++||||||+++|||++|+.|+....... ............ .
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHH
Confidence 112235788999999887654 5889999999999999999999885432111 000000000000 0
Q ss_pred ----ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 ----RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.. ........+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 01112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.94 Aligned_cols=261 Identities=25% Similarity=0.295 Sum_probs=194.5
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------ 593 (848)
..++|++.+.||+|+||.||++... +++.||+|++... .....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999865 5889999998643 233456678899999999999999999988643
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||+.+ +|...+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999975 55555521 2788888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c------------cc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N------------LL 740 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~------------~~ 740 (848)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... . +.
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987643321 2234688999999999999999999999999999999999999854321100 0 00
Q ss_pred cc---cc-ccccc------Ccccccccccc----ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 741 GH---AW-SLCKN------DRAHELMDPVL----QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 741 ~~---~~-~~~~~------~~~~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. .. ..... ....+.....+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00 00000 00001111110 00111123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=337.87 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=203.1
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
-+-+++-..+||.|.||.||.|.. .+|.-.|+|.+..+ .....+...+|+.++..|+|||+|+++|+-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677788999999999999985 45888999977644 344567788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||||++|+|.+.+. ..+..++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999883 3445667777788999999999999998 99999999999999999999999999998865
Q ss_pred Cc--cccceeeeeccccccChhhhhcCC---CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 680 DE--LQGNTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 680 ~~--~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.. ....-+...||+.|||||++.+.. ..-++||||+|||+.||+||++||..++.+-.-+. ++ ..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-~V---------~~ 1456 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-HV---------AA 1456 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-HH---------hc
Confidence 42 223344678999999999998654 45789999999999999999999976654321111 00 00
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
--. .+++.....+-.+++..|++.||++|.++.|+++
T Consensus 1457 gh~----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHK----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCC----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 001 1222334556678999999999999999887765
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=308.25 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=193.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----CeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~~ 596 (848)
+++|++.++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 58899999986432 33456688899999999999999999887644 357
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++|+||+++ +|...+ ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 555444 2345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc---cCc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK---NDR 751 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 751 (848)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...+... .......... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 6432211 11223568999999998765 468999999999999999999999985432110 0000000000 000
Q ss_pred cccccccc-------c--ccCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 752 AHELMDPV-------L--QNEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 752 ~~~~~d~~-------l--~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.....+.. . ..... .....++.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0 00000 1123468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=299.03 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=195.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV 599 (848)
++|++.+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999875 478999999864432 2234567899999999999999999999877 899999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 777666432 236899999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccc-------cccc---
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGH-------AWSL--- 746 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~-------~~~~--- 746 (848)
... ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.|+........ .+... .|..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 122345788999999987654 68999999999999999999998864321100 00000 0000
Q ss_pred ---cccCccccccccccccCCCHH-HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ---CKNDRAHELMDPVLQNEVSLP-MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ---~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.............+....+.. ....+.+++..||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000111111111 2456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=322.71 Aligned_cols=265 Identities=21% Similarity=0.329 Sum_probs=184.1
Q ss_pred HhcCcceeeeecccCCccEEEEEecC--CceEEEEEe--------------c---ccCcccHHHHHHHHHHHHHcCCCce
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRL--------------S---NQSGQGLKEFKNEMMLIAKLQHRNL 583 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~--~~~vAvK~~--------------~---~~~~~~~~~~~~Ei~~l~~l~Hpni 583 (848)
..++|++.++||+|+||+||++.... +..+++|.+ . .........+++|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 222222211 0 0112234568899999999999999
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCCC--cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 584 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
+++++++...+..++|+|++.. +|..++.... .........+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999865 4444443211 1122335567789999999999999987 99999999999999
Q ss_pred cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCC-CCCCCCCc-ccc
Q 003092 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN-TGVYNTDS-FNL 739 (848)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p-~~~~~~~~-~~~ 739 (848)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.+ +....... ..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999876543221 12235799999999999999999999999999999999998754 33222111 111
Q ss_pred cccccc--ccccC------cccccc------------ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 740 LGHAWS--LCKND------RAHELM------------DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 740 ~~~~~~--~~~~~------~~~~~~------------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ..... ...+.+ .+.+.. .....++.+++.+||+.||++|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 100000 00000 000000 000000 001234667888999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.57 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=207.1
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
....|.+.+.||+|.|+.|..|++. .+.+||||.+.+..- ...+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467999999999999999999865 589999999976532 2345588999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+.+|.+.+++. +...+.+..+..++.|+..+++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999884 3344556888899999999999999987 99999999999999999999999999998763
Q ss_pred CccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
. ......+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+... +.++-++
T Consensus 208 ~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------------lk~Lr~r 266 (596)
T KOG0586|consen 208 G---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------------LKELRPR 266 (596)
T ss_pred c---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------------cccccch
Confidence 3 23445799999999999999887 689999999999999999999986322 2222233
Q ss_pred cccc--CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQN--EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+ .++..+..++.++++.++-.+|.+|+++.++-+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 3332 234445668899999999999999999999865
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=293.00 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=198.2
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999875 47899999986532 23456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-ceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~ 681 (848)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999998887542 2235789999999999999999999987 999999999999998864 6999999998765332
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......|++.|+|||++.+..++.++||||||++++||++|..|+....... ....... ....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~-----~~~~---- 220 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQ-----GYFA---- 220 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhc-----ccCC----
Confidence 1 1122458899999999998889999999999999999999999975332111 0000000 0000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.51 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=184.7
Q ss_pred eecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHHH---cCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAK---LQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~---l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
.||+|+||.||++... +++.||+|.+..... .....+.+|..++.. .+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865321 122334455544443 479999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999988774 2345899999999999999999999987 9999999999999999999999999997654322
Q ss_pred ceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....|++.|+|||.+.. ..++.++|||||||++|||++|..||.............. .... ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~----~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TLTV----NVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------hhcC----CcC
Confidence 122468999999999874 5579999999999999999999999864332111100000 0000 111
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.+.....++.+++..||+.||++|| +++|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 2222345788999999999999999 5998876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=297.52 Aligned_cols=261 Identities=24% Similarity=0.329 Sum_probs=193.5
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
|++.++||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999865 68999999987543 223467889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
+ ++|..++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 57777764322 235889999999999999999999986 99999999999999999999999999976543211
Q ss_pred cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc--cc------Ccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC--KN------DRAHE 754 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~------~~~~~ 754 (848)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +........ .+ ....+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchh
Confidence 11223568899999988664 578999999999999999999998754321100 000000000 00 00000
Q ss_pred ccccc------cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPV------LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... ............+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000011122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.36 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=193.2
Q ss_pred ecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|++|.||+++... ++.||+|++.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999754 8899999986542 23456789999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 988843 345788999999999999999999987 9999999999999999999999999998765432 2223
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
..|++.|+|||.+.+..++.++|+||||+++|||++|..|+.....+...... ...+.......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN------------DILKGNGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH------------HHhccCCCCCCCccc
Confidence 46889999999998888999999999999999999999998644321111100 000000011111122
Q ss_pred HHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 769 LVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
...+.+++..||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=325.55 Aligned_cols=252 Identities=28% Similarity=0.429 Sum_probs=183.9
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
-..+|+.++.||+||||.||+++.+ +|+.||||++... +.+....+.+|+.+|++|+|||||+++..+.+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467889999999999999999864 8999999999754 3445667889999999999999999986432210
Q ss_pred --------------------------------------------------------------------------------
Q 003092 595 -------------------------------------------------------------------------------- 594 (848)
Q Consensus 595 -------------------------------------------------------------------------------- 594 (848)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ---------------------------------eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH
Q 003092 595 ---------------------------------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641 (848)
Q Consensus 595 ---------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH 641 (848)
.+||=||||+..++.+++.+..... .....++++++|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 1345566776666666553322111 35667899999999999999
Q ss_pred hcCCCceEecccCCCcEEeccCCCceeeccccccccC---C-------------CccccceeeeeccccccChhhhhcCC
Q 003092 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG---G-------------DELQGNTKRIVGTYGYMSPEYALEGV 705 (848)
Q Consensus 642 ~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~---~-------------~~~~~~~~~~~gt~~y~APE~~~~~~ 705 (848)
+++ ||||||||.||+++++..|||+|||+|+... . .......+..+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998721 0 00111233468999999999997654
Q ss_pred ---CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc--cCCCHHHHHHHHHHHHhcc
Q 003092 706 ---FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ--NEVSLPMLVRYINVALLCV 780 (848)
Q Consensus 706 ---~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~cl 780 (848)
|+.|+|+|||||+|+||+. ||+..-+.. ..+ ..+-+..+. ..+..++...=..++++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-~iL------------~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-SIL------------TNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHH-HHH------------HhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 9999999999999999984 343211111 011 111111111 1122333445568999999
Q ss_pred ccCcCCCCCHHHHHH
Q 003092 781 QENAEDRPTMSDVVS 795 (848)
Q Consensus 781 ~~dP~~RPt~~evl~ 795 (848)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999976
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=297.48 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=192.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCe-----
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGE----- 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~----- 595 (848)
++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 588999998865422 23467888999999995 6999999999887665
Q ss_pred EEEEEEeccCCcccccccCCCc--ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFG 672 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFG 672 (848)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 67666643222 346799999999999999999999987 999999999999998 8899999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc--ccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL--CKN 749 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~ 749 (848)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ +....... ...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9986543211 1112356889999998865 4578999999999999999999998854321110 00000000 000
Q ss_pred Cc---ccccc--------ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 DR---AHELM--------DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ~~---~~~~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ..... .+.......+....++.+++..||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00000 000000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.50 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=195.5
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIYE 601 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV~E 601 (848)
|++.++||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999875 47899999997653 33456788999999999999999999999988 89999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 776666332 246889999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccc-------ccccccc--
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGH-------AWSLCKN-- 749 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~-------~~~~~~~-- 749 (848)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .+... .+.....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 11 1222356889999998765 4578999999999999999999999864432110 00000 0000000
Q ss_pred ----CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 ----DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ----~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+.......+...+.+++..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000101011112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=288.20 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.+.||+|+||.||++... +++.||+|++..... ...+++.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999875 588999999876533 4567789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
+++++|..++.... ....+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999988875432 2367899999999999999999999987 9999999999999999999999999998765443
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+....... +.. .. ... ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~---~~-~~~----~~----- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL---KI-LKG----QY----- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH---HH-hcC----CC-----
Confidence 12233568999999999999899999999999999999999999975432111 000 00 000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.26 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=191.7
Q ss_pred eeeccc--CCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G--~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+| +||+||++.+. .++.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 89999999874 68999999986432 23457789999999999999999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc--
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-- 683 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 683 (848)
++|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99988775432 234788899999999999999999887 999999999999999999999999865433221100
Q ss_pred ---cceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc---cc--------
Q 003092 684 ---GNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS---LC-------- 747 (848)
Q Consensus 684 ---~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~-------- 747 (848)
.......++..|+|||++.+. .++.++||||||+++|||++|+.|+................ ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 011112356779999999764 47899999999999999999999986433211000000000 00
Q ss_pred --------------------ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 --------------------KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 --------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............+...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000111111112223345667899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.51 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=201.5
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.++||+|+||.||++... +++.+|+|.+... ......++.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999754 5789999998753 233456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
+++++|..++... .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999998887442 22356889999999999999999999987 9999999999999999999999999998775441
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....+++.|+|||.+.+..++.++|+||||++++||++|+.|+...+.... .. . ......
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~----~---------~~~~~~ 218 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RY----K---------VQRGKY 218 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H---------HhcCCC
Confidence 1224588899999999999999999999999999999999999854332110 00 0 000001
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........++.+++..|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=293.40 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=196.0
Q ss_pred ecccCCccEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||.||+++... ++.||+|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999999875433 4567789999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc------
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL------ 682 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~------ 682 (848)
..++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 8888432 36889999999999999999999987 99999999999999999999999999876543311
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
........++..|+|||.+.....+.++||||||+++|||++|+.|+........ .. . ........
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~---~---------~~~~~~~~ 220 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQ---N---------ILNGKIEW 220 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH---H---------HhcCCcCC
Confidence 1122335688899999999988899999999999999999999999754332110 00 0 00000000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.........+.+++..||+.+|++||++.++.+.|+..
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 00000245678999999999999999997777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.48 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=191.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999986542 2334678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 680 (848)
|+++ +|..++... ....+++..+..++.||+.||+|||+.+ ++||||||+||++++ ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9965 565555321 2233577888899999999999999987 999999999999985 567999999999765432
Q ss_pred ccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccccc----ccccc-Ccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAW----SLCKN-DRA 752 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~----~~~~~-~~~ 752 (848)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|+.|+........ ....... ..+.. ...
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1 111224578899999998764 578999999999999999999999854321100 0000000 00000 000
Q ss_pred cccc------ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELM------DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... .+.......+....++.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000011122346788999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=289.82 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=195.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~ 596 (848)
.+|++.+.||+|+||.||+|... +++.||+|.+... ..+....+++|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 5889999987532 223456788999999999999999999998764 468
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++|+||+++++|..++.. ...+++....+++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999887742 234788889999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... .......|+..|+|||++.+..++.++||||||+++|||++|+.|+....... .. .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~-------------~~~ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AI-------------FKI 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HH-------------HHH
Confidence 6432111 11223568999999999998889999999999999999999999985322110 00 000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+......+.+++.+|++ +|.+||+..+++.
T Consensus 222 ~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00001111223344578899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=287.84 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=201.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|++.++||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999999976543 4567899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999888743 256899999999999999999999887 99999999999999999999999999987754332
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....++..|+|||.+.+..++.++|||+||+++++|++|+.|+........ .+..... ...
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~----------~~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIVQD----------DHP 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhcc----------CCC
Confidence 1 2234688999999999888889999999999999999999998753321100 0000000 001
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112223457789999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=282.59 Aligned_cols=240 Identities=24% Similarity=0.298 Sum_probs=195.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCccc---HHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|..+++||+|.||.|.+++-+ .++.||+|++++..--. ...-..|-++|+..+||.+..+...+...+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999854 58999999998764322 33345688999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||..+|.|..+| .+...+++.....+-.+|+.||.|||+.+ ||.||||.+|.|+|++|++||+||||++.-.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999998777 45667888888889999999999999987 9999999999999999999999999998532
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.....++.+||||.|+|||++....|..++|.|.+||++|||+.|+.||...+.+. +-++ +
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------LFeL---I 380 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------LFEL---I 380 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------HHHH---H
Confidence 22345667899999999999999999999999999999999999999985322211 1111 1
Q ss_pred ccc--CCCHHHHHHHHHHHHhccccCcCCCCC
Q 003092 760 LQN--EVSLPMLVRYINVALLCVQENAEDRPT 789 (848)
Q Consensus 760 l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt 789 (848)
+.. .++.....+...+....|..||.+|..
T Consensus 381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred HhhhccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 111 122223345677888899999999964
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=297.50 Aligned_cols=247 Identities=30% Similarity=0.461 Sum_probs=192.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777889999999999999864 58899999986432 233457889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++ +|.+.+.. ....+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 55555432 2345889999999999999999999987 999999999999999999999999998754322
Q ss_pred ccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
....|++.|+|||++. .+.++.++||||||+++|||++|+.|+........ . .......
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~---~~~~~~~------- 240 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQNE------- 240 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H---HHHHhcc-------
Confidence 2346889999999974 45689999999999999999999998743221100 0 0000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
............+.+++.+||+.+|++||++.++++.+
T Consensus 241 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 241 --SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred --CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 00011112334678899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=298.14 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=192.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~l 598 (848)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999875 588999999864322 2234567899999999999999999998765 56899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++ +|..++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 666655322 246889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cccc--------ccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLG--------HAWSLCK 748 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~--------~~~~~~~ 748 (848)
.... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .... ..|....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 4321 1112345788999999876 4578999999999999999999998853321110 0000 0000000
Q ss_pred cCcccccc--c-ccccc--CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELM--D-PVLQN--EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~--d-~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........ . ..... .........+.+++..|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0 00000 000012345678999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=292.89 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=189.3
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcC-CCceeeeeeeeeeC--CeEEEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ--GEKILIYE 601 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~--~~~~lV~E 601 (848)
|++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 577899999999999999864 58899999987542 222234457899999985 99999999999987 89999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++ +|...+.. ....+++..+..++.||+.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 66555532 2346899999999999999999999987 999999999999999 999999999998764332
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc-----------cccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS-----------LCKN 749 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 749 (848)
. .....++..|+|||++.. +.++.++|||||||++|||++|+.|+...+... ....... ....
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcc
Confidence 1 122457899999998754 557899999999999999999999985433211 0000000 0000
Q ss_pred Cccccccccccc-c---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 DRAHELMDPVLQ-N---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ~~~~~~~d~~l~-~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+... . .........+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 0 001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=324.09 Aligned_cols=264 Identities=30% Similarity=0.438 Sum_probs=208.2
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecC--------CceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeee
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~ 590 (848)
+...++..+.+.||+|.||.|++|.... ...||||.++... ....+.+..|+++|+.+ +||||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3444566777899999999999997431 3479999998653 34567899999999999 699999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCCC------c-----c--cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 591 IEQGEKILIYEYMVNKSLDVFLFDPT------K-----K--HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 591 ~~~~~~~lV~Ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
...+..++|+||+..|+|..+|.... . . ..+...+.+.++.|||.|++||++.. +|||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999986544 0 0 24888999999999999999999986 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeee-eccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCC
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRI-VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTD 735 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~ 735 (848)
||+.++..+||+|||+|+.............. .-...|||||.+....|+.|+|||||||+||||+| |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999977655544322111 13456999999999999999999999999999999 77776431100
Q ss_pred ccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 736 SFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+ .+.+.+-.+-..+..+..++.++++.||+.+|++||++.++++.++..+
T Consensus 529 -~~l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 -EEL-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -HHH-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 000 1111111111223334567889999999999999999999999998854
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=295.79 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=190.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------- 594 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------- 594 (848)
++|++.++||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57999999999999999999865 58899999886432 222345678999999999999999999987654
Q ss_pred -eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 55555532 2235789999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccc--cceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cccccccccc--
Q 003092 674 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLC-- 747 (848)
Q Consensus 674 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~-- 747 (848)
+......... .......++..|+|||.+.+.. ++.++||||||+++|||++|..|+........ ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9876433211 1112345788999999887654 68899999999999999999988754322100 0000000000
Q ss_pred ---ccCcccccccc---------ccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 ---KNDRAHELMDP---------VLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ---~~~~~~~~~d~---------~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+. ..... ........+.+++..||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 00000 00001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=301.72 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=195.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~ 596 (848)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999865 58999999987542 2345677889999999999999999988753 3568
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 57777663 2344899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcccc--ceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cc----ccc----cc
Q 003092 677 FGGDELQG--NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NL----LGH----AW 744 (848)
Q Consensus 677 ~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~----~~~----~~ 744 (848)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... .. .+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 64332111 1123478899999999866 4588999999999999999999999854321100 00 000 00
Q ss_pred cccccCcccccccccc-ccCC-----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKNDRAHELMDPVL-QNEV-----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....+...+.++..- .... ......++.+++..||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000111111000 0001 0113457889999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=306.28 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=189.7
Q ss_pred eeeeecccCCccEEEEEec-CCceEEEEEec--c--cCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe--EEEEEE
Q 003092 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS--N--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE--KILIYE 601 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~--~--~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~--~~lV~E 601 (848)
..++||+|+|-+||+|.+. +|-+||--.++ . +++...++|..|+++|+.|+|||||+++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3469999999999999864 47777743322 1 234556899999999999999999999999987664 789999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~ 680 (848)
.+..|+|..++. +.+.++.....++++||++||.|||++. ++|||||||-+||+|+. -|.|||+|+|||+.....
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999984 3445777888999999999999999986 58999999999999975 589999999999987543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ...+.|||.|||||+.. ..|++.+||||||+.|+||+|+.-|+..-..... .+.....+...+-+.
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~SGiKP~sl~--- 266 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTSGIKPAALS--- 266 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHcCCCHHHhh---
Confidence 3 33478999999999776 7899999999999999999999998753322111 011111111111111
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.. .++.+++..|+.. .++|||+.|+++
T Consensus 267 --kV~d---Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 --KVKD---PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --ccCC---HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1112 2567889999998 999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=295.83 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=190.5
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.++...+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555555555544 6899999998754 3445678999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc----
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---- 682 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~---- 682 (848)
+|..++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9988885432 235788889999999999999999987 99999999999999999999999999875532211
Q ss_pred -ccceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc----ccccccC-----
Q 003092 683 -QGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA----WSLCKND----- 750 (848)
Q Consensus 683 -~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~----- 750 (848)
........++..|+|||++... .++.++||||||+++|||++|+.||........ ..... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhh
Confidence 1112234578899999998763 578999999999999999999999864321110 00000 0000000
Q ss_pred --cccc----cccccc----ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 --RAHE----LMDPVL----QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 --~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... ..++.. ..........++.+++..||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000100 11122234557889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=291.18 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=189.7
Q ss_pred ecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||+||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 58899999986432 22345567899999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
..++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 888754322 36889999999999999999999987 9999999999999999999999999998654321 1223
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
..++..|+|||++.+..++.++||||||+++++|++|+.|+.......... . ....... .....+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~---------~~~~~~~-~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E---------LKRRTLE-MAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H---------HHhcccc-ccccCCccC
Confidence 457889999999998889999999999999999999999985433211000 0 0000000 000111223
Q ss_pred HHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 769 LVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
...+.+++..||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44678999999999999999 5555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=302.41 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=194.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----Ce
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~ 595 (848)
.++|.+.+.||+|+||+||+++.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357999999999999999999864 5889999998653 233456678899999999999999999987644 35
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 56666653 2346889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccccc--------ccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGH--------AWS 745 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~--------~~~ 745 (848)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+... ...... .+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764332 11223467889999998875 468999999999999999999999985332100 000000 000
Q ss_pred ccccCccccccc-------cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 746 LCKNDRAHELMD-------PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 746 ~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..........+. +... ........++.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000 0000 0011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=294.89 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=193.6
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~---- 594 (848)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999975 48899999986542 233456788999999999999999999987654
Q ss_pred ------eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 595 ------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 595 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 44444422 2346889999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+|||++......... ......++..|+|||.+.+. .++.++|||||||+++||++|+.|+....... .........
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHh
Confidence 999999876543211 11123467889999988654 56899999999999999999999885322110 000000000
Q ss_pred ccC---ccccc--------cc------cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KND---RAHEL--------MD------PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~---~~~~~--------~d------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ....+ .+ ...... .......+.+++..||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000 00 000000 0012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=294.38 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=194.1
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCccc
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986555555677899999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeee
Q 003092 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (848)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (848)
+++. ...+++.....++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8763 234788999999999999999999987 99999999999999999999999999876543221 12335
Q ss_pred eccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHH
Q 003092 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPML 769 (848)
Q Consensus 690 ~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 769 (848)
.|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ...+.+.+.. .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~---------~~~~~~~~~~--~~~~~ 243 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMI---------RDNLPPKLKN--LHKVS 243 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---------HhhCCcccCC--cccCC
Confidence 68899999999988889999999999999999999999975322110 00000 0000011100 01123
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 770 VRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 770 ~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35778899999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=287.39 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=188.3
Q ss_pred HHHhcCcceeeee--cccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 521 TAATENFSIQSKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 521 ~~~~~~f~i~~~L--G~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
....++|++.+.+ |+|+||.||++... +++.+|+|.+....... .|+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344677777776 99999999999864 57889999986532211 123222223 799999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-Cceeecccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMAR 675 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~ 675 (848)
++||||+++++|..++.. ...+++..+..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999888843 237899999999999999999999987 99999999999999998 99999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... ...++..|+|||++.+..++.++||||||+++|||++|+.|+................
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 222 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR---------- 222 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh----------
Confidence 654322 2468899999999999999999999999999999999999986332221111110000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCC-HHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-MSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 795 (848)
..... .........+.+++..||+.+|++||+ +.|+++
T Consensus 223 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 QQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 011123446889999999999999996 588764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=301.78 Aligned_cols=264 Identities=26% Similarity=0.334 Sum_probs=194.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC--CeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ--GEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~--~~~~ 597 (848)
.++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 468999999999999999999875 5789999988542 233455678899999999 999999999998653 3689
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++ +|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999974 77666632 26788889999999999999999987 999999999999999999999999999876
Q ss_pred CCCccc---cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc--------
Q 003092 678 GGDELQ---GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS-------- 745 (848)
Q Consensus 678 ~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-------- 745 (848)
...... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.|+........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Confidence 543321 12233568999999998765 4578999999999999999999999854322110 0000000
Q ss_pred --ccccCcccccccccccc------CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 746 --LCKNDRAHELMDPVLQN------EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 746 --~~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..........++..... .........+.+++..||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000011100000 0001134568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=290.90 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=198.3
Q ss_pred CcceeeeecccCCccEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
+|++.+.||+|++|.||+++.. +++.||||.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999743 46789999986432 23346688999999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|..++.. ...+++..+..++.|++++|+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999887742 345788899999999999999999887 99999999999999999999999999887
Q ss_pred cCCCccccceeeeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
+..... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+...+.... ...... .
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~---------~ 223 (288)
T cd05583 155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISR---------R 223 (288)
T ss_pred cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHH---------H
Confidence 643321 1122346899999999987765 78899999999999999999999753221100 000000 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.... ....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 224 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0000 0011122234678899999999999999999998877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=287.64 Aligned_cols=245 Identities=22% Similarity=0.266 Sum_probs=188.4
Q ss_pred eeecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHH-HHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l-~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 588999999865421 2223345555544 445899999999999999999999999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
++|..++.. ...+++..+..++.||++||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999988842 345789999999999999999999987 99999999999999999999999999876432
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....+++.|+|||.+.+..++.++||||||+++|||++|..|+........ . ........ .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~~~------~~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--F----DNILSRRI------NWPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--H----HHHHhccc------CCCCccc
Confidence 2234688999999999988899999999999999999999999854322110 0 00000000 0000111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
......+.+++.+||+.+|++||++.++.++|+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1234568899999999999999988777666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=294.20 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=191.5
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.+.||+|+||.||+|.... ++.||||+++... .....++..|+.++.+.. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678899999999999999999865 8899999987543 233456677887777774 999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++ ++..++.. ....+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99864 55554422 1236889999999999999999999742 3999999999999999999999999999866432
Q ss_pred ccccceeeeeccccccChhhhhcCC----CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+........ ... ...... .
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~---~~~~~~-~---- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLT---KILQEE-P---- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHH---HHhcCC-C----
Confidence 211 1235788999999987554 78899999999999999999999854222110 000 000000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
+... .......++.+++.+||+.+|++||++.++++.
T Consensus 237 -~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001134468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=291.94 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=196.3
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
|++.+.||+|++|.||++... +++.+|+|++..... .....+.+|++++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999865 588999999875432 24567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++ +|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 86 666666332 246889999999999999999999987 9999999999999999999999999998775443
Q ss_pred cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc--ccCccccccc---
Q 003092 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC--KNDRAHELMD--- 757 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~d--- 757 (848)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...+.... +........ .........+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhh
Confidence 111224578899999998876 789999999999999999999988754332110 000000000 0000000000
Q ss_pred ---ccc-------ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 ---PVL-------QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ---~~l-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ..........++.+++..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111224567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=287.62 Aligned_cols=261 Identities=24% Similarity=0.342 Sum_probs=191.7
Q ss_pred cceeeeecccCCccEEEEEecC-CceEEEEEecccCc--ccHHHHHHHHHHHHHc---CCCceeeeeeeeeeCCe-----
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGE----- 595 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~~~~~----- 595 (848)
|++.+.||+|+||.||+|+... ++.||+|++..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6778999999999999999764 88999999974322 2234566788877766 59999999999988776
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.+++|||+.+ +|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 676666432 2235889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccccc-----cccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAW-----SLCK 748 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~-----~~~~ 748 (848)
....... .....++..|+|||++.+..++.++||||||+++|||++|..|+........ ....... ....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 7643321 1223578899999999999999999999999999999999888754322110 0000000 0000
Q ss_pred cC-ccccccccccc---cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 ND-RAHELMDPVLQ---NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~-~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ........... ..........+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000000 0111123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=290.81 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=200.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999875 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999888843 336899999999999999999999987 99999999999999999999999999987654
Q ss_pred Cccc------------------cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 680 DELQ------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 680 ~~~~------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
.... .......++..|+|||++....++.++||||||++++++++|+.|+....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HHH
Confidence 3321 22233467899999999998889999999999999999999999976433110 000
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCH----HHHHH
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTM----SDVVS 795 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 795 (848)
. ..+ .....+......+.+++..||+.+|++||++ .++++
T Consensus 233 ~------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 K------------ILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H------------HHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 000 0011112224568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.48 Aligned_cols=241 Identities=25% Similarity=0.321 Sum_probs=184.7
Q ss_pred eecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHH---HHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMML---IAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~---l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
.||+|+||.||++... .++.||+|.+..... .....+..|..+ ++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 478999999865421 122234444443 444579999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999988773 3346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred ceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.|+............. ....... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~----~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------MTLTMAV----E 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---------HhhccCC----C
Confidence 2234689999999998754 68999999999999999999999986432111000000 0000011 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.+.....++.+++..|++.+|++|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1112245788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=293.15 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=191.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
.++|++.++||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 588999998864322 22346788999999999999999999875433
Q ss_pred --eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 595 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
..++|+||+.. ++...+.. ....+++..+..++.||++||+|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999976 44444422 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCcccc---------ceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cc-c
Q 003092 673 MARMFGGDELQG---------NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NL-L 740 (848)
Q Consensus 673 la~~~~~~~~~~---------~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~-~ 740 (848)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+........ .. .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998664332111 11234678899999988754 578999999999999999999998754322110 00 0
Q ss_pred c-------ccccccccC------ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 741 G-------HAWSLCKND------RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 741 ~-------~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+..+... .......+.+... .......+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 000000000 0000000000000 0112246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=293.23 Aligned_cols=246 Identities=33% Similarity=0.472 Sum_probs=191.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45777789999999999999865 5788999998642 2234567889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+. +++...+.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 466555532 2345788999999999999999999987 999999999999999999999999998765322
Q ss_pred ccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+........ . ....... .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~------~ 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQNE------S 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--H---HHHhhcC------C
Confidence 2346889999999985 35678899999999999999999998743321110 0 0000000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
+. .........+.+++.+||+.+|++||++.++++.
T Consensus 232 ~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00 0111233467889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=290.10 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=193.2
Q ss_pred CcceeeeecccCCccEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
+|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999863 57899999987532 22346788999999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999888743 345788889999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
....... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+....... ....... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~---------~ 223 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISR---------R 223 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHH---------H
Confidence 6433211 22235689999999998753 46789999999999999999999975322110 0000000 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.... ....+......+.+++..||+.+|++|| ++.++++
T Consensus 224 ~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 0011122334678899999999999997 5666544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=275.60 Aligned_cols=202 Identities=27% Similarity=0.424 Sum_probs=167.1
Q ss_pred cCcceeeeecccCCccEEEEEecC-----CceEEEEEecccCcc-c-HHHHHHHHHHHHHcCCCceeeeeeeeee-CCeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-G-LKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~-~-~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~~ 596 (848)
..|++..+||+|.||.||++.-.+ .+++|||+++..... + -....+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568889999999999999995332 347999999755321 2 2456789999999999999999999987 7899
Q ss_pred EEEEEeccCCccccccc--CCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC----CCceeec
Q 003092 597 ILIYEYMVNKSLDVFLF--DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISD 670 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~D 670 (848)
++++||.+...+ .+++ ...+.+.++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999998544 4442 2344568999999999999999999999874 9999999999999887 8999999
Q ss_pred cccccccCCCccc-cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCC
Q 003092 671 FGMARMFGGDELQ-GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTG 730 (848)
Q Consensus 671 FGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~ 730 (848)
||+++.+.+.-.. .....++-|..|.|||.+.+. .|+.+.|||+.||++.||++-++-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999998665322 134457789999999999875 58999999999999999999887664
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=289.19 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=192.6
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEEec
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
|++.+.||+|++|+||+|... .++.||||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 577899999999999999975 478899999865432 22334567999999999 999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
+++|...+.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778877664322 346799999999999999999999987 99999999999999999999999999986643221
Q ss_pred cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-----ccccc-ccccc-cCccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-----LLGHA-WSLCK-NDRAHEL 755 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-----~~~~~-~~~~~-~~~~~~~ 755 (848)
.....++..|+|||++.. ..++.++||||||++++||++|+.|+......... ..... ...+. .......
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122457889999998754 45789999999999999999999887543221100 00000 00000 0000000
Q ss_pred ccccccc-------CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQN-------EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
++..+.. ........++.+++..||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.06 Aligned_cols=243 Identities=30% Similarity=0.447 Sum_probs=188.9
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
|...++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 58899999986432 23346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+.+ ++..++.. ....+++..+..++.||+.+|+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 965 55554432 2345889999999999999999999987 99999999999999999999999999864322
Q ss_pred ccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.....|+..|+|||++. ...++.++||||||+++|||++|..|+........ ........ ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~~----- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQND-SPT----- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC-CCC-----
Confidence 22356889999999984 45688999999999999999999998743321110 00000000 000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++.+||+.+|++||++.+++.
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112235788999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=298.13 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=198.1
Q ss_pred CcceeeeecccCCccEEEEEecC-CceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----eEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-----~~~ 597 (848)
+|++.+.||+|++|.||+|+... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999998754 8899999987643 344577899999999999999999999988775 789
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++ +|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999985 67666632 337889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccc-cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cc-ccc-------cccc
Q 003092 678 GGDELQ-GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NL-LGH-------AWSL 746 (848)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~-~~~-------~~~~ 746 (848)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .. ... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 543210 112234678899999999887 789999999999999999999999854432110 00 000 0000
Q ss_pred cccCccccccccccc-c-----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 CKNDRAHELMDPVLQ-N-----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+..... . .........+.+++..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000000000 0 001113456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=298.37 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=191.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC----------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ---------- 593 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~---------- 593 (848)
.+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999865 5889999998766666677889999999999999999999776543
Q ss_pred ----CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCcee
Q 003092 594 ----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKI 668 (848)
Q Consensus 594 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl 668 (848)
...++||||+++ +|..++. ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 357899999974 7766552 235788999999999999999999987 999999999999974 567899
Q ss_pred eccccccccCCCccc-cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 669 SDFGMARMFGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 669 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 999999865432111 11122357889999998765 5578999999999999999999999854321110 00000000
Q ss_pred c--ccCccc-------cccc-cccccCC-----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 C--KNDRAH-------ELMD-PVLQNEV-----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~--~~~~~~-------~~~d-~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ...... ..+. ....... ......++.+++..||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 000000 0000 0000000 0112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.41 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=189.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------C
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~ 594 (848)
.++|.+.+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999864 5899999998653 222345688999999999999999999998654 3
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 56899999864 444433 235788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc--c-----
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS--L----- 746 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--~----- 746 (848)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+... .+...... .
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 765322 123467889999999876 468899999999999999999999986432110 00000000 0
Q ss_pred ---cccCccccccc--ccc-ccCC---CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ---CKNDRAHELMD--PVL-QNEV---SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ---~~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........... +.. .... .+.....+.+++..||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 000 0000 0112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=270.76 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=192.5
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++.+.+..||.|..|+|++.+... |...|||.+.... .+..+++...+.++.+- +.|.||+.+|+|..+...++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344556789999999999999764 7899999997654 44566777777776665 48999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
.|.. -++.++. ..++.+++..+-++...+.+||.||.+++ .|||||+||+|||+|+.|++||+|||++-.+.+..
T Consensus 172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8743 2333332 23456888888899999999999999876 79999999999999999999999999997765432
Q ss_pred cccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
...+..|-+.|||||-+.. ..|+.++||||||++++||.||.-|+...+.+...+ ..+ ..+ .-|
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-tkv---ln~------ePP 313 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-TKV---LNE------EPP 313 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-HHH---Hhc------CCC
Confidence 2233579999999999864 358899999999999999999999987655443211 111 000 112
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+... ....+.+++..||++|+.+||...++++
T Consensus 314 ~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222111 3446888999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.40 Aligned_cols=264 Identities=24% Similarity=0.303 Sum_probs=193.9
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ- 593 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~- 593 (848)
.++...+++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556778999999999999999999985 468899999986532 22346688899999999999999999988643
Q ss_pred -----CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 594 -----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 594 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
...+++++++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467788876 677776653 235789999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccc--c
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAW--S 745 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--~ 745 (848)
+|||+++..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+...+... .+..... .
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 235 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 999999865322 223468899999999876 567899999999999999999999975332111 0000000 0
Q ss_pred c--------cccCccccc---ccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 L--------CKNDRAHEL---MDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~--------~~~~~~~~~---~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ......... +...... ........++.+++..|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 000000000 0000000 000012346789999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.00 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=192.9
Q ss_pred CcceeeeecccCCccEEEEEecC-CceEEEEEeccc-----CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998654 455666665432 122334567899999999999999999999999999999
Q ss_pred EEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|||+++++|..++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998877532 23456899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+...... ... . .....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~---~---------~~~~~ 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVV---L---------RIVEG 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH---H---------HHHcC
Confidence 3321 122346888999999998888899999999999999999999987422110 000 0 00000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....+.....++.+++.+||+.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 001112234457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=295.78 Aligned_cols=258 Identities=23% Similarity=0.310 Sum_probs=192.3
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-----
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----- 594 (848)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4578999999999999999999854 58899999986432 223456889999999999999999999887543
Q ss_pred -eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 468999998 667776663 245889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc---------
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA--------- 743 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~--------- 743 (848)
+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+........ +....
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHH
Confidence 9865432 223467899999999876 4578999999999999999999999864321100 00000
Q ss_pred -ccccccCcccccc-------ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 -WSLCKNDRAHELM-------DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 -~~~~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............. ...+. .........+.+++.+|++.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 00000 001112335789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=277.69 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=212.5
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEecC------CceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeee
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~ 589 (848)
..++.....++++...+-+|.||.||.|.+.+ .+.|-+|.++.. +.-....+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45566667789999999999999999996543 456778877654 33456778899999999999999999999
Q ss_pred eeeCC-eEEEEEEeccCCccccccc-----CCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC
Q 003092 590 CIEQG-EKILIYEYMVNKSLDVFLF-----DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (848)
Q Consensus 590 ~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~ 663 (848)
+.++. ..+++|.++.-|+|..+|. +......+...+...++.|++.|++|||.++ +||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 98754 6688899999999999997 5555566777888899999999999999987 9999999999999999
Q ss_pred CCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCc-ccccc
Q 003092 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDS-FNLLG 741 (848)
Q Consensus 664 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~-~~~~~ 741 (848)
.++||+|=.+++.+-..++......--....||+||.+....|+.++|||||||+||||+| |+.|+...++.+ ..++.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999998766665544443445679999999999999999999999999999999 888865433221 11111
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.-.+-.-+..++.++..++.-||...|++||+++|++.-|.+
T Consensus 513 ----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 513 ----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111112233466789999999999999999999999998865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.45 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=195.4
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566789999999999999875 48999999987653 334567889999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++ +|..++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 84 7888774321 46889999999999999999999987 99999999999999999999999999987643321
Q ss_pred cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccc-------ccccccccCc-c
Q 003092 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLG-------HAWSLCKNDR-A 752 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~~~-~ 752 (848)
......++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .+.. ..|....... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223467789999998876 789999999999999999999888754321100 0000 0000000000 0
Q ss_pred cccccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......... .........+.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 001112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=293.11 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=191.9
Q ss_pred cCcc-eeeeecccCCccEEEEEec-CCceEEEEEecccCccc--------------HHHHHHHHHHHHHcCCCceeeeee
Q 003092 525 ENFS-IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLLG 588 (848)
Q Consensus 525 ~~f~-i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l~Hpniv~l~~ 588 (848)
++|. +.+.||+|+||+||+|... .++.||||++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999865 58899999986432211 125778999999999999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 589 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
++..++..++||||+. ++|..++. ....+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 57777663 3345889999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCcc------------ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCC
Q 003092 669 SDFGMARMFGGDEL------------QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735 (848)
Q Consensus 669 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~ 735 (848)
+|||++........ ........+++.|+|||++.+. .++.++||||||+++|||++|+.|+...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987652111 0111123468899999998764 4689999999999999999999998644321
Q ss_pred ccccccccccccc---cC--------cccccccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 736 SFNLLGHAWSLCK---ND--------RAHELMDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 736 ~~~~~~~~~~~~~---~~--------~~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .......... .. ............ ........++.+++..||+.+|++||++.|++.
T Consensus 241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 0000000000 00 000000000000 001112346789999999999999999999986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=292.87 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=189.4
Q ss_pred CcceeeeecccCCccEEEEEec-C--CceEEEEEecccC--cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC----Ce
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-N--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ----GE 595 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~--~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~----~~ 595 (848)
+|++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999865 3 6789999986532 22356788899999999 599999999876433 45
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++++||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788889886 56766663 3346889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc--cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccc-------cc
Q 003092 676 MFGGDELQ--GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLG-------HA 743 (848)
Q Consensus 676 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~-------~~ 743 (848)
.+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+...+.... . ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76433211 11223568999999998876 4689999999999999999999998764331100 0 000 00
Q ss_pred ccccccCccccccc-------cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 WSLCKNDRAHELMD-------PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 ~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.............. ..+. .........+.+++.+|++.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0000 000112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=292.35 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=193.1
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee-CCeEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKI 597 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~~~ 597 (848)
..+++|++.++||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45688999999999999999999865 6889999988643 22345678899999999999999999999876 55788
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|+||+. ++|..++. ...+++.....++.|+++||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 87 lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELLG-TDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehhc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999984 57766663 235678888899999999999999987 999999999999999999999999999754
Q ss_pred CCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-----ccccc----ccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-----NLLGH----AWSLC 747 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-----~~~~~----~~~~~ 747 (848)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ..... .....
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 122457889999998766 5689999999999999999999998854321000 00000 00000
Q ss_pred ccCccccccccc-cccCCCH-----HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAHELMDPV-LQNEVSL-----PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+++... .....+. .....+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000010000 0001111 12357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=286.58 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=193.5
Q ss_pred eeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
.++||+|.||+||-|+++ +|+.||||++.+.. .+....+.+|+.+|+.+.||.||.+--.|+..+..++|||.+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 389999999999999875 59999999997653 345578999999999999999999999999999999999999765
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccccccCCCccc
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~ 683 (848)
-|+-+| ...+..+++.....++.||+.||.|||.++ |+|+||||+|||+.. ..++||+|||+|+.++....
T Consensus 649 MLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555545 234567888888899999999999999987 999999999999954 45699999999999976543
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
...++|||.|+|||+++.+.|+..-|+||.||++|--++|..||....+-..++... .++ ...
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-----------aFM----yPp 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-----------AFM----YPP 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-----------ccc----cCC
Confidence 345789999999999999999999999999999999999999986432211111110 111 111
Q ss_pred CCH-HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSL-PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+. +.....++++...||..=++|-+....+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111 12335678888888888888888776643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=272.48 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=197.9
Q ss_pred eeecccCCccEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
+.||+|+|+.|-.+. +.++++||||++.+.......+..+|++++...+ |+||+.|+++|+++...|||||.|.+|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999986 6689999999999887777889999999999995 99999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeeccccccccCCC-----
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMFGGD----- 680 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~----- 680 (848)
-.++ .+.+.+++.++.+++++|+.||.+||.++ |.||||||+|||..+..+ +||+||.|+.-+...
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 7777 35567889999999999999999999998 999999999999977665 799999987644211
Q ss_pred ccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc--cc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR--AH 753 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 753 (848)
.......+.+|+..|||||+.. ...|+.++|.|||||+||-|++|-+||...=.... .|.--+.-+ ..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-----GWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-----GWDRGEVCRVCQN 312 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-----CccCCCccHHHHH
Confidence 1112223467999999999874 23578999999999999999999999854322110 111111000 11
Q ss_pred cccccccccCCCHH------HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLP------MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.++..+..+.+..| ...+..+++...+..++.+|.++.+++.
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23333333333322 3445678888888999999999988875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=310.21 Aligned_cols=257 Identities=23% Similarity=0.258 Sum_probs=201.8
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEecC-CceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
...+....++|.+.++||+|+||.|..++++. ++.||+|++++. ......-|..|-.+|..-+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34555667899999999999999999999764 789999999863 23445678999999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
..++|+|||||+||+|-.++.. ...+++..+..++.+|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999888743 236899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhh----c-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL----E-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~----~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
.+-.+..+.. ......+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||....- ...
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veT----- 289 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VET----- 289 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHH-----
Confidence 9987764332 2334468999999999986 3 6789999999999999999999999853211 000
Q ss_pred ccCcccccccc--ccccCCCHHHHHHHHHHHHhccccCcCCCCC---HHHHHH
Q 003092 748 KNDRAHELMDP--VLQNEVSLPMLVRYINVALLCVQENAEDRPT---MSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~--~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 795 (848)
...+++. .+.-+.....+++..+++...+. +|+.|.. +.++..
T Consensus 290 ----Y~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 290 ----YGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ----HHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 0111111 11101111234566777776554 8899988 777654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.27 Aligned_cols=259 Identities=25% Similarity=0.332 Sum_probs=193.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe-----
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~----- 595 (848)
.++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 578999999999999999999875 4789999998643 22334667889999999999999999998876554
Q ss_pred -EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 596 -KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 596 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 4577776632 45889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccccc-------c
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLGHA-------W 744 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~~~-------~ 744 (848)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ . +.... .
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 865432 2234678899999998753 678999999999999999999999853321100 0 00000 0
Q ss_pred cccccCcccccccccccc-C-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKNDRAHELMDPVLQN-E-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...........+...... . .......++.+++..|++.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000000 0 00112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=312.26 Aligned_cols=145 Identities=29% Similarity=0.448 Sum_probs=129.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|... .++.||||++.... ......+..|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999876 58899999987542 223467889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
||+.+++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999888743 335788889999999999999999986 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=292.30 Aligned_cols=239 Identities=22% Similarity=0.269 Sum_probs=194.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++.|.+...+|.|+|+.|-.+... .++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 678888999999999999999864 58899999997652 2234577666666 79999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe-ccCCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~ 680 (848)
++.++-+.+-+. ...... ..+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999987655442 222222 677789999999999999987 9999999999999 69999999999999877554
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
..+.+-|..|.|||++....|++++|+||||++||+|++|+.|+...+.+ .+++..+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei~~~i~ 527 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEIHTRIQ 527 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHHHHhhc
Confidence 22346788999999999999999999999999999999999998644332 12222222
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.++...+....+++.+|||.||.+||+|.++..
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 33344445667889999999999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.48 Aligned_cols=236 Identities=25% Similarity=0.321 Sum_probs=190.3
Q ss_pred ecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999875432 2456789999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceee
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 688 (848)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 888743 235889999999999999999999976 9999999999999999999999999998764432 12233
Q ss_pred eeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 689 ~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
..++..|+|||...+...+.++|+||||+++|||++|+.|+...+... ... ..... ....+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~------------~~~~~--~~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYE------------KILKD--PLRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH------------HHhcC--CCCCCCCC
Confidence 568889999999998888999999999999999999999985332210 000 00000 00111122
Q ss_pred HHHHHHHHHhccccCcCCCCCHHH
Q 003092 769 LVRYINVALLCVQENAEDRPTMSD 792 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~e 792 (848)
...+.+++..||+.||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 457789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=292.14 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=208.2
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeee-
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE- 592 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~- 592 (848)
.+..+...++.|++.++||+|.+|.||+++. ++++.+|+|++... ....++++.|.++++.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3444455678899999999999999999985 46888999988654 33456778899999988 69999999999874
Q ss_pred ----CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 593 ----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 593 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
+++++||||||.+|+.-+++.... ...+.|..+..|+++++.|+++||.+. ++|||||-.|||++.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 569999999999999988886554 667899999999999999999999886 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 743 (848)
.|||++..+... ..+..+..|||.|||||++.. ..|+.++|+||||++..||.-|.+|+-..+.-.. .
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----L 237 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L 237 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----h
Confidence 999999877543 234455789999999999863 3477899999999999999999999643322110 0
Q ss_pred ccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....++. ...++ -+..-..++.+++..||..|-++||++.++++
T Consensus 238 F~IpRNP-PPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 FLIPRNP-PPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCCCCC-Ccccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111 11111 13345678999999999999999999999875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=272.29 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=193.1
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+.+-+..||.|+||+|+|-.++ .|+..|||+++.... .+.+++..|.+...+- +.||||+++|.+..++..++-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999875 589999999986543 5667888888876555 789999999999999999999999
Q ss_pred ccCCcccccccC--CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 603 MVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 603 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|.- ||+.+-.. ..++..++++..-.|..-..+||.||.... +|||||+||+||||+..|.+||+|||++-.+.+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 954 55443211 134456888888888888999999998764 6999999999999999999999999999766433
Q ss_pred ccccceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
. ..+.-.|-..|||||-+.. ..|+.++||||||++|||+.||+.|+...+.-..++ ......+. ..+.
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql----~~Vv~gdp-p~l~-- 291 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL----CQVVIGDP-PILL-- 291 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH----HHHHcCCC-Ceec--
Confidence 2 1223468889999999863 348999999999999999999999976554321111 11111111 1111
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
...........+..++..|+.+|..+||...++.++
T Consensus 292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111112345578889999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=270.05 Aligned_cols=220 Identities=18% Similarity=0.116 Sum_probs=174.8
Q ss_pred cCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccccccC
Q 003092 536 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (848)
Q Consensus 536 G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 614 (848)
|.+|.||+++.. +++.||+|++.... .+..|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999865 58899999987542 234555666667899999999999999999999999999999887743
Q ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeecccc
Q 003092 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (848)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (848)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 234889999999999999999999987 9999999999999999999999999887654321 12346778
Q ss_pred ccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHH
Q 003092 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYIN 774 (848)
Q Consensus 695 y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 774 (848)
|+|||.+.+..++.++||||+|+++|||++|+.|+........ ..... ..+......+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~~~----~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THTTL----NIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccccc----CCcccCCHHHHH
Confidence 9999999888899999999999999999999987543221100 00000 011112346788
Q ss_pred HHHhccccCcCCCCCHH
Q 003092 775 VALLCVQENAEDRPTMS 791 (848)
Q Consensus 775 l~~~cl~~dP~~RPt~~ 791 (848)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=273.34 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=194.8
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc-C-cc-----cHHHHHHHHHHHHHcCCCceeeeeeeeeeC-Ce
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-S-GQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~-~-~~-----~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-~~ 595 (848)
++|-++..||+|||+.||++.+ ...+.||||+-... + .. -.+...+|..+-+.|+||.||++++++.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5688889999999999999974 45778999975422 1 11 123356799999999999999999999754 57
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec---cCCCceeeccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFG 672 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFG 672 (848)
.+-|+|||++.+|+.+| ...+.+++.++..|+.||+.||.||.+.. ++|||=||||.||||- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 78999999999999999 45567899999999999999999999874 6899999999999994 45789999999
Q ss_pred cccccCCCcccc-----ceeeeeccccccChhhhhcC----CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc
Q 003092 673 MARMFGGDELQG-----NTKRIVGTYGYMSPEYALEG----VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 673 la~~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~----~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 743 (848)
|++.+..+.+.. .+....||..|++||.+.-+ ..+.|+||||.||++|..+.|+.||+-.... ..++...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-QdILqeN 697 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-QDILQEN 697 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-HHHHhhh
Confidence 999987654432 24456799999999987643 3688999999999999999999999743321 1111110
Q ss_pred ccccccCcccccccc-ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 744 WSLCKNDRAHELMDP-VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
.++.. ...-+..+....+...++++||++..++|....++.
T Consensus 698 ----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 698 ----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 01110 011111122334677899999999999998777654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=273.14 Aligned_cols=240 Identities=25% Similarity=0.330 Sum_probs=192.0
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~l 598 (848)
..+|..+.+||+|+||.|.++.-+. .+.||||++++.. ....+--+.|-++|+.. +-|.++.++.++..-+++++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578889999999999999997654 5679999998652 12233345677788777 46789999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+.+|+|-..++ +-..+.+..+..++.+||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999866663 3445667778889999999999999998 9999999999999999999999999998532
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
-+ ...+.+.+|||.|+|||++...+|+..+|.|||||+||||+.|++||+..+++. ++..
T Consensus 502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------------------lF~a 561 (683)
T KOG0696|consen 502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------------LFQA 561 (683)
T ss_pred cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------------------HHHH
Confidence 22 234567899999999999999999999999999999999999999997655432 1111
Q ss_pred cccc--CCCHHHHHHHHHHHHhccccCcCCCCC
Q 003092 759 VLQN--EVSLPMLVRYINVALLCVQENAEDRPT 789 (848)
Q Consensus 759 ~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt 789 (848)
+... .++...+.+...+....+..+|.+|..
T Consensus 562 I~ehnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2111 233344556778888888999999854
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=260.83 Aligned_cols=246 Identities=22% Similarity=0.248 Sum_probs=192.4
Q ss_pred HhcCccee-eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeee----CCe
Q 003092 523 ATENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGE 595 (848)
Q Consensus 523 ~~~~f~i~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~----~~~ 595 (848)
.+++|++. ++||-|-.|.|-.+..+ .++.+|+|++... ....+|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 68999999999999865 5889999998643 3447788886665 69999999999864 346
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFG 672 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFG 672 (848)
+.+|||.|++|.|..-+.+. ....+.+.++..|++||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999997777543 3446889999999999999999999987 999999999999964 5568999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+|+.... .....+.+-||.|.|||++....|+..+|+||+||++|-|+.|-+||...... .+
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--ai------------- 271 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AI------------- 271 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cC-------------
Confidence 9987543 23344568899999999999999999999999999999999999998432221 11
Q ss_pred ccccccc-cccC--CCH----HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPV-LQNE--VSL----PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~-l~~~--~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..-+... ..+. ++. ..++...++++.+|..+|.+|.|+.++..
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111111 1121 222 23556788999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=263.46 Aligned_cols=237 Identities=28% Similarity=0.353 Sum_probs=190.8
Q ss_pred CCccEEEEEecC-CceEEEEEecccCccc-HHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccccccC
Q 003092 537 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (848)
Q Consensus 537 ~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 614 (848)
+||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+|++++++.+..+...++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999997665444 68899999999999999999999999999999999999999999888743
Q ss_pred CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeecccc
Q 003092 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (848)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (848)
.. .+++..+..++.+++++++|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 22 2788999999999999999999986 9999999999999999999999999998775432 2234568889
Q ss_pred ccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHH-HHHHHH
Q 003092 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLP-MLVRYI 773 (848)
Q Consensus 695 y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~ 773 (848)
|+|||.+....++.++|||+||+++++|++|..|+....... ..... ... .......... ...++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~----~~~--------~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKK----IGK--------PKPPFPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHH----Hhc--------cCCCCccccccCCHHHH
Confidence 999999998889999999999999999999999875421110 00000 000 0000000000 335788
Q ss_pred HHHHhccccCcCCCCCHHHHHH
Q 003092 774 NVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 774 ~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=295.79 Aligned_cols=259 Identities=20% Similarity=0.228 Sum_probs=166.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-----CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeee------ee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CI 591 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~------~~ 591 (848)
..++|++.++||+|+||.||+|++.+ ++.||||++...... +....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 689999988643211 111111 1222223333322221 24
Q ss_pred eCCeEEEEEEeccCCcccccccCCCcc-----------------cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 592 EQGEKILIYEYMVNKSLDVFLFDPTKK-----------------HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 592 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
.+.+.++||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999998877532210 11123345679999999999999987 9999999
Q ss_pred CCcEEecc-CCCceeeccccccccCCCccccceeeeeccccccChhhhhcC----------------------CCCcccc
Q 003092 655 ASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG----------------------VFSVKSD 711 (848)
Q Consensus 655 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~~~ksD 711 (848)
|+|||++. ++.+||+|||+|+.+..... .......+|+.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986643321 122346789999999976432 2345679
Q ss_pred eeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc----cccccccccccC----C--CHHHHHHHHHHHHhccc
Q 003092 712 VFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR----AHELMDPVLQNE----V--SLPMLVRYINVALLCVQ 781 (848)
Q Consensus 712 VwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~l~~l~~~cl~ 781 (848)
||||||+||||+++..+.+.. ...+.. .+...+. ......+..... . .........+++..||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~---~~~~~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN---LIQFNR---QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH---HHHHHH---HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999876653211 000000 0000000 000000000000 0 00011234589999999
Q ss_pred cCcCCCCCHHHHHH
Q 003092 782 ENAEDRPTMSDVVS 795 (848)
Q Consensus 782 ~dP~~RPt~~evl~ 795 (848)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=292.04 Aligned_cols=246 Identities=27% Similarity=0.408 Sum_probs=189.2
Q ss_pred cceeeeecccCCcc-EEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 527 FSIQSKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 527 f~i~~~LG~G~fG~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
|.-.+.+|.|.-|+ ||+|.+ +|++||||++-. +..+...+|+..|+.- +||||||+++.-.++..+|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44457889999887 799998 688999998854 3345567899999998 69999999999999999999999996
Q ss_pred CCcccccccCCCcc-cccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---C--CCceeeccccccccC
Q 003092 605 NKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---H--MNPKISDFGMARMFG 678 (848)
Q Consensus 605 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kl~DFGla~~~~ 678 (848)
. +|++++...... ..........+..|++.||++||+.+ ||||||||+||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 788877542111 11111345678899999999999976 999999999999975 2 568999999999987
Q ss_pred CCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhC-CCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS-KKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.+... .......||-+|+|||++....-+.++||+|+||++|+.++| .+||+..-..+.+++.....+.. +
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~-------L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH-------L 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee-------e
Confidence 65432 234456799999999999999889999999999999999995 89998654444444332221111 1
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+. ... +..+++.+|++.+|..||++.+|+.
T Consensus 736 ~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 EPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 011 6778999999999999999999963
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=274.39 Aligned_cols=207 Identities=23% Similarity=0.340 Sum_probs=174.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..-|..++.||-|+||.|.+++.. ....||+|.+++.+ .......+.|-.||..-+.+=||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 345888899999999999999744 46789999997653 33445678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC-
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG- 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~- 678 (848)
|||+++|++-.+| -+...+++..+..++.++..|+++.|..+ +|||||||+|||||.+|++||.||||+.-+.
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 9999999997777 34567888999999999999999999887 9999999999999999999999999985331
Q ss_pred --CCccc-------------------------------------cceeeeeccccccChhhhhcCCCCcccceeehHHHH
Q 003092 679 --GDELQ-------------------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719 (848)
Q Consensus 679 --~~~~~-------------------------------------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl 719 (848)
+..+. ......+||+.|+|||++....|+..+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 10000 001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCc
Q 003092 720 LEILSSKKNTGVYNTDS 736 (848)
Q Consensus 720 ~elltg~~p~~~~~~~~ 736 (848)
|||+.|+.||.......
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999986544433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=284.16 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=178.5
Q ss_pred HhcCcceeeeecccCCccEEEEEe-----------------cCCceEEEEEecccCcccHHH--------------HHHH
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKE--------------FKNE 571 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~--------------~~~E 571 (848)
..++|++.++||+|+||+||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 234679999986543322233 3447
Q ss_pred HHHHHHcCCCce-----eeeeeeeee--------CCeEEEEEEeccCCcccccccCCC---------------------c
Q 003092 572 MMLIAKLQHRNL-----VRLLGCCIE--------QGEKILIYEYMVNKSLDVFLFDPT---------------------K 617 (848)
Q Consensus 572 i~~l~~l~Hpni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 617 (848)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677777653 357899999999999988875321 1
Q ss_pred ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccC
Q 003092 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697 (848)
Q Consensus 618 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 697 (848)
...+++..+..++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788899999999999999987 99999999999999999999999999976543221 11112345889999
Q ss_pred hhhhhcCC--------------------C--CcccceeehHHHHHHHHhCCC-CCCCCCCCccccc-----ccccccccc
Q 003092 698 PEYALEGV--------------------F--SVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLL-----GHAWSLCKN 749 (848)
Q Consensus 698 PE~~~~~~--------------------~--~~ksDVwSlGvvl~elltg~~-p~~~~~~~~~~~~-----~~~~~~~~~ 749 (848)
||.+.... + ..+.||||+||+++||+++.. |+.........+. ...|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99876432 1 134799999999999999875 4432110000000 000111111
Q ss_pred CccccccccccccCCCHHHHHHHHHHHHhccccCc---CCCCCHHHHHH
Q 003092 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENA---EDRPTMSDVVS 795 (848)
Q Consensus 750 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~ 795 (848)
.. .+- ...........+++..++..+| .+|+|+.|+++
T Consensus 459 ~~----~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK----YDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC----CCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 000 0011123467788888998765 68999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=256.66 Aligned_cols=248 Identities=21% Similarity=0.341 Sum_probs=197.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~l 598 (848)
..+|.++.+||+|+|..|..+++. ..+.||+|++++. ..+.++-...|-.+...- +||.+|.++.++..+.++++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999875 4788999998764 344556667777777666 79999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|.||.++|+|-.++ +++..++++.+..+..+|.-||.|||+.+ ||.||||.+|||||.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999985544 56667899999999999999999999998 9999999999999999999999999998542
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC--CccccccccccccccCcccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT--DSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.+ ...+.+++|||.|.|||++.+..|...+|.|+|||+++||+.|+.||+..+. ...+...+..... +
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi--------l 472 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI--------L 472 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH--------h
Confidence 22 2345678999999999999999999999999999999999999999975431 1111111111111 1
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCC
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 789 (848)
++.+ .++.....+...+...-+.+||.+|..
T Consensus 473 ekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1111 122333445667888899999999854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=237.50 Aligned_cols=195 Identities=26% Similarity=0.424 Sum_probs=161.7
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+|.-.++||+|.||+||+|+.. .++.||+|+++... +..-....+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556689999999999999865 47889999987543 22345678999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
|.. +|..+.. .-...++.+.+..++.|+++||.++|+++ +.||||||+|.||+.+|++|++|||+++.++-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 4444432 23456788899999999999999999987 99999999999999999999999999998764421
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCC
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKN 728 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p 728 (848)
. ....+-|..|.+|.++.+. .|+...|+||-||++.|+....+|
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 1 1223568899999999875 489999999999999999985555
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=263.86 Aligned_cols=268 Identities=21% Similarity=0.258 Sum_probs=198.0
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcC--CCc----eeeeeee
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--HRN----LVRLLGC 589 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--Hpn----iv~l~~~ 589 (848)
+......+.+|.+...+|+|.||.|-++.... +..||||+++.-. .-.+..+-|+++|.++. .|+ +|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 33334457899999999999999999998643 6889999987543 23345577999999993 233 7788888
Q ss_pred eeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--------
Q 003092 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-------- 661 (848)
Q Consensus 590 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-------- 661 (848)
+...++.++|+|.+ +.|+.+++.. .+...++...+..|+.|+++++++||+.. ++|.||||+|||+.
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 99999999999988 4477777743 23456788899999999999999999987 99999999999983
Q ss_pred ------------cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCC
Q 003092 662 ------------QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 662 ------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
+...++|+|||.|+.-.... ..++.|.-|.|||++.+-.++.++||||+||||+|+.+|..-|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 13458999999998654332 4578999999999999999999999999999999999999877
Q ss_pred CCCCC-Ccccccccc--------------ccccccCcc-----------cccccccc----ccCCCHHHHHHHHHHHHhc
Q 003092 730 GVYNT-DSFNLLGHA--------------WSLCKNDRA-----------HELMDPVL----QNEVSLPMLVRYINVALLC 779 (848)
Q Consensus 730 ~~~~~-~~~~~~~~~--------------~~~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l~~~c 779 (848)
...+. +...+.+.. ......+++ ....++.. .-.....+..++++++..|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 65441 111111100 000000000 00000000 0012334666899999999
Q ss_pred cccCcCCCCCHHHHHH
Q 003092 780 VQENAEDRPTMSDVVS 795 (848)
Q Consensus 780 l~~dP~~RPt~~evl~ 795 (848)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=255.07 Aligned_cols=265 Identities=23% Similarity=0.399 Sum_probs=187.6
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEeccc-Cccc-HHHHHHHHHHHHHcCCCceeeeeeeeeeC--------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-SGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-------- 593 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~-~~~~-~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-------- 593 (848)
..|+-..+||+|.||.||+|+..+ ++.||+|+.--. ...+ -....+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345566799999999999998654 778998865322 1222 23457899999999999999999988532
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||++|+. +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999987 45555532 3345778889999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCcccc--ceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCC-cccccc--------
Q 003092 674 ARMFGGDELQG--NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLG-------- 741 (848)
Q Consensus 674 a~~~~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~-~~~~~~-------- 741 (848)
++.+....... .-...+-|..|++||.+.+ ..|+++.|||..||++.||+++.+-+....+. ...+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98775332221 1222356899999999886 46899999999999999999998766433211 111111
Q ss_pred ccccccccCcccccc--ccccccCCC--HH------HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 742 HAWSLCKNDRAHELM--DPVLQNEVS--LP------MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~--d~~l~~~~~--~~------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+|....+-...+.+ .|.-.+... .. ...+..+++..++..||.+|+.+++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 122222221111111 111111100 00 1125678889999999999999998864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=230.15 Aligned_cols=110 Identities=53% Similarity=0.795 Sum_probs=82.7
Q ss_pred CCeeEEeecCCCCCcCC--CceEEEecCCCEEEEcCCCCeEEee-cccCCc-ccceEEEecCCCEEEEcCCCCCCccccc
Q 003092 86 PDTVVWVANRNSPIVDK--NGVLTVSNRGNLVLLNQSNGTIWSS-NVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYL 161 (848)
Q Consensus 86 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~lvl~~~~~~~~W~t-~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~ 161 (848)
++||||+|||+.|+.+. .++|.|+.||+|||+++.++++|++ ++.+.+ ..+.|.|+|+|||||++.+ +++|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEE
Confidence 36999999999999654 4899999999999999999999999 666554 6788999999999999864 4899
Q ss_pred ccccCCCcccccccCccccccccCCcceEEeeCCCCCCC
Q 003092 162 WQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200 (848)
Q Consensus 162 WqSFd~PtDtlLpg~klg~~~~t~~~~~l~Sw~s~~dps 200 (848)
||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888778899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=238.42 Aligned_cols=214 Identities=28% Similarity=0.379 Sum_probs=172.1
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
+....+...-.+.||+|++|.|-+-++. +|+..|+|++... ..+..++...|+.+..+. ..|.+|.++|...+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3444455666789999999999988864 6899999999755 345567778888886665 799999999999999999
Q ss_pred EEEEEeccCCcccccccC-CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 597 ILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
++.||.|.- ||+.+-.+ ..+...+++...-+|+..+..||.|||++- .+||||+||+||||+.+|++||+|||.+-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999954 55554322 245567889999999999999999999964 79999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhc----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALE----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL 739 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~ 739 (848)
.+.+.-. .+...|-..|||||.+.. ..|+.|+||||||++++||.+++.|++...++..++
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 7654321 111357789999998863 368999999999999999999999987665554433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=269.54 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=198.4
Q ss_pred cCcceeeeecccCCccEEEEEecCCc-eEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~-~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++++...||-||||.|=++...... .+|+|++++.. ....+.+..|-.+|...+.|.||+++..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666779999999999999875433 48999887642 334455778999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|-|-+|.|...|. .+..++......++.-+.+|++|||.++ ||.|||||+|.|++.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999998884 3456777788888999999999999987 999999999999999999999999999998654
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. .+-++||||.|.|||++..+..+.++|.||||+++|||++|++||...++-. +++. ..-+|.+
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~i 638 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDKI 638 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhhh
Confidence 3 5667899999999999999999999999999999999999999996544321 1111 0111111
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
.++........++++..+..+|.+|.. ..+|.+
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 112222335678888888999999977 555544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.37 Aligned_cols=195 Identities=25% Similarity=0.359 Sum_probs=167.3
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc--------ccHHHHHHHHHHHHHcC---CCceeeeeeeeee
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIE 592 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~ 592 (848)
.+|...++||+|+||.|+.+.++. ..+|+||.+.+..- ...-..-.||++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999864 67899998876421 11122456999999997 9999999999999
Q ss_pred CCeEEEEEEeccCC-cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 593 QGEKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 593 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
++.+||+||-...| +|.+++ ..+..+++.++.-|++||+-|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999987554 555666 45667899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCC
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~ 729 (848)
|.|.....+. ...++||..|.|||++.+.+| ...-|||++|++||.++..+.|+
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9998775543 445789999999999999998 56789999999999999888775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=246.52 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=186.1
Q ss_pred ceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----CeEEEE
Q 003092 528 SIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEKILI 599 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~~~lV 599 (848)
+-.+.||-|+||.||.++++ +|+.||+|++.+- +-...+++.+|+++|..++|.|++..++...-. .++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999875 5899999998653 223457788999999999999999988876533 366788
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
.|.|.. +|..++ .....++...+.-+.+||++||+|||+.+ |.||||||.|.|++.+..+||+|||+|+..+.
T Consensus 136 TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 888855 555555 23345677777889999999999999987 99999999999999999999999999997655
Q ss_pred CccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCC-Cccccccccc---------cccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNT-DSFNLLGHAW---------SLCK 748 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~~---------~~~~ 748 (848)
++....+ ..+-|..|.|||++++. .|+.+.||||.||++.||+..+.-|...+. ...++..... ..+.
T Consensus 209 d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 4433322 34568899999999975 589999999999999999988776643332 1111111110 0011
Q ss_pred cCcccccc----c---cccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 749 NDRAHELM----D---PVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 749 ~~~~~~~~----d---~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
..+..-+- . +.+... .+...-.+.+++...++..||++|.+..+.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11000000 0 000000 00111224556777888999999999998877553
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=234.81 Aligned_cols=257 Identities=20% Similarity=0.336 Sum_probs=190.4
Q ss_pred hcCcceeeeecccCCccEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCC--eEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG--EKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~--~~~lV 599 (848)
.++|++.+++|+|.++.||.|. ..+.+.++||+++.- ..+.+++|+.+|..|. ||||+++++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999997 456788999999754 3467889999999997 999999999987654 56799
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~~~ 678 (848)
+||+.+.+...+- ..++..++..++.+++.||.|+|+.| |+|||+||.||+||.. ..++|+|+|||....
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999987754432 24566677889999999999999998 9999999999999864 569999999999876
Q ss_pred CCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccC------c
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND------R 751 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~ 751 (848)
...... -.+.+..|--||.+..- .|+..-|+|||||+|..|+..+.||-....+..+++..+.-+...+ .
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 543221 23567789999998764 5789999999999999999999998543333323322221111000 0
Q ss_pred ccccccccccc----------------CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQN----------------EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~----------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..-.+++.+.+ ....-...+.++++...|..|.++|||++|...
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00011221111 111112346788888999999999999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.09 Aligned_cols=210 Identities=37% Similarity=0.598 Sum_probs=182.4
Q ss_pred ecccCCccEEEEEecC-CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccc
Q 003092 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 610 (848)
||+|.+|.||++.... ++++++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999999765432 35778999999999999999999999999999999999999999988
Q ss_pred cccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCCCccccceeee
Q 003092 611 FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRI 689 (848)
Q Consensus 611 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 689 (848)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 874322 45788999999999999999999987 999999999999999 89999999999987654321 12234
Q ss_pred eccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHH
Q 003092 690 VGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM 768 (848)
Q Consensus 690 ~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 768 (848)
.+...|++||..... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 788999999999999998
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 769 LVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 769 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367889999999999999999999863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=214.06 Aligned_cols=108 Identities=40% Similarity=0.886 Sum_probs=102.9
Q ss_pred eccCCCCCcccccCCC-CcceeeeeEEEecCCeeEEEEEecCCCeEEEEEEccCCcEEEEEEEecCCceEEEEecCCCCc
Q 003092 226 TCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC 304 (848)
Q Consensus 226 ~~sg~w~g~~~~~~p~-~~~~~~~~~~v~n~~e~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~C 304 (848)
||+|+|||..|+++|+ ....++.+.|+.+.+|++|+|...+.++++|++||++|++++|.|++..+.|.++|.+|.+.|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 8999999999999999 445678888999999999999999999999999999999999999999999999999999999
Q ss_pred -cccCcCCCccccCCCCCccccCCCCccCC
Q 003092 305 -HYGDCGPNSICSVDQTSHCECLEGFKFKS 333 (848)
Q Consensus 305 -~yg~CG~~g~C~~~~~~~C~Cl~Gf~~~~ 333 (848)
.|+.||+||+|+.+..+.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 89999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-27 Score=260.04 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=200.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++...+|.|.||.|||++.. .++..|||+++-.......-..+|+-+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3478999999999999999999865 588899999987777777778899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
||.+|+|++.-+ ....+++.+.....++.++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 999999988653 4457888888899999999999999988 799999999999999999999999999877543
Q ss_pred cccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
....+.+.||+.|||||+.. .+.|..++|||++|+...|+---.+|.....+- ..+...- ....++
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmT---------kS~~qp 234 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMT---------KSGFQP 234 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhh---------ccCCCC
Confidence 23445578999999999874 567899999999999999987655552211110 0000000 011111
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.-.+ -.....+-+-++++.++..+|++||++..++.
T Consensus 235 p~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1110 01123345778999999999999999987753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=240.95 Aligned_cols=132 Identities=26% Similarity=0.369 Sum_probs=107.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-----C---Cceeeeeeeeee--
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLLGCCIE-- 592 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---pniv~l~~~~~~-- 592 (848)
..+|.+.++||.|.|++||++.+. ..+.||+|+.+.. ..-.+..+.||++|+.++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999865 4678999998653 223455688999999994 3 359999999975
Q ss_pred --CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 593 --QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 593 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
+.++++|+|++....|..+.+ ...+.++...+.+|++||+.||.|||..+ +|||.||||+|||+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 458999999997655544442 23345788899999999999999999987 79999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=231.71 Aligned_cols=198 Identities=33% Similarity=0.476 Sum_probs=171.4
Q ss_pred cceeeeecccCCccEEEEEecC-CceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999865 889999999865444 57789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+++|..++..... .+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AA 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-cc
Confidence 9999888743221 1788999999999999999999986 9999999999999999999999999998775432 11
Q ss_pred ceeeeeccccccChhhh-hcCCCCcccceeehHHHHHHHHhCCCCCC
Q 003092 685 NTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~elltg~~p~~ 730 (848)
......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 22345688899999998 66677889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=205.09 Aligned_cols=115 Identities=47% Similarity=0.778 Sum_probs=102.4
Q ss_pred cccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEEee
Q 003092 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (848)
Q Consensus 48 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t 127 (848)
++|.+|++|+|++|.|++|||.+......|.+|||+..+.++||.|||+.| ....+.|.|+.||+|||+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578899999999999999999987654589999998876789999999998 5677899999999999999999999999
Q ss_pred cccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCC
Q 003092 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168 (848)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~P 168 (848)
++.+......|+|+|||||||++.++ .+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEEcCCCCC
Confidence 98764456778999999999998753 7899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=245.01 Aligned_cols=208 Identities=23% Similarity=0.280 Sum_probs=171.7
Q ss_pred eeHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC------CCceeeee
Q 003092 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ------HRNLVRLL 587 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~------Hpniv~l~ 587 (848)
+.+.-.+....+|.+....|+|-|++|..|... .|++||||++.+.. .-.+.=+.|+++|++|+ .-|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344444556678999999999999999999864 48899999997642 22344578999999995 35899999
Q ss_pred eeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-Cc
Q 003092 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NP 666 (848)
Q Consensus 588 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~ 666 (848)
..|...++++||+|-+. -+|.++|........|....+..++.|+.-||..|...+ |+|.||||.|||+++.. .+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 99999999999999774 367777776667777888899999999999999999876 99999999999998754 57
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
||+|||.|......+.. ...-+..|.|||++.+.+|+...|+||.||+||||.||+.-|..
T Consensus 577 KLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred eeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 99999999876554321 12335689999999999999999999999999999999987643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-26 Score=231.40 Aligned_cols=259 Identities=25% Similarity=0.270 Sum_probs=186.6
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------Ce
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~~ 595 (848)
.+|.-++.+|.|.- .|-.+.+ -.+++||+|++... ..+..++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777889999988 5555543 35889999987543 345677888999999999999999999998643 36
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.|+|||+|.. +|...+. -.++-.....|..|+..|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7999999965 5544443 23566778899999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-CCcc----------------c
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSF----------------N 738 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~-~~~~----------------~ 738 (848)
.-... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|...+ -+.+ +
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 65433 12334578899999999999889999999999999999999987654221 0100 0
Q ss_pred cccccccccccCccc------c-ccccccccC--CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 739 LLGHAWSLCKNDRAH------E-LMDPVLQNE--VSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~------~-~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
+...+.....+.... + +-|...... .+........+++..||-.+|++|.+++++++.
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011111111110000 0 001111100 111223346688999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=218.89 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=183.6
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeee-eeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC-CIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~-~~~~~~~~lV~E 601 (848)
+.|.|.+.||+|.||.+-+++++. .+.+++|.+... ....++|.+|...--.| .|.||+.-+++ |...+.+.+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 679999999999999999999865 678999988653 23467889998876666 58999987654 556678889999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--cCCCceeeccccccccCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGG 679 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~ 679 (848)
|++.|+|...+.. ..+.+.-..+++.|++.||.|||+++ +||||||.+||||- +..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999877733 45677888899999999999999987 99999999999993 455899999999986543
Q ss_pred CccccceeeeeccccccChhhhhcC-----CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEG-----VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
. .....-+..|.|||++... ...+.+|||.||++++.+++|+.|+.........+..+ ..+......
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~--~~w~~rk~~- 247 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW--EQWLKRKNP- 247 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH--HHHhcccCc-
Confidence 2 1223356789999987643 24678999999999999999999997432222112111 111111111
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.+... -.+..+++.++..+-+..+|++|=...++.++
T Consensus 248 ----~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ----ALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ----cCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11111 11233456777788889999999666665554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=227.84 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=191.8
Q ss_pred HHhcCcceeeeecccCCccEEEEEecC----CceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
...+.|...++||+|.|++||++.+.. .+.||+|.+...+. ..++.+|+++|..+ -+.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 344678889999999999999997543 56899999876533 36689999999999 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeecccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMAR 675 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~ 675 (848)
.+|+||+++-...++.. .++...+..+++.+.+||+++|.++ ||||||||+|+|.+. .+.-.|.|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 99999999987666652 3567888899999999999999998 999999999999974 5678999999997
Q ss_pred ccCCCc-------------cc---------------------c---c-----eeeeeccccccChhhhhcC-CCCcccce
Q 003092 676 MFGGDE-------------LQ---------------------G---N-----TKRIVGTYGYMSPEYALEG-VFSVKSDV 712 (848)
Q Consensus 676 ~~~~~~-------------~~---------------------~---~-----~~~~~gt~~y~APE~~~~~-~~~~ksDV 712 (848)
...... .. . . .....||++|.|||++..- ..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 221100 00 0 0 0013599999999999865 46899999
Q ss_pred eehHHHHHHHHhCCCCCCCCCCCcccccccc----------------c-cccccCcccc---c------c--ccccc---
Q 003092 713 FSFGVLMLEILSSKKNTGVYNTDSFNLLGHA----------------W-SLCKNDRAHE---L------M--DPVLQ--- 761 (848)
Q Consensus 713 wSlGvvl~elltg~~p~~~~~~~~~~~~~~~----------------~-~~~~~~~~~~---~------~--d~~l~--- 761 (848)
||.||++.-+++++.||.....+...+...+ . .++...++.. + + .....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999854332221111100 0 0111011000 0 0 00000
Q ss_pred -----cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 -----NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 -----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....-....++++..+|++.||.+|.|+++.++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0011112336789999999999999999999876
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=193.18 Aligned_cols=113 Identities=50% Similarity=0.807 Sum_probs=99.1
Q ss_pred cccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEEee
Q 003092 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (848)
Q Consensus 48 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t 127 (848)
+.|..|++|+|+++.|++|||.+.. ...+.+|||+..+.++||+|||+.|+.+ .+.|.|+.||+|||++.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~-q~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIM-QNDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCC-CCCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 5688899999999999999999864 4689999998866789999999999654 4899999999999999999999999
Q ss_pred cccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCC
Q 003092 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (848)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 167 (848)
++........|+|+|||||||++..+ .+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEeCCCCC
Confidence 98744456678999999999998753 799999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=266.84 Aligned_cols=196 Identities=19% Similarity=0.255 Sum_probs=137.7
Q ss_pred HcCC-Cceeeeeeee-------eeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003092 577 KLQH-RNLVRLLGCC-------IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (848)
Q Consensus 577 ~l~H-pniv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (848)
.++| +||+++++.+ .+....++++||+ .++|..+|... ...+++..+..++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5777888877 3334677888987 55888888532 345899999999999999999999987 9
Q ss_pred EecccCCCcEEecc-------------------CCCceeeccccccccCCCcc--------------ccceeeeeccccc
Q 003092 649 IHRDLKASNILLDQ-------------------HMNPKISDFGMARMFGGDEL--------------QGNTKRIVGTYGY 695 (848)
Q Consensus 649 iHrDlkp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 695 (848)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45567777777764321000 0001123588899
Q ss_pred cChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHH
Q 003092 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINV 775 (848)
Q Consensus 696 ~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 775 (848)
||||++.+..++.++|||||||+||||++|..|+...... .. .. . ...+.+. ......+..++
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~---~~-~----~~~~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MS---SL-R----HRVLPPQ-----ILLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HH---HH-H----HhhcChh-----hhhcCHHHHHH
Confidence 9999999999999999999999999999987764311100 00 00 0 0001110 01112345678
Q ss_pred HHhccccCcCCCCCHHHHHH
Q 003092 776 ALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 776 ~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+||+.+|.+||+|.|+++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=224.10 Aligned_cols=176 Identities=19% Similarity=0.227 Sum_probs=134.4
Q ss_pred HHhcCcceeeeecccCCccEEEEEec--CCceEEEEEeccc-----CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~--~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~ 594 (848)
...++|++.++||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++++|+|++..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999864 4777899987533 12235668999999999999999853322 25
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc-CCCcEEeccCCCceeecccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGl 673 (848)
..++||||+++++|.... .. . ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 689999999999885221 10 0 1467889999999999987 999999 99999999999999999999
Q ss_pred ccccCCCcccc------ceeeeeccccccChhhhhcCC------CCccccee
Q 003092 674 ARMFGGDELQG------NTKRIVGTYGYMSPEYALEGV------FSVKSDVF 713 (848)
Q Consensus 674 a~~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~------~~~ksDVw 713 (848)
|+.+....... .-....+++.|+|||.+.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99775432111 113467889999999986543 23446777
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-23 Score=205.45 Aligned_cols=167 Identities=17% Similarity=0.109 Sum_probs=122.0
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
|+|.+++.. ....+++..+..++.||+.||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 567777742 2346899999999999999999999875 999999999999999 99998654322
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+........ .. .+. .....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~------~~-~~~-~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP------AD-DPR-DRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc------cC-Ccc-ccccH
Confidence 25899999999999999999999999999999999999997533211111100000000 00 000 00011
Q ss_pred HHHHH--HHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 766 LPMLV--RYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 766 ~~~~~--~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..... ++.+++..||+.+|++||++.|+++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11222 588999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=215.34 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=191.3
Q ss_pred CcceeeeecccCCccEEEEEecCC--ceEEEEEecccCcccHHHHHHHHHHHHHcCC----Cceeeeeeee-eeCCeEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-IEQGEKIL 598 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H----pniv~l~~~~-~~~~~~~l 598 (848)
+|.+.++||+|+||.||++..... ..+|+|............++.|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 5789998766543333378889999999973 5888888888 47778899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-----CCceeecccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-----MNPKISDFGM 673 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kl~DFGl 673 (848)
||+.+ +.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99966 667777653333 567899999999999999999999988 9999999999999765 4699999999
Q ss_pred cc--ccCCCcc----ccc--eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 674 AR--MFGGDEL----QGN--TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 674 a~--~~~~~~~----~~~--~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
++ .+..... ... .....||..|.+++.+.+...+.+.|+||++.++.|++.|..|+........ ....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~-- 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKF-- 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHH--
Confidence 99 4322211 111 1235699999999999999999999999999999999999998743221110 0000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
........... .....+. .+.++...+-..+..++|....+...|.......
T Consensus 250 --~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 --EKDPRKLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred --HHHhhhhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00000000110 1112223 3344444444579999999999999887765444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=201.36 Aligned_cols=260 Identities=29% Similarity=0.389 Sum_probs=195.3
Q ss_pred cceeeeecccCCccEEEEEecCCceEEEEEecccCcc---cHHHHHHHHHHHHHcCCC-ceeeeeeeeeeCCeEEEEEEe
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~Hp-niv~l~~~~~~~~~~~lV~Ey 602 (848)
|.+.+.||.|+||.||++... ..+|+|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999876 78899998765332 367899999999999988 799999999777778999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccCCCc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~ 681 (848)
+.++++..++........+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999855532211136788899999999999999999987 99999999999999998 79999999998665443
Q ss_pred ccc----ceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCC--ccccccccccccccCcc
Q 003092 682 LQG----NTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD--SFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 682 ~~~----~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 752 (848)
... ......||..|+|||.+.+ ..+....|+|++|++++++++|..|+...... ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2355789999999999988 57889999999999999999999996543321 01111111000000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.................+.+++..++..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467788889999999999999887763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=190.50 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=194.3
Q ss_pred hcCcceeeeecccCCccEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.-+|.+.++||+|.||.++.|+ +-++++||||.-... ....++..|.+..+.|. .++|...+-+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3579999999999999999997 568999999975433 33467788999888884 6899988888888888899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-----Cceeeccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-----NPKISDFGMARM 676 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kl~DFGla~~ 676 (848)
.+ +.||+++..-. ...++..++.-++.|++.-++|+|+++ +|-|||||+|+||...+ .+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 56777765322 345788999999999999999999987 99999999999997544 489999999998
Q ss_pred cCCCcc-----ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 677 FGGDEL-----QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 677 ~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
+.+... ....+...||.+||+-..+.+...+.+.|+-|||-++++.+-|..||.....+.... . +....+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~--k-YeKIGe~K 255 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE--K-YEKIGETK 255 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH--H-HHHhcccc
Confidence 865432 234455789999999999999999999999999999999999999997654332100 0 00000000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
...-++....+ -+.++..+++.++. .+-++-|...-+.+.+...+..
T Consensus 256 r~T~i~~Lc~g--~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 256 RSTPIEVLCEG--FPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccCCHHHHHhc--CHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHh
Confidence 01111111111 23455555666654 4777788877776666555433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-21 Score=193.91 Aligned_cols=245 Identities=21% Similarity=0.343 Sum_probs=185.0
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+..+|.+...|..|+|++. |..+++|++.... ...-+.|..|.-.|+-+.||||+.+++.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3458899999999999994 5566778775432 233467888999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEe-cccCCCcEEeccCCCceee--ccccccccCCCccc
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH-RDLKASNILLDQHMNPKIS--DFGMARMFGGDELQ 683 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH-rDlkp~NILl~~~~~~kl~--DFGla~~~~~~~~~ 683 (848)
+|...|++. ..-..+-.++.+++.+||+|++|||+.. +++- --|.+..|+||++.+++|+ |--++..
T Consensus 273 slynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 999988653 3345677888999999999999999987 3444 3688999999999998874 2111110
Q ss_pred cceeeeeccccccChhhhhcCCCC---cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFS---VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~---~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....-.|.||+||.++.++-+ .++|+|||++++|||.|.+.||.....-+..+. ...+-+...
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------ialeglrv~- 409 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------IALEGLRVH- 409 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------hhhcccccc-
Confidence 1112346899999999877654 579999999999999999999865443221111 111222222
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+++-....+.+++.-|...||.+||.+..|+-.|+..
T Consensus 410 ---ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 ---IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ---CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2233344677888999999999999999999998865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=190.90 Aligned_cols=172 Identities=14% Similarity=0.156 Sum_probs=135.0
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHH---H------HHHHHHHHHHcCCCceeeeeeeeee
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK---E------FKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~---~------~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
....+|++.++||.|+||.||.... +++.+|||.+.+....... . +.+|+..+.++.||+|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999755 5778999999755332222 2 6899999999999999999888653
Q ss_pred C--------CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 593 Q--------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 593 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
. +..++||||+++.+|.++. .++. ....+++.+|..+|..+ ++||||||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 3578999999999986653 1222 24568999999999987 99999999999999988
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHH
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ell 723 (848)
++|+|||.......... ...++....|..++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998875532211 011455667788999999999987664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-21 Score=185.85 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=193.0
Q ss_pred hcCcceeeeecccCCccEEEEE-ecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC-CceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~~~~~~~~~~~lV~E 601 (848)
..+|.+.++||.|+||-+|.|. ..+|.+||||.-+.... ..++..|..+...|+| ..|..+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999997 45799999998765432 3456788999999976 678888888888999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC---CCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~~~ 678 (848)
.+ +.+|++++.-. ...++..+++-++.|++.-++|+|..+ +|||||||+|+|..-+ ..+.++|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 56777765322 234677788899999999999999988 9999999999999644 458999999999875
Q ss_pred CCcc-----ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 679 GDEL-----QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 679 ~~~~-----~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
+... ........||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|..||......... .......+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---QKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---HHHHHHHHhhcC
Confidence 4322 22344578999999998888888899999999999999999999998654322110 000001111111
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
..++.. ... .+.++...+..|-+..-++-|...-+.+++.-.+..+
T Consensus 243 ~~ie~L-C~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 243 TPIEVL-CKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCHHHH-hCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 111111 111 2335666677788888888898777766554443333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-21 Score=225.70 Aligned_cols=253 Identities=20% Similarity=0.229 Sum_probs=184.1
Q ss_pred eeeeecccCCccEEEEEec-CCceEEEEEec----cc-Cc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQ-SG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~----~~-~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..+.+|.|++|.|+..... ..+.++.|.+. .. .. .....+..|+.+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999988877543 33434444332 11 11 111225667777888899999998888887777777799
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++ +|..++.. ...+...++..++.|+..|++|||+.+ |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 88777732 245777888999999999999999998 9999999999999999999999999998775443
Q ss_pred cc--cceeeeeccccccChhhhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 682 LQ--GNTKRIVGTYGYMSPEYALEGVFSV-KSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 682 ~~--~~~~~~~gt~~y~APE~~~~~~~~~-ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. ......+|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||-.............. ....-..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-------~~~~~~~ 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-------SDQRNIF 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-------ccccccc
Confidence 33 4455578999999999999999976 489999999999999999998643322211100000 0000000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.-...+......+...++..+|+.+|.+|.|+.+|++
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001122234456778999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=185.57 Aligned_cols=139 Identities=17% Similarity=0.143 Sum_probs=107.9
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcc--c-------HHH-----------------HHHHHHHHHHcCCCce
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 583 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~Hpni 583 (848)
.+.||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998754211 1 112 2459999999988877
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHH-HhcCCCceEecccCCCcEEecc
Q 003092 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 584 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiHrDlkp~NILl~~ 662 (848)
.....+. ....++||||++++++..... ....++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 223489999999987654321 234678889999999999999999 6766 99999999999998
Q ss_pred CCCceeecccccccc
Q 003092 663 HMNPKISDFGMARMF 677 (848)
Q Consensus 663 ~~~~kl~DFGla~~~ 677 (848)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=180.43 Aligned_cols=141 Identities=19% Similarity=0.219 Sum_probs=111.4
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcc---------------------c-----HHHHHHHHHHHHHcCCCce
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---------------------G-----LKEFKNEMMLIAKLQHRNL 583 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~Hpni 583 (848)
.+.||+|++|.||+|...+|+.||||+++..... . ...++.|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 0 1224678999999999987
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEecc
Q 003092 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 584 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 662 (848)
.....+... ..++||||++++++..... ....++.....+++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444333 3489999999885533221 22356778889999999999999999 76 99999999999999
Q ss_pred CCCceeeccccccccCC
Q 003092 663 HMNPKISDFGMARMFGG 679 (848)
Q Consensus 663 ~~~~kl~DFGla~~~~~ 679 (848)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-18 Score=170.02 Aligned_cols=183 Identities=16% Similarity=0.142 Sum_probs=138.3
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccCc----ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEEec
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|++|. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457999999999997765 677888777754432 11235889999999995 5889998886 4579999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc-CCCcEEeccCCCceeeccccccccCCCcc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
.+.+|...+. . ....++.|++++|.++|.++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9988754321 0 11357789999999999988 999999 79999999999999999999986543221
Q ss_pred c----c--c-----eeeeeccccccChhhhhcC-CCC-cccceeehHHHHHHHHhCCCCC
Q 003092 683 Q----G--N-----TKRIVGTYGYMSPEYALEG-VFS-VKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 683 ~----~--~-----~~~~~gt~~y~APE~~~~~-~~~-~ksDVwSlGvvl~elltg~~p~ 729 (848)
. . . ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|++.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 0 0 1123468899999865433 233 5679999999999999998774
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-18 Score=191.34 Aligned_cols=215 Identities=24% Similarity=0.370 Sum_probs=160.7
Q ss_pred HHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 575 l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|+.||+|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999865 3446888899999999999999999864 23999999
Q ss_pred CCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCC-------CCcccceeehHHHHHHHHhCCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-------FSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-------~~~ksDVwSlGvvl~elltg~~ 727 (848)
+.|.++|....+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111111123456799999987642 4677999999999999999999
Q ss_pred CCCCCCCCcc--ccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 728 NTGVYNTDSF--NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 728 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
||+....... .+...+.. .....+.|.+.... +...++..++..||..+|++||++.+|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9876432221 11111111 11122223222111 2233688999999999999999999998887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=178.53 Aligned_cols=233 Identities=19% Similarity=0.245 Sum_probs=149.3
Q ss_pred CcceeeeecccCCccEEEEEecC-CceEEEEEeccc---CcccHHHHHHHHHHHHHcCC----------Cceeeeeeeee
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGCCI 591 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~H----------pniv~l~~~~~ 591 (848)
.+...+.||.|+++.||.+++.. ++++|||++... ....++++++|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667899999999999999865 899999987543 23456778887766655432 22333333222
Q ss_pred e---------C--C------eEEEEEEeccCCccccccc---CC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 003092 592 E---------Q--G------EKILIYEYMVNKSLDVFLF---DP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (848)
Q Consensus 592 ~---------~--~------~~~lV~Ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (848)
- . . ..+++|+-+ .++|..++. .. .....+....+..+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 1 1 225566666 446655532 11 11234555666788899999999999998 999
Q ss_pred cccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcC--------CCCcccceeehHHHHHHH
Q 003092 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG--------VFSVKSDVFSFGVLMLEI 722 (848)
Q Consensus 651 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--------~~~~ksDVwSlGvvl~el 722 (848)
+||||+|++++++|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988764432111 2345789999987542 478899999999999999
Q ss_pred HhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCC
Q 003092 723 LSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR 787 (848)
Q Consensus 723 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R 787 (848)
..++.|++.......... .+ ..+. ..++.+..++..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999875432211000 11 1233 556678899999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=204.82 Aligned_cols=198 Identities=22% Similarity=0.244 Sum_probs=159.8
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEE
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~ 597 (848)
....+.|.|.+.||+|+||+||+|...+|+.||+|+-+.... .+|.-=.+++.+|+ -+.|..+..++.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 344578999999999999999999988899999998765422 22333344455554 244555666667778889
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-------CCCceeec
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMNPKISD 670 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~kl~D 670 (848)
||+||.+.|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|+||.. ...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999988884 5667899999999999999999999987 999999999999942 34589999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~ 727 (848)
||.+..+.--.........++|-.+--+|...+.+++..+|.|.|+.+++-|+.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999876543222234455789999999999999999999999999999999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=201.47 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=176.1
Q ss_pred CcceeeeecccCCccEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHH--HHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMML--IAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~--l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++...+.||++.|=+|.++++++|. |+||++-+..+ -..+.|+++++- ...++|||.+.+...-..+..-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677889999999999999998887 89999876653 345556555444 4455899999988776666667788888
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC-c
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD-E 681 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-~ 681 (848)
..+. |.+-+ ..+..+...+..-|+.|++.||..+|..+ |+|+|||.+||||+.=.=+.|+||-.-+...-. +
T Consensus 103 vkhn-LyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKHN-LYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhhh-hhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7663 33333 34456777788889999999999999988 999999999999999888999999877644211 1
Q ss_pred cccceeeeecc----ccccChhhhhcC----------C-CCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 682 LQGNTKRIVGT----YGYMSPEYALEG----------V-FSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 682 ~~~~~~~~~gt----~~y~APE~~~~~----------~-~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
.......+..| ..|+|||-+... . .+++-||||+||++.||++ |+++|... +++.+ +
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY--r 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY--R 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH--h
Confidence 11122222222 369999987541 1 4678899999999999999 56665311 11110 0
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
-........+++.+- + ..+.++++.|++.||++|.++.+.++.-.+.
T Consensus 249 ~~~~~~~e~~Le~Ie----d----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIE----D----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCccCHHHHHHhCc----C----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 000111112222211 1 1577899999999999999999998864443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6e-19 Score=195.59 Aligned_cols=223 Identities=26% Similarity=0.328 Sum_probs=174.9
Q ss_pred eecccCCccEEEEE----ecCCceEEEEEecccCcc--cHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEEecc
Q 003092 532 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~----~~~~~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|+|.||.|+.++ .+.+.-+|+|.+.+.... .....+.|..++..++ ||.+|+++..+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999764 234678999988754321 1124566888888987 9999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|.|...+ .......+.....+...++-+++.+|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99886666 33445666677778888999999999987 99999999999999999999999999987643322
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc--c
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ--N 762 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~ 762 (848)
.|||..|||||++. ....++|.||||++++||++|-.||+. +.+..++. -
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~ 204 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAEL 204 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhcc
Confidence 28999999999998 668899999999999999999999864 11111111 1
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
..+........+++..+...+|..|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2333444556677888888899999765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=168.33 Aligned_cols=135 Identities=22% Similarity=0.259 Sum_probs=105.2
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc-----CCCceeeeeeeeeeCC---e-EEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCIEQG---E-KILIY 600 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~Hpniv~l~~~~~~~~---~-~~lV~ 600 (848)
.+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ +||||+++++++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46999999999996 444333479988765445567899999999999 5799999999998763 3 33789
Q ss_pred Ee--ccCCcccccccCCCcccccCHHHHHHHHHHHHHHH-HHHHhcCCCceEecccCCCcEEecc----CCCceeecccc
Q 003092 601 EY--MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL-LYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDFGM 673 (848)
Q Consensus 601 Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kl~DFGl 673 (848)
|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 558999999843 224444 35677888777 9999987 999999999999974 34799999554
Q ss_pred cc
Q 003092 674 AR 675 (848)
Q Consensus 674 a~ 675 (848)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=8e-17 Score=167.70 Aligned_cols=151 Identities=18% Similarity=0.145 Sum_probs=114.6
Q ss_pred HHHHHhcCcceeeeecccCCccEEEEE--ecCCceEEEEEecccCcc------------------------cHHHHHHHH
Q 003092 519 SVTAATENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKNEM 572 (848)
Q Consensus 519 ~i~~~~~~f~i~~~LG~G~fG~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~Ei 572 (848)
.+......|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 344444568899999999999999998 457999999998643210 012357899
Q ss_pred HHHHHcCCCc--eeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 003092 573 MLIAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (848)
Q Consensus 573 ~~l~~l~Hpn--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (848)
..+.++.+.. +.+.++. ...++||||+++.+|..... ....+.......++.||+.+|++||+.+ .|+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 9999997633 3444432 24589999999988765442 2233455667889999999999999875 4999
Q ss_pred cccCCCcEEeccCCCceeeccccccccCC
Q 003092 651 RDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 651 rDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||||+||+++ ++.++|+|||.+.....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999999 88999999999986543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7e-17 Score=168.51 Aligned_cols=197 Identities=20% Similarity=0.262 Sum_probs=129.9
Q ss_pred CCCceeeeeeeeeeC---------------------------CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHH
Q 003092 579 QHRNLVRLLGCCIEQ---------------------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631 (848)
Q Consensus 579 ~Hpniv~l~~~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 631 (848)
+|||||++.++|.+. ..+|+||.-.+. +|..++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 499999999887532 245777775544 555555322 234555677899
Q ss_pred HHHHHHHHHHhcCCCceEecccCCCcEEe--ccCC--CceeeccccccccCCC--cc--ccceeeeeccccccChhhhhc
Q 003092 632 GIAQGLLYLHQYSRLRIIHRDLKASNILL--DQHM--NPKISDFGMARMFGGD--EL--QGNTKRIVGTYGYMSPEYALE 703 (848)
Q Consensus 632 qia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~--~~--~~~~~~~~gt~~y~APE~~~~ 703 (848)
|+++|+.|||.++ |.|||+|++|||| |+|+ .++|+|||.+---... +. ....-..-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999987 9999999999999 4443 3689999976432211 11 111112346778999999864
Q ss_pred CC--C----CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHH
Q 003092 704 GV--F----SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVAL 777 (848)
Q Consensus 704 ~~--~----~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~ 777 (848)
.+ . -.|+|.|+.|.+.||+++...||...++-...... .++.--|.+ +......+.+++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPal----p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPAL----PSRVPPVARQLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCC----cccCChHHHHHHH
Confidence 32 1 36899999999999999999997542221111110 111111222 2223335678888
Q ss_pred hccccCcCCCCCHHHHHHHH
Q 003092 778 LCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 778 ~cl~~dP~~RPt~~evl~~L 797 (848)
..++.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999976655544
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=134.31 Aligned_cols=66 Identities=56% Similarity=1.191 Sum_probs=59.6
Q ss_pred CCCCCcceeeccCCCCCccccccccccCHHHHHHHhhhcCcceeeccccccCCCcceeeeccccccc
Q 003092 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDL 413 (848)
Q Consensus 347 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~w~~~l~~~ 413 (848)
|+.+|+|+++++|++|++....++.++++++|++.||+||||+||+|.++. ++++|++|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999877776789999999999999999999998665 679999999999985
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=160.17 Aligned_cols=145 Identities=19% Similarity=0.167 Sum_probs=112.5
Q ss_pred HHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCc----------------------ccHHHHHHHHHHHH
Q 003092 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMMLIA 576 (848)
Q Consensus 519 ~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~----------------------~~~~~~~~Ei~~l~ 576 (848)
++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999987899999998754320 01123577899999
Q ss_pred HcCCCc--eeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 577 KLQHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 577 ~l~Hpn--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
.+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 3456899999999988665310 234578899999999999976 9999999
Q ss_pred CCcEEeccCCCceeeccccccccCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|+||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=162.41 Aligned_cols=134 Identities=19% Similarity=0.293 Sum_probs=112.9
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcc--------cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5899999999999987 6778999986543211 124578899999999999998888787778888999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
+++++|.+++... .+ .+..++.+++.+|++||+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998877321 12 67889999999999999987 99999999999999 78999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=157.97 Aligned_cols=130 Identities=21% Similarity=0.329 Sum_probs=106.3
Q ss_pred eecccCCccEEEEEecCCceEEEEEecccCc--------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.||+|+||.||+|.+ ++..|++|....... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998654321 11356788999999999988766666666777789999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++++|.+.+.... ..++.+++.+|++||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999877663211 078999999999999987 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.2e-16 Score=181.69 Aligned_cols=136 Identities=19% Similarity=0.296 Sum_probs=110.8
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEe-ccc-Cc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQ-SG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~-~~~-~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
..|...++||+|+||+||+|.+... .+++|+. .+. .. ...+++.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4456678999999999999987544 3444432 211 11 1235688999999999999999888888777788
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++. ....++.+++++|+|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999987662 35678999999999999987 9999999999999 678999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.1e-17 Score=176.52 Aligned_cols=192 Identities=24% Similarity=0.267 Sum_probs=137.1
Q ss_pred cceeeeecccCCccEEEEEecC----CceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeee------eeeee---
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLL------GCCIE--- 592 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~------~~~~~--- 592 (848)
..+.+..+..+++.++...... ...++.|..............+++-.+.... |++.+..- .....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 3344566677777776654322 2334444443332122223334444444444 44333221 01111
Q ss_pred --CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeec
Q 003092 593 --QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 593 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
....++.|+++...+|.++|.........++.....++.|++.|+.| ++ .+|||+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 23578999999999999999766666677888899999999999999 44 99999999999999999999999
Q ss_pred cccccccCCCc----cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh
Q 003092 671 FGMARMFGGDE----LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (848)
Q Consensus 671 FGla~~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt 724 (848)
||+........ .........||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99998776544 2223445789999999999999999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-16 Score=181.07 Aligned_cols=215 Identities=22% Similarity=0.295 Sum_probs=141.6
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..+|..++.|..|+||.||.++++. .+.+|+| ++++.-- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence 4689999999999999999998864 6788984 4332100 011 22233344443
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC--
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD-- 680 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~-- 680 (848)
|+-...+ ...+.++. +++.+++|||+.+ |+|||+||+|.||+.-|++|+.|||+++..-..
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2211112 11122222 2377899999987 999999999999999999999999998754221
Q ss_pred -----------ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003092 681 -----------ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 681 -----------~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
...-..+.++||+.|.|||++....|...+|.|++|+++||.+-|+.||.....+. ++..+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg~visd--- 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVISD--- 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHhhhhhh---
Confidence 11112344689999999999999999999999999999999999999986442221 11111000
Q ss_pred CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 750 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
. +.-.+...+...+..+++.+.|+.+|..|---....
T Consensus 274 -----~---i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 274 -----D---IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred -----h---ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 0 000001122233677888899999999995433333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=140.19 Aligned_cols=135 Identities=22% Similarity=0.236 Sum_probs=115.0
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC--CceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+..+..++| +++++++.+...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999754 7899999865433 5678999999999976 58999998888888899999999988
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4556678899999999999987555699999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.1e-15 Score=148.45 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=98.8
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcc--cHHH----------------------HHHHHHHHHHcCCCc--e
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 583 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~Hpn--i 583 (848)
.+.||+|+||+||+|...++++||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998653211 1111 135666666665443 4
Q ss_pred eeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEecc
Q 003092 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 584 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~ 662 (848)
.+.+++ ...++||||++++.+......... . ......++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999999654221111000 1 15567899999999999998 65 99999999999999
Q ss_pred CCCceeeccccccccC
Q 003092 663 HMNPKISDFGMARMFG 678 (848)
Q Consensus 663 ~~~~kl~DFGla~~~~ 678 (848)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=6e-14 Score=146.46 Aligned_cols=134 Identities=22% Similarity=0.264 Sum_probs=103.6
Q ss_pred eeec-ccCCccEEEEEecCCceEEEEEecccC-------------cccHHHHHHHHHHHHHcCCCce--eeeeeeeeeCC
Q 003092 531 SKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQG 594 (848)
Q Consensus 531 ~~LG-~G~fG~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~Ei~~l~~l~Hpni--v~l~~~~~~~~ 594 (848)
..|| .||.|+||.+... +..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 8999999999874 6789999885311 1223567889999999998875 67777654332
Q ss_pred ----eEEEEEEeccC-CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 595 ----EKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 595 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
..++|||++++ .+|..++.. ..++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688776632 223333 3678999999999988 9999999999999999999999
Q ss_pred ccccccc
Q 003092 670 DFGMARM 676 (848)
Q Consensus 670 DFGla~~ 676 (848)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.6e-15 Score=173.20 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=186.8
Q ss_pred cCcceeeeecccCCccEEEEEecC--CceEEEEEecccC--cccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~--~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV 599 (848)
..|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999999886533 3456777665443 223344555777777776 99999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH-hcCCCceEecccCCCcEEeccCC-Cceeecccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH-QYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 677 (848)
.||..++++...+... .....+......++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999987766321 1113455666788999999999999 665 99999999999999999 9999999999988
Q ss_pred CC-Cccccceeeeec-cccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 678 GG-DELQGNTKRIVG-TYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 678 ~~-~~~~~~~~~~~g-t~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.. ..........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+............+.... .....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 252 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFTQ 252 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccccc
Confidence 76 444444555678 99999999998854 47889999999999999999999865443322221111000 00000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...........++...++..+|..|.+.+++..
T Consensus 253 --------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 253 --------LPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------CccccCChhhhhcccccccCCchhccccccccc
Confidence 000111224456667788889999999888754
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=115.87 Aligned_cols=71 Identities=24% Similarity=0.422 Sum_probs=60.7
Q ss_pred CCCCCcceeeccCCCCCccccccccccCHHHHHHHhhh---cCcceeeccccccCCCcceeeecccc-cccccCCCCCCC
Q 003092 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK---NCSCRAYANSKVTDGGSGCLMWFGDL-IDLKKTDNHTNG 422 (848)
Q Consensus 347 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~c~~w~~~l-~~~~~~~~~~~~ 422 (848)
|..+++|+++.+|++|++.. +++++|++.|++ ||||+||+|.+. +.||++|++++ +|++. ....|
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~--~~~~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRK--EFSHG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHh--ccCCC
Confidence 45568899999999999754 689999999999 999999999753 46899999999 99887 44558
Q ss_pred eeEEEe
Q 003092 423 VSIYIR 428 (848)
Q Consensus 423 ~~~ylr 428 (848)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 899997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.6e-13 Score=150.04 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=99.5
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccH----------------------------------------HHHHH
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------KEFKN 570 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 570 (848)
+.||.|++|.||+|++.+|+.||||+.+....+.. -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865321110 02445
Q ss_pred HHHHHHHcC----CCceeeeeeee-eeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHH-HHHHHHhcC
Q 003092 571 EMMLIAKLQ----HRNLVRLLGCC-IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ-GLLYLHQYS 644 (848)
Q Consensus 571 Ei~~l~~l~----Hpniv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~~~ 644 (848)
|+..+.++. |.+-+.+-.++ ......++||||+++++|.+....... .. .+.+++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 32223332333 234567999999999999876532111 11 23456666665 467788776
Q ss_pred CCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 645 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
++|+|+||.||+++.++.++|+|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=111.78 Aligned_cols=80 Identities=41% Similarity=0.877 Sum_probs=64.8
Q ss_pred CCCCCCC---CcceeeccCCCCCccccccccccCHHHHHHHhhhcCcceeeccccccCCCcceeeecccccccccCCCCC
Q 003092 344 SSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHT 420 (848)
Q Consensus 344 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~w~~~l~~~~~~~~~~ 420 (848)
+++|... +.|++++++++|+..... .+.++++|++.||+||+|+||+|.+ ++++|.+|.+.+.+.+. ...
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~--~~~ 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRS--LSS 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEe--ecC
Confidence 4567544 689999999999886543 7789999999999999999999973 36799999999998765 233
Q ss_pred CCeeEEEecc
Q 003092 421 NGVSIYIRVP 430 (848)
Q Consensus 421 ~~~~~ylrvp 430 (848)
.+.++|||+|
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 3578999986
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=121.65 Aligned_cols=130 Identities=23% Similarity=0.154 Sum_probs=97.7
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCcee-eeeeeeeeCCeEEEEEEeccCCccc
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
+.|+.|.++.||+++.. ++.|++|....... ....+..|+.++..+.+.+++ +++... ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 67899999999999874 77899998765432 223468899999999765544 444432 33458999999998875
Q ss_pred ccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
... .....++.+++++|+.||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 011245678999999999876 33469999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.3e-12 Score=139.05 Aligned_cols=249 Identities=24% Similarity=0.284 Sum_probs=176.3
Q ss_pred cCcceeeeecc--cCCccEEEEEe--c-CCceEEEEEeccc--CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 525 ENFSIQSKLGE--GGFGPVYKGRL--L-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~--G~fG~Vy~~~~--~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
..|.+.+.+|. |.+|.||.+.. . ++..+|+|+-+.. .......=.+|+...+++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677789999 99999999986 3 4778999974322 122222225677777777 599999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHH----HHHHHHhcCCCceEecccCCCcEEeccC-CCceeecc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDF 671 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DF 671 (848)
++-+|++. .+|..+.+ .....++......+..+..+ ||..+|+.+ ++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 45555443 22334666677778888888 999999987 9999999999999999 88999999
Q ss_pred ccccccCCCccccce---eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 672 GMARMFGGDELQGNT---KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 672 Gla~~~~~~~~~~~~---~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|+...+......... .+..|...|++||.. .+.++.++|+|++|.++.|...+-......... .|...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence 999998766533222 233688899999955 466799999999999999999876553211101 122222
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+..+ -+.... ....++..++.++++.+|-.|++.+.+..
T Consensus 340 ~~~i---p~e~~~-----~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGYI---PLEFCE-----GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccC---chhhhc-----CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 2111 111111 11223444778899999999999888764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.5e-11 Score=137.96 Aligned_cols=145 Identities=19% Similarity=0.232 Sum_probs=94.4
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCccc----------------------------------HH---
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQG----------------------------------LK--- 566 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~----------------------------------~~--- 566 (848)
..|.. +.||+|++|.||+|++.+ |++||||++++...+. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 9999999987542110 01
Q ss_pred ---HHHHHHHHHHHcC----CCceeeeeeeeee-CCeEEEEEEeccCCcccccccCCCcc---cccCHHHHHHHHHHHHH
Q 003092 567 ---EFKNEMMLIAKLQ----HRNLVRLLGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKK---HLLGWQLRVRIIDGIAQ 635 (848)
Q Consensus 567 ---~~~~Ei~~l~~l~----Hpniv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~ 635 (848)
+|.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++-.-.... ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1334554444442 3333443344332 45778999999999986632111111 122222233333333
Q ss_pred HHHHHHhcCCCceEecccCCCcEEeccCC----CceeeccccccccCCC
Q 003092 636 GLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGMARMFGGD 680 (848)
Q Consensus 636 ~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGla~~~~~~ 680 (848)
+.. +++|+|+||.||+++.++ .++++|||++..+...
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334 499999999999999988 9999999999877543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.3e-11 Score=126.83 Aligned_cols=154 Identities=23% Similarity=0.288 Sum_probs=116.1
Q ss_pred HHHHHcCCCceeeeeeeeeeC-----CeEEEEEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003092 573 MLIAKLQHRNLVRLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646 (848)
Q Consensus 573 ~~l~~l~Hpniv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 646 (848)
.-|-.+.|.|||+++.|+.+. .+..++.|||..|++..+|.+.. ....+......+++.||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999988643 46789999999999999996543 2345677777899999999999999975 6
Q ss_pred ceEecccCCCcEEeccCCCceeeccccccccC---CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHH
Q 003092 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFG---GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723 (848)
Q Consensus 647 ~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~---~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ell 723 (848)
+|+|+++..+-|++..++-+||.--- ...+. .......+....+-++|.|||.=.....+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999888874211 11110 001111223345778999999766666778999999999999998
Q ss_pred hCCCC
Q 003092 724 SSKKN 728 (848)
Q Consensus 724 tg~~p 728 (848)
-++.-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 77643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.3e-10 Score=111.23 Aligned_cols=137 Identities=15% Similarity=0.116 Sum_probs=98.6
Q ss_pred eeeecccCCccEEEEEecC-------CceEEEEEecccC------------c----------ccHHHH----HHHHHHHH
Q 003092 530 QSKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS------------G----------QGLKEF----KNEMMLIA 576 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~------------~----------~~~~~~----~~Ei~~l~ 576 (848)
...||.|.-+.||.|...+ +..+|||+.+... . ...+.+ ++|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 4789999864210 0 011223 37999999
Q ss_pred HcCC--CceeeeeeeeeeCCeEEEEEEeccCCcccc-cccCCCcccccCHHHHHHHHHHHHHHHHHH-HhcCCCceEecc
Q 003092 577 KLQH--RNLVRLLGCCIEQGEKILIYEYMVNKSLDV-FLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRD 652 (848)
Q Consensus 577 ~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiHrD 652 (848)
++.. -++.+++++ ...++||||+.+..+.. .+ +...++.+....+..+++.+|..| |..+ |||+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9953 456666654 56789999998754321 12 112344455667889999999999 7766 99999
Q ss_pred cCCCcEEeccCCCceeeccccccccC
Q 003092 653 LKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 653 lkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.6e-10 Score=114.31 Aligned_cols=142 Identities=18% Similarity=0.262 Sum_probs=110.4
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHHHcCC--CceeeeeeeeeeC---CeEEEEEEecc
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQ---GEKILIYEYMV 604 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~---~~~~lV~Ey~~ 604 (848)
+.|+.|..+.||+++..+|+.+++|....... .....+..|+++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886678999998765332 245678999999999976 4457777776654 25689999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS---------------------------------------- 644 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 644 (848)
+.++...+.. ..++......++.++++.|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 24667777788888999998888521
Q ss_pred -------------CCceEecccCCCcEEecc--CCCceeeccccccc
Q 003092 645 -------------RLRIIHRDLKASNILLDQ--HMNPKISDFGMARM 676 (848)
Q Consensus 645 -------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~ 676 (848)
+..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9e-11 Score=131.24 Aligned_cols=245 Identities=18% Similarity=0.185 Sum_probs=172.5
Q ss_pred HhcCcceeeeecccCCccEEEEEec--CCceEEEEEecccCcccHHH--HHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~--~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
...+|.....||.|.|+.|++.... ++..|++|.+.+.......+ -..|+.+...+ .|.+++++...+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3467889999999999999998643 46789999886654333322 24566666666 5999999988888888888
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeeccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARM 676 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 676 (848)
+--||++++++...+ .-...+++..++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999876554 23345777888999999999999999876 9999999999999886 7889999999875
Q ss_pred cCCCccccceeeeecccccc--ChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQGNTKRIVGTYGYM--SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
+.-.. . ....+.+++ +|+......+..+.|++|||..+.|.+++..-.... .+ ...
T Consensus 417 ~~~~~----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----~~-------------~~~ 474 (524)
T KOG0601|consen 417 LAFSS----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----VQ-------------SLT 474 (524)
T ss_pred cceec----c-cccccccccccchhhccccccccccccccccccccccccCcccCccc----cc-------------cee
Confidence 32111 0 112233444 555556677899999999999999999876532110 00 011
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
+....+..... ...++..+...+...++..||.+.++..+.
T Consensus 475 i~~~~~p~~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 475 IRSGDTPNLPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred eecccccCCCc--hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 11111111111 113455566677788999999988876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.2e-10 Score=125.00 Aligned_cols=168 Identities=18% Similarity=0.217 Sum_probs=126.4
Q ss_pred ecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHH
Q 003092 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL 625 (848)
Q Consensus 546 ~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 625 (848)
..++.+|.|...+..........++-++.|+.++||||++++.....++..|+|+|-+.- |..++. .+....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk------~l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLK------ELGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHH------HhHHHH
Confidence 446889999988776554455677888999999999999999999999999999997643 222231 233556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCC
Q 003092 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705 (848)
Q Consensus 626 ~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~ 705 (848)
..-.+.||+.||.+||+.+ +++|++|.-..|+|+..|+.||++|.++........ .......-..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6678899999999999876 699999999999999999999999998865432221 111122233566676544322
Q ss_pred CCcccceeehHHHHHHHHhCCC
Q 003092 706 FSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 706 ~~~ksDVwSlGvvl~elltg~~ 727 (848)
-..|.|.||++++|++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 35699999999999999843
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.4e-09 Score=101.47 Aligned_cols=131 Identities=21% Similarity=0.321 Sum_probs=101.3
Q ss_pred eeecccCCccEEEEEecCCceEEEEE-ecccC-c------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQS-G------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~-~~~~~-~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..+++|+-+.+|.+.+. |.++++|. +++.- . -...+-.+|+.++.+++--.|....-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999763 44466663 22221 1 1134567899999999876776666677788888999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988777332 2567888888999999988 99999999999998765 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-10 Score=134.75 Aligned_cols=246 Identities=18% Similarity=0.215 Sum_probs=163.4
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
...+.+.+.+-+-+|.++.++.+.-. .|...++|..... .....+....+-.++-...||-+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567888889999999999977532 2333333332211 1112222233333333345677776666666677889
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
||++|+.+++|...|+.. ...+.+.....+..+.++++|||... +.|||++|.|+|+..+++.+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999988777533 23444455566777889999999875 899999999999999999999999854322
Q ss_pred CCC-------------------------ccc----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCC
Q 003092 678 GGD-------------------------ELQ----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (848)
Q Consensus 678 ~~~-------------------------~~~----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p 728 (848)
..- ... .......||+.|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 112235799999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccCccccccccccccCC-----CHHHHHHHHHHHHhccccCcCCCCCHH
Q 003092 729 TGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV-----SLPMLVRYINVALLCVQENAEDRPTMS 791 (848)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ 791 (848)
+...... +.++.++.... ......+..+++...+..+|.+|-.|.
T Consensus 1035 ~na~tpq------------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ------------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchh------------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7532211 11111111111 111223455566667778888887766
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.7e-09 Score=98.78 Aligned_cols=143 Identities=23% Similarity=0.289 Sum_probs=104.1
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEE-ecccC-------cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQS-------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~-~~~~~-------~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
....|-+|+-+.|+++.+ .|+...||. +.+.- .-..++.++|++.|.++.--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 567766763 33221 112466789999999997666655555666777778999
Q ss_pred EeccCC-cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeeccccccc
Q 003092 601 EYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARM 676 (848)
Q Consensus 601 Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~ 676 (848)
||+++. ++.+++....... ...+....++..|-+.+.-||..+ |||+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 999873 5566654332222 222333678889999999999988 999999999999966543 58999999853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.8e-08 Score=98.11 Aligned_cols=125 Identities=25% Similarity=0.272 Sum_probs=81.8
Q ss_pred EEEEEecCCceEEEEEecccC-------------c--------c-----cHHHHHHHHHHHHHcCCC--ceeeeeeeeee
Q 003092 541 VYKGRLLNGQEVAVKRLSNQS-------------G--------Q-----GLKEFKNEMMLIAKLQHR--NLVRLLGCCIE 592 (848)
Q Consensus 541 Vy~~~~~~~~~vAvK~~~~~~-------------~--------~-----~~~~~~~Ei~~l~~l~Hp--niv~l~~~~~~ 592 (848)
||.|...+|..+|||+.+... . . .....++|.+.|.++..- ++.+++.+
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence 899998889999999864311 0 0 123467899999999765 45666644
Q ss_pred CCeEEEEEEecc--CCcccccccCCCcccccCHHHHHHHHHHHHHHHHH-HHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 593 QGEKILIYEYMV--NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 593 ~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
....+||||++ +..+..+.. . .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|+
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~-~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKD-V----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHH-C----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred -eCCEEEEEecCCCccchhhHHh-c----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 24579999999 544443221 1 11133456677788886666 46665 9999999999999988 99999
Q ss_pred ccccccccC
Q 003092 670 DFGMARMFG 678 (848)
Q Consensus 670 DFGla~~~~ 678 (848)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.3e-08 Score=106.68 Aligned_cols=169 Identities=20% Similarity=0.308 Sum_probs=127.5
Q ss_pred CccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeee----eCCeEEEEEEeccCC-ccccc
Q 003092 538 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI----EQGEKILIYEYMVNK-SLDVF 611 (848)
Q Consensus 538 fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~----~~~~~~lV~Ey~~~g-sL~~~ 611 (848)
-.+.|++.. .+|..|++|+++....+.......-++.++++.|+|||++..++. .+..+++||+|.++. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 456789874 479999999996544444333455688999999999999999887 345789999999864 55443
Q ss_pred ccCC------------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 612 LFDP------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 612 l~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
-+.. ......++...+.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3221 22345778899999999999999999998 87799999999999999999998888876544
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCC
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p 728 (848)
+.. +| +.+ -.+-|.=.||.++..|.+|...
T Consensus 446 d~~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT--------------EP--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------cc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11 111 1345777899999999998654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=101.77 Aligned_cols=140 Identities=17% Similarity=0.130 Sum_probs=99.1
Q ss_pred eecccCCccEEEEEecCCceEEEEEecccCcc-----------cHHHHHHHHHHHHHcCCCce--eeeeeeeee-----C
Q 003092 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNL--VRLLGCCIE-----Q 593 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~Hpni--v~l~~~~~~-----~ 593 (848)
.+-+-....|++..+ +|+.|.||+....... ....+.+|...+.++...+| ++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 444444445667665 6788999977433211 11247899999999854433 344555543 2
Q ss_pred CeEEEEEEeccCC-cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-------CCC
Q 003092 594 GEKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMN 665 (848)
Q Consensus 594 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------~~~ 665 (848)
..-++|+|++++. +|.+++.+.. ....+...+..++.+++..++-||+.+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 7777763211 223455677789999999999999998 999999999999985 467
Q ss_pred ceeeccccccc
Q 003092 666 PKISDFGMARM 676 (848)
Q Consensus 666 ~kl~DFGla~~ 676 (848)
+.|+||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.8e-07 Score=93.41 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=96.8
Q ss_pred cceeeeecccCCccEEEEEecCCceEEEEEecccC-----------------c-----ccHHHHHHHHHHHHHcCCC--c
Q 003092 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-----------------G-----QGLKEFKNEMMLIAKLQHR--N 582 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~-----------------~-----~~~~~~~~Ei~~l~~l~Hp--n 582 (848)
..+.++||.|.-+.||.|..+.|.++|||.=+... . ......++|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999532110 0 1123457899999999655 6
Q ss_pred eeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc
Q 003092 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 583 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 662 (848)
|.+.++. +...+||||+++-.|...-. +....-.++..|++-+..+-..+ |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7776654 57789999999976644321 11222233444444444333444 999999999999999
Q ss_pred CCCceeeccccccccC
Q 003092 663 HMNPKISDFGMARMFG 678 (848)
Q Consensus 663 ~~~~kl~DFGla~~~~ 678 (848)
+|.+.++||--+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.8e-07 Score=103.48 Aligned_cols=142 Identities=15% Similarity=0.187 Sum_probs=92.2
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCccc------------------------------HHH----------HHH
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG------------------------------LKE----------FKN 570 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~------------------------------~~~----------~~~ 570 (848)
+.|+.++-|.||+|++.+|+.||||+.++.-.+. .++ +..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999975432110 111 234
Q ss_pred HHHHHHHcC-----CCceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHH-HHHHhcC
Q 003092 571 EMMLIAKLQ-----HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL-LYLHQYS 644 (848)
Q Consensus 571 Ei~~l~~l~-----Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~ 644 (848)
|+.-+.+++ .|+|.-..=+....+...|+|||++|-.+.+...-.. ..++.. .++..++++. ..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhc-
Confidence 555555542 3443322223334578899999999998877642211 223322 2222222221 111112
Q ss_pred CCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 645 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
+++|.|.+|.||+++.++++.+.|||+...+...
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 4999999999999999999999999999877543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.4e-06 Score=89.64 Aligned_cols=191 Identities=15% Similarity=0.166 Sum_probs=124.8
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceee--------eeeeeeeCCeEEEE
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR--------LLGCCIEQGEKILI 599 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~--------l~~~~~~~~~~~lV 599 (848)
....||+|+-+-+|..-.-.+ -+-|+++........+ .++.|... .||-+-. ++|- .++...-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhc--hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEe
Confidence 457899999999996532112 2446666543322221 23333333 5664332 1111 112236678
Q ss_pred EEeccCCcccccccC----CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 600 YEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
|..+.+.---..++. .+.-....|.-.++.++.+|.+.+.||..+ .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 887766532122221 222345789999999999999999999998 8889999999999999999999854332
Q ss_pred ccCCCccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhC-CCCCCC
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSS-KKNTGV 731 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg-~~p~~~ 731 (848)
...++. ...-.+|...|.+||... +-.-+...|-|.||+++++++.| ++|+..
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 221111 112246889999999765 23346789999999999999986 889754
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-06 Score=78.53 Aligned_cols=100 Identities=24% Similarity=0.416 Sum_probs=68.8
Q ss_pred CeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEee-cCCCCCcCCCceEEEecCCCEEEEcCCCCeEEeecccCC
Q 003092 54 ETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVA-NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSRE 132 (848)
Q Consensus 54 ~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~ 132 (848)
+.+.+.+|.+.|-|..+|+ |-|. +. ..+++|.+ +..... ...+.+.|+.||||||+|..+.++|++. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~-~~-~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLY-DS-NGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSSGNVLWQSF--DY 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEE-ET-TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred cccccccccccceECCCCe-----EEEE-cC-CCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence 4566655899999999886 4443 22 35779999 555441 2678999999999999999999999993 23
Q ss_pred cccceEEEec--CCCEEEEcCCCCCCcccccccccCCCc
Q 003092 133 VKNPVAQLLD--NGNLVIRDNSGSNSTESYLWQSFDYPT 169 (848)
Q Consensus 133 ~~~~~a~l~d--~GNlVl~~~~~~~~~~~~~WqSFd~Pt 169 (848)
....+...++ +||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 3556667888 99999 7543 257888866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-06 Score=88.57 Aligned_cols=107 Identities=22% Similarity=0.209 Sum_probs=83.0
Q ss_pred HHHHHHHHHHHHHcCCC--ceeeeeeeeeeCC----eEEEEEEeccCC-cccccccCCCcccccCHHHHHHHHHHHHHHH
Q 003092 565 LKEFKNEMMLIAKLQHR--NLVRLLGCCIEQG----EKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637 (848)
Q Consensus 565 ~~~~~~Ei~~l~~l~Hp--niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 637 (848)
.....+|...+.++..- .+.+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 34678899988888543 3455666655432 458999999884 78777743211 55666788999999999
Q ss_pred HHHHhcCCCceEecccCCCcEEeccCC---Cceeecccccccc
Q 003092 638 LYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARMF 677 (848)
Q Consensus 638 ~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~~ 677 (848)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.9e-06 Score=85.60 Aligned_cols=132 Identities=19% Similarity=0.193 Sum_probs=86.0
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeeeeeeeCCeEEEEEEeccCCc-
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKS- 607 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~~~~~~~~~lV~Ey~~~gs- 607 (848)
.+||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 35567888876532 3455788999999986443 4667777777778889999999963
Q ss_pred ccccccCCCcccccCHHHHHHHHHHHHHHH---------------------------------------HHHHh-cCCCc
Q 003092 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGL---------------------------------------LYLHQ-YSRLR 647 (848)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L---------------------------------------~yLH~-~~~~~ 647 (848)
+...+.. +......++..+++.+ .+|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2111100 0011111111111111 22221 11235
Q ss_pred eEecccCCCcEEeccCCCceeecccccc
Q 003092 648 IIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 648 iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=4.4e-06 Score=83.93 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=101.4
Q ss_pred ecccCCccEEEEEecCCceEEEEEecccC------cccHHHHHHHHHHHHHcCCCc--eeeeeeeeeeC----CeEEEEE
Q 003092 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQ----GEKILIY 600 (848)
Q Consensus 533 LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~~~~~----~~~~lV~ 600 (848)
-|+||-+-|+...+ +|+.+-+|+-.+.. +-+...|.+|...|.+|..-+ +.+........ -+-.||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36688889998776 44568888765221 346678999999999996433 44444222111 2467999
Q ss_pred EeccC-CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC--ceeeccccccc
Q 003092 601 EYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMARM 676 (848)
Q Consensus 601 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 676 (848)
|-+++ .+|.+++.+. .....+...+..++.++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 4677666332 1234567777899999999999999998 999999999999986667 99999987764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.8e-06 Score=79.14 Aligned_cols=87 Identities=25% Similarity=0.322 Sum_probs=61.6
Q ss_pred eEEEecCCCEEEEcCC-CCeEEeecccCCc-ccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 105 VLTVSNRGNLVLLNQS-NGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 105 ~l~~~~~g~lvl~~~~-~~~~W~t~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
.+.++.||+||+++.. +.++|++++.... .++.+.|+++|||||++.++ .++|+|= |
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~-----t----------- 81 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDG-----RVVWSSN-----T----------- 81 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCC-----CEEEEec-----c-----------
Confidence 3557789999999765 5899999986543 33678999999999998653 6788861 1
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeecc
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCT 228 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~s 228 (848)
....|.+.+.++.+|...++-.. ..+.|.+
T Consensus 82 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~S 111 (114)
T smart00108 82 ---------------TGANGNYVLVLLDDGNLVIYDSD-GNFLWQS 111 (114)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEeCC
Confidence 11345678888888877654332 3466754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.7e-07 Score=104.95 Aligned_cols=152 Identities=19% Similarity=0.263 Sum_probs=99.9
Q ss_pred HHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccc-------eeeeeccccccChhhhh
Q 003092 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-------TKRIVGTYGYMSPEYAL 702 (848)
Q Consensus 630 ~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~APE~~~ 702 (848)
+.+++.|+.|+|..- .+||++|.|++|.++..+..||+.|+.+........... ..-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999865 699999999999999999999999999876654211111 01123456899999999
Q ss_pred cCCCCcccceeehHHHHHHHHhCCCC-CCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccc
Q 003092 703 EGVFSVKSDVFSFGVLMLEILSSKKN-TGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQ 781 (848)
Q Consensus 703 ~~~~~~ksDVwSlGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~ 781 (848)
+...+.++|+||+|+++|.+..|..+ +...+..... . ......+.- .-..+.....++.+=+..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~----~~~~~~~~~----~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----S----FSRNLLNAG----AFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh----h----hhhcccccc----cccccccCcHHHHHHHHHHhc
Confidence 98889999999999999999855443 2221111000 0 000000000 001112233456666677888
Q ss_pred cCcCCCCCHHHHHH
Q 003092 782 ENAEDRPTMSDVVS 795 (848)
Q Consensus 782 ~dP~~RPt~~evl~ 795 (848)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 89999998877654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.1e-06 Score=72.64 Aligned_cols=73 Identities=36% Similarity=0.793 Sum_probs=54.8
Q ss_pred CCcceeeccCCCCCccccccccccCHHHHHHHhhh-cCcceeeccccccCCCcceeeec-ccccccccCCCCCCCeeEEE
Q 003092 350 GDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMWF-GDLIDLKKTDNHTNGVSIYI 427 (848)
Q Consensus 350 ~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~c~~w~-~~l~~~~~~~~~~~~~~~yl 427 (848)
...|++++++++++..... ....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+... ....+.++|.
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~--~~~~~~~~y~ 76 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARL--FPSGGVDLYE 76 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCcccccee--cccCCceeEE
Confidence 3569999999999665432 356899999999999 99999999974 467999999 77666552 2333445554
Q ss_pred e
Q 003092 428 R 428 (848)
Q Consensus 428 r 428 (848)
+
T Consensus 77 ~ 77 (78)
T smart00473 77 K 77 (78)
T ss_pred e
Confidence 4
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-05 Score=80.06 Aligned_cols=138 Identities=16% Similarity=0.189 Sum_probs=93.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHH---------HHHHHHHHHcCCCce---eeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQHRNL---VRLLGCC 590 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~---------~~Ei~~l~~l~Hpni---v~l~~~~ 590 (848)
...+|.+.+++-......|.+-.. +++.+.+|..++......+.| .+++..+.+++...+ ..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888877777777666 678899998876543333332 234555555543222 2222222
Q ss_pred e-----eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 591 I-----EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 591 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
. .....+++|||++|..|.++.. +++ .+...+++++.-||..| +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2235679999999988765431 222 24456778899999988 99999999999998654
Q ss_pred ceeeccccccc
Q 003092 666 PKISDFGMARM 676 (848)
Q Consensus 666 ~kl~DFGla~~ 676 (848)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.6e-05 Score=79.38 Aligned_cols=153 Identities=18% Similarity=0.211 Sum_probs=100.7
Q ss_pred eeHHHHHHHhcCcceeeee---cccCCccEEEEEecCCceEEEEEecccCcc---------c----------HH-----H
Q 003092 515 FSFASVTAATENFSIQSKL---GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---------G----------LK-----E 567 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~L---G~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~---------~----------~~-----~ 567 (848)
.+...+....++..+.+.. ..|.-+.||+|...++..+|||++...... + .+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 3455566666666665554 456667799998878999999998543211 0 01 1
Q ss_pred HHHHHHHHHHcC--CCceeeeeeeeeeCCeEEEEEEeccCCcc-cccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC
Q 003092 568 FKNEMMLIAKLQ--HRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644 (848)
Q Consensus 568 ~~~Ei~~l~~l~--Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~ 644 (848)
..+|..-|.++. +-.+.+.+++. .-.|||||+..... .-.|.+ ..+...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 245666777763 44555555443 45799999976521 122211 12223356667777888888777633
Q ss_pred CCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 645 ~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
++||+||..-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8899999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.4e-05 Score=81.18 Aligned_cols=143 Identities=21% Similarity=0.181 Sum_probs=85.3
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC--ceeeeeeeee---eCCeEEEEEEecc
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCI---EQGEKILIYEYMV 604 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~l~~~~~---~~~~~~lV~Ey~~ 604 (848)
.+.|+.|..+.||+....+ ..+++|..... .....+..|+.++..+... .+.+++.... .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 68999987654 4456788899999888533 3556666443 2335789999999
Q ss_pred CCccccc----------------c---cCC-CcccccCHHH---------HHH------------HHHHHHH-HHHHHHh
Q 003092 605 NKSLDVF----------------L---FDP-TKKHLLGWQL---------RVR------------IIDGIAQ-GLLYLHQ 642 (848)
Q Consensus 605 ~gsL~~~----------------l---~~~-~~~~~l~~~~---------~~~------------i~~qia~-~L~yLH~ 642 (848)
+..+... + +.. .......... ... ....+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 9877660 0 001 0000001000 000 0112222 3333432
Q ss_pred ----cCCCceEecccCCCcEEec-cCCCceeecccccc
Q 003092 643 ----YSRLRIIHRDLKASNILLD-QHMNPKISDFGMAR 675 (848)
Q Consensus 643 ----~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~ 675 (848)
..+..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 56666799999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.7e-06 Score=75.68 Aligned_cols=87 Identities=24% Similarity=0.257 Sum_probs=61.0
Q ss_pred EEEec-CCCEEEEcCC-CCeEEeecccCC-cccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 106 LTVSN-RGNLVLLNQS-NGTIWSSNVSRE-VKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 106 l~~~~-~g~lvl~~~~-~~~~W~t~~~~~-~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
+.++. ||+||+++.. +.++|++++... ...+.+.|+++|||||++.++ .++|+|=-
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~~---------------- 82 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG-----TVVWSSNT---------------- 82 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC-----cEEEEecc----------------
Confidence 45666 9999999765 589999998653 345667899999999998753 67888531
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTG 229 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg 229 (848)
....+.+.+.++.+|...++-.+ ..+.|.+.
T Consensus 83 ---------------~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 83 ---------------TRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ---------------cCCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 11245678888888876543332 35567653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.4e-07 Score=100.66 Aligned_cols=188 Identities=18% Similarity=0.117 Sum_probs=135.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc-eeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~~~~~~~~~~~lV~E 601 (848)
.+.-+.....+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33445555678999999999987544444445544322 34456889999999999 7888888888888999999
Q ss_pred eccCC-cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 602 YMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
++..+ +-.... ....-.+..-....+.+.-++++++||+.. =+||| ||+..+ +..+..||+.+..+...
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 211111 011112233334456667788999999853 48998 777765 67899999999877654
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCC
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p 728 (848)
. ..+...+|+.++|||+..+..+..+.|+|++|+--.++.-|.+|
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 3 23446799999999999999999999999999987777777665
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.4e-05 Score=91.17 Aligned_cols=142 Identities=18% Similarity=0.217 Sum_probs=91.0
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCccc-------------------------------------HHHHHHHHH
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------------LKEFKNEMM 573 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------------------------~~~~~~Ei~ 573 (848)
+.||.-+.|.||+|++++|+.||||+-++.-... .-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999876532111 011344554
Q ss_pred HHHHc----CCCc---eeeeeeeee-eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCC
Q 003092 574 LIAKL----QHRN---LVRLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645 (848)
Q Consensus 574 ~l~~l----~Hpn---iv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 645 (848)
-..++ .|-+ -|.+-.++. ....+.|+||||+|..+++...- .+..++... ++..+.++.. +..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYL--EQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHH--HHHHh
Confidence 44443 3555 122222332 34578999999999988776321 222344443 3333333222 22112
Q ss_pred CceEecccCCCcEEecc----CCCceeeccccccccCC
Q 003092 646 LRIIHRDLKASNILLDQ----HMNPKISDFGMARMFGG 679 (848)
Q Consensus 646 ~~iiHrDlkp~NILl~~----~~~~kl~DFGla~~~~~ 679 (848)
.+++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 24999999999999984 67899999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.1e-05 Score=80.45 Aligned_cols=140 Identities=14% Similarity=0.098 Sum_probs=85.2
Q ss_pred eecccCC-ccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEEeccCCccc
Q 003092 532 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 532 ~LG~G~f-G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~ 609 (848)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 778998764 4678888875432 345678999998884 444667777776666789999999998775
Q ss_pred cccc-------------------CCCc-ccccCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 003092 610 VFLF-------------------DPTK-KHLLGW--QLRVRIID--------------------GIAQGLLYLHQ----Y 643 (848)
Q Consensus 610 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------qia~~L~yLH~----~ 643 (848)
.... .... ...... ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 000000 00000000 01111122211 1
Q ss_pred CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 644 ~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22458999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.8e-05 Score=77.97 Aligned_cols=105 Identities=21% Similarity=0.204 Sum_probs=84.2
Q ss_pred HHHHHHHHHcCC-CceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003092 569 KNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647 (848)
Q Consensus 569 ~~Ei~~l~~l~H-pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 647 (848)
.+|..+++.+++ +++++++|+| ..++|.||...+++...-.....-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 6999999999 45789999998765422101112234689999999999999999999865556
Q ss_pred eEecccCCCcEEeccCCCceeecccccccc
Q 003092 648 IIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 648 iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+.-.|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=89.15 Aligned_cols=79 Identities=19% Similarity=0.385 Sum_probs=58.4
Q ss_pred eeeecccCCccEEEEEecCC---ceEEEEEecccC-cccHHHHHHHHHHHHHcC-CCce--eeeeeeeeeC---CeEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCIEQ---GEKILI 599 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-Hpni--v~l~~~~~~~---~~~~lV 599 (848)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999876553 467888765432 123457889999999995 6665 7777777654 467899
Q ss_pred EEeccCCcc
Q 003092 600 YEYMVNKSL 608 (848)
Q Consensus 600 ~Ey~~~gsL 608 (848)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00019 Score=74.97 Aligned_cols=74 Identities=14% Similarity=0.212 Sum_probs=47.1
Q ss_pred eeecccCCc-cEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC---ceeeeeeeeeeC---CeEEEEEEec
Q 003092 531 SKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCIEQ---GEKILIYEYM 603 (848)
Q Consensus 531 ~~LG~G~fG-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~~~~~~~---~~~~lV~Ey~ 603 (848)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... -+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 48975 245778865432 2345788999999888532 234444433222 2347899999
Q ss_pred cCCcccc
Q 003092 604 VNKSLDV 610 (848)
Q Consensus 604 ~~gsL~~ 610 (848)
++.++..
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00047 Score=74.63 Aligned_cols=77 Identities=12% Similarity=0.098 Sum_probs=57.1
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC---Cceeeeeeeeee---CCeEEEEEEe
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCIE---QGEKILIYEY 602 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---pniv~l~~~~~~---~~~~~lV~Ey 602 (848)
-.+.||.|..+.||+....++ .+.+|..+.. .....+..|++.|+.|.. ..+.+.++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 356899999999999876555 4666764331 123578999999999853 467888887754 3668999999
Q ss_pred ccCCcc
Q 003092 603 MVNKSL 608 (848)
Q Consensus 603 ~~~gsL 608 (848)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00028 Score=70.47 Aligned_cols=125 Identities=24% Similarity=0.398 Sum_probs=90.1
Q ss_pred cCcceeeeecccCC-ccEEEEEecCCceEEEEEeccc---C---------c---------ccHHHHHHHHHHHHHcC---
Q 003092 525 ENFSIQSKLGEGGF-GPVYKGRLLNGQEVAVKRLSNQ---S---------G---------QGLKEFKNEMMLIAKLQ--- 579 (848)
Q Consensus 525 ~~f~i~~~LG~G~f-G~Vy~~~~~~~~~vAvK~~~~~---~---------~---------~~~~~~~~Ei~~l~~l~--- 579 (848)
.+++.++.||.|.- |.||++++ +|+.||+|.+..- . . .-...|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999998 6789999994220 0 0 11235788998888775
Q ss_pred CCce--eeeeeeeeeC------------------CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHH
Q 003092 580 HRNL--VRLLGCCIEQ------------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639 (848)
Q Consensus 580 Hpni--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 639 (848)
+.++ |+.+|+..-. ....||.||.+... .+ ..+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4456 8999987432 12356777765532 11 22345667778888
Q ss_pred HHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 640 LH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999985 3489999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00026 Score=71.34 Aligned_cols=127 Identities=18% Similarity=0.243 Sum_probs=88.3
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccC----------------cccHHHHHHHHHHHHHcC------CCceeeeee
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLLG 588 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------Hpniv~l~~ 588 (848)
..||+|+.-.||. +++.....||+..... ....++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5899999999996 4555667888886654 223566777777766665 788999999
Q ss_pred eeeeCCeEEEEEEeccCC--c----ccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc
Q 003092 589 CCIEQGEKILIYEYMVNK--S----LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 589 ~~~~~~~~~lV~Ey~~~g--s----L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 662 (848)
....+....+|+|.+.+. . |.+++ ....++. ...+. +-+-..||-+++ |+.+||+|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 999999999999987543 2 33444 2333443 33333 334445666655 999999999999954
Q ss_pred CC----Cceeec
Q 003092 663 HM----NPKISD 670 (848)
Q Consensus 663 ~~----~~kl~D 670 (848)
.. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00043 Score=72.20 Aligned_cols=74 Identities=19% Similarity=0.268 Sum_probs=49.3
Q ss_pred eeecccCCccEEEEEecC--CceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEEeccCCc
Q 003092 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
+.|..|-...+|+....+ ++.|++|+....... .....+|+.++..+...++ +++++... -.+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 578888888999998654 678899977543222 1233578999998854333 34443322 247999999877
Q ss_pred cc
Q 003092 608 LD 609 (848)
Q Consensus 608 L~ 609 (848)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00028 Score=68.22 Aligned_cols=129 Identities=21% Similarity=0.285 Sum_probs=85.5
Q ss_pred ceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceee-eeeeeeeCCeEEEEEEeccCC
Q 003092 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~-l~~~~~~~~~~~lV~Ey~~~g 606 (848)
+..+.|++|.+|.||+|.+. +.++|+|+-+.++ ....++.|+++|..++-.++-+ ++.+ ++-.+.|||+.+.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence 34578999999999999984 5588999865543 3477899999999998766543 3333 2334559999998
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC-CCcEEeccCCCceeeccccccc
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK-ASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk-p~NILl~~~~~~kl~DFGla~~ 676 (848)
.|...-... +. +.+..+++.---|-..+ |-|..|. |..++|-.+..+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 775543111 11 22333444423344344 8888886 4444454555999999999974
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00045 Score=73.14 Aligned_cols=139 Identities=14% Similarity=0.100 Sum_probs=79.7
Q ss_pred eecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEEeccCCcccc
Q 003092 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKSLDV 610 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~ 610 (848)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++... . -.+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 456688889998874 567888987654322211235789999999864333 3344332 1 368999999877643
Q ss_pred c-----------------ccCCCc-ccccCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCceEecccCCCc
Q 003092 611 F-----------------LFDPTK-KHLLGWQLR-VRIIDG---------IAQGLLYLHQY-----SRLRIIHRDLKASN 657 (848)
Q Consensus 611 ~-----------------l~~~~~-~~~l~~~~~-~~i~~q---------ia~~L~yLH~~-----~~~~iiHrDlkp~N 657 (848)
. ++.... ...++.... .....+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 111110 111111111 111111 11112222111 12358999999999
Q ss_pred EEeccCCCceeeccccccc
Q 003092 658 ILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~ 676 (848)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 79999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=71.53 Aligned_cols=142 Identities=17% Similarity=0.128 Sum_probs=87.3
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeeee------eeeCCeEEEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CIEQGEKILIYE 601 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~------~~~~~~~~lV~E 601 (848)
.+.|..|....+|+.... +..+++|+... ...+++..|++++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457778888899998764 45788998764 23456778888888885433 4444432 123456789999
Q ss_pred eccCCccccc----c----------cCC----Cc----ccccCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 003092 602 YMVNKSLDVF----L----------FDP----TK----KHLLGWQLRV----------RIIDGIAQGLLYLHQ----YSR 645 (848)
Q Consensus 602 y~~~gsL~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~qia~~L~yLH~----~~~ 645 (848)
|++|..+... . +.. .. .....|.... .....+...+.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0 100 00 0111221110 111223344455543 123
Q ss_pred CceEecccCCCcEEeccCCCceeecccccc
Q 003092 646 LRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 646 ~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0012 Score=73.68 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=54.3
Q ss_pred eeecccCCccEEEEEecCC-ceEEEEEeccc------C-cccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEEEE
Q 003092 531 SKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ------S-GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~-~~vAvK~~~~~------~-~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~lV 599 (848)
+.||.|.+..||++...+| +.|+||.-... . +...+++..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5899999999999998776 58999985421 1 224567788888888873 2456667666 44567899
Q ss_pred EEeccCC
Q 003092 600 YEYMVNK 606 (848)
Q Consensus 600 ~Ey~~~g 606 (848)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999863
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0029 Score=69.36 Aligned_cols=141 Identities=17% Similarity=0.174 Sum_probs=78.9
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeee------eeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG------CCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~------~~~~~~~~~lV~Ey 602 (848)
+.|+.|....+|+....+| .+++|++.. ...+.+..|+.++..|...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5677787789999876554 688998752 12344455666666664222 333332 11234567899999
Q ss_pred ccCCccccc--------------ccCCCc--------ccccCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 003092 603 MVNKSLDVF--------------LFDPTK--------KHLLGW-QLRVR------------II-DGIAQGLLYLHQY--- 643 (848)
Q Consensus 603 ~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~-~qia~~L~yLH~~--- 643 (848)
+++..+... ++.... ...+.| ..... .+ ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 998764221 010000 001111 11111 11 1111222333211
Q ss_pred -CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 644 -SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 644 -~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999976556899999885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0039 Score=67.90 Aligned_cols=143 Identities=18% Similarity=0.201 Sum_probs=84.2
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeeeee------eeCCeEEEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCC------IEQGEKILIYE 601 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~~------~~~~~~~lV~E 601 (848)
.+.++.|....+|+....++ .+++|+..... ..++...|++++..|...+ +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999876444 67788775421 2345566777887774322 34444321 22456789999
Q ss_pred eccCCccccc--------------ccCCCcc---------cccCHHHHH------------HHHHHHHHHHHHHHh----
Q 003092 602 YMVNKSLDVF--------------LFDPTKK---------HLLGWQLRV------------RIIDGIAQGLLYLHQ---- 642 (848)
Q Consensus 602 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~qia~~L~yLH~---- 642 (848)
|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998664311 1110000 011121110 011223345555542
Q ss_pred cCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 643 ~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
..+..++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0027 Score=69.05 Aligned_cols=141 Identities=27% Similarity=0.328 Sum_probs=84.1
Q ss_pred eeecccCCccEEEEEecC-------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~Ey 602 (848)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+...++ .++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 466677777899987654 47899998765432 23445788888888854333 34454443 2 358999
Q ss_pred ccCCccccc-c----------------cCCCccc------ccC--HHHHH--------------------------HHHH
Q 003092 603 MVNKSLDVF-L----------------FDPTKKH------LLG--WQLRV--------------------------RIID 631 (848)
Q Consensus 603 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~--------------------------~i~~ 631 (848)
++|..+... + |...... ..+ +.... .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1 1111100 000 10100 0112
Q ss_pred HHHHHHHHHHh------cCCCceEecccCCCcEEeccC----CCceeeccccccc
Q 003092 632 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (848)
Q Consensus 632 qia~~L~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 676 (848)
.+...+..|.. ..+..++|+|+.|.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 234568999999999999985 8899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0055 Score=65.67 Aligned_cols=75 Identities=16% Similarity=0.207 Sum_probs=49.1
Q ss_pred ceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEEEEEEecc
Q 003092 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
+-.+.|+-|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+.+++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345678989999999987 567889999875 233456888999999983 3457788888877777799999998
Q ss_pred CC
Q 003092 605 NK 606 (848)
Q Consensus 605 ~g 606 (848)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0011 Score=80.33 Aligned_cols=199 Identities=19% Similarity=0.204 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE----EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHH
Q 003092 565 LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640 (848)
Q Consensus 565 ~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL 640 (848)
+...+.|...+.++.|+|+++++.+-.+....- +..|++..-++...+ .....++......+..++..||+|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence 344556778888999999999999887654433 234556555554444 2334567778888899999999999
Q ss_pred HhcCCCceEecccCCC---cEEeccCCCceee--ccccccccCCCccccceeeeeccccccChhhhhcCCCCc--cccee
Q 003092 641 HQYSRLRIIHRDLKAS---NILLDQHMNPKIS--DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV--KSDVF 713 (848)
Q Consensus 641 H~~~~~~iiHrDlkp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~--ksDVw 713 (848)
|+.. ..|.-+..+ +.-.+.++.+.++ ||+.++......... ...-+..+.|||......+.. +.|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence 9874 555544444 4555667777777 999888765433211 123455678888777666554 47999
Q ss_pred ehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHH
Q 003092 714 SFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793 (848)
Q Consensus 714 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 793 (848)
.+|..+..+..|..+....- ....+++... .. .+.+....|+..++++|+++.++
T Consensus 377 ~lgll~~~~~~~~~i~~~~~-----------------~~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSA-----------------VPVSLLDVLS----TS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHHhhhhhcCccccccc-----------------chhhhhcccc----ch----hhhhhhhhhcchhhhhccchhhh
Confidence 99999999998776532110 0111111111 00 34556678999999999999999
Q ss_pred HHHH
Q 003092 794 VSMI 797 (848)
Q Consensus 794 l~~L 797 (848)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0086 Score=66.26 Aligned_cols=141 Identities=17% Similarity=0.235 Sum_probs=82.8
Q ss_pred eeecccCCccEEEEEecC-----CceEEEEEecccCcccHHHHHHHHHHHHHcCCCcee-eeeeeeeeCCeEEEEEEecc
Q 003092 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv-~l~~~~~~~~~~~lV~Ey~~ 604 (848)
+.|-.|-.-.+|+....+ ++.|++|+..........+ .+|..+++.+..-++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456557788899987532 3678999887654443443 7799999988644443 455554322 5899998
Q ss_pred CCccccc-----------------ccCCC--ccc-ccCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 003092 605 NKSLDVF-----------------LFDPT--KKH-LLGWQLRVRIIDG-----------------IAQGLLYL----HQ- 642 (848)
Q Consensus 605 ~gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~q-----------------ia~~L~yL----H~- 642 (848)
+.++... +|... ... ...+....++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 000 1112222222211 11112222 21
Q ss_pred cCCCceEecccCCCcEEecc-CCCceeeccccccc
Q 003092 643 YSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARM 676 (848)
Q Consensus 643 ~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~ 676 (848)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999998863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0013 Score=69.21 Aligned_cols=136 Identities=14% Similarity=0.132 Sum_probs=92.3
Q ss_pred CcceeeeecccCCccEEEEEecCCceEEEEEeccc-----------------CcccH-----HHHHHHHHHHHHcCC--C
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----------------SGQGL-----KEFKNEMMLIAKLQH--R 581 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~-----------------~~~~~-----~~~~~Ei~~l~~l~H--p 581 (848)
-+.+.++||-|.-+-||.+-..+|++.++|.-+.. ....+ -...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 36678999999999999999989999999842110 00111 223568888888853 2
Q ss_pred ceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 582 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
-|.+.+++ .+.++|||++.+-.|...-+ ..+... +...+..-+--|-.++ +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 34455443 57889999998877654331 112222 2233333344455555 99999999999999
Q ss_pred cCCCceeecccccccc
Q 003092 662 QHMNPKISDFGMARMF 677 (848)
Q Consensus 662 ~~~~~kl~DFGla~~~ 677 (848)
+++.++++||--....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999866544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0099 Score=63.92 Aligned_cols=142 Identities=18% Similarity=0.175 Sum_probs=95.5
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEecccC---------ccc-------------H----HHHHHHHHHHHHcCCCc
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS---------GQG-------------L----KEFKNEMMLIAKLQHRN 582 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~---------~~~-------------~----~~~~~Ei~~l~~l~Hpn 582 (848)
+...|..|.-+.||.+.-.+|..+|||+++-.. -.+ . --.+.|++-|++|..-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345678888999999999899999999874210 000 0 11346777788876544
Q ss_pred eeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc
Q 003092 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 583 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 662 (848)
|.-.--+. -....|||+|+.... +-....+...++...+..+-.|++.-+.-|-+.+ ++||.||.--|+|+.
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 32211111 124579999996422 2222223445666677778888888888888776 699999999999984
Q ss_pred CCCceeeccccccccC
Q 003092 663 HMNPKISDFGMARMFG 678 (848)
Q Consensus 663 ~~~~kl~DFGla~~~~ 678 (848)
+|.+.|+|-+-+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 5689999988776443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.011 Score=63.25 Aligned_cols=31 Identities=26% Similarity=0.516 Sum_probs=25.8
Q ss_pred CceEecccCCCcEEeccCCC-ceeeccccccc
Q 003092 646 LRIIHRDLKASNILLDQHMN-PKISDFGMARM 676 (848)
Q Consensus 646 ~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~ 676 (848)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.018 Score=62.20 Aligned_cols=137 Identities=19% Similarity=0.255 Sum_probs=83.7
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecc--cCcccHHHHHHHHHHHHHcCC--CceeeeeeeeeeCC--eEEEEEEec
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQG--EKILIYEYM 603 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~~--~~~lV~Ey~ 603 (848)
.+++-.|..-.+|..... ++++++. ... ..........+|..+|+.+.- .-+.+.+++|.++. ..+.||+|.
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433334444433 6778887 331 223344556788888888743 33455677776665 669999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHH-HHHHHHHHHHHh----------------------------------------
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRII-DGIAQGLLYLHQ---------------------------------------- 642 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qia~~L~yLH~---------------------------------------- 642 (848)
++......+..... . .+++ ..+++.|+-||+
T Consensus 108 eGe~~~~~~~~~~~----~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPESL----G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCcccc----h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 98644332211100 0 1111 244444444443
Q ss_pred ----------c-----CCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 643 ----------Y-----SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 643 ----------~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
+ ++..++|+|+.+.||+++.+.-+-|.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 245699999999999999998899999999864
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0041 Score=51.89 Aligned_cols=51 Identities=12% Similarity=0.277 Sum_probs=36.8
Q ss_pred eeccCCCCCccccccccccCHHHHHHHhhhcCcceeeccccccCCCcceeeeccc
Q 003092 355 KLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGD 409 (848)
Q Consensus 355 ~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~c~~w~~~ 409 (848)
.++++.+++..... ....+.++|++.|+.+|+|.||.|.. +...|+++.+.
T Consensus 8 ~~~~~~~~g~d~~~-~~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 8 QGSNVDFRGGDLST-VFASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred ccCCCccccCCcce-eecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 33566666543322 23568999999999999999999963 34679988764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.052 Score=60.61 Aligned_cols=73 Identities=10% Similarity=0.040 Sum_probs=50.1
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccC-------cccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-------GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~lV 599 (848)
.+.||.|....||+... .++.++||+-.... +....+-..|++.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 45679999764211 113344455667776663 247778887776 456788
Q ss_pred EEeccC
Q 003092 600 YEYMVN 605 (848)
Q Consensus 600 ~Ey~~~ 605 (848)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.0061 Score=45.77 Aligned_cols=43 Identities=40% Similarity=0.646 Sum_probs=32.2
Q ss_pred CCCCCCCCCCcccccCCCCccccCCCCCCC--CccccccceeeeeccCC
Q 003092 802 FNLPSPKEPPFTTFTKGKNMKYSSNSTSGT--SEFCSVNDVTVSLIYPR 848 (848)
Q Consensus 802 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--s~~~~~~~~~~~~~~~~ 848 (848)
..||.|++|+|...+.... ..++++. .+.+++|++|+|.|++|
T Consensus 4 ~~LP~PKqPgF~~~r~~~e----~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSE----TDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCC----cCCCcccccCCCCCeeeEEEEeEecC
Confidence 5799999999998766321 2222233 37899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.04 Score=60.38 Aligned_cols=72 Identities=14% Similarity=0.169 Sum_probs=48.3
Q ss_pred eecccCCccEEEEEecCC-ceEEEEEeccc-------CcccHHHHHHHHHHHHHcC--CC-ceeeeeeeeeeCCeEEEEE
Q 003092 532 KLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ--HR-NLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 532 ~LG~G~fG~Vy~~~~~~~-~~vAvK~~~~~-------~~~~~~~~~~Ei~~l~~l~--Hp-niv~l~~~~~~~~~~~lV~ 600 (848)
.||.|....||++...++ +.|+||.-... -+-..++..-|.+.|+... -| .+.+++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 589999999999997654 58999974321 1334456667778886663 24 3444443 3556667999
Q ss_pred EeccC
Q 003092 601 EYMVN 605 (848)
Q Consensus 601 Ey~~~ 605 (848)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.11 Score=56.55 Aligned_cols=65 Identities=17% Similarity=0.266 Sum_probs=40.7
Q ss_pred cEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC--ceeeeeee------eeeCCeEEEEEEeccCCccc
Q 003092 540 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGC------CIEQGEKILIYEYMVNKSLD 609 (848)
Q Consensus 540 ~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~l~~~------~~~~~~~~lV~Ey~~~gsL~ 609 (848)
.||+....+| .+++|+++.. .+.+..|+..+..|... .+++++.. ...++..++|+||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876444 6889987532 24456677777777433 33343322 22356789999999986653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.026 Score=57.78 Aligned_cols=31 Identities=35% Similarity=0.525 Sum_probs=21.9
Q ss_pred CceEecccCCCcEEe-ccCCCceeeccccccc
Q 003092 646 LRIIHRDLKASNILL-DQHMNPKISDFGMARM 676 (848)
Q Consensus 646 ~~iiHrDlkp~NILl-~~~~~~kl~DFGla~~ 676 (848)
..+.|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 357999999999999 8899999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 848 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-25 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-25 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-25 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-25 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-25 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-24 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-136
Identities = 104/304 (34%), Positives = 155/304 (50%), Gaps = 18/304 (5%)
Query: 506 KSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN 559
+ D+ FSF + T NF +K+GEGGFG VYKG + N VAVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 560 ----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
+ + ++F E+ ++AK QH NLV LLG + + L+Y YM N SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L W +R +I G A G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735
T RIVGT YM+PE L G + KSD++SFGV++LEI++ + +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 736 SFNLLGHAWSLCKNDRA-HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
LL + ++ + +D + N+ + +VA C+ E RP + V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 795 SMIN 798
++
Sbjct: 299 QLLQ 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-134
Identities = 115/287 (40%), Positives = 168/287 (58%), Gaps = 6/287 (2%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMM 573
FS + A++NFS ++ LG GGFG VYKGRL +G VAVKRL + QG + +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDG 632
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + + L W R RI G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+GL YLH + +IIHRD+KA+NILLD+ + DFG+A++ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT---GVYNTDSFNLLGHAWSLCKN 749
G+++PEY G S K+DVF +GV++LE+++ ++ + N D LL L K
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+ L+D LQ + + I VALLC Q + +RP MS+VV M
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 368 bits (946), Expect = e-121
Identities = 104/289 (35%), Positives = 170/289 (58%), Gaps = 5/289 (1%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDGI 633
++ +H +LV L+G C E+ E ILIY+YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHAWSLCKNDRA 752
GY+ PEY ++G + KSDV+SFGV++ E+L ++ + NL A N +
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
+++DP L +++ L ++ + A+ C+ ++EDRP+M DV+ + L
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-93
Identities = 75/320 (23%), Positives = 129/320 (40%), Gaps = 29/320 (9%)
Query: 503 GKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 562
G SS ++ + + G FG V+K +L + VAVK Q
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60
Query: 563 QGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYMVNKSLDVFLFDPTKK 618
Q + + E+ + ++H N+++ +G + LI + SL FL K
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KA 115
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDQHMNPKISDF 671
+++ W I + +A+GL YLH+ + I HRD+K+ N+LL ++ I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-----FSVKSDVFSFGVLMLEILSSK 726
G+A F + G+T VGT YM+PE + ++ D+++ G+++ E+ S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 727 KNTGV----YNTDSFNLLGHAWSLCKNDRA--HELMDPVLQNEV-SLPMLVRYINVALLC 779
Y +G SL H+ PVL++ + C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 780 VQENAEDRPTMSDVVSMINN 799
+AE R + V I
Sbjct: 296 WDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-80
Identities = 71/334 (21%), Positives = 124/334 (37%), Gaps = 42/334 (12%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 575 IAKLQHRNLVRLLGCCIE-----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
+ ++H N+ R + + E +L+ EY N SL +L H W R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 630 IDGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG---- 679
+ +GL YLH + + I HRDL + N+L+ ISDFG++ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 680 --DELQGNTKRIVGTYGYMSPEYALEGVFSV--------KSDVFSFGVLMLEILSSKKNT 729
E VGT YM+PE LEG ++ + D+++ G++ EI +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 730 GVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM----------LVRYINVALLC 779
+ + + + ++ V + + + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 780 VQENAEDRPTMSDVVSMINNELFNLPSPKEPPFT 813
++AE R T + + K T
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-63
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 24/287 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+ L+ EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 645 RLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763
+S K DVFS+G+++ E+++ +K ++ W++ R P L
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR------PPLIKN 228
Query: 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
+ + + C ++ RP+M ++V ++ + + P EP
Sbjct: 229 LP-KPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-61
Identities = 71/278 (25%), Positives = 133/278 (47%), Gaps = 22/278 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ +I+ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G + ++ EY+ SL L + L + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
I+HR+LK+ N+L+D+ K+ DFG++R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
+ + KSDV+SFGV++ E+ + ++ + +G K R +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KCKR------LEIP 261
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
++ P + I C RP+ + ++ ++
Sbjct: 262 RNLN-PQVAAIIE---GCWTNEPWKRPSFATIMDLLRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-60
Identities = 67/311 (21%), Positives = 115/311 (36%), Gaps = 53/311 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ LG+G FG K G+ + +K L + + F E+ ++ L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
++ +G + I EY+ +L + + W RV IA G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR------------IVG 691
+ IIHRDL + N L+ ++ N ++DFG+AR+ ++ Q R +VG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751
+M+PE + K DVFSFG+++ EI+
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV------------------------N 220
Query: 752 AHELMDPV-----LQNEVSLPMLV------RYINVALLCVQENAEDRPTMSDVVSMINNE 800
A P L L + + + C + E RP+ + +
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
Query: 801 LFNLPSPKEPP 811
+L
Sbjct: 281 RMHLAGHLPLG 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-59
Identities = 69/281 (24%), Positives = 133/281 (47%), Gaps = 25/281 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ +G I + ++ SL L K + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
IIHRDLK++NI L + KI DFG+A +++ G+ +M+PE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
+S +SDV++FG+++ E+++ + + + N D + +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSL----SPD 246
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + + P ++ + C+++ ++RP+ +++ I
Sbjct: 247 LSKVRSNCPKRMKRL--MAECLKKKRDERPSFPRILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-59
Identities = 71/290 (24%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 576
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
L H N+V+L G ++ E++ L L D K H + W +++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ Y+ I+HRDL++ NI L + K++DFG+++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 692 TYGYMSPE--YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749
+ +M+PE A E ++ K+D +SF +++ IL+ + ++ S+ + + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE 245
Query: 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
P + + P L I LC + + RP S +V ++
Sbjct: 246 GLR-----PTIPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 9e-58
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 43/291 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQH 580
+++ +G GGFG VY+ G EVAVK Q ++ + E L A L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ L G C+++ L+ E+ L+ L + + V IA+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDELQGNTKRIVGT 692
H + + IIHRDLK+SNIL+ Q + KI+DFG+AR + G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GA 177
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752
Y +M+PE +FS SDV+S+GVL+ E+L+ + + +
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---PF---------------RGIDG 219
Query: 753 HELMDPVLQNEVSLPM----LVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ V N+++LP+ + + C + RP+ ++++ +
Sbjct: 220 LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-57
Identities = 59/283 (20%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ + +KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 583 LVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ +LG C I +M SL L + T ++ V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFL 127
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H L I L + ++++D+ M +IS + F + + +++PE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 701 ALEG----VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
AL+ +D++SF VL+ E+++ + + S +G + R
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREV---PFADLSNMEIGMKV-ALEGLR----- 229
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
P + +S P + + + +C+ E+ RP +V ++
Sbjct: 230 -PTIPPGIS-PHVSKLMK---ICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-55
Identities = 69/300 (23%), Positives = 124/300 (41%), Gaps = 36/300 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
E I +G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G C+ +I ++L + D L +I I +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA 148
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI---VGTYGYMSPE 699
I+H+DLK+ N+ D + I+DFG+ + G + ++ G +++PE
Sbjct: 149 ---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 700 ---------YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750
+ FS SDVF+ G + E+ + + W +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH-----AREWPFKTQPAEAIIWQMGTGM 259
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
+ P L +++ + + ++ L C E+RPT + ++ M+ P
Sbjct: 260 K------PNL-SQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-54
Identities = 69/307 (22%), Positives = 122/307 (39%), Gaps = 45/307 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 581
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 582 NLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
N++ + + LI Y SL +L + L +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 638 LYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIV 690
+LH + I HRDLK+ NIL+ ++ I+D G+A M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 691 GTYGYMSPE------YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS---FNLLG 741
GT YM+PE + D+++FG+++ E+ + G+ ++++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 742 HAWSLC--------KNDRAHELMDPVLQNEV-SLPMLVRYINVALLCVQENAEDRPTMSD 792
+ S R P + N S P L + C +N R T
Sbjct: 239 NDPSFEDMRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 793 VVSMINN 799
+ +
Sbjct: 293 IKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 35/301 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 582
+ + ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 583 LVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
++ + I+ LI +Y N SL +L K L + +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 639 YLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVG 691
+LH + I HRDLK+ NIL+ ++ I+D G+A F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 692 TYGYMSPEYALEGVFSV-------KSDVFSFGVLMLEILSSKKNTGV---YNTDSFNLLG 741
T YM PE L+ + +D++SFG+++ E+ + G+ Y +L+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 742 HAWSLCKNDRA--HELMDPVL-QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
S + + P S L + + C N R T V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 799 N 799
Sbjct: 328 K 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 66/303 (21%), Positives = 127/303 (41%), Gaps = 47/303 (15%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 586
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 587 LGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ + L+ +Y + SL +L ++ + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 643 -----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGY 695
+ I HRDLK+ NIL+ ++ I+D G+A D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 696 MSPEYALEGVFSV-------KSDVFSFGVLMLEILSSKKNTGV---YNTDSFNLLGHAWS 745
M+PE L+ ++ ++D+++ G++ EI G+ Y ++L+ S
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 746 LCKNDRAHELMDPVLQNEV---------SLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+ E+ V + ++ S L + C N R T +
Sbjct: 277 V------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 797 INN 799
++
Sbjct: 331 LSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-50
Identities = 70/285 (24%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+VRL+G C ++ ++ E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEY 700
IHRDL A N L+ + KISDFGM+R G +++ + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCK----NDRAHE 754
G +S +SDV+SFG+L+ E S + + N + + L D
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
LM C RP+ S + + +
Sbjct: 347 LM--------------------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 62/307 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQL 625
QH ++V+ G C + I+++EYM + L+ FL K LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--EL 682
+ I IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 683 QGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSF 737
G+T R +M PE + F+ +SDV+SFGV++ EI + K + NT+
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 738 NLLGHAWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSD 792
+ L C +++M L C Q + R + +
Sbjct: 246 ECITQGRVLERPRVCP-KEVYDVM--------------------LGCWQREPQQRLNIKE 284
Query: 793 VVSMINN 799
+ +++
Sbjct: 285 IYKILHA 291
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 36/295 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R IHRDL NIL++ KI DFG+ ++ D+ ++ +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA-WSLCKN 749
+ +PE E FSV SDV+SFGV++ E+ + + + + ++G+
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 750 DRAHELMDPVLQNE-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
L++ + N P + Y + C N RP+ D+ ++
Sbjct: 239 ---FHLIELLKNNGRLPRPDGCPDEI-Y-MIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 79/306 (25%), Positives = 128/306 (41%), Gaps = 39/306 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H ++++ GCC + G L+ EY+ SL +L +H +G + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RI 689
+ YLH IHRDL A N+LLD KI DFG+A+ ++ +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749
+ +PE E F SDV+SFGV + E+L+ ++ T L+G A
Sbjct: 203 -----WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 750 DRAHELMDPVLQNEVSLPMLVR-----YINVALLCVQENAEDRPTMSDVVSMINNELFNL 804
L + + + E LP + Y ++ C + A RPT +++ ++ +
Sbjct: 258 ---LRLTELLERGER-LPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPIL-KTVHEK 311
Query: 805 PSPKEP 810
+ P
Sbjct: 312 YQGQAP 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 76/330 (23%), Positives = 130/330 (39%), Gaps = 65/330 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ S+LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G G + L+ EY+ + L FL + L + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R +HRDL A NIL++ + KI+DFG+A++ D+ ++ +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS----------------SKKNTGVYNT 734
+ +PE + +FS +SDV+SFGV++ E+ + + +
Sbjct: 196 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 735 DSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTM 790
LL L HELM LC + +DRP+
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM--------------------KLCWAPSPQDRPSF 291
Query: 791 SDVVSMINNELFNLPSPKEPPFTTFTKGKN 820
S + ++ + FT +GK+
Sbjct: 292 SALGPQLDMLWSGSRGCETHAFTAHPEGKH 321
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-49
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 36/295 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R IHRDL NIL++ KI DFG+ ++ D+ ++ +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA-WSLCKN 749
+ +PE E FSV SDV+SFGV++ E+ + + + + ++G+
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 750 DRAHELMDPVLQNEVSLPMLVR-----YINVALLCVQENAEDRPTMSDVVSMINN 799
L++ + N LP Y + C N RP+ D+ ++
Sbjct: 270 ---FHLIELLKNNGR-LPRPDGCPDEIY-MIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-49
Identities = 90/298 (30%), Positives = 139/298 (46%), Gaps = 42/298 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL ++ I I EYM N SL FL P+ L +L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFI---E 126
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYAL 702
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHEL 755
G F++KSDV+SFG+L+ EI++ + G+ N + L + + C + ++L
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-EELYQL 242
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSP--KEPP 811
M LC +E EDRPT + S++ + F + P
Sbjct: 243 M--------------------RLCWKERPEDRPTFDYLRSVL-EDFFTATEGQYQPQP 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-49
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + I EYM SL +L + L G L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 133
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMS 697
+HRDL A N+L+ + K+SDFG+ + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKND 750
PE E FS KSDV+SFG+L+ EI S + + D + + + C
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP-P 241
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+E+M C +A RP+ + + +
Sbjct: 242 AVYEVM--------------------KNCWHLDAAMRPSFLQLREQLEH 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 89/308 (28%), Positives = 131/308 (42%), Gaps = 63/308 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQ 624
LQH N+V LLG + +I+ Y + L FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--E 681
V ++ IA G+ YL S ++H+DL N+L+ +N KISD G+ R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 682 LQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDS 736
L GN+ R +M+PE + G FS+ SD++S+GV++ E+ S G N D
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 737 FNLLGHAWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMS 791
++ + L C + LM + C E RP
Sbjct: 240 VEMIRNRQVLPCPDDCP-AWVYALM--------------------IECWNEFPSRRPRFK 278
Query: 792 DVVSMINN 799
D+ S +
Sbjct: 279 DIHSRLRA 286
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 8e-49
Identities = 83/300 (27%), Positives = 125/300 (41%), Gaps = 57/300 (19%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 141
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
YL + + +HRDL A N +LD+ K++DFG+AR D + G
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKL 194
Query: 695 ---YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL--- 746
+M+ E F+ KSDV+SFGVL+ E+++ V D L L
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254
Query: 747 --CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804
C D +E+M L C AE RP+ S++VS I+
Sbjct: 255 EYCP-DPLYEVM--------------------LKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-49
Identities = 83/314 (26%), Positives = 134/314 (42%), Gaps = 62/314 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLR 626
QH+++VR G C E ++++EYM + L+ FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQ 683
+ + +A G++YL + L +HRDL N L+ Q + KI DFGM+R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 684 GNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFN 738
G T R +M PE L F+ +SDV+SFGV++ EI + K + NT++ +
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 739 LLGHAWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
+ L C + +M C Q + R ++ DV
Sbjct: 272 CITQGRELERPRACP-PEVYAIM--------------------RGCWQREPQQRHSIKDV 310
Query: 794 VSMINNELFNLPSP 807
+ + L P
Sbjct: 311 HARL-QALAQAPPV 323
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-48
Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 40/295 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 127
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYA 701
+ IHRDL A N L+ ++ K++DFG++R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHE 754
FS+KSDV++FGVL+ EI + + G+ + + LL + + C ++ +E
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-EKVYE 243
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
LM C Q N DRP+ +++ +F S +
Sbjct: 244 LM--------------------RACWQWNPSDRPSFAEIHQAF-ETMFQESSISD 277
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 85/309 (27%), Positives = 135/309 (43%), Gaps = 59/309 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 579 QHRNLVRLLGCCIEQG-----EKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRI 629
H N++RLLG CIE + ++I +M L +L + KH+ L ++
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKF 152
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNT 686
+ IA G+ YL S +HRDL A N +L M ++DFG+++ ++ GD
Sbjct: 153 MVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 687 K---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLG 741
K + +++ E + V++ KSDV++FGV M EI + GV N + ++ L
Sbjct: 210 KMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 742 HAWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
H L C D +E+M C + + DRPT S +
Sbjct: 264 HGHRLKQPEDCL-DELYEIM--------------------YSCWRTDPLDRPTFSVLRLQ 302
Query: 797 INNELFNLP 805
+ L +LP
Sbjct: 303 LEKLLESLP 311
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 36/294 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H N+V+ G C E G LI E++ + SL +L P K+ + + +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RI 689
+ YL + +HRDL A N+L++ KI DFG+ + D+ ++ +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749
+ +PE ++ F + SDV+SFGV + E+L+ + ++G
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 750 DRAHELMDPVLQNEVSLPMLVR-----YINVALLCVQENAEDRPTMSDVVSMIN 798
L++ + + + LP Y + C + +R + +++
Sbjct: 250 ---TRLVNTLKEGKR-LPCPPNCPDEVY-QLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-48
Identities = 76/294 (25%), Positives = 137/294 (46%), Gaps = 38/294 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 334
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYA 701
+ IHR+L A N L+ ++ K++DFG++R+ GD T + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCK----NDRAHEL 755
FS+KSDV++FGVL+ EI + + G+ + + LL + + + ++ +EL
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
M C Q N DRP+ +++ +F S +
Sbjct: 452 M--------------------RACWQWNPSDRPSFAEIHQAF-ETMFQESSISD 484
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-48
Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + + QL + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQL-LEMCKDVCEAMEYL---E 137
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+ +HRDL A N L++ K+SDFG++R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHEL 755
FS KSD+++FGVLM EI S K N+++ + L +++ + +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA-SEKVYTI 253
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPS 806
M C E A++RPT ++S I ++ + S
Sbjct: 254 M--------------------YSCWHEKADERPTFKILLSNI-LDVMDEES 283
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-48
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + L G L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 305
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+HRDL A N+L+ + K+SDFG+ + Q K V + +PE E
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHELM 756
FS KSDV+SFG+L+ EI S + + D + + + C +++M
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP-PAVYDVM 419
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
C +A RPT + + +
Sbjct: 420 --------------------KNCWHLDAATRPTFLQLREQLEH 442
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-47
Identities = 77/292 (26%), Positives = 132/292 (45%), Gaps = 40/292 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L ++ I I E+M SL FL +L + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI---E 301
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYAL 702
+ IHRDL+A+NIL+ + KI+DFG+AR+ +E T R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL--GH---AWSLCKNDRAHEL 755
G F++KSDV+SFG+L++EI++ + G+ N + L G+ C + + +
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP-EELYNI 417
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSP 807
M + C + E+RPT + S++ ++ +
Sbjct: 418 M--------------------MRCWKNRPEERPTFEYIQSVL-DDFYTATES 448
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L+ E+M + L +L + L + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETL-LGMCLDVCEGMAYL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+IHRDL A N L+ ++ K+SDFGM R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHEL 755
+S KSDV+SFGVLM E+ S K N++ + + L + +++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA-STHVYQI 237
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
M C +E EDRP S ++ +
Sbjct: 238 M--------------------NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 62/312 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHLLGWQL 625
H N++ LLG C +G L EY + +L FL + T L QL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G +
Sbjct: 145 -LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKK 198
Query: 686 TK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFN 738
T R +M+ E V++ SDV+S+GVL+ EI+S G+ + +
Sbjct: 199 TMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 739 LLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
L + L K +D ++LM C +E +RP+ + ++
Sbjct: 253 KLPQGYRLEKPLNCDDEVYDLM--------------------RQCWREKPYERPSFAQIL 292
Query: 795 SMINNELFNLPS 806
+N L +
Sbjct: 293 VSLNRMLEERKT 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 41/292 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 580 HRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++ L+G + + YM + L F+ P +++ L + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDL-ISFGLQVARGME 138
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYM 696
YL + + +HRDL A N +LD+ K++DFG+AR E + +
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKN 749
+ E F+ KSDV+SFGVL+ E+L+ + D + L L C
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP- 254
Query: 750 DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
D +++M C + + RPT +V + +
Sbjct: 255 DSLYQVM--------------------QQCWEADPAVRPTFRVLVGEVEQIV 286
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-47
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 297
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 705 VFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCK----NDRAHELMDP 758
F++KSDV+SFG+L+ E+ + + G+ N + + + + + + H+LM
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM-- 414
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTF 815
C ++ E+RPT + + + + F P+ P
Sbjct: 415 ------------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEPQYQPGENL 452
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G C ++ ++ EY+ N L +L + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+ IHRDL A N L+D+ + K+SDFGM R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAHEL 755
+S KSDV++FG+LM E+ S K N++ + L +D +++
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA-SDTIYQI 237
Query: 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
M C E E RPT ++S I
Sbjct: 238 M--------------------YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-47
Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 55/299 (18%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 205
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
+L + + +HRDL A N +LD+ K++DFG+AR E + T
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLP 259
Query: 695 --YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL---- 746
+M+ E F+ KSDV+SFGVL+ E+++ V D L L
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319
Query: 747 -CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804
C D +E+M L C AE RP+ S++VS I+
Sbjct: 320 YCP-DPLYEVM--------------------LKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-47
Identities = 81/305 (26%), Positives = 131/305 (42%), Gaps = 59/305 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRI 629
++VRLLG + ++I E M L +L +P ++ +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM-IQM 143
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNT 686
IA G+ YL + + +HRDL A N ++ + KI DFGM R ++ D G
Sbjct: 144 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200
Query: 687 K---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL- 740
R +MSPE +GVF+ SDV+SFGV++ EI + + G+ N +
Sbjct: 201 LLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 741 -GHAWS---LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
G C D ELM +C Q N + RP+ +++S
Sbjct: 255 EGGLLDKPDNCP-DMLFELM--------------------RMCWQYNPKMRPSFLEIISS 293
Query: 797 INNEL 801
I E+
Sbjct: 294 IKEEM 298
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-47
Identities = 77/317 (24%), Positives = 135/317 (42%), Gaps = 54/317 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 579 QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVR 628
H ++ +L+G + K +I +M + L FL +L L VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL-VR 141
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGN 685
+ IA G+ YL S IHRDL A N +L + M ++DFG++R ++ GD
Sbjct: 142 FMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHA 743
+K V +++ E + +++V SDV++FGV M EI++ + G+ N + +N L
Sbjct: 199 SKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 744 WSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
L C + ++LM C + + RP+ + + +
Sbjct: 256 NRLKQPPECM-EEVYDLM--------------------YQCWSADPKQRPSFTCLRMELE 294
Query: 799 NELFNLPSPKEPPFTTF 815
N L +L +
Sbjct: 295 NILGHLSVLSTSQDPLY 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 34/297 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 380
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 705 VFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCK----NDRAHELMDP 758
F++KSDV+SFG+L+ E+ + + G+ N + + + + + + H+LM
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM-- 497
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTTF 815
C ++ E+RPT + + + + F P+ P
Sbjct: 498 ------------------CQCWRKEPEERPTFEYLQAFL-EDYFTSTEPQYQPGENL 535
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 81/315 (25%), Positives = 123/315 (39%), Gaps = 58/315 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR-MFGGD--ELQGNTK 687
A G YL IHRD+ A N LL KI DFGMAR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 688 ---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGH 742
+ +M PE +EG+F+ K+D +SFGVL+ EI S N + +
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
Query: 743 AWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ C + +M C Q EDRP + ++ I
Sbjct: 261 GGRMDPPKNCP-GPVYRIM--------------------TQCWQHQPEDRPNFAIILERI 299
Query: 798 NNELFNLPSPKEPPF 812
P
Sbjct: 300 EY-CTQDPDVINTAL 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 86/339 (25%), Positives = 142/339 (41%), Gaps = 63/339 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
N SI +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G + +++ EYM N SLD FL QL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQL-VGMLRGIASGMKY 162
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY---- 695
L S + +HRDL A NIL++ ++ K+SDFG+ R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 696 --------MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWS 745
SPE F+ SDV+S+G+++ E++S + + N D + +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268
Query: 746 L-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800
L C ++LM L C Q++ +RP +VS++ ++
Sbjct: 269 LPPPMDCP-AALYQLM--------------------LDCWQKDRNNRPKFEQIVSIL-DK 306
Query: 801 LFNLPSPKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVND 839
L P + + + N+ S + F + D
Sbjct: 307 LIRNPGSLKIITSAAARPSNL-LLDQSNVDITTFRTTGD 344
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 81/315 (25%), Positives = 124/315 (39%), Gaps = 58/315 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR-MFGGD--ELQGNTK 687
A G YL IHRD+ A N LL KI DFGMAR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 688 ---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGH 742
+ +M PE +EG+F+ K+D +SFGVL+ EI S N + +
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 743 AWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ C + +M C Q EDRP + ++ I
Sbjct: 302 GGRMDPPKNCP-GPVYRIM--------------------TQCWQHQPEDRPNFAIILERI 340
Query: 798 NNELFNLPSPKEPPF 812
+ P
Sbjct: 341 EYCTQD-PDVINTAL 354
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 66/301 (21%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
+ ++ RLLG C+ ++ I + M L ++ + ++LL W + IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 695 Y---------MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHA 743
M+ E L +++ +SDV+S+GV + E+++ G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
Query: 744 WSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
L C D + +M C +A+ RP +++ +
Sbjct: 236 ERLPQPPICTID-VYMIM--------------------RKCWMIDADSRPKFRELIIEFS 274
Query: 799 N 799
Sbjct: 275 K 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 82/307 (26%), Positives = 129/307 (42%), Gaps = 62/307 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
I+ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G +++ EYM N SLD FL QL V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQL-VGMLRGVGAGMRY 166
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY---- 695
L S L +HRDL A N+L+D ++ K+SDFG++R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 696 --------MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWS 745
+PE FS SDV+SFGV+M E+L+ + + N D + + +
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR 272
Query: 746 L-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800
L C H+LM L C ++ RP S +VS++ +
Sbjct: 273 LPAPMGCP-HALHQLM--------------------LDCWHKDRAQRPRFSQIVSVL-DA 310
Query: 801 LFNLPSP 807
L P
Sbjct: 311 LIRSPES 317
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 80/329 (24%), Positives = 136/329 (41%), Gaps = 74/329 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 155 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 680 DELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVY 732
D + T + +M+PE + V++ +SDV+SFGVLM EI + + G+
Sbjct: 211 DYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 733 NTDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP 788
+ F LL + K + + +M C RP
Sbjct: 265 VEELFKLLKEGHRMDKPANCTNELYMMM--------------------RDCWHAVPSQRP 304
Query: 789 TMSDVVSMINNEL--------FNLPSPKE 809
T +V ++ L +L P E
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-45
Identities = 76/318 (23%), Positives = 123/318 (38%), Gaps = 71/318 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------------------FDPT 616
+ N+V+LLG C L++EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR- 675
L ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 676 MFGGD--ELQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN-- 728
++ D + GN R +M PE ++ +SDV+++GV++ EI S
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 729 TGVYNTDSFNLLGHAWSL-----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQEN 783
G+ + + + L C + LM LC +
Sbjct: 278 YGMAHEEVIYYVRDGNILACPENCP-LELYNLM--------------------RLCWSKL 316
Query: 784 AEDRPTMSDVVSMINNEL 801
DRP+ + ++
Sbjct: 317 PADRPSFCSIHRILQRMC 334
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 81/325 (24%), Positives = 138/325 (42%), Gaps = 85/325 (26%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------------------- 612
+ H ++++L G C + G +LI EY SL FL
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 613 --FDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668
T L+ WQ I+QG+ YL + ++++HRDL A NIL+ + KI
Sbjct: 143 DERALTMGDLISFAWQ--------ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 669 SDFGMAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
SDFG++R ++ D ++ + +M+ E + +++ +SDV+SFGVL+ EI
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 723 LSSKKN--TGVYNTDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVA 776
++ N G+ FNLL + + ++ + LM
Sbjct: 246 VTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLM-------------------- 285
Query: 777 LLCVQENAEDRPTMSDVVSMINNEL 801
L C ++ + RP +D+ + +
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKMM 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 77/313 (24%), Positives = 132/313 (42%), Gaps = 66/313 (21%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 201 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 680 DELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVY 732
D + T + +M+PE + V++ +SDV+SFGVLM EI + + G+
Sbjct: 257 DYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 733 NTDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP 788
+ F LL + K + + +M C RP
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYMMM--------------------RDCWHAVPSQRP 350
Query: 789 TMSDVVSMINNEL 801
T +V ++ L
Sbjct: 351 TFKQLVEDLDRIL 363
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 81/302 (26%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + QL V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQL-VGMLRGIAAGMK 161
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG---- 694
YL + + +HRDL A NIL++ ++ K+SDFG++R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 695 --YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL---- 746
+ +PE F+ SDV+SFG++M E+++ + + N + + + L
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273
Query: 747 -CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805
C ++LM + C Q+ RP +D+VS++ ++L P
Sbjct: 274 DCP-SAIYQLM--------------------MQCWQQERARRPKFADIVSIL-DKLIRAP 311
Query: 806 SP 807
Sbjct: 312 DS 313
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 45/298 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL K L L + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR-KYSLDLASL-ILYAYQLSTALAY 131
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMS 697
L R +HRD+ A N+L+ + K+ DFG++R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKND 750
PE F+ SDV+ FGV M EIL GV N D + + L C
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP-P 244
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808
+ LM C + RP +++ + + + + +
Sbjct: 245 TLYSLM--------------------TKCWAYDPSRRPRFTELKAQL-STILEEEKAQ 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
RL+G C Q E +++ E L FL ++ + + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL--- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL----QGNTKRIVGTYGYMSPE 699
+HRDL A N+LL KISDFG+++ G D+ + K + + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRA 752
FS +SDV+S+GV M E LS + + + + + C
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPEL 242
Query: 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKE 809
+ LM C EDRP V + ++L S E
Sbjct: 243 YALM--------------------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 69/294 (23%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 578
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
H ++VRLLG C ++ + +Y+ SL + + LL W + IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVG 691
+G+ YL ++HR+L A N+LL +++DFG+A + D+ K +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI- 181
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL--- 746
+M+ E G ++ +SDV+S+GV + E+++ G+ + +LL L
Sbjct: 182 --KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP 239
Query: 747 --CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
C D + +M + C + RPT ++ +
Sbjct: 240 QICTID-VYMVM--------------------VKCWMIDENIRPTFKELANEFT 272
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 81/326 (24%), Positives = 139/326 (42%), Gaps = 72/326 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ ++ I + M L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--- 695
YL R++HRDL A N+L+ + KI+DFG+A++ G +E Y
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179
Query: 696 ------MSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTDSFNLLGHAWSL- 746
M+ E L +++ +SDV+S+GV + E+++ SK G+ ++ ++L L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 747 ----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI----- 797
C D + +M + C +A+ RP +++
Sbjct: 240 QPPICTID-VYMIM--------------------VKCWMIDADSRPKFRELIIEFSKMAR 278
Query: 798 ---------NNELFNLPSPKEPPFTT 814
+E +LPSP + F
Sbjct: 279 DPQRYLVIQGDERMHLPSPTDSNFYR 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-44
Identities = 81/323 (25%), Positives = 138/323 (42%), Gaps = 65/323 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------FDPTKKHLLGWQL 625
+ +H+N++ LLG C + G +I EY +L +L + H QL
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 626 R----VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 681 --ELQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYN 733
+ N + + +M+PE + +++ +SDV+SFGVL+ EI + + GV
Sbjct: 246 YYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 734 TDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
+ F LL + K + + +M C RPT
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMMM--------------------RDCWHAVPSQRPT 339
Query: 790 MSDVVSMINNELFNLPSPKEPPF 812
+V ++ + L S +E +
Sbjct: 340 FKQLVEDLDR-IVALTSNQEMGY 361
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 73/303 (24%), Positives = 122/303 (40%), Gaps = 59/303 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQ 635
H ++V+L+G E+ I I E L +L L+ + L I +
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTK---RIV 690
+ YL + +HRD+ NIL+ K+ DFG++R ++ T+ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-- 746
+MSPE F+ SDV+ F V M EILS K + N D +L L
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235
Query: 747 ---CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803
C + LM C + DRP +++V + ++++
Sbjct: 236 PDLC-PPVLYTLM--------------------TRCWDYDPSDRPRFTELVCSL-SDVYQ 273
Query: 804 LPS 806
+
Sbjct: 274 MEK 276
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-44
Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 64/312 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 578 L-QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL-------------FDPTKKHLLG 622
+ H N+V LLG C + G + +I E+ +L +L + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE 681
+ + +A+G+ +L + + IHRDL A NILL + KI DFG+AR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 682 LQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGV-YN 733
+ +M+PE + V++++SDV+SFGVL+ EI S + GV +
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 734 TDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
+ L + ++ M L C RPT
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTM--------------------LDCWHGEPSQRPT 297
Query: 790 MSDVVSMINNEL 801
S++V + N L
Sbjct: 298 FSELVEHLGNLL 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 58/301 (19%), Positives = 107/301 (35%), Gaps = 62/301 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
KL H++LV G C+ E IL+ E++ SLD +L + W+L + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAA 125
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDELQGNTKR 688
+ +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 689 IVGTYGY-----MSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL 740
+ PE ++ +D +SFG + EI S + + +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 741 GHAWSLCK--NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
L L+ C+ + RP+ ++ +N
Sbjct: 232 EDRHQLPAPKAAELANLI--------------------NNCMDYEPDHRPSFRAIIRDLN 271
Query: 799 N 799
+
Sbjct: 272 S 272
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L E E ++ +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ +VR++G C + E L+ E L+ +L +H+ + + ++ ++ G+
Sbjct: 76 DNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGM 130
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTY 693
YL +HRDL A N+LL KISDFG+++ DE Q + K V
Sbjct: 131 KYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV--- 184
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSLCK--- 748
+ +PE FS KSDV+SFGVLM E S + G+ ++ +L +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 244
Query: 749 -NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPS 806
++LM LC + E+RP + V + N +++ +
Sbjct: 245 CPREMYDLM--------------------NLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + K+ + E SL L + H L L R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLLGTL-SRYAVQVAEGM 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YG 694
YL R IHRDL A N+LL KI DFG+ R ++ + +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE FS SD + FGV + E+ +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 68/308 (22%), Positives = 117/308 (37%), Gaps = 55/308 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
L H N+V LLG C G ++I EY L FL + + D
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
+A+G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGV-YNTDSF 737
+ +M+PE V++ +SDV+S+G+ + E+ S + G+ ++ +
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 738 NLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
++ + + +++M C + RPT +
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIM--------------------KTCWDADPLKRPTFKQI 298
Query: 794 VSMINNEL 801
V +I ++
Sbjct: 299 VQLIEKQI 306
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 77/310 (24%), Positives = 123/310 (39%), Gaps = 63/310 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQ 624
L QH N+V LLG C G ++I EY L FL F
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE-- 681
L + +AQG+ +L + IHRD+ A N+LL KI DFG+AR +
Sbjct: 166 L-LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 682 LQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVY-NTD 735
++GN + + +M+PE + V++V+SDV+S+G+L+ EI S N G+ N+
Sbjct: 222 VKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 736 SFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMS 791
+ L+ + + + + +M C RPT
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIM--------------------QACWALEPTHRPTFQ 315
Query: 792 DVVSMINNEL 801
+ S + +
Sbjct: 316 QICSFLQEQA 325
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-42
Identities = 68/298 (22%), Positives = 115/298 (38%), Gaps = 45/298 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL +K L + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMS 697
L R +HRD+ A N+L+ + K+ DFG++R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKND 750
PE F+ SDV+ FGV M EIL GV N D + + L C
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP-P 619
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808
+ LM C + RP +++ + + + + +
Sbjct: 620 TLYSLM--------------------TKCWAYDPSRRPRFTELKAQL-STILEEEKLQ 656
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-41
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 45/297 (15%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL+G C + + + E L FL ++ + + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL---E 453
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTYGYMSPEY 700
+HR+L A N+LL KISDFG+++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHAWSL-----CKNDRAH 753
FS +SDV+S+GV M E LS + + + + + C +
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP-PELY 569
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
LM C EDRP V + ++L S E
Sbjct: 570 ALM--------------------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 72/318 (22%), Positives = 123/318 (38%), Gaps = 70/318 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRII 630
L H N+V LLG C G LI+EY L +L F + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 631 DG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR- 675
D +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 676 MFGGDELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN-- 728
+ + +M+PE EG++++KSDV+S+G+L+ EI S N
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 729 TGV-YNTDSFNLLGHAWSLCK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQEN 783
G+ + + + L+ + + + + + + +M C +
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM--------------------QSCWAFD 315
Query: 784 AEDRPTMSDVVSMINNEL 801
+ RP+ ++ S + +L
Sbjct: 316 SRKRPSFPNLTSFLGCQL 333
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 68/318 (21%), Positives = 122/318 (38%), Gaps = 48/318 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 583 LVRLLGCCIE---------QGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRII 630
+VR +E K+ +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-- 688
IA+ + +LH ++HRDLK SNI K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 689 --------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740
VGT YMSPE +S K D+FS G+++ E+L Y +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--------YPFSTQMER 233
Query: 741 GHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800
+ +N + L E + + + + +RP ++ I N
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVM------VQ---DMLSPSPMERPEAINI---IENA 281
Query: 801 LF-NLPSPKEPPFTTFTK 817
+F +L P + ++
Sbjct: 282 VFEDLDFPGKTVLRQRSR 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 584 VRLLGCCIEQGEKI----------------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRV 627
V GC + E+ +L+ ++ + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
+ + I +G+ Y+H ++I+RDLK SNI L KI DFG+ D G
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747
R GT YMSPE + + D+++ G+++ E+L + T F ++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKF------FTDL 231
Query: 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
++ ++ D + L++ + + EDRP S++
Sbjct: 232 RDGIISDIFDKKEKT------LLQ------KLLSKKPEDRPNTSEI 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 44/273 (16%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 589 CCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
+ +L+ E M + +L +L K+ ++ ++ I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 644 SRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK NI + + KI D G+A + K ++GT +M+PE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 703 EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA------HELM 756
E DV++FG+ MLE+ +S+ + +S C+N +
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSE---------------YPYSECQNAAQIYRRVTSGVK 247
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPT 789
P + I C+++N ++R +
Sbjct: 248 PASFDKVAI-PEVKEIIE---GCIRQNKDERYS 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 22/274 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 580
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLY 639
N+++ IE E ++ E L + K+ L+ + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
+H R++HRD+K +N+ + K+ D G+ R F ++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
E ++ KSD++S G L+ E+ + + + D NL + + D P+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCD-----YPPL 258
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
+ S + + +C+ + E RP ++ V
Sbjct: 259 PSDHYSEEL----RQLVNMCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 62/293 (21%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+ E G ++ +Y L + + K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+I+HRD+K+ NI L + ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
++ KSD+++ G ++ E+ + K + S L+ ++
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMK---------------NLVLKIIS 239
Query: 762 NEVSLPMLVRY----INVALLCVQENAEDRPTMSDVVSM--INNELFNLPSPK 808
P+ + Y ++ + N DRP+++ ++ I + SP+
Sbjct: 240 GSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQ 291
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMM 573
F S++ +SI ++G GG V++ Q A+K L Q L ++NE+
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 574 LIAKLQHRNL--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ KLQ + +RL I ++ E N L+ +L KK + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWK 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ + + +HQ+ I+H DLK +N L+ K+ DFG+A D VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 692 TYGYMSPEYALEGV------------FSVKSDVFSFGVLMLEILSSK 726
T YM PE A++ + S KSDV+S G ++ + K
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 64/266 (24%), Positives = 102/266 (38%), Gaps = 19/266 (7%)
Query: 466 RKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE 525
+ + +D + L F + R F G+ + + S +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSF---RGEASETLQSPGYDPSRPESFF--QQ 57
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+F S+LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
VRL E G L E SL L Q+ + D L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHLH 174
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++H D+K +NI L K+ DFG+ G + G YM+PE
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE-L 227
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK 727
L+G + +DVFS G+ +LE+ + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 27/257 (10%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+ ++ G D +S SV +SI ++G GG V++
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVL 76
Query: 546 LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQGEKILIYE 601
Q A+K L Q L ++NE+ + KLQ + +RL I ++ E
Sbjct: 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
N L+ +L KK + R + + + +HQ+ I+H DLK +N L+
Sbjct: 137 C-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV------------FSVK 709
K+ DFG+A D VG YM PE A++ + S K
Sbjct: 190 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPK 247
Query: 710 SDVFSFGVLMLEILSSK 726
SDV+S G ++ + K
Sbjct: 248 SDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+SI ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 583 L--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+RL I ++ E N L+ +L KK + R + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE- 699
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 700 ----------YALEGVFSVKSDVFSFGVLMLEILSSK 726
+ S KSDV+S G ++ + K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF---------LFD--PTKKHLLGWQLRVRIID 631
+VR +E+ + + KS L+D ++ R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF------------GG 679
I + L Y+H IIHRDLK NI +D+ N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 680 DELQGNTKRIVGTYGYMSPE-YALEGVFSVKSDVFSFGVLMLEIL 723
N +GT Y++ E G ++ K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 639 YLHQ--YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H+ ++HRDLK +N+ LD N K+ DFG+AR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILS 724
SPE ++ KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCA 211
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 64/315 (20%), Positives = 121/315 (38%), Gaps = 48/315 (15%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
V +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 579 QHRNLVRLLGCCIEQGEK----ILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGI 633
H N++RL+ C+ + L+ + +L + K + L + ++ GI
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-----MFGGDELQGNTKR 688
+GL +H HRDLK +NILL P + D G + G +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 689 I--VGTYGYMSPE------YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740
T Y +PE + V ++DV+S G ++ ++ + ++
Sbjct: 201 AAQRCTISYRAPELFSVQSHC---VIDERTDVWSLGCVLYAMM--------FGEGPYD-- 247
Query: 741 GHAWSLCKNDRAHELMDPVLQNEVSLPMLVRY----INVALLCVQENAEDRPTMSDVVSM 796
+ + + +QN++S+P R+ + + + RP + ++S
Sbjct: 248 -------MVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 797 INNELFNLPSPKEPP 811
+ E P+P +
Sbjct: 301 L--EALQPPAPGQHT 313
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 592 EQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
E I I+ E + SL L Q I +GL YLH +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 651 RDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV--FS 707
RD+K N+L++ + KISDFG ++ G + T+ GT YM+PE +G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 708 VKSDVFSFGVLMLEILSSK 726
+D++S G ++E+ + K
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 71/328 (21%), Positives = 125/328 (38%), Gaps = 45/328 (13%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKR 556
E + D + + + + ++F S+LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 557 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--F 613
+ + E+ ++ + +V G GE + E+M SLD L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
+ +LG ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG+
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI------LSSKK 727
+ + N+ VGT YMSPE +SV+SD++S G+ ++E+ +
Sbjct: 179 SGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 728 NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM----LVRYIN--------- 774
+ + G A R + PM L+ YI
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294
Query: 775 ----------VALLCVQENAEDRPTMSD 792
V C+ +N +R +
Sbjct: 295 GVFSLEFQDFVN-KCLIKNPAERADLKQ 321
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 575
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA- 634
+ V G +G+ + E M + SLD F K G + I+ IA
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 635 ---QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L +LH S+L +IHRD+K SN+L++ K+ DFG++ D++ + G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AG 171
Query: 692 TYGYMSPE----YALEGVFSVKSDVFSFGVLMLEI 722
YM+PE + +SVKSD++S G+ M+E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L + I+HR++K NI+ D K++DFG AR DE + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 696 MSPE--------YALEGVFSVKSDVFSFGVLMLEILS 724
+ P+ + + D++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + E ++ EY+ SL D + + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++IHRD+K+ NILL + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 703 EGVFSVKSDVFSFGVLMLE 721
+ K D++S G++ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 42/203 (20%), Positives = 82/203 (40%), Gaps = 24/203 (11%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
++ + GG G +Y +NG+ V +K L + + E +A++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 586 LL--GCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ ++ + Y EY+ +SL L + + I L YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYL 198
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H + +++ DLK NI+L + K+ D G + GT G+ +PE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEI 248
Query: 701 ALEGVFSVKSDVFSFGVLMLEIL 723
G +V +D+++ G + +
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH+ R+IHRDLK N+ L++ + KI DFG+A D + + GT Y++
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + S + DV+S G +M +L K
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH R R+IHRDLK N+ L++ + KI DFG+A D + + GT Y++
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 183
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + S + DV+S G +M +L K
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L + I+HR++K NI+ D K++DFG AR DE + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 696 MSPE--------YALEGVFSVKSDVFSFGVLMLEILS 724
+ P+ + + D++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 518 ASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 577 KLQHRNLVRLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
L +V L G E G + I+ E + SL + + L + + +
Sbjct: 106 GLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALE 161
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKR---IVG 691
GL YLH RI+H D+KA N+LL + + DFG A D L + I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +M+PE + K D++S +ML +L+
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
I KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
++ E L+ EY+ +L ++ L + + I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+RI+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGE 187
Query: 705 VFSVKSDVFSFGVLMLEIL 723
+D++S G+++ E+L
Sbjct: 188 ATDECTDIYSIGIVLYEML 206
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 55/204 (26%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LLG G+ ++ E+ ++D + + L Q++V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
RIIHRDLKA N+L+ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 700 --YALEGVFSVKSDVFSFGVLMLE 721
+ + K+D++S G+ ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 581
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V+ G +G+ + E M + S D F +L + I+ I + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
+L L+IIHRD+K SNILLD+ N K+ DFG++ + G YM+
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMA 193
Query: 698 PE----YALEGVFSVKSDVFSFGVLMLEI 722
PE A + V+SDV+S G+ + E+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 584
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R C + + + E +L ++ K + ++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 644 SRLRIIHRDLKASNILL-----DQHMNPKISDFGMARMFGGDEL-QGNTKRIVGTYGYMS 697
L I+HRDLK NIL+ + ISDFG+ + + GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 698 PEY---ALEGVFSVKSDVFSFGVLMLEILS 724
PE + + D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V + + E ++ E++ +L D + L + + + + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+IHRD+K+ +ILL K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 703 EGVFSVKSDVFSFGVLMLE 721
+++ + D++S G++++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+V+ G + + ++ EY S+ D + K L ++ I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIAT-ILQSTLKGLEYLH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+R IHRD+KA NILL+ + K++DFG+A + NT ++GT +M+PE
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 702 LEGVFSVKSDVFSFGVLMLE 721
E ++ +D++S G+ +E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 55/297 (18%), Positives = 103/297 (34%), Gaps = 56/297 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 579
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGL 637
H ++VR E ++ EY SL + + +L+ ++ + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDFGMARMFG 678
Y+H + ++H D+K SNI + + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF 737
+ + G +++ E E K+D+F+ + ++ ++
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE--------PLP 231
Query: 738 NLLGHAW-SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
G W + + P + +S + + + + E RP+ +
Sbjct: 232 R-NGDQWHEIRQGRL------PRIPQVLSQEF----TELLKVMIHPDPERRPSAMAL 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
+ ++ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 584 VRLLGCCIEQGEKI-------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
V + +K+ L EY L +L L ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
L YLH+ RIIHRDLK NI+L Q + KI D G A+ EL VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
Y++PE + ++V D +SFG L E ++
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/201 (27%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S D + L I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL +H K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 192 KQSAYDSKADIWSLGITAIEL 212
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 40/303 (13%), Positives = 85/303 (28%), Gaps = 67/303 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 580
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 581 --------RNLVRLLGCC-----------IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+LV+ + + +Y M + L + H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH ++H L+ +I+LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 679 GDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGV-- 731
G R + + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-----CADLP 316
Query: 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMS 791
D+ A + + ++ ++P VR + L + EDR
Sbjct: 317 NTDDA---------------ALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPL 359
Query: 792 DVV 794
+
Sbjct: 360 QAM 362
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 582
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V + + E L+ + + S+ D+ K L I I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM-ARMFGGDELQGNTKR--IVGTYG 694
YLH + IHRD+KA NILL + + +I+DFG+ A + G ++ N R VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 695 YMSPEYALEGV-FSVKSDVFSFGVLMLEI 722
+M+PE + + K+D++SFG+ +E+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 65/342 (19%), Positives = 123/342 (35%), Gaps = 60/342 (17%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
+V ++ L EGGF VY+ + + +G+E A+KRL + + + E+ + K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 578 LQ-HRNLVRLLGCCIEQGEK-------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ E+ L+ + L FL + L ++I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+ + ++H + IIHRDLK N+LL K+ DFG A + +
Sbjct: 142 FYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 690 ----------VGTYGYMSPEYALEGVFSV--------KSDVFSFGVLMLEILSSKKNTGV 731
T Y +PE + + K D+++ G ++ +
Sbjct: 201 RALVEEEITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLL--------C 247
Query: 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRY----INVALLCVQENAEDR 787
+ F ++ + S+P ++ +Q N E+R
Sbjct: 248 FRQHPFE--------------DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 788 PTMSDVVSMINNELFNLPSPKEPPFTTFTKGKNMKYSSNSTS 829
++++VV + + P T + +N Y S + S
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSPITELLE-QNGGYGSATLS 334
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
E+F + + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTK---KHLLGWQLRVRIIDGIAQG 636
+++ L E + L+ E N + K K + R + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
+LYLH + I+HRDL SN+LL ++MN KI+DFG+A + T + GT Y+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEIL 723
SPE A ++SDV+S G + +L
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 22/233 (9%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-S 558
G K + A + ++G G G V+K R G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 559 NQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF---LFD 614
+ + + K ++ +++ +V+ G I + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
P + +LG ++ I + L YL + +IHRD+K SNILLD+ K+ DFG++
Sbjct: 120 PIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 675 RMFGGDELQGNTKRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEI 722
D+ + G YM+PE + + +++DV+S G+ ++E+
Sbjct: 173 GRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 8e-30
Identities = 28/318 (8%), Positives = 66/318 (20%), Gaps = 50/318 (15%)
Query: 513 PLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 568
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 569 KNEMMLIAKLQHRNLVRLLGCC--------------------------IEQGEKILIYEY 602
A+L + +L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 603 MV---NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
F + G + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL--EGVFSVKSDVFSFGV 717
+ + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 718 LMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVAL 777
+ + + R + LP V+ +
Sbjct: 282 SIYRVW-----CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336
Query: 778 LCVQENAEDRPTMSDVVS 795
L + R + +
Sbjct: 337 LNF--DRRRRLLPLEAME 352
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
+ LG GG V+ R L + ++VAVK L + F+ E A L H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 585 RLLGCCIEQGEKILIY----EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + + EY+ +L + + + + + +I Q L +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NTKRIVGTYGYMSPE 699
H + IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 700 YALEGVFSVKSDVFSFGVLMLEIL 723
A +SDV+S G ++ E+L
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVL 213
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 567
++ I L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSL-----DVFLFDPTKKHLL 621
FKNE+ +I +++ + G I +++ +IYEYM N S+ F+ D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
Q+ II + Y+H + I HRD+K SNIL+D++ K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVK-------SDVFSFGVLMLEIL 723
++G GTY +M PE FS + D++S G+ + +
Sbjct: 207 IKG----SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D L + KK L ++ + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM-ARMFGGDELQGNTKR--IVGTYGYM 696
LH +IHRD+KA NILL + K+ DFG + M VGT +M
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWM 217
Query: 697 SPE---YALEGVFSVKSDVFSFGVLMLEI 722
+PE EG + K DV+S G+ +E+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
++ +G GG G VY+ + + VA+K +S + E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G+ + + L L ++ L V I+ I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALE 703
HRD+K NIL+ + DFG+A ++L Q VGT YM+PE E
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSE 209
Query: 704 GVFSVKSDVFSFGVLMLEIL 723
+ ++D+++ ++ E L
Sbjct: 210 SHATYRADIYALTCVLYECL 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 67/344 (19%), Positives = 111/344 (32%), Gaps = 86/344 (25%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F +G GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID----------- 631
+VR +E + E D P V+I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 632 ----GIAQGLLY----------LHQYSRLR-----------------------------I 648
+ LY L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK----------RIVGTYGYMSP 698
+HRDLK SNI K+ DFG+ DE + VGT YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
E +S K D+FS G+++ E+L Y+ + + +N + L
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELL--------YSFSTQMERVRIITDVRNLKFPLLFTQ 297
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802
E + + + + +RP +D+ I N +F
Sbjct: 298 KYPQEHMM------VQ---DMLSPSPTERPEATDI---IENAIF 329
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 56/227 (24%), Positives = 85/227 (37%), Gaps = 36/227 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVR 585
+ LG G G V G+ VAVKR+ E+ +L H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 586 LLGCCIEQGEKI-LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
C + + E N +L + L + ++ IA G+ +L
Sbjct: 74 YY-CSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 641 HQYSRLRIIHRDLKASNILLD-------------QHMNPKISDFGMARMFGGDE--LQGN 685
H L+IIHRDLK NIL+ +++ ISDFG+ + + + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 686 TKRIVGTYGYMSPEYALEGVFSV-------KSDVFSFGVLMLEILSS 725
GT G+ +PE E D+FS G + ILS
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 42/308 (13%), Positives = 89/308 (28%), Gaps = 74/308 (24%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 579
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 580 ----------------HRNLVRLLGCC--IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+ ++R+ + + +Y M + L + H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH Y ++H L+ +I+LDQ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 679 GDELQGNTKRIVGTYGYMSPEYAL-----------EGVFSVKSDVFSFGVLMLEILSSKK 727
G + G+ PE + + D ++ G+++ I
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW---- 307
Query: 728 NTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR 787
D A + + ++ ++P VR + L EDR
Sbjct: 308 -CADL---PIT----------KDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--PKEDR 351
Query: 788 PTMSDVVS 795
+
Sbjct: 352 LLPLQAME 359
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
E+F I LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G ++ LI EY ++ L K Q I +A L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
Y H R+IHRD+K N+LL KI+DFG + + GT Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPP 176
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E + K D++S GVL E L
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 34/222 (15%), Positives = 67/222 (30%), Gaps = 22/222 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD--VFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ + Q +L+ E +L + L+ T + ++ L + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----------KISDFGMARMFGGDELQG 684
+ +H IIH D+K N +L + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T G+ E ++ + D F + +L
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 56/315 (17%), Positives = 101/315 (32%), Gaps = 48/315 (15%)
Query: 518 ASVTAATENFSIQSKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEM 572
+S + + + +G+G V R G+ V V+R L S + + + E+
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+ H N+V I E ++ +M S D L + I+
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT----- 686
G+ + L Y+H + +HR +KAS+IL+ +S +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 687 KRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEI---------------------- 722
K V ++SPE + + + KSD++S G+ E+
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 723 ----LSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRY----IN 774
L A S + P + S P + +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 775 VALLCVQENAEDRPT 789
C+Q N + RP+
Sbjct: 313 FVEQCLQRNPDARPS 327
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRI 629
+L+H+N+VRL + L++E+ S + L K L +QL
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQL---- 110
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+GL + H ++HRDLK N+L++++ K+++FG+AR F G ++ + +
Sbjct: 111 ----LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 690 VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKK 727
V T Y P+ ++S D++S G + E+ ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L H N+V L+ + L++E+M V L D K L +QL
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQL----- 128
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+G+ + HQ+ RI+HRDLK N+L++ K++DFG+AR F G ++ T +V
Sbjct: 129 ---LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +P+ + +S D++S G + E+++ K
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQ 563
S + E ++I LG+G FG V K + + QE AVK + ++ +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 564 GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLL 621
E+ L+ KL H N+++L + ++ E L FD +K
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678
RII + G+ Y+H+ I+HRDLK NILL ++ + KI DFG++ F
Sbjct: 120 EHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ K +GT Y++PE L G + K DV+S GV++ +LS
Sbjct: 176 QNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L ++ L+ E L FD + II + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
YLH+ I+HRDLK N+LL ++ KI DFG++ +F + K +GT Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++PE L + K DV+S GV++ +L+
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLA 232
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL 565
S SL +++ F + +G G +G VYKGR + GQ A+K + + +G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEE 64
Query: 566 KEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSL-DVFLFDPTK 617
+E K E+ ++ K HRN+ G I++ L+ E+ S+ D L TK
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTK 122
Query: 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+ L + I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 678 GGDELQGNTKRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEI 722
+ NT +GT +M+PE + + KSD++S G+ +E+
Sbjct: 180 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 19/227 (8%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFS----IQSKLGEGGFGPVYKGR-LLNGQEVAVKR 556
+ DK + + V + I +LG G FG V++ G+ K
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-- 614
++ KNE+ ++ +L H L+ L ++ E +LI E++ LFD
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE----LFDRI 139
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFG 672
+ + + + + +GL ++H+ I+H D+K NI+ + KI DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+A DE K T + +PE +D+++ GVL
Sbjct: 197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 22/234 (9%)
Query: 501 GDGKDKSKDSSLP-LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS 558
G G + P +F S ++ + Q LG+G FG V + + GQE AVK +S
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 559 N---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
+ + E+ L+ +L H N+++L ++G L+ E L FD
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE 116
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISD 670
++K RII + G+ Y+H+ +I+HRDLK N+LL + N +I D
Sbjct: 117 IISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIID 172
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
FG++ F + K +GT Y++PE L G + K DV+S GV++ +LS
Sbjct: 173 FGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 575
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+L+H N+VRL + + L++E+M + K +D T + L ++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ QGL + H+ +I+HRDLK N+L+++ K+ DFG+AR F G + + +V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y +P+ + +S D++S G ++ E+++ K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L+H N+V+L + +L++E++ + + L T K L QL
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQL----- 109
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
G+ Y H R++HRDLK N+L+++ KI+DFG+AR F G ++ T IV
Sbjct: 110 ---LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +P+ + +S D++S G + E+++
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 576
+ +K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 577 KLQHRNLVRLLGCCIEQGEKI--------LIYEYMVN------KSLDVFLFDPTKKHLLG 622
L+H N+V L+ C + L++++ + ++ V K ++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG---G 679
L GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F
Sbjct: 131 QML--------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 680 DELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
+ T R+V T Y PE L E + D++ G +M E+ +
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 39/221 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 573
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRV 627
L+ +L H N++ LL + L++++M + K + L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LMT-- 121
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFG+A+ F G + T
Sbjct: 122 ------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 688 RIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSK 726
++V T Y +PE L G ++ V D+++ G ++ E+L
Sbjct: 172 QVV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 578
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+H N+V L + L++EY+ + K L +QL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL Y H+ +++HRDLK N+L+++ K++DFG+AR + +V T
Sbjct: 110 -LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y P+ L +S + D++ G + E+ + +
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + +KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVRII 630
+LQHRN++ L LI+EY + K +D + K L +QL
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQL----- 141
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN 685
G+ + H R +HRDLK N+LL KI DFG+AR F G ++
Sbjct: 142 ---INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 686 TKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T I+ T Y PE L +S D++S + E+L
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGR-LLNGQ 550
+ F VTA + LG G FG V+K G
Sbjct: 56 SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115
Query: 551 EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610
++A K + + + +E KNE+ ++ +L H NL++L + + +L+ EY+
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE--- 172
Query: 611 FLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-- 666
LFD + + L + + I +G+ ++HQ + I+H DLK NIL
Sbjct: 173 -LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQI 228
Query: 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
KI DFG+AR + E K GT +++PE S +D++S GV+
Sbjct: 229 KIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
++F I LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGL 637
H N++R+ ++I L+ E+ L + K Q ++ +A L
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEIL 723
PE K D++ GVL E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
E ++I LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L + ++ E L FD +K RII + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
Y+H+ I+HRDLK NILL ++ + KI DFG++ F + K +GT Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 696 MSPEYALEGVFSVKSDVFSFGVLM 719
++PE L G + K DV+S GV++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ +++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++RL + + L+ E LF+ K+ RI+ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 641 HQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
H+ L + HRDLK N L K+ DFG+A F ++ + VGT Y+S
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 698 PEYALEGVFSVKSDVFSFGVLM 719
P+ LEG++ + D +S GV+M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 577
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGW---QLRVRIIDG 632
L+H ++V LL G +++E+M L + + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGR 193
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
VGT +M+PE + DV+ GV++
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 581
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-----PTKKHLLGWQLRVRIIDGIAQG 636
N++++ + ++ E L + + L ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 637 LLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
L Y H ++H+DLK NIL H KI DFG+A +F DE GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLM 719
YM+PE + + K D++S GV+M
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 577
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRIID 631
L+H NLV LL C ++ L++E++ + L++F D + L +Q+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQI------ 133
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
G+ + H + IIHRD+K NIL+ Q K+ DFG AR + +
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 692 TYGYMSPEYALEGVF---SVKSDVFSFGVLMLEILSSK 726
T Y +PE + V +V DV++ G L+ E+ +
Sbjct: 187 TRWYRAPELLVGDVKYGKAV--DVWAIGCLVTEMFMGE 222
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 569
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 570 NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRV 627
NE+ L+ L H N+++L ++ L+ E+ L F+ +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQG 684
I+ I G+ YLH+ I+HRD+K NILL + +N KI DFG++ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +GT Y++PE L+ ++ K DV+S GV+M +L
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 529 IQSKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHR 581
K+G G +G VYK + + ++ A+K++ S E+ L+ +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 582 NLVRLLGCCIEQGEKI--LIYEYM--------------VNKSLDVFLFDPTKKHLLGWQL 625
N++ L + ++ L+++Y V L K LL +Q+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQI 137
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG--G 679
G+ YLH ++HRDLK +NIL+ KI+D G AR+F
Sbjct: 138 --------LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 680 DELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
L +V T+ Y +PE L ++ D+++ G + E+L+S+
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 15/223 (6%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ 560
+ P +++ I +LG G FG V++ G A K +
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKK 618
+ + E+ ++ L+H LV L + E ++IYE+M LF+ +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEH 249
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARM 676
+ + V + + +GL ++H+ +H DLK NI+ + K+ DFG+
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ + K GT + +PE A +D++S GVL
Sbjct: 307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+++ + +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
+++H N++ L + + +LI E + L FD + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD-------------FLAEKESLT 106
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH RI H DLK NI+L P K+ DFG+A
Sbjct: 107 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRI 629
+L+H NLV LL + L++EY V LD + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQT---- 111
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
Q + + H++ IHRD+K NIL+ +H K+ DFG AR+ +
Sbjct: 112 ----LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 690 VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y SPE + + + DV++ G + E+LS
Sbjct: 164 A-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 576
+S S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
+++H N++++L E L+ E + LD LF + L L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQLV 140
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+ YL IIHRD+K NI++ + K+ DFG A +L GT
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIE 194
Query: 695 YMSPEYALEGVFSVKS------DVFSFGVLM 719
Y +PE V +++S GV +
Sbjct: 195 YCAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 50/274 (18%), Positives = 86/274 (31%), Gaps = 60/274 (21%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RL 557
S F S+ + + ++ +G+G +G V A+K ++
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 558 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------------CIEQGEKILIYEYMVN 605
+ + ++ K E+ L+ KL H N+ RL G + + +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH---LLDKLNV 121
Query: 606 KSLDVFLFDPTKKHLLGWQLRV----------------------------RIIDGIAQGL 637
D I+ I L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 638 LYLHQYSRLRIIHRDLKASNILL--DQHMNPKISDFGMARMFGGDELQGNT--KRIVGTY 693
YLH I HRD+K N L ++ K+ DFG+++ F GT
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 694 GYMSPEYALEGV---FSVKSDVFSFGVLMLEILS 724
+++PE L + K D +S GVL+ +L
Sbjct: 239 YFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 588 G-CCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLR---VRIIDGIAQGLLYLH 641
E+ +K+ ++ EY V + + D +K Q ++IDG+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+H+D+K N+LL KIS G+A + G+ + PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE-- 181
Query: 702 LEGVFS-------VKSDVFSFGV 717
+ + K D++S GV
Sbjct: 182 ---IANGLDTFSGFKVDIWSAGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++QH N++ L + + ILI E + L FD + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FD-------------FLAEKESLT 112
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 170 FGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 575
AT + +++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 576 AKLQ---HRNLVRLLGCCIEQGEKI-----LIYEYM-------VNKSLDVFLFDPTKKHL 620
+L+ H N+VRL+ C L++E++ ++K+ L T K L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
+ Q +GL +LH I+HRDLK NIL+ K++DFG+AR++
Sbjct: 126 M-RQF--------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 174 --MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 42/214 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
++ L E ++I+E++ + F+ RI
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FE-------------RINTSAFELNEREIV 105
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGN 685
+ + L +LH I H D++ NI+ + KI +FG AR +
Sbjct: 106 SYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-- 160
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ + Y +PE V S +D++S G L+
Sbjct: 161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 48/226 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 582
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 583 LVRLLGCCIEQGEKI------LIYEYM---VNKSLDVFL-----FDPTKKHLLGWQLRVR 628
+V L G+K L+ EY+ V ++ + L +QL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTK 687
+ L Y+H + I HRD+K N+LLD K+ DFG A++ + N
Sbjct: 151 -----LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 688 RIVGTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEILSSK 726
I Y Y +PE Y + D++S G +M E++ +
Sbjct: 201 YICSRY-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 36/222 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 576
+ + +++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 577 KLQHRNLVRLL----GCCIEQGEKI-LIYEYM-------VNKSLDVFLFDPTKKHLLGWQ 624
+H N+VRL ++ K+ L++E++ ++K + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
L +GL +LH + R++HRDLK NIL+ K++DFG+AR++
Sbjct: 129 L--------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G+G F V R +L G+EVA+K + + L++ E+ ++ L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 583 LVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH---------LLGWQLRVRIIDG 632
+V+L IE + + LI EY + FD H Q I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQ----IVSA 126
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ Y H + RI+HRDLKA N+LLD MN KI+DFG + F G
Sbjct: 127 VQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGA 176
Query: 693 YGYMSPEYALEGVFS------VKSDVFSFGVLM 719
Y +PE +F + DV+S GV++
Sbjct: 177 PPYAAPE-----LFQGKKYDGPEVDVWSLGVIL 204
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+V L L+ + + L FD RI++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FD-------------RILERGVYTEKDASL 110
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
+ + YLH+ I+HRDLK N+L +++ I+DFG+++M +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY++PE + +S D +S GV+
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 51/228 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 582 NLVRLLGCCIEQGEKI------LIYEYM---VNKSLDVF------LFDPTKKHLLGWQLR 626
N+VRL GEK L+ +Y+ V + + L K + +QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL- 165
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGN 685
+ L Y+H I HRD+K N+LLD K+ DFG A+ E N
Sbjct: 166 -------FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--N 213
Query: 686 TKRIVGTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEILSSK 726
I Y Y +PE Y + DV+S G ++ E+L +
Sbjct: 214 VSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 107
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 108 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT GY+SPE + +S D+++ GV +L IL
Sbjct: 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYIL 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++P
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 699 EYALEGVFS------VKSDVFSFGV 717
E + DV+S G+
Sbjct: 177 E-----LLKRREFHAEPVDVWSCGI 196
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 130
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY+SPE + +S D+++ GV++
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 557
++D++LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
S + Q L+E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
K L + R +I+ + + + LH+ L I+HRDLK NILLD MN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPE------YALEGVFSVKSDVFSFGVLM 719
+ E + + GT Y++PE + + D++S GV+M
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 53/254 (20%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN 559
G G S +++ + + F ++ G+G FG V G+ G VA+K++
Sbjct: 1 GPGSMMSLNAAAA--ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 560 QSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCCIEQGEK-------ILIYEYM----- 603
F+N M +A L H N+V+L GE+ ++ EY+
Sbjct: 59 D-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH 113
Query: 604 -VNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660
++ P + +QL + + LH S + + HRD+K N+L+
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQL--------IRSIGCLHLPS-VNVCHRDIKPHNVLV 164
Query: 661 DQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPE-------YALEGVFSVKSDV 712
++ K+ DFG A+ E N I Y Y +PE Y + D+
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEP--NVAYICSRY-YRAPELIFGNQHY------TTAVDI 215
Query: 713 FSFGVLMLEILSSK 726
+S G + E++ +
Sbjct: 216 WSVGCIFAEMMLGE 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 47/225 (20%), Positives = 89/225 (39%), Gaps = 53/225 (23%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 574
+ + + LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+ KL H ++++ + + ++ E M L FD +++
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FD-------------KVVGNKR 110
Query: 633 ------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677
+ + YLH IIHRDLK N+LL ++ KI+DFG +++
Sbjct: 111 LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 678 GGDELQGNTKRIVGTYGYMSPE---YALEGVFSVKSDVFSFGVLM 719
G L + + GT Y++PE ++ D +S GV++
Sbjct: 168 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++P
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 699 EYALEGVFS------VKSDVFSFGV 717
E + DV+S G+
Sbjct: 177 E-----LLKRREFHAEPVDVWSCGI 196
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKE 567
++++ ++G+G +G V + A+K LS
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 568 FKNEMML------IA---KLQHRNLVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFD- 614
+ + IA KL H N+V+L+ ++ + +Y E + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEV 128
Query: 615 PTKKHLLGWQLRV---RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
PT K L Q R +I GI YLH +IIHRD+K SN+L+ + + KI+DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 672 GMARMF-GGDELQGNTKRIVGTYGYMSPEYALEGVFSV----KSDVFSFGV 717
G++ F G D L VGT +M+PE +L + DV++ GV
Sbjct: 182 GVSNEFKGSDAL---LSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 53/244 (21%)
Query: 506 KSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-------RL 557
+S L +A+ + + + +G G V + G E AVK RL
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
S + + ++E + E ++ ++ H +++ L+ L+++ M L FD
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FD- 189
Query: 616 TKKHLLGWQLRVRIIDG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLD 661
+ + + + + +LH I+HRDLK NILLD
Sbjct: 190 ------------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE------YALEGVFSVKSDVFSF 715
+M ++SDFG + E + + GT GY++PE + + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 716 GVLM 719
GV++
Sbjct: 292 GVIL 295
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
TE + + +LG+G F V + +L GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+G LI++ + L F+ I+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-------------DIVAREYYSEADA 112
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQ 683
I + +L+ HQ + ++HR+LK N+LL + K++DFG+A G+ Q
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--Q 167
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY+SPE + + D+++ GV++
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 574
+ + + LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDG 632
+ KL H ++++ + + ++ E M LFD K L +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCK-LYFYQ 247
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
+ + YLH+ IIHRDLK N+LL ++ KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 690 VGTYGYMSPE---YALEGVFSVKSDVFSFGVLM 719
GT Y++PE ++ D +S GV++
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRVRIIDG---- 632
V+L Q ++ L Y L L ++ ++ D
Sbjct: 90 PFFVKLYFTF--QDDEKL---YFG---LSYAKNGELLK----YIR----KIGSFDETCTR 133
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I L YLH IIHRDLK NILL++ M+ +I+DFG A++ + Q
Sbjct: 134 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
VGT Y+SPE E SD+++ G ++ ++++
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 56/240 (23%), Positives = 87/240 (36%), Gaps = 47/240 (19%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVK--RLSN 559
D F S+ + + SK LG G F V + GQE A K +
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 560 QSGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
+ E +E+ ++ + ++ L E ILI EY + F
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS---- 118
Query: 619 HLLGWQLRVRIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
+ I +G+ YLHQ I+H DLK NILL
Sbjct: 119 ---------LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166
Query: 661 -DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ KI DFGM+R G + I+GT Y++PE + +D+++ G++
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMML 574
+ + LG+GGFG V+ G L + +VA+K + + S E +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 575 IAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHL-------LGWQLR 626
A H ++RLL E E L+ E + + D+F + K L Q
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLERPLP-AQDLFDYITEKGPLGEGPSRCFFGQ-- 147
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGN 685
++ I + H ++HRD+K NIL+D K+ DFG + +
Sbjct: 148 --VVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--- 195
Query: 686 TKRIVGTYGYMSPEYALEGVFS------VKSDVFSFGVL 718
GT Y PE S + + V+S G+L
Sbjct: 196 -TDFDGTRVYSPPE-----WISRHQYHALPATVWSLGIL 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 34/211 (16%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 578
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 579 QHR--NLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
++RLL E+ + LI E D LFD T++ L +L +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVL 159
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + + H ++HRD+K NIL+D K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 694 GYMSPEYALEGVFS------VKSDVFSFGVL 718
Y PE + V+S G+L
Sbjct: 213 VYSPPE-----WIRYHRYHGRSAAVWSLGIL 238
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 66/315 (20%), Positives = 107/315 (33%), Gaps = 77/315 (24%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
+ + +Q LGEG V L+ QE AVK + Q G E+ ++ + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------- 631
RN++ L+ E+ L++E M S+ I
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LS-------------HIHKRRHFNELEA 113
Query: 632 -----GIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF-----G 678
+A L +LH I HRDLK NIL +Q KI DF +
Sbjct: 114 SVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSV------KSDVFSFGVLMLEILSSKKNTGV- 731
G+ YM+PE +E + D++S GV++ +LS G
Sbjct: 171 SPISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVILYILLS-----GYP 224
Query: 732 -YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPM------------LVRYINVALL 778
+ + G + L + + + + P L+ LL
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS----KLL 280
Query: 779 CVQENAEDRPTMSDV 793
+A+ R + + V
Sbjct: 281 VR--DAKQRLSAAQV 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 43/214 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ F ++S+LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+++L E L+ E + L FD RI++
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-------------RIVEKGYYSERDAAD 152
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
I + + YLH+ I+HRDLK N+L KI+DFG++++ L
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--- 206
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K + GT GY +PE + + D++S G++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 48/209 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQG 636
I ++ EY+ L FD KH G Q I+ +
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKH--GRVEEMEARRLFQQ----ILSAVD-- 125
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
Y H R ++HRDLK N+LLD HMN KI+DFG++ M E + G+ Y
Sbjct: 126 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYA 177
Query: 697 SPEYALEGVFS------VKSDVFSFGVLM 719
+PE V S + D++S GV++
Sbjct: 178 APE-----VISGRLYAGPEVDIWSCGVIL 201
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 69/261 (26%), Positives = 108/261 (41%), Gaps = 53/261 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQL----RVRI-I 630
+V + +K+ I + M L HL + +R
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--------HYHLSQHGVFSEADMRFYA 298
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I GL ++H +++RDLK +NILLD+H + +ISD G+A F + V
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351
Query: 691 GTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA-WSL 746
GT+GYM+PE +GV S D FS G ++ ++L GH+ +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLR----------------GHSPFRQ 393
Query: 747 CKNDRAHELMDPVLQNEVSLP 767
K HE+ L V LP
Sbjct: 394 HKTKDKHEIDRMTLTMAVELP 414
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + ++ E M L D +K + ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 641 HQYSRLRIIHRDLKASNILL-DQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H ++HRDLK SNIL D+ NP +I DFG A+ + G T ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187
Query: 697 SPEYALEGVFSVKSDVFSFGVLM 719
+PE + D++S GVL+
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 48/209 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQG 636
I I ++ EY+ L FD K+ G Q I+ G+
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKN--GRLDEKESRRLFQQ----ILSGVD-- 130
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
Y H R ++HRDLK N+LLD HMN KI+DFG++ M E + G+ Y
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYA 182
Query: 697 SPEYALEGVFS------VKSDVFSFGVLM 719
+PE V S + D++S GV++
Sbjct: 183 APE-----VISGRLYAGPEVDIWSSGVIL 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 65/217 (29%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 588
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 589 CCIEQGEKILIYEYMVNKSLDVF---------LFDPTKKHLLG-----------WQLRVR 628
Y+ + + D+ LFD + Q
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
II I Y H R +I+HRDLK N+LLD ++N KI+DFG++ + K
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKT 166
Query: 689 IVGTYGYMSPEYALEGVFS------VKSDVFSFGVLM 719
G+ Y +PE V + + DV+S G+++
Sbjct: 167 SCGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVL 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-20
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + L+ M + +++ + + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
+LHQ II+RDLK N+LLD N +ISD G+A + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E L + D F+ GV + E++
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 67/228 (29%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
T+++ + + LG G G V + GQ+ A+K L + + + E+ +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRII 630
++V +L +YE M + + LF RI
Sbjct: 82 PHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS-------------RIQ 118
Query: 631 DG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDF 671
+ I + +LH I HRD+K N+L ++ K++DF
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDF 175
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
G A+ + LQ T Y++PE + D++S GV+M
Sbjct: 176 GFAKETTQNALQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 44/207 (21%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------------GIAQ 635
+Q L+ E + L F+ RI +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE-------------RIKKKKHFSETEASYIMRKLVS 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ ++H + ++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLM 719
Y +PE + + D++S GV++
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 43/245 (17%), Positives = 94/245 (38%), Gaps = 53/245 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-------------- 627
N+++L+ G++ + + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 628 -----RIIDG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
+++ + + + ++H L I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 664 MNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLE 721
N K+ DFG A+ + + I + Y +PE L ++ D++S G + E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 722 ILSSK 726
++ K
Sbjct: 235 LILGK 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-19
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + + L+ M L ++ + + R I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAAEICCGLE 300
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
LH R RI++RDLK NILLD H + +ISD G+A + K VGT GYM+P
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP 354
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E ++ D ++ G L+ E++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMI 379
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-19
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 36/179 (20%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRI 689
+A+G+ +L + + IHRDL A NILL + KI DFG+AR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGV-YNTDSFNLLGHAWSL 746
+ +M+PE + V++++SDV+SFGVL+ EI S + GV + + L +
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 747 CK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
++ M L C RPT S++V + N L
Sbjct: 316 RAPDYTTPEMYQTM--------------------LDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 34/160 (21%), Positives = 57/160 (35%), Gaps = 19/160 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H N+V LLG C + G + +I E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 4e-19
Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 41/201 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + I+ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 574 LIAKLQHRNLVRLLGCCI----EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L H ++V++L I E+ +++ ++ E + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ + G+ Y+H S I+HRDLK +N L++Q + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 683 QGNTKRIVGTYGYMSPEYALE 703
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTFPH 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 581
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 582 NLVRLLGCCIEQGEK--ILIYEYMVNKSLDVF---LFDPTKKHLLGWQLRVRIIDGIAQG 636
N++ L + + L++E++ N L D + + +++ +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-YEI--------LKA 142
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L Y H S I+HRD+K N+++D +H ++ D+G+A Q R+ Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 696 MSPEYALEGVFSVKS-DVFSFGVLMLEILSSKK 727
PE ++ S D++S G ++ ++ K+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 53/216 (24%), Positives = 80/216 (37%), Gaps = 68/216 (31%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 591 IEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLG-----------WQLRVRI 629
E ++ + + L++ G Q +
Sbjct: 82 ---------KEVILTPT-HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQ----L 125
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGDELQGNTK 687
+ G++ Y H ++I HRDLK N LLD KI DFG ++ K
Sbjct: 126 LSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 175
Query: 688 RIVGTYGYMSPEYALEGVFS------VKSDVFSFGV 717
VGT Y++PE V +DV+S GV
Sbjct: 176 STVGTPAYIAPE-----VLLRQEYDGKIADVWSCGV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 57/307 (18%), Positives = 99/307 (32%), Gaps = 101/307 (32%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 590 CIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRIIDG------- 632
+YE + + LF RI D
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS-------------RIQDRGDQAFTE 160
Query: 633 ---------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGD 680
I + + YLH + I HRD+K N+L + K++DFG A+
Sbjct: 161 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740
+ T Y++PE + D++S GV+M IL L
Sbjct: 218 N---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY-IL---------------LC 258
Query: 741 GHA--WSLCKNDRAHELMDPVLQNEVSLP------------MLVRYINVALLCVQENAED 786
G+ +S + + + + P ML+R LL
Sbjct: 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR----NLLKT--EPTQ 312
Query: 787 RPTMSDV 793
R T+++
Sbjct: 313 RMTITEF 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 572
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ H N++ L + E L+ E M V + + ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ I GL LH+ ++HRDL NILL + + I DF +AR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
N V Y +PE ++ F+ D++S G +M E+ + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 23/200 (11%), Positives = 57/200 (28%), Gaps = 43/200 (21%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNL 583
+ G ++ L ++VA+ + Q L+E + + ++++ +
Sbjct: 35 LLIFHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R+L + +++ E++ SL +R + +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH-- 146
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
R + S + +S G + M
Sbjct: 147 -RAGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA---- 179
Query: 704 GVFSVKSDVFSFGVLMLEIL 723
+ + D+ G + +L
Sbjct: 180 ---NPQDDIRGIGASLYALL 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + ++ E M + + + + L +LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L G+ +LH IIHRDLK SNI++ KI DFG+AR G +
Sbjct: 136 MLC---------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + D++S G +M E++
Sbjct: 184 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ + + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIID 631
N++ LL + L+ +M + K + + + ++L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ +GL Y+H ++HRDLK N+ +++ KI DFG+AR E+ G V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY----VV 185
Query: 692 TYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L ++ D++S G +M E+L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 6e-17
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + L+ E M + + + + L +LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ G+ +LH IIHRDLK SNI++ KI DFG+AR G +
Sbjct: 173 --------MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 219
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + D++S G +M E++ K
Sbjct: 220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 54/225 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 580
++F I +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG----WQL---------RV 627
LV L Q E+ + +MV +D LLG + L V
Sbjct: 75 PFLVNLWYSF--QDEEDM---FMV---VD---------LLLGGDLRYHLQQNVHFKEETV 117
Query: 628 RI-IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
++ I + L YL RIIHRD+K NILLD+H + I+DF +A M +
Sbjct: 118 KLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I 171
Query: 687 KRIVGTYGYMSPEYALEGVFSVKS--------DVFSFGVLMLEIL 723
+ GT YM+PE +FS + D +S GV E+L
Sbjct: 172 TTMAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 51/229 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
++ S +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ + +H N++ + IEQ + + ++ + M + K+ L + + L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFL- 134
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q LR GL Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 135 YQILR---------GLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DP 180
Query: 682 LQGNTKRI---VGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
+T + V T Y +PE L ++ D++S G ++ E+LS++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 43/203 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+N+ I+ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L+ ++RL I ++ E + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ L G ++H IIHRDLK +N LL+Q + K+ DFG+AR ++
Sbjct: 136 YNLLL---------GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 682 LQGNTKRIVGTYGYMSPEYALEG 704
+ L+
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKK 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 43/257 (16%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
N + +E +D + + TA + F LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 546 L-LNGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
+G A+K L Q LK+ NE ++ + LV+L + L
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNL--- 116
Query: 602 YMVNKSLDVF----LFDPTKKHLLGWQLR-VRIIDG---------IAQGLLYLHQYSRLR 647
YMV ++ +F LR + I YLH
Sbjct: 117 YMV---MEYVAGGEMF---------SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
+I+RDLK N+L+DQ +++DFG A+ ++G T + GT ++PE L ++
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 708 VKSDVFSFGVLMLEILS 724
D ++ GVL+ E+ +
Sbjct: 217 KAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
E+F I +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
+ + L + + L+ +Y V +K D + R +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-----------MARFYL 181
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ + +HQ L +HRD+K NIL+D + + +++DFG D + V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 691 GTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEIL 723
GT Y+SPE +G + + D +S GV M E+L
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 583 LVRLL-------------GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
+V++ + + + ++ EYM V + L + + +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--LLEEHARLFM- 126
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGD 680
+Q LR GL Y+H + ++HRDLK +N+ ++ + + KI DFG+AR+
Sbjct: 127 YQLLR---------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 681 ELQGN--TKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
++ +V T Y SP L ++ D+++ G + E+L+ K
Sbjct: 175 YSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVR 628
N++ LL ++ L+ +M + K L + + L+ +Q
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLV-YQ---- 136
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
+ +GL Y+H IIHRDLK N+ +++ KI DFG+AR E+ G
Sbjct: 137 ----MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTGY--- 185
Query: 689 IVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L ++ D++S G +M E+++ K
Sbjct: 186 -VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 3e-15
Identities = 34/199 (17%), Positives = 57/199 (28%), Gaps = 46/199 (23%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 574
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 575 IAKLQ---------HRNLVRLLGCCIEQGE--KILIYEYMVNKSLDVFLFDPTK------ 617
+L + L QG +L+ + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 618 ------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
L I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 660 LDQHMNPKISDFGMARMFG 678
L + K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 60/237 (25%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ +F ++S LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +H N++ + + +I E M V + L D ++ +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFI- 118
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q LR + LH + +IHRDLK SN+L++ + + K+ DFG+AR+ DE
Sbjct: 119 YQTLR---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DE 164
Query: 682 LQGNTKRIVGTYGYMSPEY-------ALEGVFSVKS-----DVFSFGVLMLEILSSK 726
+ G M E+ A E + + DV+S G ++ E+ +
Sbjct: 165 SAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 497 CEADGDGKDKSKDSSLPLFSFASVTAAT-----ENFSIQSKLGEGGFGPVYKGRLLNGQE 551
+ K+K+ D+ L + E++ + +G G FG V R + ++
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 552 V-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607
V A+K LS + F E ++A +V+L Q ++ L YMV
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRYL---YMV--- 147
Query: 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQ--------GLLYLHQYSRLRIIHRDLKASNIL 659
++ + P L+ + + A+ L +H + IHRD+K N+L
Sbjct: 148 ME---YMP-GGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNML 200
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE----YALEGVFSVKSDVFSF 715
LD+ + K++DFG + + VGT Y+SPE +G + + D +S
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 716 GVLMLEIL 723
GV + E+L
Sbjct: 260 GVFLYEML 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAK 577
+ KLG G F V+ + ++N VA+K + E K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 578 LQHRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ ++++LL +G +++E L L KK+ + + + I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHR-GIPLIYVKQI 136
Query: 634 AQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNP------KISDFGMARMFGGDELQ 683
++ GL Y+H R IIH D+K N+L++ +P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY- 192
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ T Y SPE L + +D++S L+ E+++
Sbjct: 193 ---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 49/226 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
E + S +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ ++H N++ LL +E+ + L+ M + K L D + L+
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLI 138
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR DE
Sbjct: 139 -YQ--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-ADE 185
Query: 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
+ G V T Y +PE L ++ D++S G +M E+L+ +
Sbjct: 186 MTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 45/219 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
++F I LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF-----LFDPTKKHLLGWQLR-VRIIDG-- 632
++R+ G Q + + +M+ +D + LF LR +
Sbjct: 66 PFIIRMWGTF--QDAQQI---FMI---MD-YIEGGELF---------SLLRKSQRFPNPV 107
Query: 633 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ L YLH II+RDLK NILLD++ + KI+DFG A+ +
Sbjct: 108 AKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDV 159
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
T + GT Y++PE ++ D +SFG+L+ E+L+
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F I +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
R + +L + + L+ EY V +K + + R +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-----------MARFYL 168
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I + +H+ L +HRD+K NILLD+ + +++DFG D + V
Sbjct: 169 AEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAV 224
Query: 691 GTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEIL 723
GT Y+SPE G + + D ++ GV E+
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 42/196 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 574 LIAKLQ-HRNLVRLLGCCI-EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQ 624
++ +L H N+V LL + + L+++YM V ++ L K++++ +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVV-YQ 117
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
++ + YLH S ++HRD+K SNILL+ + K++DFG++R F
Sbjct: 118 LIK---------VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 684 GNTKRIVGTYGYMSPE 699
N + + +
Sbjct: 166 TNNIPLSINENTENFD 181
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-13
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ LT + G++L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
K + + GN V+ + ++W+S+ R N V L ++GN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 162 WQSFDY 167
W + Y
Sbjct: 103 WSTGTY 108
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 41/203 (20%), Positives = 81/203 (39%), Gaps = 40/203 (19%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMML----- 574
+ + +G+GGFG +Y + + + VK + +G E K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 575 IAKLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSL-DVFLFDP---TKKHLL 621
I K ++ LG + Y +M+ L ++ + ++K +L
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMFGG 679
QL +RI+D + Y+H++ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 156 --QLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 680 DEL-----QGNTKRIVGTYGYMS 697
+ + + GT + S
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ I S +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
+V L + + L++E L L+D + + G L R +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVG 691
LL+L L IIH DLK NILL KI DFG + G + + I
Sbjct: 167 CTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI---YQYIQS 221
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
+ Y SPE L + + D++S G +++E
Sbjct: 222 RF-YRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 47/258 (18%)
Query: 488 GITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL 547
GI+ + + L ++ A +F +G+G FG V R
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 548 NGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
+ AVK L ++ KE K+ M L+ ++H LV L + +K+ Y
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL----Y 115
Query: 603 MVNKSLDVF-----LFDPTKKHLLGWQL---------RVRI-IDGIAQGLLYLHQYSRLR 647
V LD + LF + L R R IA L YLH L
Sbjct: 116 FV---LD-YINGGELF---------YHLQRERCFLEPRARFYAAEIASALGYLHS---LN 159
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
I++RDLK NILLD + ++DFG+ + + T GT Y++PE +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYLAPEVLHKQP 215
Query: 706 FSVKSDVFSFGVLMLEIL 723
+ D + G ++ E+L
Sbjct: 216 YDRTVDWWCLGAVLYEML 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRI-ID 631
L L + +++ + EY L VF D R R
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGA 255
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRI 689
I L YLH S +++RDLK N++LD+ + KI+DFG+ + + G K
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTF 309
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + + D + GV+M E++
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 20/138 (14%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKN 749
GT Y++PE + D ++ GVLM E++ G S F+++G + + +N
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-----AG----RSPFDIVGSSDNPDQN 265
Query: 750 DRAHELMDPVLQNEVSLP 767
L +L+ ++ +P
Sbjct: 266 TE-DYLFQVILEKQIRIP 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 39/137 (28%), Positives = 69/137 (50%), Gaps = 18/137 (13%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750
GT Y++PE + D ++ GVLM E+++ + F+++G + + +N
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDNPDQNT 223
Query: 751 RAHELMDPVLQNEVSLP 767
L +L+ ++ +P
Sbjct: 224 E-DYLFQVILEKQIRIP 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 126
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G TK
Sbjct: 127 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTK 179
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++FGVL+ E+L
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 447
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G TK
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTK 500
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++FGVL+ E+L
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-12
Identities = 25/123 (20%), Positives = 43/123 (34%), Gaps = 19/123 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
++L+ + G +L + L + Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
L N GNLV+ +QSN IW + + + + V L + N+VI +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 162 WQS 164
W +
Sbjct: 103 WAT 105
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I L YLH +++RD+K N++LD+ + KI+DFG+ + + G K
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + + D + GV+M E++
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L +LHQ II+RDLK NI+L+ + K++DFG+ + + G T
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFC 182
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT YM+PE + + D +S G LM ++L
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
+A L +LH L II+RDLK NILLD+ + K++DFG+++ + +
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYSFC 187
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT YM+PE + +D +SFGVLM E+L
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 38/186 (20%), Positives = 67/186 (36%), Gaps = 63/186 (33%)
Query: 521 TAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
A +++ + S+ LG G G V + ++ A+K L + + + E+ L +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRV 627
Q ++VR++ +YE + + LF
Sbjct: 68 SQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS------------- 104
Query: 628 RIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKI 668
RI D I + + YLH + I HRD+K N+L + K+
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 161
Query: 669 SDFGMA 674
+DFG A
Sbjct: 162 TDFGFA 167
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 35/208 (16%), Positives = 76/208 (36%), Gaps = 48/208 (23%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 569
+ ++S G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 570 -----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHL 620
N+ + + +G + Q + Y ++V +SL D + KH+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHV 155
Query: 621 LG----WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMA 674
L Q+ R++D + +LH+ +H ++ A NI +D ++ + +G A
Sbjct: 156 LSERSVLQVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 675 RMF--GGDEL---QGNTKRIVGTYGYMS 697
+ G + +G+ G ++S
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ + +G+G FG V K Q VA+K + N+ Q +E + ++ L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQD 154
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
N++ +L + + +E L + L++ KK G+ L VR I
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVG 691
Q L LH + RIIH DLK NILL Q K+ DFG + + + +
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQ 261
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+ Y +PE L + + D++S G ++ E+
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L +LH+ L II+RD+K NILLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 693 YGYMSPEYALEG----VFSVKSDVFSFGVLMLEIL 723
YM+P+ G +V D +S GVLM E+L
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELL 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 36/192 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGL 637
++ ++ E + SL+ LFD + + QL R+
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRME------- 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMFGGDELQGNT------ 686
Y+H + +I+RD+K N L+ + N I DF +A+ + + +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYRE 173
Query: 687 -KRIVGTYGYMS 697
K + GT YMS
Sbjct: 174 HKSLTGTARYMS 185
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 579
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
H L + C + E + + EY +N +S F R
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEY-LNGGDLMYHIQSCHKFDLS-----------RATFY 123
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
I GL +LH I++RDLK NILLD+ + KI+DFGM + M G T
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTN 176
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE L ++ D +SFGVL+ E+L
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA--RMFGGDELQGNTKRIV 690
I L++LH II+RDLK N+LLD + K++DFGM + G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE E ++ D ++ GVL+ E+L
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 1e-11
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 18/124 (14%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGK-- 48
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 49 ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQS 164
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-05
Identities = 17/72 (23%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ + + + N NLVL + +N +W+S + + V ++ ++GNLVI S +
Sbjct: 13 GGSLAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAI 71
Query: 156 STESYLWQSFDY 167
+ Q+ +Y
Sbjct: 72 WASNTNRQNGNY 83
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 35/199 (17%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IA 576
+ + K+G GGFG +Y ++ A VK ++G E K + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 577 KLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHLLG--WQL 625
K R + LG K Y +MV L + QL
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ-KISGQNGTFKKSTVLQL 156
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMFGGDEL- 682
+R++D + Y+H+ +H D+KA+N+LL ++ +D+G++ + +
Sbjct: 157 GIRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 683 ----QGNTKRIVGTYGYMS 697
+ K GT + S
Sbjct: 210 KQYQENPRKGHNGTIEFTS 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIA 634
+ + E +L+ + + SL+ L D + Q+ R+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQ---- 120
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMFGGDELQGN---- 685
+H+ S +++RD+K N L+ + + + DFGM + + D +
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPY 172
Query: 686 --TKRIVGTYGYMS 697
K + GT YMS
Sbjct: 173 REKKNLSGTARYMS 186
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 36/192 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 582
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQ 635
+ + C E +++ E + SL+ LF+ + L Q+ RI
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQMISRIE----- 119
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMFGGDELQGNT------ 686
Y+H + IHRD+K N L+ I DFG+A+ + + + +
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRE 171
Query: 687 -KRIVGTYGYMS 697
K + GT Y S
Sbjct: 172 NKNLTGTARYAS 183
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 5e-11
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + +L + + L + + YQ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
LT+ + GNLV+ + +N +W S + L +G VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 162 WQS 164
W
Sbjct: 103 WSL 105
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
F + K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGG 62
Query: 582 NLV-RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR--VRIIDGIAQGLL 638
+ + +E +L+ + + SL+ LF+ + L L+ + + D + +
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL---SLKTVLMLADQMINRVE 117
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMFGGDELQG------NTKRI 689
++H S +HRD+K N L+ I DFG+A+ + D K +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNL 173
Query: 690 VGTYGYMS 697
GT Y S
Sbjct: 174 TGTARYAS 181
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-10
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 19/129 (14%)
Query: 37 FSLAADTLTPTTLIRDGE-TLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANR 95
FS D P L ++ + + + + Y + +W N
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATNT 56
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ G LV++ N T+W S V+ + + V L + N+VI ++
Sbjct: 57 GGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--- 111
Query: 156 STESYLWQS 164
LW +
Sbjct: 112 -----LWAT 115
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 5e-10
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L + R+ + Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
+ L++ + GNLV+ + N IW+SN E N V L + N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 162 WQS 164
W +
Sbjct: 102 WAT 104
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 8e-09
Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 23/126 (18%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSP 98
L + L + L + F+L Y G W N+
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNLV-LYNGNWQS------------NTA 45
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
++ LT+++ G LV+ N T+W S N A + +G LV+ S
Sbjct: 46 NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 159 SYLWQS 164
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 17/125 (13%), Positives = 44/125 (35%), Gaps = 18/125 (14%)
Query: 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPI 99
+ L + ++ D L + + + L + + +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
++ + + + G L + + T++ SN + + V L NG V+ +
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 160 YLWQS 164
+W +
Sbjct: 108 -VWST 111
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 1e-08
Identities = 94/636 (14%), Positives = 181/636 (28%), Gaps = 187/636 (29%)
Query: 245 FIFQPIVVQNKDEVYYMYESYSSPIIM------ILRV-NPLGQVQRLIW---HEMSTGWQ 294
+F+ V N D + + I+ I+ + + RL W + Q
Sbjct: 23 SVFEDAFVDNFD-CKDV-QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 295 VFFTAPDPFCHYGDCGPNSICSVDQTSHCECLEGF---KFKSQQNQTC------VRSHSS 345
F V + ++ F K++Q Q +
Sbjct: 81 KFVE-----------------EVLRINY-----KFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 346 DCKSGDRFKKLDDIKLPDLLDVSLNES-MNLKE-----------CEAECLKNCSCRAYAN 393
F K ++ L ++ + L+ + C +Y
Sbjct: 119 LYNDNQVFAKY-NVSRLQPYL-KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY-- 174
Query: 394 SKVTDGGSGCLMW--FG-------DLIDLKK-----TDNHTNGVSIYIRVPAS-EQGNKK 438
KV + W L L+K N T+ + +
Sbjct: 175 -KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 439 LLWIIVILVLP--LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVN--MGITTRTN 494
L ++ L++L V A+ W+ AF+++ + +TTR
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWN------------------AFNLSCKILLTTR-- 273
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY-KGRLLNGQEVA 553
K + F S T I P K LL +
Sbjct: 274 ----------FKQ------VTDFLSAATTTH---ISLDHHSMTLTPDEVKSLLLKYLDCR 314
Query: 554 VKRLSNQSGQGL--------KEFKNEMMLIAKLQHRN---LVRLLGCCIEQGEKILIYEY 602
+ L + + ++ + +H N L ++ + E +
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 603 MVNKSLDVFLFD---PTKKHLLG--W-QLRVRIIDGIAQGLLYLHQYS---------RLR 647
L VF PT LL W + + + LH+YS +
Sbjct: 375 F--DRLSVFPPSAHIPTI--LLSLIWFDVIKSDVMVVVNK---LHKYSLVEKQPKESTIS 427
Query: 648 I--IHRDLKASNILLDQHMNPKISD-FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
I I+ +LK + + ++ I D + + + F D+L + Y Y + L+
Sbjct: 428 IPSIYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDL---IPPYLDQYFYSHIGHHLKN 483
Query: 705 V-FSVKSDVFSFGVLMLEILSSK-KNTGV---YNTDSFNLL-------GHAWSLCKNDRA 752
+ + +F L L K ++ + N L + +C ND
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY---ICDNDPK 540
Query: 753 HE-----LMDPVLQNEVSLPMLVRY-----INVALL 778
+E ++D + + E L+ + +AL+
Sbjct: 541 YERLVNAILDFLPKIE---ENLICSKYTDLLRIALM 573
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 50/228 (21%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDG 632
V + G + +E L F+ K++ + L +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDFGM 673
+ L +LH ++ H DLK NIL +++DFG
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
A F + IV T Y PE LE ++ DV+S G ++ E
Sbjct: 189 A-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-08
Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 37 FSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRN 96
+ L ++ L + +L + Y W +N +
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCNL------VLY---GGKYGWQSNTH 50
Query: 97 SPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVI 148
++ L ++++G L++ + TIWSS S + V L D+G VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-07
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSG 153
+ + KN L + NLVL W SN ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVL--YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 154 SNSTESYLWQS 164
+W S
Sbjct: 74 KT-----IWSS 79
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 44/227 (19%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 582 ----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDGIA 634
N+V+ G + LI+E L L++ ++ G+ + I
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR------ 688
+ L YL ++ + H DLK NILLD K G TK
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 689 --------------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
I+ T Y +PE L + V SD++SFG ++ E
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 54/230 (23%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ-LRVRIIDGIA 634
V++L G +++E L + +D K++ G+ R+ I +A
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKEN--GFLPFRLDHIRKMA 124
Query: 635 QGLL----YLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDF 671
+ +LH ++ H DLK NIL Q K+ DF
Sbjct: 125 YQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
G A + + +V T Y +PE L +S DV+S G +++E
Sbjct: 182 GSA-TYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 53/276 (19%), Positives = 90/276 (32%), Gaps = 94/276 (34%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + KLG G F V+ + + VA+K + + + +E I L+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDE---IRLLKS-- 89
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF------------LFDPTKKHLLGWQLR---- 626
+ + MV + LD F +F+ HLL W ++
Sbjct: 90 --------VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ 141
Query: 627 ------VR-IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL------------------- 660
V+ II + QGL YLH ++ RIIH D+K NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 661 ------------------------------DQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ + KI+D G A + +
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DI 254
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y S E + ++ +D++S + E+ +
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 8/78 (10%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D V + N+ + G + +L N +W+S SR V L + NL
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 147 VIRDNSGSNSTESYLWQS 164
I + LW +
Sbjct: 226 AIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 24/146 (16%), Positives = 43/146 (29%), Gaps = 11/146 (7%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D VW +N + + + G LV+L N WSS + N V L + +
Sbjct: 44 DVRVWASNTAGATGCR---AVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
I LW S +++ L + S +
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWN 232
RL + + +++ + T
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (112), Expect = 8e-06
Identities = 30/162 (18%), Positives = 52/162 (32%), Gaps = 22/162 (13%)
Query: 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNS 97
+ L + G+ L+SP+QRF+L G + VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNL------VIQD--NGATVWVANEQQ 62
Query: 98 PIV------DKNGVLTVSNRGNLVLLNQSNGTIWSS-----NVSREVKNPVAQLLDNGNL 146
P +K L + L + S +W + + + L D+GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTML---QGMKLGWDLRTG 185
V+ D+ + + +L + G G
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAG 164
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
+ ++ + NLVL N + SN + +L + G L I + +
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 159 SY 160
Y
Sbjct: 75 VY 76
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 | Back alignment and structure |
|---|
Score = 38.6 bits (89), Expect = 9e-04
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 5/50 (10%)
Query: 304 CHYGDCGPNSICSV--DQTSHCECLEGFKFKSQQNQTCVRSHSSDCKSGD 351
C C NS C D+ C+CL +K Q+ CV + + C +
Sbjct: 7 CVKKQCPQNSGCFRHLDEREECKCLLNYK---QEGDKCVENPNPTCNENN 53
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 848 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.76 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.74 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.6 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.57 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.32 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.04 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.04 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.73 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.73 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.02 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 91.92 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 83.36 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.53 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 80.15 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=453.24 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=214.4
Q ss_pred cCcceeeeecccCCccEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 67899999999999999999864 367899999987777777889999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCC----------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 599 IYEYMVNKSLDVFLFDP----------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
|||||++|+|.++|... .....++|..+.+|+.||++||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999998543 22356999999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||....... +....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i---- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI---- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH----
Confidence 99999997755443333444679999999999999999999999999999999999 899986433211 11100
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
..+. ....+...+.++.+++..||+.||++||||.||++.|++...
T Consensus 244 ~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0000 001122334578899999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=454.63 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=207.4
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357889999999999999999864 36789999998777777789999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 598 LIYEYMVNKSLDVFLFDPT------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
||||||++|+|.++++... ....++|..+++|+.||++||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999886532 2346899999999999999999999987 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAW 744 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 744 (848)
+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~-- 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDC-- 272 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHH--
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHH--
Confidence 99999999998765544444455789999999999999999999999999999999999 899986433211 1100
Q ss_pred cccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
. ..+. ....+.....++.+++..||+.||++||||.||++.|+.+..
T Consensus 273 -i-~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 273 -I-TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -H-HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -H-HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 0 0000 001122234578899999999999999999999999988743
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=447.79 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=211.9
Q ss_pred cCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45778899999999999999863 36789999997543 345678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 598 LIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
+|||||++|+|.++|.... ....++|..+.+|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999985432 2346899999999999999999999987 99999999999999999
Q ss_pred CceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccc
Q 003092 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHA 743 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 743 (848)
.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~- 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEM- 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHH-
Confidence 999999999997755444444455689999999999999999999999999999999999 88998643321 11111
Q ss_pred ccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...+. ....+...+..+.+++..||+.||++||||.||++.|+..
T Consensus 260 ---i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 ---IRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ---HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---HHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01110 0112223445788999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=438.88 Aligned_cols=264 Identities=26% Similarity=0.420 Sum_probs=203.8
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..+++++.++||+|+||+||+|++. ..||||+++.. ..+..++|.+|+.+|++++|||||++++++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3467889999999999999999874 36999998643 33456789999999999999999999998865 5689999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|||++|+|.++|... ...+++..+.+|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999988543 346899999999999999999999987 999999999999999999999999999877544
Q ss_pred ccccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.........+||+.|||||++.+ ++|+.++|||||||+||||+||+.||........ +.. ..... ...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~----~~~~~----~~~ 256 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIF----MVGRG----YAS 256 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH----HHHTT----CCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHH----HHhcC----CCC
Confidence 43334455789999999999964 4689999999999999999999999864332111 000 00000 011
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
+.+. ......+..+.+++..||+.||++||||.||++.|+.+...+
T Consensus 257 p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 257 PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111 112223457889999999999999999999999987664333
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=433.06 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=207.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 58999999997665556677899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 9999998884 245899999999999999999999987 9999999999999999999999999999875432
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ...... ... ..+.+.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i----~~~-----~~~~~~-- 291 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMI----RDN-----LPPRLK-- 291 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH----HHS-----SCCCCS--
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH----HcC-----CCCCCC--
Confidence 2234578999999999999999999999999999999999999998543211 111000 000 000110
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......++.+++..||+.||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11123457889999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=439.33 Aligned_cols=269 Identities=27% Similarity=0.386 Sum_probs=217.0
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccCc-ccHHHHHHHHHHHHHcCC-Cceeeee
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH-RNLVRLL 587 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~H-pniv~l~ 587 (848)
....++...++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344555677899999999999999999998643 35799999976543 345779999999999965 8999999
Q ss_pred eeeeeC-CeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc
Q 003092 588 GCCIEQ-GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653 (848)
Q Consensus 588 ~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl 653 (848)
++|.+. +.+++|||||++|+|.++|.... ....+++..+..++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 57899999999999999985432 2345899999999999999999999987 999999
Q ss_pred CCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCC
Q 003092 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (848)
Q Consensus 654 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~ 732 (848)
||+||||++++.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765544444555789999999999999999999999999999999998 89998643
Q ss_pred CCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 733 NTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..... +. .....+ .....+.....++.+++..||+.||++|||+.||++.|++.+
T Consensus 292 ~~~~~-~~----~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 292 KIDEE-FC----RRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCSHH-HH----HHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHH-HH----HHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 32211 00 000010 001112223447889999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=429.82 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=208.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 5899999999753 2345678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999884 3457899999999999999999999987 999999999999999999999999999988655
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.. .+... .. +.. .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~---i~-~~~------~-- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAK---II-KLE------Y-- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH---HH-HTC------C--
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HH-cCC------C--
Confidence 4444556689999999999999999999999999999999999999998643221 11100 00 000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
.++.....++.+++..||+.||++|||+.|++
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11112234688999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=434.44 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=200.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+++.++||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999875 5899999999754 23446789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... +...+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999988532 3345789999999999999999999987 9999999999999999999999999998764321
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... +.. ..... ..
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~---~i~~~-~~--------- 242 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVL---KIISG-SF--------- 242 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH---HHHHT-CC---------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH---HHHcC-CC---------
Confidence 12234689999999999999999999999999999999999999986432211 110 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........++.+++..||+.||++|||+.|+++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112223457889999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=431.24 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=206.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.|++.++||+|+||+||+|++. +|+.||||+++.... ..+|+.+|++++|||||++++++.+++.++|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56889999999999999999975 589999999975432 246999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccCCCcc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDEL 682 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 682 (848)
++|+|.+++. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999884 3456899999999999999999999987 99999999999999987 699999999998754322
Q ss_pred cc---ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 683 QG---NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 683 ~~---~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ .. ........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~~~~~~------- 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CL---KIASEPPP------- 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HH---HHHHSCCG-------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH---HHHcCCCC-------
Confidence 11 22346899999999999999999999999999999999999999864432211 10 00000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
. ...+......+.+++..||+.||++|||+.|+++.|...+....
T Consensus 275 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 275 I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0 01122234578899999999999999999999999887765443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=426.86 Aligned_cols=271 Identities=23% Similarity=0.291 Sum_probs=203.1
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----eEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----~~~lV~ 600 (848)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688999999999999999998 6899999999754321 223345666677899999999999998764 689999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-----CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
|||++|+|.+++. ...++|..+.+++.|+++||+|||++ +.++||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999984 34589999999999999999999986 23469999999999999999999999999998
Q ss_pred ccCCCcc--ccceeeeeccccccChhhhhcC------CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 676 MFGGDEL--QGNTKRIVGTYGYMSPEYALEG------VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 676 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
....... .......+||+.|||||++.+. .++.++|||||||+||||+||+.|++.................
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7754332 1223346899999999999764 4678999999999999999999887644322211111100000
Q ss_pred -----ccCcccccccccccc-CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 748 -----KNDRAHELMDPVLQN-EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 748 -----~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
........+++.+.. ..+.+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 000011112222221 122345667889999999999999999999999998763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.30 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=196.1
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILI 599 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~lV 599 (848)
|++.++||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++++|||||++++++.. +..++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999875 4889999999654 33446779999999999999999999999865 3468999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~ 678 (848)
||||++|+|.+++. +...+++..+..++.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999884 3457899999999999999999999875 35999999999999984 7999999999998643
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .+.. ....... .+
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~~~----~i~~~~~----~~ 249 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYR----RVTSGVK----PA 249 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHH----HHTTTCC----CG
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HHHH----HHHcCCC----CC
Confidence 32 2345789999999998865 69999999999999999999999985332211 1100 0000000 01
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ..++.+++..||+.||++|||+.|+++
T Consensus 250 ~~~~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 235788999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=434.03 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=207.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999975 5899999999876666667789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
|++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999998883 345899999999999999999999987 9999999999999999999999999999875432
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ...... .. ...+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i----~~-----~~~~~~~- 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMI----RD-----NLPPRLK- 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH----HH-----SCCCCCS-
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHH----Hc-----CCCCCCc-
Confidence 2234578999999999999999999999999999999999999998543211 111000 00 0011111
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......++.+++..||+.||++|||+.|+++
T Consensus 369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122346889999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=410.25 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=188.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||+||+|+.. +++.||||++++.. ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 58999999997542 334567999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+ +|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 578877773 3456899999999999999999999987 999999999999999999999999999876443
Q ss_pred ccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.. .+.... .+.. .
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~i----~~~~------~- 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKNI----SNGV------Y- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH----HHTC------C-
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH----HcCC------C-
Confidence 2 2334689999999999998886 57999999999999999999998643211 111000 0000 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.....++.+++..||+.||++|||+.|+++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011122346789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=417.38 Aligned_cols=242 Identities=25% Similarity=0.312 Sum_probs=191.9
Q ss_pred cCcceeeeecccCCccEEEEEec----CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.++||+|+||+||+|+.. .++.||||++++.. .....++.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999997542 2334568899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999884 3457899999999999999999999987 9999999999999999999999999998754
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... +.... . +..
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i---~-~~~------- 242 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTMI---L-KAK------- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---H-HCC-------
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHHH---H-cCC-------
Confidence 332 22334689999999999999999999999999999999999999986432211 11000 0 000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
. ..+.....++.+++..||+.||++|||+
T Consensus 243 -~--~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 -L--GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -C--CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -C--CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 1111233468899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=405.61 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=188.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC--------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-------- 594 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-------- 594 (848)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999875 589999999975443 34567899999999999999999999987654
Q ss_pred ----eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeec
Q 003092 595 ----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 595 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
.+++||||+++|+|.+++.........++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999866554455667778999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccc----------cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccc
Q 003092 671 FGMARMFGGDELQ----------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740 (848)
Q Consensus 671 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~ 740 (848)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||..... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~-- 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVR-- 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHH--
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHH--
Confidence 9999987543221 11234579999999999999999999999999999999996 5431100 000
Q ss_pred cccccccccCccccccccccccCCCH---HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 741 GHAWSLCKNDRAHELMDPVLQNEVSL---PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 741 ~~~~~~~~~~~~~~~~d~~l~~~~~~---~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+........++ .......+++..||+.||++|||+.|+++
T Consensus 236 --------------~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 --------------TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --------------HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------------HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000111111 12234678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=389.95 Aligned_cols=283 Identities=37% Similarity=0.623 Sum_probs=237.2
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
++.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34445557789999999999999999999988899999999987766677889999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
.++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999998865432 335899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCC-ccccccccccccccCccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 753 (848)
+...............||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......+...........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8765433333334457999999999999999999999999999999999999998654322 222222222233344455
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+++.+...........+.+++..||+.||++|||+.|+++.|+..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 556666666677788889999999999999999999999999998874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=393.61 Aligned_cols=198 Identities=24% Similarity=0.368 Sum_probs=170.0
Q ss_pred HhcCcceeeeecccCCccEEEEEec----CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999753 36789999986543 346788999999998 6999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeeccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARM 676 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~~ 676 (848)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999988872 4889999999999999999999987 9999999999999877 7999999999986
Q ss_pred cCCCccc--------------------------cceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCC
Q 003092 677 FGGDELQ--------------------------GNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 677 ~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
....... ......+||+.|||||++.+.. |+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6432211 1122357999999999998764 899999999999999999999998
Q ss_pred CC
Q 003092 730 GV 731 (848)
Q Consensus 730 ~~ 731 (848)
..
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=400.27 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=197.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee------CCe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QGE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~------~~~ 595 (848)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999875 58999999997543 2345678899999999999999999998753 367
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
+++|||||+ |+|..++. ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 56877774 3457899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcc--ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCc-ccccccc--------
Q 003092 676 MFGGDEL--QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHA-------- 743 (848)
Q Consensus 676 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~-------- 743 (848)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+... .......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 7644321 2233457899999999998875 46999999999999999999999986443211 0000000
Q ss_pred ccccccCccccccccccc-cCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 WSLCKNDRAHELMDPVLQ-NEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 ~~~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+...........+..... ...+ .....++.+++.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000000 0000 012346789999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=385.32 Aligned_cols=289 Identities=40% Similarity=0.656 Sum_probs=242.1
Q ss_pred CCCeeeHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeee
Q 003092 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (848)
Q Consensus 511 ~l~~~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~ 589 (848)
.+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999987899999999976432 233468999999999999999999999
Q ss_pred eeeCCeEEEEEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 590 CIEQGEKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 590 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
+......++||||+++++|.+++.... ....+++..+..++.||+.||+|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999886543 3445899999999999999999999983334999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCC---CCCcccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY---NTDSFNLLGHAWS 745 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~---~~~~~~~~~~~~~ 745 (848)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... .........+...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987654322 2233356999999999999999999999999999999999999998532 1222233334444
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...........+..+...........+.+++..||+.||++|||+.||+++|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4455556666777777777888899999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=409.88 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=206.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||+||+|+.. +|+.||+|++........+.+.+|+.+|+.++|||||++++++.++..+++|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999875 58999999998766556678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC--CCceeeccccccccCCCc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGDE 681 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~ 681 (848)
++|+|.+++.. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999888743 3346899999999999999999999987 9999999999999854 899999999999875433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... ..... .... .. +.....
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~i---~~~~--~~-~~~~~~ 380 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNV---KSCD--WN-MDDSAF 380 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH---HTTC--CC-CCSGGG
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHH---HhCC--CC-CCcccc
Confidence 2345689999999999999999999999999999999999999986433211 11000 0000 00 000001
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ....++.+++..||+.||++|||+.|+++
T Consensus 381 ~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 S----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12346789999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=404.70 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=197.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHH---HHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNE---MMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E---i~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.++||+|+||+||+|+.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.+.+.++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999975 58999999996531 2223333444 56666778999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..+|. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999998884 3456899999999999999999999987 999999999999999999999999999877
Q ss_pred CCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......... ++.
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---------------~i~ 403 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------------EID 403 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---------------HHH
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---------------HHH
Confidence 5432 345689999999999975 57999999999999999999999998643221110 000
Q ss_pred ccccc--cCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 757 DPVLQ--NEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 757 d~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
...+. ...+.....++.+++..||+.||++|++ +.||++
T Consensus 404 ~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00000 0112223447889999999999999998 677754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=364.99 Aligned_cols=283 Identities=36% Similarity=0.551 Sum_probs=228.6
Q ss_pred CCCeeeHHHHHHHhcCccee------eeecccCCccEEEEEecCCceEEEEEecccC----cccHHHHHHHHHHHHHcCC
Q 003092 511 SLPLFSFASVTAATENFSIQ------SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQH 580 (848)
Q Consensus 511 ~l~~~~~~~i~~~~~~f~i~------~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H 580 (848)
..+.|++.++..++++|... ++||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999998877 8999999999999987 68899999986532 3346789999999999999
Q ss_pred CceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 581 pniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999998865555567899999999999999999999987 9999999999999
Q ss_pred ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccc
Q 003092 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740 (848)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~ 740 (848)
+.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.|+........ +.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~ 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HH
Confidence 9999999999999987654332222334579999999998764 589999999999999999999999865443221 10
Q ss_pred ccccccc-ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 741 GHAWSLC-KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 741 ~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
....... ......+.+++.+ ..........+.+++..||+.||++||++.++++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0000000 0111222233332 234556777899999999999999999999999999876
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.14 Aligned_cols=234 Identities=20% Similarity=0.215 Sum_probs=182.8
Q ss_pred hhcccccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCC----CceEEEecCC
Q 003092 37 FSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDK----NGVLTVSNRG 112 (848)
Q Consensus 37 ~~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g 112 (848)
++++.|+|++|++|++|++|+|++|.|+||||.++ ++|+ |+ ... |||+|||++|+.++ +++|+|+.||
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 35678999999999999999999999999999554 5677 77 445 99999999999875 8899999999
Q ss_pred CEEE--EcCCCCeEEeecccCC-----cccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCccccccccC
Q 003092 113 NLVL--LNQSNGTIWSSNVSRE-----VKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG 185 (848)
Q Consensus 113 ~lvl--~~~~~~~~W~t~~~~~-----~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~t~ 185 (848)
+||| .|++|.+||+|+++.. ..+..|+|+|+|||||++ + .+|||| |||||+|||||||.++++|
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-----~~lWqS--~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-----LALWNG--TPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-----EEEEES--CTTSCCCCSCTTCEEECSS
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-----ceeeCc--ccccccccccccccccccC
Confidence 9999 7888999999998652 345789999999999997 2 689999 9999999999999999998
Q ss_pred CcceEEeeCCCCCCCCCceEEEeecccCcEEEEEc-CCceeeccCCCCCcccc-cCCCCcceeeeeEEEecCCeeEEEEE
Q 003092 186 LERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN-GSAKYTCTGPWNGVAFG-SAPSNTTFIFQPIVVQNKDEVYYMYE 263 (848)
Q Consensus 186 ~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~-~~~~y~~sg~w~g~~~~-~~p~~~~~~~~~~~v~n~~e~~~~~~ 263 (848)
.. | ++.+||++|.|+++++++|. +++|+ ++.+||++|.|++.... .+.... .+.+.++.+ ..+.++
T Consensus 153 ~~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dG----nLvl~d~~~-~~vWsS 220 (276)
T 3m7h_A 153 SE--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDG----NLVVYGAGN-AVLWHS 220 (276)
T ss_dssp EE--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTS----CEEEECTTS-CEEEEC
T ss_pred cc--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCC----eEEEEeCCC-cEEEEe
Confidence 75 4 78899999999999999984 45565 46899999999763210 001111 112233322 223333
Q ss_pred ecCCCeEEEEEEccCCcEEEEEEEecCCceEEEEecCCC
Q 003092 264 SYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDP 302 (848)
Q Consensus 264 ~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~~~~ 302 (848)
.......+|++|+.||+++.|.| ...|..++..|..
T Consensus 221 ~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 221 HTGGHASAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp SCTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred cCCCCCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 33233358999999999999999 3567777666653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=370.37 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=205.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..++|++.++||+|+||+||+|+. .++.||||++.... ....+++.+|+.++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 457899999999999999999987 68899999987543 334567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++........+++..+..++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999866544456899999999999999999999874 24999999999999999999999999999865432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .... .... .
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~---~~~~---------~ 256 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAV---GFKC---------K 256 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHH---HHSC---------C
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH---HhcC---------C
Confidence 2 123346799999999999999999999999999999999999999864432111 0000 0000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
....+......+.+++..||+.||++|||+.++++.|+..+....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 001112233468899999999999999999999999998876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=367.11 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=213.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 368999999999999999999875 5889999999776667778899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999988532 346899999999999999999999987 99999999999999999999999999987654322
Q ss_pred ccc------------eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccC
Q 003092 683 QGN------------TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750 (848)
Q Consensus 683 ~~~------------~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 750 (848)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 111 114579999999999999999999999999999999999999876443222111100
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
.....+.. .+......+.+++..||+.||++|||+.++++.|+.....+
T Consensus 236 -~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 -VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 01111111 11222336788999999999999999999999998775443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=377.05 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=211.3
Q ss_pred hcCcceeeeecccCCccEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeC
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~ 593 (848)
.++|++.+.||+|+||.||+|+.. .+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999863 24579999997653 33467899999999999 899999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl 660 (848)
+..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999998885432 1245789999999999999999999987 9999999999999
Q ss_pred ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccc
Q 003092 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNL 739 (848)
Q Consensus 661 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~ 739 (848)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999997765443333334567889999999999999999999999999999999 8998864332111
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.. ..... .....+......+.+++..||+.||++||++.|+++.|+.++
T Consensus 315 ~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH----HHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 00000 001112223457889999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.24 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=206.5
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 45889999999776666678899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999988842 35889999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+...... ....... +.+
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~------~~~-- 236 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGT------PEL-- 236 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHCS------CCC--
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCC------CCC--
Confidence 2334679999999999999999999999999999999999999985432211000 0000000 000
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111223346889999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=367.00 Aligned_cols=269 Identities=25% Similarity=0.359 Sum_probs=207.4
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----eEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----~~~lV 599 (848)
.++|++.++||+|+||+||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 478999999999999999999874 7899999996543 23445677999999999999999999998754 47999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-------CCCceEecccCCCcEEeccCCCceeeccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-------SRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
|||+++|+|.+++.. ..+++..+..++.||++||+|||+. +..+|+||||||+|||++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999998843 3589999999999999999999987 01139999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcC-----CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEG-----VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||............ ....
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~~~~ 254 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE--EEIG 254 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH--HHHC
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh--hhhc
Confidence 99887655443334446799999999999873 5667899999999999999999998654322111000 0000
Q ss_pred ccCccc--------cccccccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 748 KNDRAH--------ELMDPVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 748 ~~~~~~--------~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...... ....+.+... .......++.+++..||+.||++|||+.||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000 0111111111 1223556799999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=365.87 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=208.2
Q ss_pred hcCcceeeeecccCCccEEEEEec----CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.++||+|+||.||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 2446999999764 33446779999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999988532 346889999999999999999999987 9999999999999999999999999998775
Q ss_pred CCcccc-ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .... +
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~-------------~ 267 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISS-------------V 267 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH-------------H
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH-------------H
Confidence 432211 1222356788999999999999999999999999999999 999975432211 0000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
........+......+.+++..||+.||++||++.+|++.|+..+...
T Consensus 268 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 000011112223457889999999999999999999999999886443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=372.11 Aligned_cols=270 Identities=27% Similarity=0.391 Sum_probs=214.1
Q ss_pred eeHHHHHHHhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeee
Q 003092 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 586 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l 586 (848)
+.........++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344556667789999999999999999999742 35789999997643 33456799999999999 79999999
Q ss_pred eeeeeeCC-eEEEEEEeccCCcccccccCCCc------------------------------------------------
Q 003092 587 LGCCIEQG-EKILIYEYMVNKSLDVFLFDPTK------------------------------------------------ 617 (848)
Q Consensus 587 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 617 (848)
++++.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999988865432
Q ss_pred ---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 618 ---------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 618 ---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999987 99999999999999999999999999987754433
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
........||+.|+|||++.+..++.++||||||+++|||++ |+.|+.......... ...... ..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~---------~~ 314 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEG---------TR 314 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-----HHHHHT---------CC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-----HHHHcC---------CC
Confidence 333445678999999999999999999999999999999998 999986433221100 000000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...+.....++.+++..||+.||++|||+.|+++.|++.+
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 0111122346889999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=376.30 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=209.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..++|++.++||+|+||.||+|++. +++.||||+++... ....++|.+|+.+|++++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4478999999999999999999986 68899999987543 233456889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999988842 2345889999999999999999999987 999999999999999999999999999876544
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
..........+++.|+|||++..+.++.++||||||+++|||++ |..|+........ . +.+...
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~--~-------------~~~~~~ 331 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT--R-------------EFVEKG 331 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH--H-------------HHHHTT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------------HHHHcC
Confidence 33222223356789999999999999999999999999999998 8888764332110 0 000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.....+......+.+++..||+.||++|||+.++++.|+++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 000111223346889999999999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.70 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=202.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999876 688999999865432 334668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999988884 3345899999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+. ... ....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~---~~~~--- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKK---TYLN--- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTC---TTST---
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----ccc---ccCC---
Confidence 3333345689999999999988776 7899999999999999999999865433221111100 000 0000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++..||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01122346788999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=364.14 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=203.8
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999987 46899999999754 3345677889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999888742 345889999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
. .....+||+.|+|||++.+..+. .++|||||||++|||++|+.||...+... +....
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------------------~~~~i 226 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------------------LRERV 226 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------------HHHHH
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------------------HHHHH
Confidence 2 22345799999999999988875 79999999999999999999986433111 00000
Q ss_pred ccc--CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQN--EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+ ..+......+.+++..||+.||++|||+.|+++
T Consensus 227 ~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 111123446889999999999999999999976
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=358.04 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=213.0
Q ss_pred CeeeHHHHHHHhcC----------cceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCC
Q 003092 513 PLFSFASVTAATEN----------FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR 581 (848)
Q Consensus 513 ~~~~~~~i~~~~~~----------f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp 581 (848)
+.++++++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777777777654 778889999999999999976 6899999999877666778899999999999999
Q ss_pred ceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 582 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999998874 235899999999999999999999987 99999999999999
Q ss_pred cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999987654321 2234679999999999999999999999999999999999999985432111 000
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. . . ....+.+. ........+.+++..||+.||++|||+.|+++
T Consensus 252 ~---~-~-----~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 R---L-R-----DSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H---H-H-----HSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H---H-h-----cCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0 00000010 01122346788999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.66 Aligned_cols=276 Identities=26% Similarity=0.383 Sum_probs=207.4
Q ss_pred hcCcceeeeecccCCccEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~ 596 (848)
.++|++.++||+|+||+||+|++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 24789999999877666678899999999999999999999998654 568
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999988532 335889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc-ccccCcccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS-LCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 754 (848)
....... .......+|..|+|||++.+..++.++||||||+++|||++|..|+................ ........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 12223457788999999999999999999999999999999998875322110000000000 000000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
.+........+.....++.+++..||+.||++|||+.|+++.|++...++
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 01111111122234457889999999999999999999999998876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=363.44 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=200.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCc----eEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|++.++||+|+||+||+|++. +++ .||+|.+... .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 367999999999999999999864 344 3688888643 3355678999999999999999999999998754 78
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|+||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999998888542 346889999999999999999999987 999999999999999999999999999987
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ . ..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~-------------~~~ 232 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S-------------SIL 232 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H-------------HHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--H-------------HHH
Confidence 65544333444567889999999999999999999999999999999 9999864332211 0 001
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
........+......+.+++..||+.+|++||++.|+++.|+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000011112223447889999999999999999999999997764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.35 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=209.4
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36799999999999999999998888999999997543 34577999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999998853 2345889999999999999999999987 999999999999999999999999999876543221
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ..... ..... .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~---------~~~~~----~ 226 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI---------STGFR----L 226 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH---------HTTCC----C
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHH---------hcCcc----C
Confidence 1222456788999999999999999999999999999999 898876432211 00000 00000 0
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+......+.+++..||+.||++||++.|+++.|++..
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111112346889999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.21 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=199.6
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHH--cCCCceeeeeeeeeeC----CeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQ----GEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~~~~~~~----~~~~ 597 (848)
.++|++.++||+|+||+||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999988 6899999998653 34556677777777 7999999999987653 4689
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecccCCCcEEeccCCCceee
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
+||||+++|+|.+++. ...+++..+.+++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999883 346899999999999999999999 554 9999999999999999999999
Q ss_pred ccccccccCCCccc--cceeeeeccccccChhhhhcC------CCCcccceeehHHHHHHHHhC----------CCCCCC
Q 003092 670 DFGMARMFGGDELQ--GNTKRIVGTYGYMSPEYALEG------VFSVKSDVFSFGVLMLEILSS----------KKNTGV 731 (848)
Q Consensus 670 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~elltg----------~~p~~~ 731 (848)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876443221 112234799999999999877 556799999999999999999 555533
Q ss_pred CCCCccccccccccccccCcccccccccc-ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVL-QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
........... ..... .....+.+ ...........+.+++..||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDM-RKVVC----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHH-HHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhh-hHHHh----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22111110000 00000 00001111 1112234667899999999999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.26 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=212.5
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4578999999999999999999862 34789999997543 3456788999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 596 KILIYEYMVNKSLDVFLFDPTK---------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
.++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999988854322 234889999999999999999999987 9999999
Q ss_pred CCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~ 733 (848)
|+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333334567889999999999999999999999999999999 999985433
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
.... .. ...... ...........+.+++..||+.||++||++.|+++.|++.+.
T Consensus 258 ~~~~--~~----~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 258 PERL--FN----LLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGGH--HH----HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH--HH----HhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2111 00 000000 011112234578899999999999999999999999988743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=348.35 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=209.8
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.+.||+|+||.||+|...++..||||++.... ...+++.+|++++++++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46899999999999999999998888899999997543 34577999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999888843 2345899999999999999999999987 999999999999999999999999999876544322
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.......... . ..... ..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--~---~~~~~---~~------- 224 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL--K---VSQGH---RL------- 224 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--H---HHTTC---CC-------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH--H---HHcCC---CC-------
Confidence 1 222456778999999999999999999999999999999 999986433221100 0 00000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
..+......+.+++..||+.||++|||+.|+++.|+....
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 0111123468889999999999999999999999988743
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.79 Aligned_cols=266 Identities=27% Similarity=0.420 Sum_probs=209.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.+.||+|+||.||+|+.. .++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 35679999997542 34457899999999999 8999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCCc--------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTK--------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999998865332 134789999999999999999999987 9999999
Q ss_pred CCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~ 733 (848)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433333334568899999999999999999999999999999998 999986443
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.... .. ..... ......+......+.+++..||+.||++||++.++++.|+..+...+
T Consensus 280 ~~~~-~~----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDAN-FY----KLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSHH-HH----HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHHH-HH----HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 2211 00 00000 00111112234578899999999999999999999999988755433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.23 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=205.5
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.++||+|+||.||+|+. .++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 6799999999999999999987 4788999998643 34578999999999999999999999887 34789999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-ceeeccccccccCCCccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDELQ 683 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 683 (848)
+++|.+++........+++..+..++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999876555556788999999999999999999954345999999999999998887 799999999765432
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....||+.|+|||++.+..++.++||||||+++|||++|+.|+............ ..... . .+...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~-~-----~~~~~-- 226 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW---AVHNG-T-----RPPLI-- 226 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH---HHHTT-C-----CCCCB--
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH---HHhcC-C-----CCCcc--
Confidence 22346999999999999999999999999999999999999998644332211110 00000 0 01111
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPP 811 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~ 811 (848)
......+.+++..||+.||++|||+.++++.|+......+.+.+|.
T Consensus 227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 1123467889999999999999999999999998876666555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=365.37 Aligned_cols=266 Identities=25% Similarity=0.405 Sum_probs=213.0
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
+....++|++.+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456889999999999999999998753 4789999997653 3345779999999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCc---------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEec
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTK---------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHr 651 (848)
++..++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999988854321 256899999999999999999999987 9999
Q ss_pred ccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCC
Q 003092 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTG 730 (848)
Q Consensus 652 Dlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~ 730 (848)
||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987654433333444578999999999999999999999999999999999 988875
Q ss_pred CCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 731 VYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
...... ... ....... ...+.....++.+++..||+.||++||++.++++.|++....
T Consensus 279 ~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAHEE--VIY----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCHHH--HHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCChHH--HHH----HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 432211 000 0000000 011122334788999999999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.93 Aligned_cols=277 Identities=24% Similarity=0.350 Sum_probs=211.6
Q ss_pred hcCcceeeeecccCCccEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeee--eCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI--EQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~--~~~~~ 596 (848)
.++|++.++||+|+||.||++++ ..++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36899999999999999999984 347899999998776666778999999999999999999999887 45678
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999888432 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+........................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543221 122334688899999999999999999999999999999999998743221110000000000000001111
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
+...............+.+++..||+.||++|||+.|+++.|+..+....
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111112233345578899999999999999999999999998865444
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=369.59 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=213.3
Q ss_pred HhcCcceeeeecccCCccEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
..++|++.++||+|+||.||+|+.. .++.||||++.... ....+++.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4578999999999999999999853 23579999997653 34457789999999999 99999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
++..++||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999998885432 1245899999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
|++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987765443334444568899999999999999999999999999999999 999875432211
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
+.. ..... .....+.....++.+++..||+.||++||++.||++.|+..+..
T Consensus 302 ~~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 302 LFK----LLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHH----HHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 100 00000 00111122334788999999999999999999999999888543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=370.70 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=197.7
Q ss_pred hcCcceeeeecccCCccEEEEEec----CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999865 4678999999764 33445789999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 2346889999999999999999999987 9999999999999999999999999998775
Q ss_pred CCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ..+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~-------------~~i 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VI-------------KAV 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HH-------------HHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------------HHH
Confidence 43211 11222346788999999999999999999999999999998 999975432111 00 001
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
...............+.+++..||+.||++||++.+|+++|+..+.
T Consensus 264 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111111122334578899999999999999999999999987754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.58 Aligned_cols=266 Identities=24% Similarity=0.405 Sum_probs=195.0
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCC-c---eEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNG-Q---EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~-~---~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
...++|++.+.||+|+||.||+|+.... + .||||++... .....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3457899999999999999999986543 2 7999999754 34456789999999999999999999999987765
Q ss_pred E------EEEEEeccCCcccccccCCC---cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 596 K------ILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 596 ~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
. ++||||+++++|..++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999988874322 2225899999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ ...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~--- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNY--- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHH---
Confidence 9999999987755443333334567889999999999999999999999999999999 8888764332111 000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
. .... ...........+.+++..||+.||++|||+.++++.|++.+....
T Consensus 252 ~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 L-IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp H-HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred H-hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 0 0000 001112233578899999999999999999999999998865443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.13 Aligned_cols=273 Identities=17% Similarity=0.187 Sum_probs=212.3
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999986 4689999999875432 34688999999999 99999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-----ceeeccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKISDFGMARM 676 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 676 (848)
|+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999888532 356899999999999999999999987 999999999999998887 99999999987
Q ss_pred cCCCcccc-----ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccC
Q 003092 677 FGGDELQG-----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKND 750 (848)
Q Consensus 677 ~~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 750 (848)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI----GDT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH----HHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH----Hhh
Confidence 65433211 12356899999999999999999999999999999999999999865432211 000000 000
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTT 814 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~ 814 (848)
... .....+.. ... ++.+++..||+.+|++||++.+|++.|++.......+....+.+
T Consensus 236 ~~~-~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 236 KRA-TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp HHH-SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred hcc-CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 000 00000000 012 78899999999999999999999999987765554433333333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=353.38 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=204.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|+||.||+++.. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 368999999999999999999865 58899999985432 23457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999998884 3346899999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..... .. +.
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-----~~~~~-----~~-~~ 231 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQD-----SV-PN 231 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH-----HHHSS-----CC-CC
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhhc-----cC-CC
Confidence 321 22334679999999999999999999999999999999999999986433211000 00000 00 00
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHhcccC
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRP-TMSDVVSMINNELF 802 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 802 (848)
............+.+++.+||+.||++|| ++.++.+.|+..+.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011112334688999999999999998 89999999987754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.29 Aligned_cols=260 Identities=29% Similarity=0.422 Sum_probs=207.6
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.++||+|+||.||+|++. .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 368999999999999999999843 3568999999654 334556789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC---Cceee
Q 003092 597 ILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKIS 669 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~ 669 (848)
++||||+++|+|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999998885422 2245889999999999999999999987 99999999999999555 59999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |..|+....... +.... .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i----~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFV----T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----H
Confidence 9999986543332333334568999999999999999999999999999999998 888875432211 00000 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.. ............+.+++..||+.||++||++.+|++.|+...
T Consensus 301 ~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 00 000111223346889999999999999999999999997664
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.85 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=213.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC--eEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~--~~~lV 599 (848)
.++|++.++||+|+||+||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3679999999999999999999764 8899999997543 344677889999999999999999999998765 78999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe----ccCCCceeecccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 675 (848)
|||+++++|..++........+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999876555555899999999999999999999987 9999999999999 778889999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhh--------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--ccccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYAL--------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN--LLGHAWS 745 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~~~ 745 (848)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 7754332 22357999999999987 577899999999999999999999998643321110 0000000
Q ss_pred ccccCcc---ccc------cccc--cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 746 LCKNDRA---HEL------MDPV--LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 746 ~~~~~~~---~~~------~d~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....... ... .... ............+.+++..||+.||++|||+.|+++...+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0000000 000 0001 112344566778899999999999999999999999887763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=376.79 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=211.0
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
...++|++.++||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4457899999999999999999999888899999997643 45788999999999999999999999986 667899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999988532 2235788899999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
... .....+|+.|+|||++....++.++||||||+++|||++ |+.|+....... .... +....
T Consensus 339 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~-------------i~~~~ 402 (454)
T 1qcf_A 339 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRA-------------LERGY 402 (454)
T ss_dssp HHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH-------------HHHTC
T ss_pred eec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHH-------------HHcCC
Confidence 221 122456889999999999999999999999999999999 999985432111 0000 00000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
....+.....++.+++..||+.||++|||+.+|+++|+.....
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 0111122345788999999999999999999999999887543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=347.68 Aligned_cols=253 Identities=29% Similarity=0.472 Sum_probs=196.3
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccC----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+|.+ .++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36899999999999999999997 48899999986542 23457889999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc--------CCCceeecc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--------HMNPKISDF 671 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~kl~DF 671 (848)
|||+++++|..++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999988873 346889999999999999999999987666999999999999986 778999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
|+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......... ....
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~--- 228 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVAM--- 228 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHT---
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhc---
Confidence 9998664332 223579999999999999999999999999999999999999986433211100 0000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.......+......+.+++..||+.||++|||+.|+++.|++
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 000111122233478899999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=356.61 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=212.9
Q ss_pred HhcCcceeeeecccCCccEEEEEe------cCCceEEEEEecccCc-ccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.+.||+|+||.||+|+. ..++.||||++..... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 447899999999999999999985 2367899999976533 3457799999999999 9999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCCc---------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTK---------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999988854322 225899999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987765443333334568889999999999999999999999999999999 99887644322110
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
. ..+...............+.+++..||+.||++|||+.|+++.|++.+.+
T Consensus 258 -~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 258 -Y-------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -H-------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -H-------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0 00000001111122334788999999999999999999999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=358.86 Aligned_cols=251 Identities=24% Similarity=0.301 Sum_probs=203.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.++||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 468999999999999999999875 588999999975432 2357899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC----Cceeeccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFG 672 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 672 (848)
++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999884 3456899999999999999999999987 99999999999998877 79999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..... ....
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~~i----~~~~- 234 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANI----TAVS- 234 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH----HTTC-
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhcC-
Confidence 998775432 2234679999999999999999999999999999999999999985432111 00000 0000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
-.+++.... .....+.+++..||+.||++|||+.|+++
T Consensus 235 -~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 -YDFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000001 12346789999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.65 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=203.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|+||+||+++.. +++.||||++++. .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999875 5899999999754 234567789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999988773 3456889999999999999999999987 99999999999999999999999999986432
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+... +... .. .. .
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~---i~-~~--------~ 221 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFEL---IL-ME--------E 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---HH-HC--------C
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HHHH---HH-cC--------C
Confidence 22 22345689999999999999999999999999999999999999985432111 0000 00 00 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
...+.....++.+++..||+.||++|| ++.|+++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 011112334688999999999999999 8999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.32 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=203.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.+.||+|+||.||++... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999875 4789999998653 33456788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc--CCCceeeccccccccCCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGD 680 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 680 (848)
+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999888843 2346899999999999999999999987 999999999999987 789999999999877543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||....... .... ..... . ......
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~---i~~~~-~--~~~~~~ 226 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIEN---IMNAE-Y--TFDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH---HHHTC-C--CCCHHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHH---HHcCC-C--CCChhh
Confidence 2 2344679999999999999989999999999999999999999985432211 0000 00000 0 000000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ....++.+++..||+.||++|||+.|+++
T Consensus 227 ~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 12346889999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=377.16 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=211.4
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++.++||+|+||.||+|.+.. ++.||||+++... ...++|.+|+.+|++++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34679999999999999999999865 8899999997543 356889999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999988542 2345889999999999999999999987 9999999999999999999999999998775433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.. ......+++.|+|||++....++.++||||||+++|||++ |+.|+....... +. +.+....
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~-------------~~~~~~~ 436 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY-------------ELLEKDY 436 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH-------------HHHHTTC
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HH-------------HHHHcCC
Confidence 22 1222456789999999999999999999999999999999 888875433211 00 0011111
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++|||+.+|++.|+..+
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11112223457889999999999999999999999998874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=374.69 Aligned_cols=262 Identities=27% Similarity=0.434 Sum_probs=206.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.++||+|+||.||+|.+..+..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 457899999999999999999999888889999997643 345789999999999999999999999876 678999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999988431 2345889999999999999999999987 99999999999999999999999999987654322
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......+|+.|+|||++..+.++.++||||||+++|||++ |+.|+....... ..... .. ...
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i----~~---------~~~ 399 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV----ER---------GYR 399 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HT---------TCC
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----Hc---------CCC
Confidence 1 1223457889999999999999999999999999999999 888875432111 00000 00 000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCC
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPS 806 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 806 (848)
...+......+.+++..||+.||++|||+.++++.|+..+.....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111223345788999999999999999999999999988655443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=350.12 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=207.1
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.+.||+|+||.||++...+++.||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457899999999999999999999888899999997543 3457799999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999988542 345899999999999999999999987 99999999999999999999999999987654321
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ ... . .....
T Consensus 176 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~---~------~~~~~---- 239 (283)
T 3gen_A 176 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEH---I------AQGLR---- 239 (283)
T ss_dssp H-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH---H------HTTCC----
T ss_pred c-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHH---H------hcccC----
Confidence 1 1222356788999999999999999999999999999998 9999864332110 000 0 00000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...+......+.+++..||+.+|++|||+.++++.|++.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0111112346889999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=359.78 Aligned_cols=271 Identities=28% Similarity=0.366 Sum_probs=208.5
Q ss_pred cceeeeecccCCccEEEEEec-----CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-----~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~l 598 (848)
|++.++||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999988643 47889999997653 34467799999999999999999999999874 67899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999998843 34889999999999999999999987 9999999999999999999999999998875
Q ss_pred CCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+........................+.++
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 22333568889999999999999999999999999999999999875322111111000000000001111111
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
..............+.+++..||+.||++|||+.|+++.|+.....+
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111222334457899999999999999999999999998775443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.27 Aligned_cols=274 Identities=17% Similarity=0.221 Sum_probs=214.7
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46899999999999999999986 468999999986543 234578899999999 79999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-----ceeeccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKISDFGMARM 676 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~DFGla~~ 676 (848)
|+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999988532 335899999999999999999999987 999999999999988776 99999999987
Q ss_pred cCCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccC
Q 003092 677 FGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKND 750 (848)
Q Consensus 677 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 750 (848)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE----K 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH----H
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh----h
Confidence 7544321 123446799999999999999999999999999999999999999865432111 00000000 0
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTT 814 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~ 814 (848)
.. ....+.+.. .....+.+++..||+.||++||++.+|++.|++.+..+......++.+
T Consensus 237 ~~-~~~~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 295 (298)
T 1csn_A 237 KQ-STPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 295 (298)
T ss_dssp HH-HSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred cc-CccHHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence 00 000000011 123478899999999999999999999999998876665554444443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.00 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------- 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------- 594 (848)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367999999999999999999976 68999999997543 335678999999999999999999999986654
Q ss_pred --------------------------------------------------eEEEEEEeccCCcccccccCCCcccccCHH
Q 003092 595 --------------------------------------------------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQ 624 (848)
Q Consensus 595 --------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 624 (848)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 379999999999999998766666667778
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc----------cceeeeecccc
Q 003092 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ----------GNTKRIVGTYG 694 (848)
Q Consensus 625 ~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 694 (848)
.+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999987 999999999999999999999999999887554211 11233579999
Q ss_pred ccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC---HHHHHH
Q 003092 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS---LPMLVR 771 (848)
Q Consensus 695 y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~ 771 (848)
|+|||++.+..++.++||||||+++|||++|..|+... . +.+........+ ......
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~----------------~~~~~~~~~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----V----------------RIITDVRNLKFPLLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----H----------------HHHHHHHTTCCCHHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----H----------------HHHHHhhccCCCcccccCChh
Confidence 99999999999999999999999999999986653100 0 000000011111 123346
Q ss_pred HHHHHHhccccCcCCCCCHHHHHH
Q 003092 772 YINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 772 l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+++..||+.||++|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 788999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.54 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=198.9
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||+||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 37899999999999999999998889999999987542 2235678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9986 56555533 3345889999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--ccccc-------cccccc--
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN--LLGHA-------WSLCKN-- 749 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~-------~~~~~~-- 749 (848)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... +.... +.....
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 12233578999999999876 56899999999999999999999998654332110 00000 000000
Q ss_pred ---CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 ---DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+.............++.+++..||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000000001112346789999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.13 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=210.9
Q ss_pred HhcCcceeeeecccCCccEEEEEec--------CCceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4578999999999999999999863 36789999997543 34467789999999999 89999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
.+..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999998865332 234889999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 99999999999999987765443333344567889999999999999999999999999999999 999875432111
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
+... .... ............+.+++..||+.+|++||++.|+++.|++++.
T Consensus 268 ~~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 LFKL----LKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0000 0001112233468899999999999999999999999988753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=355.52 Aligned_cols=272 Identities=24% Similarity=0.369 Sum_probs=205.9
Q ss_pred cCcceeeeecccCCccEEEEEe-----cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~ 596 (848)
+.|++.++||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5699999999999999999984 357899999997543 34567899999999999999999999999876 678
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999988843 2345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... .......||..|+|||++.+..++.++||||||+++|||++|+.|+..........................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544321 222335688899999999999999999999999999999999987532110000000000000000000001
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+........+......+.+++..||+.||++|||+.++++.|++.+
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111122234457889999999999999999999999998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=349.43 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=194.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--------------------------ccHHHHHHHHHHHH
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 576 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 576 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999865 588999999865421 12356889999999
Q ss_pred HcCCCceeeeeeeeee--CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 577 KLQHRNLVRLLGCCIE--QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 577 ~l~Hpniv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
+++||||+++++++.+ ....++||||+++++|..++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56899999999999998765 3346899999999999999999999987 9999999
Q ss_pred CCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCC---CCcccceeehHHHHHHHHhCCCCCCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123357999999999998665 47889999999999999999999853
Q ss_pred CCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... .... . ... .............+.+++..||+.||++||++.|+++
T Consensus 243 ~~~~~--~~~~---~-~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMC--LHSK---I-KSQ--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHH--HHHH---H-HHC--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHH--HHHH---H-hcc--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32110 0000 0 000 0000001122346889999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=361.79 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=198.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 4889999999754 233456788999999998 7999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999988874 3356899999999999999999999987 999999999999999999999999999864
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + +.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~----------------~~ 234 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--L----------------FE 234 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----------------HH
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--H----------------HH
Confidence 3222 22345689999999999999999999999999999999999999986433211 0 00
Q ss_pred ccccc--CCCHHHHHHHHHHHHhccccCcCCCCCH------HHHHH
Q 003092 758 PVLQN--EVSLPMLVRYINVALLCVQENAEDRPTM------SDVVS 795 (848)
Q Consensus 758 ~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 795 (848)
.++.. ..+......+.+++..||+.||++||++ .|+++
T Consensus 235 ~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 235 AILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11111 1111233468899999999999999998 66664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.29 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=202.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCce----EEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~----vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.++||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67999999999999999999864 3444 7888875432 334466788999999999999999999886 567899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999998888542 346888999999999999999999987 9999999999999999999999999999876
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............||+.|+|||++.+..++.++||||||+++|||++ |+.||......... . ......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~~------ 234 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP--D----LLEKGE------ 234 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH--H----HHHTTC------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH--H----HHHcCC------
Confidence 5544444445678899999999999999999999999999999999 99998654322110 0 000000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
....+......+.+++..||+.||++||++.|+++.|+....
T Consensus 235 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ---RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000111122256789999999999999999999999987743
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=358.42 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=199.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCce----EEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~----vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|++.++||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 368999999999999999999864 3444 577777543 3456788999999999999999999999998754 88
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+|+||+.+++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999998888532 345889999999999999999999987 999999999999999999999999999877
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ . ..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~-------------~~~ 232 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S-------------SIL 232 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H-------------HHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--H-------------HHH
Confidence 54433333334567889999999999999999999999999999999 9999864432211 0 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
..............++.+++..||+.||++||++.|+++.|+....
T Consensus 233 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 233 EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0000111122234468899999999999999999999999988753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=349.85 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999875 588999999875432 2467899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC----Cceeeccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFG 672 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 672 (848)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999998843 356899999999999999999999987 99999999999999887 79999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... ... .
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~---~~~-~- 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANV---SAV-N- 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH---HHT-C-
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHH---Hhc-C-
Confidence 998775332 2234579999999999999999999999999999999999999985332111 00000 000 0
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ....... .....+.+++..||+.||++|||+.|+++
T Consensus 234 ~~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE-FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC-CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000001 12346788999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=362.59 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=198.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.++||+|+||+||+++.. +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3468999999999999999999976 47899999997542 23345678899999887 8999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999988874 3456899999999999999999999987 999999999999999999999999999863
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+..
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~---------~~~~~~~ 272 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQ 272 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C---------CHHHHHH
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh---------hHHHHHH
Confidence 3221 2334578999999999999999999999999999999999999998643221100000 0000001
Q ss_pred ccccc--CCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 758 PVLQN--EVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 758 ~~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
..+.. ..+.....++.+++..||+.||++||++
T Consensus 273 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11111 1122234578899999999999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=369.09 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=204.7
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC-eEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~-~~~lV~E 601 (848)
..++|++.++||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3468999999999999999999884 7899999997643 4578999999999999999999999987765 7999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999988532 2234789999999999999999999987 999999999999999999999999999854322
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.|+........ ... . ..+ .
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~---i-~~~---------~ 403 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPR---V-EKG---------Y 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHH---H-HTT---------C
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH---H-HcC---------C
Confidence 122367889999999999999999999999999999998 9999864432211 000 0 000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112223457889999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.71 Aligned_cols=269 Identities=27% Similarity=0.388 Sum_probs=213.2
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHHHc-CCCceeeee
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLL 587 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~ 587 (848)
.........++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34445556789999999999999999999742 357899999976533 3456789999999999 799999999
Q ss_pred eeeeeCC-eEEEEEEeccCCcccccccCCCc-------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEeccc
Q 003092 588 GCCIEQG-EKILIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653 (848)
Q Consensus 588 ~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDl 653 (848)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987755 58999999999999998865432 223889999999999999999999987 999999
Q ss_pred CCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCC
Q 003092 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (848)
Q Consensus 654 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~ 732 (848)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987754433333344678999999999999999999999999999999998 99998543
Q ss_pred CCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 733 NTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....... ....... ..........++.+++..||+.||++|||+.|+++.|++.+
T Consensus 255 ~~~~~~~-----~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDEEFC-----RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSHHHH-----HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHH-----HHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3221100 0000000 00111112346888999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=357.09 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=211.9
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
.....++|++.+.||+|+||.||+|+.. .++.||||++.... .....++.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3445688999999999999999999764 36789999997543 2345678999999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
.+..++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence 999999999999999998885321 1245688999999999999999999987 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAW 744 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 744 (848)
+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~--- 251 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLR--- 251 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHH---
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHH---
Confidence 99999999987654433333334567899999999999999999999999999999999 788875432211 000
Q ss_pred cccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 745 SLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 745 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
....... ..........+.+++..||+.||++||++.|+++.|++.+.
T Consensus 252 -~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 -FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0000000 01112233468899999999999999999999999988743
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=344.83 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=198.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 58899999997543 2335778899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|++++.+..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 998755544432 2356899999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc--ccccCc---cccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS--LCKNDR---AHEL 755 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~---~~~~ 755 (848)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.........+...... ...... ....
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 1 223357899999999998766 7999999999999999999888853222111100000000 000000 0000
Q ss_pred -------cc--cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 -------MD--PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 -------~d--~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ..............+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 00000111223456789999999999999999999976
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=356.87 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=201.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 367999999999999999999875 5899999998642 1224678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeecccc
Q 003092 598 LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGM 673 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGl 673 (848)
+||||+++++|...+... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999997766432 22335889999999999999999999987 999999999999987655 99999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +... . .....
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---i-~~~~~- 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---LFEG---I-IKGKY- 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---HHHH---H-HHTCC-
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---HHHH---H-HcCCC-
Confidence 987754332 123357999999999999999999999999999999999999998542211 0000 0 00000
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+.... ....++.+++..||+.||++|||+.|+++
T Consensus 250 -~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 -KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 12346889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=360.77 Aligned_cols=282 Identities=16% Similarity=0.207 Sum_probs=211.4
Q ss_pred HhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccCcccH-----------HHHHHHHHHHHHcCCCceee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVR 585 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~~~~~-----------~~~~~Ei~~l~~l~Hpniv~ 585 (848)
..++|++.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998754 47899999876432111 12334556667778999999
Q ss_pred eeeeeeeC----CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 586 LLGCCIEQ----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 586 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
+++++... ...++||||+ +++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998775 4589999999 9999988853 2356899999999999999999999987 99999999999999
Q ss_pred --cCCCceeeccccccccCCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Q 003092 662 --QHMNPKISDFGMARMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (848)
Q Consensus 662 --~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~ 734 (848)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876533211 112335699999999999999999999999999999999999999864322
Q ss_pred CccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 003092 735 DSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTT 814 (848)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~ 814 (848)
..... .... ........+++++.+... ....++.+++..||+.+|++||++.+|+++|++.+.....+...++.+
T Consensus 267 ~~~~~-~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 267 DPKYV-RDSK-IRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp CHHHH-HHHH-HHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred CHHHH-HHHH-HHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 21100 0000 000111222333332211 123468889999999999999999999999999887766665555555
Q ss_pred c
Q 003092 815 F 815 (848)
Q Consensus 815 ~ 815 (848)
.
T Consensus 342 ~ 342 (364)
T 3op5_A 342 S 342 (364)
T ss_dssp -
T ss_pred E
Confidence 4
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=344.84 Aligned_cols=261 Identities=31% Similarity=0.449 Sum_probs=208.9
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
..++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. ++..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346899999999999999999998888899999997543 34678999999999999999999999876 4568999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999988432 2236889999999999999999999987 99999999999999999999999999987754332
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... .... . ... ...
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~---~-~~~-----~~~--- 229 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN---L-ERG-----YRM--- 229 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH---H-HTT-----CCC---
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHH---H-hcc-----cCC---
Confidence 2 1222457889999999999999999999999999999999 888875432111 0000 0 000 000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.........+.+++..||+.||++|||+.++++.|++.+....
T Consensus 230 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 1111223478899999999999999999999999988765443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.36 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=209.6
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecC-C-----ceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
....++|++.+.||+|+||.||+|.... + +.||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445789999999999999999998643 2 479999997653 23457789999999999 89999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-----------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~ 661 (848)
++..++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 999999999999999988875321 1235789999999999999999999987 99999999999999
Q ss_pred cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccc
Q 003092 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLL 740 (848)
Q Consensus 662 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 740 (848)
.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..|+.........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-- 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence 999999999999987654332222334567889999999999999999999999999999998 88887543321110
Q ss_pred cccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 741 GHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 741 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
. ..+........+......+.+++..||+.||++|||+.|+++.|++..
T Consensus 277 ---~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 ---Y---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ---H---------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---H---------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 0 000000000111112346889999999999999999999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.33 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=195.7
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCC--CceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998754 33445788999999999986 9999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 567899888843 356889999999999999999999987 99999999999997 67899999999987755
Q ss_pred CccccceeeeeccccccChhhhhc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------- 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------- 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----------
Confidence 443333445689999999999975 67899999999999999999999998532221100
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
....+++......+.....++.+++..||+.||++|||+.|+++.
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011111111111111123467899999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=344.52 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=197.4
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||+|+...++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986543 23357788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 77776643 2345889999999999999999999987 99999999999999999999999999987643221
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccccc----ccccCccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWS----LCKNDRAHEL 755 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~----~~~~~~~~~~ 755 (848)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .+...... .+........
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 12235789999999999764 589999999999999999999999864332110 00000000 0000000000
Q ss_pred cccccc-------cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDPVLQ-------NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.++... .........++.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 010000 0011123346789999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=357.43 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=202.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3468999999999999999999875 58899999997542 33457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC---Cceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~ 676 (848)
|||+++++|.+.+.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999887743 346899999999999999999999987 99999999999998654 599999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... ...... ...
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~----i~~~~~-~~~ 250 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQ----IKAGAY-DYP 250 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHTCC-CCC
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH----HHhCCC-CCC
Confidence 65432 1233579999999999999999999999999999999999999985432111 0000 000000 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+. ......++.+++..||+.||++||++.|+++
T Consensus 251 ~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 251 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp TTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0112346889999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.96 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=194.5
Q ss_pred hcCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4789999999999999999998743 4569999987643 334577899999999999999999999974 567899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999988843 2345889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... .... . ....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~---i-~~~~------ 234 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR---I-ENGE------ 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH---H-HTTC------
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH---H-HcCC------
Confidence 43221 2223457889999999999999999999999999999997 888886433211 1000 0 0000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++||++.|+++.|++.+
T Consensus 235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111223446889999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.17 Aligned_cols=267 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecC----CceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~ 594 (848)
....++|.+.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3455789999999999999999998643 457999998754 2344577999999999999999999999998765
Q ss_pred -----eEEEEEEeccCCcccccccCC---CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 595 -----EKILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 595 -----~~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
..++||||+++++|..++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 349999999999998887432 23456899999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+........ ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~--- 261 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDY--- 261 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHH---
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHH---
Confidence 9999999987755443333344567889999999999999999999999999999999 8888754332110 000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
. .... . ..........+.+++..||+.||++||++.++++.|+..+..+|
T Consensus 262 ~-~~~~-----~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 L-LHGH-----R----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp H-HTTC-----C----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred H-HcCC-----C----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 0000 0 01111223468899999999999999999999999998866554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=344.91 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=210.0
Q ss_pred hcCcceee-eecccCCccEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|.+.+ .||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35677776 9999999999999854 47789999997653 34567899999999999999999999999 5667999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998853 3446899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----i~~~~----- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF----IEQGK----- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHH----HHTTC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH----HhcCC-----
Confidence 43221 12223457899999999999999999999999999999998 999986433211 0000 00000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCC
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSP 807 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 807 (848)
....+......+.+++..||+.||++||++.++++.|++.+.+...+
T Consensus 231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 01112223457889999999999999999999999998886554433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.23 Aligned_cols=251 Identities=23% Similarity=0.397 Sum_probs=203.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC-C-------ceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
.++|++.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998653 3 4699999987766777889999999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC--------ce
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--------PK 667 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~k 667 (848)
.++||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999998853 2334889999999999999999999987 999999999999998887 99
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCC-CCCCCCcccccccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNT-GVYNTDSFNLLGHAWS 745 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~-~~~~~~~~~~~~~~~~ 745 (848)
|+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+ ........ ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~--- 230 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQF--- 230 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH---
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HHH---
Confidence 9999999765322 23468999999999987 67899999999999999999965543 22111100 000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
.... ...+.....++.+++..||+.||++|||+.|+++.|++.+.
T Consensus 231 ~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0000 00111112357789999999999999999999999988754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.07 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=202.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999875 58999999997542 234677889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999988843 346889999999999999999999987 999999999999999999999999999875432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+... ... .++...+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~------------~i~~~~~ 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYE------------KILNAEL 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH------------HHHHCCC
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCCC
Confidence 234689999999999999999999999999999999999999985432110 000 0000000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..+.....++.+++..||+.||++|| ++.|+++
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11122234688999999999999999 8888874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.57 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=211.3
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++.++||+|+||.||+|.... ++.||+|++... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999764 889999999753 3456789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999888542 2345889999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+........ . +.+....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~-------------~~~~~~~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y-------------ELLEKDY 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H-------------HHHHTTC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------------HHHhccC
Confidence 2 22223467889999999999999999999999999999999 8888754332111 0 0000001
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++||++.|+++.|+..+
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11111223357889999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=365.26 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=201.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999864 58999999987543 23456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec---cCCCceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~ 676 (848)
|||+++|+|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999887743 346899999999999999999999987 99999999999998 467899999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+... +... ..... ....
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~----i~~~~-~~~~ 233 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQ----IKAGA-YDFP 233 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH----HHHTC-CCCC
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHH----HHhCC-CCCC
Confidence 654322 1233579999999999999999999999999999999999999985432111 0000 00000 0000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ........++.+++..||+.||++|||+.|+++
T Consensus 234 ~-----~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 S-----PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 000112346889999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.86 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=202.3
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~ 596 (848)
...++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45579999999999999999999975 58899999997542 34556788899999987 999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999988884 3346889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... . ...
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~---i-~~~------ 233 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHS---I-RMD------ 233 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---H-HHC------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHH---H-HhC------
Confidence 53222 22345689999999999999999999999999999999999999986432211 1000 0 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHH-HHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMS-DVV 794 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 794 (848)
.+ ..+.....++.+++..||+.||++||++. +++
T Consensus 234 ~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 00 11111234688999999999999999997 664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.26 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=205.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999875 5889999999776555567889999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc--CCCceeeccccccccCCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGD 680 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~ 680 (848)
+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999888743 2346899999999999999999999987 999999999999974 577999999999877543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .... ...+
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i---~~~~---~~~~--- 270 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNV---KRCD---WEFD--- 270 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH---HHCC---CCCC---
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCC---CCCC---
Confidence 2 2334579999999999999999999999999999999999999986432111 10000 0000 0000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........++.+++..||+.||++|||+.|+++
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0111122346889999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.70 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=194.4
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
..++|++.++||+|+||.||+|+.. ..||||++.... ....+.+.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3478999999999999999999863 359999987543 34457799999999999999999999965 556789999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999888843 3456889999999999999999999987 999999999999999999999999999866543
Q ss_pred ccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..........||+.|+|||++. +..++.++||||||+++|||++|+.||........ +.. ....... .
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~~~----~ 244 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIE----MVGRGSL----S 244 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHH----HHHHTSC----C
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHH----Hhccccc----C
Confidence 3233334467999999999986 66788999999999999999999999864332211 000 0000000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+.+. ........++.+++..||+.+|++||++.++++.|++..
T Consensus 245 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0000 111223457889999999999999999999999998874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=353.57 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=199.5
Q ss_pred cCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999997 468899999986431 233467899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+ +|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 677766663 3346899999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .. ......
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~------------~i~~~~ 224 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FK------------KVNSCV 224 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BC------------CCCSSC
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HH------------HHHcCC
Confidence 32 233579999999999988876 7899999999999999999999864322110 00 000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+......+.+++..||+.||++|||+.|+++
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111122346789999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.34 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=208.4
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 36799999999999999999998888899999997643 34578999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999888432 345789999999999999999999987 999999999999999999999999999876433211
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN 762 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 762 (848)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .... . ... .. .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~---i-~~~-----~~----~ 224 (267)
T 3t9t_A 161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED---I-STG-----FR----L 224 (267)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---H-HTT-----CC----C
T ss_pred -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHH---H-hcC-----Cc----C
Confidence 1222457789999999999999999999999999999999 888875432111 0000 0 000 00 0
Q ss_pred CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 763 EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 763 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
..+......+.+++..||+.||++||++.++++.|++..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111122346889999999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.80 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=202.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 68999999999999999999875 4789999998653 2345678899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+.+|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999888843 346899999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-cccccccccccCcccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-LLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 756 (848)
. .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||......... +.... .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------~ 233 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------E 233 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------H
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------h
Confidence 2 2344689999999999874 45899999999999999999999998643322110 00000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCC-HHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-MSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 795 (848)
.. ....+......+.+++..||+.||++||+ +.++.+
T Consensus 234 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 00112223457889999999999999999 676654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=367.31 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=206.2
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
+.++....++|++.++||+|+||+||+|+... ++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999765 7899999996532 2223448899999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
++..++||||+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999988542 346899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+... ..... .
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~~i---~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKI---M 294 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH---H
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHHhh---h
Confidence 99876543221 223368999999999997 5678999999999999999999999986432211 00000 0
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHH
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 795 (848)
... ....-+. .......++.+++..||+.+|++ ||++.|+++
T Consensus 295 ~~~--~~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 295 NHK--ERFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp THH--HHCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hcc--ccccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 0000000 00112346888999999988888 999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.29 Aligned_cols=275 Identities=23% Similarity=0.304 Sum_probs=200.6
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc--CCCceeeeeeeeeeC----C
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCIEQ----G 594 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l--~Hpniv~l~~~~~~~----~ 594 (848)
....++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999874 899999998643 234445555555554 899999999999887 7
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC-----CCceEecccCCCcEEeccCCCceee
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
..++||||+++++|.+++. ...+++..+..++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 8999999999999999883 335899999999999999999999871 1239999999999999999999999
Q ss_pred ccccccccCCCcccc--ceeeeeccccccChhhhhcCCCCcc------cceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 670 DFGMARMFGGDELQG--NTKRIVGTYGYMSPEYALEGVFSVK------SDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 670 DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~k------sDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
|||+++.+....... ......||+.|+|||++.+.....+ +|||||||++|||++|..|++...........
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998765432221 1223579999999999988776665 99999999999999995554322111100000
Q ss_pred ccc-----cccccCccccccccccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 742 HAW-----SLCKNDRAHELMDPVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 742 ~~~-----~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
... .............+..... .......++.+++..||+.||++|||+.||++.|+.....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 000 0000000000111111111 1225667899999999999999999999999999887543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=360.54 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=195.7
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcC--CCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~--Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||++....++.||||++... .....+.+.+|+.+|++++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999878999999998654 2345678999999999996 59999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899888843 346788899999999999999999987 99999999999995 58999999999987754
Q ss_pred CccccceeeeeccccccChhhhhc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~--------- 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------- 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---------
Confidence 433333344679999999999875 468999999999999999999999985332111000
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+++......+......+.+++..||+.||++||++.|+++
T Consensus 278 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 ----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 0111111111111111346789999999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=363.57 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=205.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999975 68999999996542 234567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999998884 3456899999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... +.. . +.+..
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~---~---------i~~~~ 232 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFK---K---------ICDGI 232 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHH---H---------HHTTC
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHH---H---------HhcCC
Confidence 22 234579999999999998876 789999999999999999999986432211 000 0 00000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH--HHhcc
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS--MINNE 800 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 800 (848)
. ..+.....++.+++..||+.||++|||+.|+++ .+.+.
T Consensus 233 ~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 011112346789999999999999999999986 45444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.03 Aligned_cols=257 Identities=20% Similarity=0.235 Sum_probs=204.9
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~ 593 (848)
..+....++|++.++||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456689999999999999999999976 48899999986521 22334578999999999999999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||+++|+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999988874 235889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCC----CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKN 749 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 749 (848)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... ..
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~--------- 282 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TY--------- 282 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---------
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--HH---------
Confidence 987654321 1223468999999999998765 8899999999999999999999986432111 00
Q ss_pred Cccccccccc--cccCCCHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 003092 750 DRAHELMDPV--LQNEVSLPMLVRYINVALLCVQENAED--RPTMSDVVSM 796 (848)
Q Consensus 750 ~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 796 (848)
..++... +.-........++.+++..||+.+|++ ||++.||++.
T Consensus 283 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 ---SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000000 000001112346889999999999988 9999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.14 Aligned_cols=254 Identities=28% Similarity=0.526 Sum_probs=201.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc-------cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999874 6889999998654322 1267899999999999999999999986655
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-----ceeec
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKISD 670 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kl~D 670 (848)
++||||+++++|.+.+.. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999777754 3346899999999999999999999874 24999999999999988776 99999
Q ss_pred cccccccCCCccccceeeeeccccccChhhh--hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYA--LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||............... .
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~ 244 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---E 244 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---H
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---c
Confidence 999985432 23346799999999998 4556789999999999999999999998654432211111000 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
....+ .........+.+++..||+.||++|||+.|+++.|++
T Consensus 245 -----~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 -----EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----SCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----cCCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 00111 1122234478899999999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=357.34 Aligned_cols=268 Identities=18% Similarity=0.246 Sum_probs=202.9
Q ss_pred hcCcceeeeeccc--CCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G--~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 99999999976 58999999997543 3345778899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999888543 2245889999999999999999999987 9999999999999999999999999987553
Q ss_pred CCcc-----ccceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc---c
Q 003092 679 GDEL-----QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC---K 748 (848)
Q Consensus 679 ~~~~-----~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~ 748 (848)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.................. .
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2211 111223478999999999987 57899999999999999999999998654332211000000000 0
Q ss_pred c------------------Cccccccccc---------cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 N------------------DRAHELMDPV---------LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~------------------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ....+.+... ............+.+++..||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 0000000000 000011123446889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=376.60 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=210.8
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
...++|++.++||+|+||.||+|.+..+..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3457899999999999999999999888889999997643 345789999999999999999999999876 67899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999988431 2245889999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.. ......++..|+|||++....++.++||||||++||||++ |+.|+....... +.... ... .
T Consensus 418 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i----~~~---------~ 481 (535)
T 2h8h_A 418 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQV----ERG---------Y 481 (535)
T ss_dssp HH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHH----HTT---------C
T ss_pred ee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcC---------C
Confidence 11 1122356789999999999999999999999999999999 888875432111 10000 000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
...........+.+++..||+.||++|||+.+|+++|+..+....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 001122234578899999999999999999999999998865443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.95 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=198.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67999999999999999999975 48899999997542 23456688999999998 899999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999988874 3346899999999999999999999987 99999999999999999999999999986432
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....+....
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---------~~~~~~~~i 231 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQVI 231 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHH
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc---------cHHHHHHHH
Confidence 21 2234468999999999999999999999999999999999999998643221100000 000000000
Q ss_pred ccc--CCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 760 LQN--EVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 760 l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
... ..+.....++.+++..||+.||++||++
T Consensus 232 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000 1122234578899999999999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.34 Aligned_cols=244 Identities=24% Similarity=0.294 Sum_probs=190.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||+||+|+.. +++.||||++.... .....++..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 68999999986542 23334555666666665 8999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+ +++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 5677666643 2346899999999999999999999987 999999999999999999999999999876433
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ......||+.|+|||++.+ .++.++||||||+++|||++|..++..... +...... ...+.+
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~----~~~~~~ 273 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQG----YLPPEF 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTT----CCCHHH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhcc----CCCccc
Confidence 2 2233569999999998875 789999999999999999999766431100 0000000 011111
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ....++.+++..||+.||++|||+.|+++
T Consensus 274 ~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 12346889999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.71 Aligned_cols=244 Identities=21% Similarity=0.273 Sum_probs=202.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999975 58999999996542 245677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999888842 345889999999999999999999987 999999999999999999999999999876432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .. .... .
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~---~i-~~~~--------~ 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYE---KI-VSGK--------V 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HH-HHCC--------C
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HHH---HH-HcCC--------C
Confidence 234689999999999999999999999999999999999999985432111 000 00 0000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..+......+.+++..||+.||++||+ +.||++
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111123346889999999999999998 888865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.30 Aligned_cols=267 Identities=17% Similarity=0.195 Sum_probs=198.6
Q ss_pred hcCcceeeeecccCCccEEEEEec----CCceEEEEEecccCcc-----------cHHHHHHHHHHHHHcCCCceeeeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLLG 588 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~Hpniv~l~~ 588 (848)
.++|++.++||+|+||.||+|... .++.||||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 4678999998764321 1234667888999999999999999
Q ss_pred eeee----CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC
Q 003092 589 CCIE----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 589 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
++.. ....++||||+ +++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999998843 337899999999999999999999987 99999999999999887
Q ss_pred --CceeeccccccccCCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc
Q 003092 665 --NPKISDFGMARMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF 737 (848)
Q Consensus 665 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~ 737 (848)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 111345799999999999999999999999999999999999999853222111
Q ss_pred ccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 738 NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
......... .. .....+..... ......++.+++..||+.||++||++.+|++.|++...
T Consensus 269 ~~~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKTNL-LD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHH-HH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHhh-cc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110000000 00 00000000000 00223478899999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.80 Aligned_cols=261 Identities=25% Similarity=0.333 Sum_probs=204.8
Q ss_pred CcceeeeecccCCccEEEEEecC-C---ceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE-EEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK-ILI 599 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~-~lV 599 (848)
.|.+.++||+|+||+||+|.+.+ + ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999998643 2 2699999976433 4567889999999999999999999999876655 999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+.+++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999998854 3356789999999999999999999987 99999999999999999999999999987654
Q ss_pred Cccc--cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 680 DELQ--GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ...... +.
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~-------------~~ 242 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHF-------------LA 242 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHH-------------HH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHH-------------hh
Confidence 3321 2223456889999999999999999999999999999999966654221111 000000 00
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.......+......+.+++..||+.||++|||+.++++.|++.+..+.
T Consensus 243 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 000001111223468899999999999999999999999988865554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.99 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=204.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999875 58899999987543 3345788999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999998884 3346889999999999999999999987 9999999999999999999999999998764333
Q ss_pred cccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.|+............+. ... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~--~~~~--- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKK--TYLN--- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTC--TTST---
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hcc--cccC---
Confidence 2223344679999999999988775 7899999999999999999999865433221111100 000 0000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........+.+++..||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122346788999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.74 Aligned_cols=261 Identities=20% Similarity=0.229 Sum_probs=200.1
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-----CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~ 593 (848)
+....++|++.++||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4456688999999999999999999874 5788999998643 234567899999999999999999999999999
Q ss_pred CeEEEEEEeccCCcccccccCC-------------------------------------CcccccCHHHHHHHHHHHHHH
Q 003092 594 GEKILIYEYMVNKSLDVFLFDP-------------------------------------TKKHLLGWQLRVRIIDGIAQG 636 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qia~~ 636 (848)
+..++||||+++++|.+++... .....+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999998877411 012234677888999999999
Q ss_pred HHHHHhcCCCceEecccCCCcEEeccCC--CceeeccccccccCCCcc--ccceeeeeccccccChhhhhc--CCCCccc
Q 003092 637 LLYLHQYSRLRIIHRDLKASNILLDQHM--NPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALE--GVFSVKS 710 (848)
Q Consensus 637 L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~~~~--~~~~~ks 710 (848)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999987 99999999999998776 899999999987643211 112334679999999999975 6789999
Q ss_pred ceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 711 DVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 711 DVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
||||||+++|||++|+.||......... ....... .....+. .......+.+++..||+.||++||++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~--~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTI-----SQVLNKK--LCFENPN-----YNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHH-----HHHHHCC--CCTTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHhcc--cccCCcc-----cccCCHHHHHHHHHHcCCChhHCCCH
Confidence 9999999999999999998643321100 0000000 0000000 01123468899999999999999999
Q ss_pred HHHHH
Q 003092 791 SDVVS 795 (848)
Q Consensus 791 ~evl~ 795 (848)
.|+++
T Consensus 326 ~~~l~ 330 (345)
T 3hko_A 326 MRALQ 330 (345)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.84 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=191.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 58899999997543 2346788999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC--ceeeccccccccCCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMARMFGGD 680 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~ 680 (848)
+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999988874 2346899999999999999999999987 999999999999987766 999999999754322
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVK-SDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~k-sDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ..... .......
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~---------~~~~~~~ 238 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTI---------QRILSVK 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHH---------HHHHTTC
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHH---------HHHhcCC
Confidence 12234579999999999998888665 8999999999999999999864332111 00000 0000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000001112346789999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.40 Aligned_cols=274 Identities=19% Similarity=0.251 Sum_probs=211.4
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeee-eeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-IEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~-~~~~~~~lV~E 601 (848)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.+++.++|++++..+..+ .++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999996 4689999999865433 34688999999999998877666655 56678899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 678 (848)
|+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999888842 2345899999999999999999999987 9999999999999 588999999999998775
Q ss_pred CCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccccccccccccCcc
Q 003092 679 GDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKNDRA 752 (848)
Q Consensus 679 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 752 (848)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----EKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----HHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc----cccc
Confidence 54321 11234679999999999999999999999999999999999999986533211 11000000 0000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCccc
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFTT 814 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~~ 814 (848)
. ...+.+.. ....++.+++..||+.||++||++.++++.|++.+.....+...++.+
T Consensus 236 ~-~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 236 S-TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp H-SCHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred C-CchHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 0 00000111 123468899999999999999999999999998876666555544544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=349.95 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=194.2
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe----
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE---- 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~---- 595 (848)
.++|++.++||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 37899999999999999999996 468899999997643 2335678999999999999999999999876543
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999884 3346899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~---- 235 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVRED---- 235 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCC----
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCC----
Confidence 76543221 2233457999999999999999999999999999999999999998543321100 0000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH-HHhcc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS-MINNE 800 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~-~L~~~ 800 (848)
...+.. .......++.+++..||+.||++||++.+++. .|...
T Consensus 236 ~~~~~~---~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 PIPPSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCHHH---HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCccc---ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000000 00112346889999999999999997666554 44443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.75 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=213.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC--eEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~--~~~lV 599 (848)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3679999999999999999999764 8999999997543 344677889999999999999999999998765 78999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe----ccCCCceeecccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl~DFGla~ 675 (848)
|||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999866544455899999999999999999999987 9999999999999 777889999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhc--------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALE--------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .......
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKII 240 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHh
Confidence 7654332 223579999999999875 567889999999999999999999986433211100 0000000
Q ss_pred ccC---cc---ccc------cccc--cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 748 KND---RA---HEL------MDPV--LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 748 ~~~---~~---~~~------~d~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
... .. ... .... ............+.+++..||+.||++||++.|+++.++.++.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 000 00 000 0000 1123445667788899999999999999999999998877754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.21 Aligned_cols=264 Identities=21% Similarity=0.239 Sum_probs=205.1
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~ 597 (848)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999987 4689999999977666667889999999999999999999999873 34789
Q ss_pred EEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
+||||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999998887532 23456899999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCcccc-------ceeeeeccccccChhhhhcCC---CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 677 FGGDELQG-------NTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 677 ~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~---~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-----
Confidence 53211100 011235799999999987554 689999999999999999999997431111000000
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
.+...............+.+++..||+.||++||++.++++.|+....
T Consensus 259 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 --------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000000011112233478899999999999999999999999988743
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.43 Aligned_cols=266 Identities=21% Similarity=0.260 Sum_probs=192.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeee--------e
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCI--------E 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~--------~ 592 (848)
...+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468999999999999999999965 58899999997666666778999999999996 999999999984 3
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
....++||||+. |+|.+++........+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345899999996 678777754334456899999999999999999999874 249999999999999999999999999
Q ss_pred cccccCCCcccc----------ceeeeeccccccChhhh---hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc
Q 003092 673 MARMFGGDELQG----------NTKRIVGTYGYMSPEYA---LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL 739 (848)
Q Consensus 673 la~~~~~~~~~~----------~~~~~~gt~~y~APE~~---~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~ 739 (848)
+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+....... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--I 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--h
Confidence 998765432211 11235699999999998 56678999999999999999999999985322110 0
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCC
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~ 808 (848)
. ...............+.+++..||+.||++||++.|+++.|+......+...
T Consensus 262 ~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 262 V----------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred h----------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 0 0000000011112246789999999999999999999999988765444333
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=351.27 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=187.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999976 47889999997543 34668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 678 (848)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999888843 345899999999999999999999987 999999999999975 8899999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... . . .... .....
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~---i-~~~~-~~~~~- 272 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-R---I-LNCE-YYFIS- 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH-H---H-HTTC-CCCCT-
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH-H---H-HhCC-CccCC-
Confidence 332 22345799999999999999999999999999999999999999854332211000 0 0 0000 00000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++..||+.||++|||+.|+++
T Consensus 273 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 ----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123346889999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.16 Aligned_cols=252 Identities=20% Similarity=0.358 Sum_probs=203.3
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC--CeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~--~~~~lV~ 600 (848)
++|++.++||+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 6799999999999999999998 48899999997543 34457799999999999999999999999877 7889999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++... ....+++..+..++.||++||+|||+.+ ..|+||||||+|||++.++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999998643 2235899999999999999999999864 34999999999999999999999999987653222
Q ss_pred ccccceeeeeccccccChhhhhcCCCCc---ccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSV---KSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~---ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
...||+.|+|||++.+..++. ++||||||+++|||++|+.|+......... ..... ....
T Consensus 167 -------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~-----~~~~ 229 (271)
T 3kmu_A 167 -------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----MKVAL-----EGLR 229 (271)
T ss_dssp -------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----HHHHH-----SCCC
T ss_pred -------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----HHHHh-----cCCC
Confidence 246899999999998776554 799999999999999999998643321110 00000 0011
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
+ ..+......+.+++..||+.||++|||+.|+++.|++.
T Consensus 230 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 230 P----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 11222334688999999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.78 Aligned_cols=271 Identities=18% Similarity=0.267 Sum_probs=206.0
Q ss_pred HhcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeee-eeCCeEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-IEQGEKILIY 600 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~-~~~~~~~lV~ 600 (848)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999986 4688999998765432 24578899999999988877766665 5677889999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeecccccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~ 677 (848)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99998887432 345899999999999999999999987 9999999999999 88999999999999877
Q ss_pred CCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccCc
Q 003092 678 GGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKNDR 751 (848)
Q Consensus 678 ~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 751 (848)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---------- 228 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---------- 228 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----------
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----------
Confidence 544321 122346799999999999999999999999999999999999999865432211 1000
Q ss_pred cccccccccccC---CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 003092 752 AHELMDPVLQNE---VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPFT 813 (848)
Q Consensus 752 ~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~~~ 813 (848)
.......... ........+.+++..||+.||++||++.++++.|++.+........-++.
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 4hgt_A 229 --RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp --HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred --hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence 0000000000 00111347889999999999999999999999999887655444333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=348.42 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=187.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 368999999999999999999865 58899999997543 2345778999999999999999999999999999999999
Q ss_pred eccCCcccccccCC---CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|++ ++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 4777766422 12245889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccc-------ccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLG-------HAWSLCK 748 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~-------~~~~~~~ 748 (848)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . +.. ..|....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3221 1223578999999999986 4689999999999999999999999864432110 0 000 0000000
Q ss_pred c---------CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 N---------DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~---------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ......+...+..........++.+++..||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000001111111123347889999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=353.04 Aligned_cols=272 Identities=25% Similarity=0.363 Sum_probs=196.3
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHH--HHHcCCCceeeeeeeeee-----CCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML--IAKLQHRNLVRLLGCCIE-----QGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~--l~~l~Hpniv~l~~~~~~-----~~~~ 596 (848)
.++|++.++||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 37899999999999999999987 68999999996532 3344444444 455899999999986542 2367
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC------CCceEecccCCCcEEeccCCCceeec
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS------RLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
++||||+++|+|.+++. ....++..+.+++.||++||+|||+.. +.+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 89999999999999883 234588899999999999999999881 11399999999999999999999999
Q ss_pred cccccccCCCccc------cceeeeeccccccChhhhhc-------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc
Q 003092 671 FGMARMFGGDELQ------GNTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF 737 (848)
Q Consensus 671 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~ 737 (848)
||+++.+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999877543211 11223469999999999987 4567899999999999999999877533221110
Q ss_pred ccccccccccccCc---c-----ccccccccccC--CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 738 NLLGHAWSLCKNDR---A-----HELMDPVLQNE--VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 738 ~~~~~~~~~~~~~~---~-----~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
.............. . .....+.+... ........+.+++..||+.||++|||+.|+++.|++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00000000000000 0 00011111111 1223556799999999999999999999999999887643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.55 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=202.4
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999998754 678999999876666778899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccccCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 679 (848)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999988773 3345889999999999999999999987 9999999999999 7889999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.|+........ ... . ..... ......
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~---~-~~~~~-~~~~~~ 230 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--MLK---I-REGTF-TFPEKD 230 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH---H-HHCCC-CCCHHH
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HHH---H-HhCCC-CCCchh
Confidence 33 22335799999999988654 89999999999999999999999864322110 000 0 00000 000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ......+.+++..||+.||++||++.++++
T Consensus 231 -~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 -W----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -h----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 012346889999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.64 Aligned_cols=261 Identities=28% Similarity=0.393 Sum_probs=203.2
Q ss_pred cCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeee-eCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI-EQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~-~~~~~~l 598 (848)
.+|++.++||+|+||.||+|+..+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568899999999999999998643 2358999987643 344577999999999999999999999865 4567899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999998853 3345789999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccc--cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCC-CCCCCCCCCccccccccccccccCccccc
Q 003092 679 GDELQ--GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 679 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|. +|+........ .... . ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~---~-~~~---- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYL---L-QGR---- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHH---H-TTC----
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHH---h-cCC----
Confidence 43321 1223356788999999999999999999999999999999954 45433222111 0000 0 000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.. ..+......+.+++..||+.||++||++.|+++.|++.+..+.
T Consensus 250 -~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 -RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -CC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0111123468899999999999999999999999998865543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.85 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=191.7
Q ss_pred hcCcceeeeecccCCccEEEEEe----cCCceEEEEEecccC----cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
.++|++.++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999987 368899999997542 2344667899999999999999999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999988874 3346889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .+
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~------------~i 233 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TID------------KI 233 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH------------HH
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHH------------HH
Confidence 643222 12233579999999999999999999999999999999999999986432111 000 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.... ...+......+.+++..||+.||++|| ++.|+++
T Consensus 234 ~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 LKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0000 011122334788999999999999999 6777765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.16 Aligned_cols=249 Identities=24% Similarity=0.306 Sum_probs=201.7
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-CceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.++||+|+||.||+|+... ++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999764 789999999754 234567788999999988 8999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999988884 3346889999999999999999999987 999999999999999999999999999864
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +... ++.
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~~------------i~~ 235 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQS------------IME 235 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH------------HHH
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHHH------------HHh
Confidence 3222 22345689999999999999999999999999999999999999986432211 1000 000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
... ..+.....++.+++..||+.||++||+ +.++++
T Consensus 236 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000 111223457889999999999999996 466654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.13 Aligned_cols=247 Identities=26% Similarity=0.304 Sum_probs=194.8
Q ss_pred eeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccCCc
Q 003092 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
..+.||+|+||.||+|+.. +++.||+|++........+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3678999999999999864 588999999987665667889999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe--ccCCCceeeccccccccCCCccccc
Q 003092 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL--DQHMNPKISDFGMARMFGGDELQGN 685 (848)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 685 (848)
|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9887743 2345889999999999999999999987 9999999999999 5677899999999987754332
Q ss_pred eeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCC
Q 003092 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVS 765 (848)
Q Consensus 686 ~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 765 (848)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .... ..... ....... .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~---i~~~~--~~~~~~~-~---- 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNN---ILACR--WDLEDEE-F---- 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH---HHHTC--CCSCSGG-G----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHhcc--CCCChhh-h----
Confidence 223469999999999999999999999999999999999999986433211 0000 00000 0000000 0
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 766 LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 766 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....++.+++..||+.||++||++.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112346889999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=343.90 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=204.6
Q ss_pred HhcCcceee-eecccCCccEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 523 ATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 523 ~~~~f~i~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
..++|++.+ .||+|+||.||+|.+. .++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788888 9999999999999643 36789999997543 23367899999999999999999999998 66788
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999998843 345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~~~~~~--- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA----MLEKGE--- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTTC---
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcCC---
Confidence 7543321 12222456789999999999999999999999999999999 999986433211 000 000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
....+......+.+++..||+.||++||++.++++.|++.+..
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999887543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.86 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=195.3
Q ss_pred cCcceeeeecccCCccEEEEEecC--C--ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeee-CCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~--~--~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~~~l 598 (848)
..|++.++||+|+||.||+|++.+ + ..||||.+.... ....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 357788999999999999998643 2 368999987543 3456789999999999999999999998764 457899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999998853 3345788999999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccc--ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccc
Q 003092 679 GDELQG--NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 679 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+|+........ .... ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~----~~~~---- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYL----LQGR---- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHH----HTTC----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHH----HcCC----
Confidence 432211 2223467889999999999999999999999999999999 5666643322111 0000 0000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.. ..+......+.+++..||+.||++||++.|+++.|++.+..+.
T Consensus 314 -~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 -RL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0111223468899999999999999999999999998865544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.69 Aligned_cols=257 Identities=27% Similarity=0.359 Sum_probs=201.7
Q ss_pred HhcCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.+.||+|+||.||+|+... +..||||.+.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34789999999999999999998643 2359999997653 3456789999999999999999999999764 4568
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999988843 2345889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ .... ....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~~~---~~~~------ 231 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IGVL---EKGD------ 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HHHH---HHTC------
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HHHH---hcCC------
Confidence 543221 1223457889999999999999999999999999999998 9999854322111 0000 0000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++||++.|+++.|++.+
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00111122346889999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=344.78 Aligned_cols=268 Identities=22% Similarity=0.300 Sum_probs=205.7
Q ss_pred HHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHH--cCCCceeeeeeeeeeCC--
Q 003092 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQG-- 594 (848)
Q Consensus 519 ~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~Hpniv~l~~~~~~~~-- 594 (848)
......++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3344567899999999999999999988 5899999999643 34677889999988 78999999999998876
Q ss_pred --eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH--------hcCCCceEecccCCCcEEeccCC
Q 003092 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDQHM 664 (848)
Q Consensus 595 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiHrDlkp~NILl~~~~ 664 (848)
..++||||+++++|.+++. ...+++..+..++.||++||+||| +.+ |+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 8899999999999999884 245889999999999999999999 554 99999999999999999
Q ss_pred CceeeccccccccCCCcccc--ceeeeeccccccChhhhhcC------CCCcccceeehHHHHHHHHhC----------C
Q 003092 665 NPKISDFGMARMFGGDELQG--NTKRIVGTYGYMSPEYALEG------VFSVKSDVFSFGVLMLEILSS----------K 726 (848)
Q Consensus 665 ~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~~~~~------~~~~ksDVwSlGvvl~elltg----------~ 726 (848)
.+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999998765433211 22345799999999999876 344789999999999999999 4
Q ss_pred CCCCCCCCCccccccccccccccCcccccccccccc-CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 727 KNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQN-EVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 727 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
.|+.............. ... ......+.+.. .........+.+++..||+.||++|||+.||++.|+++..
T Consensus 265 ~p~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMR-KVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CTTTTTSCSSCCHHHHH-HHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCccccCcCcccHHHHH-HHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 45432211110000000 000 00111111111 1123566789999999999999999999999999988743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=376.02 Aligned_cols=259 Identities=26% Similarity=0.396 Sum_probs=202.8
Q ss_pred cCcceee-eecccCCccEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+.+|++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4555555 8999999999999864 35679999997653 3457889999999999999999999999876 568999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999998853 3456899999999999999999999987 99999999999999999999999999987654
Q ss_pred Cccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 680 DELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 680 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +.. .....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~----~i~~~------- 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA----FIEQG------- 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHH----HHHTT-------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcC-------
Confidence 3221 11222346789999999999999999999999999999998 999986443221 100 00000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
.....+.....++.+++..||+.+|++||++.+|++.|+..+..+
T Consensus 556 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 556 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 001112223457889999999999999999999999998875443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.98 Aligned_cols=255 Identities=15% Similarity=0.152 Sum_probs=205.2
Q ss_pred HHhcCcceeeeecccCCccEEEEE------ecCCceEEEEEecccCcccHHHHHHHHHHHHHcC---CCceeeeeeeeee
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIE 592 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~ 592 (848)
...++|++.++||+|+||+||+|. ...++.||||++... ...++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345789999999999999999994 345889999999754 3467888888888887 9999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCC--CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc--------
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDP--TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------- 662 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-------- 662 (848)
++..++||||+++|+|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 99999999999999999988532 13456899999999999999999999987 999999999999998
Q ss_pred ---CCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc
Q 003092 663 ---HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL 739 (848)
Q Consensus 663 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~ 739 (848)
++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.|+.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999997654322222334467999999999999999999999999999999999999997422211100
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCC-CCHHHHHHHHhcccC
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR-PTMSDVVSMINNELF 802 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~~~~ 802 (848)
+...+... +....+.+++..|++.+|.+| |++.++.+.|++.+.
T Consensus 295 ----------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 ----------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 11111111 123456778889999999988 778888888877654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=345.01 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=205.7
Q ss_pred eeeHHHHHHHhcCccee-eeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHc-CCCceeeeee
Q 003092 514 LFSFASVTAATENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLG 588 (848)
Q Consensus 514 ~~~~~~i~~~~~~f~i~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~Hpniv~l~~ 588 (848)
...+.......++|.+. ++||+|+||.||+|... +++.||||++.... .....++.+|+.++.++ .||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455556667788887 89999999999999875 58999999987542 34467899999999999 4699999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCC
Q 003092 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMN 665 (848)
Q Consensus 589 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~ 665 (848)
++.+.+..++||||+++++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 999999999999999999998887432 3356899999999999999999999987 999999999999988 789
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~ 247 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--NISQ 247 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--HHHh
Confidence 9999999998765332 2234579999999999999999999999999999999999999985433211100 0000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ...............+.+++..||+.||++|||+.|+++
T Consensus 248 ~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 V----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp T----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 000001111123346889999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.02 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=197.5
Q ss_pred cCccee-eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+.|++. ++||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 578885 78999999999999864 6899999999876666678899999999995 79999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~~ 678 (848)
|+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999888843 346889999999999999999999987 999999999999988776 9999999998664
Q ss_pred CCcc-----ccceeeeeccccccChhhhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 679 GDEL-----QGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 679 ~~~~-----~~~~~~~~gt~~y~APE~~~~-----~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~ 242 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE---AC 242 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc---cc
Confidence 2211 111223569999999999975 5689999999999999999999999865432211000000 00
Q ss_pred cCccccccccccccC--CCH----HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNE--VSL----PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~--~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+........ .+. .....+.+++..||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000111111111 111 12346889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.79 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=199.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~ 594 (848)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 468999999999999999999864 588999999875421 13345778999999999999999999999999
Q ss_pred eEEEEEEeccCC-cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 595 EKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 595 ~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
..++||||+..| +|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 88887743 345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 98775433 2234679999999999998887 88999999999999999999998532110
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... .+.....++.+++..||+.||++|||+.|+++
T Consensus 237 ---~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ---VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ---TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 01112346889999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.76 Aligned_cols=210 Identities=28% Similarity=0.340 Sum_probs=180.3
Q ss_pred CCeeeHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-----CCceee
Q 003092 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVR 585 (848)
Q Consensus 512 l~~~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv~ 585 (848)
...+++.......++|++.++||+|+||+||+|+.. +++.||||++... ....+.+..|+.++++++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 334555555666789999999999999999999874 5889999999642 344566788999999997 999999
Q ss_pred eeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---
Q 003092 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--- 662 (848)
Q Consensus 586 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~--- 662 (848)
+++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 88998887533 2235889999999999999999999987 999999999999975
Q ss_pred ----------------------CCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHH
Q 003092 663 ----------------------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLML 720 (848)
Q Consensus 663 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ 720 (848)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999865432 23457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 003092 721 EILSSKKNTGVY 732 (848)
Q Consensus 721 elltg~~p~~~~ 732 (848)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999998643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.99 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=200.8
Q ss_pred hcCcceeeeecccCCccEEEEEecC-----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
.++|++.+.||+|+||.||+|.... +..||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3678899999999999999998653 2359999997543 334567899999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999998853 2346889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccc
Q 003092 678 GGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... +... . ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~---~-~~~----- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKA---I-NDG----- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---H-HTT-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHH---H-HCC-----
Confidence 543211 11222356889999999999999999999999999999999 999985332111 0000 0 000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
............+.+++..||+.+|++||++.++++.|++.+.
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0001112234468899999999999999999999999988753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=342.20 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=203.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.+.||+|+||.||+++.. +++.||||++..... ...+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999975 588999999875432 1367899999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC----Cceeeccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFG 672 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFG 672 (848)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999998843 346889999999999999999999987 99999999999999888 79999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... . ..
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i---~-~~-- 233 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANI---T-SV-- 233 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH---H-TT--
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH---H-hc--
Confidence 998765432 1233579999999999999999999999999999999999999985432111 00000 0 00
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....+.... .....+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SYDFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000111111 12346789999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=351.21 Aligned_cols=273 Identities=26% Similarity=0.395 Sum_probs=208.2
Q ss_pred hcCcceeeeecccCCccEEEEEe-----cCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC--eE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~--~~ 596 (848)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36799999999999999999984 357899999998766666788999999999999999999999987654 78
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999988532 245889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc-ccccCcccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS-LCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 754 (848)
....... .......++..|+|||++.+..++.++||||||+++|||++|..|+................ ........+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543221 11223457788999999999999999999999999999999998864221100000000000 000000001
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.+........+.....++.+++..||+.||++||++.|+++.|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111011112233457889999999999999999999999998763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=341.66 Aligned_cols=263 Identities=25% Similarity=0.297 Sum_probs=196.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999975 489999999865432 235678899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999887632 345889999999999999999999987 9999999999999999999999999998765332
Q ss_pred cccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc-c-ccccc-------cc-ccC
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL-L-GHAWS-------LC-KND 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~-~-~~~~~-------~~-~~~ 750 (848)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.......... . ..... .. ...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 1233578999999999986 568999999999999999999999986543211100 0 00000 00 000
Q ss_pred ccc--cccccccccC---CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAH--ELMDPVLQNE---VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~--~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ...++..... ........+.+++..||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000000000 00112346789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.82 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=204.1
Q ss_pred HHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 517 ~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
+.+.....++|++.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4445556789999999999999999999975 58999999997532 2234557899999999999999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
.+..++||||+++|+|..++... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999988432 236889999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCccccceeeeeccccccChhhhh-------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL-------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ...
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~--- 281 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YGK--- 281 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH---
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HHH---
Confidence 9987654322 1223358999999999997 35789999999999999999999999864332110 000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCC---CCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDR---PTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~ 795 (848)
..... ....-+.. ......++.+++..||+ +|++| |++.|+++
T Consensus 282 i~~~~--~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 IVHYK--EHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHhcc--cCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00000 00000111 11123478899999999 99998 58888875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.98 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=202.9
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee---------
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--------- 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--------- 592 (848)
...+|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999976 68999999997543 356789999999999999999998854
Q ss_pred -------CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC
Q 003092 593 -------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (848)
Q Consensus 593 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~ 665 (848)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44589999999999999988532 2346889999999999999999999987 999999999999999999
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .. .
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~----~- 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----KF----F- 228 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----HH----H-
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----HH----H-
Confidence 99999999987754321 223569999999999999999999999999999999999988752100 00 0
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
..+.+..+ +......+.+++..||+.||++||++.|+++.|.....
T Consensus 229 -------~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 229 -------TDLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -------HHHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -------HHhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00011111 11223457889999999999999999999999987643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.59 Aligned_cols=275 Identities=16% Similarity=0.199 Sum_probs=209.7
Q ss_pred hcCcceeeeecccCCccEEEEEecC---------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceee---------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 585 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~--------- 585 (848)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998763 789999998754 45789999999999999988
Q ss_pred ------eeeeeee-CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcE
Q 003092 586 ------LLGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (848)
Q Consensus 586 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NI 658 (848)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667765 67889999999 99999988532 2356899999999999999999999987 99999999999
Q ss_pred EeccCC--CceeeccccccccCCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Q 003092 659 LLDQHM--NPKISDFGMARMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (848)
Q Consensus 659 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~ 731 (848)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876533211 111234799999999999999999999999999999999999999865
Q ss_pred CCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 003092 732 YNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPP 811 (848)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~ 811 (848)
.......+........ .....+.+.... ......++.+++..||+.||++||++.+++++|++.+.........+
T Consensus 271 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~ 345 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDP 345 (352)
T ss_dssp GTTCHHHHHHHHHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred CCcCHHHHHHHHHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcc
Confidence 4322111111110000 001111111100 00123478899999999999999999999999998876665444443
Q ss_pred cc
Q 003092 812 FT 813 (848)
Q Consensus 812 ~~ 813 (848)
+.
T Consensus 346 ~d 347 (352)
T 2jii_A 346 IG 347 (352)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=340.21 Aligned_cols=262 Identities=22% Similarity=0.258 Sum_probs=198.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999975 588999999975432 2347789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999988842 346889999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... +.. ..... ...+
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~~~~~----~~~~- 254 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--MGA----HINQA----IPRP- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--HHH----HHHSC----CCCG-
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--HHH----HhccC----CCCc-
Confidence 321 12234579999999999999999999999999999999999999986432210 000 00000 0000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHhcccCCCC
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRP-TMSDVVSMINNELFNLP 805 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 805 (848)
..........+.+++..||+.||++|| ++.++++.|++.+....
T Consensus 255 --~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 --STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 001111233678899999999999999 99999999998755443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.15 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=198.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57999999999999999999864 6899999999753 2334577899999999999999999999999999999999
Q ss_pred EeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999998887432 12456889999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.........+.... .... ..+
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~----~~~- 257 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----EQCD----YPP- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHH----HTTC----SCC-
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHh----hccc----CCC-
Confidence 321 22335789999999999999999999999999999999999999854322211111000 0000 000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCC
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSP 807 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 807 (848)
........++.+++..||+.||++||++.+|++.|++.......|
T Consensus 258 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 258 ---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp ---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 001122346889999999999999999999999998875444433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.77 Aligned_cols=260 Identities=29% Similarity=0.429 Sum_probs=202.7
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 478999999999999999999842 4678999999754 334566789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceee
Q 003092 597 ILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKIS 669 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~ 669 (848)
++||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999885432 2245889999999999999999999987 999999999999984 4569999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ..... .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFV----T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHH----h
Confidence 9999986644333333334568899999999999999999999999999999998 888875432111 00000 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
... ...........+.+++..||+.||++||++.++++.|+...
T Consensus 260 ~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 000 00111122346889999999999999999999999987664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=335.71 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=182.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999874 68999999986432 23357789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999988853 2346889999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .. ......
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~------------~~~~~~ 228 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LN------------KVVLAD 228 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HH------------HHhhcc
Confidence 221 12235799999999999999999999999999999999999999864332110 00 000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+.....++.+++..||+.||++||++.++++
T Consensus 229 ~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 Y--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 011112346789999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.73 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=204.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCce--EEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~--vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.+.||+|+||.||+|+.. +++. +|||.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999865 4554 499998753 234456789999999999 899999999999999999999
Q ss_pred EEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
|||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999886532 2346899999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... +...
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~--- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEK--- 253 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHH---
Confidence 9999999974322 112223457889999999999999999999999999999998 999985432211 0000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 804 (848)
. .. .............+.+++..||+.||++||++.|+++.|+..+...
T Consensus 254 ~-~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 254 L-PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp G-GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred h-hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00 0000111223347889999999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=339.93 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=196.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-----cccHHHHHHHHHHHHHcC---CCceeeeeeeeeeC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~ 593 (848)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4579999999999999999999964 58899999986432 122356778888877775 99999999999876
Q ss_pred C-----eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCcee
Q 003092 594 G-----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (848)
Q Consensus 594 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl 668 (848)
. ..++||||+. ++|..++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999998 58888775432 234899999999999999999999987 999999999999999999999
Q ss_pred eccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-ccccccccc
Q 003092 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-LLGHAWSLC 747 (848)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~ 747 (848)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998764332 223457899999999999999999999999999999999999998643321100 000000000
Q ss_pred ccCccc---ccccccccc-------CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAH---ELMDPVLQN-------EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~---~~~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ......+.. .........+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 000000000 001123346889999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.15 Aligned_cols=251 Identities=23% Similarity=0.334 Sum_probs=201.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999875 48899999986542 334577889999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeecccccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGla~~~ 677 (848)
||+++++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999977763 3356889999999999999999999987 999999999999987665 999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ..... .... .....
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~----~~~~-~~~~~ 228 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQI----KAGA-YDYPS 228 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHTC-CCCCT
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHH----Hhcc-ccCCc
Confidence 54322 223579999999999999999999999999999999999999985432211 00000 0000 00000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++..||+.||++|||+.|+++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 -----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000112346889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=364.64 Aligned_cols=248 Identities=20% Similarity=0.258 Sum_probs=192.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999865 5889999999753 233456678899999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|||+++++|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999988873 34568999999999999999999998 66 9999999999999999999999999998643
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.... ...
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i------------~~~ 364 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI------------LME 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH------------HHC
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH------------HhC
Confidence 322 12334689999999999999999999999999999999999999985432211 00000 000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
. ...+.....++.+++..||+.||++|| ++.|+++
T Consensus 365 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 011112234688999999999999999 9999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=337.08 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=198.7
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4789999999999999999998754 6789999986432 23356789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999988874 2345889999999999999999999987 99999999999999999999999999865443
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ... ... .
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~---~~~-------~--- 222 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKR---ISR-------V--- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH---HHH-------T---
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHH---HHh-------C---
Confidence 22 2335789999999999999999999999999999999999999864321110 000 000 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+......+.+++..||+.||++||++.|+++
T Consensus 223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00111122346789999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.42 Aligned_cols=246 Identities=32% Similarity=0.468 Sum_probs=196.9
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999986 468999999997543 23346789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+. |+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99998 466555532 2346889999999999999999999987 99999999999999999999999999986543
Q ss_pred CccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
. ....||+.|+|||++. .+.++.++||||||+++|||++|+.|+........ ........
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~------ 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE------ 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC------
Confidence 2 2357999999999985 56789999999999999999999999754321110 00010100
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.. ........+.+++..||+.||++|||+.++++
T Consensus 270 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000 01112346788999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.76 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=179.7
Q ss_pred cCccee---eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQ---SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~---~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++. ++||+|+||.||++... +++.||||++... ....+.+|+.+++++. ||||+++++++.++...++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 345553 78999999999999975 5889999999653 4467789999999997 99999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC---Cceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kl~DFGla~~ 676 (848)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 999999999888843 356899999999999999999999987 99999999999998766 799999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
...... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..... ....+.+
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------~~~~~~~ 225 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-----------TSAVEIM 225 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-----------CCHHHHH
T ss_pred cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-----------ccHHHHH
Confidence 644321 223457899999999999999999999999999999999999998654321100 0000111
Q ss_pred ccccccCC--C----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEV--S----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~--~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.....+.. . .....++.+++..||+.||++|||+.|+++
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111111 1 112457889999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.11 Aligned_cols=245 Identities=22% Similarity=0.282 Sum_probs=190.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHH-HHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~-l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.++||+|+||.||+++.. +++.||||++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999976 47889999997643 2234556677776 567899999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999988874 3446888999999999999999999987 9999999999999999999999999998643
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... +.. .++..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~------------~i~~~ 254 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD------------NILNK 254 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--HHH------------HHHHS
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HHH------------HHHhc
Confidence 222 22345689999999999999999999999999999999999999985432111 000 00000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSD 792 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 792 (848)
.+ ..+......+.+++..||+.||++||++.+
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 00 011122346889999999999999999854
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.06 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=204.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999864 58899999997543 3456889999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999998883 246889999999999999999999987 9999999999999999999999999998765433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .. .... ...+.+.
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~~~------~~~~~~~ 240 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LF---LIPK------NNPPTLE 240 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHHH------SCCCCCC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HH---Hhhc------CCCCCCc
Confidence 2 22345799999999999999999999999999999999999999864322110 00 0000 0011111
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .....+.+++..||+.||++|||+.|+++
T Consensus 241 ~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 G----NYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp S----SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c----ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 22346889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=355.23 Aligned_cols=202 Identities=28% Similarity=0.446 Sum_probs=162.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCC--eE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG--EK 596 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~--~~ 596 (848)
..++|++.++||+|+||.||+|... +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 5889999998643 2344567889999999997 999999999997544 78
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||++ ++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 57777663 246889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcc-------------------ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 677 FGGDEL-------------------QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 677 ~~~~~~-------------------~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 643110 111233579999999999987 67899999999999999999999998644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.83 Aligned_cols=251 Identities=19% Similarity=0.220 Sum_probs=189.3
Q ss_pred cCccee-eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHH-cCCCceeeeeeeeee----CCeEE
Q 003092 525 ENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 525 ~~f~i~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~-l~Hpniv~l~~~~~~----~~~~~ 597 (848)
++|.+. ++||+|+||+||++... +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567776 78999999999999875 5889999998642 456788988755 489999999999875 56789
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 674 (848)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999888543 2345899999999999999999999987 999999999999997 788999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............ .
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~-~ 285 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY-E 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC-C
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc-c
Confidence 8764322 223467999999999999999999999999999999999999998643321110 000000000000 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...........++.+++..||+.||++|||+.|+++
T Consensus 286 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 -----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000001123446889999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=335.92 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=196.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999976 6899999998754 233457788999999999 999999999999999999999
Q ss_pred EEeccCCcccccccCCCc-ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC---------------
Q 003092 600 YEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--------------- 663 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--------------- 663 (848)
|||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999998853221 245899999999999999999999987 9999999999999844
Q ss_pred ----CCceeeccccccccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccc
Q 003092 664 ----MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN 738 (848)
Q Consensus 664 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~ 738 (848)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23589999999999876 567899999999999999999876432110
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+........ +. .+......+.+++..||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGRL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTCC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCCC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 000000000 11 11122346889999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=359.12 Aligned_cols=260 Identities=23% Similarity=0.259 Sum_probs=192.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------C
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~ 594 (848)
.++|++.++||+|+||+||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999865 5889999999754 334467788999999999999999999998654 4
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||++++.+. .+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~l~~-~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCCHHH-HHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 679999999876443 331 23788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-cccc----------
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLGH---------- 742 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~~---------- 742 (848)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . +...
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764432 23346899999999999999999999999999999999999999865431100 0 0000
Q ss_pred -----cccccccC------ccccccccccccCC---CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 743 -----AWSLCKND------RAHELMDPVLQNEV---SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 743 -----~~~~~~~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........ .....+...+.... ......++.+++.+||+.||++|||+.|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000000000000 0112457889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=352.86 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=189.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--------cccHHHHHHHHHHHHHcCCCceeeeeeeeee
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~ 592 (848)
...++|.+.++||+|+||.||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34579999999999999999999875 47899999987532 112235789999999999999999999974
Q ss_pred CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC---CCceee
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKIS 669 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~ 669 (848)
.+..++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 556899999999999988774 3456899999999999999999999987 9999999999999654 459999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
|||+++...... .....+||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ +...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~---- 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQ---- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHH----
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHH----
Confidence 999998765332 2334679999999999863 6688999999999999999999999864332111 0000
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ... +.... .....+.+++..||+.||++||++.|+++
T Consensus 357 i~~~~~-~~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKY-NFI-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCC-CCC-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCC-CCC-chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 000 00000 12346889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=346.67 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=197.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.+.||+|+||.||++... +++.||||++...... ..+|++++.++ +||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999875 5889999999765332 35688888888 79999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC----CCceeecccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISDFGMARMF 677 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~~ 677 (848)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999888743 346899999999999999999999987 9999999999998443 34999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-cccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 756 (848)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..+... . .....
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i-~~~~~---- 240 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---I-GSGKF---- 240 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---H-HHCCC----
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---H-ccCCc----
Confidence 54321 2234579999999999998889999999999999999999999986432211 111100 0 00000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+...........+.+++..||+.||++||++.|+++
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111123457889999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.61 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=199.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|.....||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999864 57899999998766666788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeeccccccccCCCcc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 682 (848)
++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999998865444445678889999999999999999987 999999999999987 89999999999987653221
Q ss_pred ccceeeeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.............. .....+
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~~~-- 245 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG---------MFKVHP-- 245 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH---------HHCCCC--
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc---------cccccc--
Confidence 123357999999999998754 78999999999999999999999853322111000000 000011
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.....++.+++..||+.||++||++.|+++
T Consensus 246 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 --EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112223447889999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.43 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=196.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 67999999999999999999875 58899999987653 34568899999999999999999999999999999999999
Q ss_pred ccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccccC
Q 003092 603 MVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678 (848)
Q Consensus 603 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 678 (848)
+++++|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999998877432 22356899999999999999999999987 9999999999999 456789999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... ......||+.|+|||++. +.++.++||||||+++|||++|+.||......... ... ... .+
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--~~~---~~~-------~~ 242 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKA---TYK-------EP 242 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHH---HHC-------CC
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--hhh---ccC-------Cc
Confidence 432 223457999999999875 56899999999999999999999998643321110 000 000 00
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ....+...++.+++..||+.||++|||+.|+++
T Consensus 243 ~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 NYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000012346788999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=362.93 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=204.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 5899999999653 233456788999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|..++.... ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999988885432 335899999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~---------- 403 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE---------- 403 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHH----------
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhc----------
Confidence 32 223458999999999999999999999999999999999999998643321100 000000000
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.....+.....++.+++..||+.||++|| ++.||++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00111222345788999999999999999 6788764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.00 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=195.8
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-CeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-~~~~lV~Ey 602 (848)
.++|++.+.||+|+||.||+++. .++.||||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46899999999999999999987 5889999999754 3457889999999999999999999997654 478999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999888432 2224788999999999999999999987 999999999999999999999999999865432
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.|+....... ... ..... ..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~----~~~~~-----~~---- 232 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKG-----YK---- 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH----HHTTT-----CC----
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcC-----CC----
Confidence 123467889999999999999999999999999999998 999876433211 000 00000 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
..........+.+++..||+.||++||++.|+++.|++.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111122334688999999999999999999999999876
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.66 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|.+.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4689999999999999999999764 7889999986542 23457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999988773 3356889999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ . ...... . .
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~~-~------~- 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--Y---LRIKKN-E------Y- 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHHT-C------C-
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--H---HHHhcC-C------C-
Confidence 321 22345799999999999999999999999999999999999999864321110 0 000000 0 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++..||+.||++||++.|+++
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346788999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.80 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=191.1
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
...++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999864 588999999975432 234567899999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-----cCCCceeecccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----QHMNPKISDFGM 673 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~kl~DFGl 673 (848)
||||+++ +|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 8877773 3345889999999999999999999987 99999999999994 455699999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccc--ccccc-
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAW--SLCKN- 749 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--~~~~~- 749 (848)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +..... .....
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchh
Confidence 987653321 22335689999999999875 489999999999999999999999864332110 000000 00000
Q ss_pred ------------CccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 750 ------------DRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 750 ------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+..........++.+++..||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000000001112346789999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.14 Aligned_cols=263 Identities=21% Similarity=0.316 Sum_probs=191.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 5889999998654322 122456799999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 985 77666643 2346889999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccCccccccc---
Q 003092 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKNDRAHELMD--- 757 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d--- 757 (848)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ....................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12223578999999999886 5689999999999999999999999865432110 00000000000000000000
Q ss_pred ------ccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 ------PVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ------~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.... ........++.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 000112346789999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=372.87 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=196.9
Q ss_pred eeecccCCccEEEEEec---CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.+|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 58999999999999653 35789999997643 334688999999999999999999999986 4568899999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc-cc
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-QG 684 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 684 (848)
|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999884 3456889999999999999999999987 99999999999999999999999999987754332 12
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. +.+.......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~-------------~~i~~~~~~~ 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT-------------AMLEKGERMG 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH-------------HHHHTTCCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------------HHHHcCCCCC
Confidence 2233457889999999999999999999999999999998 999986433211 00 0000000111
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.+.....++.+++..||+.||++||++.+|++.|++..
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12223457889999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.01 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=199.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999976 589999999865421 24678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC----Cceeecccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGM 673 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 673 (848)
+||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999998884 3446899999999999999999999987 99999999999998877 899999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ..... ....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~~~-- 227 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTNI----SAVN-- 227 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHH----HTTC--
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHHh----Hhcc--
Confidence 98764432 1233569999999999999999999999999999999999999985432111 00000 0000
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....+.... .....+.+++..||+.||++||++.|+++
T Consensus 228 ~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000000001 12346789999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=355.32 Aligned_cols=242 Identities=15% Similarity=0.174 Sum_probs=188.5
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEeccc---CcccHHHHHHHH---HHHHHcCCCceeeee-------ee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEM---MLIAKLQHRNLVRLL-------GC 589 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~Ei---~~l~~l~Hpniv~l~-------~~ 589 (848)
.++|++.++||+|+||.||+|+. .+++.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 45899999999743 334567889999 455556899999998 55
Q ss_pred eeeCC-----------------eEEEEEEeccCCcccccccCCC----cccccCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003092 590 CIEQG-----------------EKILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (848)
Q Consensus 590 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (848)
+...+ ..++||||+ +|+|.+++.... ....+++..+..++.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 54443 278999999 679988885321 1234556888899999999999999987 9
Q ss_pred EecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcC-----------CCCcccceeehHH
Q 003092 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-----------VFSVKSDVFSFGV 717 (848)
Q Consensus 649 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~~~ksDVwSlGv 717 (848)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 718 LMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 718 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
++|||++|+.||........ +....... .....++.+++..||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~------------------~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG------------------SEWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC------------------SGGGGSSC--CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc------------------hhhhhhhc--cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999854322110 00000000 112346889999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.30 Aligned_cols=258 Identities=27% Similarity=0.365 Sum_probs=196.3
Q ss_pred hcCcceeeeecccCCccEEEEEecC--Cc--eEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~--~~--~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.++||+|+||+||+|++.. ++ .||||+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998642 33 6899998754 2345678999999999999999999999988765 8
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999888743 2345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... ... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~---~~~~~~~--- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILH---KIDKEGE--- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH---HHHTSCC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHH---HHHccCC---
Confidence 7543221 12233567889999999999999999999999999999999 999985433211 000 0000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...........+.+++..||+.||++||++.++++.|++..
T Consensus 243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 00111123357889999999999999999999999998874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.66 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=203.4
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc--------ccHHHHHHHHHHHHHc-CCCceeeee
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKL-QHRNLVRLL 587 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l-~Hpniv~l~ 587 (848)
.......++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445678999999999999999999985 689999999865431 1245678999999999 799999999
Q ss_pred eeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCce
Q 003092 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (848)
Q Consensus 588 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~k 667 (848)
+++......++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999988884 3346899999999999999999999987 99999999999999999999
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhhc------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLR 315 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHH
Confidence 99999998775432 2234679999999999874 358899999999999999999999985422110 000
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. .... .....+.. . .....+.+++..||+.||++||++.|+++
T Consensus 316 ~i----~~~~-~~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MI----MEGQ-YQFSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH----HHTC-CCCCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH----HhCC-CCCCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000 00000000 0 11246889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.01 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=197.3
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc--ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 689999999999999999999754 88999999865432 234668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999998877632 345889999999999999999999987 9999999999999999999999999998764332
Q ss_pred cccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--cccc-------ccccc-ccC
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN--LLGH-------AWSLC-KND 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~--~~~~-------~~~~~-~~~ 750 (848)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... .... ..... ...
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 12235689999999999875 6899999999999999999999998654321100 0000 00000 000
Q ss_pred ccccccccccccCC-----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAHELMDPVLQNEV-----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......+.+.... .......+.+++..||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000001111000 1123457889999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=358.89 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=202.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999975 58999999996532 24457789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
|||+++|+|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999988886543 2446899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .++...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--------------~~~~~~ 404 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--------------KELKQR 404 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--------------HHHHHH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--------------HHHHHH
Confidence 4322 223458999999999999999999999999999999999999998643321100 000000
Q ss_pred cccc--CCCHHHHHHHHHHHHhccccCcCCCCCH
Q 003092 759 VLQN--EVSLPMLVRYINVALLCVQENAEDRPTM 790 (848)
Q Consensus 759 ~l~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 790 (848)
.+.. ..+......+.+++..||+.||++||++
T Consensus 405 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 405 VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0000 1122234578899999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.79 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=202.8
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|.+.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3689999999999999999999764 7889999986542 23456789999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999988773 3346889999999999999999999987 99999999999999999999999999987643
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ . ... .... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~---~~~-~~~~------~- 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--Y---LRI-KKNE------Y- 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHH-HTTC------C-
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHH-hhcc------C-
Confidence 221 22335799999999999999999999999999999999999999864321110 0 000 0000 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++..||+.||++||++.|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011122346788999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=337.96 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=196.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee--------C
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--------Q 593 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--------~ 593 (848)
++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 68999999999999999999974 68999999986543 2335678899999999999999999999987 4
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 568999999986 45444432 2245889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcc--ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccc-------
Q 003092 674 ARMFGGDEL--QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGH------- 742 (848)
Q Consensus 674 a~~~~~~~~--~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~------- 742 (848)
++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........ .....
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987653221 122234578999999999876 4579999999999999999999999865432110 00000
Q ss_pred -cccccccCccccccccccccCCCHH-------HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 743 -AWSLCKNDRAHELMDPVLQNEVSLP-------MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 743 -~~~~~~~~~~~~~~d~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.........+.+........... ....+.+++..||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000000000000001111 1235789999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=356.75 Aligned_cols=197 Identities=25% Similarity=0.389 Sum_probs=154.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----Ce
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~ 595 (848)
.++|++.++||+|+||+||+|+.. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999865 5889999998653 233457789999999999999999999998543 57
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 57777763 3346899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc-------------------------cceeeeeccccccChhhh-hcCCCCcccceeehHHHHHHHHhCCC
Q 003092 676 MFGGDELQ-------------------------GNTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 676 ~~~~~~~~-------------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~elltg~~ 727 (848)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 76432111 122345789999999986 45679999999999999999999533
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.22 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=167.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----Ce
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~ 595 (848)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999875 4789999999754 233457889999999999999999999999776 57
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||++ ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 48887774 3346899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc--------------------cceeeeeccccccChhhh-hcCCCCcccceeehHHHHHHHHhCCCCCC
Q 003092 676 MFGGDELQ--------------------GNTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (848)
Q Consensus 676 ~~~~~~~~--------------------~~~~~~~gt~~y~APE~~-~~~~~~~ksDVwSlGvvl~elltg~~p~~ 730 (848)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 77543211 112456899999999986 45669999999999999999999766654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.70 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=201.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999875 47889999986432 234577899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999888743 345889999999999999999999987 999999999999999999999999999765432
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .. ... .. +.
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~~~-~~------~~-- 229 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--HR---RIV-NV------DL-- 229 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHH-TT------CC--
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--HH---HHh-cc------cc--
Confidence 2 2335799999999999999999999999999999999999999864321110 00 000 00 00
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+......+.+++..||+.||++||++.++++
T Consensus 230 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 --KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111122346789999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.88 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=200.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~l 598 (848)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999875 58899999997542 3345778999999999999999999998854 568999
Q ss_pred EEEeccCCcccccccCCC-cccccCHHHHHHHHHHHHHHHHHHHhcC--CCceEecccCCCcEEeccCCCceeecccccc
Q 003092 599 IYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999998885422 2334899999999999999999999875 1349999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... +... ......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGK----IREGKF--- 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHTCC---
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHH----Hhhccc---
Confidence 7654321 1123468999999999999999999999999999999999999986433211 0000 000000
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 797 (848)
...+.....++.+++..||+.||++||++.|+++.+
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 011122345788999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=347.18 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=200.4
Q ss_pred hcCcceeeeecccCCccEEEEEe----cCCceEEEEEecccC----cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999987 368899999987532 23345678899999999 6999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999888843 346889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
+.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .......
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~------ 278 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI------ 278 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH------
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH------
Confidence 87643322 122345799999999999863 4789999999999999999999998643321110 0000000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVSM 796 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 796 (848)
... ....+......+.+++..||+.||++|| ++.|+++.
T Consensus 279 ---~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 ---LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ---HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---hcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 000 0111222334678899999999999999 89998763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.75 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCccc-----------------HHHHHHHHHHHHHcCCCceeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-----------------LKEFKNEMMLIAKLQHRNLVRL 586 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~Hpniv~l 586 (848)
.++|++.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 89999999986532111 1789999999999999999999
Q ss_pred eeeeeeCCeEEEEEEeccCCccccc------ccCCCcccccCHHHHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEE
Q 003092 587 LGCCIEQGEKILIYEYMVNKSLDVF------LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNIL 659 (848)
Q Consensus 587 ~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NIL 659 (848)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225678999999999999999999998 76 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcC-CCCc-ccceeehHHHHHHHHhCCCCCCCCCCCcc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSV-KSDVFSFGVLMLEILSSKKNTGVYNTDSF 737 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~-ksDVwSlGvvl~elltg~~p~~~~~~~~~ 737 (848)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.|+........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876443 23345799999999999887 6766 99999999999999999999865433111
Q ss_pred ccccccccc-c-ccCccccccccccc---cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 738 NLLGHAWSL-C-KNDRAHELMDPVLQ---NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 738 ~~~~~~~~~-~-~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........ . ..........+... ..........+.+++..||+.||++||++.|+++
T Consensus 261 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0 00000000000000 0001223447889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=336.44 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=199.0
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeee--CCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE--QGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~--~~~~~lV 599 (848)
.++|++.++||+|+||.||+|+. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999986 45889999998643 3577899999999997 9999999999987 6678999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~ 678 (848)
|||+++++|..++. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988772 3788899999999999999999987 99999999999999776 89999999998765
Q ss_pred CCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc--------cc-
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL--------CK- 748 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~- 748 (848)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.........+....... ..
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4332 233578999999999987 6789999999999999999999999843322111111000000 00
Q ss_pred -------------cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 -------------NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 -------------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......................++.+++..||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000011111111112223457889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=348.23 Aligned_cols=253 Identities=10% Similarity=0.081 Sum_probs=180.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc---ccHHHHHHHHHHHHHc--CCCceeeee-------eeee
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKL--QHRNLVRLL-------GCCI 591 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l--~Hpniv~l~-------~~~~ 591 (848)
.+|++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 46899999999999999999975 689999999986532 3456678886666655 599988755 3443
Q ss_pred eC-----------------CeEEEEEEeccCCcccccccCCCcccccCHHHH------HHHHHHHHHHHHHHHhcCCCce
Q 003092 592 EQ-----------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR------VRIIDGIAQGLLYLHQYSRLRI 648 (848)
Q Consensus 592 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~i 648 (848)
.. ...++||||++ ++|.+++... ...+++..+ ..++.||++||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 32 34799999999 8999888532 223344555 678899999999999987 9
Q ss_pred EecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCC
Q 003092 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSK 726 (848)
Q Consensus 649 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~ 726 (848)
+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999876432 113457799999999987 67999999999999999999999
Q ss_pred CCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 727 KNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 727 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.||............. ......................+.+++..||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKR-------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCB-------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhh-------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9987543221111000 0000000000000011123447889999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.54 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=199.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999875 5889999999865544556789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccccCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 679 (848)
+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999988773 2346889999999999999999999987 9999999999999 7889999999999976543
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....... +.... .... .. .
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i----~~~~-~~-~--- 226 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKI----KEGY-YE-F--- 226 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHH----HHCC-CC-C---
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH----HcCC-CC-C---
Confidence 21 223468999999999999999999999999999999999999985432111 00000 0000 00 0
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...........+.+++..||+.||++||++.|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 -ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111123347889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=348.22 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=202.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999875 58899999997653 3345778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999988843 34688999999999999999999985 5 999999999999999999999999999765321
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc-----------------
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA----------------- 743 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----------------- 743 (848)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22345799999999999999999999999999999999999999864332111000000
Q ss_pred -------ccccccCcccccccccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 -------WSLCKNDRAHELMDPVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 -------~~~~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+.++..... .........+.+++..||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000111111110 011113446889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=339.01 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=186.1
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
...++|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44578999999999999999999864 58899999986543 34457788999999999999999999999999999999
Q ss_pred EEeccCCcccccccC-----CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 600 YEYMVNKSLDVFLFD-----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
|||+++++|.+++.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999888743 123456899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcc---ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccC
Q 003092 675 RMFGGDEL---QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750 (848)
Q Consensus 675 ~~~~~~~~---~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 750 (848)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----HhccC
Confidence 87643321 111234579999999999876 5689999999999999999999999865433211100 00000
Q ss_pred ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....................+.+++..||+.||++||++.|+++
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000000111112346788999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.86 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=185.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-c-cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~-~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..++|++.++||+|+||.||+++.. +++.||||++..... . ..+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3478999999999999999999874 688999999975422 2 233344555567888999999999999999999999
Q ss_pred EEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
|||+++ +|..++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 766655321 2345689999999999999999999997 6 999999999999999999999999999876
Q ss_pred CCCccccceeeeeccccccChhhh----hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYA----LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+.........+.... ..
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~---- 229 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV----EE---- 229 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH----HS----
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh----cc----
Confidence 5432 12234699999999996 566789999999999999999999999864332211111000 00
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............++.+++..||+.||++|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 -----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0000011122346889999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.74 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=196.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~ 597 (848)
+.|.+.++||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888999999999999999875 4788999998754 23456778999999999999999999999875 35689
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCceeeccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARM 676 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~ 676 (848)
+||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999884 3356889999999999999999999874 2499999999999997 789999999999976
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.......... . ...... .
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~----~~~~~~----~ 247 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-R----RVTSGV----K 247 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-H----HHTTTC----C
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH-H----HHhccC----C
Confidence 5432 233457999999999876 458999999999999999999999986433211100 0 000000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....... ...++.+++..||+.||++|||+.|+++
T Consensus 248 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011111 1236889999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=354.24 Aligned_cols=261 Identities=19% Similarity=0.285 Sum_probs=203.7
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccCcccHHHHHHHHHHHHHcCC-CceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||.||+|+. .+++.||||++..... ..++..|+++++.++| +++..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999986 4589999998865432 2457899999999987 556666667778889999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~~~ 678 (848)
|+ +++|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 89998888432 346899999999999999999999987 9999999999999 689999999999998775
Q ss_pred CCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccCcc
Q 003092 679 GDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKNDRA 752 (848)
Q Consensus 679 ~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 752 (848)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i----~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----SEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH----HHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH----hhccc
Confidence 44321 122356799999999999999999999999999999999999999865432211 000000 00000
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...+... ... ...++.+++..||+.+|++||++.+|+++|++.+
T Consensus 234 ~~~~~~l-~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIEAL-CRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHHHH-HTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHH-hcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0011110 011 1347889999999999999999999999988764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.31 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=197.8
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999976 488999999987766778899999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999887743 2345889999999999999999999987 9999999999999999999999999986432111
Q ss_pred cccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.......||+.|+|||++. +..++.++||||||+++|||++|+.|+...+.... . ........ ...
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~~~~-~~~- 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L---LKIAKSDP-PTL- 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHHHHSCC-CCC-
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H---HHHhccCC-ccc-
Confidence 1122357999999999984 56789999999999999999999999864332110 0 00000000 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++..||+.||++|||+.++++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011122346889999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=340.11 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=197.4
Q ss_pred eeHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcC--CCceeeeeeee
Q 003092 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCC 590 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~--Hpniv~l~~~~ 590 (848)
+.+..+....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3344444566889999999999999999999888999999998654 2345678899999999997 59999999999
Q ss_pred eeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeec
Q 003092 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 591 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
..+...++||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 667899888743 346889999999999999999999987 999999999999964 8999999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhhc-----------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL 739 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-----------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~ 739 (848)
||+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.........+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999987754433333344579999999999875 468889999999999999999999985432211100
Q ss_pred ccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 740 LGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 740 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+++......+......+.+++..||+.||++||++.|+++
T Consensus 250 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 250 -------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -------------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0111111111111112346888999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.44 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=194.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999976 68999999986532 23467889999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999888843 345889999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+....... ... ......
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----~~~~~~------- 227 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFK----KIRGGV------- 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCC-------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHH----HhhcCc-------
Confidence 321 223568999999999988776 689999999999999999999985432111 000 000000
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+......+.+++..||+.||++|||+.|+++
T Consensus 228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0011112346788999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=330.84 Aligned_cols=251 Identities=21% Similarity=0.254 Sum_probs=196.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC----cccHHHHHHHHHHHHHcCCCceeeeeeeee--eCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI--EQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~--~~~~~ 596 (848)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999875 57899999997542 234678999999999999999999999984 45688
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||++++ |..++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999987 44444322 2456889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCC--CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.|+....... .... . ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~---i-~~~~--- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFEN---I-GKGS--- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH---H-HHCC---
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHH---H-hcCC---
Confidence 75433333334457999999999998654 4789999999999999999999986432110 0000 0 0000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+......+.+++..||+.||++||++.|+++
T Consensus 230 ---~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 ---Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ---C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 011122346788999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=369.51 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=203.1
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~ 597 (848)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 4788999999753 234456788899999988 7999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+.+ ||||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999988884 3346899999999999999999999987 999999999999999999999999999864
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...+... +.. .++.
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~~~------------~i~~ 556 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQ------------SIME 556 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--HHH------------HHHh
Confidence 3322 22345789999999999999999999999999999999999999986433211 100 0000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCH-----HHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTM-----SDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 795 (848)
..+ .++.....++.+++..||+.||++||++ .||++
T Consensus 557 ~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 000 1122234578899999999999999998 66654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=355.95 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=199.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.++||+|+||+||+++.. +++.||||++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999875 5889999998643 2345678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec---cCCCceeecccccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~ 677 (848)
||+++++|.+.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999977773 3346899999999999999999999987 99999999999995 5667999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ..... ...... ...
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i----~~~~~~-~~~ 243 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRV----ETGKYA-FDL 243 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHTCCC-SCS
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhCCCC-CCC
Confidence 5432 2233579999999999875 58999999999999999999999985432211 10000 000000 000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+. .......+.+++..||+.||++|||+.|+++
T Consensus 244 ~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0112346889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.38 Aligned_cols=260 Identities=20% Similarity=0.279 Sum_probs=193.9
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe------EEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE------KIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~------~~l 598 (848)
.+|++.++||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 579999999999999999999877777999988654322 2469999999999999999999965443 789
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCceeecccccccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMF 677 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~ 677 (848)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998765444322233456889999999999999999999987 99999999999999 7999999999999876
Q ss_pred CCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc----------
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL---------- 746 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------- 746 (848)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.......
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence 44322 2235789999999999765 589999999999999999999999865432110 00000000
Q ss_pred ----cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ----CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ----~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........................++.+++..||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000000000111123347889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=357.53 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=201.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999975 68999999986542 34567899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---ccCCCceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kl~DFGla~~ 676 (848)
|||+.+++|.+.+.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999887743 345899999999999999999999987 9999999999999 5678999999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ..... ..... ...
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i----~~~~~-~~~ 247 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKV----EKGKY-TFE 247 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHCCC-CCC
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHH----HcCCC-CCC
Confidence 65432 2233579999999999876 68999999999999999999999986433211 10000 00000 000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+. .......+.+++..||+.||++|||+.|+++
T Consensus 248 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 0122346889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=354.95 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=198.0
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-------------ccHHHHHHHHHHHHHcCCCceeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLLG 588 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-------------~~~~~~~~Ei~~l~~l~Hpniv~l~~ 588 (848)
..++|++.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3478999999999999999999975 478999999875321 33577899999999999999999999
Q ss_pred eeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC---C
Q 003092 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---N 665 (848)
Q Consensus 589 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~---~ 665 (848)
++.+....++||||+++|+|.+.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999987773 3356899999999999999999999987 99999999999998776 6
Q ss_pred ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 666 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||....... +....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i-- 259 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKV-- 259 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH--
Confidence 9999999998775432 223457999999999877 568999999999999999999999986433211 00000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... ........ ....++.+++..||+.||++|||+.|+++
T Consensus 260 --~~~~~--~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 --EKGKY--YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHCCC--CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HcCCC--CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000000 12346889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=355.96 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999975 58899999987543 334678899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeecccccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla~~~ 677 (848)
||+++|+|.+.+. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999977763 3346889999999999999999999987 999999999999976 455999999999877
Q ss_pred CCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|..||....... +.... .... .....
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i----~~~~-~~~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKV----EKGK-YTFDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHTC-CCCCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhCC-CCCCc
Confidence 5432 223457999999999876 569999999999999999999999986433211 10000 0000 00000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.. ......+.+++..||+.||++|||+.|+++
T Consensus 259 ~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 112346889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=341.97 Aligned_cols=258 Identities=24% Similarity=0.322 Sum_probs=192.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 368999999999999999999874 5899999998653 2334567899999999999999999999997653
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7888887742 45889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccccc-------c
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLGHA-------W 744 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~~~-------~ 744 (848)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... . +.... .
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 876432 233578999999999987 6799999999999999999999999864332110 0 00000 0
Q ss_pred cccccCcccc-------ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKNDRAHE-------LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.......... .....+. .........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 0000000 011122346889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.86 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=194.1
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999975 4889999998753221 134678999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999987 67666643 3345788899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccccccc----c-c
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAWSL----C-K 748 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~----~-~ 748 (848)
+..... ......||+.|+|||++.+. .++.++||||||+++|||++|..|+........ .+....... + .
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 643321 22335789999999999764 489999999999999999999998754332110 000000000 0 0
Q ss_pred cCccccccccccccCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVSM 796 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 796 (848)
.....+.+........+ ......+.+++..||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000000001 1123578899999999999999999999873
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=316.57 Aligned_cols=215 Identities=13% Similarity=0.174 Sum_probs=168.3
Q ss_pred cccccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEc
Q 003092 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (848)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 118 (848)
++.|+|.+|++|.+|++| ++|.|+|||+.+++ +.+ |.. .|+||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 577999999999999999 48999999998876 334 433 699999999988 57899999999999999
Q ss_pred CCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccc-cccCcccccc-ccCC-----cceEE
Q 003092 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTM-LQGMKLGWDL-RTGL-----ERYQT 191 (848)
Q Consensus 119 ~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtl-Lpg~klg~~~-~t~~-----~~~l~ 191 (848)
++|.+||+|++.....++.|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998765556789999999999994 26999999999877 5665 5554 5555 55676
Q ss_pred eeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCCCCCcccccCCC-C-cceeeeeEEEecCCeeEEEEEecCCCe
Q 003092 192 SWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-N-TTFIFQPIVVQNKDEVYYMYESYSSPI 269 (848)
Q Consensus 192 Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~w~g~~~~~~p~-~-~~~~~~~~~v~n~~e~~~~~~~~~~~~ 269 (848)
+.+||++|.|+++++++| +++++++..+||++|+|++. +...++ . ...++ .+-.+.++++.+|..... .
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~--ly~~~~~~vw~s~~~~~~-~ 213 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMD--VLTNQNIAVWTSGNSRSA-G 213 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEE--EEETTTEEEEECCCCCSS-S
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEE--EEeCCCcEEEEeCCCCCC-C
Confidence 478999999999999998 78889988999999999753 444443 1 11111 122344455555554433 4
Q ss_pred EEEEEEccCCcEEEEE
Q 003092 270 IMILRVNPLGQVQRLI 285 (848)
Q Consensus 270 ~~rl~l~~~G~l~~~~ 285 (848)
.+|++|++||++++|.
T Consensus 214 ~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 214 RYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CCEEEECSSSCEEEEC
T ss_pred CEEEEEcCCCcEEEeC
Confidence 6899999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=343.42 Aligned_cols=269 Identities=26% Similarity=0.434 Sum_probs=199.3
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
....++|++.+.||+|+||.||+|+.. ..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 344578999999999999999999874 359999987542 2334667889999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999998854 2346888999999999999999999987 99999999999998 6799999999987653
Q ss_pred CCc---cccceeeeeccccccChhhhhc---------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 679 GDE---LQGNTKRIVGTYGYMSPEYALE---------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 679 ~~~---~~~~~~~~~gt~~y~APE~~~~---------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
... .........||+.|+|||++.. ..++.++||||||+++|||++|+.|+........ . +..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~ 255 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--I---WQM 255 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--H---HHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHh
Confidence 221 1122233469999999999874 4578899999999999999999999864332111 0 000
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCCCCCC
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPP 811 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~~~ 811 (848)
. .. ..+... ......++.+++..||+.||++|||+.+++++|++..........|.
T Consensus 256 ~-~~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 256 G-TG-----MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp H-TT-----CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred c-cC-----CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 0 00 001110 00112357889999999999999999999999998866554444443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.48 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=201.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---------cccHHHHHHHHHHHHHcC-CCceeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCI 591 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~ 591 (848)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999975 58899999986542 122456889999999995 999999999999
Q ss_pred eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 592 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
.....++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999998884 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhh------cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
|++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.|+....... ....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~--- 240 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRM--- 240 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHH---
Confidence 9998765432 223357899999999986 4568899999999999999999999985432111 0000
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..... .. ...........+.+++..||+.||++||++.|+++
T Consensus 241 ~-~~~~~-~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 I-MSGNY-QF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-HHTCC-CC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-hcCCc-cc-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 00000 00 00001123456889999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.57 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=198.9
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC--------CCceeeeeeeee---
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCI--- 591 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~--------Hpniv~l~~~~~--- 591 (848)
.++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999643 334577889999999996 788999999987
Q ss_pred -eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCC-----
Q 003092 592 -EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHM----- 664 (848)
Q Consensus 592 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~----- 664 (848)
.....++||||+.++.++.++.. ....+++..+..++.||++||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 55688999999965555444422 224588999999999999999999997 6 99999999999998775
Q ss_pred --------------------------------------------CceeeccccccccCCCccccceeeeeccccccChhh
Q 003092 665 --------------------------------------------NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700 (848)
Q Consensus 665 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~ 700 (848)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876432 223578999999999
Q ss_pred hhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc----ccccccc------------------cc-cCccccccc
Q 003092 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL----LGHAWSL------------------CK-NDRAHELMD 757 (848)
Q Consensus 701 ~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~------------------~~-~~~~~~~~d 757 (848)
+.+..++.++|||||||++|||++|+.||.......... ....... .. ........+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999986543221100 0000000 00 000000000
Q ss_pred -------ccc--ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 -------PVL--QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 -------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+ ...........+.+++..||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 01234556678999999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=333.65 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=194.0
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--------cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~ 593 (848)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999875 47899999986532 12234588999999999999999999998665
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeec
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISD 670 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~D 670 (848)
. .++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999988774 3456889999999999999999999987 999999999999987665 99999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........ +... .
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~----~ 232 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQ----I 232 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHH----H
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHH----H
Confidence 999987654321 22356899999999975 46789999999999999999999999864332211 0000 0
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... . ..+.... .....+.+++..||+.||++||++.|+++
T Consensus 233 ~~~~~-~-~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKY-N-FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCC-C-CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCcc-c-cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 0000001 12346889999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=342.34 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred eHHHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcc-----------cHHHHHHHHHHHHHcCCCcee
Q 003092 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLV 584 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~Hpniv 584 (848)
...++....++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456677788999999999999999999999888999999998653221 237889999999999999999
Q ss_pred eeeeeeeeC-----CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 585 RLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 585 ~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
++++++... ...++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 368999999984 66665542 3346899999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~ 738 (848)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999998554322 2234578999999999887 678999999999999999999999986433111
Q ss_pred ccccccccccc-----------Ccccccccccccc-------CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 739 LLGHAWSLCKN-----------DRAHELMDPVLQN-------EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 739 ~~~~~~~~~~~-----------~~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........... ....+.+...+.. .........+.+++..||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000000000 0000000000000 001112346889999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.87 Aligned_cols=260 Identities=26% Similarity=0.436 Sum_probs=197.6
Q ss_pred eeHHHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 515 ~~~~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
+.+..+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 333444456789999999999999999999974 68899999986543 3457889999999999 89999999999987
Q ss_pred ------CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 593 ------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 593 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 46889999999999999888543 2356889999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~ 741 (848)
||+|||++....... .......||+.|+|||++. +..++.++||||||+++|||++|+.|+........
T Consensus 169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---- 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 242 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----
T ss_pred EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----
Confidence 999999998764322 1223457999999999987 56789999999999999999999999854321110
Q ss_pred ccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 742 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....... .. +.. ........+.+++..||+.||++||++.++++
T Consensus 243 -~~~~~~~-~~-----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 -LFLIPRN-PA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHHHHHS-CC-----CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHhhcC-cc-----ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 00 000 01112346889999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=348.47 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=190.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------CeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~~~~ 597 (848)
.+|++.++||+|+||.||+|++. +++.||||++..... .+.+|+++|++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999975 589999999865422 234799999999999999999998642 2367
Q ss_pred EEEEeccCCcccccccC-CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-CCceeecccccc
Q 003092 598 LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMAR 675 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kl~DFGla~ 675 (848)
+||||++++ +...+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 999999874 3333321 123456899999999999999999999987 9999999999999965 568999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc-------
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC------- 747 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------- 747 (848)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+........
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 7644321 2235789999999999765 78999999999999999999999986533211 0100000000
Q ss_pred --ccCccccccccccc-----cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 --KNDRAHELMDPVLQ-----NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 --~~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......+..-+.+. ..+......++.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000000 0011122357889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.80 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=198.6
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 48999999997543 35778999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999888742 2356889999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ........ .+..
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~------~~~~- 245 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIPTNP------PPTF- 245 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC------CCCC-
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCC------Cccc-
Confidence 1 22345799999999999999999999999999999999999999864322110 00000000 0000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.+++..||+.||++|||+.++++
T Consensus 246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001112346889999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.99 Aligned_cols=260 Identities=23% Similarity=0.257 Sum_probs=189.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999865 5889999999753 2334567889999999999999999999997654
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999986 5555552 24788999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccccccc----ccc-
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHAW----SLC- 747 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~~----~~~- 747 (848)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .+..... ...
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8764322 12335799999999999999999999999999999999999999865432110 0000000 000
Q ss_pred ----------ccC------ccccccccccccCC---CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 ----------KND------RAHELMDPVLQNEV---SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ----------~~~------~~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... .....+........ .......+.+++..||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 00000000000000 1123557889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=343.98 Aligned_cols=199 Identities=24% Similarity=0.310 Sum_probs=170.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc------CCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l------~Hpniv~l~~~~~~~~~~ 596 (848)
..+|++.++||+|+||.||+|... +++.||||++... ....+++.+|+.+++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999865 4889999999753 33446778899999888 467999999999999999
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC--ceeeccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMA 674 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kl~DFGla 674 (848)
++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999997 5776666432 2234889999999999999999999987 999999999999999987 999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~ 733 (848)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 223579999999999999999999999999999999999999986543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.88 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=197.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----CeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~~ 596 (848)
.++|++.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999865 57899999997543 33457789999999999999999999998754 468
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+++ +|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~~-~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccCc-CHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 999999985 7777663 345889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-cceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccC---c
Q 003092 677 FGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND---R 751 (848)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 751 (848)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........... .
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 6533221 11234579999999998765 4589999999999999999999999864432111 00000000000 0
Q ss_pred cccc--------ccccc-ccCC-----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHEL--------MDPVL-QNEV-----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~--------~d~~l-~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... ..... .... ......++.+++..||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000 0000 0112346889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.43 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=192.4
Q ss_pred hcCcceeeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeee-----------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI----------- 591 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~----------- 591 (848)
.++|++.+.||+|+||.||+|.... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3689999999999999999999764 8999999998766667788999999999999999999998873
Q ss_pred ---eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCce
Q 003092 592 ---EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPK 667 (848)
Q Consensus 592 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 667 (848)
+....++||||++ ++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 4468899999998 58888773 345889999999999999999999987 99999999999997 567999
Q ss_pred eeccccccccCCCcc-ccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccc
Q 003092 668 ISDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAW 744 (848)
Q Consensus 668 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~ 744 (848)
|+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999987643221 112223467899999999876 6789999999999999999999999864432110 0000000
Q ss_pred cccccCcccc---c----cccccc-cCC-----CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKNDRAHE---L----MDPVLQ-NEV-----SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~~~~~---~----~d~~l~-~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+ . +..... ... ......++.+++..||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000 0 000000 000 0112456889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=342.68 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=193.0
Q ss_pred HHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------ 593 (848)
....++|++.++||+|+||+||+|+.. +++.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999864 6899999998654322 24799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHH
Q 003092 594 --------------------------------GEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYL 640 (848)
Q Consensus 594 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yL 640 (848)
...++||||+++ +|...+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 348899999985 666555321 2345689999999999999999999
Q ss_pred HhcCCCceEecccCCCcEEec-cCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCC-CCcccceeehHHH
Q 003092 641 HQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVL 718 (848)
Q Consensus 641 H~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvv 718 (848)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999998 68899999999998764433 222357899999999988754 8999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcccccccccccc--------------ccCccccccccccccCCCHHHHHHHHHHHHhccccCc
Q 003092 719 MLEILSSKKNTGVYNTDSFNLLGHAWSLC--------------KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENA 784 (848)
Q Consensus 719 l~elltg~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP 784 (848)
+|||++|+.||........ +........ .................+......+.+++..||+.||
T Consensus 232 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999865332110 000000000 0000000000000111122234468899999999999
Q ss_pred CCCCCHHHHHH
Q 003092 785 EDRPTMSDVVS 795 (848)
Q Consensus 785 ~~RPt~~evl~ 795 (848)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.50 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=181.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------C
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~ 594 (848)
.++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 378999999999999999999864 5889999998653 233457788999999999999999999998654 5
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
..++|+||+ +++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6788887732 46899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCc-ccccccccc-------
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS-FNLLGHAWS------- 745 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~~------- 745 (848)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+... .........
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 234579999999999987 678999999999999999999999986443211 000000000
Q ss_pred -ccccCccccccccccc-cCCCH-----HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 -LCKNDRAHELMDPVLQ-NEVSL-----PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 -~~~~~~~~~~~d~~l~-~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+..... ..... .....+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000000000 00011 11346789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=366.25 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred HHHhcCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~ 595 (848)
....++|++.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445789999999999999999998743 4579999987543 334577999999999999999999999985 467
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999998853 2345889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... .... .....
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~---i~~~~---- 609 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR---IENGE---- 609 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHH---HHHTC----
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH---HHcCC----
Confidence 77543322 2223467889999999999999999999999999999997 888875432211 1000 00000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+......+.+++..||+.||++||++.++++.|++.+
T Consensus 610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00111223347889999999999999999999999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=339.95 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=189.4
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe-
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE- 595 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~- 595 (848)
.......++|++.++||+|+||.||+|+.. +++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999975 58899999986543 233456788889999999999999999976443
Q ss_pred ------EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH--hcCCCceEecccCCCcEEecc-CCCc
Q 003092 596 ------KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--QYSRLRIIHRDLKASNILLDQ-HMNP 666 (848)
Q Consensus 596 ------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~iiHrDlkp~NILl~~-~~~~ 666 (848)
.++||||++++.+..+.........+++..+..++.||+.||+||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999997644333222234556888999999999999999999 766 999999999999997 8999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ +......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHH
Confidence 9999999987654332 22356899999999987655 89999999999999999999999865432110 0000000
Q ss_pred c----------c-ccCccccccc------cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 L----------C-KNDRAHELMD------PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~----------~-~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. . .........+ ..............+.+++..||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 0000000000 00001112224567899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.81 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=196.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-----CeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-----~~~ 596 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999975 58899999997543 33456788999999999999999999988764 678
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
++||||+. ++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 57777663 246889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccc--------ceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccc--cccc--
Q 003092 677 FGGDELQG--------NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNL--LGHA-- 743 (848)
Q Consensus 677 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~--~~~~-- 743 (848)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...+...... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65332111 1223578999999998765 678999999999999999999999986543211000 0000
Q ss_pred ------ccccccCccccccccccc-cC-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 ------WSLCKNDRAHELMDPVLQ-NE-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 ------~~~~~~~~~~~~~d~~l~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..........+.+..... .. .......++.+++..||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000000 00 00122346789999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=328.82 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=197.2
Q ss_pred HhcCcceeeeecccCCccEEEEEec--CCceEEEEEecccC--cccHHHHHHHHHHHHHc---CCCceeeeeeeee----
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCI---- 591 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~---- 591 (848)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 57899999986432 22234566788877776 8999999999987
Q ss_pred -eCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeec
Q 003092 592 -EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (848)
Q Consensus 592 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~D 670 (848)
.....++||||++ ++|..++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 5888777432 2234889999999999999999999987 99999999999999999999999
Q ss_pred cccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccc----c
Q 003092 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHA----W 744 (848)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~----~ 744 (848)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .+.... .
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99998764322 22345789999999999999999999999999999999999999864332110 000000 0
Q ss_pred cccccC-c-ccccccc---ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKND-R-AHELMDP---VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~-~-~~~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+... . ....+.. .............+.+++..||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0 0000000 0000111123346789999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=341.44 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=187.2
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.|.+.++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.++...++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776667999999998653 345678999999987 8999999999999999999999999
Q ss_pred cCCcccccccCCCccc----ccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC-------------CCc
Q 003092 604 VNKSLDVFLFDPTKKH----LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-------------MNP 666 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~ 666 (848)
. |+|.+++....... ...+..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69988885432211 1234456789999999999999987 9999999999999754 489
Q ss_pred eeeccccccccCCCccc--cceeeeeccccccChhhhhc-------CCCCcccceeehHHHHHHHHh-CCCCCCCCCCCc
Q 003092 667 KISDFGMARMFGGDELQ--GNTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDS 736 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~~~~-------~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~ 736 (848)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.|++......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987543321 12234579999999999976 668999999999999999999 899986432221
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+..... . .+............++.+++..||+.||++|||+.||++
T Consensus 248 ~~i~~~~~---~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRGIF---S--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTCC---C--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCCC---C--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110000 0 000111123445678899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=341.71 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=153.0
Q ss_pred cCcce-eeeecccCCccEEEEEec---CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEE
Q 003092 525 ENFSI-QSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKIL 598 (848)
Q Consensus 525 ~~f~i-~~~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~l 598 (848)
+.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|+.+|++++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 458999999999999965 47889999997542 23568899999999999999999999954 678999
Q ss_pred EEEeccCCcccccccCC------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe----ccCCCcee
Q 003092 599 IYEYMVNKSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKI 668 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kl 668 (848)
||||+++ +|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999986 555544211 12234899999999999999999999987 9999999999999 77899999
Q ss_pred eccccccccCCCcc-ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 669 SDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 669 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
+|||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987654321 1223346799999999999874 5899999999999999999999998644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=328.99 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=200.4
Q ss_pred hcCcceeeeecccCCccEEEEEe-c-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc------eeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-L-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~~~~~~~~~ 595 (848)
.++|++.++||+|+||.||+|.. . +++.||||++... ....+.+.+|+.+++.++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36899999999999999999986 3 5789999999653 334577889999999997665 9999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-------------
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ------------- 662 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~------------- 662 (848)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 78887777432 2235789999999999999999999987 999999999999987
Q ss_pred ------CCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc
Q 003092 663 ------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (848)
Q Consensus 663 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~ 736 (848)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 233579999999999999999999999999999999999999986543211
Q ss_pred c-ccccccc--------cccccCc------------------ccccccccc-ccCCCHHHHHHHHHHHHhccccCcCCCC
Q 003092 737 F-NLLGHAW--------SLCKNDR------------------AHELMDPVL-QNEVSLPMLVRYINVALLCVQENAEDRP 788 (848)
Q Consensus 737 ~-~~~~~~~--------~~~~~~~------------------~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RP 788 (848)
. ....... ....... ......+.. ..........++.+++..||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 0 0000000 0000000 000000000 0112334567889999999999999999
Q ss_pred CHHHHHH
Q 003092 789 TMSDVVS 795 (848)
Q Consensus 789 t~~evl~ 795 (848)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.09 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=190.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee----------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE---------- 592 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~---------- 592 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999975 6889999999643 3446778999999999999999999998865
Q ss_pred ---CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 593 ---QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 593 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
....++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3578999999999999998853 2345778899999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCcc------------ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCc
Q 003092 670 DFGMARMFGGDEL------------QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (848)
Q Consensus 670 DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~ 736 (848)
|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999987643210 1122345699999999999865 68999999999999999998 3321100 0
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....... .. ....+...........+.+++..||+.||++|||+.++++
T Consensus 235 ~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKL----RS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH----HS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhc----cc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000000 00 0001111222333456789999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.89 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=199.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
..++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999875 58899999986542 34567899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC---CCceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kl~DFGla~~ 676 (848)
|||+++++|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999777632 346889999999999999999999987 9999999999999754 4699999999987
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|+.|+....... .... . ...... ..
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~---~-~~~~~~-~~ 242 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKR---V-ETGKYA-FD 242 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---H-HHCCCC-CC
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHH---H-HcCCCC-CC
Confidence 654321 223468999999998875 48999999999999999999999986432211 1000 0 000000 00
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+. ......++.+++..||+.||++|||+.|+++
T Consensus 243 ~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SGG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 0112346889999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.74 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=176.6
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHH-HHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~-~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 378999999999999999999975 58899999997643 233445666666 667789999999999999999999999
Q ss_pred EeccCCcccccccC--CCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 601 EYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 601 Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
||+++ +|..++.. ......+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 66555531 11245688999999999999999999997 6 999999999999999999999999999876
Q ss_pred CCCccccceeeeeccccccChhhh----hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYA----LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~----~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+.........+.. ... ..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~-~~-- 246 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----VVK-GD-- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----CCC-SC--
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----Hhc-CC--
Confidence 4332 12234699999999998 4567899999999999999999999998643321111100 000 00
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+...........+.+++..||+.||++||++.++++
T Consensus 247 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ---PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111111122347889999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.66 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=192.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE----
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK---- 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~---- 596 (848)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 58899999997542 23357788999999999999999999999877654
Q ss_pred --EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 597 --ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 597 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
++||||+. ++|...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 46666552 23889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc-------
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL------- 746 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------- 746 (848)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .......
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 264 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHH
Confidence 865432 233578999999999987 6789999999999999999999999864331110 0000000
Q ss_pred ----cccCcccccccccccc-C-----CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ----CKNDRAHELMDPVLQN-E-----VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ----~~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+...... . ........+.+++..||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000000000 0 00112457889999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.15 Aligned_cols=252 Identities=19% Similarity=0.204 Sum_probs=172.0
Q ss_pred hcCcceee-eecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEE
Q 003092 524 TENFSIQS-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 524 ~~~f~i~~-~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~ 597 (848)
.++|++.+ +||+|+||.||+|... +++.||||++.... ....+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 47899855 6999999999999976 58999999986531 222223334667799999999999876 44689
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 674 (848)
+||||+++++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999988643 2246899999999999999999999987 999999999999976 455999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ........ .
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~---~- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRL---G- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhc---c-
Confidence 8654322 234578999999999999999999999999999999999999985433221100 00000000 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...............+.+++..||+.||++|||+.|+++
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 --QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111123446889999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=328.56 Aligned_cols=261 Identities=20% Similarity=0.313 Sum_probs=197.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-----------CCceeeeeeeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCI 591 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~~~~~ 591 (848)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999864 5889999999743 334567889999999886 899999999998
Q ss_pred eCC----eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEecc----
Q 003092 592 EQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQ---- 662 (848)
Q Consensus 592 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~---- 662 (848)
..+ ..++||||+ +++|..++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++.
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 888888775322 33588999999999999999999997 6 999999999999953
Q ss_pred --CCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc--
Q 003092 663 --HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-- 738 (848)
Q Consensus 663 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-- 738 (848)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 447999999999876432 22347899999999999999999999999999999999999998644321100
Q ss_pred --cccccccc------------------cccCccccc--------ccccc--ccCCCHHHHHHHHHHHHhccccCcCCCC
Q 003092 739 --LLGHAWSL------------------CKNDRAHEL--------MDPVL--QNEVSLPMLVRYINVALLCVQENAEDRP 788 (848)
Q Consensus 739 --~~~~~~~~------------------~~~~~~~~~--------~d~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RP 788 (848)
........ ......... +...+ ....+.....++.+++..||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000000 000000000 00000 1123456677899999999999999999
Q ss_pred CHHHHHH
Q 003092 789 TMSDVVS 795 (848)
Q Consensus 789 t~~evl~ 795 (848)
|+.|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.35 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=192.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe------
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE------ 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~------ 595 (848)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 68999999999999999999875 58999999997542 2335678999999999999999999999987653
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||++ ++|..++. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 57776652 23889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc--------
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL-------- 746 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 746 (848)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+... ........
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEF 247 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 65432 233578999999999987 678999999999999999999999986433110 00000000
Q ss_pred ---cccCcccccc-------ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ---CKNDRAHELM-------DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ---~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+ .+.+ ..........+.+++..||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0000 0111223457889999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.97 Aligned_cols=243 Identities=21% Similarity=0.371 Sum_probs=197.2
Q ss_pred HHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc------cHHHHHHHHHHHHHcC--CCceeeeeeeee
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKLQ--HRNLVRLLGCCI 591 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l~--Hpniv~l~~~~~ 591 (848)
....++|++.++||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999864 5889999998754321 2245678999999996 599999999999
Q ss_pred eCCeEEEEEEeccC-CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCceee
Q 003092 592 EQGEKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKIS 669 (848)
Q Consensus 592 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~ 669 (848)
..+..++|||++.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 888887742 456889999999999999999999987 99999999999999 78999999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+..... .. .
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~-------~ 257 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----II-------R 257 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH-------H
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----hh-------c
Confidence 999998765432 223569999999999987776 6889999999999999999999753210 00 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ...... ...++.+++..||+.||++||++.|+++
T Consensus 258 ~~-------~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQ-------VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CC-------CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc-------cccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001111 2346789999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.44 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=169.7
Q ss_pred HhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-CC-----ceeeeeeeeeeCCe
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCCIEQGE 595 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----niv~l~~~~~~~~~ 595 (848)
..++|++.++||+|+||+||+|+.. +++.||||++... .....++..|+.+++.++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999875 5789999999743 334567788999999885 55 49999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--cCCCceeecccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGM 673 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGl 673 (848)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||++ ..+|+||||||+||||+ .++.+||+|||+
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999975 8877774332 23588999999999999999999953 13599999999999994 578899999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~ 732 (848)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 22357999999999999999999999999999999999999998654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.13 Aligned_cols=243 Identities=22% Similarity=0.379 Sum_probs=189.7
Q ss_pred HHHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcc------cHHHHHHHHHHHHHc----CCCceeeeeee
Q 003092 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKL----QHRNLVRLLGC 589 (848)
Q Consensus 521 ~~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~------~~~~~~~Ei~~l~~l----~Hpniv~l~~~ 589 (848)
....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345578999999999999999999864 5889999999654321 223456799999999 89999999999
Q ss_pred eeeCCeEEEEEEe-ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCce
Q 003092 590 CIEQGEKILIYEY-MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPK 667 (848)
Q Consensus 590 ~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~k 667 (848)
+...+..++|||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999888843 345899999999999999999999987 99999999999999 889999
Q ss_pred eeccccccccCCCccccceeeeeccccccChhhhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc
Q 003092 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746 (848)
Q Consensus 668 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 746 (848)
|+|||+++...... .....||+.|+|||++.+..+. .++||||||+++|||++|+.|+..... ..
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~------ 246 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----IL------ 246 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH------
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----Hh------
Confidence 99999998775432 2335699999999999877764 589999999999999999999753210 00
Q ss_pred cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... ........++.+++..||+.||++||++.|+++
T Consensus 247 ----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 ----------EAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----------HTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------hhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 011122346788999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.07 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=196.4
Q ss_pred hcCcceeeeecccCCccEEEEEec-CC-ceEEEEEecccCcccHHHHHHHHHHHHHcCCCc------eeeeeeeeeeCCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCIEQGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------iv~l~~~~~~~~~ 595 (848)
.++|++.++||+|+||+||+|... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999874 34 68999999653 334567889999999998766 8999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEe---------------
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL--------------- 660 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl--------------- 660 (848)
.++||||+.++ +...+.. .....+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~~~~-l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELLGKN-TFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECCCCB-HHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEeccCCC-hHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999554 4444432 12245889999999999999999999987 9999999999999
Q ss_pred ----ccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCc
Q 003092 661 ----DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (848)
Q Consensus 661 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~ 736 (848)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999865332 233579999999999999999999999999999999999999986543211
Q ss_pred c-ccccccc--------cccccCc------------------ccccccccc-ccCCCHHHHHHHHHHHHhccccCcCCCC
Q 003092 737 F-NLLGHAW--------SLCKNDR------------------AHELMDPVL-QNEVSLPMLVRYINVALLCVQENAEDRP 788 (848)
Q Consensus 737 ~-~~~~~~~--------~~~~~~~------------------~~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RP 788 (848)
. ....... ....... ..+...+.. ...........+.+++..||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 0 0000000 0000000 000000000 0011233456788999999999999999
Q ss_pred CHHHHHH
Q 003092 789 TMSDVVS 795 (848)
Q Consensus 789 t~~evl~ 795 (848)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=336.09 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=185.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEEEE
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
...+|.+.++||+|+||+|+.....+++.||||++..... ..+.+|+.+|+++ +|||||++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3457999999999999997655556789999999965432 2356899999999 79999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-----CCCceeeccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARM 676 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~ 676 (848)
|+. |+|.+++.... ....+..+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 997 58888775432 23444566789999999999999987 999999999999943 33578999999987
Q ss_pred cCCCcc-ccceeeeeccccccChhhhh---cCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCc
Q 003092 677 FGGDEL-QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~APE~~~---~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |..|++........... ...
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~------~~~- 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL------GAC- 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT------TCC-
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh------ccC-
Confidence 754321 12233467999999999997 4567889999999999999999 88887533222111100 000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... .........+.+++..||+.||++|||+.||++
T Consensus 246 ~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 011233445789999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.62 Aligned_cols=251 Identities=22% Similarity=0.382 Sum_probs=177.1
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc-cc-HHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-~~-~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999975 589999999975432 22 234455556788889999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
||+ ++.+..+.. .....+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 444444332 1234688999999999999999999985 6 99999999999999999999999999986644
Q ss_pred CccccceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.|+.........+. . .....
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~---~~~~~---- 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-K---VLQEE---- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH-H---HHHSC----
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH-H---HhccC----
Confidence 32 122357999999999994 55688999999999999999999999864322111000 0 00000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+.+.. ......++.+++..||+.||++||++.|+++
T Consensus 247 --~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000100 0112346889999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=345.28 Aligned_cols=258 Identities=25% Similarity=0.310 Sum_probs=198.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeee------CCeE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QGEK 596 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~------~~~~ 596 (848)
++|++.++||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999874 5889999998754 33446779999999999999999999998765 6678
Q ss_pred EEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC---ceeecccc
Q 003092 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGM 673 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kl~DFGl 673 (848)
++||||+++++|..++........+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999876555556889999999999999999999987 999999999999997765 89999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc-
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA- 752 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 752 (848)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .+..........
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC------
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccchh
Confidence 987654332 233579999999999999999999999999999999999999985431110 000000000000
Q ss_pred ---cc------ccccc--cccCCCHHHHHHHHHHHHhccccCcCCCCCHHH
Q 003092 753 ---HE------LMDPV--LQNEVSLPMLVRYINVALLCVQENAEDRPTMSD 792 (848)
Q Consensus 753 ---~~------~~d~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 792 (848)
.+ ..... ............+.+++..||+.||++|||+.|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 00000 011234446678999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=350.10 Aligned_cols=239 Identities=20% Similarity=0.303 Sum_probs=191.5
Q ss_pred hcCcceeeeecccCCccEEEEEec--CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCe-----
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~----- 595 (848)
.++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999975 58899999986543 3445678999999999999999999999987665
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|..++.. .+++..+..++.||++||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999876632 6899999999999999999999987 9999999999999886 89999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
..... ....||+.|+|||++.++. +.++||||||+++|||++|..|+...... .+
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GL 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SC
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------cc
Confidence 76432 3457999999999988765 89999999999999999998775421100 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCC-HHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-MSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~~~ 800 (848)
. ...........+.+++..||+.||++||+ +.++...|...
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00001122346889999999999999995 55565555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=305.04 Aligned_cols=231 Identities=12% Similarity=0.089 Sum_probs=181.9
Q ss_pred cCcceeeeecccCCccEEEEEecC-CceEEEEEecccCc---ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 689999999999999999999754 89999999976532 33477899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++++|.+++.. . .....+.+++.||+.||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999998832 1 245568899999999999999987 9999999999999999999998543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
|++| ++.++||||||+++|||++|+.||......... .......... ...+.
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~----~~~~~- 226 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQ----PIEPA- 226 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSC----BCCHH-
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccC----CCChh-
Confidence 3333 688999999999999999999998654322100 0000000000 00000
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
........++.+++..||+.||++| |+.|+++.|+....
T Consensus 227 --~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 227 --DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp --HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred --hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0011123468899999999999999 99999999988643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=324.66 Aligned_cols=241 Identities=15% Similarity=0.179 Sum_probs=178.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCC-Cceee---------eeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH-RNLVR---------LLGC 589 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H-pniv~---------l~~~ 589 (848)
...|.+.++||+|+||+||+|++. +++.||||++.... ....+.+++|+.+++.++| +|... ....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 356888899999999999999964 58999999987432 2346789999999999987 32111 1111
Q ss_pred ------------eee-----CCeEEEEEEeccCCcccccccC----CCcccccCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003092 590 ------------CIE-----QGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (848)
Q Consensus 590 ------------~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (848)
... ....+++|+++ +++|.+++.. ......+++..+..++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 12345666654 5788777631 223456888999999999999999999987 9
Q ss_pred EecccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhh----------hcCCCCcccceeehHHH
Q 003092 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA----------LEGVFSVKSDVFSFGVL 718 (848)
Q Consensus 649 iHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~~~ksDVwSlGvv 718 (848)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865432 334577 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 003092 719 MLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 719 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 794 (848)
+|||++|+.||....... ..+..+.... .....+.+++..||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~------------------~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG------------------GSEWIFRSCK--NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS------------------CSGGGGSSCC--CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh------------------hHHHHHhhcc--cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986432211 1111111111 1124688999999999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.66 Aligned_cols=226 Identities=19% Similarity=0.232 Sum_probs=176.3
Q ss_pred cCccee-eeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHH-HHcCCCceeeeeeeeee----CCeEE
Q 003092 525 ENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 525 ~~f~i~-~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l-~~l~Hpniv~l~~~~~~----~~~~~ 597 (848)
++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567777 78999999999999874 5889999998642 4567899888 55699999999999887 67889
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 674 (848)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999888542 2246899999999999999999999987 999999999999998 788999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.... +..++.++||||||+++|||++|+.||.......... .... .
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~--------~ 213 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT--------R 213 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCC--------S
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHH--------H
Confidence 7532 2346789999999999999999999985433211000 0000 0
Q ss_pred ccccccccCCC----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVS----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..... ...+ .....++.+++..||+.||++|||+.|+++
T Consensus 214 ~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 214 IRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 0011 112346889999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=316.56 Aligned_cols=242 Identities=15% Similarity=0.148 Sum_probs=181.0
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccC--------cccHHHHHHHHHHHHHcC---------CCceeee
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL 586 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------Hpniv~l 586 (848)
.++|++.++||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 78999999997542 234578999999999996 6666655
Q ss_pred eee-----------------eee-------------CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHH
Q 003092 587 LGC-----------------CIE-------------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636 (848)
Q Consensus 587 ~~~-----------------~~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~ 636 (848)
.++ +.+ ....++||||+++|++...+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 554 333 678999999999997655552 2457899999999999999
Q ss_pred HHHHH-hcCCCceEecccCCCcEEeccCC--------------------CceeeccccccccCCCccccceeeeeccccc
Q 003092 637 LLYLH-QYSRLRIIHRDLKASNILLDQHM--------------------NPKISDFGMARMFGGDELQGNTKRIVGTYGY 695 (848)
Q Consensus 637 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 695 (848)
|+||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999876432 35899999
Q ss_pred cChhhhhcCCCCcccceeehHHH-HHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHH
Q 003092 696 MSPEYALEGVFSVKSDVFSFGVL-MLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYIN 774 (848)
Q Consensus 696 ~APE~~~~~~~~~ksDVwSlGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 774 (848)
+|||++.+.. +.++|||||+++ .+++++|..|+...... ..... ...... ................++.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~---~~~~~~----~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTD---KMLKQM----TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHH---HHHHTC----CCSSCCCSHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-hHHHH---hhhhhh----ccCcccchhhhhhcCHHHHH
Confidence 9999998766 899999998777 77788888886310000 00000 000000 00000000112235668999
Q ss_pred HHHhccccCcCCCCCHHHHH
Q 003092 775 VALLCVQENAEDRPTMSDVV 794 (848)
Q Consensus 775 l~~~cl~~dP~~RPt~~evl 794 (848)
++..||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-28 Score=284.75 Aligned_cols=185 Identities=16% Similarity=0.135 Sum_probs=130.3
Q ss_pred eeecccCCccEEEEE-ecCCceEEEEEecccC----------cccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEE
Q 003092 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~-~~~~~~vAvK~~~~~~----------~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~l 598 (848)
...+.|+.|.+..++ .-.|+.||+|.+.... ....++|.+|+++|+++ .|+||+++++++.+++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356777787777664 3458999999996542 23356799999999999 79999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||++|++|.+.|.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999853 3345543 58999999999999998 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~ 727 (848)
.... .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 4322 2334689999999998875 46778999999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-25 Score=258.90 Aligned_cols=185 Identities=17% Similarity=0.175 Sum_probs=145.8
Q ss_pred ceeeeecccCCccEEEEEecCCceEEEEEecccCc--------ccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
...++||+|+||.||+|.. .++.+|+|+...... ...+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457999999999999954 578899998654221 1135589999999999999999777777788888999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999998843 4589999999999999987 999999999999998 999999999998755
Q ss_pred Ccccc-----ceeeeeccccccChhhhhc--CCCCcccceeehHHHHHHHHhCCCCC
Q 003092 680 DELQG-----NTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 680 ~~~~~-----~~~~~~gt~~y~APE~~~~--~~~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
..... ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1235689999999999987 66888999999998888887766553
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=179.18 Aligned_cols=105 Identities=19% Similarity=0.377 Sum_probs=93.2
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.+||.|.+|++|.| |.|.|.|+.+|| |.++. ..++||+|||+.|. ...+.|.|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 378999999999999998 889999999997 77765 35999999999994 45689999999999999999
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
+.+||+|+++....++.|+|+||||||||+. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999988766678899999999999963 49998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=216.74 Aligned_cols=164 Identities=18% Similarity=0.135 Sum_probs=128.6
Q ss_pred HHHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCc------------------ccHHHHHHHHHHHHHcC
Q 003092 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQ 579 (848)
Q Consensus 518 ~~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~Ei~~l~~l~ 579 (848)
..+......|.+.+.||+|+||.||+|...+++.||||.++.... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344455667888899999999999999987799999999864321 13456899999999999
Q ss_pred CCceeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 580 Hpniv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
| +++.+++. .+..++||||+++++|.. +.. .....++.||++||+|||+.+ |+||||||+|||
T Consensus 163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 66666543 356699999999999987 411 224479999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhc----------CCCCcccceee
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE----------GVFSVKSDVFS 714 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~----------~~~~~ksDVwS 714 (848)
++ ++.+||+|||+|+. +..++|||++.. ..|...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 99999999999963 345789998754 34455556553
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-21 Score=174.90 Aligned_cols=108 Identities=19% Similarity=0.334 Sum_probs=96.1
Q ss_pred cccccCCCCcccCCCCeEE--cCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEE
Q 003092 39 LAADTLTPTTLIRDGETLV--SPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVL 116 (848)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl 116 (848)
++.|+|.+|++|.+|++|+ |++|.|+|+|+.+|+ + +||++ .++||+|||+.| +.++.|.|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5789999999999999999 999999999999886 2 67876 799999999876 4568999999999999
Q ss_pred EcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 117 LNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 117 ~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
+|.++.++|+|.+........++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999998765556788999999999996 269997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.9e-21 Score=172.53 Aligned_cols=110 Identities=25% Similarity=0.423 Sum_probs=96.7
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.+||.|.+|++|+ ++|.|.|+|+.+|+ + ++|+ ..++||+||++.| +..+.|.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 48899999999999999 99999999999987 3 6776 4799999999876 45689999999999999999
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCc
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPT 169 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~Pt 169 (848)
+.++|+|.+........++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999987666667889999999999963 5999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=168.79 Aligned_cols=110 Identities=20% Similarity=0.348 Sum_probs=95.0
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ + ++|+ ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 7999999998886 3 2455 4799999999988 35689999999999999998
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcc
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTD 170 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtD 170 (848)
+.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999987555567899999999999952 69999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=167.15 Aligned_cols=110 Identities=26% Similarity=0.469 Sum_probs=94.5
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
+|+|.+||.|.+|++| .+|.|.|+|+.+|+ + ++|+. .++||+||++.+ +.++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 47999999999987 3 45765 699999999764 456899999999999999 8
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCC
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~P 168 (848)
+.++|+|.+........++|+++|||||++.. +.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 88999999876656678999999999999743 36899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=162.74 Aligned_cols=104 Identities=27% Similarity=0.444 Sum_probs=89.9
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.++|.|||.|.+|+.|+ +|.|.|+|+.+|+ +-+ |+. .++||++|++.+ +..+.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 6999999999986 433 554 699999999876 45689999999999999999
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
+.++|++++.+....+.|+|+||||||||+. ++|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 9999999987655567899999999999973 59997
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.5e-19 Score=185.07 Aligned_cols=141 Identities=15% Similarity=0.167 Sum_probs=105.6
Q ss_pred CcceeeeecccCCccEEEEEe-cCCce--EEEEEecccCcc------------------------cHHHHHHHHHHHHHc
Q 003092 526 NFSIQSKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLKEFKNEMMLIAKL 578 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~-~~~~~--vAvK~~~~~~~~------------------------~~~~~~~Ei~~l~~l 578 (848)
-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999997 67888 999987543111 113678999999999
Q ss_pred CCCce--eeeeeeeeeCCeEEEEEEeccC-CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHH-hcCCCceEecccC
Q 003092 579 QHRNL--VRLLGCCIEQGEKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH-QYSRLRIIHRDLK 654 (848)
Q Consensus 579 ~Hpni--v~l~~~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~iiHrDlk 654 (848)
.|+++ +.++.. ...++||||+.+ |.+...+.+... ..++..+..++.||+.+|.||| +.+ |+|||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--ELKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--GGGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--ccChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 98864 333332 356899999953 432222211101 1234567889999999999999 776 9999999
Q ss_pred CCcEEeccCCCceeecccccccc
Q 003092 655 ASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~ 677 (848)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=156.81 Aligned_cols=105 Identities=20% Similarity=0.329 Sum_probs=89.8
Q ss_pred cccccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEc
Q 003092 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (848)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 118 (848)
++.|+|.|||.|.+|+.|+| |.|.|.|..+|+ |.+ |+. ++||++|++.. +..+.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 57899999999999999998 569999988886 555 554 58999999863 456899999999999999
Q ss_pred CCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 119 ~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
.++.++|++++......+.|+|+||||||||+. .+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 999999999986555557899999999999973 59987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.74 E-value=7.1e-18 Score=153.00 Aligned_cols=107 Identities=16% Similarity=0.290 Sum_probs=91.8
Q ss_pred ccccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcC
Q 003092 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQ 119 (848)
Q Consensus 40 ~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~ 119 (848)
+.|+|.+||.|.+|+.|.+ |.|.|.|+.+|+ |.++. ....++||.+|+..+ +..+.|.|+.||||||+|.
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~-~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTK-GSKTNIVWESGTSGR--GQHCFMRLGHSGELDITDD 74 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE-TTTTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEE-CCCCEEEEECCcccC--CcCEEEEEeCCCcEEEECC
Confidence 6799999999999999986 899999999987 66643 224689999999875 4568999999999999999
Q ss_pred CCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 120 SNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 120 ~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
++.++|++++......+.|+|+||||||||+ ..||+|
T Consensus 75 ~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 75 RLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 9999999998765555789999999999996 359997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-17 Score=147.61 Aligned_cols=103 Identities=21% Similarity=0.359 Sum_probs=87.4
Q ss_pred cccccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEc
Q 003092 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (848)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~ 118 (848)
+|.|+|.|||.|.+|+.|. +|.|.|.|+.+|+ |-+ |.. +|.+|+..+ +..+.|.|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L~--~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHLK--NGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEeE--CCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 4789999999999999994 6999999999887 333 432 799999875 457899999999999999
Q ss_pred CCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 119 ~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
.++.++|++++.+....+.|+|+||||||||+ ..+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 99999999998765456789999999999996 359997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.9e-16 Score=143.67 Aligned_cols=96 Identities=24% Similarity=0.410 Sum_probs=79.9
Q ss_pred CCcCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCc
Q 003092 98 PIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMK 177 (848)
Q Consensus 98 p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~k 177 (848)
|+.+...+|.|+.||||||++. ++++|++++.+...++.|+|+|+|||||++ ++ .++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCc-----------
Confidence 3345568899999999999987 789999998765556789999999999998 43 68999993
Q ss_pred cccccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEc-CCceeeccCCCCC
Q 003092 178 LGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN-GSAKYTCTGPWNG 233 (848)
Q Consensus 178 lg~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~-~~~~y~~sg~w~g 233 (848)
+|++|.|++.++++|. +++|. +..+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999997 55665 5779999999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.8e-16 Score=173.75 Aligned_cols=139 Identities=14% Similarity=0.157 Sum_probs=99.4
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCc--------------ccHHHH--------HHHHHHHHHcCCCc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLKEF--------KNEMMLIAKLQHRN 582 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~--------------~~~~~~--------~~Ei~~l~~l~Hpn 582 (848)
.=|++.++||+|+||.||+|...+|+.||||+++.... ...... ..|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999998899999998753210 011112 23555555554433
Q ss_pred eeeeeeeeeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc
Q 003092 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (848)
Q Consensus 583 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~ 662 (848)
+....-+. ....+|||||++++.|..+.. ......++.||+.+|.|||..+ ||||||||.|||+++
T Consensus 175 v~vp~p~~--~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIA--QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEE--EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeee--ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 32111111 123479999999988765542 1234568899999999999987 999999999999988
Q ss_pred CCC----------ceeecccccccc
Q 003092 663 HMN----------PKISDFGMARMF 677 (848)
Q Consensus 663 ~~~----------~kl~DFGla~~~ 677 (848)
++. +.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 773 899999987654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=5e-16 Score=140.12 Aligned_cols=90 Identities=27% Similarity=0.347 Sum_probs=75.5
Q ss_pred CCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccc
Q 003092 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGW 180 (848)
Q Consensus 101 ~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~ 180 (848)
+...+|.|+.||||||++ .+++||++++.+...++.++|+|+|||||++.++ .++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~-----~~~W~S~--------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSN-----RVIWQTK--------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECC---------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCC-----cEEEecC---------------
Confidence 346789999999999998 5899999998765556789999999999998653 7899999
Q ss_pred ccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCCC
Q 003092 181 DLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (848)
Q Consensus 181 ~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~w 231 (848)
.+|++|.|++.++.+|. ++++++ +||+++.+
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35567999999999997 566765 89999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=3.7e-15 Score=136.23 Aligned_cols=87 Identities=25% Similarity=0.310 Sum_probs=73.6
Q ss_pred CceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 103 ~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
...|.|+.||||||++. +++||++++.....++.++|+|+|||||++.++ .++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~-----~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCC-----cEEEcCC-----------------
Confidence 46789999999999987 899999998765556789999999999998653 7899999
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
.||++|.|++.++++|. ++++. .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999997 55666 38999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=136.19 Aligned_cols=103 Identities=17% Similarity=0.264 Sum_probs=84.5
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.|||.|.+|+.|. +|.|.|.|+.+|+ |.+ |.. .. ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 58999999999999995 5999999999987 444 433 23 999999876 44689999999999999988
Q ss_pred CC-eEEeecccC--CcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 121 NG-TIWSSNVSR--EVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 121 ~~-~~W~t~~~~--~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
+. ++|+|++.. ....+.++|++|||||||+ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2345778999999999996 359987
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-14 Score=132.87 Aligned_cols=91 Identities=29% Similarity=0.400 Sum_probs=76.3
Q ss_pred CceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 103 ~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
...|.|+.||||||++ .++++|++++.....++.++|+++|||||++.++ .++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~-----~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNN-----NDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCc-----eEEEEcCCC---------------
Confidence 5678899999999998 5889999998765556788999999999998643 689999997
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCCCCCc
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGV 234 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~w~g~ 234 (848)
|++|.|++.++.+|. +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 566765 89999999753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=133.32 Aligned_cols=111 Identities=25% Similarity=0.449 Sum_probs=86.6
Q ss_pred cccccCCCCcc----cCCCCeEEcC----CCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEec
Q 003092 39 LAADTLTPTTL----IRDGETLVSP----SQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSN 110 (848)
Q Consensus 39 ~~~~~l~~~~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~ 110 (848)
...|+|.||+. |..|+.|.|+ .|.|.|.|...| + +-+ |++ ..+++|.+++.++ +. +.|.|+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dG---n--lvL-y~~-~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDG---N--LVA-YGP-NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTS---C--EEE-ECT-TSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCc---e--EEE-EeC-CCeEEEECCCCCC--cc-EEEEEcC
Confidence 35699999999 8899998764 355555554444 2 333 332 3589999999886 33 7899999
Q ss_pred CCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCC
Q 003092 111 RGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (848)
Q Consensus 111 ~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 167 (848)
||+|+++|.++.++|++++.+. ....|+|++|||||||+. +++||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 9999999998899999998754 357889999999999963 479999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=111.53 Aligned_cols=94 Identities=21% Similarity=0.287 Sum_probs=71.5
Q ss_pred CCCcCCCceEEEecCCCEEEEcC-CCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCccccccc
Q 003092 97 SPIVDKNGVLTVSNRGNLVLLNQ-SNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQG 175 (848)
Q Consensus 97 ~p~~~~~~~l~~~~~g~lvl~~~-~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg 175 (848)
+|+.+...+|.|+.||||||++. .+.++|++++.+...++.++|+++|||||++.++ .++|||=.+
T Consensus 19 ~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~-----~~iW~S~t~-------- 85 (113)
T 3mez_B 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRL-----NTVFVSNTV-------- 85 (113)
T ss_dssp CEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECSCC--------
T ss_pred CEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCC-----CEEEECCCc--------
Confidence 44455568899999999999998 4899999998765556788999999999998653 679996321
Q ss_pred CccccccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 176 MKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 176 ~klg~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
...|.|.+.++.+|...+ |. .+.|.+|+
T Consensus 86 -----------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 86 -----------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp -----------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred -----------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 012458888998887654 44 57898875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.8e-11 Score=128.63 Aligned_cols=145 Identities=17% Similarity=0.096 Sum_probs=114.4
Q ss_pred HHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~ 600 (848)
.....|++...++.|+.+.||++.. .++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446798888999999999999975 36889999987532223346889999999994 677889999999889999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY------------------------------------- 643 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------------------------------------- 643 (848)
||+++.+|...+. +......++.+++++|+.||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999998866431 1122347888999999999982
Q ss_pred -------------------CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 644 -------------------SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 644 -------------------~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.+..++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876556799999874
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-11 Score=107.72 Aligned_cols=92 Identities=18% Similarity=0.235 Sum_probs=69.8
Q ss_pred cCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCccc
Q 003092 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLG 179 (848)
Q Consensus 100 ~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg 179 (848)
.+....|.|+.||||||++.++ +|++++.+...++.++|+++|||||++.++ ..++|||.-+
T Consensus 18 ~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------------ 79 (111)
T 3mez_A 18 SYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------------ 79 (111)
T ss_dssp EETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS------------
T ss_pred ecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc------------
Confidence 3446789999999999999876 999998765556788999999999998653 2359998721
Q ss_pred cccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 180 WDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 180 ~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
.....|.|.+.++.+|...+ |. .++|.++.
T Consensus 80 -----------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 -----------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp -----------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred -----------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 01124678999999997654 44 67898763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=9.8e-11 Score=122.44 Aligned_cols=138 Identities=17% Similarity=0.155 Sum_probs=103.1
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~~~~~~~~~lV~Ey 602 (848)
.++.+....+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554443456669999998777888999997653 2345788999999996544 55688888877889999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS-------------------------------------- 644 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------- 644 (848)
+++.+|. ... . ....++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998874 211 1 12357788888888888743
Q ss_pred -----------------CCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 645 -----------------RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 645 -----------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
+..++|+|++|.|||++++..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998853
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.04 E-value=5e-10 Score=100.43 Aligned_cols=90 Identities=27% Similarity=0.425 Sum_probs=68.0
Q ss_pred CCcCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCc
Q 003092 98 PIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMK 177 (848)
Q Consensus 98 p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~k 177 (848)
|+.+....|.|+.||||||+++ +|++++.+...++.++|+++|||||++.++ .++|+|-.
T Consensus 17 ~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~-----~~vWss~t----------- 76 (109)
T 3r0e_A 17 HLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDG-----STVWKSGA----------- 76 (109)
T ss_dssp EEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECCC-----------
T ss_pred EeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCC-----CEEEcCCC-----------
Confidence 3344567899999999999984 799998866556788999999999998643 67897521
Q ss_pred cccccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCCC
Q 003092 178 LGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (848)
Q Consensus 178 lg~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~w 231 (848)
....+.|.+.++.+|...+ +. .+.|.+|.|
T Consensus 77 --------------------~~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 --------------------QSVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW 106 (109)
T ss_dssp --------------------CCSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred --------------------cCCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence 0123567889999986554 44 688999887
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.04 E-value=5.7e-10 Score=100.22 Aligned_cols=85 Identities=24% Similarity=0.319 Sum_probs=64.8
Q ss_pred CceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 103 ~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
...|.|+.||||||++. .++|++++.+...++.++|+++|||||++.++ .++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~-----~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF-----KTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTC-----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCC-----CEEEEcCCcC--------------
Confidence 46789999999999976 58999998765556788999999999998653 6899975310
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTG 229 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg 229 (848)
..|.|.+.++.+|...+ |. .+.|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVI--YG--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEE--EC--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEE--ec--CCEecCC
Confidence 12457888888886654 44 3778776
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1e-09 Score=98.58 Aligned_cols=87 Identities=23% Similarity=0.328 Sum_probs=65.8
Q ss_pred CceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 103 ~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
...|.|+.||||||++. +.++|++++.+...++.++|+++|||||++.++ .++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~-----~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRN-----NPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTS-----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCC-----CEEEECCCCC--------------
Confidence 56799999999999987 789999998765556788999999999998653 6899875311
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
..+.|.+.++.+|...+ +.. +.|.+|.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVI--YGT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEE--EES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEE--ECC--CEEeCCC
Confidence 12457888888887553 432 6677653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=4.4e-09 Score=115.76 Aligned_cols=142 Identities=15% Similarity=0.235 Sum_probs=106.9
Q ss_pred eeeeecccCCccEEEEEecCCceEEEEEec--ccC-cccHHHHHHHHHHHHHcC--CCceeeeeeeeeeC---CeEEEEE
Q 003092 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQ---GEKILIY 600 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~Ei~~l~~l~--Hpniv~l~~~~~~~---~~~~lV~ 600 (848)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999875 4678888875 322 123456788999999997 45678888888766 4589999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS------------------------------------ 644 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 644 (848)
||+++..+.+.. ...++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874322 123567788899999999999999731
Q ss_pred -------------------CCceEecccCCCcEEeccCCC--ceeeccccccc
Q 003092 645 -------------------RLRIIHRDLKASNILLDQHMN--PKISDFGMARM 676 (848)
Q Consensus 645 -------------------~~~iiHrDlkp~NILl~~~~~--~kl~DFGla~~ 676 (848)
+..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.75 E-value=3e-08 Score=88.02 Aligned_cols=55 Identities=33% Similarity=0.498 Sum_probs=45.3
Q ss_pred ceEEEecCCCEEEEcCCCCeEEeecccCCc-ccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 104 GVLTVSNRGNLVLLNQSNGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 104 ~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
-+|.|+.||||||++ .+++||++++.... .++.+.|++||||||++.++ ++||+|
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~-----~~vWss 76 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG-----RSLWAS 76 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC-----CEEEEC
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCc-----EEEEEe
Confidence 468899999999997 46899999986543 34678999999999998764 678985
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.73 E-value=5.1e-09 Score=112.46 Aligned_cols=186 Identities=18% Similarity=0.204 Sum_probs=121.2
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCc--eeeeeeeeeeCC---eEEEEEEecc
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCIEQG---EKILIYEYMV 604 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpn--iv~l~~~~~~~~---~~~lV~Ey~~ 604 (848)
+.++.|....||+.. +.+++|+.... .....+.+|+++|+.+. +.. +.+.+....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999863 56899986532 34567899999999984 433 344444433332 3478999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS---------------------------------------- 644 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 644 (848)
+..+..... ..++..++..++.++++.|+.||+..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988754321 23566777888889999999888621
Q ss_pred ---------------CCceEecccCCCcEEecc--CCCceeeccccccccCCCc-ccccee-----------eeeccccc
Q 003092 645 ---------------RLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGDE-LQGNTK-----------RIVGTYGY 695 (848)
Q Consensus 645 ---------------~~~iiHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~-~~~~~~-----------~~~gt~~y 695 (848)
+..++|+|++|.||++++ +..+.|+||+.+..-.... ...... ......+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 235899999999999998 4567899999986532210 000000 00001111
Q ss_pred cC-hhhhhcCCCCcccceeehHHHHHHHHhCCCCC
Q 003092 696 MS-PEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (848)
Q Consensus 696 ~A-PE~~~~~~~~~ksDVwSlGvvl~elltg~~p~ 729 (848)
.. |+..... ....+.|+++.++|++.+|..++
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 22358999999999999987663
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=5.2e-07 Score=92.82 Aligned_cols=105 Identities=21% Similarity=0.339 Sum_probs=77.7
Q ss_pred ccccCCCCc-------ccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCC
Q 003092 40 AADTLTPTT-------LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRG 112 (848)
Q Consensus 40 ~~~~l~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g 112 (848)
..|+|.+|| .|..++.+. .|.|.|.|.+.|+ +-+|.. ..++|.++.... ..++.++|+.||
T Consensus 124 g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~---~~~~W~s~~~~~--~~~~~~~L~~~G 191 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAGK--GTGCRAVLQPNG 191 (236)
T ss_dssp CCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCSS--CSSCEEEEETTT
T ss_pred cceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcC---CEeEEeCCCcCC--CCceEEEECCCC
Confidence 457788888 555555554 5899999987763 555533 268898887543 245789999999
Q ss_pred CEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 113 NLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 113 ~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
+|++++.++.++|.+.+........++|.++|||+++.. .+|+|
T Consensus 192 nl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~--------~~W~s 235 (236)
T 1dlp_A 192 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 235 (236)
T ss_dssp EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred cEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC--------CCccC
Confidence 999999888899999876444456789999999999953 48986
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.6e-06 Score=89.28 Aligned_cols=140 Identities=18% Similarity=0.146 Sum_probs=99.9
Q ss_pred cCcceeeeecccCCc-cEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG-~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E 601 (848)
..|+. +.+..|..| .||+.... ++..+++|+-... ....+..|+..|+.+. +--+.++++++.+++..++|||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 356666666 58988764 4567899986532 3467888999999884 4447788888988999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS------------------------------------- 644 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------- 644 (848)
++++.++...... .......+..++++.|+.||...
T Consensus 101 ~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 101 AIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999876544311 11223456666777777777421
Q ss_pred ------------------CCceEecccCCCcEEeccCCCceeecccccc
Q 003092 645 ------------------RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 645 ------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
+..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999885
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.6e-06 Score=90.15 Aligned_cols=136 Identities=21% Similarity=0.205 Sum_probs=95.7
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC---ceeeeeeeee-eCCeEEEEEEeccC
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCI-EQGEKILIYEYMVN 605 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~~~~~-~~~~~~lV~Ey~~~ 605 (848)
.+.++.|....||+. ++.+++|+... ......+..|+++|..+.+. .+.+.+.+.. ..+..++|||++++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357888888899987 57789998532 23456789999999999752 3556666654 34567899999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY------------------------------------------ 643 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------------------------------------------ 643 (848)
..+..... ..++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88755221 1134445555666666666666642
Q ss_pred ---------------CCCceEecccCCCcEEecc---CCCc-eeeccccccc
Q 003092 644 ---------------SRLRIIHRDLKASNILLDQ---HMNP-KISDFGMARM 676 (848)
Q Consensus 644 ---------------~~~~iiHrDlkp~NILl~~---~~~~-kl~DFGla~~ 676 (848)
.+..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.2e-06 Score=92.55 Aligned_cols=81 Identities=9% Similarity=-0.007 Sum_probs=57.8
Q ss_pred eeee-cccCCccEEEEEec-------CCceEEEEEecccC---cccHHHHHHHHHHHHHcC-C--CceeeeeeeeeeC--
Q 003092 530 QSKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCIEQ-- 593 (848)
Q Consensus 530 ~~~L-G~G~fG~Vy~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-H--pniv~l~~~~~~~-- 593 (848)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4678 88989999998764 26788999865432 111245788999998884 3 3577788777655
Q ss_pred -CeEEEEEEeccCCcccc
Q 003092 594 -GEKILIYEYMVNKSLDV 610 (848)
Q Consensus 594 -~~~~lV~Ey~~~gsL~~ 610 (848)
+..++||||+++..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999987754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=5.6e-05 Score=79.98 Aligned_cols=80 Identities=16% Similarity=0.239 Sum_probs=59.4
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC---ceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp---niv~l~~~~~~~~~~~lV~E 601 (848)
....-.+.+|.|..+.||+.++.+|+.|.+|+...........|..|++.|+.|... -+.+.++. . ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEE
Confidence 455667889999999999999999999999987655444456688999999998422 23444443 2 3478999
Q ss_pred eccCCcc
Q 003092 602 YMVNKSL 608 (848)
Q Consensus 602 y~~~gsL 608 (848)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9887653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.3e-05 Score=83.66 Aligned_cols=140 Identities=16% Similarity=0.172 Sum_probs=82.1
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC--Cceeeeee------eeeeCCeEEEEEEe
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLG------CCIEQGEKILIYEY 602 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~~------~~~~~~~~~lV~Ey 602 (848)
+.|+.|..+.||+....++ .+++|+.... ..++..|+.++..|.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4666677899999987544 5899998652 2344556666666631 12344443 12346678999999
Q ss_pred ccCCcccc--------------cccC----C--C-c----ccccCHHHH-------------------------------
Q 003092 603 MVNKSLDV--------------FLFD----P--T-K----KHLLGWQLR------------------------------- 626 (848)
Q Consensus 603 ~~~gsL~~--------------~l~~----~--~-~----~~~l~~~~~------------------------------- 626 (848)
+++..+.. .++. . . . ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0110 0 0 0 001122110
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 627 VRIIDGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 627 ~~i~~qia~~L~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
..+...+..++++|+. ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111234446667763 124569999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.5e-05 Score=84.75 Aligned_cols=75 Identities=9% Similarity=0.148 Sum_probs=50.7
Q ss_pred eeeecccCCccEEEEEec-CCceEEEEEecccCc-------ccHHHHHHHHHHHHHcCC--Cc-eeeeeeeeeeCCeEEE
Q 003092 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RN-LVRLLGCCIEQGEKIL 598 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--pn-iv~l~~~~~~~~~~~l 598 (848)
.+.||.|..+.||++... +++.++||....... ...+++..|+++++.+.+ |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 467899998653211 234567889999988843 33 4455543 3455689
Q ss_pred EEEeccCC
Q 003092 599 IYEYMVNK 606 (848)
Q Consensus 599 V~Ey~~~g 606 (848)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00018 Score=76.93 Aligned_cols=138 Identities=20% Similarity=0.118 Sum_probs=92.5
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC---CCceeeeeeeeeeCCeEEEEEEeccCC
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIYEYMVNK 606 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---Hpniv~l~~~~~~~~~~~lV~Ey~~~g 606 (848)
.+.|+.|....+|+... +++.+++|+.... ....+..|++.|+.|. ...+.+.+.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46899999999999886 5678889987542 3567889999999884 356888888888788899999999987
Q ss_pred ccccc-----------ccCCCc--------c-----------cccCHHHHH---HHHH----------------HHHH-H
Q 003092 607 SLDVF-----------LFDPTK--------K-----------HLLGWQLRV---RIID----------------GIAQ-G 636 (848)
Q Consensus 607 sL~~~-----------l~~~~~--------~-----------~~l~~~~~~---~i~~----------------qia~-~ 636 (848)
.+..- |+.... . -.-+|...+ ++.. .+.. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 65321 111110 0 012344322 1111 1111 1
Q ss_pred HHHHHh-cCCCceEecccCCCcEEeccCCCceeeccc
Q 003092 637 LLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (848)
Q Consensus 637 L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFG 672 (848)
...|.. ..++.++|+|+.+.||+++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2345799999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00053 Score=73.47 Aligned_cols=156 Identities=13% Similarity=0.115 Sum_probs=88.0
Q ss_pred HHHHHHHhcCcce-----eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCc--eeeeeee
Q 003092 517 FASVTAATENFSI-----QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC 589 (848)
Q Consensus 517 ~~~i~~~~~~f~i-----~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--iv~l~~~ 589 (848)
.+++.....+|.+ .+.|+.|....+|+....++ .+++|+..... ..+++..|+.++..+...+ +.+++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3444444444543 35677788899999987555 68899886521 2234567888888774222 3334321
Q ss_pred ------eeeCCeEEEEEEeccCCccccc--------------ccC------CCc---ccccCHHHHHH------------
Q 003092 590 ------CIEQGEKILIYEYMVNKSLDVF--------------LFD------PTK---KHLLGWQLRVR------------ 628 (848)
Q Consensus 590 ------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~------~~~---~~~l~~~~~~~------------ 628 (848)
....+..+++++|+++..+... ++. ... .....|...+.
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 1234567899999998765321 110 000 00112222110
Q ss_pred HHHHHHHHHHHHHhc----CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 629 IIDGIAQGLLYLHQY----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 629 i~~qia~~L~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
+...+.+.++.++.. .+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455556532 23469999999999999887656899999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00037 Score=77.97 Aligned_cols=73 Identities=11% Similarity=0.116 Sum_probs=46.0
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEeccc------C-c--ccHHHHHHHHHHHHH-cCCCceeeeeeeeeeCCeEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ------S-G--QGLKEFKNEMMLIAK-LQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~------~-~--~~~~~~~~Ei~~l~~-l~Hpniv~l~~~~~~~~~~~lV 599 (848)
.+.||.|....||++.. +++.++||..... . . .....++.|+..+.. ..+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46899999999999965 5678999953221 0 1 122334444443322 2234566666654 5667999
Q ss_pred EEec-cC
Q 003092 600 YEYM-VN 605 (848)
Q Consensus 600 ~Ey~-~~ 605 (848)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0013 Score=70.48 Aligned_cols=142 Identities=14% Similarity=0.144 Sum_probs=84.1
Q ss_pred eeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCC--ceeeeeee-----eeeCCeEEEEEEec
Q 003092 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGC-----CIEQGEKILIYEYM 603 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hp--niv~l~~~-----~~~~~~~~lV~Ey~ 603 (848)
+.|+ |....||+....+|+.+++|...... .....+..|+.++..+... .+++++.. ...++..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877677789999986432 2345677888888888422 24444443 12345668899999
Q ss_pred cCCccccc--------------ccC----C--CcccccCHHHH----HH---------------HHHHHHHHHHHHHhc-
Q 003092 604 VNKSLDVF--------------LFD----P--TKKHLLGWQLR----VR---------------IIDGIAQGLLYLHQY- 643 (848)
Q Consensus 604 ~~gsL~~~--------------l~~----~--~~~~~l~~~~~----~~---------------i~~qia~~L~yLH~~- 643 (848)
++..+... ++. . ......++... .. +...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98665310 010 0 00111121110 00 111111223333321
Q ss_pred ---CCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 644 ---SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 644 ---~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00091 Score=74.92 Aligned_cols=74 Identities=20% Similarity=0.264 Sum_probs=51.3
Q ss_pred eeeecccCCccEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIY 600 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~ 600 (848)
.+.|+.|-...||+....+ ++.+++|+.... ...+.+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578888899999998753 468999988432 112556689999998853333 566665432 2899
Q ss_pred EeccCCccc
Q 003092 601 EYMVNKSLD 609 (848)
Q Consensus 601 Ey~~~gsL~ 609 (848)
||+++..+.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999876653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0012 Score=70.10 Aligned_cols=128 Identities=15% Similarity=0.144 Sum_probs=77.1
Q ss_pred eeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEEec-cCCc
Q 003092 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYM-VNKS 607 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~-~~gs 607 (848)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++ .++++. ..+.-++|+||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 668899876532221 123568888888753333 355544 333457899999 6655
Q ss_pred ccccccCCCcccccCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 003092 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ--------------------------------------------- 642 (848)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~--------------------------------------------- 642 (848)
+...... .+..+..++++.|+-||+
T Consensus 95 l~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 5320000 000122222233333332
Q ss_pred -----cCCCceEecccCCCcEEeccCCCceeeccccccc
Q 003092 643 -----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 643 -----~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
..+..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 12335899999999999 6677889999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0018 Score=71.12 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=82.1
Q ss_pred eeecccCCccEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEEEEEE
Q 003092 531 SKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~lV~E 601 (848)
+.|..|-...+|+....+ ++.|++|+.... ......+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 577778888899988642 468999986432 234566778999998885 3223556665543 29999
Q ss_pred eccCCccccc-c----------------cCCC--ccccc--CHHHHHHHHHHHH-------------------HHHHHHH
Q 003092 602 YMVNKSLDVF-L----------------FDPT--KKHLL--GWQLRVRIIDGIA-------------------QGLLYLH 641 (848)
Q Consensus 602 y~~~gsL~~~-l----------------~~~~--~~~~l--~~~~~~~i~~qia-------------------~~L~yLH 641 (848)
|+++..|..- + +... ..+.. -+..+.++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998776421 1 1110 01111 1333333333321 1223332
Q ss_pred ----hc-CCCceEecccCCCcEEeccC----CCceeecccccc
Q 003092 642 ----QY-SRLRIIHRDLKASNILLDQH----MNPKISDFGMAR 675 (848)
Q Consensus 642 ----~~-~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~ 675 (848)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23468999999999999876 789999999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0052 Score=69.20 Aligned_cols=75 Identities=12% Similarity=0.101 Sum_probs=49.8
Q ss_pred eeeecccCCccEEEEEecC-CceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEEeccCCc
Q 003092 530 QSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
.+.|+.|-...+|+....+ ++.+++|+.........+ -..|..++..|...++ .++++.+. + .+||||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578889899999998755 478889987543222221 2689999999965554 46666652 2 25999999866
Q ss_pred cc
Q 003092 608 LD 609 (848)
Q Consensus 608 L~ 609 (848)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 63
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0037 Score=67.24 Aligned_cols=141 Identities=15% Similarity=0.139 Sum_probs=71.6
Q ss_pred eeecccCCcc-EEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC--CceeeeeeeeeeCCeEEEEEEeccCCc
Q 003092 531 SKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILIYEYMVNKS 607 (848)
Q Consensus 531 ~~LG~G~fG~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gs 607 (848)
+.|+.|.... +|+....+++.+++|....... ..+..|+.++..+.. -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565555444 6677654467777776543221 234567777777742 23556666543333 68999987655
Q ss_pred cccccc---------------------CCCc--ccccCHHHHH--------------------HHHHHHHHHHHHHH---
Q 003092 608 LDVFLF---------------------DPTK--KHLLGWQLRV--------------------RIIDGIAQGLLYLH--- 641 (848)
Q Consensus 608 L~~~l~---------------------~~~~--~~~l~~~~~~--------------------~i~~qia~~L~yLH--- 641 (848)
+...+. .... ....+..... .....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 432211 1000 0001110000 00011122222221
Q ss_pred hcCCCceEecccCCCcEEeccC----CCceeeccccccc
Q 003092 642 QYSRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (848)
Q Consensus 642 ~~~~~~iiHrDlkp~NILl~~~----~~~kl~DFGla~~ 676 (848)
...+..++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1224469999999999999874 6789999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0033 Score=68.76 Aligned_cols=73 Identities=14% Similarity=0.151 Sum_probs=45.0
Q ss_pred eeecccCCccEEEEEecC---------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCc-eeeeeeeeeeCCeEEEEE
Q 003092 531 SKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~~~~~~~~~~~lV~ 600 (848)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 578888888999998654 267888887543221 122467888888885333 34565443 2 26899
Q ss_pred EeccCCcc
Q 003092 601 EYMVNKSL 608 (848)
Q Consensus 601 Ey~~~gsL 608 (848)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.013 Score=63.34 Aligned_cols=66 Identities=11% Similarity=0.076 Sum_probs=43.7
Q ss_pred cCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC---Cceeeeeee------eeeCCeEEEEEEeccCC
Q 003092 536 GGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGC------CIEQGEKILIYEYMVNK 606 (848)
Q Consensus 536 G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H---pniv~l~~~------~~~~~~~~lV~Ey~~~g 606 (848)
|....||+....+| .+++|+...... ..|+.++..|.. |.+++.+.. ....+..++||+|+++.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33678999987666 899998765431 356666666632 224455432 23356789999999987
Q ss_pred cc
Q 003092 607 SL 608 (848)
Q Consensus 607 sL 608 (848)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.16 E-value=0.13 Score=57.05 Aligned_cols=74 Identities=14% Similarity=0.156 Sum_probs=49.2
Q ss_pred eeeecccCCccEEEEEecC--------CceEEEEEecccCcccHHHHHHHHHHHHHcCCCc-eeeeeeeeeeCCeEEEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-iv~l~~~~~~~~~~~lV~ 600 (848)
.+.|..|-...+|+....+ ++.|++|+......... ...+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3577778888999998753 57899998754332222 2367888888885323 34555432 2 26899
Q ss_pred EeccCCcc
Q 003092 601 EYMVNKSL 608 (848)
Q Consensus 601 Ey~~~gsL 608 (848)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.35 E-value=0.048 Score=54.04 Aligned_cols=98 Identities=12% Similarity=0.049 Sum_probs=61.5
Q ss_pred cccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccccce
Q 003092 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (848)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 686 (848)
+|.++|. ....++++++++.++.|.+.+|.-+-... .+ ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4556663 34568999999999999999887762211 01 1233457899999999987764 1110
Q ss_pred eeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh
Q 003092 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (848)
Q Consensus 687 ~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt 724 (848)
.....+.|||... ...+.+.=|||||+++|..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1223566888653 344678889999999999985
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.02 E-value=0.34 Score=53.32 Aligned_cols=30 Identities=27% Similarity=0.406 Sum_probs=25.2
Q ss_pred ceEecccCCCcEEe------ccCCCceeeccccccc
Q 003092 647 RIIHRDLKASNILL------DQHMNPKISDFGMARM 676 (848)
Q Consensus 647 ~iiHrDlkp~NILl------~~~~~~kl~DFGla~~ 676 (848)
.++|+|+.+.|||+ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998853
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=91.92 E-value=7.6 Score=39.73 Aligned_cols=66 Identities=15% Similarity=0.297 Sum_probs=42.1
Q ss_pred CCeeEEeecCCCC--C----cCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcC
Q 003092 86 PDTVVWVANRNSP--I----VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDN 151 (848)
Q Consensus 86 ~~~~vW~an~~~p--~----~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~ 151 (848)
..+++|...+..+ + ....+.+-++.++.+..+|.+|..+|............+..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4588899887642 1 1123444445566677778889999998864222223356778888888753
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=83.36 E-value=6.1 Score=40.48 Aligned_cols=65 Identities=20% Similarity=0.155 Sum_probs=40.3
Q ss_pred CeeEEeecCCCCCcC----CCc-eEEEecCC-CEEEEcCC-CCeEEeecccCCc-----ccceEEEecCCCEEEEcC
Q 003092 87 DTVVWVANRNSPIVD----KNG-VLTVSNRG-NLVLLNQS-NGTIWSSNVSREV-----KNPVAQLLDNGNLVIRDN 151 (848)
Q Consensus 87 ~~~vW~an~~~p~~~----~~~-~l~~~~~g-~lvl~~~~-~~~~W~t~~~~~~-----~~~~a~l~d~GNlVl~~~ 151 (848)
..++|...+..+..+ .++ .+....++ .++..|.+ |.++|........ ....+.++.+||+++.+.
T Consensus 155 G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~~ 231 (276)
T 3no2_A 155 GQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICNW 231 (276)
T ss_dssp SCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEEE
T ss_pred CCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEec
Confidence 588999887532211 122 33334433 47777887 9999998743211 123357889999999873
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.53 E-value=0.22 Score=55.94 Aligned_cols=60 Identities=12% Similarity=0.130 Sum_probs=18.0
Q ss_pred eeeeecccCCccEEEEEecC-CceEEE------EEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeee
Q 003092 529 IQSKLGEGGFGPVYKGRLLN-GQEVAV------KRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~~-~~~vAv------K~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~ 591 (848)
+.++|| ||.||+|.+.. ..+||| |..... ..+....|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 99999998754 368898 766542 2233456888999999999999999988764
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=80.15 E-value=0.52 Score=39.14 Aligned_cols=47 Identities=28% Similarity=0.473 Sum_probs=37.1
Q ss_pred CCCCccccCcCCCccccC--CCCCccccCCCCccCCCCCCcccccCCCCCCC
Q 003092 300 PDPFCHYGDCGPNSICSV--DQTSHCECLEGFKFKSQQNQTCVRSHSSDCKS 349 (848)
Q Consensus 300 ~~~~C~yg~CG~~g~C~~--~~~~~C~Cl~Gf~~~~~~~~gC~r~~~l~C~~ 349 (848)
+...|.+..|+.|+.|-. +....|.|+.||.... ..|++.....|..
T Consensus 3 ~~h~C~~tkcp~NA~Cyr~~dg~EecRCllnykk~~---~kCV~~~~~~C~~ 51 (95)
T 1b9w_A 3 SEHRCIDTNVPENAACYRYLDGTEEWRCLLYFKEDA---GKCVPAPNMTCKD 51 (95)
T ss_dssp GGGSCSSCCCCTTEEEEECTTSCEEEEECTTEEEET---TEEEECTTCCTTT
T ss_pred cCcccccCCCCCCcCeEEEcCCCEEEEEECCeEecC---CEEEcCCCCCccc
Confidence 346787789999999974 4678999999998853 3688888777753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 848 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-26 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-22 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 9e-71
Identities = 65/284 (22%), Positives = 133/284 (46%), Gaps = 19/284 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+G + ++ ++ SL L K + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 702
IIHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 703 -EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
+ +S +SDV++FG+++ E+++ + ++ + + + L + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805
+ P ++ + C+++ ++RP +++ I +LP
Sbjct: 234 VRSNCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-67
Identities = 76/273 (27%), Positives = 125/273 (45%), Gaps = 21/273 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L++E+M + L +L ++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+IHRDL A N L+ ++ K+SDFGM R D+ ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
+S KSDV+SFGVLM E+ S K ++S + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRLAST- 229
Query: 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ C +E EDRP S ++ +
Sbjct: 230 ------HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-67
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 21/275 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL + +I EYM N SL FL P+ L + + IA+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E + +PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
F++KSDV+SFG+L+ EI++ + + + + + +R + ++ P +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRP---DNC 235
Query: 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + LC +E EDRPT + S++ +
Sbjct: 236 PEEL----YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 1e-65
Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 21/273 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + +H Q + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+ +HRDL A N L++ K+SDFG++R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
FS KSD+++FGVLM EI S K + ++ + + L P L +E
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNSETAEHIAQGLRLYRPHLASE- 228
Query: 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ + C E A++RPT ++S I
Sbjct: 229 ------KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-65
Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 21/286 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L + ++ EYM SL FL T K+L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764
F++KSDV+SFG+L+ E+ + + + + + L + +R + + P E
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCP---PEC 239
Query: 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
+ ++ C ++ E+RPT + + + + + +P
Sbjct: 240 PESL----HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-64
Identities = 62/298 (20%), Positives = 120/298 (40%), Gaps = 29/298 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+Q +G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 585 RLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + L+ +Y + SL +L ++ + + +++ A GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 641 HQ-----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTY 693
H + I HRDLK+ NIL+ ++ I+D G+A D + VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 694 GYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-----NLLGH 742
YM+PE + + ++D+++ G++ EI G++
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 743 AWSLCKNDRAHELMDPVLQNEV-SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + + + P + N S L + C N R T + ++
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 3e-63
Identities = 76/311 (24%), Positives = 131/311 (42%), Gaps = 36/311 (11%)
Query: 515 FSFASVTAATENFS---------IQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 560
F+F A F+ I+ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
+ + ++F +E ++ + H N++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 681 ELQGNTKRIVG---TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF 737
+G + +PE F+ SDV+S+G++M E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 738 NLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI 797
+ N ++ + + + L C Q++ RP +V+ +
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 798 NNELFNLPSPK 808
+ + N S K
Sbjct: 288 DKMIRNPNSLK 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (538), Expect = 6e-63
Identities = 70/276 (25%), Positives = 130/276 (47%), Gaps = 21/276 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ IHRDL A N L+ ++ K++DFG++R+ GD + + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763
FS+KSDV++FGVL+ EI + + + + +EL++ + E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236
Query: 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + C Q N DRP+ +++
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-62
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 31/282 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + +LG ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+HRDL A N+L+ + K+SDFG+ + E + +PE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763
FS KSDV+SFG+L+ EI S G L + K + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYS----FGRVPYPRIPLKDVVPRVEKGYK------MDAPDG 224
Query: 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI----NNEL 801
+ V C +A RP+ + + +EL
Sbjct: 225 CPPAV----YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-62
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 39/301 (12%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 580
++F S+LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L K + Q+ ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKK------NTGVYNTDSFNLLGHAWSLCKNDRAHE 754
+SV+SD++S G+ ++E+ + + + G A R
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 755 LMDPVLQNEVSLPMLVRYINVALL----------------------CVQENAEDRPTMSD 792
+ PM + + ++ C+ +N +R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 793 V 793
+
Sbjct: 295 L 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-62
Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 26/294 (8%)
Query: 523 ATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
+N I +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L + +VRL+G C + +L+ E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-IVGTYGYM 696
YL + +HRDL A N+LL KISDFG+++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
+PE FS +SDV+S+GV M E LS + + K +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFI 225
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
+ + E + C EDRP V + ++L S E
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-60
Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 44/305 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK------------------ 618
L H N+V LLG C G LI+EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 619 --HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
++L ++ + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736
D +M+PE EG++++KSDV+S+G+L+ EI S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-------- 265
Query: 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+ + ++L+ + + + C ++ RP+ ++ S
Sbjct: 266 -----PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 797 INNEL 801
+ +L
Sbjct: 321 LGCQL 325
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 9e-60
Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D+ K L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 700 YAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
L EG + K DV+S G+ +E+ + N + + + +N+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPLFNMNAMSALYHIAQNES----- 231
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795
P LQ+ +++ C+Q+ +DRPT ++
Sbjct: 232 -PALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (516), Expect = 1e-59
Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L ++ + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL----------------- 620
+ N+V+LLG C L++EYM L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 621 ----LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
L ++ I +A G+ YL + + +HRDL N L+ ++M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736
+ +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------P 242
Query: 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSM 796
+ + H + + L P L + N+ LC + DRP+ + +
Sbjct: 243 YYGMAHEEVIYYVRDGNILACP---ENCPLEL----YNLMRLCWSKLPADRPSFCSIHRI 295
Query: 797 I 797
+
Sbjct: 296 L 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-59
Identities = 67/300 (22%), Positives = 112/300 (37%), Gaps = 39/300 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---------------L 621
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741
+M+PE V++ +SDV+S+G+ + E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
+ + + ++++ + ++ C + RPT +V +I ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 25/287 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ G E + L EY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 703 EGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
F + DV+S G+++ +L G D + +S K + + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808
+ + + + EN R T+ D+ + +N P K
Sbjct: 234 SAP--------LALLHKILVENPSARITIPDIK---KDRWYNKPLKK 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 65/278 (23%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ L + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 639 YLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H+ S ++HRDLK +N+ LD N K+ DFG+AR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
SPE ++ KSD++S G L+ E+ + +F+ A + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYEL-----CALMPPFTAFSQKELAGKIREGKF----- 231
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVV 794
+ S + + + RP++ +++
Sbjct: 232 -RRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 7e-59
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 28/287 (9%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L N++ E E ++ +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ +VR++G C E +L+ E L+ +L + + + + ++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMK 121
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK-RIVGTYGYMS 697
YL + +HRDL A N+LL KISDFG+++ DE + + +
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
PE FS KSDV+SFGVLM E S + + K +++
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLE 224
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNL 804
+ ++ LC + E+RP + V + N +++
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-58
Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 27/275 (9%)
Query: 532 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 587 LGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LG C+ +G +++ YM + L F+ + T + + + + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEYALE 703
+ +HRDL A N +LD+ K++DFG+AR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763
F+ KSDV+SFGVL+ E+++ N L + R L+ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRR---LLQP---EY 258
Query: 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798
P+ V L C AE RP+ S++VS I+
Sbjct: 259 CPDPL----YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 73/308 (23%), Positives = 131/308 (42%), Gaps = 40/308 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ LI + M L + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL R++HRDL A N+L+ + KI+DFG+A++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
E L +++ +SDV+S+GV + E+++ + +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMI--------------NNELFNL 804
+ + + + C +A+ RP +++ +E +L
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 805 PSPKEPPF 812
PSP + F
Sbjct: 289 PSPTDSNF 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 60/276 (21%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + ++ E+ ++D + + + L + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+IIHRDLKA NIL + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 703 -----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
+ + K+DV+S G+ ++E+ N + + K++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMA-----EIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
+ + C+++N + R T S +
Sbjct: 239 SRWSSNF--------KDFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-58
Identities = 68/277 (24%), Positives = 128/277 (46%), Gaps = 30/277 (10%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNL 583
++G G F VYKG EVA L ++ + + FK E ++ LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 584 VRLLGCCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
VR + +L+ E M + +L +L + ++ ++ I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 640 LHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
LH + IIHRDLK NI + + KI D G+A + K ++GT +M+P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
E E + DV++FG+ MLE+ +S+ ++ +A + + R + P
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYR--RVTSGVKP 231
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795
++V++P + + C+++N ++R ++ D+++
Sbjct: 232 ASFDKVAIPEV---KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 4e-58
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 26/291 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + K V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMS 697
YL + +HRDL A NIL++ ++ K+SDFG++R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
PE F+ SDV+SFG++M E+++ + + N + ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIN 227
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPK 808
+ + + + C Q+ RP +D+VS+++ + S K
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 3e-57
Identities = 68/279 (24%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+ + ++ N+V L + E ++ EY+ S L D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754
+M+PE + K D++S G++ +E++ G + N L + + N
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI-----EGEPPYLNENPLRALYLIATNGT--- 233
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
P LQN L + R + C+ + E R + ++
Sbjct: 234 ---PELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-57
Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 580
E+F I LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++RL G + LI EY ++ L +K Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760
+ K D++S GVL E L K + + E +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFEANTYQETYKRIS 217
Query: 761 QNEVSLPMLV--RYINVALLCVQENAEDRPTMSDVVS 795
+ E + P V ++ ++ N RP + +V+
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 71/285 (24%), Positives = 109/285 (38%), Gaps = 35/285 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + ++ E SL L LLG R +A+G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGM 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NTKRIVGTYGYM 696
YL R IHRDL A N+LL KI DFG+ R ++ + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
+PE FS SD + FGV + E+ + + +++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLNGSQIL 224
Query: 757 DPVLQNEVSLPMLVRY----INVALLCVQENAEDRPTMSDVVSMI 797
+ + LP NV + C EDRPT + +
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 78/324 (24%), Positives = 132/324 (40%), Gaps = 43/324 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQLR 626
H N++ LLG C +G L EY + +L FL + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL 746
+M+ E V++ SDV+S+GVL+ EI+S + + A
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------TPYCGMTCAELY 236
Query: 747 CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPS 806
K + + L P + ++ C +E +RP+ + ++ +N L
Sbjct: 237 EKLPQGYRLEKP---LNCDDEV----YDLMRQCWREKPYERPSFAQILVSLNRML----- 284
Query: 807 PKEPPFTTFTKGKNMKYSSNSTSG 830
+ + T + Y+ S
Sbjct: 285 EERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-54
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 26/280 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E +I E L F +K+ L + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L R +HRD+ A N+L+ + K+ DFG++R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
F+ SDV+ FGV M EIL GV + +R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILM----HGVKPFQGVKNNDVIGRIENGER------LP 229
Query: 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + ++ C + RP +++ + ++
Sbjct: 230 MPPNCPPTL----YSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 33/302 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRII 630
++VRLLG + ++I E M L +L +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
IA G+ YL+ + +HRDL A N ++ + KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKND 750
+MSPE +GVF+ SDV+SFGV++ EI + + + N+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242
Query: 751 RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEP 810
+ + + + +C Q N + RP+ +++S I E+ P +E
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM--EPGFREV 300
Query: 811 PF 812
F
Sbjct: 301 SF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-53
Identities = 74/299 (24%), Positives = 114/299 (38%), Gaps = 38/299 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 577 KLQHRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLF-------------DPTKKHLLG 622
H N+V LLG C + G +++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ + +A+G+ +L + IHRDL A NILL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742
+M+PE + V++++SDV+SFGVL+ EI S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245
Query: 743 AWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801
K D L C RPT S++V + N L
Sbjct: 246 FCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 70/298 (23%), Positives = 121/298 (40%), Gaps = 40/298 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------------L 621
+ +H+N++ LLG C + G +I EY +L +L L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ V +A+G+ YL + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741
T +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------------- 235
Query: 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799
+ + +L+ + + + C RPT +V ++
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 30/275 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
V+L + + Y N L ++ A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYT---AEIVSAL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
IIHRDLK NILL++ M+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760
E SD+++ G ++ ++++ + + + ++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRAGNEYLIFQKII 223
Query: 761 QNEVSLP--MLVRYINVALLCVQENAEDRPTMSDV 793
+ E P + ++ + +A R ++
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (461), Expect = 2e-51
Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 30/311 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ I +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L + E ++IYE+M L + D + + + V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+H DLK NI+ + K+ DFG+ + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
+D++S GVL +LS F +L MD
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS--------PFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDV-----VSMINNELFN--LPSPKEPPFTT 814
+ +S + + + R T+ ++ N + +PS +
Sbjct: 250 SGISEDG----KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305
Query: 815 FTKGKNMKYSS 825
K K +
Sbjct: 306 SIKTKYDAWPE 316
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (443), Expect = 6e-49
Identities = 60/320 (18%), Positives = 115/320 (35%), Gaps = 41/320 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + I +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L ++ E +LI E++ L + + + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+H D+K NI+ + KI DFG+A DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
+D+++ GVL +LS S + E + V +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL------------------SPFAGEDDLETLQNVKR 242
Query: 762 NEVSLPMLVRY------INVALLCVQENAEDRPTMSDVVSM------INNELFNLPSPKE 809
+ + +Q+ R T+ D + +N +PS +
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY 302
Query: 810 PPFTTFTKGKNMKYSSNSTS 829
K K + + +
Sbjct: 303 NKIRQKIKEKYADWPAPQPA 322
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 6e-47
Identities = 54/295 (18%), Positives = 104/295 (35%), Gaps = 24/295 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + K+G G FG +Y G + G+EVA+K ++ + E + +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+ C +G+ ++ ++ SL+ ++K + + + D + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---S 121
Query: 646 LRIIHRDLKASNIL---LDQHMNPKISDFGMARMFGGDELQGN-----TKRIVGTYGYMS 697
IHRD+K N L + I DFG+A+ + + K + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757
L S + D+ S G +++ + S K E++
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPF 812
+E C +D+P S + + N + F
Sbjct: 242 KGYPSEF--------ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 4e-46
Identities = 61/337 (18%), Positives = 124/337 (36%), Gaps = 45/337 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L E ++I+E++ + + T L + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761
V S +D++S G L+ +LS + + ++++ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI------------------NPFLAETNQQIIENIMN 217
Query: 762 NEVSLPMLVRY------INVALLCVQENAEDRPTMSDV---------VSMINNELFNLPS 806
E + ++ + + + R T S+ + ++ ++
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLK 277
Query: 807 PKEPPFTTFTKGKNMKYSSNSTSGTSEFCSVNDVTVS 843
+ T K NM S+ S S V+V+
Sbjct: 278 HRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVA 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-46
Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 22/289 (7%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
++ S +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N++ + + + Y+V + L+ K L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
++HRDLK SN+LL+ + KI DFG+AR+ D V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 701 ALEGVFSVKS-DVFSFGVLMLEILSSK-----KNTGVYNTDSFNLLG----HAWSLCKND 750
L KS D++S G ++ E+LS++ K+ +LG + N
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 751 RAHE-LMDPVLQNEVSLPMLVRYINVALL-----CVQENAEDRPTMSDV 793
+A L+ +N+V L + L + N R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 1e-45
Identities = 65/280 (23%), Positives = 115/280 (41%), Gaps = 28/280 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 579
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 580 HRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H +V + + ++ EY+ +L + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-GDELQGNTKRIVGTYG 694
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754
Y+SPE A +SDV+S G ++ E+L TG + + A+ + D
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVL-----TGEPPFTGDSPVSVAYQHVREDP--- 231
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-TMSDV 793
+ +S + V L + +N E+R T +++
Sbjct: 232 IPPSARHEGLSADL----DAVVLKALAKNPENRYQTAAEM 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (416), Expect = 3e-45
Identities = 69/274 (25%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 577
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V + + I + M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
++H +++RDLK +NILLD+H + +ISD G+A F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756
PE +GV + +D FS G ++ ++L + T + + DR M
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---------DRMTLTM 224
Query: 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTM 790
L + S P L + +Q + R
Sbjct: 225 AVELPDSFS-PELRSLLE---GLLQRDVNRRLGC 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (410), Expect = 6e-45
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
++F I LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++R+ G + + +I +Y+ L L + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
II+RDLK NILLD++ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKK 727
++ D +SFG+L+ E+L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 8e-45
Identities = 65/316 (20%), Positives = 120/316 (37%), Gaps = 31/316 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L G LI + + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 642 QYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
I+HRDLK N+L D+ ISDFG+++M + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758
E + +S D +S GV+ +L G N + K + D
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILL-----CGYPPFYDENDAKLFEQILKAEYE---FDS 230
Query: 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV-----VSMINNELFNLPSPKEPPFT 813
+++S + ++++ E R T ++ N+
Sbjct: 231 PYWDDISDSA----KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
Query: 814 TFTKGKNMKYSSNSTS 829
K + N+T+
Sbjct: 287 KNFAKSKWKQAFNATA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 8e-45
Identities = 47/299 (15%), Positives = 106/299 (35%), Gaps = 26/299 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ + ++G ++ ++ SL+ L + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN-----TKRIVGTY 693
+++RD+K N L+ + + + DFGM + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753
YMS L S + D+ + G + + L G + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFL-----RGSLPWQGLKAATNKQKYERIGEKK 232
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSPKEPPF 812
+ +Y++ + P + + + L L + ++ F
Sbjct: 233 QSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 9e-44
Identities = 64/275 (23%), Positives = 100/275 (36%), Gaps = 33/275 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H L + + + EY+ L + H I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH I++RDLK NILLD+ + KI+DFGM + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
L ++ D +SFGVL+ E+L + S EL +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------------------SPFHGQDEEELFHSI 215
Query: 760 LQNEVSLPMLVRYINVALL--CVQENAEDRPTMSD 792
+ P + LL E R +
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 1e-43
Identities = 58/292 (19%), Positives = 110/292 (37%), Gaps = 50/292 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 574
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 575 IAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ K+ H N+++L L+++ M L +L T+K L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + LH +L I+HRDLK NILLD MN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 694 GYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747
Y++PE + + + D++S GV+M +L+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------------------PPF 215
Query: 748 KNDRAHELMDPVLQNEVSLPMLVR------YINVALLCVQENAEDRPTMSDV 793
+ + ++ ++ ++ + + R T +
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-43
Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 27/292 (9%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 575
A + + +++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD---VFLFDPTKKHLLGWQLRVRIIDG 632
+H N+VRL C +V + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +GL +LH R++HRDLK NIL+ K++DFG+AR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN-TGVYNTDSFNLL--------GHA 743
Y +PE L+ ++ D++S G + E+ K G + D +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 744 WSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALL--CVQENAEDRPTMSDV 793
W Q + + LL C+ N R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 5e-43
Identities = 59/285 (20%), Positives = 117/285 (41%), Gaps = 24/285 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+L + +L++E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
R++HRDLK N+L+++ KI+DFG+AR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 703 -EGVFSVKSDVFSFGVLMLEILSSK-------------KNTGVYNTDSFNLLGHAWSLCK 748
+S D++S G + E+++ + + T + + L K
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
D + +P+ + I++ ++ + R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 24/286 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LL + + L++E++ D + + L + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE-Y 700
+ R++HRDLK N+L++ K++DFG+AR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK-------------KNTGVYNTDSFNLLGHAWSLC 747
+S D++S G + E+++ + + T + S+
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
+ ++V P+ ++ + + R +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-42
Identities = 67/323 (20%), Positives = 119/323 (36%), Gaps = 44/323 (13%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 585 RLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
RL GEK L+ +Y+ V K L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 639 YLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
Y+H I HRD+K N+LLD K+ DFG A+ E + + + Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDS--------FNLLGHAWSLCK 748
PE ++ DV+S G ++ E+L + ++ DS +LG
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 749 NDRAHELMDPVLQNEVSLPMLVRY--------INVALLCVQENAEDRPTMSDV-----VS 795
+ + + P + I + ++ R T +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 796 MINNELFNLPS-PKEPPFTTFTK 817
+ + LP+ P FT
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTT 330
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 31/300 (10%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 585
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LL + L++++M +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-G 704
I+HRDLK +N+LLD++ K++DFG+A+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 705 VFSVKSDVFSFGVLMLEILSSK-----KNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759
++ V D+++ G ++ E+L + T F LG D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 760 LQNEVSLPMLVRYINVA-----LL--CVQENAEDRPTMSDVVSMINNELF-NLPSPKEPP 811
++ +P+ + L+ N R T + + + F N P P
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGPTPGC 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 58/299 (19%), Positives = 107/299 (35%), Gaps = 50/299 (16%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 579
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 580 --HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++RLL +LI E T++ L +L + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 697 SPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755
PE+ + V+S G+L+ +++ E
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------------IPFEH 212
Query: 756 MDPVLQNEVSLPMLV--RYINVALLCVQENAEDRPTMSDVVSMINNELF-NLPSPKEPP 811
+ +++ +V V ++ C+ DRPT ++ N+ ++ P+E
Sbjct: 213 DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI---QNHPWMQDVLLPQETA 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 60/286 (20%), Positives = 105/286 (36%), Gaps = 44/286 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 577
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+QH N++ L + + ILI E + L +K L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFGGDELQGNTKRIVGTY 693
++ L+I H DLK NI+L P KI DFG+A K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753
+++PE +++D++S GV+ +LS D
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS------------------PFLGDTKQ 222
Query: 754 ELMDPVLQNEVSLPMLVR------YINVALLCVQENAEDRPTMSDV 793
E + V + + ++ + R T+ D
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 66/317 (20%), Positives = 130/317 (41%), Gaps = 40/317 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 582 NLVRLLGCCIEQGEKI--------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
N+V L+ C + L++++ + + K R++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVG 691
GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLL--------G 741
T Y PE L E + D++ G +M E+ + G L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 742 HAWSLCKNDRAHELMDPVLQNEVSLPMLVRY-------INVALLCVQENAEDRPTMSDVV 794
W N +E ++ V + + ++ +++ + + R D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA- 302
Query: 795 SMINNELF-NLPSPKEP 810
+N++ F + P P +
Sbjct: 303 --LNHDFFWSDPMPSDL 317
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 51/279 (18%), Positives = 104/279 (37%), Gaps = 30/279 (10%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+++ + S+ LG G G V + ++ A+K L + + + E+ L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 582 NLVRLLGCC----IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++VR++ + +++ E + L + D + + I+ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYG 694
YLH + I HRD+K N+L K++DFG A+ T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754
Y++PE + D++S GV+M + G S + L + + R +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDV 793
P + + I ++ R T+++
Sbjct: 234 YEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 56/286 (19%), Positives = 113/286 (39%), Gaps = 24/286 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+VRL + L++E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++HRDLK N+L++++ K+++FG+AR F G ++ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTDSFNLLGHAWSLCKNDRAHELMD-- 757
++S D++S G + E+ ++ + G D + ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 758 -----PVLQNEVSLPMLVRYINVALL-----CVQENAEDRPTMSDV 793
P+ SL +V +N ++ N R + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-38
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
L L + EY L L + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+++RD+K N++LD+ + KI+DFG+ + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+ + D + GV+M E++ +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 67/308 (21%), Positives = 122/308 (39%), Gaps = 32/308 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 582 NLVRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ LL + Y+V + L K LG ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H IIHRDLK N+ +++ KI DFG+AR + V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 701 ALEGV-FSVKSDVFSFGVLMLEILSSK-----KNTGVYNTDSFNLLG----HAWSLCKND 750
L + ++ D++S G +M E+++ K + + + G ++D
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 751 RAHELMDPVLQNE-VSLPMLVRYINVALL-----CVQENAEDRPTMSDVVSMINNELF-N 803
A M + + E ++ + + + +AE R T + + + F +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA---LAHPYFES 306
Query: 804 LPSPKEPP 811
L ++ P
Sbjct: 307 LHDTEDEP 314
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-36
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LV+L + ++ EY+ + L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H L +I+RDLK N+L+DQ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
L ++ D ++ GVL+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 30/278 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 576
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 577 KLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ LV L + + LI +Y+ L L + Q+ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
+L L +L II+RD+K NILLD + + ++DFG+++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 696 MSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753
M+P+ G D +S GVLM E+L+ F + G S + R
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS--------PFTVDGEKNSQAEISRRI 248
Query: 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMS 791
+P E+S + I + ++ + R
Sbjct: 249 LKSEPPYPQEMS-ALAKDLIQ---RLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-33
Identities = 50/297 (16%), Positives = 115/297 (38%), Gaps = 43/297 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 582
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 583 LVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + + L++E++ N L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 641 HQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
H + I+HRD+K N+++D +H ++ D+G+A + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 700 YALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS------FNLLGHAWSLCKNDRA 752
++ ++ D++S G ++ ++ K+ + + +LG D+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 753 HELMDPVLQNEVSLPMLVRYINVALL----------------CVQENAEDRPTMSDV 793
+ +DP + + R+ ++ + + R T +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 6e-32
Identities = 75/309 (24%), Positives = 120/309 (38%), Gaps = 32/309 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
E + S +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 581 RNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
N++ LL Y+V + L + K L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
+H IIHRDLK SN+ +++ KI DFG+AR V T Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPE 188
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSK-------------KNTGVYNTDSFNLLGHAWS 745
L + ++ D++S G +M E+L+ + + T LL S
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALL--CVQENAEDRPTMSDVVSMINNELF- 802
+ L N ++ + + V LL + +++ R T + + + F
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA---LAHAYFA 305
Query: 803 NLPSPKEPP 811
P + P
Sbjct: 306 QYHDPDDEP 314
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 581
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 582 NLVRLLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
N++ LL Q + L+ E M V + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
G+ +LH IIHRDLK SNI++ KI DFG+AR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+PE L + D++S G +M E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 8e-29
Identities = 40/215 (18%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 586 LLGCCIEQGEKILIY-------------EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
K+L + + V + L + + +I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVG 691
+ GL Y+H+ R IIH D+K N+L++ + +A + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y SPE L + +D++S L+ E+++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (259), Expect = 4e-26
Identities = 31/158 (19%), Positives = 63/158 (39%), Gaps = 20/158 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAK 577
+I +GEG V+ E VK ++ + S + +K F + A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ R L +L G + + +Y + N ++ + L D + + + + ++D I + +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I+H DL N+L+ I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 91.6 bits (227), Expect = 1e-22
Identities = 24/118 (20%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 50 IRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVS 109
+ +GE L Q ++ + ++ + ++ T VW +N K +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58
Query: 110 NRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GN V+ + ++W+S+ R N V L ++GN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 71.2 bits (174), Expect = 1e-15
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L F + ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
++ L++ GNLV+ N SN IW+SN + N V L + N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 162 WQSFDY 167
W + +
Sbjct: 102 WATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.8 bits (168), Expect = 1e-14
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 80 IWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVA 138
I Y D + + L++ NLVL ++ + +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFD--YPTDTML 173
L NG + + N +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.6 bits (126), Expect = 6e-09
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 5/110 (4%)
Query: 43 TLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDK 102
L T + + +Q +L + + + ++ + D VW N+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWS--TNTAGKGT 66
Query: 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNS 152
+ G + +L N +W+S SR V L + NL I +
Sbjct: 67 GCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.7 bits (167), Expect = 1e-14
Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGKAS 50
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 51 GC--VLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQSFDYPTD 170
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.3 bits (164), Expect = 4e-14
Identities = 21/138 (15%), Positives = 43/138 (31%), Gaps = 22/138 (15%)
Query: 30 IFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTV 89
I + L T + ++ + + + + Y +
Sbjct: 3 IIFSKQPDDNHPQILHAT----ESLEILFGTHVYRFIMQTDCNL------VLYD--NNNP 50
Query: 90 VWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIR 149
+W N + G LV++ N T+W S V+ + + V L + N+VI
Sbjct: 51 IWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108
Query: 150 DNSGSNSTESYLWQSFDY 167
++ LW +
Sbjct: 109 GDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.2 bits (130), Expect = 2e-09
Identities = 29/130 (22%), Positives = 43/130 (33%), Gaps = 22/130 (16%)
Query: 35 IKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVAN 94
I F L+ + P TL ++L S F S + ++ D VW +N
Sbjct: 3 ILFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASN 51
Query: 95 RNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGS 154
+ + G LV+L N WSS + N V L + + I
Sbjct: 52 TAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG-- 106
Query: 155 NSTESYLWQS 164
LW S
Sbjct: 107 ------LWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 848 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.84 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.66 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.63 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.54 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.5 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.36 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.05 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.94 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.69 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.02 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.53 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.87 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.71 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.37 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.01 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=415.20 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=203.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||+|+.. +++.||||+++... .+..+++.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999975 58999999997543 33456789999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999884 3456899999999999999999999987 99999999999999999999999999998754443
Q ss_pred ccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||............. ..... .
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~--------~ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT--------Y 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCT--------T
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCC--------C
Confidence 334455789999999999998876 578999999999999999999986443221111100 00000 0
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001122346788999999999999999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=416.21 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=199.0
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 579999999999999999999988899999999753 3456789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999988753 3356889999999999999999999987 999999999999999999999999999877544322
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+.... .. ......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i----~~---------~~~~~~ 223 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDI----ST---------GFRLYK 223 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHH----HH---------TCCCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHH----Hh---------cCCCCC
Confidence 223357999999999999999999999999999999999965443221111 1111100 00 000111
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+.....++.+++..||+.||++||||+||++.|+++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1222347889999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=419.43 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=204.7
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||+||+|++. ..||||+++.. ..+..++|++|+.+|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 468999999999999999999863 46999998654 34567889999999999999999999998754 56899999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+++|+|.+++... ...+++..+..++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999988542 345899999999999999999999987 9999999999999999999999999998776544
Q ss_pred cccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.........||+.|||||++.+ ..|+.++|||||||++|||+||+.||........ +. ...... ...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~----~~~~~~----~~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----FMVGRG----YLSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH----HHHHHT----SCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HH----HHHhcC----CCCC
Confidence 4444456789999999999864 4589999999999999999999999864332211 00 000000 0111
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
.+. ......+.++.+++.+||+.||++||||.||++.|+.+..++|
T Consensus 230 ~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 110 1112233578899999999999999999999999988765555
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-49 Score=419.66 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=211.9
Q ss_pred HHhcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 522 ~~~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
...++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+.+|++++|||||++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44578999999999999999999976 4889999999754 345678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++... ....+++..+..++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999998888542 3356899999999999999999999987 999999999999999999999999999977544
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
... ......||+.|+|||++.++.|+.++|||||||++|||++|+.|+....... .+. +.+....
T Consensus 169 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~-------------~~i~~~~ 233 (287)
T d1opja_ 169 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVY-------------ELLEKDY 233 (287)
T ss_dssp SSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHH-------------HHHHTTC
T ss_pred Cce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHH-------------HHHhcCC
Confidence 322 2223568999999999999999999999999999999999777653221110 110 0111111
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+.....++.+++..||+.||++||||.||++.|+..+
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11122223457889999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=415.66 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=206.5
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
.++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|+++|++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4689999999999999999999988889999999754 3456789999999999999999999998754 5678999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|.+++... ....+++..+.+|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999998876432 3345899999999999999999999987 999999999999999999999999999987654322
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......||+.|||||++.++.++.++|||||||++|||+||+.|+....... .+.... .. ...+ .
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~~i----~~-----~~~~----~ 230 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL----ER-----GYRM----V 230 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH----HT-----TCCC----C
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHHHH----Hh-----cCCC----C
Confidence 2223578999999999999999999999999999999999766643222111 111000 00 0011 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.+.....++.+++.+||+.||++||||.||+++|++.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1122334688999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=407.15 Aligned_cols=245 Identities=26% Similarity=0.348 Sum_probs=204.5
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||+||+|+.. +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 5889999998643 2344677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++. +...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999988884 3456899999999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||...+... .... . ... +.
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~---i-~~~------~~-- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKR---I-SRV------EF-- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH---H-HTT------CC--
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHHH---H-HcC------CC--
Confidence 2 334679999999999999999999999999999999999999986432111 1100 0 000 00
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.....++.+++..||+.||++|||+.|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111123346889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=410.54 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=206.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999864 58999999998766666788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999988763 346899999999999999999999987 99999999999999999999999999998754332
Q ss_pred cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. ........ .. + .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~---~~~~~~~~-~~-----~--~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL---YLIATNGT-PE-----L--Q 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHHCS-CC-----C--S
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HH---HHHHhCCC-CC-----C--C
Confidence 2334679999999999999999999999999999999999999985432211 00 00000000 00 0 1
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+......+.+++..||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223457889999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-48 Score=416.87 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=198.2
Q ss_pred cCcceeeeecccCCccEEEEEecC-C---ceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~---~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.++||+|+||+||+|++.. + ..||||++... .....++|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568889999999999999998753 3 25899988654 344567899999999999999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|..++.. ....+++..+.+++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999987753 3346899999999999999999999987 99999999999999999999999999987754
Q ss_pred Ccccc---ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccc
Q 003092 680 DELQG---NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 680 ~~~~~---~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
..... ......||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+.... ..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i----~~------ 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAI----EQ------ 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHH----HT------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHH----Hc------
Confidence 33221 1222458999999999999999999999999999999998 89987543221 111000 00
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
......+......+.+++.+||+.||++||||.||++.|++++.
T Consensus 249 ---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 00111222334578899999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=403.57 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=210.2
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.++||+|+||+||+|+++++++||||+++... ...++|++|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999997643 346789999999999999999999999999999999999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999888643 3456889999999999999999999987 999999999999999999999999999877554332
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +... ..... ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~---i~~~~----------~~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEH---IAQGL----------RLY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHH---HHTTC----------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHH---HHhCC----------CCC
Confidence 2333579999999999999999999999999999999998 788886544221 1110 00000 001
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINN 799 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 799 (848)
.+.....++.+++..||+.||++|||+.||++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111223478899999999999999999999998854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=417.68 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=207.2
Q ss_pred HhcCcceeeeecccCCccEEEEEecC-C-----ceEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~-~-----~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.++||+|+||+||+|++.. + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34789999999999999999998653 2 36999998654 334457789999999998 8999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCCc--------------------ccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccC
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTK--------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlk 654 (848)
..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999998854321 245899999999999999999999987 9999999
Q ss_pred CCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCC
Q 003092 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (848)
Q Consensus 655 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~ 733 (848)
|+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ |+.||...+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655443333345678999999999999999999999999999999998 899986543
Q ss_pred CCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHh
Q 003092 734 TDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMIN 798 (848)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 798 (848)
.... + ....... .....+.....++.+++..||+.||++|||++||+++|.
T Consensus 272 ~~~~-~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN-F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH-H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH-H----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3211 0 0011111 111112223457889999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=409.87 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=205.0
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEecc
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~ 604 (848)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||++++++. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 689999999999999999999988889999999654 345678999999999999999999999985 456899999999
Q ss_pred CCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcccc
Q 003092 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (848)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 684 (848)
+|+|..++... ....++|..++.++.||++||+|||+++ |+||||||+||||++++++||+|||+++........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99998877432 2345899999999999999999999987 999999999999999999999999999876543322
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccccCC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEV 764 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 764 (848)
......||+.|+|||++..+.++.++||||||+++|||++|+.|+....... .+.... .. ......
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i----~~---------~~~~~~ 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV----ER---------GYRMPC 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH----HT---------TCCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHH----Hh---------cCCCCC
Confidence 2233579999999999999999999999999999999999776653322111 111110 00 011112
Q ss_pred CHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCC
Q 003092 765 SLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLP 805 (848)
Q Consensus 765 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 805 (848)
+.....++.+++.+||+.||++||+|.+|+++|++.+...+
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 22334578899999999999999999999999998866554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=406.61 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=207.3
Q ss_pred hcCcceee-eecccCCccEEEEEec---CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~-~LG~G~fG~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 36778887 4999999999999764 24579999997653 3456789999999999999999999999864 56899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|.+++.. ....+++..+.+++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999988743 3346899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcc-ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCcccccc
Q 003092 679 GDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 679 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.... ........||+.|||||++.++.++.++|||||||++|||+| |+.||....... +... ...+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~----i~~~~----- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAF----IEQGK----- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHH----HHTTC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcCC-----
Confidence 5432 222334578999999999999999999999999999999998 899986443221 1110 01110
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+...+.++.+++..||+.||++||||.+|++.|+...
T Consensus 230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01122233457889999999999999999999999997654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=408.34 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=193.8
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee--CCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--~~~~~lV 599 (848)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999875 58899999987543 3345678999999999999999999999865 4568999
Q ss_pred EEeccCCcccccccCC-CcccccCHHHHHHHHHHHHHHHHHHHhcCC--CceEecccCCCcEEeccCCCceeeccccccc
Q 003092 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~--~~iiHrDlkp~NILl~~~~~~kl~DFGla~~ 676 (848)
|||+++|+|.+++... .....+++..+..++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999888533 234568999999999999999999998652 3599999999999999999999999999998
Q ss_pred cCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... +... ......
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~----i~~~~~---- 231 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGK----IREGKF---- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH----HHHTCC----
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHH----HHcCCC----
Confidence 754322 2334689999999999999999999999999999999999999986433211 1100 000000
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...+.....++.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0112223457889999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=405.66 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=197.5
Q ss_pred eeecccCCccEEEEEecC---CceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEeccC
Q 003092 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~---~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~~~ 605 (848)
++||+|+||+||+|.+.. ++.||||+++... ....++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998653 4679999997542 3345789999999999999999999999854 567899999999
Q ss_pred CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc-c
Q 003092 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-G 684 (848)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 684 (848)
|+|..++. ....+++..+.+++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99998884 3456899999999999999999999987 999999999999999999999999999977544322 2
Q ss_pred ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccccC
Q 003092 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNE 763 (848)
Q Consensus 685 ~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 763 (848)
......||+.|||||++.+..++.++|||||||++|||++ |+.||....... +... ...+. ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~----i~~~~---------~~~ 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAM----LEKGE---------RMG 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----HHTTC---------CCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHH----HHcCC---------CCC
Confidence 2334579999999999999999999999999999999998 899986433211 1110 01110 011
Q ss_pred CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 764 VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 764 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
.+...+.++.+++.+||+.||++|||+.+|+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1222345788999999999999999999999988765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=406.70 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=199.3
Q ss_pred cCcceeeeecccCCccEEEEEecCC-----ceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
+.|++.++||+|+||.||+|.+... ..||||+++... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688999999999999999987542 369999997543 3345679999999999999999999999999999999
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+.++++..++.. ....+++..+.+++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999998876643 3346899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
..... .......||+.|||||++.++.++.++|||||||++|||++++.|+...... ..+.. .+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~-------------~i~ 227 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMK-------------AIN 227 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHH-------------HHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHH-------------HHh
Confidence 43222 2223356899999999999999999999999999999999976664322111 11110 011
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.......+.....++.+++.+||+.||++||||.||+++|+.++
T Consensus 228 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11111222223457889999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=406.36 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=205.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
+.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999975 58899999998776677788999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999887643 2346899999999999999999999987 9999999999999999999999999997653221
Q ss_pred cceeeeeccccccChhhhh-----cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 684 GNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 684 ~~~~~~~gt~~y~APE~~~-----~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
......+||+.|||||++. +..|+.++|||||||++|||++|+.||...+.... .. ...... ..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~---~i~~~~-~~----- 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LL---KIAKSE-PP----- 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH---HHHHSC-CC-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HH---HHHcCC-CC-----
Confidence 1223467999999999984 45689999999999999999999999864432211 00 000000 00
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+ ..+.....++.+++..||+.||++|||+.|+++
T Consensus 234 ~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 011223457889999999999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=407.68 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=202.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5899999998643 2345678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999988773 4456899999999999999999999987 999999999999999999999999999987654
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.........+||+.|||||++.+..++.++|||||||++|||++|+.||...+... +... .. +.. .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~---i~-~~~------~-- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQK---II-KLE------Y-- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---HH-TTC------C--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHHH---HH-cCC------C--
Confidence 44444455689999999999999999999999999999999999999986432211 1000 00 000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
..+.....++.+++..||+.||++|||+.|++.
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111223346889999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=413.55 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=204.2
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||+||+|+.. +|+.||+|+++... ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 58999999997653 3345678999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-CCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
|+++|+|..++. +...+++..+..++.||+.||+|||+. + |+||||||+||||++++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999884 345689999999999999999999974 5 999999999999999999999999999876322
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc-------------
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC------------- 747 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 747 (848)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..............
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 233468999999999999999999999999999999999999998654322111100000000
Q ss_pred -------c----cCcccccccccccc----CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 -------K----NDRAHELMDPVLQN----EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 -------~----~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .....+..+..... ........++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 00000000000000 000112346889999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-47 Score=409.64 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=212.2
Q ss_pred HHHHHhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHHHcCCCceeeeeeeee
Q 003092 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (848)
Q Consensus 519 ~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~ 591 (848)
+++.+.++|++.++||+|+||+||+|+.. +++.||||+++.... +..++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34456688999999999999999999864 246899999976533 34577999999999999999999999999
Q ss_pred eCCeEEEEEEeccCCcccccccCCC---------------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEe
Q 003092 592 EQGEKILIYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (848)
Q Consensus 592 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (848)
..+..++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999998885321 2234889999999999999999999987 999
Q ss_pred cccCCCcEEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCC-CCC
Q 003092 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNT 729 (848)
Q Consensus 651 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~-~p~ 729 (848)
|||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +|+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998775544444444567999999999999999999999999999999999986 455
Q ss_pred CCCCCCccccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 730 GVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
...+... +... ...+.. ...+...+.++.+++..||+.+|++||||.||+++|++++
T Consensus 244 ~~~~~~e--~~~~----v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE--VIYY----VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH--HHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH--HHHH----HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4332211 1110 011110 0112223347889999999999999999999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=397.39 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=195.3
Q ss_pred cceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee----CCeEEEE
Q 003092 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILI 599 (848)
Q Consensus 527 f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~----~~~~~lV 599 (848)
|++.++||+|+||+||+|++. +++.||+|++... .....+.|.+|+++|++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366779999999999999875 5789999998754 33445779999999999999999999999865 3467999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec-cCCCceeeccccccccC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFG 678 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kl~DFGla~~~~ 678 (848)
|||+++|+|.+++. +...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999998884 3456899999999999999999999875 3599999999999996 57899999999998654
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
.. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||....... .+.... ..... .+
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i----~~~~~----~~ 232 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRV----TSGVK----PA 232 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHH----TTTCC----CG
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHH----HcCCC----Cc
Confidence 32 2345689999999998865 59999999999999999999999985432211 110000 00000 01
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+... ...++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 2235788999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=405.17 Aligned_cols=245 Identities=32% Similarity=0.492 Sum_probs=199.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
+.|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999864 58899999997543 234567899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999876653 3456899999999999999999999987 99999999999999999999999999986543
Q ss_pred ccccceeeeeccccccChhhhhc---CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~---~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.....||+.|||||++.+ +.|+.++|||||||++|||++|+.||....... .. ....... .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~---~~i~~~~------~ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL---YHIAQNE------S 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHSC------C
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HH---HHHHhCC------C
Confidence 234679999999999864 468999999999999999999999985332111 00 0000000 0
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+.+ ........+.+++..||+.||++|||+.|+++
T Consensus 232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 001 11122347889999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-46 Score=405.97 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=206.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 68999999999999999999875 58999999998766666778999999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--cCCCceeeccccccccCCCc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 681 (848)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999888743 2346899999999999999999999987 99999999999995 46789999999999875433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......||+.|||||++.+..++.++|||||||++|||++|+.||...+... ..... ..... . .....
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i---~~~~~--~-~~~~~- 248 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNV---KSCDW--N-MDDSA- 248 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH---HHTCC--C-SCCGG-
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCCC--C-CCccc-
Confidence 2345689999999999999999999999999999999999999986432211 11000 00000 0 00000
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
......++.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 ---FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112346889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=401.68 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=188.5
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999975 58899999997543 2334668899999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec---cCCCceeeccccccccC
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMFG 678 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~ 678 (848)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999988843 456899999999999999999999987 99999999999994 57899999999998764
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDP 758 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 758 (848)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +... ..... .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~---i~~~~-------~ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQ---ILKAE-------Y 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH---HHTTC-------C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHH---HhccC-------C
Confidence 432 2234679999999999999999999999999999999999999986432211 1000 00000 0
Q ss_pred ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 759 VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 759 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............++.+++..||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001111223347889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-46 Score=405.78 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=206.4
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEec
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey~ 603 (848)
++|++.++||+|+||+||+|+.. +|+.||||+++.......+.+++|+.+|++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999874 58999999998765556678899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec--cCCCceeeccccccccCCCc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~ 681 (848)
++|+|.+.+. .....+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999977663 23446899999999999999999999987 99999999999997 67899999999999876433
Q ss_pred cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
......||+.|||||++.+..++.++|||||||++|||++|+.||....... ..... .. . +....
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i---~~-~------~~~~~ 248 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNV---KR-C------DWEFD 248 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH---HH-C------CCCCC
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---Hh-C------CCCCC
Confidence 2345689999999999999999999999999999999999999986433211 10000 00 0 00001
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........++.+++..||+.||++|||+.|+++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111123346889999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=401.83 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=200.5
Q ss_pred HHHHhcCcceeeeecccCCccEEEEEecC------CceEEEEEecccC-cccHHHHHHHHHHHHHc-CCCceeeeeeeee
Q 003092 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (848)
Q Consensus 520 i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~ 591 (848)
++...++|++.++||+|+||.||+|++.. ++.||||+++... ....+++.+|...+.++ +|+||+.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 33455789999999999999999998642 4689999997543 34456788888888887 6899999999987
Q ss_pred eC-CeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCc
Q 003092 592 EQ-GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (848)
Q Consensus 592 ~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~N 657 (848)
+. ...++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ||||||||+|
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N 164 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 164 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence 65 46899999999999999885432 2345899999999999999999999987 9999999999
Q ss_pred EEeccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCC-CCCCCCCCCc
Q 003092 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNTGVYNTDS 736 (848)
Q Consensus 658 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~-~p~~~~~~~~ 736 (848)
|||++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++|. .|+.......
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999998776554444445578999999999999999999999999999999999975 4554332211
Q ss_pred cccccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 737 FNLLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
. +. .....+. .+ ..+.....++.+++.+||+.||++|||+.||++.|++++
T Consensus 245 ~-~~----~~~~~~~-----~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 E-FC----RRLKEGT-----RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H-HH----HHHHHTC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HH----HHHhcCC-----CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 00 0000100 01 111223346889999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=401.46 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=200.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCc----eEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~----~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
++|++.++||+|+||+||+|.+. +|+ +||+|+++.. ..+..++|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999864 343 5899988654 345678899999999999999999999999865 5678
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
++||+.+++|..++.. ....+++..+.+++.||++||+|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999998777643 3456899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
............||+.|||||++.++.++.++|||||||++|||+| |+.|+....... +.. ....
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~----~i~~-------- 228 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEK-------- 228 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHH----HHHH--------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHc--------
Confidence 5544444445679999999999999999999999999999999998 788875433221 100 0000
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
......+.....++.+++.+||+.||++|||+.||++.|+..
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 001111222345788999999999999999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=392.52 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=203.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC------cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+++|+.+|++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 67999999999999999999974 58999999986432 224678999999999999999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC----Cceeecccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGM 673 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kl~DFGl 673 (848)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999998884 3356899999999999999999999987 99999999999998776 499999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .... .. ....
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~---i~-~~~~- 233 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN---VS-AVNY- 233 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---HH-TTCC-
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHH---HH-hcCC-
Confidence 98875433 2234579999999999999999999999999999999999999986432211 0000 00 0000
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+.... .....+.+++..||+.||++|||+.|+++
T Consensus 234 ~-~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E-FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000001 12346789999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=390.97 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=195.1
Q ss_pred hcCcceeeeecccCCccEEEEEecC----CceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~l 598 (848)
.++|++.+.||+|+||.||+|++.. +..||||.++... ....+.|.+|+.+|++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998643 3468999986543 334577999999999999999999999985 567899
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccC
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~ 678 (848)
||||+++|+|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999887642 3446899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccc
Q 003092 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMD 757 (848)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 757 (848)
.... .......||+.|+|||++.+..++.++|||||||++|||++ |..|+....... +.... ....
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i----~~~~------ 226 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI----ENGE------ 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTC------
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHH----HcCC------
Confidence 4332 22334678999999999999999999999999999999998 788875433221 11000 0110
Q ss_pred cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 758 PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 758 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
....+...+.++.+++..||+.||++|||+.||++.|+.++
T Consensus 227 ---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00112223457889999999999999999999999987753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=391.48 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=195.5
Q ss_pred cCcceeeeecccCCccEEEEEecC--C--ceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~--~--~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.+.||+|+||.||+|++.. + .+||||++... ..+..++|.+|+.+|++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998643 2 37899998754 23446789999999999999999999999965 4678
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|++.+.+.. ....+++..+.+++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999998877643 3456899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCccc-cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccc
Q 003092 678 GGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHEL 755 (848)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (848)
...... .......||..|+|||++.+..++.++||||||+++|||++ |+.||...+... .. ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~---~~i~~~~~---- 232 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--IL---HKIDKEGE---- 232 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---HHHHTSCC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HH---HHHHhCCC----
Confidence 544322 22334568899999999999999999999999999999998 899985433221 11 11111110
Q ss_pred cccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 756 MDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 756 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
........+..+.+++..||+.||++||||.||+++|.+.
T Consensus 233 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0011112234688999999999999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=388.84 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=196.7
Q ss_pred hcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC-CeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~-~~~~lV~Ey 602 (848)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||+++++++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 36789999999999999999998 5789999999754 3457899999999999999999999998654 568999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+++|+|.+++... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999988532 2335899999999999999999999987 999999999999999999999999999865432
Q ss_pred ccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
.....+|+.|+|||++.++.++.++||||||+++|||++ |+.|+....... +.... .++ ..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i----~~~---------~~ 218 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----EKG---------YK 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHH----TTT---------CC
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcC---------CC
Confidence 233568999999999999999999999999999999998 677664332211 11110 111 11
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
...+.....++.+++.+||+.||++||||.|++++|++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 112222335788999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=396.72 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=211.4
Q ss_pred HhcCcceeeeecccCCccEEEEEec------CCceEEEEEecccCc-ccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCC
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~ 594 (848)
..++|++.++||+|+||.||+|++. .++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4478999999999999999999863 356899999976533 3456789999999999 6999999999999999
Q ss_pred eEEEEEEeccCCcccccccCCC---------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 595 EKILIYEYMVNKSLDVFLFDPT---------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
..++||||+++|+|..++.... ....+++..+.+++.||++||+|||+++ |+||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999998885432 2335889999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCC-CCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN-TGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p-~~~~~~~~~~ 738 (848)
++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++++.| +...+....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 999999999999999987655444444557899999999999999999999999999999999995544 433222111
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+ .+.++.......+.....++.+++.+||+.||++||||.||+++|++.+
T Consensus 257 ~-------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 F-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H-------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 0 0111111111112223457889999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=394.17 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=208.1
Q ss_pred HhcCcceeeeecccCCccEEEEEecC--------CceEEEEEecccCc-ccHHHHHHHHHHHHHc-CCCceeeeeeeeee
Q 003092 523 ATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (848)
Q Consensus 523 ~~~~f~i~~~LG~G~fG~Vy~~~~~~--------~~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~ 592 (848)
..++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34789999999999999999998533 24799999976543 4467889999999998 79999999999999
Q ss_pred CCeEEEEEEeccCCcccccccCCC-------------cccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEE
Q 003092 593 QGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (848)
Q Consensus 593 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NIL 659 (848)
++..++||||+++|+|.+++.... ....+++..+.+++.||+.||+|||+.+ ||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999885432 1345899999999999999999999987 999999999999
Q ss_pred eccCCCceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCCccc
Q 003092 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNTDSFN 738 (848)
Q Consensus 660 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~ellt-g~~p~~~~~~~~~~ 738 (848)
++.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |..|+.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-- 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence 99999999999999998765554445555789999999999999999999999999999999998 677765333211
Q ss_pred cccccccccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 739 LLGHAWSLCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
+. .....+. ....+.....++.+++.+||+.||++|||+.||+++|++++
T Consensus 246 ~~----~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LF----KLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH----HHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11 1111111 11111223347889999999999999999999999998763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=396.59 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=204.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999974 6899999999753 2345678899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999988873 4456889999999999999999999987 999999999999999999999999999876433
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... +.. ...... .
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~----~i~~~~------~-- 222 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE----LILMEE------I-- 222 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCC------C--
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HHH----HHhcCC------C--
Confidence 2 22344789999999999999999999999999999999999999986433211 100 000000 0
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
..+.....++.+++..||+.||++||+ +.|+++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111223346789999999999999995 777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=392.06 Aligned_cols=270 Identities=23% Similarity=0.302 Sum_probs=200.5
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----eEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----~~~lV~ 600 (848)
++|.+.++||+|+||.||+|++ +|+.||||+++..... ....+.|+..+..++|||||++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5688999999999999999997 6899999999653221 122334555566789999999999998754 679999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhc-----CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
||+++|+|..++.. ..++|..+.+++.|++.||+|||+. +..+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999943 3589999999999999999999974 23469999999999999999999999999998
Q ss_pred ccCCCcc--ccceeeeeccccccChhhhhcCC------CCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 676 MFGGDEL--QGNTKRIVGTYGYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 676 ~~~~~~~--~~~~~~~~gt~~y~APE~~~~~~------~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
....... ........||+.|+|||++.+.. ++.++|||||||+||||++|..|++.................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 7754322 22334568999999999987643 677999999999999999999887543322211111000000
Q ss_pred -----ccCccccccccccccC-CCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcc
Q 003092 748 -----KNDRAHELMDPVLQNE-VSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNE 800 (848)
Q Consensus 748 -----~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 800 (848)
......+.+++.+... ...+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0000111112222111 1233556788999999999999999999999999765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-45 Score=393.00 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=202.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 5899999999753 2345678999999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999888773 4456788888999999999999999987 999999999999999999999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+... .+...+
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------------------~~~~i~ 214 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------------------TYEKIL 214 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------------------HHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------------------HHHHHH
Confidence 234689999999999999999999999999999999999999986432211 001111
Q ss_pred cc--CCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 761 QN--EVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 761 ~~--~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
.+ ..+.....++.+++.+||+.||++|| |+.++++
T Consensus 215 ~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 215 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 10 11122334688999999999999996 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=392.54 Aligned_cols=257 Identities=29% Similarity=0.425 Sum_probs=203.9
Q ss_pred cCcceeeeecccCCccEEEEEecC-Cc--eEEEEEeccc-CcccHHHHHHHHHHHHHc-CCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~-~~--~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.++||+|+||.||+|++.+ +. .||||+++.. .....++|.+|+++|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999998754 43 5788988654 344567899999999999 799999999999999999999
Q ss_pred EEeccCCcccccccCC-------------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCc
Q 003092 600 YEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 666 (848)
|||+++|+|.++++.. .....+++..+.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998653 23457899999999999999999999987 9999999999999999999
Q ss_pred eeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCC-CCCCCCCCcccccccccc
Q 003092 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDSFNLLGHAWS 745 (848)
Q Consensus 667 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~ 745 (848)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. |+...+.. .+...+
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i-- 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL-- 239 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHG--
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHH--
Confidence 999999998654221 2234569999999999999999999999999999999999765 45322211 111100
Q ss_pred ccccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 746 LCKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
... .....+.....++.+++.+||+.||++||||.||++.|+.++.
T Consensus 240 -~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 240 -PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -GGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -Hhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 000 0111122234578899999999999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=389.25 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=201.8
Q ss_pred eeeecccCCccEEEEEecCC----ceEEEEEeccc-CcccHHHHHHHHHHHHHcCCCceeeeeeeeee-CCeEEEEEEec
Q 003092 530 QSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKILIYEYM 603 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~~----~~vAvK~~~~~-~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-~~~~~lV~Ey~ 603 (848)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899999754 44456889999999999999999999999876 46899999999
Q ss_pred cCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCccc
Q 003092 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (848)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 683 (848)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999988753 3345678889999999999999999987 999999999999999999999999999977544322
Q ss_pred c--ceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccccc
Q 003092 684 G--NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVLQ 761 (848)
Q Consensus 684 ~--~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 761 (848)
. ......||+.|+|||++..+.++.++||||||+++|||++|+.|+....... .+.... ..+. .+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i----~~g~-----~~--- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYL----LQGR-----RL--- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH----HTTC-----CC---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHH----HcCC-----CC---
Confidence 2 2223578999999999999999999999999999999999888765322111 111100 0110 00
Q ss_pred cCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCC
Q 003092 762 NEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFN 803 (848)
Q Consensus 762 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 803 (848)
..+.....++.+++.+||+.||++||+|.||++.|++++..
T Consensus 254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01112234688999999999999999999999999888543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=392.63 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=209.9
Q ss_pred hcCcceeeeecccCCccEEEEEec------CCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~ 596 (848)
.++|++.++||+|+||+||+|.+. +++.||||+++... .+....|.+|+.++++++|||||++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478999999999999999999863 25789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCcccccccCC-------CcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 597 ILIYEYMVNKSLDVFLFDP-------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 597 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
++||||+++|+|..++... .....+++..+.+++.|+++||+|||+++ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999998887432 12234688999999999999999999986 9999999999999999999999
Q ss_pred ccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCC-CCCCCCCCCccccccccccccc
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNTGVYNTDSFNLLGHAWSLCK 748 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 748 (848)
|||+|+...............||+.|+|||.+.++.++.++||||||+++|||++|. .|+...+... ..... .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i----~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFV----M 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHH----H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----H
Confidence 999998776554444444567999999999999999999999999999999999985 5554322111 11000 0
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhccc
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNEL 801 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 801 (848)
.... ...+......+.+++..||+.+|++||||.+|+++|++.+
T Consensus 250 ~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0000 0111223347889999999999999999999999998863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=384.36 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=203.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.++|++.++||+|+||+||+|... +++.||||+++... .....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 368999999999999999999875 58899999997643 2345688999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccC--CCceeeccccccccCCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGD 680 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~ 680 (848)
+++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999988843 2346899999999999999999999987 9999999999999854 47999999999876543
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+..++
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------------------~~~~i~ 216 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------------------IIENIM 216 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------------------HHHHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------------------HHHHHH
Confidence 2 2344679999999999999999999999999999999999999986433211 111111
Q ss_pred ccCC--CH----HHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 761 QNEV--SL----PMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 761 ~~~~--~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... +. ....++.+++..||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 11 12346789999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-44 Score=383.38 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=198.7
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----e
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----E 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----~ 595 (848)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.|.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 368999999999999999999864 68999999997543 234567999999999999999999999997654 4
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+++++|..++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999988773 3456899999999999999999999987 9999999999999999999999999987
Q ss_pred ccCCCc-cccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 676 MFGGDE-LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 676 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
...... ........+||+.|||||++.+..++.++|||||||++|||++|+.||........ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~-- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPI-- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCC--
Confidence 664332 22233456899999999999999999999999999999999999999864322110 0000011000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHhcc
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRP-TMSDVVSMINNE 800 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~ 800 (848)
.+. ......+.++.+++.+||+.||++|| |++++++.|...
T Consensus 233 --~~~---~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --CGG---GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CCc---hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 000 01111234688999999999999999 899998877653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-44 Score=390.87 Aligned_cols=244 Identities=21% Similarity=0.274 Sum_probs=203.2
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~ 600 (848)
++|++.++||+|+||.||+|++. +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 5899999998643 2345677899999999999999999999999999999999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 680 (848)
||+.+|+|..++. +...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999988873 3456899999999999999999999987 999999999999999999999999999977532
Q ss_pred ccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccccccc
Q 003092 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPVL 760 (848)
Q Consensus 681 ~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 760 (848)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .+... ... . ..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~---i~~-~--------~~ 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEK---IVS-G--------KV 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH---HHH-C--------CC
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHH---Hhc-C--------CC
Confidence 23468999999999999999999999999999999999999998643211 11000 000 0 00
Q ss_pred ccCCCHHHHHHHHHHHHhccccCcCCCC-----CHHHHHH
Q 003092 761 QNEVSLPMLVRYINVALLCVQENAEDRP-----TMSDVVS 795 (848)
Q Consensus 761 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 795 (848)
..+.....++.+++..||+.||++|+ |+.|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11112334688999999999999994 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.1e-44 Score=377.07 Aligned_cols=250 Identities=23% Similarity=0.293 Sum_probs=202.0
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc---------ccHHHHHHHHHHHHHcC-CCceeeeeeeeeeC
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ 593 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~---------~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~ 593 (848)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999874 689999999875421 12346889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
+..++||||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999884 3456899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhc------CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccccccc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE------GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLC 747 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 747 (848)
++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+... ... ...
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~~---~i~ 228 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLR---MIM 228 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HHH---HHH
Confidence 99875433 2234679999999999863 346889999999999999999999986443211 000 000
Q ss_pred ccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 KNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.... + .........+.++.+++.+||+.||++|||+.||++
T Consensus 229 -~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 -SGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -hCCC-C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 0 001111123457889999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9e-44 Score=391.47 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=196.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC---cccHHHHHHH---HHHHHHcCCCceeeeeeeeeeCCeEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNE---MMLIAKLQHRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E---i~~l~~l~Hpniv~l~~~~~~~~~~~ 597 (848)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999975 58999999986431 2223334444 56666678999999999999999999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999998884 3456789999999999999999999987 999999999999999999999999999977
Q ss_pred CCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELM 756 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (848)
.... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||........... . ..... .
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~-~~~~~------~ 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D-RMTLT------M 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--H-HHSSS------C
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--H-Hhccc------C
Confidence 5432 334579999999999975 5689999999999999999999999865433211100 0 00000 0
Q ss_pred ccccccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 757 DPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 757 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
.. ..+.....++.+++..||+.||++||| +.|+++
T Consensus 225 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 111122346889999999999999999 678764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=382.71 Aligned_cols=257 Identities=25% Similarity=0.296 Sum_probs=193.1
Q ss_pred eeeeecccCCccEEEEEec-CCceEEEEEecccCcc-----cHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 529 i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
.+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4589999999999999975 5899999998654221 135688999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+.++++..+. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998876655 34456888999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc---cccCc---cccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL---CKNDR---AHEL 755 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~---~~~~ 755 (848)
.....+||+.|+|||++... .|+.++|||||||++|||++|+.||....... ........ ..... ....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhcc
Confidence 22335799999999998754 57999999999999999999999985432211 00000000 00000 0000
Q ss_pred ccc-ccc--cCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 756 MDP-VLQ--NEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 756 ~d~-~l~--~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
... ... ...+ .....++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 000 0000 112346889999999999999999999976
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=386.82 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=201.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc---CcccHHHHHHHHHHHH-HcCCCceeeeeeeeeeCCeEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCIEQGEKILI 599 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~---~~~~~~~~~~Ei~~l~-~l~Hpniv~l~~~~~~~~~~~lV 599 (848)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5899999999753 2344566777777765 68999999999999999999999
Q ss_pred EEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCC
Q 003092 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (848)
Q Consensus 600 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 679 (848)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999884 3456889999999999999999999987 99999999999999999999999999987654
Q ss_pred CccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccccccccc
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHELMDPV 759 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 759 (848)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +... .... .+.
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~----i~~~------~~~ 221 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHS----IRMD------NPF 221 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----HHHC------CCC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHH----HHcC------CCC
Confidence 32 22334689999999999999999999999999999999999999986433211 1100 0000 011
Q ss_pred cccCCCHHHHHHHHHHHHhccccCcCCCCCHH-HHHH
Q 003092 760 LQNEVSLPMLVRYINVALLCVQENAEDRPTMS-DVVS 795 (848)
Q Consensus 760 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 795 (848)
.+.....++.+++.+||+.||++||++. |+++
T Consensus 222 ----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1112234688999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=379.02 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=198.6
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+++|++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999974 58999999996542 2346789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 998765544332 23456899999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccc-------ccccccccc-C
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLL-------GHAWSLCKN-D 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~-------~~~~~~~~~-~ 750 (848)
. ......||+.|+|||++....+ +.++|||||||++|||++|+.||...+.... ... ...+..... .
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 2 2233579999999999887664 7899999999999999999999864331110 000 000000000 0
Q ss_pred cccccccccccc---CCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 RAHELMDPVLQN---EVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ~~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
............ ........++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000000 001122346889999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=384.13 Aligned_cols=251 Identities=19% Similarity=0.211 Sum_probs=195.9
Q ss_pred cCcceee-eecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHc-CCCceeeeeeeeee----CCeEE
Q 003092 525 ENFSIQS-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGEKI 597 (848)
Q Consensus 525 ~~f~i~~-~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~Hpniv~l~~~~~~----~~~~~ 597 (848)
++|.+.+ .||+|+||+||+|+.. +++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ +..++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6898875 5999999999999874 5899999998642 5678899987665 89999999999865 45789
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc---CCCceeeccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kl~DFGla 674 (848)
+|||||++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999988542 2346899999999999999999999987 999999999999985 567999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
+....... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ............
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~--- 233 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQ--- 233 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS---
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCC---
Confidence 87754332 2346799999999999999999999999999999999999999854322110 000000000000
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. .+..........++.+++..||+.||++|||+.|+++
T Consensus 234 ~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0000001123457889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-43 Score=374.21 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=200.5
Q ss_pred cCcceeeeecccCCccEEEEEecCCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||+|++.+++.||||+++... ....+++.+|+.+|++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999996543 33467899999999999999999999999999999999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCcc
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 682 (848)
+.++.+..+. .....+++..+..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988877665 33467999999999999999999999987 99999999999999999999999999987654332
Q ss_pred ccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccc---------c--cccccc
Q 003092 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLG---------H--AWSLCK 748 (848)
Q Consensus 683 ~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~---------~--~~~~~~ 748 (848)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.... .... + ......
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334689999999998765 568999999999999999999999864331110 0000 0 000000
Q ss_pred cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 749 NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 749 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.........+.............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000001111122346889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=372.37 Aligned_cols=239 Identities=22% Similarity=0.373 Sum_probs=193.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCc------ccHHHHHHHHHHHHHcC--CCceeeeeeeeeeCCe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQGE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~--Hpniv~l~~~~~~~~~ 595 (848)
++|++.++||+|+||+||+|+.. +++.||||++..... ....++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 67999999999999999999875 589999999875321 12244678999999996 8999999999999999
Q ss_pred EEEEEEeccC-CcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-CCCceeecccc
Q 003092 596 KILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGM 673 (848)
Q Consensus 596 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kl~DFGl 673 (848)
.++||||+.+ +++..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 45555552 3456899999999999999999999987 999999999999985 47899999999
Q ss_pred ccccCCCccccceeeeeccccccChhhhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcc
Q 003092 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRA 752 (848)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 752 (848)
|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +. ..
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~-------~~--- 219 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----II-------RG--- 219 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH-------HC---
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hh-------hc---
Confidence 98754332 234679999999999988776 5779999999999999999999853210 00 00
Q ss_pred ccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 753 HELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 753 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
. ..+... ...++.+++.+||+.||++|||+.|+++
T Consensus 220 ~----~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 Q----VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C----CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 001111 2346889999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=372.56 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=195.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-C-CceEEEEEecccC--cccHHHHHHHHHHHHHc---CCCceeeeeeeeee----
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIE---- 592 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~-~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l---~Hpniv~l~~~~~~---- 592 (848)
.++|++.++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999874 3 5679999986532 22234566788777766 79999999999863
Q ss_pred -CCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecc
Q 003092 593 -QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (848)
Q Consensus 593 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DF 671 (848)
....+++|||+.++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 347899999999987654432 34456889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--cccccc----cc
Q 003092 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLLGHA----WS 745 (848)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~~~~----~~ 745 (848)
|+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||........ .+.... ..
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9998654322 33456899999999999999999999999999999999999999864332110 000000 00
Q ss_pred ccccC-cc-cccccc---ccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKND-RA-HELMDP---VLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~-~~-~~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.+... .. ...... .............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00 000000 0000111122346788999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=365.12 Aligned_cols=262 Identities=19% Similarity=0.263 Sum_probs=196.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeee-eeeeeeCCeEEEEEEe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL-LGCCIEQGEKILIYEY 602 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l-~~~~~~~~~~~lV~Ey 602 (848)
++|++.++||+|+||+||+|++. +++.||||++..... .+++..|++++++++|+|++.. ..+..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999874 589999999875432 2457889999999987765554 5555777889999999
Q ss_pred ccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEec---cCCCceeeccccccccCC
Q 003092 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMFGG 679 (848)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kl~DFGla~~~~~ 679 (848)
+.++.+.... .....+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9655433332 23346899999999999999999999987 99999999999975 456799999999998754
Q ss_pred Cccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCcccc
Q 003092 680 DELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAHE 754 (848)
Q Consensus 680 ~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (848)
.... .......||+.|||||++.+..++.++|||||||++|||++|+.||............. .. ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~--~~-~~~~~-~ 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE--RI-SEKKM-S 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH--HH-HHHHH-H
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH--Hh-hcccC-C
Confidence 3321 22344679999999999999999999999999999999999999986543221110000 00 00000 0
Q ss_pred ccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccC
Q 003092 755 LMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELF 802 (848)
Q Consensus 755 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 802 (848)
...+.+.. ..+.++.+++..||+.+|++||++.++.++|+..+.
T Consensus 235 ~~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00001111 123468889999999999999999999998887644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=372.23 Aligned_cols=259 Identities=21% Similarity=0.260 Sum_probs=193.4
Q ss_pred CcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCCCceeeeeeeeeeC------CeEEE
Q 003092 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKIL 598 (848)
Q Consensus 526 ~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~------~~~~l 598 (848)
+|+..++||+|+||+||+|++. +++.||||++...... +.+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888999999999999999975 5899999999764322 34799999999999999999998643 24789
Q ss_pred EEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-Cceeecccccccc
Q 003092 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (848)
Q Consensus 599 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~ 677 (848)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999998765554432334557899999999999999999999987 99999999999999775 8999999999877
Q ss_pred CCCccccceeeeeccccccChhhhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCCcccccccc----------ccc
Q 003092 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHA----------WSL 746 (848)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----------~~~ 746 (848)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ +.... +..
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhh
Confidence 54332 223579999999999875 4689999999999999999999999864432110 00000 000
Q ss_pred cc----cCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 CK----NDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ~~----~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ......................++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000000011111223346889999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-41 Score=361.06 Aligned_cols=268 Identities=17% Similarity=0.213 Sum_probs=206.3
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcCC-CceeeeeeeeeeCCeEEEEEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~~~~~~~~~~~lV~E 601 (848)
.++|++.++||+|+||+||+|++. +++.||||++..... .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 368999999999999999999965 588999999865432 2457889999999975 899999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEecc-----CCCceeeccccccc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARM 676 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kl~DFGla~~ 676 (848)
|+ +++|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 5788777643 2346889999999999999999999987 999999999999974 57799999999998
Q ss_pred cCCCccc-----cceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCc
Q 003092 677 FGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDR 751 (848)
Q Consensus 677 ~~~~~~~-----~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 751 (848)
+...... ......+||+.|||||++.+..++.++|||||||++|||++|+.||........... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--~~~i~-~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIG-EKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--HHHHH-HHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--HHHHH-hcc
Confidence 7543211 123346799999999999999999999999999999999999999864432211000 00000 000
Q ss_pred cccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHhcccCCCCCC
Q 003092 752 AHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVSMINNELFNLPSP 807 (848)
Q Consensus 752 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p 807 (848)
.. ..-+.+.... +.++.+++..|++.+|++||+++.+.+.|++.+.+....
T Consensus 233 ~~-~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 233 QS-TPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HH-SCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CC-CChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 00 0000111112 246788999999999999999999999988876554433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=362.73 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=194.7
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeee--------C
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--------Q 593 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~--------~ 593 (848)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999974 6899999998644 33446778999999999999999999998855 3
Q ss_pred CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccc
Q 003092 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (848)
Q Consensus 594 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGl 673 (848)
...++||||+.++.+.... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4679999999988776544 33456788899999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccc--cceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cccccc------
Q 003092 674 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHA------ 743 (848)
Q Consensus 674 a~~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~------ 743 (848)
++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9877543322 222335799999999999865 689999999999999999999999864332110 000000
Q ss_pred --ccccccCccccccccccccCCCHH-------HHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 744 --WSLCKNDRAHELMDPVLQNEVSLP-------MLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 744 --~~~~~~~~~~~~~d~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
+...........+..........+ ....+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000000000100000011111 1235678999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-40 Score=359.26 Aligned_cols=256 Identities=18% Similarity=0.283 Sum_probs=196.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeee--CCeEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE--QGEKILIY 600 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~--~~~~~lV~ 600 (848)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999974 5899999999653 3567899999999995 9999999999874 35689999
Q ss_pred EeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCC-CceeeccccccccCC
Q 003092 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGG 679 (848)
Q Consensus 601 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 679 (848)
||+.+++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987654 35889999999999999999999987 99999999999998655 589999999987754
Q ss_pred CccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccc--------cc----
Q 003092 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAW--------SL---- 746 (848)
Q Consensus 680 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~---- 746 (848)
.. ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.|+............... ..
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 33 223457999999999988654 799999999999999999999998654322111000000 00
Q ss_pred ----------cccCccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 747 ----------CKNDRAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 747 ----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........................++.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001111111111223446889999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=353.43 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=200.9
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCCeEEEEEE
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~~~~lV~E 601 (848)
++|++.++||+|+||+||+|++. +++.||||+++... ....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 58899999986543 3346789999999999999999999999999999999999
Q ss_pred eccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccccccCCCc
Q 003092 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (848)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 681 (848)
++.+++|..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999877763 3456789999999999999999999987 9999999999999999999999999998775433
Q ss_pred cccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccc---cccC-------
Q 003092 682 LQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSL---CKND------- 750 (848)
Q Consensus 682 ~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~------- 750 (848)
. ......+++.|+|||++.... ++.++|||||||++|||++|+.|+.........+ ...... ....
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhh
Confidence 2 222346788999999988765 6899999999999999999999864322111100 000000 0000
Q ss_pred ----ccccccc-cccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 751 ----RAHELMD-PVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 751 ----~~~~~~d-~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
....... ..............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00000111223346788999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-41 Score=365.97 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=194.5
Q ss_pred hcCcceeeeecccCCccEEEEEe-cCCceEEEEEecccC-cccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC----eEE
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKI 597 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~----~~~ 597 (848)
+++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999986 468999999997543 334567899999999999999999999987643 345
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccccc
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~~~ 677 (848)
++++|+.+|+|.+++. ...+++..+..++.||++||+|||+++ ||||||||+||||++++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6667778999998883 346899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCccc-cceeeeeccccccChhhhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-ccccccccccccCc---
Q 003092 678 GGDELQ-GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHAWSLCKNDR--- 751 (848)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~APE~~~-~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~--- 751 (848)
...... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||........ ..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443222 2234467999999999985 45678999999999999999999999854321100 00000000000000
Q ss_pred -----cccccccc-cccCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 752 -----AHELMDPV-LQNEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 752 -----~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
........ .....+ .....++.+++..||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 000000 111236789999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=361.52 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=190.0
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEeccc--CcccHHHHHHHHHHHHHcCCCceeeeeeeeeeCC------
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~~~------ 594 (848)
.++|++.++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 368999999999999999999975 5899999999753 2334567899999999999999999999997654
Q ss_pred eEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeeccccc
Q 003092 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (848)
Q Consensus 595 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla 674 (848)
.+++||||+ +.+|..+. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 44555554 3346899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCccccceeeeeccccccChhhhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCCcc-cccccc--------c
Q 003092 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-NLLGHA--------W 744 (848)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~--------~ 744 (848)
+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.|+...+.... ...... +
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876443 2345799999999998865 568999999999999999999999864331110 000000 0
Q ss_pred cccccC-------ccccccccccccCCCHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 745 SLCKND-------RAHELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 745 ~~~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
...... ...+.....+. .........+.+++..||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00000000000 011112346788999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=357.89 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=198.2
Q ss_pred cCcceeeeecccCCccEEEEEec----CCceEEEEEecccC----cccHHHHHHHHHHHHHcCC-CceeeeeeeeeeCCe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~----~~~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~H-pniv~l~~~~~~~~~ 595 (848)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 37899999986432 2345678899999999977 899999999999999
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+.+|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999988874 3345678888999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccccceeeeeccccccChhhhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCCccccccccccccccCccc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHAWSLCKNDRAH 753 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (848)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ..... .
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~---~---- 247 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR---R---- 247 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH---H----
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH---h----
Confidence 76543322 23346799999999999765 3688999999999999999999998644322110 00000 0
Q ss_pred cccccccccCCCHHHHHHHHHHHHhccccCcCCCCC-----HHHHHH
Q 003092 754 ELMDPVLQNEVSLPMLVRYINVALLCVQENAEDRPT-----MSDVVS 795 (848)
Q Consensus 754 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 795 (848)
.... ....+.....++.+++..||+.||++||| ++|+++
T Consensus 248 -~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 -ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 00112223457889999999999999995 788865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=353.99 Aligned_cols=259 Identities=23% Similarity=0.238 Sum_probs=189.1
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee------CCe
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QGE 595 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~------~~~ 595 (848)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+++.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999975 58999999997542 3345678999999999999999999999864 368
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++||||+.++.+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999887665432 34789999999999999999999987 9999999999999999999999999988
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCcc--ccc----ccccccc--
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF--NLL----GHAWSLC-- 747 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~--~~~----~~~~~~~-- 747 (848)
...... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+.... .+. ......+
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 764432 23345799999999999999999999999999999999999999854331110 000 0000000
Q ss_pred ---------cc------CccccccccccccCC---CHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 748 ---------KN------DRAHELMDPVLQNEV---SLPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 748 ---------~~------~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
.. ............... ......++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000001111111111 1224567889999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=357.44 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=192.8
Q ss_pred hcCcceeeeecccCCccEEEEEec-CCceEEEEEecccC--cccHHHHHHHHHHHHHcCCCceeeeeeeeee-----CCe
Q 003092 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-----QGE 595 (848)
Q Consensus 524 ~~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~~~~~~-----~~~ 595 (848)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.+|++++|||||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999864 68999999997543 3345678899999999999999999999863 334
Q ss_pred EEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 596 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5777888899999988832 35899999999999999999999987 9999999999999999999999999997
Q ss_pred ccCCCccccceeeeeccccccChhhhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCCcc-c-ccccc-------cc
Q 003092 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSF-N-LLGHA-------WS 745 (848)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~-~-~~~~~-------~~ 745 (848)
.... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.... . +.... ..
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6532 223457999999999987765 58999999999999999999999854331110 0 00000 00
Q ss_pred ccccCccccccccccc-cCCC-----HHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 003092 746 LCKNDRAHELMDPVLQ-NEVS-----LPMLVRYINVALLCVQENAEDRPTMSDVVS 795 (848)
Q Consensus 746 ~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 795 (848)
................ .... .....++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000000000000 0000 112346789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-35 Score=324.44 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=190.3
Q ss_pred cCcceeeeecccCCccEEEEEec-CCceEEEEEecccCcccHHHHHHHHHHHHHcC-----------CCceeeeeeeeee
Q 003092 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCIE 592 (848)
Q Consensus 525 ~~f~i~~~LG~G~fG~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~~~~~~ 592 (848)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999974 68999999997542 23467788999998886 5789999988865
Q ss_pred C--CeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCC-----
Q 003092 593 Q--GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN----- 665 (848)
Q Consensus 593 ~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~----- 665 (848)
. ...+++++++..+..............+++..+..++.||+.||+|||+.. +|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 3 466777777766544333333345566788999999999999999999822 4999999999999987654
Q ss_pred -ceeeccccccccCCCccccceeeeeccccccChhhhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCCccc-----c
Q 003092 666 -PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN-----L 739 (848)
Q Consensus 666 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~ksDVwSlGvvl~elltg~~p~~~~~~~~~~-----~ 739 (848)
++|+|||.+...... ....+||+.|+|||++....++.++||||+||+++||++|+.||......... +
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 899999999865322 23467999999999999999999999999999999999999998643321100 0
Q ss_pred ccccccc-----------------cccC----ccccc----ccccc--ccCCCHHHHHHHHHHHHhccccCcCCCCCHHH
Q 003092 740 LGHAWSL-----------------CKND----RAHEL----MDPVL--QNEVSLPMLVRYINVALLCVQENAEDRPTMSD 792 (848)
Q Consensus 740 ~~~~~~~-----------------~~~~----~~~~~----~d~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 792 (848)
......+ .... ..... ..... ..........++.+++..||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 0000000 0000 00000 00000 11234456778999999999999999999999
Q ss_pred HHH
Q 003092 793 VVS 795 (848)
Q Consensus 793 vl~ 795 (848)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1e-22 Score=202.22 Aligned_cols=164 Identities=18% Similarity=0.188 Sum_probs=121.2
Q ss_pred ceeeeecccCCccEEEEEecCCceEEEEEecccCc------------------ccHHHHHHHHHHHHHcCCCceeeeeee
Q 003092 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (848)
Q Consensus 528 ~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~Ei~~l~~l~Hpniv~l~~~ 589 (848)
.+.++||+|+||+||+|+..+|++||||+++.... .....+..|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46799999999999999988899999998753210 012334568889999999999988765
Q ss_pred eeeCCeEEEEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcCCCceEecccCCCcEEeccCCCceee
Q 003092 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (848)
Q Consensus 590 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kl~ 669 (848)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998876433 233445679999999999999987 9999999999999865 48999
Q ss_pred ccccccccCCCccccceeeeeccccccChh-----hhhcCCCCcccceeehHHHH
Q 003092 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLM 719 (848)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~APE-----~~~~~~~~~ksDVwSlGvvl 719 (848)
|||+|........ ..|.... ....+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999976543221 0111111 02246788999999975443
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.86 E-value=5.3e-22 Score=176.25 Aligned_cols=107 Identities=25% Similarity=0.367 Sum_probs=95.2
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.+||.|.+|+.|. +|.|.|.|+.+|| |.|+.. .++||.||++.| +..+.|.|+.||+|||++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999996 5999999999998 777653 589999999987 56678999999999999999
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCC
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 167 (848)
|.+||++++.......+|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987777777899999999999964 38999987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=7.1e-22 Score=177.15 Aligned_cols=112 Identities=25% Similarity=0.422 Sum_probs=97.3
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
+|+|.|||.|.+|+.|+| |.|.|+|+.+|| |.++. ..++||.||++.| ...+.|.|+.||+|||+++
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 489999999999999986 999999999997 77765 3599999999987 4567899999999999996
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcc
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTD 170 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtD 170 (848)
+.++|++++........|+|+||||||||+.++ .++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~-----~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTS-----CEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCCC-----cEEecCCCccCC
Confidence 567888887766667789999999999998653 689999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.84 E-value=2.8e-21 Score=171.56 Aligned_cols=108 Identities=22% Similarity=0.366 Sum_probs=93.8
Q ss_pred cccCCCCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCC
Q 003092 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (848)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~ 120 (848)
.|+|.|||.|.+|+.|.+ |.|.|+|+.+|+ |.++. ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 378999999999999986 889999999987 66654 35899999999984 45788999999999999999
Q ss_pred CCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCC
Q 003092 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (848)
Q Consensus 121 ~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~ 167 (848)
|.+||+|+++.....+.|+|+||||||||+. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999987666677899999999999963 49999865
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=2.1e-16 Score=141.58 Aligned_cols=101 Identities=19% Similarity=0.365 Sum_probs=84.0
Q ss_pred cccCCCCeE--EcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEE
Q 003092 48 TLIRDGETL--VSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIW 125 (848)
Q Consensus 48 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W 125 (848)
|.|.+++.| .+..|.|.|.|+.+|| |.++ + ..++||.||+..+ +..+.|.|+.||+|||+|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 455566655 5579999999999998 6553 3 3589999999876 4568999999999999999999999
Q ss_pred eecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccC
Q 003092 126 SSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFD 166 (848)
Q Consensus 126 ~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd 166 (848)
++++.+......++|+||||||||++ .+|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 99988776777889999999999963 5999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=3.2e-16 Score=140.88 Aligned_cols=101 Identities=21% Similarity=0.283 Sum_probs=85.6
Q ss_pred EEEEecC-CCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCc
Q 003092 79 GIWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST 157 (848)
Q Consensus 79 ~iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~ 157 (848)
.|||..+ ..+.+|++|+++|+....-+|.|+.||||||++. +.++|++++.+....+.|.|+++|||||++.++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~---- 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN---- 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC----
Confidence 5888877 5689999999999988788999999999999985 678999998877777889999999999998753
Q ss_pred ccccccccCCCcccccccCccccccccCCcceEEeeCCCCCCCCCceEEEeecccCcEE
Q 003092 158 ESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQV 216 (848)
Q Consensus 158 ~~~~WqSFd~PtDtlLpg~klg~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~ 216 (848)
++|||||. +.++|.|.+.++++|..-+
T Consensus 86 -~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 86 -IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp -EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred -CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 78999973 2356788999999997654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=3.4e-15 Score=132.64 Aligned_cols=99 Identities=22% Similarity=0.328 Sum_probs=82.8
Q ss_pred CcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEEe
Q 003092 47 TTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWS 126 (848)
Q Consensus 47 ~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~ 126 (848)
.|.|.+|+.|. +|.|.|.|+.+|+ |.++. ..++||.+|+.. ...+.+.|+.||||||+|.++.+||+
T Consensus 14 ~~tl~~~~~l~--~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 14 PQTLHAAQSLE--LSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CSCCCTTCEEC--STTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred cceecCCCcEE--cCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEE
Confidence 36777777774 5889999999998 77754 358899999864 34678999999999999999999999
Q ss_pred ecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccC
Q 003092 127 SNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFD 166 (848)
Q Consensus 127 t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd 166 (848)
+.+......++++|++|||||||+. .+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEECS--------EEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeCC--------CeecCCC
Confidence 9998777778899999999999953 4899853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.50 E-value=8e-15 Score=130.18 Aligned_cols=109 Identities=22% Similarity=0.255 Sum_probs=87.7
Q ss_pred EEEecC-CCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcc
Q 003092 80 IWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158 (848)
Q Consensus 80 iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~ 158 (848)
|||.-. ..+..|..+.++++.....+|.|+.||||||++ .+.++|++++.+. .+..|.|+|+|||||++.++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~~~----- 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQN----- 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTTT-----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEccCC-----
Confidence 555533 557789999999998888899999999999998 5789999998754 45678999999999998754
Q ss_pred cccccccCCCcccccccCccccccccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 159 SYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 159 ~~~WqSFd~PtDtlLpg~klg~~~~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
.+||||+- +.++|.|.+.++++|... +| +.++|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence 78999763 346799999999999854 45 347898764
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.36 E-value=7.1e-13 Score=118.67 Aligned_cols=99 Identities=20% Similarity=0.327 Sum_probs=79.5
Q ss_pred CCcccCCCCeEEcCCCeEEEeeeCCCCCCCcEEEEEEecCCCeeEEeecCCCCCcCCCceEEEecCCCEEEEcCCCCeEE
Q 003092 46 PTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIW 125 (848)
Q Consensus 46 ~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~lvl~~~~~~~~W 125 (848)
+.+.|.+++.|. .|.|.|.|..+|+ |.|+. ...+||.++... .+..+.+.|+.+|||||+|.++.++|
T Consensus 22 ~~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCCB--CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCeeE--cCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 345566666664 4779999999887 66653 357899998754 35668899999999999999999999
Q ss_pred eecccCCcccceEEEecCCCEEEEcCCCCCCcccccccc
Q 003092 126 SSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (848)
Q Consensus 126 ~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqS 164 (848)
++++........++|++|||||||+. .+|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 99998777777889999999999953 48986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.05 E-value=3.3e-10 Score=99.22 Aligned_cols=86 Identities=24% Similarity=0.392 Sum_probs=65.4
Q ss_pred ceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCccccccc
Q 003092 104 GVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLR 183 (848)
Q Consensus 104 ~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~ 183 (848)
-+|.|+.||||||++ .+.+||++++.+....+.+.|+++|||||++.++ ++||+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g-----~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSN-----KPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEEC-------------------
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCc-----cceEEc-------------------
Confidence 457899999999997 5689999998877667788999999999998764 788975
Q ss_pred cCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 184 TGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 184 t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
......+.|.+.++.+|..-+ +. .+.|.++.
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~t 106 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVI--YG--TDRWATGT 106 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEE--EE--CCCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEE--eC--CCcccCCC
Confidence 112235678888888887654 43 34676653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=1.4e-09 Score=96.50 Aligned_cols=85 Identities=25% Similarity=0.315 Sum_probs=65.8
Q ss_pred eEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccccc
Q 003092 105 VLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRT 184 (848)
Q Consensus 105 ~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~~t 184 (848)
.|.|+.||||||+++ +.++|++++.+....+.+.|+++|||||++.++ .+||+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g-----~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCC-----cEEEECC-------------------
Confidence 588999999999975 568999998877667789999999999998764 6788752
Q ss_pred CCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 185 GLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 185 ~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
..-+.|.|.+.++.+|...+ |. .+.|.+|.
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred ------------CcCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 11235678899999987654 42 46787763
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.69 E-value=3.6e-08 Score=85.97 Aligned_cols=86 Identities=28% Similarity=0.388 Sum_probs=63.8
Q ss_pred ceEEEecCCCEEEEcCCCCeEEeecccCCc-ccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 104 GVLTVSNRGNLVLLNQSNGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 104 ~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~-~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
-.|.|+.||||||+. .+.+||++++.... .++.+.|+++|||||++.++ .++|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~s------------------ 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-----RSLWAS------------------ 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS-----CEEEEC------------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC-----cEEEEE------------------
Confidence 567899999999986 66899999987543 35668999999999998754 778986
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcCCceeeccCC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~~~~y~~sg~ 230 (848)
......|.|.+.++.+|... ++. .+.|.|+.
T Consensus 77 -------------~t~~~~~~~~l~L~ddGNlv--ly~--~~~W~S~t 107 (109)
T d1kj1a_ 77 -------------HSVRGNGNYVLVLQEDGNVV--IYG--SDIWSTGT 107 (109)
T ss_dssp -------------CCCCCSSCCEEEECTTSCEE--EEC--CEEEECCC
T ss_pred -------------eeECCCCCEEEEEeCCCcEE--EEC--CCEecCCC
Confidence 11113467888999888764 343 35787654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.61 E-value=6.7e-08 Score=84.85 Aligned_cols=88 Identities=25% Similarity=0.418 Sum_probs=65.0
Q ss_pred CceEEEecCCCEEEEcCCCCeEEeecccCCcccceEEEecCCCEEEEcCCCCCCcccccccccCCCcccccccCcccccc
Q 003092 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (848)
Q Consensus 103 ~~~l~~~~~g~lvl~~~~~~~~W~t~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~~WqSFd~PtDtlLpg~klg~~~ 182 (848)
.-.|.|+.||||||++ .+.+||++++.....++.+.|+.+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 3568899999999997 578999999877666677899999999999853 455643
Q ss_pred ccCCcceEEeeCCCCCCCCCceEEEeecccCcEEEEEcC-CceeeccCC
Q 003092 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNG-SAKYTCTGP 230 (848)
Q Consensus 183 ~t~~~~~l~Sw~s~~dps~G~fs~~~d~~g~~q~~~~~~-~~~y~~sg~ 230 (848)
...-..|.+.+.++.+|... +++. ..+.|.|+.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCC
Confidence 22223467889999988764 3443 456787653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=2.6e-07 Score=94.01 Aligned_cols=148 Identities=17% Similarity=0.118 Sum_probs=103.9
Q ss_pred HHHHHhcCcceeeeecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcC-CCceeeeeeeeeeCCeEE
Q 003092 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKI 597 (848)
Q Consensus 519 ~i~~~~~~f~i~~~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~~~~~~~~~~~ 597 (848)
++....+.|++.+..+-++...||+... +++.+.||+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555567788766544444568998864 56678899887655445556788999988884 444677888888888999
Q ss_pred EEEEeccCCcccccccCCCcccccCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 003092 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS--------------------------------- 644 (848)
Q Consensus 598 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------- 644 (848)
+||+++++..+....... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998775433111 112334555666666666421
Q ss_pred -----------------------CCceEecccCCCcEEeccCCCceeecccccc
Q 003092 645 -----------------------RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 645 -----------------------~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799999885
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.4e-05 Score=80.27 Aligned_cols=130 Identities=18% Similarity=0.167 Sum_probs=87.8
Q ss_pred eecccCC-ccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCC--CceeeeeeeeeeCCeEEEEEEeccCCcc
Q 003092 532 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (848)
Q Consensus 532 ~LG~G~f-G~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~~~~~~~~~~~lV~Ey~~~gsL 608 (848)
.+..|.. +.||+....++..+.+|...... ...+..|+..++.+.. -.+.+++.+..+++..++|||++++..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 5555654 57899988778888999865433 2346778888888743 3356778888888889999999998776
Q ss_pred cccccCCCcccccCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 003092 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ---------------------------------------------- 642 (848)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~---------------------------------------------- 642 (848)
..... . ...++.++++.|+-||.
T Consensus 94 ~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 44210 0 01122233333333332
Q ss_pred -----c----CCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 643 -----Y----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 643 -----~----~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
. .+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12348999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.40 E-value=0.00019 Score=76.90 Aligned_cols=76 Identities=11% Similarity=0.137 Sum_probs=49.8
Q ss_pred eeeecccCCccEEEEEecC-CceEEEEEeccc-------CcccHHHHHHHHHHHHHcC-C--CceeeeeeeeeeCCeEEE
Q 003092 530 QSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCIEQGEKIL 598 (848)
Q Consensus 530 ~~~LG~G~fG~Vy~~~~~~-~~~vAvK~~~~~-------~~~~~~~~~~Ei~~l~~l~-H--pniv~l~~~~~~~~~~~l 598 (848)
.+.||.|....||+....+ ++.|+||.-... .+....+...|++.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999998654 678999975421 1123445667888888773 3 335555544 4556689
Q ss_pred EEEeccCCc
Q 003092 599 IYEYMVNKS 607 (848)
Q Consensus 599 V~Ey~~~gs 607 (848)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.19 E-value=0.00057 Score=71.00 Aligned_cols=135 Identities=15% Similarity=0.124 Sum_probs=80.7
Q ss_pred CccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCce--eeee-----eeeeeCCeEEEEEEeccCCcccc
Q 003092 538 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL-----GCCIEQGEKILIYEYMVNKSLDV 610 (848)
Q Consensus 538 fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~ 610 (848)
--.||+++..+|+.|++|+.+... ...+++..|+..+..|...++ +..+ .....++..+.+++++++..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 357999999899999999986542 245778889999988853322 1111 12245667889999998765432
Q ss_pred cc------------------c--CCCcccccCH-------------------HHHHHHHHHHHHHHHHHHh----cCCCc
Q 003092 611 FL------------------F--DPTKKHLLGW-------------------QLRVRIIDGIAQGLLYLHQ----YSRLR 647 (848)
Q Consensus 611 ~l------------------~--~~~~~~~l~~-------------------~~~~~i~~qia~~L~yLH~----~~~~~ 647 (848)
.- . ........++ .....+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 10 0 0000111111 1111222223333333332 22446
Q ss_pred eEecccCCCcEEeccCCCceeecccccc
Q 003092 648 IIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 648 iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
+||+|+.|.|||++++ ..++||+-+.
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999754 4589999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0051 Score=65.31 Aligned_cols=73 Identities=21% Similarity=0.271 Sum_probs=49.6
Q ss_pred eeecccCCccEEEEEecCC--------ceEEEEEecccCcccHHHHHHHHHHHHHcCCCce-eeeeeeeeeCCeEEEEEE
Q 003092 531 SKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYE 601 (848)
Q Consensus 531 ~~LG~G~fG~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~~~~~~~~~~~lV~E 601 (848)
+.|+.|-.-.+|++...++ +.|.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 6788888889999987542 3466666542 2 233455789999998853344 467776642 58999
Q ss_pred eccCCccc
Q 003092 602 YMVNKSLD 609 (848)
Q Consensus 602 y~~~gsL~ 609 (848)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99886653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.02 E-value=0.039 Score=56.00 Aligned_cols=157 Identities=12% Similarity=0.003 Sum_probs=82.9
Q ss_pred eHHHHHHHhcCcceee-----eecccCCccEEEEEecCCceEEEEEecccCcccHHHHHHHHHHHHHcCCCce--eeeee
Q 003092 516 SFASVTAATENFSIQS-----KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLG 588 (848)
Q Consensus 516 ~~~~i~~~~~~f~i~~-----~LG~G~fG~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni--v~l~~ 588 (848)
+.+++.....+|.+.+ .|..|---+.|+.+..+| .+++|+..... ..+++..|++++..|.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 3455666666776643 344566677899887555 58999986532 23455667778877753322 22111
Q ss_pred ------eeeeCCeEEEEEEeccCCccccccc--------------------CCC--cccc----------------cCHH
Q 003092 589 ------CCIEQGEKILIYEYMVNKSLDVFLF--------------------DPT--KKHL----------------LGWQ 624 (848)
Q Consensus 589 ------~~~~~~~~~lV~Ey~~~gsL~~~l~--------------------~~~--~~~~----------------l~~~ 624 (848)
+.........++.++.+......-. ... .... ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 1223455667777766544322110 000 0000 0000
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCceEecccCCCcEEeccCCCceeecccccc
Q 003092 625 LRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (848)
Q Consensus 625 ~~~~i~~qia~~L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kl~DFGla~ 675 (848)
.....+..+...+.-.+. .-+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 223469999999999999988777899999885
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.53 E-value=0.13 Score=34.24 Aligned_cols=30 Identities=30% Similarity=0.674 Sum_probs=24.3
Q ss_pred CCccccCcCCCccccCC-CCCccccCCCCcc
Q 003092 302 PFCHYGDCGPNSICSVD-QTSHCECLEGFKF 331 (848)
Q Consensus 302 ~~C~yg~CG~~g~C~~~-~~~~C~Cl~Gf~~ 331 (848)
|.|....|...|.|... ..-.|.|++||.-
T Consensus 1 D~C~~~PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTTTCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCCCCCCCCCcEEECCCCCEEEECCCCCCc
Confidence 56877889999999854 4568999999954
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.87 E-value=0.13 Score=34.26 Aligned_cols=30 Identities=20% Similarity=0.554 Sum_probs=24.3
Q ss_pred CCccccCcCCCccccCC-CCCccccCCCCcc
Q 003092 302 PFCHYGDCGPNSICSVD-QTSHCECLEGFKF 331 (848)
Q Consensus 302 ~~C~yg~CG~~g~C~~~-~~~~C~Cl~Gf~~ 331 (848)
|.|....|...|.|... ..-.|.|++||.-
T Consensus 2 d~C~~~PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECVSNPCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTTTCCCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCcCCCCCCCCEEECCCCCEEEeCCCCCcc
Confidence 67878889999999854 4458999999954
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.71 E-value=0.24 Score=31.38 Aligned_cols=31 Identities=32% Similarity=0.627 Sum_probs=23.3
Q ss_pred CCc-cccCcCCCccccCC-CCCccccCCCCccCC
Q 003092 302 PFC-HYGDCGPNSICSVD-QTSHCECLEGFKFKS 333 (848)
Q Consensus 302 ~~C-~yg~CG~~g~C~~~-~~~~C~Cl~Gf~~~~ 333 (848)
|.| .-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 678 667888 6788743 344799999999864
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.37 E-value=0.23 Score=32.10 Aligned_cols=30 Identities=30% Similarity=0.561 Sum_probs=24.0
Q ss_pred CCccccCcCCCccccCC-CCCccccCCCCcc
Q 003092 302 PFCHYGDCGPNSICSVD-QTSHCECLEGFKF 331 (848)
Q Consensus 302 ~~C~yg~CG~~g~C~~~-~~~~C~Cl~Gf~~ 331 (848)
|.|....|...|.|... ..-+|.|++||.-
T Consensus 1 d~C~~~PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 1 DECASSPCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp CTTTTCCSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCCCCCCCCCCcEEECCCCCeEEECCCCCCC
Confidence 56878889999999743 4568999999963
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.01 E-value=0.24 Score=33.50 Aligned_cols=29 Identities=24% Similarity=0.666 Sum_probs=23.0
Q ss_pred CCc-c-ccCcCCCccccCC-CCCccccCCCCc
Q 003092 302 PFC-H-YGDCGPNSICSVD-QTSHCECLEGFK 330 (848)
Q Consensus 302 ~~C-~-yg~CG~~g~C~~~-~~~~C~Cl~Gf~ 330 (848)
++| . ...|..+|.|... ..-.|.|++||.
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 668 3 6789999999754 345899999996
|